0001165527-13-000168.txt : 20130214 0001165527-13-000168.hdr.sgml : 20130214 20130214143201 ACCESSION NUMBER: 0001165527-13-000168 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130214 DATE AS OF CHANGE: 20130214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stevia Corp CENTRAL INDEX KEY: 0001439813 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 980537233 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53781 FILM NUMBER: 13612054 BUSINESS ADDRESS: STREET 1: 7117 US 31 S CITY: INDIANAPOLIS STATE: IN ZIP: 46227 BUSINESS PHONE: 888-250-2566 MAIL ADDRESS: STREET 1: 7117 US 31 S CITY: INDIANAPOLIS STATE: IN ZIP: 46227 FORMER COMPANY: FORMER CONFORMED NAME: Interpro Management Corp DATE OF NAME CHANGE: 20110307 FORMER COMPANY: FORMER CONFORMED NAME: Stevia Corp. DATE OF NAME CHANGE: 20110303 FORMER COMPANY: FORMER CONFORMED NAME: INTERPRO MANAGEMENT CORP. DATE OF NAME CHANGE: 20080711 10-Q 1 g6626.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2012 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number 000-53781 STEVIA CORP. (Name of registrant as specified in its charter) Nevada 98-0537233 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification Number) 7117 US 31 S, Indianapolis, IN 46227 (Address of Principal Executive Offices) (Zip Code) (888) 250-2566 (Registrant's telephone number) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered ------------------- ----------------------------------------- None None Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [ ] No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X] Yes [ ] No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Non-accelerated filer [ ] Accelerated filer [ ] Large accelerated filer [ ] Smaller Reporting company [X] (Do not check if smaller reporting company) Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. Class Outstanding at January 18, 2013 ----- ------------------------------- Common stock, $.001 par value 66,555,635 STEVIA CORP. FORM 10-Q DECEMBER 31, 2012 INDEX PAGE ---- PART I - FINANCIAL INFORMATION Item 1. Financial Statements................................................. 4 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations................................................39 Item 3. Quantitative and Qualitative Disclosures About Market Risk...........41 Item 4. Controls and Procedures..............................................42 PART II - OTHER INFORMATION Item 1. Legal Proceedings....................................................42 Item 1A. Risk Factors.........................................................42 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds..........43 Item 3. Defaults Upon Senior Securities......................................43 Item 4. Mine Safety Disclosures..............................................43 Item 5. Other Information....................................................43 Item 6. Exhibits.............................................................43 Signatures....................................................................44 2 FORWARD-LOOKING STATEMENTS This Report on Form 10-Q contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Reference is made in particular to the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, and other forward-looking statements included in this report. Such statements may be identified by the use of forward-looking terminology such as "may," "will," "expect," "believe," "estimate," "anticipate," "intend," "continue," or similar terms, variations of such terms, or the negative of such terms. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Such statements address future events and conditions concerning, among others, capital expenditures, earnings, litigation, regulatory matters, liquidity and capital resources, and accounting matters. Actual results in each case could differ materially from those anticipated in such statements by reason of factors such as future economic conditions, changes in consumer demand, legislative, regulatory and competitive developments in markets in which we operate, results of litigation, and other circumstances affecting anticipated revenues and costs, and the risk factors set forth under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 31, 2012, filed on June 29, 2012. As used in this Form 10-Q, "we," "us" and "our" refer to Stevia Corp., which is also sometimes referred to as the "Company." YOU SHOULD NOT PLACE UNDUE RELIANCE ON THESE FORWARD LOOKING STATEMENTS The forward-looking statements made in this report on Form 10-Q relate only to events or information as of the date on which the statements are made in this report on Form 10-Q. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this report and the documents that we reference in this report, including documents referenced by incorporation, completely and with the understanding that our actual future results may be materially different from what we expect or hope. 3 PART I--FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS Stevia Corp. December 31, 2012 and 2011 Index to the Consolidated Financial Statements Contents Page(s) -------- ------- Consolidated Balance Sheets at December 31, 2012 (Unaudited) and March 31, 2012................................................................5 Consolidated Statements of Operations for the Nine and Three Months Ended December 31, 2012, for the Period from April 11, 2011 (Inception) through December 31, 2011 and for the Three Months Ended December 31, 2011 (Unaudited)...................................................................6 Consolidated Statement of Equity (Deficit) for the Period from April 11, 2011 (Inception) through December 31, 2012 (Unaudited).............................7 Consolidated Statements of Cash Flows for the Nine Months Ended December 31, 2012 and for the Period from April 11, 2011 (Inception) through December 31, 2011 (Unaudited) ................................................8 Notes to the Consolidated Financial Statements (Unaudited).....................9 4 Stevia Corp. Consolidated Balance Sheets
December 31, March 31, 2012 2012 ------------ ------------ (Unaudited) ASSETS CURRENT ASSETS: Cash $ 5,978 $ 15,698 Accounts receivable 120,659 -- Prepayments and other current assets 26,016 168,874 ------------ ------------ TOTAL CURRENT ASSETS 152,653 184,572 ------------ ------------ NON-CURRENT ASSETS: Property and equipment 7,925 3,036 Accumulated depreciation (762) -- ------------ ------------ Property and equipment, net 7,163 3,036 Acquired technology 1,635,300 -- Accumulatd amortization (54,510) -- ------------ ------------ Acquired technology, net 1,580,790 -- Website development costs 5,315 5,315 Accumulated amortization (1,602) (801) ------------ ------------ Website development costs, net 3,713 4,514 ------------ ------------ Security deposit 15,000 15,000 ------------ ------------ TOTAL ASSETS $ 1,759,319 $ 207,122 ============ ============ LIABILITIES AND EQUITY (DEFICIT) CURRENT LIABILITIES: Accounts payable $ 627,929 $ 237,288 Accounts payable - President and CEO 41,689 20,220 Accrued expenses 11,445 5,400 Accrued interest 28,178 15,521 Advances from president and significant stockholder 21,238 19,138 Convertible notes payable 400,000 700,000 ------------ ------------ TOTAL CURRENT LIABILITIES 1,130,479 997,567 ------------ ------------ NON-CURRENT LIABILITIES: Derivative liability 106,561 -- ------------ ------------ TOTAL NON-CURRENT LIABILITIES 106,561 -- ------------ ------------ TOTAL LIABILITIES 1,237,040 997,567 ------------ ------------ EQUITY (DEFICIT) Stevia Corp stockholders' equity (deficit): Preferred stock at $0.001 par value: 1,000,000 shares authorized; none issued or outstanding -- -- Common stock at $0.001 par value: 100,000,000 shares authorized, 63,555,635 and 58,354,775 shares issued and outstanding, respectively 63,556 58,355 Additional paid-in capital 4,222,085 1,474,751 Accumulated deficit (3,666,024) (2,323,551) ------------ ------------ TOTAL STEVIA CORP STOCKHOLDERS' EQUITY (DEFICIT) 619,617 (790,445) ------------ ------------ Non-controlling interest in subsidiary (97,338) -- ------------ ------------ TOTAL EQUITY (DEFICIT) 522,279 (790,445) ------------ ------------ TOTAL LIABILITIES AND EQUITY (DEFICIT) $ 1,759,319 $ 207,122 ============ ============
See accompanying notes to the consolidated financial statements. 5 Stevia Corp. Consolidated Statements of Operations
For the Period from For the For the April 11, 2011 For the Nine Months Three Months (inception) Three Months Ended Ended through Ended December 31, December 31, December 31, December 31, 2012 2012 2011 2011 ------------ ------------ ------------ ------------ (Unaudited) (Unaudited) (Unaudited) (Unaudited) REVENUES $ 120,939 $ 8,142 $ 1,300 $ -- COST OF REVENUES Farm expenses 66,743 66,743 -- -- Farm field lease 21,250 6,250 -- -- Farm management services - related party 652,550 60,000 120,000 60,000 ------------ ------------ ------------ ------------ TOTAL COST OF REVENUES 740,543 132,993 120,000 60,000 ------------ ------------ ------------ ------------ Gross margin (619,604) (124,851) (118,700) (60,000) OPERATING EXPENSES: Directors' fees 281,250 93,750 93,750 93,750 Professional fees 352,031 123,356 117,183 73,454 Research and development 118,669 -- 144,369 39,172 Salary and compensation - officer -- -- 750,000 750,000 Salary and compensation - others 110,982 59,105 -- -- General and administrative expenses 204,616 69,302 36,160 14,868 ------------ ------------ ------------ ------------ TOTAL OPERATING EXPENSES 1,067,548 345,513 1,141,462 971,244 ------------ ------------ ------------ ------------ Loss from operations (1,687,152) (470,364) (1,260,162) (1,031,244) OTHER (INCOME) EXPENSE: Change in fair value of derivative liability (305,244) (73,723) -- -- Financing cost 16,125 2,807 18,000 9,000 Foreign currency transaction gain (loss) 1,316 1 -- -- Interest expense 40,462 10,130 25,123 15,630 Interest income -- -- (44) -- ------------ ------------ ------------ ------------ TOTAL OTHER (INCOME) EXPENSE (247,341) (60,785) 43,079 24,630 ------------ ------------ ------------ ------------ Loss before income taxes and noncontrolling interest (1,439,811) (409,579) (1,303,241) (1,055,874) ------------ ------------ ------------ ------------ Income tax provision -- -- -- -- ------------ ------------ ------------ ------------ Net loss before non-controlling interest (1,439,811) (409,579) (1,303,241) (1,055,874) Net loss attributable to the non-controlling interest (97,338) (44,978) -- -- ------------ ------------ ------------ ------------ NET LOSS ATTRIBUTABLE TO STEVIA CORP $ (1,342,473) $ (364,601) $ (1,303,241) $ (1,055,874) ============ ============ ============ ============ Net loss per common share - Basic and diluted: $ (0.02) $ (0.01) $ (0.03) $ (0.02) ============ ============ ============ ============ Weighted average common shares outstanding - basic and diluted 61,613,572 63,225,253 40,575,587 54,854,293 ============ ============ ============ ============
See accompanying notes to the consolidated financial statements. 6 Stevia Corp. Consolidated Statement of Equity (Deficit) For the Period from April 11, 2011 (Inception) through December 31, 2012 (Unaudited)
Common Stock, $0.001 Par Value Total STEV -------------------- Additional Stockholders' Non- Total Number of paid-in Accumulated Equity controlling Equity Shares Amount Capital Deficit (Deficit) Interest (Deficit) ------ ------ ------- ------- --------- -------- --------- Balance, April 11, 2011 (inception) 6,000,000 $ 6,000 $ (5,900) $ -- $ 100 $ -- $ 100 Common shares deemed issued in reverse acquisition 79,800,000 79,800 (198,088) (118,288) (118,288) Common shares cancelled in reverse acquisition (33,000,000) (33,000) 33,000 -- -- Common shares issued for cash at $0.25 per share on October 4, 2011 400,000 400 99,600 100,000 100,000 Common shares issued for notes conversion at $0.25 per share on October 4, 2011 1,400,000 1,400 348,600 350,000 350,000 Common shares issued for conversion of accrued interest at $0.25 per share on October 4, 2011 74,850 75 18,638 18,713 18,713 Common shares cancelled by significant stockholder on October 4, 2011 (3,000,000) (3,000) 3,000 -- -- Common shares issued for future director services on October 4, 2011 3,000,000 3,000 747,000 750,000 750,000 Common shares issued for future director services on October 4, 2011 (750,000) (750,000) (750,000) Common shares issued for future director services on October 4, 2011 earned during the period 187,500 187,500 187,500 Make good shares released to officer for achieving the first milestone on December 23, 2011 3,000,000 3,000 747,000 750,000 750,000 Common shares issued for notes conversion at $0.25 per share on January 18, 2012 600,000 600 149,400 150,000 150,000 Common shares issued for conversion of accrued interest at $0.25 per share on January 18, 2012 17,425 17 4,339 4,356 4,356 Common shares issued for financing services upon agreement at $1.50 per share on January 26, 2012 35,000 35 52,465 52,500 52,500 Common shares issued for consulting services at $1.39 per share on March 31, 2012 27,500 28 38,197 38,225 38,225 Net loss (2,323,551) (2,323,551) (2,323,551) ----------- --------- ----------- ----------- ----------- -------- ----------- Balance, March 31, 2012 58,354,775 58,355 1,474,751 (2,323,551) (790,445) -- (790,445) Restricted common shares issued for farm management services to a related party valued at $0.79 per share discounted at 69% on July 5, 2012 500,000 500 272,050 272,550 272,550 Restriced common shares issued for technology rights valued at $0.79 per share discounted 69% on July 5, 2012 3,000,000 3,000 1,632,300 1,635,300 1,635,300 Common shares issued for notes conversion at $0.832143 per share on July 6, 2012 600,858 601 499,399 500,000 500,000 Common shares issued for conversion of accrued interest at $0.832143 per share on July 6, 2012 33,335 33 27,706 27,739 27,739 Common shares and warrants issued for cash to two investors at $0.46875 per unit on August 6, 2012 1,066,667 1,067 498,933 500,000 500,000 Warrants issued to investors in connection with the sale of equity units on August 6, 2012 (381,301) (381,301) (381,301) Commissions and legal fees in connection with the stock sales on August 6, 2012 (52,500) (52,500) (52,500) Warrants issued to placement agent in connection with the sale of equity units on August 6, 2012 (30,504) (30,504) (30,504) Common shares issued for future director services on October 4, 2011 earned during the period 281,250 281,250 281,250 Net loss (1,342,473) (1,342,473) (97,338) (1,439,811) ----------- --------- ----------- ----------- ----------- -------- ----------- Balance, December 31, 2012 63,555,635 $ 63,556 $ 4,222,085 $(3,666,024) $ 619,617 $(97,338) $ 522,279 =========== ========= =========== =========== =========== ======== ===========
See accompanying notes to the consolidated financial statements. 7 Stevia Corp. Consolidated Statements of Cash Flows
For the Period from For the April 11, 2011 Nine Months (inception) Ended through December 31, December 31, 2012 2011 ------------ ------------ (Unaudited) (Unaudited) CASH FLOWS FROM OPERATING ACTIVITIES: Net loss $ (1,439,811) $ (1,303,241) Adjustments to reconcile net loss to net cash used in operating activities Depreciation expense 762 -- Amortization expense 55,311 534 Change in fair value of derivative liability (305,244) -- Common shares issued for compensation -- 750,000 Common shares issued for director services earned during the period 281,250 93,750 Common shares issued for services-related party 272,550 -- Common shares issued for outside services -- -- Changes in operating assets and liabilities: Accounts receivable (120,659) -- Prepaid expenses 142,858 (49,219) Accounts payable 390,641 (36,067) Accounts payable - related parties 21,469 15,150 Accrued expenses 6,045 310 Accrued interest 40,397 33,958 ------------ ------------ NET CASH USED IN OPERATING ACTIVITIES (654,431) (509,825) ------------ ------------ CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property, plant and equipment (4,889) -- Proceeds from disposal of property and equipment -- -- Website development costs -- (5,315) Cash received from reverse acquisition -- 3,198 ------------ ------------ NET CASH USED IN INVESTING ACTIVITIES (4,889) (2,117) ------------ ------------ CASH FLOWS FROM FINANCING ACTIVITIES: Advances from president and stockholder 2,100 200 Proceeds from issuance of convertible notes 200,000 750,000 Proceeds from sale of common stock, net of costs 447,500 100,000 ------------ ------------ NET CASH PROVIDED BY FINANCING ACTIVITIES 649,600 850,200 ------------ ------------ Net change in cash (9,720) 338,258 Cash at beginning of period 15,698 -- ------------ ------------ CASH AT END OF PERIOD $ 5,978 $ 338,258 ============ ============ SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: Interest paid $ -- $ -- ============ ============ Income tax paid $ -- $ -- ============ ============ NON-CASH INVESTING AND FINANCING ACTIVITIES: Issuance of common stock for conversion of convertible notes $ 500,000 $ 350,000 ============ ============ Issuance of common stock for conversion of accrued interest $ 27,739 $ 18,712 ============ ============
See accompanying notes to the consolidated financial statements. 8 Stevia Corp. December 31, 2012 and 2011 Notes to the Consolidated Financial Statements (Unaudited) NOTE 1 - ORGANIZATION AND OPERATIONS STEVIA CORP. (FORMERLY INTERPRO MANAGEMENT CORP.) Interpro Management Corp ("Interpro") was incorporated under the laws of the State of Nevada on May 21, 2007. Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization's efficiency through planning and monitoring the daily operations of a business. The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011. On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. ("Stevia" or the "Company") and effectuated a 35 for 1 (1:35) forward stock split of all of its issued and outstanding shares of common stock (the "Stock Split"). All shares and per share amounts in the consolidated financial statements have been adjusted to give retroactive effect to the Stock Split. STEVIA VENTURES INTERNATIONAL LTD. Stevia Ventures International Ltd. ("Ventures") was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands ("BVI"). Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia. ACQUISITION OF STEVIA VENTURES INTERNATIONAL LTD. RECOGNIZED AS A REVERSE ACQUISITION On June 23, 2011 (the "Closing Date"), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the "Share Exchange Agreement") by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder"). Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company's former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation. As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares are being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement"). Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock immediately after the consummation of the Share Exchange Agreement the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition. As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification. The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition. The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost. The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction. 9 FORMATION OF STEVIA ASIA LIMITED On March 19, 2012, the Company formed Stevia Asia Limited ("Stevia Asia") under the laws of the Hong Kong Special Administrative Region ("HK SAR") of the People's Republic of China ("PRC"), a wholly-owned subsidiary. FORMATION OF STEVIA TECHNEW LIMITED (FORMERLY HERO TACT LIMITED)/COOPERATIVE AGREEMENT On April 28, 2012, Stevia Asia formed Hero Tact Limited, a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited ("Stevia Technew"). Stevia Technew intends to facilitate a joint venture relationship with the Company's technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou's affiliates Technew Technology Limited. Prior to July 5, 2012, the date of entry into Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities. On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% of the shares (representing 30% of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities. The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission ("SEC") to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read in conjunction with the financial statements of the Company for the period from April 11, 2011 (inception) through March 31, 2012 and notes thereto contained in the Company's Annual Report on Form 10-K as filed with the SEC on June 29, 2012. PRINCIPLES OF CONSOLIDATION The Company applies the guidance of Topic 810 "CONSOLIDATION" of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity. Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries--all entities in which a parent has a controlling financial interest--shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee. Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, in which the parent's power to control exists. 10 The Company's consolidated subsidiaries and/or entities are as follows:
Date of incorporation or formation Name of consolidated State or other jurisdiction of (date of acquisition, subsidiary or entity incorporation or organization if applicable) Attributable interest -------------------- ----------------------------- -------------- --------------------- Stevia Ventures The Territory of the April 11, 2011 100% International Ltd. British Virgin Islands Stevia Asia Limited Hong Kong SAR March 19, 2012 100% Stevia Technew Limited Hong Kong SAR April 28, 2012 70%
The consolidated financial statements include all accounts of the Company as of December 31, 2012, for the interim period then ended and for the period from June 23, 2011 (date of acquisition) through December 31, 2011; Stevia Ventures International Ltd. as of December 31, 2012, for the interim period then ended and for the period from April 11, 2011 (inception) through December 31, 2011; Stevia Asia Limited as of December 31, 2012 and for the period from March 19, 2012 (inception) through December 31, 2012; and Stevia Technew Limited as of December 31, 2012 and for the period from April 28, 2012 (inception) through December 31, 2012. All inter-company balances and transactions have been eliminated. RECLASSIFICATION Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses. USE OF ESTIMATES AND ASSUMPTIONS The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company's significant estimates and assumptions include the fair value of financial instruments; the carrying value, recoverability and impairment of long-lived assets, including the values assigned to and the estimated useful lives of website development costs; interest rate; revenue recognized or recognizable; sales returns and allowances; foreign currency exchange rate; income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; expected term of share options and similar instruments, expected volatility of the entity's shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s); and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. 11 FAIR VALUE OF FINANCIAL INSTRUMENTS The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable, accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments. The Company's convertible notes payable approximates the fair value of such instrument based upon management's best estimate of interest rates that would be available to the Company for similar financial arrangements at December 31, 2012 and March 31, 2012. The Company's Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date. It is not, however, practical to determine the fair value of advances from president and significant stockholder, if any, due to their related party nature. FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS LEVEL 3 FINANCIAL LIABILITIES - DERIVATIVE WARRANT LIABILITIES The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability at every reporting period and recognizes gains or losses in the consolidated statements of operations and comprehensive income (loss) that are attributable to the change in the fair value of the derivative warrant liability. CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company's long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. 12 The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. The key assumptions used in management's estimates of projected cash flow deal largely with forecasts of sales levels and gross margins. These forecasts are typically based on historical trends and take into account recent developments as well as management's plans and intentions. Other factors, such as increased competition or a decrease in the desirability of the Company's products or services, could lead to lower projected sales levels, which would adversely impact cash flows. A significant change in cash flows in the future could result in an impairment of long lived assets. The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations. FISCAL YEAR END The Company elected March 31 as its fiscal year ending date. CASH EQUIVALENTS The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. PROPERTY AND EQUIPMENT Property and equipment is recorded at cost. Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. INTANGIBLE ASSETS OTHER THAN GOODWILL The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill. Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill inclusive of acquired technology and website development costs on a straight-line basis over their relevant estimated useful lives of fifteen (15) and five (5) years, respectively. Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts. RELATED PARTIES The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly 13 influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value. The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation. From time to time, the Company may employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates. The Company does not use derivatives for speculation or trading purposes. Changes in the fair value of derivatives are recorded each period in current earnings or through other comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and the type of hedge transaction. The ineffective portion of all hedges is recognized in current earnings. The Company has sales and purchase commitments denominated in foreign currencies. Foreign currency forward contracts are used to hedge against the risk of change in the fair value of these commitments attributable to fluctuations in exchange rates ("Fair Value Hedges"). Changes in the fair value of the derivative instrument are generally offset in the income statement by changes in the fair value of the item being hedged. The Company did not employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates for the interim period ended December 31, 2012 or 2011. DERIVATIVE LIABILITY The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date. 14 The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions. The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency. The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss). The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm. The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models. In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives). The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features. Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on the underlying factors which led to potential scenarios. Probabilities were assigned to each scenario based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants. COMMITMENT AND CONTINGENCIES The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company's business, financial position, and results of operations or cash flows. NON-CONTROLLING INTEREST The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interest in Stevia Technew Limited, its majority owned subsidiary in the consolidated statements of balance sheets within the equity section, separately from the Company's stockholders' equity. Non-controlling interest represents the non-controlling interest holder's proportionate share of the equity of the Company's majority-owned subsidiary, Stevia Technew Limited. Non-controlling interest is adjusted for the non-controlling interest holder's proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance. 15 REVENUE RECOGNITION The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured. RESEARCH AND DEVELOPMENT The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 "ACCOUNTING FOR RESEARCH AND DEVELOPMENT COSTS") and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 "RESEARCH AND DEVELOPMENT ARRANGEMENTS") for research and development costs. Research and development costs are charged to expense as incurred. Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions. NON-REFUNDABLE ADVANCE PAYMENTS FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES The research and development arrangements usually involve specific research and development projects. Often times, the Company makes non-refundable advances upon signing of these arrangements. The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 "ACCOUNTING FOR NONREFUNDABLE ADVANCE PAYMENTS FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES") for those non-refundable advances. Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized. Such amounts are recognized as an expense as the related goods are delivered or the related services are performed. The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered. If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense. STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: * Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the 16 fair value (or calculated value) of the instruments. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the SIMPLIFIED METHOD, I.E., EXPECTED TERM = ((VESTING TERM + ORIGINAL CONTRACTUAL TERM) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. * Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. * Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. * Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments. The Company's policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR SERVICES The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50"). Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: * Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder's expected exercise behavior. If the Company is a newly formed corporation or shares of the Company are 17 thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. * Expected volatility of the entity's shares and the method used to estimate it. An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility. A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. * Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments. * Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments. Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic. Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9,an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised. Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded. INCOME TAX PROVISION The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent 18 management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date. The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management's opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary. UNCERTAIN TAX POSITIONS The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the interim period ended December 31, 2012 or for the period from April 11, 2011 (Inception) through December 31, 2011. LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL's to annual limitations which could reduce or defer the NOL. Section 382 imposes limitations on a corporation's ability to utilize NOLs if it experiences an "ownership change." In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period. In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years. The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs. NET INCOME (LOSS) PER COMMON SHARE Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants. The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive: 19 Potentially Outstanding Dilutive Common Shares --------------------------- For the Period from For the April 11, 2011 Interim Period (inception) Ended through December 31, December 31, 2012 2011 ---------- --------- MAKE GOOD ESCROW SHARES Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"). 3,000,000 6,000,000 CONVERTIBLE NOTE SHARES On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be at $0.46875 per share, at which the Company completed a private placement with gross proceeds of at least $100,000 on August 6, 2012, the same as the next private placement price on a per share basis provided the Company complete a private placement with gross proceeds of at least $100,000. 426,667 -- On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be at $0.46875 per share, at which the Company completed a private placement with gross proceeds of at least $100,000 on August 6, 2012, the same as the next private placement price on a per share basis provided the Company complete a private placement with gross proceeds of at least $100,000. 426,667 -- WARRANT SHARES On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. 1,152,000 -- ---------- ---------- TOTAL POTENTIALLY OUTSTANDING DILUTIVE COMMON SHARES 5,005,334 6,000,000 ========== ========== CASH FLOWS REPORTING The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification. 20 SUBSEQUENT EVENTS The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS FASB ACCOUNTING STANDARDS UPDATE NO. 2011-08 In September 2011, the FASB issued the FASB Accounting Standards Update No. 2011-08 "INTANGIBLES--GOODWILL AND OTHER: TESTING GOODWILL FOR IMPAIRMENT" ("ASU 2011-08"). This Update is to simplify how public and nonpublic entities test goodwill for impairment. The amendments permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Topic 350. Under the amendments in this Update, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. The guidance is effective for interim and annual periods beginning on or after December 15, 2011. Early adoption is permitted. FASB ACCOUNTING STANDARDS UPDATE NO. 2011-11 In December 2011, the FASB issued the FASB Accounting Standards Update No. 2011-11 "BALANCE SHEET: DISCLOSURES ABOUT OFFSETTING ASSETS AND LIABILITIES" ("ASU 2011-11"). This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS. The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. FASB ACCOUNTING STANDARDS UPDATE NO. 2012-02 In July 2012, the FASB issued the FASB Accounting Standards Update No. 2012-02 "INTANGIBLES--GOODWILL AND OTHER (TOPIC 350) TESTING INDEFINITE-LIVED INTANGIBLE ASSETS FOR IMPAIRMENT" ("ASU 2012-02"). This Update is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. This guidance builds upon the guidance in ASU 2011-08, entitled TESTING GOODWILL FOR IMPAIRMENT. ASU 2011-08 was issued on September 15, 2011, and feedback from stakeholders during the exposure period related to the goodwill impairment testing guidance was that the guidance also would be helpful in impairment testing for intangible assets other than goodwill. The revised standard allows an entity the option to first assess qualitatively whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired, thus necessitating that it perform the quantitative impairment test. An entity is not required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired. This Update is effective for annual and interim impairment tests performed in fiscal years beginning after September 15, 2012. Earlier implementation is permitted. 21 OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements. NOTE 3 - GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had an accumulated deficit at December 31, 2012, a net loss and net cash used in operating activities for the interim period then ended. These factors raise substantial doubt about the Company's ability to continue as a going concern. While the Company is attempting to generate sufficient revenues, the Company's cash position may not be sufficient enough to support the Company's daily operations. Management intends to raise additional funds by way of a public or private offering. Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate sufficient revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company's ability to further implement its business plan and generate sufficient revenues. The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. NOTE 4 - PREPAID EXPENSES Prepaid expenses consisted of the following: December 31, March 31, 2012 2012 -------- -------- Prepaid research and development $ 23,336 $128,445 Prepaid rent -- 21,250 Retainer -- 15,000 Other 2,680 4,179 -------- -------- $ 26,016 $168,874 ======== ======== NOTE 5 - PROPERTY AND EQUIPMENT Property and equipment, stated at cost, less accumulated depreciation consisted of the following: Estimated Useful Life December 31, March 31, (Years) 2012 2012 ------- -------- -------- Property and equipment 5 $ 7,925 $ 3,036 Less accumulated depreciation (762) -- -------- -------- $ 7,163 $ 3,036 ======== ======== 22 DEPRECIATION EXPENSE The Company acquired furniture and fixture near the end of February 2012 and started to depreciate as of April 1, 2012. Depreciation expense for the interim period ended December 31, 2012 was $762. NOTE 6 - ACQUIRED TECHNOLOGY On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company's common stock. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market for a total value of $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years. Estimated Useful Life December 31, March 31, (Years) 2012 2012 ------- ---------- ---------- Technology right 15 $1,635,300 $ -- Less accumulated amortization (54,510) -- ---------- ---------- $1,580,790 $ -- ========== ========== AMORTIZATION EXPENSE Amortization expense for the interim period ended December 31, 2012 was $54,510. NOTE 7 - WEBSITE DEVELOPMENT COSTS Website development costs, stated at cost, less accumulated amortization consisted of the following: Estimated Useful Life December 31, March 31, (Years) 2012 2012 ------- ---------- ---------- Website development costs 5 $ 5,315 $ 5,315 Accumulated amortization (1,602) (801) ----------- ---------- $ 3,713 $ 4,514 ========== ========== AMORTIZATION EXPENSE Amortization expense was $801 and $534 for the interim period ended December 31, 2012 and for the period from April 11, 2011 (inception) through December 31, 2011, respectively. NOTE 8 - RELATED PARTY TRANSACTIONS RELATED PARTIES Related parties with whom the Company had transactions are: Related Parties Relationship --------------- ------------ George Blankenbaker President and significant stockholder of the Company Leverage Investments LLC An entity owned and controlled by the president and significant stockholder of the Company Technew Technology Limited Non-controlling interest holder Growers Synergy Pte Ltd. An entity owned and controlled by the president and significant stockholder of the Company Guangzhou Health Technology An entity owned and controlled by Development Company Limited Non-controlling interest holder 23 ADVANCES FROM STOCKHOLDER From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand. LEASE OF CERTAIN OFFICE SPACE FROM LEVERAGE INVESTMENTS, LLC The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011. For the interim period ended December 31, 2012, the Company recorded $4,500 in rent expenses due Leverage Investment LLC. FARM MANAGEMENT AND OFF-TAKE AGREEMENT WITH GROWERS SYNERGY PTE LTD. For the Period from July 1, 2011 through October 31, 2011, the Company engaged Growers Synergy Pte Ltd. to provide farm management services on a month-to-month basis, at $20,000 per month. On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a Singapore corporation owned and controlled by the president and major stockholder of the Company. Under the terms of the Management Agreement, the Company will engage GSPL to supervise the Company's farm management operations, recommend quality farm management programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services for a term of two (2) years from the date of signing, at $20,000 per month. The Management Agreement may be terminated by the Company upon 30 day notice. In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company's GSPL supervised farms. Farm management services provided by Growers Synergy Pte Ltd. is as follows: For the Period from For the April 11, 2011 Interim Period (inception) Ended through December 31, December 31, 2012 2011 -------- -------- Farm management services received and farm management services booked $180,000 $ -- -------- -------- $180,000 $ -- ======== ======== Future minimum payments required under this agreement at December 31, 2012 were as follows: Fiscal Year Ending March 31: 2013 (remainder of the fiscal year) $ 60,000 2014 140,000 -------- $200,000 ======== CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW On July 5, 2012, Stevia Asia, entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% shares (representing 30% of the of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to provide $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities. 24 For the interim period ended December 31, 2012, Stevia Asia provided Stevia Technew $230,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related party. NOTE 9 - CONVERTIBLE NOTES PAYABLE On February 14, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,890.41 to 1,000,000 and 63,561 shares of the Company's common stock at $0.25 per share, respectively. On June 23, 2011, the Company issued a convertible note in the amount of $100,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $100,000 and accrued interest through the date of conversion of $2,821.92 to 400,000 and 11,288 shares of the Company's common stock at $0.25 per share. On October 4, 2011, the Company issued a convertible note in the amount of $150,000 with interest at 10% per annum due one (1) year from the date of issuance. On January 18, 2012, the note holder converted the entire principal of $150,000 and accrued interest through the date of conversion of $4,356 to 617,425 shares of the Company's common stock at $0.25 per share. Convertible notes payable consisted of the following: December 31, March 31, 2012 2012 -------- -------- On November 16, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company complete a private placement with gross proceeds of at least $100,000. On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,959 to 319,607 shares of the Company's common stock at $0.83 per share. -- 250,000 On January 16, 2012, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company complete a private placement with gross proceeds of at least $100,000. On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $11,781 to 314,586 shares of the Company's common stock at $0.83 per share. -- 250,000 On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be at $0.46875 per share, at which the Company completed a private placement with gross proceeds of at least $100,000 on August 6, 2012, the same as the next private placement price on a per share basis provided the Company complete a private placement with gross proceeds of at least $100,000. 200,000 200,000 On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be at $0.46875 per share, at which the Company completed a private placement with gross proceeds of at least $100,000 on August 6, 2012, the same as the next private placement price on a per share basis provided the Company complete a private placement with gross proceeds of at least $100,000. 200,000 -- -------- -------- $400,000 $700,000 ======== ======== 25 NOTE 10 - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS (I) WARRANTS ISSUED ON AUGUST 6, 2012 DESCRIPTION OF WARRANTS AND FAIR VALUE ON DATE OF GRANT On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. DERIVATIVE ANALYSIS The exercise price of August 6, 2012 warrants and the number of shares issuable upon exercise is subject to reset adjustment in the event of stock splits, stock dividends, recapitalization, most favored nation clause and similar corporate events. Pursuant to the Section 3(b) Subsequent Equity Sales of the SPA, if the Company issues any common stock or securities other than the excepted issuances, to any person or entity at a purchase or exercise price per share less than the share purchase price of the August 6, 2012 Unit Offering without the consent of the subscriber holding purchased shares, warrants or warrant shares of the August 6, 2012 Unit Offering, then the subscriber shall have the right to apply the lowest such purchase price or exercise price of the offering or sale of such new securities to the purchase price of the purchased shares then held by the subscriber (and, if necessary, the Company will issue additional shares), the reset adjustments are also referred to as full reset adjustments. Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification ("Section 815-40-15") (FORMERLY FASB EMERGING ISSUES TASK FORCE ("EITF") ISSUE NO. 07-5: DETERMINING WHETHER AN INSTRUMENT (OR EMBEDDED FEATURE) IS INDEXED TO AN ENTITY'S OWN STOCK ("EITF 07-5"))). Section 815-40-15 became effective on January 1, 2009 and the Warrants issued in the August 6, 2012 Unit Offering have been measured at fair value using a Lattice model at each reporting period with gains and losses from the change in fair value of derivative liabilities recognized on the consolidated statement of income and comprehensive income. VALUATION OF DERIVATIVE LIABILITY (A) VALUATION METHODOLOGY The Company's August 6, 2012 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset. Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections. Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability. (B) VALUATION ASSUMPTIONS The Company's 2012 derivative warrants were valued at each period ending date with the following assumptions: 26 * The stock price would fluctuate with the Company projected volatility. * The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods. * The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price. * The Holder would exercise the warrant at maturity if the stock price was above the project reset prices. * A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market * The 1,066,667 Investor Warrants $0.6405 exercise price is projected to reset from $0.87 to $0.192 at maturity; and the 85,333 Placement Agent Warrants $0.6405 exercise price is projected to reset from $0.87 to $0.192 at maturity; * No warrants have been exercised or expired. * The projected volatility curve for the valuation dates was: 1 Year 2 Year 3 Year 4 Year 5 Year ------ ------ ------ ------ ------ August 6, 2012 129% 178% 218% 252% 281% September 30, 2012 127% 173% 211% 244% 272% December 31, 2012 126% 167% 204% 235% 263% (C) FAIR VALUE OF DERIVATIVE WARRANTS The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 1,152,000 shares of the Company's common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Fair Value Measurement Using Level 3 Inputs ---------------------------- Derivative warrants Assets (Liability) Total ----------- ----- Balance, August 6, 2012 $(411,805) $(411,805) Total gains or losses (realized/unrealized) included in: Net income (loss) 231,521 231,521 Other comprehensive income (loss) -- -- Purchases, issuances and settlements -- -- Transfers in and/or out of Level 3 -- -- --------- --------- Balance, August 6, 2012 (180,284) (180,284) Total gains or losses (realized/unrealized) included in: Net income (loss) 73,723 73,723 Other comprehensive income (loss) -- -- Purchases, issuances and settlements -- -- Transfers in and/or out of Level 3 -- -- --------- --------- Balance, December 31, 2012 $(106,561) $(106,561) ========= ========= 27 (D) WARRANTS OUTSTANDING As of December 31, 2012 no warrants have been exercised and warrants to purchase 1,152,000 shares of Company common stock remain outstanding. The table below summarizes the Company's derivative warrant activity
2012 Warrant Activities Apic (Gain) Loss ---------------------------------------------------------- --------- ---------- Reclassification Total Fair Value of Change in of Fair Value of Derivative Non-derivative Warrant Derivative Derivative Derivative Shares Shares Shares Warrants Liability Liability ------ ------ ------ -------- --------- --------- Derivative warrant at August 6, 2012 1,152,000 -- 1,152,000 (411,805) -- -- Mark to market 231,521 (231,521) Derivative warrant at September 30, 2012 1,152,000 -- 1,152,000 (180,284) (231,521) Mark to market 73,723 (73,723) Derivative warrant at December 31, 2012 1,152,000 -- 1,152,000 (106,561) (305,244) (II) WARRANT ACTIVITIES The table below summarizes the Company's warrant activities through December 31, 2012: SUMMARY OF THE COMPANY'S WARRANT ACTIVITIES The table below summarizes the Company's warrant activities: Number of Exercise Weighted Average Fair Value at Aggregate Warrant Price Range Exercise Rate of Intrinsic Shares Per Share Price Issuance Value ------ --------- ----- -------- ----- Balance, March 31, 2012 -- $ -- $ -- $ -- $ -- Granted 1,152,000 0.6405 0.6405 411,805 -- Canceled -- -- -- -- -- Exercised -- -- -- -- -- Expired -- -- -- -- -- --------- ------- ------- --------- ---- Balance, December 31, 2012 1,152,000 0.6405 0.6405 411,805 -- Earned and exercisable, December 31, 2012 1,152,000 0.6405 0.6405 411,805 -- --------- ------- ------- --------- ---- Unvested, December 31, 2012 -- $ -- $ -- $ -- $ -- --------- ------- ------- --------- ----
28 The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2012:
Warrants Outstanding Warrants Exercisable ---------------------------------- ----------------------------------- Average Average Remaining Weighted Remaining Weighted Contractual Average Contractual Average Range of Number Life Exercise Number Life Exercise Exercise Prices Outstanding (in years) Price Exercisable (in years) Price --------------- ----------- ---------- ----- ----------- ---------- ----- $0.6405 1,152,000 4.60 $ 0.6405 1,152,000 4.60 $0.6405 ------- --------- ---- -------- --------- ---- ------- $0.6405 1,152,000 4.60 $ 0.6405 1,152,000 4.60 $0.6405 ======= ========= ==== ======== ========= ==== =======
NOTE 11 - EQUITY SHARES AUTHORIZED Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share. COMMON STOCK REVERSE ACQUISITION TRANSACTION Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company's former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation. As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares are being held in escrow ("Escrow Shares") pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement"). MAKE GOOD AGREEMENT SHARES (I) DURATION OF ESCROW AGREEMENT The Make Good Escrow Agreement shall terminate on the sooner of (i) the distribution of all escrow shares, or (ii) December 31, 2013. (II) DISBURSEMENT OF MAKE GOOD SHARES Upon achievement of any Milestone on or before the date associated with such Milestone on Exhibit A, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such achievement (each a "COMPLETION NOTICE"). Upon the passage of any Milestone date set forth on Exhibit A for which the Company has not achieved the associated Milestone, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such failure to achieve the milestone (each a "NON-COMPLETION NOTICE"). 29 (III) EXHIBIT A - SCHEDULE OF MILESTONES
Completion Number of Milestones Date Escrow Shares ---------- ---- ------------- I. (1) Enter into exclusive international license agreement for all Agro Genesis intellectual property and products as it applies to stevia (2) Enter into cooperative agreements to work with Vietnam Institutes (a) Medical Plant Institute in Hanoi; (b) Agricultural Science Institute of Northern Central 3,000,000 Vietnam shares only (3) Enter into farm management agreements with local if and when growers including the Provincial and National Within 180 ALL four (4) projects; days of the milestones (4) Take over management of three existing nurseries Closing Date reached(*) II. Achieve 100 Ha field trials and first test shipment of Within two (2) dry leaf years of the 1,500,000 Closing Date shares III. Test shipment of dry leaf to achieve minimum specs for Within two (2) contracted base price (currently $2.00 per kilogram) years of the 1,500,000 Closing Date shares
----- * On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone. These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation. COMMON SHARES SURRENDERED FOR CANCELLATION On October 4, 2011, a significant stockholder of the Company, Mohanad Shurrab, surrendered another 3,000,000 shares of the Company's common stock to the Company for cancellation. The Company recorded this transaction by debiting common stock at par of $3,000 and crediting additional paid-in capital of the same. COMMON SHARES ISSUED FOR CASH On October 4, 2011 the Company sold 400,000 shares of its common stock to one investor at $0.25 per share or $100,000. COMMON SHARES ISSUED FOR OBTAINING EMPLOYEE AND DIRECTOR SERVICES On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director's continuous service to the Company as directors. These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter. The Company recorded $187,500 in directors' fees for the period from April 11, 2011 (inception) through March 31, 2012. The Company recorded $281,250 in directors' fees for the interim period ended December 31, 2012. 30 COMMON SHARES ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR SERVICES EQUITY PURCHASE AGREEMENT AND RELATED REGISTRATION RIGHTS AGREEMENT (I) EQUITY PURCHASE AGREEMENT On January 26, 2012, the Company entered into an equity purchase agreement ("Equity Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership (The "Investor"). Upon the terms and subject to the conditions contained in the agreement, the Company shall issue and sell to the Investor, and the Investor shall purchase, up to Twenty Million Dollars ($20,000,000) of its common stock, par value $0.001 per share. At any time and from time to time during the Commitment Period, the period commencing on the effective date, and ending on the earlier of (i) the date on which investor shall have purchased put shares pursuant to this agreement for an aggregate purchase price of the maximum commitment amount, or (ii) the date occurring thirty six (36) months from the date of commencement of the commitment period. the Company may exercise a put by the delivery of a put notice, the number of put shares that investor shall purchase pursuant to such put shall be determined by dividing the investment amount specified in the put notice by the purchase price with respect to such put notice. However, that the investment amount identified in the applicable put notice shall not be greater than the maximum put amount and, when taken together with any prior put notices, shall not exceed the maximum commitment The purchase price shall mean 93% of the market price on such date on which the purchase price is calculated in accordance with the terms and conditions of this Agreement. (II) REGISTRATION RIGHTS AGREEMENT In connection with the Equity Purchase Agreement, on January 26, 2012, the Company entered into a registration rights agreement ("Registration Rights Agreement") with Southridge Partners II, LP, a Delaware limited partnership (the "Investor"). To induce the investor to execute and deliver the equity purchase agreement which the Company has agreed to issue and sell to the investor shares (the "put shares") of its common stock, par value $0.001 per share (the "common stock") from time to time for an aggregate investment price of up to twenty million dollars ($20,000,000) (the "registrable securities"), the Company has agreed to provide certain registration rights under the securities act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, "securities act"), and applicable state securities laws with respect to the registrable securities. (III) COMMON SHARES ISSUED UPON SIGNING As a condition for the execution of this agreement by the investor, the company issued to the investor 35,000 shares of restricted common stock (the "restricted shares") upon the signing of this agreement. The restricted shares shall have no registration rights. These shares were valued at $1.50 per share or $52,500 on the date of issuance and recorded as financing cost. MARKETING SERVICE AGREEMENT - EMPIRE RELATIONS GROUP, INC. On March 14, 2012 the Company entered into a consulting agreement (the "Consulting Agreement") with Empire Relations Group, Inc. ("Empire"). (I) SCOPE OF SERVICES Under the terms of the Consulting Agreement, the Company engaged Empire to introduce interested investors to the Company, advise the Company on available financing options, provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake. 31 (II) TERM The term of this agreement were consummated from the date hereof, and automatically terminated on May 30, 20 12. (III) COMPENSATION For the term of this agreement, the consultant shall be paid an upfront, non-refundable, non-cancellable retainer fee of 27,500 restricted shares. For the purposes of this agreement, these shares shall be considered to be fully earned by March 31, 2012. These shares were valued at $1.39 per share or $38,225 on March 31, 2012, the date when they were earned. COMMON SHARES ISSUED IN CONNECTION WITH ENTRY INTO TECHNOLOGY ACQUISITION AGREEMENT On July 5, 2012, the Company entered into a Technology Acquisition Agreement (the "Technology Acquisition Agreement") with Technew Technology Limited ("Technew"), pursuant to which the Company acquired the rights to certain technology from Technew in exchange for 3,000,000 restricted shares of the Company's common stock. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years. COMMON SHARES ISSUED TO A RELATED PARTY On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party in the consolidated statements of operations. SALE OF EQUITY UNIT INCLUSIVE OF COMMON STOCK AND WARRANTS ENTRY INTO SECURITIES PURCHASE AGREEMENT On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667 shares of the Company's common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company's common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000. At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,("GSS") that served as placement agent for the Company in the offering (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the "agent warrants") to GSS or its designee. The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for a gross proceeds of $500,000. In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500. The Company intended to use the net proceeds from the Offering to advance the Company's ability to execute its growth strategy and to aid in the commercial development of the recently announced launch of the Company's majority-owned subsidiary, Stevia Technew Limited. ENTRY INTO REGISTRATION RIGHTS AGREEMENT In connection with the equity financing on August 1, 2012, the Company also entered into a registration rights agreement with the Purchasers (the "rights agreement"). The Rights Agreement requires the Company to file a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company's entrance into the rights agreement (the "filing date") for the resale by the Purchasers of all of the Shares and all of the shares of common stock issuable upon exercise of the Warrants (the "registrable securities"). The registration statement must be declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments. If the registration statement is not filed prior to the filing date, the Company will be required to pay certain liquidated damages, not to exceed in the aggregate 6% of the purchase price paid by the Purchasers pursuant to the SPA. 32 WARRANTS ISSUANCES OF WARRANTS IN CONNECTION WITH ENTRY INTO SECURITIES PURCHASE AGREEMENT On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS or its designee, a warrant to purchase 85,333 shares of the Company's common stock representing 8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. NOTE 12 - NON-CONTROLLING INTEREST Non-controlling interest consisted of the following:
Contributed and additional Other Total paid-in Earnings and Comprehensive non-controlling capital losses Income interest ------- ------ ------ -------- Balance at March 31, 2012 $ -- $ -- $ -- $ -- Current period earnings and losses -- (97,338) -- (97,338) ------- -------- ------- -------- Balance at December 31, 2012 $ -- $(97,338) $ -- $(97,338) ======= ======== ======= ========
NOTE 13 - RESEARCH AND DEVELOPMENT AGRIBUSINESS DEVELOPMENT AGREEMENT - AGRO GENESIS PTE LTD. ENTRY INTO AGRIBUSINESS DEVELOPMENT AGREEMENT On July 16, 2011, the Company entered into an Agribusiness Development Agreement (the "Agribusiness Development Agreement") with Agro Genesis Pte Ltd. ("AGPL"), a corporation organized under the laws of the Republic of Singapore expiring two (2) years from the date of signing. Under the terms of the Agreement, the Company engaged AGPL to be the Company's technology provider consultant for stevia propagation and cultivation in Vietnam, and potentially other countries for a period of two (2) years. AGPL will be tasked with developing stevia propagation and cultivation technology in Vietnam, recommend quality agronomic programs for stevia cultivation, harvest and post harvest, alert findings on stevia propagation and cultivation that may impact profitability and develop a successful model in Vietnam that can be replicated elsewhere (the "Project"). The Project will be on-site at stevia fields in Vietnam and will have a term of at least two (2) years. For its services, AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated at $274,000 as specified in Appendix A to the Agribusiness Development Agreement. Additionally, the Company will be AGPL's exclusive distributor for AGPL's g'farm system (a novel crop production system) for stevia growing resulting from the Project. AGPL will receive a commission of no less than 2% of the price paid for crops other than stevia, from cropping systems that utilize the g'farm system resulting from the Project. All technology-related patents resulting from the Project will be jointly owned by AGPL and the Company, with the Company holding a right of first offer for the use and distribution rights to registered patents resulting from the Project. ADDENDUM TO AGRIBUSINESS DEVELOPMENT AGREEMENT On August 26, 2011, in accordance with Appendix A , 3(a), the Company and AGPL have mutually agreed to add to the current Project budget $100,000 per annum for one, on-site resident AGPL expert for 2 (two) years effective September 1, 2011, or $200,000 in aggregate for the term of the contract as specified in Appendix C. In-country accommodation for the resident expert will be born separately by the Company and is excluded from the above amount. The expert, Dr. Cho, Young-Cheol, Director, Life Sciences has been appointed and commenced on September 1, 2011. 33 TERMINATION OF AGRIBUSINESS DEVELOPMENT AGREEMENT On March 31, 2012, the Company and AGPL mutually agreed to terminate the Agribusiness Development Agreement, effective immediately. LEASE OF AGRICULTURAL LAND On December 14, 2011, the Company and Stevia Ventures Corporation ("Stevia Ventures") entered into a Land Lease Agreement with Vinh Phuc Province People's Committee Tam Dao Agriculture & Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the "Leased Property") for a term expiring five (5) years from the date of signing. The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement. Future minimum payments required under this agreement at December 31, 2012 were as follows: FISCAL YEAR ENDING MARCH 31: 2013 (remainder of the fiscal year) $ 15,000 2014 30,000 2015 30,000 2016 30,000 -------- $105,000 ======== SUPPLY AND COOPERATIVE AGREEMENT - GUANGZHOU HEALTH TECHNOLOGY DEVELOPMENT COMPANY LIMITED ENTRY INTO SUPPLY AGREEMENT On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People's Republic of China (the "Guangzhou Health"). Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years. ENTRY INTO COOPERATIVE AGREEMENT On February 21, 2012, the Company also entered into Cooperative Agreement (the "Cooperative Agreement") with Guangzhou Health Technology Development Company Limited. Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company's business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all 34 available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing. NOTE 14 - COMMITMENTS AND CONTINGENCIES SUPPLY AGREEMENT - BETWEEN STEVIA VENTURES INTERNATIONAL LTD. AND ASIA STEVIA INVESTMENT DEVELOPMENT COMPANY LTD. On April 12, 2011, Stevia Ventures International Ltd, the subsidiary of the Company entered into a Supply Agreement (the "Supply Agreement") with Asia Stevia Investment Development Company Ltd ("ASID"), a foreign-invested limited liability company incorporated in Vietnam. (I) SCOPE OF SERVICES Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID. (II) TERM This Agreement shall come into force on the Effective Date and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term"). (III) PURCHASE PRICE ASID and the Company shall review and agree on or before September 30th of each Year on the quantity of the Products to be supplied by the Supplier to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause. SUPPLY AGREEMENT - BETWEEN STEVIA VENTURES INTERNATIONAL LTD. AND STEVIA VENTURES CORPORATION On April 12, 2011, Stevia Ventures International Ltd, the subsidiary of the Company also entered into a Supply Agreement (the "Supply Agreement") with Stevia Ventures Corporation ("SVC"), a foreign-invested limited liability company incorporated in Vietnam. (I) SCOPE OF SERVICES Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC. (II) TERM This Agreement shall come into force on the Effective Date and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term"). (III) PURCHASE PRICE SVC and the Company shall review and agree on or before September 30th of each Year on the quantity of the Products to be supplied by the Supplier to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause. 35 CONSULTING AGREEMENT - DORIAN BANKS ENTRY INTO CONSULTING AGREEMENT On July 1, 2011 the Company entered into a consulting agreement (the "Consulting Agreement") with Dorian Banks ("Banks"). (I) SCOPE OF SERVICES Under the terms of the Consulting Agreement, the Company engaged the Consultant to provide advice in general business development, strategy, assistance with new business and land acquisition, introductions, and assistance with Public Relations ("PR") and Investor Relations ("IR"). (II) TERM The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continue until December 31, 2011. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Service performed by Consultant through the date of termination. (III) COMPENSATION The Company shall pay the Consultant a fee of $3,000 per month. EXTENSION OF THE CONSULTING AGREEMENT On December 30, 2011, the Consulting Agreement was extended with the same terms and conditions to December 31, 2012. SUMMARY OF THE CONSULTING FEES For the interim period ended December 31, 2012 and for the period from April 11, 2011 (inception) through December 31, 2011, the Company recorded $27,000 and $18,000 in consulting fees under the Consulting Agreement, respectively. FINANCING CONSULTING AGREEMENT - DAVID CLIFTON ENTRY INTO FINANCIAL CONSULTING AGREEMENT On July 1, 2011 the Company entered into a consulting agreement (the "Consulting Agreement") with David Clifton ( "Clifton"). (I) SCOPE OF SERVICES Under the terms of the Consulting Agreement, the Company engaged Clifton to introduce interested investors to the Company, advise the Company on available financing options and provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake. (II) TERM The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continuing until December 31, 2011. This Agreement may be terminated by either the Company or Clifton at any time prior to the end of the consulting period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Clifton for all service performed by him through the date of termination. On December 31, 2011, the financial consulting agreement expired. 36 (III) COMPENSATION The Company shall pay Clifton a fee of $3,000 per month. SUMMARY OF THE CONSULTING FEES The financial consulting agreement expired on December 31, 2011. For the period from April 11, 2011 (inception) through December 31, 2011, the Company recorded $18,000 in financing cost under this Financing Consulting Agreement. ENTRY INTO ENGAGEMENT AGREEMENT - GARDEN STATE SECURITIES INC. On June 18, 2012, the Company entered into an engagement agreement (the "Agreement") with Garden State Securities Inc. ("GSS") with respect to the engagement of GSS to act as a selling/placement agent for the Company. (I) SCOPE OF SERVICES Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company of "best efforts" Private Placement offering of debt or equity securities to fulfill the Company's business plan, and contacts for the Company possible financing sources. (II) TERM GSS shall act as the Company's exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the "Exclusive Period"). GSS shall act as the Company's non-exclusive placement agent after the Exclusive Period until terminated. (III) COMPENSATION The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company's common stock (the "Securities Financing") during the Exclusive Period; (i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the "Warrants") with "piggy back" registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investor's warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors. The Company will also pay, at closing, the expense of GSS's legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company. In addition, the Company shall cause, at its cost and expense, the "Blue sky filing" and Form D in due and proper form and substance and in a timely manner. NOTE 15 - CONCENTRATIONS AND CREDIT RISK CREDIT RISK Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents. As of December 31, 2012, substantially all of the Company's cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation ("FDIC"). However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts. CUSTOMERS AND CREDIT CONCENTRATIONS One (1) customer accounted for all of the sales for the interim period ended December 31, 2012 and accounts receivable balances at December 31, 2012. A reduction in sales from or loss of such customer would have a material adverse effect on the Company's results of operations and financial condition. 37 VENDORS AND ACCOUNTS PAYABLE CONCENTRATIONS Vendor purchase concentrations and accounts payable concentration are as follows:
Accounts Payable at Net Purchases --------------------- ---------------------- For the Period from For the April 11, 2011 Interim Period (inception) Ended through December 31, March 31, December 31, December 31, 2012 2012 2012 2011 ------ ------ ------ ------ Growers Synergy Pte. Ltd. - related party 42.5% 16.4% 49.8% --% tevia Ventures Corporation 3.7% 54.1% 10.3% --% ------ ------ ------ ------ 46.2% 70.5% 60.1% --% ====== ====== ====== ======
NOTE 16 - SUBSEQUENT EVENTS The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The Management of the Company determined that there no reportable subsequent events to be disclosed. 38 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion should be read in conjunction with our consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Forward looking statements are statements not based on historical information and which relate to future operations, strategies, financial results or other developments. Forward-looking statements are based upon estimates, forecasts, and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by us, or on our behalf. We disclaim any obligation to update forward-looking statements. OVERVIEW We were incorporated on May 21, 2007 in the State of Nevada under the name Interpro Management Corp. On March 4, 2011, we changed our name to Stevia Corp. and effectuated a 35 for 1 forward stock split of all of our issued and outstanding shares of common stock. We are a development stage company that has yet to generate significant revenue. We plan to generate revenues by (i) providing farm management services, which will provide protocols and other services to agriculture, aquaculture, and livestock operators, (ii) the sale of inputs such as fertilizer and feed to agriculture, aquaculture and livestock operators, (iii) the sale of crops and seafood produced under contract farming and (iv) the sale of products derived from the stevia plant. During the past fiscal year, we have begun our first commercial trials of stevia production in Vietnam. In connection with such production we have entered into supply agreements for the off-take of the stevia we produce and entered into an agreement with Growers Synergy Pte Ltd to assist in the management of our Vietnam day-to-day operations. We have also begun to explore commercial applications of stevia derived products and have developed and acquired certain proprietary technology relating to stevia development which we can integrate into our own stevia production and our farm management services. In connection with our intellectual property development efforts we have engaged TechNew Technology Limited ("TechNew), as our technology partner in Vietnam and on July 5, 2012 we entered into a Cooperative Agreement (the "Cooperative Agreement") through our subsidiary Stevia Asia Limited ("Stevia Asia"), with Technew and Zhang Ji, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to engage in a joint venture to develop certain intellectual property related to stevia development, such joint venture to be owned 70% by Stevia Asia and 30% by Technew (the "Joint Venture"). Pursuant to the Cooperative Agreement Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of the Joint Venture and Stevia Asia's financial capabilities. We have also continued to establish research and production relationships with local institutions and companies in Vietnam. In April, 2012 we announced plans to begin field trials in Indonesia. RESULTS OF OPERATIONS Our operations to-date have primarily consisted of securing purchase and supply contracts, office space and a research center, developing relationships with potential partners, and developing products derived from the stevia plant. We have earned nominal revenues since inception. Our auditors have issued a going concern opinion. This means that there is substantial doubt that we can continue as an on-going business for the next twelve months unless we obtain additional capital. The following discussion of the financial condition, results of operations, cash flows, and changes in our financial position should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2012, filed June 29, 2012. Such financial statements have been prepared in conformity with U.S. GAAP and are stated in United States dollars. COMPARISON OF THREE MONTH PERIODS ENDED DECEMBER 31, 2012 AND DECEMBER 31, 2011 For the three month period ended December 31, 2012 we incurred a net loss of $364,601, compared to a net loss of $1,055,874 for the three month period ended December 31, 2011. The decrease was mainly attributed to a decrease in research 39 and development expenses from $39,172 to 0, a decrease in salary and compensation expense from $750,000 to $59,105, and a decrease in income from change in fair value of derivative liability from $0 to $72,723. General and administration expenses and professional fees for the three month period ended December 31, 2012 amounted to $69,302 and $123,356 respectively, compared to $14,868 and $73,454 during the three month period ended December 31, 2011. Research and development fees for the three month period ended December 31, 2012 were $0 compared to $39,172 during the three month period ended December 31, 2011. Directors fees, officer salary and compensation and other salary and compensation were $93,750, $0 and $110,982 respectively, compared to $93,750, $750,000, $0 during the three month period ended December 31, 2011. COMPARISON OF THE NINE MONTH PERIOD ENDED DECEMBER 31, 2012 WITH THE PERIOD FROM INCEPTION (APRIL 11, 2011) TO DECEMBER 31, 2011 For the nine month period ended December 31, 2012 we incurred a net loss of $1,342,473, compared to a net loss of $1,303,241 for the period from April 11, 2011 (inception) through December 31, 2011. The increase was largely attributed to a decrease in gross margin from $(118,700) to $(619,604), offset by an increase in other income from $(43,079) to $247,341. General and administration expenses and professional fees for the nine month period ended December 31, 2012 amounted to $204,616 and $352,031 respectively, compared to $36,160 and $117,183 during the period from April 11, 2011 (inception) through December 31, 2011. Research and development fees for the nine month period ended December 31, 2012 were $118,669 compared to $144,369 during the period from April 11, 2011 (inception) through December 31, 2011. Directors' fees, officer salary and compensation and other salary and compensation for the nine month period ended December 31, 2012 amounted to $281,250, $0 and $110,982 respectively, compared to $93,750, $750,000 and $0 during the period from April 11, 2011 (inception) through December 31, 2011. LIQUIDITY AND CAPITAL RESOURCES As at December 31, 2012 we have $152,653 in current assets, and $1,130,479 in current liabilities. As at December 31, 2012 we have $5,978 in cash. As at December 31, 2012, our total assets were $1,759,319 and our total liabilities were $1,237,040. Our net working capital deficit as at December 31, 2012 was $977,826. During the nine month period ended December 31, 2012, we used cash of $654,431 in operating activities and used cash of $4,889 in investing activities, respectively. During the nine month period ended December 31, 2012, we funded our operations from the proceeds of private sales of equity and convertible notes. During the nine month period ended December 31, 2012, we raised $200,000 through the issuance of convertible notes and $447,500 through the proceeds of sales of common stock, net of costs. On August 1, 2012, we entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with certain accredited investors (the "Financing Stockholders") to raise $500,000 in a private placement financing (the "Offering"). On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Financing Stockholders: (i) an aggregate of 1,066,667 shares of the Company's common stock at a price per share of $0.46875 and (ii) warrants to purchase an equal number of shares of the Company's common stock at an exercise price of $0.6405 with a term of five (5) years, for gross proceeds of $500,000. Garden State Securities, Inc. ("GSS") served as the placement agent for such equity financing. Per the engagement agreement signed between GSS and the Company on June 18, 2012, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to $40,000, or 8.0% of the gross proceeds received in the equity financing, and (ii) issue to GSS or its designee, a warrant to purchase up to 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering) with an exercise price of $0.6405 per share and a term of five (5) years. On December 7, 2012, a Registration Statement on Form S-1 was declared effective, registering a total of 17,018,545 of our shares of common stock (the "Registered Shares"). 14,885,211of the Registered Shares are shares that we may put to Southridge Partners II, LP ("Southridge") pursuant to an equity purchase agreement (the "Equity Purchase Agreement") between Southridge and the Company, effective January 26, 2012. 1,066,667 of the Registered Shares are the shares of common stock issued to the accredited investors pursuant to the Securities Purchase Agreement, and another 1,066,667 of the Registered Shares are shares of common stock underlying warrants issued to such accredited investors pursuant to the Securities Purchase Agreement. 40 We have not put any shares to Southridge pursuant to the Equity Purchase Agreement. We are currently seeking further financing and we believe that will provide sufficient working capital to fund our operations for at least the next six months. Changes in our operating plans, increased expenses, acquisitions, or other events, may cause us to seek additional equity or debt financing in the future. Our current cash requirements are significant due to the planned development and expansion of our business. The successful implementation of our business plan is dependent upon our ability to develop valuable intellectual property relating to stevia through our research programs, as well as our ability to develop and manage our own crop and aquaculture production operations. These planned research and agricultural development activities require significant cash expenditures. We do not expect to generate the necessary cash from our operations during the next 6 to 12 months to carry out these business objectives. As such, in order to fund our operations during the next 6 to 12 months, we anticipate that we will have to raise additional capital through debt and/or equity financings, which may result in substantial dilution to our existing stockholders. There are no assurances that we will be able to raise the required working capital on terms favorable, or that such working capital will be available on any terms when needed. In addition, the terms of the Securities Purchase Agreement contain certain restrictions on our ability to engage in financing transactions for a period of two years from the effective date of the Securities Purchase Agreement. The Securities Purchase Agreement contains carveouts to such financing restrictions for certain exempted transactions including (i) issuances pursuant to a stock option plan, (ii) securities issued upon the conversion of outstanding securities, (iii) securities issued pursuant to acquisitions or other strategic transactions, (iv) up to $500,000 in stock and warrants on the same terms as set forth in the Securities Purchase Agreement, and (v) securities issued pursuant to the Southridge Equity Purchase Agreement. The terms of the Equity Purchase Agreement with Southridge also contain a prohibition on us entering into any equity line of credit with terms substantially comparable to the Equity Purchase Agreement for a period of 36 months following the date of such Equity Purchase Agreement, without Southridge's consent. OFF-BALANCE SHEET ARRANGEMENTS We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholder's equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us. CRITICAL ACCOUNTING ESTIMATES The preparation of financial statements in conformity with generally accepted accounting principles of the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. The more significant areas requiring the use of estimates include asset impairment, stock-based compensation, and future income tax amounts. Management bases its estimates on historical experience and on other assumptions considered to be reasonable under the circumstances. However, actual results may differ from the estimates. The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with GAAP. We believe certain critical accounting policies affect our more significant judgments and estimates used in the preparation of the financial statements. A description of our critical accounting policies is set forth in our Annual Report on Form 10-K for the fiscal year ended March 31, 2012, filed on June 29, 2012. As of, and for the three months ended December 31, 2012, there have been no material changes or updates to our critical accounting policies. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. 41 ITEM 4. CONTROLS AND PROCEDURES EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design of our disclosure controls and procedures (as defined by Exchange Act Rules 13a-15(e) or 15d-15(e)) as of December 31, 2012 pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are not effective as of December 31, 2012 in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms. This conclusion is based on findings that constituted material weaknesses. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company's interim financial statements will not be prevented or detected on a timely basis. In performing the above-referenced assessment, our management identified the following material weaknesses: i) We have not achieved the optimal level of segregation of duties relative to key financial reporting functions. ii) We did not have an audit committee or an independent audit committee financial expert. While not being legally obligated to have an audit committee or independent audit committee financial expert, it is the management's view that to have an audit committee, comprised of independent board members, and an independent audit committee financial expert is an important entity-level control over our financial statements. We are currently reviewing our disclosure controls and procedures related to these material weaknesses and expect to implement changes in the near term, including identifying specific areas within our governance, accounting and financial reporting processes to add adequate resources and personnel to potentially mitigate these material weaknesses. Our present management will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING There were no changes in our internal control over financial reporting that occurred during the quarter ending December 31, 2012 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting. PART II--OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS None. ITEM 1A. RISK FACTORS Not applicable. 42 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS None. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. MINE SAFETY DISCLOSURES Not applicable. ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS Exhibit Number Name ------ ---- 3.1(1) Articles of Incorporation, including all amendments to date 3.2(2) Amended and Restated Bylaws 31 Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer and Principal Financial Officer) 32 Section 1350 Certification 101* Interactive data files pursuant to Rule 405 of Regulation S-T Footnotes to Exhibits Index --------------------------- (1) Incorporated by reference to the Form S-1 filed on July 16, 2008 and the Current Report on Form 8-K filed March 9, 2011. (2) Incorporated by reference to the Current Report on Form 8-K filed on March 22, 2011. * Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability. 43 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized. STEVIA CORP. Dated: February 14, 2013 /s/ George Blankenbaker --------------------------------------- By: George Blankenbaker Its: President, Secretary, Treasurer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
EX-31 2 ex31.txt Exhibit 31 PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER'S CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, George Blankenbaker, certify that: 1. I have reviewed this report on Form 10-Q of Stevia Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Dated: February 14, 2013 /s/ George Blankenbaker ------------------------------------ By: George Blankenbaker Its: President, Secretary, Treasurer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) EX-32 3 ex32.txt Exhibit 32 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the quarterly report of Stevia Corp. (the "Company") on Form 10-Q for the period ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: February 14, 2013 /s/ George Blankenbaker --------------------------------- Name: George Blankenbaker Title: President, Secretary, Treasurer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) EX-101.PRE 4 stev-20121231_pre.xml EX-101.INS 5 stev-20121231.xml 10-Q 2012-12-31 false Stevia Corp 0001439813 --03-31 66555635 Smaller Reporting Company Yes No No 2013 Q3 5978 15698 120659 0 26016 168874 152653 184572 7925 3036 -762 0 7163 3036 1635300 0 -54510 0 1580790 0 -1602 -801 3713 4514 15000 15000 1759319 207122 627929 237288 41689 20220 11445 5400 28178 15521 21238 19138 400000 700000 1130479 997567 106561 0 106561 0 1237040 997567 0 0 63556 58355 4222085 1474751 -3666024 -2323551 619617 -790445 -97338 0 522279 -790445 1759319 207122 5315 5315 3713 4514 0.001 0.001 1000000 1000000 0 0 0 0 0.001 0.001 100000000 100000000 63555635 58354775 63555635 58354775 120939 8142 1300 0 66743 66743 0 0 21250 6250 0 0 652550 60000 120000 60000 740543 132993 120000 60000 -619604 -124851 -118700 -60000 281250 93750 93750 93750 352031 123356 117183 73454 118669 0 144369 39172 0 0 750000 750000 110982 59105 0 0 204616 69302 36160 14868 1067548 345513 1141462 971244 -1687152 -470364 -1260162 -1031244 -305244 -73723 0 0 16125 2807 18000 9000 1316 1 0 0 40462 10130 25123 15630 0 0 -44 0 -247341 -60785 43079 24630 -1439811 -409579 -1303241 -1055874 0 0 0 0 -1439811 -409579 -1303241 -1055874 -97338 -44978 0 0 -1342473 -364601 -1303241 -1055874 -0.02 -0.01 -0.03 -0.02 61613572 63225253 40575587 54854293 6000000 6000 -5900 0 100 0 100 79800000 79800 -198088 0 -118288 0 -118288 -33000000 -33000 33000 0 0 0 0 400000 400 99600 0 100000 0 100000 1400000 1400 348600 0 350000 0 350000 74850 75 18638 0 18713 0 18713 -3000000 -3000 3000 0 0 0 0 3000000 3000 747000 0 750000 0 750000 0 -750000 0 -750000 0 -750000 187500 0 187500 0 187500 3000000 3000 747000 0 750000 0 750000 600000 600 149400 0 150000 0 150000 17425 17 4339 0 4356 0 4356 35000 35 52465 0 52500 0 52500 27500 28 38197 0 38225 0 38225 0 -2323551 -2323551 0 -2323551 58354775 58355 1474751 -2323551 -790445 0 -790445 500000 500 272050 0 272550 0 272550 3000000 3000 1632300 0 1635300 0 1635300 600858 601 499399 0 500000 0 500000 33335 33 27706 0 27739 0 27739 1066667 1067 498933 0 500000 0 500000 0 -381301 -381301 -381301 0 -52500 0 -52500 0 -52500 0 -30504 0 -30504 0 -30504 0 281250 0 281250 0 281250 0 0 -1342473 -1342473 -97338 -1439811 63555635 63556 4222085 -3666024 619617 -97338 522279 -1439811 -1303241 762 0 55311 534 -305244 0 0 750000 281250 93750 272550 0 0 0 -120659 0 142858 -49219 390641 -36067 21469 15150 6045 310 40397 33958 -654431 -509825 -4889 0 0 0 0 -5315 0 3198 -4889 -2117 2100 200 200000 750000 447500 100000 649600 850200 -9720 338258 15698 0 5978 338258 0 0 0 0 500000 350000 27739 18712 <!--egx--><pre><b>NOTE 1 - ORGANIZATION AND OPERATIONS</b></pre><pre>&nbsp;</pre><pre>STEVIA CORP. (FORMERLY INTERPRO MANAGEMENT CORP.)</pre><pre>&nbsp;</pre><pre>Interpro&nbsp; Management Corp&nbsp; ("Interpro") was&nbsp; incorporated&nbsp; under the laws of the</pre><pre>State of Nevada on May 21, 2007. Interpro focused on developing and offering web</pre><pre>based software that was designed to be an online project management tool used to</pre><pre>enhance an organization's&nbsp; efficiency&nbsp; through planning and monitoring the daily</pre><pre>operations&nbsp; of a&nbsp; business.&nbsp; The Company&nbsp; discontinued&nbsp; its&nbsp; web-based&nbsp; software</pre><pre>business upon the acquisition of Stevia Ventures&nbsp; International Ltd. on June 23,</pre><pre>2011.</pre><pre>&nbsp;</pre><pre>On March 4, 2011,&nbsp; Interpro amended its Articles of&nbsp; Incorporation,&nbsp; and changed</pre><pre>its name to Stevia Corp.&nbsp; ("Stevia" or the "Company") and effectuated a 35 for 1</pre><pre>(1:35) forward stock split of all of its issued and outstanding shares of common</pre><pre>stock (the "Stock Split").</pre><pre>&nbsp;</pre><pre>All shares and per share amounts in the consolidated&nbsp; financial&nbsp; statements have</pre><pre>been adjusted to give retroactive effect to the Stock Split.</pre><pre>&nbsp;</pre><pre>STEVIA VENTURES INTERNATIONAL LTD.</pre><pre>&nbsp;</pre><pre>Stevia Ventures&nbsp; International&nbsp; Ltd.&nbsp; ("Ventures") was incorporated on April 11,</pre><pre>2011 under the laws of the&nbsp; Territory&nbsp; of the British&nbsp; Virgin&nbsp; Islands&nbsp; ("BVI").</pre><pre>Ventures owns certain rights relating to stevia&nbsp; production,&nbsp; including&nbsp; certain</pre><pre>assignable&nbsp; exclusive&nbsp; purchase&nbsp; contracts&nbsp; and an assignable&nbsp; supply&nbsp; agreement</pre><pre>related to stevia.</pre><pre>&nbsp;</pre><pre>ACQUISITION&nbsp; OF&nbsp; STEVIA&nbsp; VENTURES&nbsp; INTERNATIONAL&nbsp; LTD.&nbsp; RECOGNIZED&nbsp; AS A REVERSE</pre><pre>ACQUISITION</pre><pre>&nbsp;</pre><pre>On June 23, 2011 (the&nbsp; "Closing&nbsp; Date"),&nbsp; the Company&nbsp; closed a voluntary&nbsp; share</pre><pre>exchange&nbsp; transaction with Ventures pursuant to a Share Exchange&nbsp; Agreement (the</pre><pre>"Share&nbsp; Exchange&nbsp; Agreement")&nbsp; by and among the&nbsp; Company,&nbsp; Ventures&nbsp; and&nbsp; George</pre><pre>Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder").</pre><pre>&nbsp;</pre><pre>Immediately&nbsp; prior to the&nbsp; Share&nbsp; Exchange&nbsp; Transaction&nbsp; on June 23,&nbsp; 2011,&nbsp; the</pre><pre>Company had 79,800,000 common shares issued and outstanding. Simultaneously with</pre><pre>the&nbsp; Closing of the Share&nbsp; Exchange&nbsp; Agreement,&nbsp; on the&nbsp; Closing&nbsp; Date,&nbsp; Mohanad</pre><pre>Shurrab,&nbsp; a&nbsp; shareholder&nbsp; and,&nbsp; as of the Closing&nbsp; Date,&nbsp; the&nbsp; Company's&nbsp; former</pre><pre>Director, President,&nbsp; Treasurer and Secretary,&nbsp; surrendered 33,000,000 shares of</pre><pre>the Company's common stock to the Company for cancellation.</pre><pre>&nbsp;</pre><pre>As a result of the Share&nbsp; Exchange&nbsp; Agreement,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; 12,000,000</pre><pre>common shares for the acquisition of 100% of the issued and&nbsp; outstanding&nbsp; shares</pre><pre>of Ventures.&nbsp; Of the 12,000,000&nbsp; common shares issued 6,000,000 shares are being</pre><pre>held in escrow pending the&nbsp; achievement&nbsp; by the Company of certain&nbsp; post-Closing</pre><pre>business milestones (the&nbsp; "Milestones"),&nbsp; pursuant to the terms of the Make Good</pre><pre>Escrow Agreement,&nbsp; between the Company,&nbsp; Greenberg Traurig, LLP, as escrow agent</pre><pre>and the Ventures'&nbsp; Stockholder (the "Escrow Agreement").&nbsp; Even though the shares</pre><pre>issued only represented approximately 20.4% of the issued and outstanding common</pre><pre>stock&nbsp; immediately&nbsp; after the&nbsp; consummation of the Share Exchange&nbsp; Agreement the</pre><pre>stockholder&nbsp; of&nbsp; Ventures&nbsp; completely&nbsp; took&nbsp; over and&nbsp; controlled&nbsp; the&nbsp; board of</pre><pre>directors and management of the Company upon acquisition.</pre><pre>&nbsp;</pre><pre>As a result of the&nbsp; change in&nbsp; control&nbsp; to the then&nbsp; Ventures&nbsp; Stockholder,&nbsp; for</pre><pre>financial&nbsp; statement&nbsp; reporting&nbsp; purposes,&nbsp; the merger&nbsp; between&nbsp; the Company and</pre><pre>Ventures&nbsp; has been treated as a reverse&nbsp; acquisition&nbsp; with&nbsp; Ventures&nbsp; deemed the</pre><pre>accounting&nbsp; acquirer and the Company&nbsp; deemed the&nbsp; accounting&nbsp; acquiree under the</pre><pre>acquisition&nbsp; method of accounting in&nbsp; accordance&nbsp; with section&nbsp; 805-10-55 of the</pre><pre>FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification.&nbsp; The reverse&nbsp; acquisition is deemed a</pre><pre>capital transaction and the net assets of Ventures (the accounting acquirer) are</pre><pre>carried forward to the Company (the legal acquirer and the reporting&nbsp; entity) at</pre><pre>their carrying value before the&nbsp; acquisition.&nbsp; The acquisition&nbsp; process utilizes</pre><pre>the capital&nbsp; structure of the Company and the assets and liabilities of Ventures</pre><pre>which are recorded at their&nbsp; historical&nbsp; cost.&nbsp; The equity of the Company is the</pre><pre>historical&nbsp; equity of Ventures&nbsp; retroactively&nbsp; restated to reflect the number of</pre><pre>shares issued by the Company in the transaction.</pre><pre>&nbsp;</pre><pre>FORMATION OF STEVIA ASIA LIMITED</pre><pre>&nbsp;</pre><pre>On March 19, 2012, the Company formed Stevia Asia Limited&nbsp; ("Stevia Asia") under</pre><pre>the&nbsp; laws of the Hong&nbsp; Kong&nbsp; Special&nbsp; Administrative&nbsp; Region&nbsp; ("HK&nbsp; SAR") of the</pre><pre>People's Republic of China ("PRC"), a wholly-owned subsidiary.</pre><pre>&nbsp;</pre><pre>FORMATION OF STEVIA TECHNEW&nbsp; LIMITED&nbsp; (FORMERLY&nbsp; HERO TACT&nbsp; LIMITED)/COOPERATIVE</pre><pre>AGREEMENT</pre><pre>&nbsp;</pre><pre>On April 28,&nbsp; 2012,&nbsp; Stevia&nbsp; Asia&nbsp; formed&nbsp; Hero&nbsp; Tact&nbsp; Limited,&nbsp; a&nbsp; wholly-owned</pre><pre>subsidiary,&nbsp; under the laws of HK SAR,&nbsp; which&nbsp; subsequently&nbsp; changed its name to</pre><pre>Stevia Technew Limited ("Stevia Technew").&nbsp; Stevia Technew intends to facilitate</pre><pre>a joint venture&nbsp; relationship with the Company's&nbsp; technology partner,&nbsp; Guangzhou</pre><pre>Health China Technology&nbsp; Development Company Limited,&nbsp; operating under the trade</pre><pre>name Tech-New&nbsp; Bio-Technology&nbsp; and&nbsp; Guangzhou's&nbsp; affiliates&nbsp; Technew&nbsp; Technology</pre><pre>Limited.&nbsp; Prior to July 5, 2012, the date of entry into&nbsp; Cooperative&nbsp; Agreement,</pre><pre>Stevia Technew was inactive and had no assets or liabilities.</pre><pre>&nbsp;</pre><pre>On&nbsp; July&nbsp; 5,&nbsp; 2012,&nbsp; Stevia&nbsp; Asia&nbsp; entered&nbsp; into a&nbsp; Cooperative&nbsp; Agreement&nbsp; (the</pre><pre>"Cooperative Agreement") with Technew Technology Limited ("Technew"),&nbsp; a company</pre><pre>incorporated&nbsp; under the&nbsp; companies&nbsp; ordinance&nbsp; of Hong Kong and an&nbsp; associate of</pre><pre>Guangzhou Health China Technology&nbsp; Development Company Limited, and Zhang Jia, a</pre><pre>Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia</pre><pre>Asia and Partners have agreed to make Stevia Technew, a joint venture,&nbsp; of which</pre><pre>Stevia Asia legally and beneficially owns 70% of the shares (representing 70% of</pre><pre>the issued shares) and Technew legally and&nbsp; beneficially&nbsp; owns 30% of the shares</pre><pre>(representing&nbsp; 30% of the issued&nbsp; shares).&nbsp; The Partners will be responsible for</pre><pre>managing&nbsp; Stevia&nbsp; Technew and Stevia Asia has agreed to contribute&nbsp; $200,000 per</pre><pre>month,&nbsp; up to a total of $2,000,000 in financing,&nbsp; subject to the performance of</pre><pre>Stevia Technew and Stevia Asia's financial capabilities.</pre><pre>&nbsp;</pre><pre>The Cooperative Agreement shall automatically&nbsp; terminate upon either Stevia Asia</pre><pre>or Technew ceasing to be a shareholder in Stevia&nbsp; Technew,&nbsp; or may be terminated</pre><pre>by either Stevia Asia or Technew upon a material breach by the other party which</pre><pre>is not cured within 30 days of notice of such breach.</pre> <!--egx--><pre><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></pre><pre>&nbsp;</pre><pre>BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION</pre><pre>&nbsp;</pre><pre>The accompanying&nbsp; unaudited interim financial&nbsp; statements and related notes have</pre><pre>been prepared in accordance with accounting principles generally accepted in the</pre><pre>United States of America ("U.S.&nbsp; GAAP") for interim financial&nbsp; information,&nbsp; and</pre><pre>with the rules and&nbsp; regulations&nbsp; of the United&nbsp; States&nbsp; Securities&nbsp; and Exchange</pre><pre>Commission&nbsp; ("SEC") to Form 10-Q and Article 8 of Regulation&nbsp; S-X.&nbsp; Accordingly,</pre><pre>they do not include all of the information&nbsp; and footnotes&nbsp; required by U.S. GAAP</pre><pre>for complete financial&nbsp; statements.&nbsp; The unaudited interim financial&nbsp; statements</pre><pre>furnished&nbsp; reflect all&nbsp; adjustments&nbsp; (consisting of normal&nbsp; recurring&nbsp; accruals)</pre><pre>which are, in the opinion of&nbsp; management,&nbsp; necessary to a fair&nbsp; statement of the</pre><pre>results for the interim periods&nbsp; presented.&nbsp; Interim results are not necessarily</pre><pre>indicative of the results for the full fiscal year.&nbsp; These financial&nbsp; statements</pre><pre>should be read in conjunction&nbsp; with the financial&nbsp; statements of the Company for</pre><pre>the period&nbsp; from April 11,&nbsp; 2011&nbsp; (inception)&nbsp; through&nbsp; March 31, 2012 and notes</pre><pre>thereto&nbsp; contained in the Company's Annual Report on Form 10-K as filed with the</pre><pre>SEC on June 29, 2012.</pre><pre>&nbsp;</pre><pre>PRINCIPLES OF CONSOLIDATION</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; applies&nbsp; the&nbsp; guidance&nbsp; of Topic 810&nbsp; "CONSOLIDATION"&nbsp; of the FASB</pre><pre>Accounting&nbsp; Standards&nbsp; Codification to determine&nbsp; whether and how to consolidate</pre><pre>another&nbsp; entity.&nbsp; Pursuant&nbsp; to ASC&nbsp; Paragraph&nbsp; 810-10-15-10&nbsp; all&nbsp; majority-owned</pre><pre>subsidiaries--all&nbsp; entities&nbsp; in&nbsp; which&nbsp; a&nbsp; parent&nbsp; has a&nbsp; controlling&nbsp; financial</pre><pre>interest--shall&nbsp; be consolidated&nbsp; except (1) when control does not rest with the</pre><pre>parent,&nbsp; the majority&nbsp; owner;&nbsp; (2) if the parent is a&nbsp; broker-dealer&nbsp; within the</pre><pre>scope of Topic 940 and control is likely to be temporary;&nbsp; (3)&nbsp; consolidation by</pre><pre>an investment company within the scope of Topic 946 of a&nbsp; non-investment-company</pre><pre>investee.&nbsp; Pursuant&nbsp; to ASC&nbsp; Paragraph&nbsp; 810-10-15-8&nbsp; the usual&nbsp; condition&nbsp; for a</pre><pre>controlling financial interest is ownership of a majority voting interest,&nbsp; and,</pre><pre>therefore,&nbsp; as a general rule&nbsp; ownership by one&nbsp; reporting&nbsp; entity,&nbsp; directly or</pre><pre>indirectly,&nbsp; of more than 50 percent of the outstanding voting shares of another</pre><pre>entity is a condition&nbsp; pointing toward&nbsp; consolidation.&nbsp; The power to control may</pre><pre>also exist with a lesser&nbsp; percentage&nbsp; of&nbsp; ownership,&nbsp; for example,&nbsp; by contract,</pre><pre>lease,&nbsp; agreement&nbsp; with other&nbsp; stockholders,&nbsp; or by court&nbsp; decree.&nbsp; The&nbsp; Company</pre><pre>consolidates all&nbsp; less-than-majority-owned&nbsp; subsidiaries,&nbsp; in which the parent's</pre><pre>power to control exists.</pre><pre>&nbsp;</pre><pre>The Company's consolidated subsidiaries and/or entities are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date of incorporation</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or formation</pre><pre>Name of consolidated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State or other jurisdiction of&nbsp;&nbsp;&nbsp;&nbsp; (date of acquisition,</pre><pre>subsidiary or entity&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; incorporation or organization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if applicable)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attributable interest</pre><pre>--------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------</pre><pre>&nbsp;</pre><pre>Stevia Ventures&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Territory of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100%</pre><pre>International Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; British Virgin Islands</pre><pre>&nbsp;</pre><pre>Stevia Asia Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hong Kong SAR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 19, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100%</pre><pre>&nbsp;</pre><pre>Stevia Technew Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hong Kong SAR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 28, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70%</pre><pre>&nbsp;</pre><pre>The consolidated&nbsp; financial statements include all accounts of the Company as of</pre><pre>December&nbsp; 31,&nbsp; 2012,&nbsp; for the interim&nbsp; period then ended and for the period from</pre><pre>June 23, 2011 (date of acquisition)&nbsp; through December 31, 2011;&nbsp; Stevia Ventures</pre><pre>International&nbsp; Ltd. as of December 31, 2012,&nbsp; for the interim&nbsp; period then ended</pre><pre>and for the period from April 11, 2011&nbsp; (inception)&nbsp; through&nbsp; December 31, 2011;</pre><pre>Stevia Asia&nbsp; Limited as of&nbsp; December&nbsp; 31, 2012 and for the period from March 19,</pre><pre>2012&nbsp; (inception)&nbsp; through&nbsp; December 31, 2012; and Stevia Technew&nbsp; Limited as of</pre><pre>December&nbsp; 31, 2012 and for the period from April 28,&nbsp; 2012&nbsp; (inception)&nbsp; through</pre><pre>December 31, 2012.</pre><pre>&nbsp;</pre><pre>All inter-company balances and transactions have been eliminated.</pre><pre>&nbsp;</pre><pre>RECLASSIFICATION</pre><pre>&nbsp;</pre><pre>Certain amounts in the prior period financial&nbsp; statements have been reclassified</pre><pre>to conform to the current period presentation.&nbsp; These&nbsp; reclassifications&nbsp; had no</pre><pre>effect on reported losses.</pre><pre>&nbsp;</pre><pre>USE OF ESTIMATES AND ASSUMPTIONS</pre><pre>&nbsp;</pre><pre>The preparation of financial statements in conformity with accounting principles</pre><pre>generally&nbsp; accepted in the United States of America requires&nbsp; management to make</pre><pre>estimates&nbsp; and&nbsp; assumptions&nbsp; that&nbsp; affect&nbsp; the&nbsp; reported&nbsp; amounts&nbsp; of assets and</pre><pre>liabilities&nbsp; and disclosure of contingent&nbsp; assets and liabilities at the date of</pre><pre>the&nbsp; financial&nbsp; statements&nbsp; and the&nbsp; reported&nbsp; amounts of revenues&nbsp; and expenses</pre><pre>during the reporting period.</pre><pre>&nbsp;</pre><pre>The Company's&nbsp; significant&nbsp; estimates and assumptions&nbsp; include the fair value of</pre><pre>financial&nbsp; instruments;&nbsp; the carrying&nbsp; value,&nbsp; recoverability&nbsp; and impairment of</pre><pre>long-lived&nbsp; assets,&nbsp; including the values&nbsp; assigned to and the estimated&nbsp; useful</pre><pre>lives of&nbsp; website&nbsp; development&nbsp; costs;&nbsp; interest&nbsp; rate;&nbsp; revenue&nbsp; recognized&nbsp; or</pre><pre>recognizable;&nbsp; sales returns and&nbsp; allowances;&nbsp; foreign&nbsp; currency&nbsp; exchange rate;</pre><pre>income&nbsp; tax rate,&nbsp; income tax&nbsp; provision,&nbsp; deferred&nbsp; tax&nbsp; assets&nbsp; and&nbsp; valuation</pre><pre>allowance of deferred&nbsp; tax assets;&nbsp; expected&nbsp; term of share&nbsp; options and similar</pre><pre>instruments,&nbsp; expected&nbsp; volatility of the entity's shares and the method used to</pre><pre>estimate it, expected annual rate of quarterly dividends, and risk free rate(s);</pre><pre>and the&nbsp; assumption&nbsp; that the Company will&nbsp; continue as a going&nbsp; concern.&nbsp; Those</pre><pre>significant&nbsp; accounting&nbsp; estimates or assumptions bear the risk of change due to</pre><pre>the&nbsp; fact&nbsp; that&nbsp; there&nbsp; are&nbsp;&nbsp; uncertainties&nbsp;&nbsp; attached&nbsp; to&nbsp; those&nbsp; estimates&nbsp; or</pre><pre>assumptions,&nbsp; and certain&nbsp; estimates or assumptions&nbsp; are difficult to measure or</pre><pre>value.</pre><pre>&nbsp;</pre><pre>Management&nbsp; bases&nbsp; its&nbsp; estimates&nbsp; on&nbsp; historical&nbsp;&nbsp; experience&nbsp; and&nbsp; on&nbsp; various</pre><pre>assumptions&nbsp; that are&nbsp; believed to be&nbsp; reasonable&nbsp; in relation to the&nbsp; financial</pre><pre>statements taken as a whole under the&nbsp; circumstances,&nbsp; the results of which form</pre><pre>the&nbsp; basis&nbsp; for&nbsp; making&nbsp; judgments&nbsp; about the&nbsp; carrying&nbsp; values&nbsp; of&nbsp; assets&nbsp; and</pre><pre>liabilities that are not readily apparent from other sources.</pre><pre>&nbsp;</pre><pre>Management&nbsp; regularly&nbsp; evaluates the key factors and assumptions used to develop</pre><pre>the estimates utilizing currently&nbsp; available&nbsp; information,&nbsp; changes in facts and</pre><pre>circumstances,&nbsp; historical&nbsp; experience&nbsp; and reasonable&nbsp; assumptions.&nbsp; After such</pre><pre>evaluations, if deemed appropriate, those estimates are adjusted accordingly.</pre><pre>&nbsp;</pre><pre>Actual results could differ from those estimates.</pre><pre>&nbsp;</pre><pre>FAIR VALUE OF FINANCIAL INSTRUMENTS</pre><pre>&nbsp;</pre><pre>The Company follows&nbsp; paragraph&nbsp; 820-10-35-37&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification&nbsp; ("Paragraph&nbsp; 820-10-35-37")&nbsp; to&nbsp; measure&nbsp; the&nbsp; fair&nbsp; value&nbsp; of its</pre><pre>financial&nbsp; instruments&nbsp; and&nbsp; paragraph&nbsp;&nbsp; 825-10-50-10&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting</pre><pre>Standards&nbsp; Codification&nbsp; for&nbsp; disclosures&nbsp; about&nbsp; fair&nbsp; value&nbsp; of its&nbsp; financial</pre><pre>instruments.&nbsp; Paragraph 820-10-35-37&nbsp; establishes a framework for measuring fair</pre><pre>value in&nbsp; accounting&nbsp; principles&nbsp; generally&nbsp; accepted&nbsp; in the&nbsp; United&nbsp; States of</pre><pre>America (U.S. GAAP), and expands disclosures about fair value&nbsp; measurements.&nbsp; To</pre><pre>increase&nbsp; consistency and&nbsp; comparability in fair value&nbsp; measurements and related</pre><pre>disclosures,&nbsp; Paragraph&nbsp; 820-10-35-37&nbsp; establishes a fair value&nbsp; hierarchy which</pre><pre>prioritizes&nbsp; the inputs to valuation&nbsp; techniques used to measure fair value into</pre><pre>three (3) broad levels.&nbsp; The three (3) levels of fair value hierarchy defined by</pre><pre>Paragraph 820-10-35-37 are described below:</pre><pre>&nbsp;</pre><pre>Level 1&nbsp;&nbsp;&nbsp; Quoted market prices available in active markets for identical assets</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or liabilities as of the reporting date.</pre><pre>&nbsp;</pre><pre>Level 2&nbsp;&nbsp;&nbsp; Pricing inputs other than quoted prices in active markets included in</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Level 1, which are either directly or indirectly observable as of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reporting date.</pre><pre>&nbsp;</pre><pre>Level 3&nbsp;&nbsp;&nbsp; Pricing&nbsp; inputs&nbsp; that&nbsp; are&nbsp; generally&nbsp;&nbsp; observable&nbsp;&nbsp; inputs&nbsp; and&nbsp; not</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; corroborated by market data.</pre><pre>&nbsp;</pre><pre>Financial&nbsp; assets are&nbsp; considered&nbsp; Level 3 when their fair values are determined</pre><pre>using pricing models,&nbsp; discounted cash flow&nbsp; methodologies or similar techniques</pre><pre>and at least one significant model assumption or input is unobservable.</pre><pre>&nbsp;</pre><pre>The&nbsp; fair&nbsp; value&nbsp; hierarchy&nbsp;&nbsp; gives&nbsp; the&nbsp; highest&nbsp;&nbsp; priority&nbsp; to&nbsp; quoted&nbsp; prices</pre><pre>(unadjusted)&nbsp; in active&nbsp; markets for&nbsp; identical&nbsp; assets or&nbsp; liabilities&nbsp; and the</pre><pre>lowest&nbsp; priority&nbsp; to &nbsp;unobservable&nbsp; inputs.&nbsp; If the inputs&nbsp; used to measure&nbsp; the</pre><pre>financial&nbsp; assets and&nbsp; liabilities&nbsp; fall&nbsp; within&nbsp; more than one level&nbsp; described</pre><pre>above, the categorization is based on the lowest level input that is significant</pre><pre>to the fair value measurement of the instrument.</pre><pre>&nbsp;</pre><pre>The carrying amounts of the Company's financial assets and liabilities,&nbsp; such as</pre><pre>cash,&nbsp; accounts&nbsp; receivable,&nbsp; prepayments&nbsp; and other&nbsp; current&nbsp; assets,&nbsp; accounts</pre><pre>payable,&nbsp; accrued expenses, and accrued interest,&nbsp; approximate their fair values</pre><pre>because of the short maturity of these instruments.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company's&nbsp; convertible&nbsp; notes payable&nbsp; approximates&nbsp; the fair value of such</pre><pre>instrument based upon management's best estimate of interest rates that would be</pre><pre>available to the Company for similar financial arrangements at December 31, 2012</pre><pre>and March 31, 2012.</pre><pre>&nbsp;</pre><pre>The Company's Level 3 financial&nbsp; liabilities&nbsp; consist of the derivative&nbsp; warrant</pre><pre>issued in August 2012 for which there is no current market for these&nbsp; securities</pre><pre>such that the&nbsp; determination&nbsp; of fair value&nbsp; requires&nbsp; significant&nbsp; judgment&nbsp; or</pre><pre>estimation.&nbsp;&nbsp; The&nbsp; Company&nbsp;&nbsp; valued&nbsp; the&nbsp;&nbsp; automatic&nbsp;&nbsp; conditional&nbsp;&nbsp; conversion,</pre><pre>re-pricing/down-round,&nbsp;&nbsp; change&nbsp; of&nbsp; control;&nbsp; default&nbsp; and&nbsp; follow-on&nbsp; offering</pre><pre>provisions using a lattice model, with the assistance of a third party valuation</pre><pre>specialist,&nbsp; for which management&nbsp; understands the&nbsp; methodologies.&nbsp; These models</pre><pre>incorporate transaction details such as Company stock price,&nbsp; contractual terms,</pre><pre>maturity,&nbsp; risk free rates,&nbsp; as well as&nbsp; assumptions&nbsp; about&nbsp; future&nbsp; financings,</pre><pre>volatility,&nbsp; and holder&nbsp; behavior&nbsp; as of the date of issuance&nbsp; and each&nbsp; balance</pre><pre>sheet date.</pre><pre>&nbsp;</pre><pre>It is not,&nbsp; however,&nbsp; practical&nbsp; to&nbsp; determine&nbsp; the fair value of advances&nbsp; from</pre><pre>president&nbsp; and&nbsp; significant&nbsp; stockholder,&nbsp; if any,&nbsp; due to their&nbsp; related&nbsp; party</pre><pre>nature.</pre><pre>&nbsp;</pre><pre>FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS</pre><pre>&nbsp;</pre><pre>LEVEL 3 FINANCIAL LIABILITIES - DERIVATIVE WARRANT LIABILITIES</pre><pre>&nbsp;</pre><pre>The Company&nbsp; uses Level 3 of the fair value&nbsp; hierarchy to measure the fair value</pre><pre>of the derivative&nbsp; liabilities and revalues its derivative&nbsp; warrant liability at</pre><pre>every&nbsp; reporting&nbsp; period&nbsp; and&nbsp; recognizes&nbsp; gains or losses&nbsp; in the&nbsp; consolidated</pre><pre>statements of operations and&nbsp; comprehensive&nbsp; income (loss) that are attributable</pre><pre>to the change in the fair value of the derivative warrant liability.</pre><pre>&nbsp;</pre><pre>CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS</pre><pre>&nbsp;</pre><pre>The Company has adopted paragraph&nbsp; 360-10-35-17 of the FASB Accounting Standards</pre><pre>Codification for its long-lived assets. The Company's&nbsp; long-lived assets,&nbsp; which</pre><pre>include property and equipment,&nbsp; acquired&nbsp; technology,&nbsp; and website&nbsp; development</pre><pre>costs are reviewed for impairment&nbsp; whenever&nbsp; events or changes in&nbsp; circumstances</pre><pre>indicate that the carrying amount of an asset may not be recoverable.</pre><pre>&nbsp;</pre><pre>The Company assesses the&nbsp; recoverability&nbsp; of its long-lived&nbsp; assets by comparing</pre><pre>the projected undiscounted net cash flows associated with the related long-lived</pre><pre>asset or group of long-lived assets over their remaining&nbsp; estimated useful lives</pre><pre>against their respective carrying amounts.&nbsp; Impairment,&nbsp; if any, is based on the</pre><pre>excess of the carrying amount over the fair value of those assets. Fair value is</pre><pre>generally&nbsp; determined using the asset's expected future discounted cash flows or</pre><pre>market value, if readily determinable. If long-lived assets are determined to be</pre><pre>recoverable,&nbsp; but the newly&nbsp; determined&nbsp; remaining&nbsp; estimated&nbsp; useful&nbsp; lives are</pre><pre>shorter than originally estimated,&nbsp; the net book values of the long-lived assets</pre><pre>are depreciated over the newly determined remaining estimated useful lives.</pre><pre>&nbsp;</pre><pre>The Company considers the following to be some examples of important&nbsp; indicators</pre><pre>that may trigger an impairment&nbsp; review:&nbsp; (i)&nbsp; significant&nbsp; under-performance&nbsp; or</pre><pre>losses of assets relative to expected&nbsp; historical or projected&nbsp; future operating</pre><pre>results;&nbsp; (ii)&nbsp; significant&nbsp; changes&nbsp; in the&nbsp; manner&nbsp; or use of assets or in the</pre><pre>Company's&nbsp; overall&nbsp; strategy&nbsp; with&nbsp; respect to the manner or use of the acquired</pre><pre>assets or changes in the Company's overall business strategy;&nbsp; (iii) significant</pre><pre>negative industry or economic trends; (iv) increased competitive pressures;&nbsp; (v)</pre><pre>a&nbsp; significant&nbsp; decline in the Company's&nbsp; stock price for a sustained&nbsp; period of</pre><pre>time; and (vi) regulatory&nbsp; changes.&nbsp; The Company&nbsp; evaluates&nbsp; acquired assets for</pre><pre>potential&nbsp; impairment&nbsp; indicators at least annually and more frequently upon the</pre><pre>occurrence of such events.</pre><pre>&nbsp;</pre><pre>The key assumptions&nbsp; used in management's&nbsp; estimates of projected cash flow deal</pre><pre>largely with&nbsp; forecasts of sales levels and gross margins.&nbsp; These&nbsp; forecasts are</pre><pre>typically based on historical&nbsp; trends and take into account recent&nbsp; developments</pre><pre>as well as management's plans and intentions.&nbsp; Other factors,&nbsp; such as increased</pre><pre>competition&nbsp; or a decrease&nbsp; in the&nbsp; desirability&nbsp; of the&nbsp; Company's&nbsp; products or</pre><pre>services,&nbsp; could lead to lower&nbsp; projected&nbsp; sales levels,&nbsp; which would&nbsp; adversely</pre><pre>impact cash flows. A significant change in cash flows in the future could result</pre><pre>in an impairment of long lived assets.</pre><pre>&nbsp;</pre><pre>The&nbsp; impairment&nbsp; charges,&nbsp; if any,&nbsp; is&nbsp; included&nbsp; in&nbsp; operating&nbsp; expenses in the</pre><pre>accompanying consolidated statements of operations.</pre><pre>&nbsp;</pre><pre>FISCAL YEAR END</pre><pre>&nbsp;</pre><pre>The Company elected March 31 as its fiscal year ending date.</pre><pre>&nbsp;</pre><pre>CASH EQUIVALENTS</pre><pre>&nbsp;</pre><pre>The Company&nbsp; considers all highly liquid&nbsp; investments&nbsp; with&nbsp; maturities of three</pre><pre>months or less at the time of purchase to be cash equivalents.</pre><pre>&nbsp;</pre><pre>PROPERTY AND EQUIPMENT</pre><pre>&nbsp;</pre><pre>Property and equipment is recorded at cost. Expenditures for major additions and</pre><pre>betterments are&nbsp; capitalized.&nbsp; Maintenance and repairs are charged to operations</pre><pre>as&nbsp; incurred.&nbsp;&nbsp; Depreciation&nbsp; of&nbsp; furniture&nbsp; and&nbsp; fixture&nbsp; is&nbsp; computed&nbsp; by&nbsp; the</pre><pre>straight-line&nbsp; method&nbsp; (after&nbsp; taking into account&nbsp; their&nbsp; respective&nbsp; estimated</pre><pre>residual values) over the assets&nbsp; estimated useful life of five (5) years.&nbsp; Upon</pre><pre>sale or retirement of property and equipment,&nbsp; the related cost and&nbsp; accumulated</pre><pre>depreciation&nbsp; are removed from the accounts and any gain or loss is reflected in</pre><pre>the statements of operations.</pre><pre>&nbsp;</pre><pre>INTANGIBLE ASSETS OTHER THAN GOODWILL</pre><pre>&nbsp;</pre><pre>The Company has adopted paragraph&nbsp; 350-30-25-3 of the FASB Accounting&nbsp; Standards</pre><pre>Codification for intangible assets other than goodwill.&nbsp; Under the requirements,</pre><pre>the Company&nbsp; amortizes the&nbsp; acquisition&nbsp; costs of&nbsp; intangible&nbsp; assets other than</pre><pre>goodwill&nbsp; inclusive of acquired&nbsp; technology and website&nbsp; development&nbsp; costs on a</pre><pre>straight-line&nbsp; basis over their relevant&nbsp; estimated useful lives of fifteen (15)</pre><pre>and five (5) years,&nbsp; respectively.&nbsp; Upon becoming fully&nbsp; amortized,&nbsp; the related</pre><pre>cost and accumulated amortization are removed from the accounts.</pre><pre>&nbsp;</pre><pre>RELATED PARTIES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; follows&nbsp;&nbsp; subtopic&nbsp;&nbsp; 850-10&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification for the identification of related parties and disclosure of related</pre><pre>party transactions.</pre><pre>&nbsp;</pre><pre>Pursuant to Section&nbsp; 850-10-20 the related&nbsp; parties include a. affiliates of the</pre><pre>Company;&nbsp; b. entities for which&nbsp; investments in their equity securities would be</pre><pre>required,&nbsp; absent the&nbsp; election&nbsp; of the fair value&nbsp; option&nbsp; under the Fair Value</pre><pre>Option Subsection of Section 825-10-15, to be accounted for by the equity method</pre><pre>by the investing entity; c. trusts for the benefit of employees, such as pension</pre><pre>and&nbsp; profit-sharing&nbsp; trusts&nbsp; that are&nbsp; managed&nbsp; by or under the&nbsp; trusteeship&nbsp; of</pre><pre>management; d. principal owners of the Company; e. management of the Company; f.</pre><pre>other&nbsp; parties&nbsp; with which the&nbsp; Company&nbsp; may deal if one party&nbsp; controls&nbsp; or can</pre><pre>significantly&nbsp; influence the management or operating policies of the other to an</pre><pre>extent&nbsp; that one of the&nbsp; transacting&nbsp; parties&nbsp; might&nbsp; be&nbsp; prevented&nbsp; from&nbsp; fully</pre><pre>pursuing its own separate interests; and g. other parties that can significantly</pre><pre>influence the&nbsp; management or operating&nbsp; policies of the&nbsp; transacting&nbsp; parties or</pre><pre>that&nbsp; have an&nbsp; ownership&nbsp; interest&nbsp; in one of the&nbsp; transacting&nbsp; parties&nbsp; and can</pre><pre>significantly&nbsp; influence&nbsp; the&nbsp; other&nbsp; to an&nbsp; extent&nbsp; that&nbsp; one&nbsp; or&nbsp; more&nbsp; of the</pre><pre>transacting&nbsp; parties&nbsp; might be&nbsp; prevented&nbsp; from fully&nbsp; pursuing its own separate</pre><pre>interests.</pre><pre>&nbsp;</pre><pre>The financial&nbsp; statements&nbsp; shall include&nbsp; disclosures of material&nbsp; related party</pre><pre>transactions,&nbsp; other than compensation&nbsp; arrangements,&nbsp; expense&nbsp; allowances,&nbsp; and</pre><pre>other similar items in the ordinary course of business.&nbsp; However,&nbsp; disclosure of</pre><pre>transactions&nbsp; that are eliminated in the preparation of consolidated or combined</pre><pre>financial statements is not required in those statements.&nbsp; The disclosures shall</pre><pre>include: a. the nature of the relationship(s)&nbsp; involved; b. a description of the</pre><pre>transactions, including transactions to which no amounts or nominal amounts were</pre><pre>ascribed, for each of the periods for which income statements are presented, and</pre><pre>such other&nbsp; information&nbsp; deemed&nbsp; necessary to an understanding of the effects of</pre><pre>the&nbsp; transactions&nbsp; on&nbsp; the&nbsp; financial&nbsp; statements;&nbsp; c.&nbsp; the&nbsp; dollar&nbsp; amounts&nbsp; of</pre><pre>transactions&nbsp; for each of the periods for which income&nbsp; statements are presented</pre><pre>and the effects of any change in the method of establishing&nbsp; the terms from that</pre><pre>used in the preceding&nbsp; period;&nbsp; and d. amounts due from or to related parties as</pre><pre>of the date of each balance sheet presented and, if not otherwise apparent,&nbsp; the</pre><pre>terms and manner of settlement.</pre><pre>&nbsp;</pre><pre>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</pre><pre>&nbsp;</pre><pre>The Company&nbsp; accounts&nbsp; for&nbsp; derivative&nbsp; instruments&nbsp; and hedging&nbsp; activities&nbsp; in</pre><pre>accordance&nbsp; with&nbsp; paragraph&nbsp;&nbsp; 810-10-05-4&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies</pre><pre>to recognize all&nbsp; derivative&nbsp; instruments as either assets or liabilities in the</pre><pre>balance sheet at fair value.&nbsp; The&nbsp; accounting for changes in the fair value of a</pre><pre>derivative&nbsp; instrument&nbsp; depends&nbsp; upon:&nbsp; (i)&nbsp; whether&nbsp; the&nbsp; derivative&nbsp; has&nbsp; been</pre><pre>designated and qualifies as part of a hedging relationship, and (ii) the type of</pre><pre>hedging relationship.&nbsp; For those derivative&nbsp; instruments that are designated and</pre><pre>qualify as hedging instruments,&nbsp; a company must designate the hedging instrument</pre><pre>based upon the exposure&nbsp; being&nbsp; hedged as either a fair value&nbsp; hedge,&nbsp; cash flow</pre><pre>hedge or hedge of a net investment in a foreign operation.</pre><pre>&nbsp;</pre><pre>From time to time, the Company may employ foreign currency forward&nbsp; contracts to</pre><pre>convert&nbsp; unforeseeable foreign currency exchange rates to fixed foreign currency</pre><pre>exchange rates.&nbsp; The Company does not use derivatives for speculation or trading</pre><pre>purposes.&nbsp; Changes in the fair value of derivatives&nbsp; are recorded each period in</pre><pre>current earnings or through other comprehensive&nbsp; income,&nbsp; depending on whether a</pre><pre>derivative is designated&nbsp; as part of a hedge&nbsp; transaction&nbsp; and the type of hedge</pre><pre>transaction.&nbsp; The&nbsp; ineffective&nbsp; portion of all hedges is&nbsp; recognized&nbsp; in current</pre><pre>earnings. The Company has sales and purchase commitments&nbsp; denominated in foreign</pre><pre>currencies.&nbsp; Foreign&nbsp; currency&nbsp; forward&nbsp; contracts are used to hedge against the</pre><pre>risk&nbsp; of&nbsp; change&nbsp; in&nbsp; the&nbsp; fair&nbsp; value &nbsp;of&nbsp; these&nbsp; commitments&nbsp; attributable&nbsp; to</pre><pre>fluctuations in exchange rates ("Fair Value Hedges").&nbsp; Changes in the fair value</pre><pre>of the&nbsp; derivative&nbsp; instrument are generally&nbsp; offset in the income&nbsp; statement by</pre><pre>changes in the fair value of the item being hedged.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; did not&nbsp; employ&nbsp; foreign&nbsp; currency&nbsp; forward&nbsp; contracts&nbsp; to convert</pre><pre>unforeseeable foreign currency exchange rates to fixed foreign currency exchange</pre><pre>rates for the interim period ended December 31, 2012 or 2011.</pre><pre>&nbsp;</pre><pre>DERIVATIVE LIABILITY</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; evaluates&nbsp; its&nbsp; convertible&nbsp; debt,&nbsp; options,&nbsp;&nbsp; warrants&nbsp; or&nbsp; other</pre><pre>contracts,&nbsp; if any, to determine if those&nbsp; contracts or embedded&nbsp; components&nbsp; of</pre><pre>those&nbsp; contracts&nbsp; qualify&nbsp; as&nbsp; derivatives&nbsp; to be&nbsp; separately&nbsp; accounted&nbsp; for in</pre><pre>accordance&nbsp; with&nbsp; paragraph&nbsp; 810-10-05-4&nbsp; and&nbsp; Section&nbsp; 815-40-25&nbsp; of&nbsp; the&nbsp; FASB</pre><pre>Accounting&nbsp; Standards&nbsp; Codification.&nbsp; The result of this accounting treatment is</pre><pre>that the fair value of the embedded derivative is marked-to-market&nbsp; each balance</pre><pre>sheet date and recorded as either an asset or a liability. In the event that the</pre><pre>fair value is recorded as a&nbsp; liability,&nbsp; the change in fair value is recorded in</pre><pre>the&nbsp; consolidated&nbsp; statement of operations&nbsp; and&nbsp; comprehensive&nbsp; income (loss) as</pre><pre>other&nbsp; income&nbsp; or&nbsp; expense.&nbsp; Upon&nbsp; conversion, &nbsp;exercise&nbsp; or&nbsp; cancellation&nbsp; of a</pre><pre>derivative&nbsp; instrument,&nbsp; the&nbsp; instrument&nbsp; is marked to fair value at the date of</pre><pre>conversion,&nbsp; exercise or&nbsp; cancellation&nbsp; and then that the related&nbsp; fair value is</pre><pre>reclassified to equity.</pre><pre>&nbsp;</pre><pre>In&nbsp; circumstances&nbsp;&nbsp; where&nbsp; the&nbsp; embedded&nbsp; conversion&nbsp; option&nbsp; in&nbsp; a&nbsp; convertible</pre><pre>instrument&nbsp; is&nbsp; required&nbsp; to be&nbsp; bifurcated&nbsp; and there are also&nbsp; other&nbsp; embedded</pre><pre>derivative&nbsp; instruments in the&nbsp; convertible&nbsp; instrument&nbsp; that are required to be</pre><pre>bifurcated, the bifurcated derivative instruments are accounted for as a single,</pre><pre>compound derivative instrument.</pre><pre>&nbsp;</pre><pre>The classification of derivative instruments, including whether such instruments</pre><pre>should be recorded as&nbsp; liabilities&nbsp; or as equity,&nbsp; is&nbsp; re-assessed at the end of</pre><pre>each&nbsp; reporting&nbsp; period.&nbsp; Equity&nbsp; instruments&nbsp; that are initially&nbsp; classified as</pre><pre>equity that become subject to reclassification&nbsp; are reclassified to liability at</pre><pre>the fair&nbsp; value&nbsp; of the&nbsp; instrument&nbsp; on the&nbsp; reclassification&nbsp; date.&nbsp; Derivative</pre><pre>instrument&nbsp; liabilities&nbsp; will be&nbsp; classified&nbsp; in the balance sheet as current or</pre><pre>non-current&nbsp; based on&nbsp; whether&nbsp; or not&nbsp; net-cash&nbsp; settlement&nbsp; of the&nbsp; derivative</pre><pre>instrument is expected within 12 months of the balance sheet date.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; adopted&nbsp; Section&nbsp; 815-40-15&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification&nbsp; ("Section&nbsp; 815-40-15")&nbsp; to determine&nbsp; whether an instrument (or an</pre><pre>embedded&nbsp; feature)&nbsp; is indexed to the&nbsp; Company's&nbsp; own stock.&nbsp; Section&nbsp; 815-40-15</pre><pre>provides&nbsp; that an entity should use a two-step&nbsp; approach to evaluate&nbsp; whether an</pre><pre>equity-linked&nbsp; financial&nbsp; instrument (or embedded feature) is indexed to its own</pre><pre>stock, including evaluating the instrument's&nbsp; contingent exercise and settlement</pre><pre>provisions.&nbsp; The adoption of Section&nbsp; 815-40-15 has affected the&nbsp; accounting for</pre><pre>(i)&nbsp; certain&nbsp; freestanding&nbsp; warrants&nbsp; that&nbsp; contain&nbsp; exercise&nbsp; price&nbsp; adjustment</pre><pre>features and (ii) convertible bonds issued by foreign subsidiaries with a strike</pre><pre>price denominated in a foreign currency.</pre><pre>&nbsp;</pre><pre>The Company marks to market the fair value of the embedded&nbsp; derivative&nbsp; warrants</pre><pre>at each&nbsp; balance&nbsp; sheet&nbsp; date and&nbsp; records&nbsp; the&nbsp; change in the fair value of the</pre><pre>embedded&nbsp; derivative&nbsp; warrants&nbsp; as other&nbsp; income or expense in the&nbsp; consolidated</pre><pre>statements of operations and comprehensive income (loss).</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; utilizes&nbsp; the&nbsp; Lattice&nbsp; model&nbsp; that&nbsp; values the&nbsp; liability&nbsp; of the</pre><pre>derivative&nbsp; warrants based on a probability&nbsp; weighted discounted cash flow model</pre><pre>with the&nbsp; assistance of the third party&nbsp; valuation&nbsp; firm. The reason the Company</pre><pre>picks the Lattice&nbsp; model is that in many cases&nbsp; there may be&nbsp; multiple&nbsp; embedded</pre><pre>features or the features of the bifurcated&nbsp; derivatives may be so complex that a</pre><pre>Black-Scholes&nbsp; valuation&nbsp; does not consider all of the terms of the&nbsp; instrument.</pre><pre>Therefore, the fair value may not be appropriately captured by simple models. In</pre><pre>other words,&nbsp; simple models such as Black-Scholes may not be appropriate in many</pre><pre>situations given complex features and terms of conversion option (e.g., combined</pre><pre>embedded&nbsp; derivatives).&nbsp; The Lattice model is based on future projections of the</pre><pre>various&nbsp; potential&nbsp; outcomes.&nbsp; The features that were analyzed and&nbsp; incorporated</pre><pre>into the model&nbsp; included the exercise&nbsp; and full reset&nbsp; features.&nbsp; Based on these</pre><pre>features,&nbsp; there are two primary events that can occur; the Holder exercises the</pre><pre>Warrants or the Warrants are held to expiration.&nbsp; The Lattice model analyzed the</pre><pre>underlying&nbsp; economic&nbsp; factors that influenced which of these events would occur,</pre><pre>when they were likely to occur,&nbsp; and the specific&nbsp; terms that would be in effect</pre><pre>at the time (i.e. stock price, exercise price,&nbsp; volatility,&nbsp; etc.).&nbsp; Projections</pre><pre>were then made on the&nbsp; underlying&nbsp; factors&nbsp; which&nbsp; led to&nbsp; potential&nbsp; scenarios.</pre><pre>Probabilities&nbsp; were assigned to each scenario&nbsp; based on management&nbsp; projections.</pre><pre>This led to a cash flow&nbsp; projection and a probability&nbsp; associated with that cash</pre><pre>flow. A discounted&nbsp; weighted&nbsp; average cash flow over the various&nbsp; scenarios&nbsp; was</pre><pre>completed to determine the value of the derivative warrants.</pre><pre>&nbsp;</pre><pre>COMMITMENT AND CONTINGENCIES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company &nbsp;follows&nbsp;&nbsp; subtopic&nbsp;&nbsp; 450-20&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification&nbsp; to report&nbsp; accounting for&nbsp; contingencies.&nbsp; Certain&nbsp; conditions may</pre><pre>exist as of the date the consolidated financial statements are issued, which may</pre><pre>result in a loss to the Company but which will only be resolved when one or more</pre><pre>future&nbsp; events&nbsp; occur or fail to occur.&nbsp; The Company&nbsp; assesses&nbsp; such&nbsp; contingent</pre><pre>liabilities, and such assessment inherently involves an exercise of judgment. In</pre><pre>assessing&nbsp; loss&nbsp; contingencies&nbsp; related to legal&nbsp; proceedings&nbsp; that are&nbsp; pending</pre><pre>against the Company or&nbsp; unasserted&nbsp; claims that may result in such&nbsp; proceedings,</pre><pre>the&nbsp; Company&nbsp; evaluates&nbsp; the&nbsp; perceived&nbsp; merits&nbsp; of&nbsp; any&nbsp; legal&nbsp; proceedings&nbsp; or</pre><pre>unasserted claims as well as the perceived merits of the amount of relief sought</pre><pre>or expected to be sought therein.</pre><pre>&nbsp;</pre><pre>If the assessment of a contingency indicates that it is probable that a material</pre><pre>loss has been incurred and the amount of the&nbsp; liability&nbsp; can be estimated,&nbsp; then</pre><pre>the estimated liability would be accrued in the Company's consolidated financial</pre><pre>statements.&nbsp;&nbsp; If&nbsp; the&nbsp; assessment&nbsp; indicates&nbsp; that&nbsp; a&nbsp; potential&nbsp; material&nbsp; loss</pre><pre>contingency&nbsp; is not&nbsp; probable&nbsp; but is&nbsp; reasonably&nbsp; possible,&nbsp; or is probable but</pre><pre>cannot&nbsp; be&nbsp; estimated,&nbsp; then the&nbsp; nature&nbsp; of the&nbsp; contingent&nbsp; liability,&nbsp; and an</pre><pre>estimate of the range of possible losses, if determinable and material, would be</pre><pre>disclosed.</pre><pre>&nbsp;</pre><pre>Loss&nbsp; contingencies&nbsp; considered&nbsp; remote are generally not disclosed&nbsp; unless they</pre><pre>involve guarantees, in which case the guarantees would be disclosed.&nbsp; Management</pre><pre>does not believe,&nbsp; based upon&nbsp; information&nbsp; available&nbsp; at this time,&nbsp; that these</pre><pre>matters&nbsp; will&nbsp; have a&nbsp; material&nbsp; adverse&nbsp; effect on the&nbsp; Company's&nbsp; consolidated</pre><pre>financial position,&nbsp; results of operations or cash flows.&nbsp; However,&nbsp; there is no</pre><pre>assurance&nbsp; that such&nbsp; matters&nbsp; will not&nbsp; materially&nbsp; and&nbsp; adversely&nbsp; affect&nbsp; the</pre><pre>Company's business, financial position, and results of operations or cash flows.</pre><pre>&nbsp;</pre><pre>NON-CONTROLLING INTEREST</pre><pre>&nbsp;</pre><pre>The Company&nbsp; follows&nbsp; paragraph&nbsp; 810-10-65-1&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification to report the&nbsp; non-controlling&nbsp; interest in Stevia Technew Limited,</pre><pre>its majority owned subsidiary in the&nbsp; consolidated&nbsp; statements of balance sheets</pre><pre>within the equity section,&nbsp; separately from the Company's&nbsp; stockholders' equity.</pre><pre>Non-controlling&nbsp;&nbsp; interest&nbsp; represents&nbsp; the&nbsp; non-controlling&nbsp; interest&nbsp; holder's</pre><pre>proportionate&nbsp; share of the equity of the Company's&nbsp; majority-owned&nbsp; subsidiary,</pre><pre>Stevia&nbsp;&nbsp; Technew&nbsp;&nbsp; Limited.&nbsp;&nbsp; Non-controlling&nbsp;&nbsp; interest&nbsp; is&nbsp; adjusted&nbsp; for&nbsp; the</pre><pre>non-controlling&nbsp; interest holder's proportionate share of the earnings or losses</pre><pre>and other comprehensive income (loss) and the non-controlling interest continues</pre><pre>to be&nbsp; attributed&nbsp; its share of losses&nbsp; even if that&nbsp; attribution&nbsp; results&nbsp; in a</pre><pre>deficit non-controlling interest balance.</pre><pre>&nbsp;</pre><pre>REVENUE RECOGNITION</pre><pre>&nbsp;</pre><pre>The Company follows&nbsp; paragraph&nbsp; 605-10-S99-1&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification for revenue recognition.&nbsp; The Company recognizes revenue when it is</pre><pre>realized or realizable and earned.&nbsp; The Company&nbsp; considers&nbsp; revenue&nbsp; realized or</pre><pre>realizable and earned when all of the following criteria are met: (i) persuasive</pre><pre>evidence of an&nbsp; arrangement&nbsp; exists,&nbsp; (ii) the&nbsp; product has been&nbsp; shipped or the</pre><pre>services have been&nbsp; rendered to the customer,&nbsp; (iii) the sales price is fixed or</pre><pre>determinable, and (iv) collectability is reasonably assured.</pre><pre>&nbsp;</pre><pre>RESEARCH AND DEVELOPMENT</pre><pre>&nbsp;</pre><pre>The Company&nbsp; follows&nbsp; paragraph&nbsp; 730-10-25-1&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification&nbsp; (formerly&nbsp; Statement&nbsp; of&nbsp; Financial &nbsp;Accounting&nbsp; Standards&nbsp; No.&nbsp; 2</pre><pre>"ACCOUNTING FOR RESEARCH AND DEVELOPMENT&nbsp; COSTS") and paragraph&nbsp; 730-20-25-11 of</pre><pre>the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification&nbsp; (formerly&nbsp; Statement of Financial</pre><pre>Accounting&nbsp; Standards&nbsp; No.&nbsp; 68&nbsp; "RESEARCH&nbsp; AND&nbsp; DEVELOPMENT&nbsp; ARRANGEMENTS")&nbsp; for</pre><pre>research and development&nbsp; costs.&nbsp; Research and development&nbsp; costs are charged to</pre><pre>expense as&nbsp; incurred.&nbsp; Research&nbsp; and&nbsp; development&nbsp; costs&nbsp; consist&nbsp; primarily&nbsp; of</pre><pre>remuneration&nbsp; for research and development&nbsp; staff,&nbsp; depreciation and maintenance</pre><pre>expenses of research and development&nbsp; equipment,&nbsp; material and testing costs for</pre><pre>research and development as well as research and development&nbsp; arrangements&nbsp; with</pre><pre>unrelated third party research and development institutions.</pre><pre>&nbsp;</pre><pre>NON-REFUNDABLE&nbsp; ADVANCE&nbsp; PAYMENTS&nbsp; FOR&nbsp; GOODS OR&nbsp; SERVICES&nbsp; TO BE USED IN FUTURE</pre><pre>RESEARCH AND DEVELOPMENT ACTIVITIES</pre><pre>&nbsp;</pre><pre>The research and development&nbsp; arrangements usually involve specific research and</pre><pre>development&nbsp; projects.&nbsp; Often times, the Company makes&nbsp; non-refundable&nbsp; advances</pre><pre>upon signing of these arrangements.&nbsp; The Company adopted paragraph&nbsp; 730-20-25-13</pre><pre>and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging</pre><pre>Issues Task Force Issue No. 07-3 "ACCOUNTING FOR NONREFUNDABLE&nbsp; ADVANCE PAYMENTS</pre><pre>FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES")</pre><pre>for those non-refundable advances.&nbsp; Non-refundable advance payments for goods or</pre><pre>services&nbsp; that will be used or&nbsp; rendered&nbsp; for future&nbsp; research&nbsp; and&nbsp; development</pre><pre>activities&nbsp; are deferred and &nbsp;capitalized.&nbsp; Such&nbsp; amounts are&nbsp; recognized&nbsp; as an</pre><pre>expense&nbsp; as the&nbsp; related&nbsp; goods&nbsp; are&nbsp; delivered&nbsp; or&nbsp; the&nbsp; related&nbsp; services&nbsp; are</pre><pre>performed.&nbsp; The management&nbsp; continues to evaluate whether the Company expect the</pre><pre>goods to be&nbsp; delivered or services to be rendered.&nbsp; If the&nbsp; management&nbsp; does not</pre><pre>expect the goods to be&nbsp; delivered or services to be&nbsp; rendered,&nbsp; the&nbsp; capitalized</pre><pre>advance payment are charged to expense.</pre><pre>&nbsp;</pre><pre>STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; accounts&nbsp; for its stock&nbsp; based&nbsp; compensation&nbsp; in which the Company</pre><pre>obtains&nbsp; employee&nbsp; services&nbsp; in&nbsp; share-based&nbsp; payment&nbsp;&nbsp; transactions&nbsp; under&nbsp; the</pre><pre>recognition and measurement&nbsp; principles of the fair value recognition provisions</pre><pre>of section 718-10-30 of the FASB Accounting Standards Codification.&nbsp; Pursuant to</pre><pre>paragraph&nbsp; 718-10-30-6&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification,&nbsp; all</pre><pre>transactions in which goods or services are the&nbsp; consideration&nbsp; received for the</pre><pre>issuance of equity&nbsp; instruments are accounted for based on the fair value of the</pre><pre>consideration&nbsp; received&nbsp; or the fair&nbsp; value&nbsp; of the&nbsp; equity&nbsp; instrument&nbsp; issued,</pre><pre>whichever is more reliably&nbsp; measurable.&nbsp; The measurement&nbsp; date used to determine</pre><pre>the fair value of the&nbsp; equity&nbsp; instrument&nbsp; issued is the&nbsp; earlier of the date on</pre><pre>which the&nbsp; performance&nbsp; is&nbsp; complete&nbsp; or the date on which it is&nbsp; probable&nbsp; that</pre><pre>performance&nbsp; will occur.&nbsp; If shares of the Company are thinly&nbsp; traded the use of</pre><pre>share&nbsp; prices&nbsp; established&nbsp; in&nbsp; the&nbsp; Company's&nbsp; most&nbsp; recent&nbsp; private&nbsp; placement</pre><pre>memorandum&nbsp; ("PPM"),&nbsp; or weekly or monthly price observations would generally be</pre><pre>more appropriate&nbsp; than the use of daily price&nbsp; observations as such shares could</pre><pre>be artificially inflated due to a larger spread between the bid and asked quotes</pre><pre>and lack of consistent trading in the market.</pre><pre>&nbsp;</pre><pre>The fair value of non-derivative&nbsp; option award is estimated on the date of grant</pre><pre>using a Black-Scholes&nbsp; option-pricing valuation model. The ranges of assumptions</pre><pre>for inputs are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected term of share options and similar&nbsp; instruments:&nbsp; The expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life of options and similar instruments&nbsp; represents the period of time</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the option and/or warrant are expected to be outstanding.&nbsp; Pursuant to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paragraph&nbsp;&nbsp; 718-10-50-2(f)(2)(i)&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp; Standards</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Codification&nbsp;&nbsp; the&nbsp; expected&nbsp;&nbsp; term&nbsp; of&nbsp; share&nbsp;&nbsp; options&nbsp; and&nbsp; similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; represents&nbsp; the period of time the&nbsp; options&nbsp; and&nbsp; similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments are expected to be outstanding&nbsp; taking into &nbsp;consideration</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of the contractual&nbsp; term of the&nbsp; instruments&nbsp; and employees'&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exercise and&nbsp; post-vesting&nbsp; employment&nbsp; termination&nbsp; behavior into the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fair&nbsp; value (or&nbsp; calculated&nbsp; value) of the&nbsp; instruments.&nbsp; Pursuant&nbsp; to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paragraph&nbsp; 718-10-S99-1,&nbsp; it may be&nbsp; appropriate to use the SIMPLIFIED</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD,&nbsp; I.E.,&nbsp; EXPECTED TERM = ((VESTING TERM + ORIGINAL&nbsp; CONTRACTUAL</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TERM) / 2),&nbsp; if (i) A&nbsp; company&nbsp; does&nbsp; not have&nbsp; sufficient&nbsp; historical</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exercise&nbsp; data to provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected term due to the limited period of time its equity shares have</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; been publicly traded; (ii) A company&nbsp; significantly&nbsp; changes the terms</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of its share&nbsp; option&nbsp; grants or the types of&nbsp; employees&nbsp; that&nbsp; receive</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; share&nbsp; option&nbsp; grants such that its&nbsp; historical&nbsp; exercise&nbsp; data may no</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; longer&nbsp; provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term; or (iii) A company has or expects to have significant structural</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in its business such that its historical&nbsp; exercise data may no</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; longer&nbsp; provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term.&nbsp; The Company uses the&nbsp; simplified &nbsp;method to calculate&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term of share options and similar&nbsp; instruments as the company does not</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have sufficient historical exercise data to provide a reasonable basis</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; upon which to estimate expected term.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; volatility&nbsp; of the&nbsp; entity's&nbsp; shares and the method&nbsp; used to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; estimate&nbsp; it.&nbsp; Pursuant&nbsp; to&nbsp; ASC&nbsp; Paragraph&nbsp;&nbsp; 718-10-50-2(f)(2)(ii)&nbsp; a</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinly-traded&nbsp; or&nbsp; nonpublic&nbsp; entity&nbsp; that uses the&nbsp; calculated&nbsp; value</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; method shall&nbsp; disclose the reasons why it is not&nbsp; practicable&nbsp; for the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company to estimate the expected&nbsp; volatility&nbsp; of its share price,&nbsp; the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; appropriate&nbsp; industry&nbsp; sector index that it has selected,&nbsp; the reasons</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for&nbsp; selecting&nbsp; that&nbsp; particular&nbsp; index,&nbsp; and&nbsp; how it&nbsp; has&nbsp; calculated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; historical&nbsp; volatility&nbsp; using that index. The Company uses the average</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; historical&nbsp; volatility of the&nbsp; comparable&nbsp; companies over the expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; contractual&nbsp; life of the share options or similar&nbsp; instruments&nbsp; as its</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected volatility.&nbsp; If shares of a company are thinly traded the use</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of&nbsp; weekly or&nbsp; monthly&nbsp; price&nbsp; observations&nbsp; would&nbsp; generally&nbsp; be more</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; appropriate than the use of daily price observations as the volatility</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calculation&nbsp; using&nbsp; daily&nbsp;&nbsp; observations&nbsp; for&nbsp; such&nbsp; shares&nbsp; could&nbsp; be</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; artificially inflated due to a larger spread between the bid and asked</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; quotes and lack of consistent trading in the market.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; * &nbsp;&nbsp;&nbsp;Expected&nbsp; annual rate of&nbsp; quarterly&nbsp; dividends.&nbsp; An entity that uses a</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; method that employs&nbsp; different&nbsp; dividend rates during the&nbsp; contractual</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term&nbsp; shall&nbsp; disclose&nbsp; the range of&nbsp; expected&nbsp; dividends&nbsp; used and the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weighted-average&nbsp; expected&nbsp; dividends.&nbsp; The expected dividend yield is</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; based on the Company's&nbsp; current dividend yield as the best estimate of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; projected&nbsp; dividend&nbsp; yield for periods within the expected term of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; share options and similar instruments.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Risk-free rate(s). An entity that uses a method that employs different</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk-free&nbsp; rates shall disclose the range of risk-free rates used. The</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk-free&nbsp; interest rate is based on the U.S.&nbsp; Treasury yield curve in</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effect at the time of grant for periods&nbsp; within the&nbsp; expected&nbsp; term of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the share options and similar instruments.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company's&nbsp; policy is to&nbsp; recognize&nbsp; compensation&nbsp; cost for awards with only</pre><pre>service&nbsp; conditions and a graded vesting schedule on a straight-line&nbsp; basis over</pre><pre>the requisite service period for the entire award.</pre><pre>&nbsp;</pre><pre>EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR</pre><pre>SERVICES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; accounts&nbsp; for&nbsp; equity&nbsp; instruments&nbsp; issued to&nbsp; parties&nbsp; other than</pre><pre>employees for acquiring&nbsp; goods or services under guidance of Subtopic&nbsp; 505-50 of</pre><pre>the FASB Accounting Standards Codification ("Subtopic 505-50").</pre><pre>&nbsp;</pre><pre>Pursuant to ASC Section&nbsp; 505-50-30,&nbsp; all transactions in which goods or services</pre><pre>are the&nbsp; consideration&nbsp; received&nbsp; for the&nbsp; issuance&nbsp; of equity&nbsp; instruments&nbsp; are</pre><pre>accounted for based on the fair value of the consideration&nbsp; received or the fair</pre><pre>value of the equity instrument&nbsp; issued,&nbsp; whichever is more reliably&nbsp; measurable.</pre><pre>The measurement&nbsp; date used to determine the fair value of the equity&nbsp; instrument</pre><pre>issued is the&nbsp; earlier of the date on which the&nbsp; performance&nbsp; is complete or the</pre><pre>date on which it is&nbsp; probable&nbsp; that&nbsp; performance&nbsp; will&nbsp; occur.&nbsp; If shares of the</pre><pre>Company are thinly traded the use of share prices&nbsp; established&nbsp; in the Company's</pre><pre>most recent private&nbsp; placement&nbsp; memorandum&nbsp; ("PPM"),&nbsp; or weekly or monthly price</pre><pre>observations&nbsp; would&nbsp; generally be more&nbsp; appropriate&nbsp; than the use of daily price</pre><pre>observations&nbsp; as such&nbsp; shares&nbsp; could be&nbsp; artificially&nbsp; inflated&nbsp; due to a larger</pre><pre>spread&nbsp; between the bid and asked quotes and lack of&nbsp; consistent&nbsp; trading in the</pre><pre>market.</pre><pre>&nbsp;</pre><pre>The fair value of&nbsp; non-derivative&nbsp; option or warrant&nbsp; award is&nbsp; estimated on the</pre><pre>date of grant using a Black-Scholes&nbsp; option-pricing&nbsp; valuation model. The ranges</pre><pre>of assumptions for inputs are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; term of share options and similar&nbsp; instruments:&nbsp; Pursuant to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paragraph&nbsp; 718-10-50-2 of the FASB Accounting&nbsp; Standards&nbsp; Codification</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the expected term of share options and similar instruments&nbsp; represents</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the period of time the options and similar instruments are expected to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; be outstanding&nbsp; taking into&nbsp; consideration&nbsp; of the contractual term of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the instruments and holder's&nbsp; expected exercise behavior into the fair</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; value (or&nbsp; calculated&nbsp; value) of the&nbsp; instruments.&nbsp; The&nbsp; Company&nbsp; uses</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; historical data to estimate holder's expected&nbsp; exercise&nbsp; behavior.&nbsp; If</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the Company is a newly formed corporation or shares of the Company are</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinly&nbsp; traded the&nbsp; contractual&nbsp; term of the share options and similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; is used as the expected term of share options and similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; as&nbsp; the&nbsp; Company&nbsp; does&nbsp; not&nbsp; have&nbsp; sufficient&nbsp; historical</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exercise&nbsp; data to provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected term.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; volatility&nbsp; of the&nbsp; entity's&nbsp; shares and the method&nbsp; used to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; estimate&nbsp; it. An&nbsp; entity&nbsp; that uses a method&nbsp; that&nbsp; employs&nbsp; different</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; volatilities&nbsp; during the contractual&nbsp; term shall disclose the range of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected&nbsp;&nbsp; volatilities&nbsp;&nbsp; used&nbsp; and&nbsp; the&nbsp;&nbsp; weighted-average&nbsp;&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; volatility.&nbsp;&nbsp; A&nbsp; thinly-traded&nbsp; or&nbsp; nonpublic&nbsp; entity&nbsp; that&nbsp; uses&nbsp; the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calculated&nbsp; value&nbsp; method&nbsp; shall&nbsp; disclose&nbsp; the&nbsp; reasons why it is not</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; practicable for the Company to estimate the expected volatility of its</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; share&nbsp; price,&nbsp; the&nbsp; appropriate&nbsp; industry&nbsp; sector&nbsp; index&nbsp; that&nbsp; it has</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; selected,&nbsp; the reasons for selecting that particular index, and how it</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; has calculated&nbsp; historical&nbsp; volatility&nbsp; using that index.&nbsp; The Company</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uses the average&nbsp; historical&nbsp; volatility of the&nbsp; comparable&nbsp; companies</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; over the&nbsp; expected&nbsp; contractual&nbsp; life of the share&nbsp; options or similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; as its&nbsp; expected&nbsp; volatility.&nbsp; If shares of a company are</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinly&nbsp; traded the use of weekly or monthly price&nbsp; observations&nbsp; would</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; generally be more appropriate than the use of daily price observations</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; as the volatility calculation using daily observations for such shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; could be artificially&nbsp; inflated due to a larger spread between the bid</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and asked quotes and lack of consistent trading in the market.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; annual rate of&nbsp; quarterly&nbsp; dividends.&nbsp; An entity that uses a</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; method that employs&nbsp; different&nbsp; dividend rates during the&nbsp; contractual</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term&nbsp; shall&nbsp; disclose&nbsp; the range of&nbsp; expected&nbsp; dividends&nbsp; used and the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weighted-average&nbsp; expected&nbsp; dividends.&nbsp; The expected dividend yield is</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; based on the Company's&nbsp; current dividend yield as the best estimate of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; projected&nbsp; dividend yield for periods within the expected&nbsp; contractual</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life of the option and similar instruments.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Risk-free rate(s). An entity that uses a method that employs different</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk-free&nbsp; rates shall disclose the range of risk-free rates used. The</pre><pre> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;risk-free&nbsp; interest rate is based on the U.S.&nbsp; Treasury yield curve in</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effect at the time of grant for periods within the contractual life of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the option and similar instruments.</pre><pre>&nbsp;</pre><pre>Pursuant to&nbsp; Paragraphs&nbsp; 505-50-25-8,&nbsp; if fully vested,&nbsp; non-forfeitable&nbsp; equity</pre><pre>instruments&nbsp; are&nbsp; issued&nbsp; at the date the&nbsp; grantor&nbsp; and&nbsp; grantee&nbsp; enter&nbsp; into an</pre><pre>agreement&nbsp; for goods or services&nbsp; (no&nbsp; specific&nbsp; performance&nbsp; is required by the</pre><pre>grantee to retain those equity instruments), then, because of the elimination of</pre><pre>any obligation on the part of the counterparty to earn the equity instruments, a</pre><pre>measurement&nbsp; date has&nbsp; been&nbsp; reached.&nbsp; A&nbsp; grantor&nbsp; shall&nbsp; recognize&nbsp; the&nbsp; equity</pre><pre>instruments&nbsp; when they are issued (in most cases,&nbsp; when the agreement is entered</pre><pre>into). Whether the corresponding cost is an immediate expense or a prepaid asset</pre><pre>(or&nbsp; whether&nbsp; the&nbsp; debit&nbsp; should be&nbsp; characterized&nbsp; as&nbsp; contra-equity&nbsp; under the</pre><pre>requirements&nbsp; of&nbsp; paragraph&nbsp; 505-50-45-1)&nbsp; depends&nbsp; on the&nbsp; specific&nbsp; facts&nbsp; and</pre><pre>circumstances.&nbsp; Pursuant to ASC&nbsp; paragraph&nbsp; 505-50-45-1,&nbsp; a grantor may conclude</pre><pre>that an asset (other than a note or a&nbsp; receivable)&nbsp; has been&nbsp; received in return</pre><pre>for fully vested, non-forfeitable equity instruments that are issued at the date</pre><pre>the grantor and grantee&nbsp; enter into an agreement&nbsp; for goods or services&nbsp; (and no</pre><pre>specific&nbsp; performance is required by the grantee in order to retain those equity</pre><pre>instruments).&nbsp; Such an asset&nbsp; shall not be&nbsp; displayed&nbsp; as&nbsp; contra-equity&nbsp; by the</pre><pre>grantor of the equity instruments.&nbsp; The transferability (or lack thereof) of the</pre><pre>equity instruments shall not affect the balance sheet display of the asset. This</pre><pre>guidance is limited to transactions in which equity&nbsp; instruments are transferred</pre><pre>to other than&nbsp; employees in exchange for goods or&nbsp; services.&nbsp; Section&nbsp; 505-50-30</pre><pre>provides&nbsp; guidance on the determination of the measurement date for transactions</pre><pre>that are within the scope of this Subtopic.</pre><pre>&nbsp;</pre><pre>Pursuant to Paragraphs&nbsp; 505-50-25-8&nbsp; and&nbsp; 505-50-25-9,an&nbsp; entity may grant fully</pre><pre>vested,&nbsp; non-forfeitable&nbsp; equity instruments that are exercisable by the grantee</pre><pre>only after a specified period of time if the terms of the agreement&nbsp; provide for</pre><pre>earlier exercisability if the grantee achieves specified performance conditions.</pre><pre>Any measured cost of the&nbsp; transaction&nbsp; shall be recognized in the same period(s)</pre><pre>and in the same&nbsp; manner as if the entity had paid cash for the goods or services</pre><pre>or used cash rebates as a sales discount&nbsp; instead of paying with, or using,&nbsp; the</pre><pre>equity instruments. &nbsp;A recognized asset, expense, or sales discount shall not be</pre><pre>reversed&nbsp; if a stock&nbsp; option&nbsp; that the&nbsp; counterparty&nbsp; has the right to&nbsp; exercise</pre><pre>expires unexercised.</pre><pre>&nbsp;</pre><pre>Pursuant to ASC paragraph&nbsp; 505-50-30-S99-1,&nbsp; if the Company&nbsp; receives a right to</pre><pre>receive&nbsp;&nbsp; future&nbsp;&nbsp; services&nbsp; in&nbsp; exchange&nbsp; for&nbsp; unvested,&nbsp;&nbsp; forfeitable&nbsp;&nbsp; equity</pre><pre>instruments,&nbsp; those equity&nbsp; instruments&nbsp; are treated as unissued for&nbsp; accounting</pre><pre>purposes until the future&nbsp; services are received (that is, the&nbsp; instruments&nbsp; are</pre><pre>not&nbsp; considered&nbsp; issued &nbsp;until&nbsp; they&nbsp; vest).&nbsp; Consequently,&nbsp; there&nbsp; would&nbsp; be no</pre><pre>recognition at the measurement date and no entry should be recorded.</pre><pre>&nbsp;</pre><pre>INCOME TAX PROVISION</pre><pre>&nbsp;</pre><pre>The Company&nbsp; accounts&nbsp; for income&nbsp; taxes&nbsp; under&nbsp; Section&nbsp; 740-10-30&nbsp; of the FASB</pre><pre>Accounting&nbsp; Standards&nbsp; Codification,&nbsp; which requires recognition of deferred tax</pre><pre>assets and liabilities&nbsp; for the expected future tax&nbsp; consequences of events that</pre><pre>have been&nbsp; included&nbsp; in the&nbsp; financial&nbsp; statements&nbsp; or tax&nbsp; returns.&nbsp; Under this</pre><pre>method, deferred tax assets and liabilities are based on the differences between</pre><pre>the financial&nbsp; statement and tax bases of assets and&nbsp; liabilities&nbsp; using enacted</pre><pre>tax&nbsp; rates in effect&nbsp; for the year in which&nbsp; the&nbsp; differences&nbsp; are&nbsp; expected&nbsp; to</pre><pre>reverse.&nbsp; Deferred tax assets are reduced by a valuation allowance to the extent</pre><pre>management&nbsp; concludes&nbsp; it is more&nbsp; likely&nbsp; than not that the assets&nbsp; will not be</pre><pre>realized.&nbsp; Deferred tax assets and&nbsp; liabilities&nbsp; are measured&nbsp; using enacted tax</pre><pre>rates expected to apply to taxable income in the years in which those&nbsp; temporary</pre><pre>differences are expected to be recovered or settled.&nbsp; The effect on deferred tax</pre><pre>assets&nbsp; and&nbsp; liabilities&nbsp; of&nbsp; a&nbsp; change&nbsp; in&nbsp; tax&nbsp; rates&nbsp; is&nbsp; recognized&nbsp; in&nbsp; the</pre><pre>consolidated&nbsp; statements of income and comprehensive income (loss) in the period</pre><pre>that includes the enactment date.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; adopted&nbsp; section&nbsp; 740-10-25&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification&nbsp;&nbsp; ("Section&nbsp;&nbsp; 740-10-25").&nbsp;&nbsp;&nbsp; Section&nbsp;&nbsp; 740-10-25&nbsp;&nbsp; addresses&nbsp;&nbsp; the</pre><pre>determination of whether tax benefits claimed or expected to be claimed on a tax</pre><pre>return should be recorded in the financial statements.&nbsp; Under Section 740-10-25,</pre><pre>the Company may recognize the tax benefit from an uncertain tax position only if</pre><pre>it is&nbsp; more&nbsp; likely&nbsp; than&nbsp; not&nbsp; that&nbsp; the tax&nbsp; position&nbsp; will&nbsp; be &nbsp;sustained&nbsp; on</pre><pre>examination&nbsp; by the taxing&nbsp; authorities,&nbsp; based on the&nbsp; technical&nbsp; merits of the</pre><pre>position.&nbsp; The tax benefits&nbsp; recognized in the financial&nbsp; statements from such a</pre><pre>position should be measured based on the largest benefit that has a greater than</pre><pre>fifty (50)&nbsp; percent&nbsp; likelihood&nbsp; of being&nbsp; realized&nbsp; upon&nbsp; ultimate&nbsp; settlement.</pre><pre>Section&nbsp; 740-10-25&nbsp; also provides&nbsp; guidance on&nbsp; de-recognition,&nbsp; classification,</pre><pre>interest&nbsp; and&nbsp; penalties&nbsp; on income&nbsp; taxes,&nbsp; accounting&nbsp; in interim&nbsp; periods and</pre><pre>requires increased disclosures.</pre><pre>&nbsp;</pre><pre>The estimated future tax effects of temporary&nbsp; differences between the tax basis</pre><pre>of assets and liabilities are reported in the accompanying&nbsp; consolidated balance</pre><pre>sheets,&nbsp; as well as tax&nbsp; credit&nbsp; carry-backs&nbsp; and&nbsp; carry-forwards.&nbsp; The&nbsp; Company</pre><pre>periodically&nbsp; reviews the&nbsp; recoverability of deferred tax assets recorded on its</pre><pre>consolidated&nbsp; balance&nbsp; sheets and provides&nbsp; valuation&nbsp; allowances&nbsp; as management</pre><pre>deems necessary.</pre><pre>&nbsp;</pre><pre>Management makes judgments as to the&nbsp; interpretation&nbsp; of the tax laws that might</pre><pre>be&nbsp; challenged&nbsp; upon an audit and cause&nbsp; changes to&nbsp; previous&nbsp; estimates&nbsp; of tax</pre><pre>liability.&nbsp;&nbsp; In&nbsp; addition,&nbsp;&nbsp; the&nbsp; Company&nbsp;&nbsp; operates&nbsp;&nbsp; within&nbsp;&nbsp; multiple&nbsp; taxing</pre><pre>jurisdictions&nbsp; and is subject to audit in these&nbsp; jurisdictions.&nbsp; In management's</pre><pre>opinion,&nbsp; adequate&nbsp; provisions for income taxes have been made for all years. If</pre><pre>actual&nbsp; taxable income by tax&nbsp; jurisdiction&nbsp; varies from&nbsp; estimates,&nbsp; additional</pre><pre>allowances or reversals of reserves may be necessary.</pre><pre>&nbsp;</pre><pre>UNCERTAIN TAX POSITIONS</pre><pre>&nbsp;</pre><pre>The Company did not take any uncertain tax positions and had no&nbsp; adjustments&nbsp; to</pre><pre>its income tax&nbsp; liabilities&nbsp; or benefits&nbsp; pursuant to the&nbsp; provisions of Section</pre><pre>740-10-25 for the interim&nbsp; period ended December 31, 2012 or for the period from</pre><pre>April 11, 2011 (Inception) through December 31, 2011.</pre><pre>&nbsp;</pre><pre>LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL</pre><pre>&nbsp;</pre><pre>Pursuant to the&nbsp; Internal&nbsp; Revenue&nbsp; Code Section 382&nbsp; ("Section&nbsp; 382"),&nbsp; certain</pre><pre>ownership changes may subject the NOL's to annual limitations which could reduce</pre><pre>or defer the NOL. Section 382 imposes limitations on a corporation's&nbsp; ability to</pre><pre>utilize NOLs if it&nbsp; experiences&nbsp; an&nbsp; "ownership&nbsp; change." In general&nbsp; terms,&nbsp; an</pre><pre>ownership&nbsp; change may result&nbsp; from&nbsp; transactions&nbsp; increasing&nbsp; the&nbsp; ownership&nbsp; of</pre><pre>certain&nbsp; stockholders&nbsp; in the stock of a corporation&nbsp; by more than 50 percentage</pre><pre>points&nbsp; over&nbsp; a&nbsp; three-year&nbsp; period.&nbsp; In&nbsp; the&nbsp; event&nbsp; of&nbsp; an&nbsp; ownership&nbsp; change,</pre><pre>utilization of the NOLs would be subject to an annual&nbsp; limitation&nbsp; under Section</pre><pre>382&nbsp; determined&nbsp; by &nbsp;multiplying&nbsp; the&nbsp; value&nbsp; of its&nbsp; stock&nbsp; at the&nbsp; time of the</pre><pre>ownership change by the applicable&nbsp; long-term tax-exempt rate. Any unused annual</pre><pre>limitation may be carried over to later years. The imposition of this limitation</pre><pre>on its ability to use the NOLs to offset future&nbsp; taxable&nbsp; income could cause the</pre><pre>Company to pay U.S.&nbsp; federal income taxes earlier than if such&nbsp; limitation&nbsp; were</pre><pre>not in&nbsp; effect&nbsp; and&nbsp; could&nbsp; cause&nbsp; such&nbsp; NOLs&nbsp; to&nbsp; expire&nbsp; unused,&nbsp; reducing&nbsp; or</pre><pre>eliminating the benefit of such NOLs.</pre><pre>&nbsp;</pre><pre>NET INCOME (LOSS) PER COMMON SHARE</pre><pre>&nbsp;</pre><pre>Net income (loss) per common share is computed&nbsp; pursuant to section 260-10-45 of</pre><pre>the FASB Accounting Standards&nbsp; Codification.&nbsp; Basic net income (loss) per common</pre><pre>share is computed by dividing net income (loss) by the weighted&nbsp; average&nbsp; number</pre><pre>of shares of common&nbsp; stock&nbsp; outstanding&nbsp; during the&nbsp; period.&nbsp; Diluted net income</pre><pre>(loss)&nbsp; per common&nbsp; share is&nbsp; computed&nbsp; by&nbsp; dividing&nbsp; net&nbsp; income&nbsp; (loss) by the</pre><pre>weighted&nbsp; average number of shares of common stock and&nbsp; potentially&nbsp; outstanding</pre><pre>shares of common stock during the period to reflect the potential&nbsp; dilution that</pre><pre>could occur from common&nbsp; shares&nbsp; issuable&nbsp; through&nbsp; contingent&nbsp; shares&nbsp; issuance</pre><pre>arrangement, stock options or warrants.</pre><pre>&nbsp;</pre><pre>The following&nbsp; table shows the&nbsp; potentially&nbsp; outstanding&nbsp; dilutive common shares</pre><pre>excluded from the diluted net income (loss) per common share calculation as they</pre><pre>were anti-dilutive:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potentially</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Outstanding Dilutive</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interim Period&nbsp;&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>MAKE GOOD ESCROW SHARES</pre><pre>&nbsp;</pre><pre>Make Good Escrow&nbsp; Agreement shares issued and</pre><pre>held with the escrow agent in connection with</pre><pre>the Share Exchange&nbsp; Agreement&nbsp; consummated on</pre><pre>June 23, 2011 pending the&nbsp; achievement by the</pre><pre>Company&nbsp; of&nbsp; certain&nbsp; post-Closing&nbsp;&nbsp; business</pre><pre>milestones (the "Milestones").&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,000,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,000,000</pre><pre>&nbsp;</pre><pre>CONVERTIBLE NOTE SHARES</pre><pre>&nbsp;</pre><pre>On&nbsp; March&nbsp; 7,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 426,667&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>On&nbsp; May&nbsp; 30,&nbsp; 2012,&nbsp;&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;426,667&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>WARRANT SHARES</pre><pre>&nbsp;</pre><pre>On August 6,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued (i)</pre><pre>warrants to purchase 1,066,667 shares, in the</pre><pre>aggregate,&nbsp; of the Company's&nbsp; common stock to</pre><pre>the investors (the "investors&nbsp; warrants") and</pre><pre>(ii)&nbsp; warrants to purchase&nbsp; 85,333&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common stock to the placement</pre><pre>agent (the "agent warrants") with an exercise</pre><pre>price of $0.6405 per share subject to certain</pre><pre>adjustments&nbsp;&nbsp;&nbsp; pursuant&nbsp;&nbsp; to&nbsp;&nbsp; Section&nbsp;&nbsp; 3(b)</pre><pre>Subsequent&nbsp; Equity&nbsp; Sales of the SPA expiring</pre><pre>five (5) years from the date of issuance.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>TOTAL POTENTIALLY OUTSTANDING DILUTIVE</pre><pre>COMMON SHARES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,005,334&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,000,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre><pre>&nbsp;</pre><pre>&nbsp;</pre><pre>CASH FLOWS REPORTING</pre><pre>&nbsp;</pre><pre>The Company adopted&nbsp; paragraph&nbsp; 230-10-45-24&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification&nbsp; for cash flows&nbsp; reporting,&nbsp; classifies&nbsp; cash receipts and payments</pre><pre>according&nbsp; to&nbsp; whether&nbsp; they&nbsp; stem&nbsp; from&nbsp; operating,&nbsp;&nbsp; investing,&nbsp; or&nbsp; financing</pre><pre>activities and provides&nbsp; definitions of each category,&nbsp; and uses the indirect or</pre><pre>reconciliation&nbsp; method ("Indirect method") as defined by paragraph&nbsp; 230-10-45-25</pre><pre>of the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification&nbsp; to&nbsp; report&nbsp; net cash flow from</pre><pre>operating&nbsp; activities&nbsp; by adjusting&nbsp; net income to reconcile it to net cash flow</pre><pre>from&nbsp; operating&nbsp; activities by removing the effects of (a) all deferrals of past</pre><pre>operating&nbsp; cash&nbsp; receipts&nbsp; and&nbsp; payments&nbsp; and all&nbsp; accruals of&nbsp; expected&nbsp; future</pre><pre>operating&nbsp; cash receipts and payments and (b) all items that are included in net</pre><pre>income that do not affect&nbsp; operating&nbsp; cash&nbsp; receipts and&nbsp; payments.&nbsp; The Company</pre><pre>reports the reporting currency&nbsp; equivalent of foreign currency cash flows, using</pre><pre>the&nbsp; current&nbsp; exchange&nbsp; rate at the time of the cash&nbsp; flows&nbsp; and the&nbsp; effect&nbsp; of</pre><pre>exchange&nbsp; rate&nbsp; changes&nbsp; on cash held in foreign&nbsp; currencies&nbsp; is&nbsp; reported&nbsp; as a</pre><pre>separate item in the reconciliation of beginning and ending balances of cash and</pre><pre>cash&nbsp; equivalents&nbsp; and&nbsp; separately&nbsp; provides&nbsp; information&nbsp; about&nbsp; investing&nbsp; and</pre><pre>financing&nbsp; activities&nbsp; not&nbsp; resulting in cash receipts or payments in the period</pre><pre>pursuant&nbsp; to&nbsp;&nbsp; paragraph&nbsp;&nbsp; 830-230-45-1 &nbsp;&nbsp;of&nbsp; the&nbsp; FASB&nbsp;&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification.</pre><pre>&nbsp;</pre><pre>SUBSEQUENT EVENTS</pre><pre>&nbsp;</pre><pre>The Company&nbsp; follows the guidance in Section&nbsp; 855-10-50&nbsp; of the FASB&nbsp; Accounting</pre><pre>Standards Codification for the disclosure of subsequent events. The Company will</pre><pre>evaluate&nbsp; subsequent&nbsp; events through the date when the financial&nbsp; statements are</pre><pre>issued.&nbsp; Pursuant to ASU 2010-09 of the FASB Accounting Standards&nbsp; Codification,</pre><pre>the Company as an SEC filer considers its financial&nbsp; statements issued when they</pre><pre>are widely distributed to users, such as through filing them on EDGAR.</pre><pre>&nbsp;</pre><pre>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</pre><pre>&nbsp;</pre><pre>FASB ACCOUNTING STANDARDS UPDATE NO. 2011-08</pre><pre>&nbsp;</pre><pre>In September&nbsp; 2011,&nbsp; the FASB issued the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Update No.</pre><pre>2011-08 "INTANGIBLES--GOODWILL AND OTHER: TESTING GOODWILL FOR IMPAIRMENT" ("ASU</pre><pre>2011-08").&nbsp; This Update is to simplify how public and&nbsp; nonpublic&nbsp; entities&nbsp; test</pre><pre>goodwill&nbsp; for&nbsp; impairment.&nbsp; The&nbsp; amendments&nbsp; permit an&nbsp; entity&nbsp; to first&nbsp; assess</pre><pre>qualitative&nbsp; factors to&nbsp; determine&nbsp; whether it is more&nbsp; likely than not that the</pre><pre>fair value of a reporting&nbsp; unit is less than its carrying&nbsp; amount as a basis for</pre><pre>determining&nbsp; whether it is necessary to perform the two-step goodwill impairment</pre><pre>test described in Topic 350.&nbsp; Under the amendments in this Update,&nbsp; an entity is</pre><pre>not required to calculate&nbsp; the fair value of a reporting&nbsp; unit unless the entity</pre><pre>determines&nbsp; that it is more likely than not that its fair value is less than its</pre><pre>carrying amount.</pre><pre>&nbsp;</pre><pre>The guidance is effective for interim and annual&nbsp; periods&nbsp; beginning on or after</pre><pre>December 15, 2011. Early adoption is permitted.</pre><pre>&nbsp;</pre><pre>FASB ACCOUNTING STANDARDS UPDATE NO. 2011-11</pre><pre>&nbsp;</pre><pre>In December&nbsp; 2011,&nbsp; the FASB&nbsp; issued the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Update No.</pre><pre>2011-11 "BALANCE SHEET:&nbsp; DISCLOSURES&nbsp; ABOUT&nbsp; OFFSETTING&nbsp; ASSETS AND LIABILITIES"</pre><pre>("ASU 2011-11").&nbsp; This Update requires an entity to disclose&nbsp; information&nbsp; about</pre><pre>offsetting and related&nbsp; arrangements to enable users of its financial statements</pre><pre>to understand the effect of those&nbsp; arrangements on its financial&nbsp; position.&nbsp; The</pre><pre>objective of this disclosure is to facilitate&nbsp; comparison between those entities</pre><pre>that prepare&nbsp; their&nbsp; financial&nbsp; statements&nbsp; on the basis of U.S.&nbsp; GAAP and those</pre><pre>entities that prepare their financial statements on the basis of IFRS.</pre><pre>&nbsp;</pre><pre>The amended guidance is effective for annual reporting&nbsp; periods&nbsp; beginning on or</pre><pre>after January 1, 2013, and interim periods within those annual periods.</pre><pre>&nbsp;</pre><pre>FASB ACCOUNTING STANDARDS UPDATE NO. 2012-02</pre><pre>&nbsp;</pre><pre>In July 2012, the FASB issued the FASB Accounting&nbsp; Standards&nbsp; Update No. 2012-02</pre><pre>"INTANGIBLES--GOODWILL AND OTHER (TOPIC 350) TESTING INDEFINITE-LIVED INTANGIBLE</pre><pre>ASSETS FOR IMPAIRMENT" ("ASU 2012-02").</pre><pre>&nbsp;</pre><pre>This&nbsp; Update&nbsp; is&nbsp; intended&nbsp; to&nbsp; reduce&nbsp; the&nbsp; cost&nbsp; and&nbsp;&nbsp; complexity&nbsp; of&nbsp; testing</pre><pre>indefinite-lived&nbsp; intangible&nbsp; assets other than&nbsp; goodwill for&nbsp; impairment.&nbsp; This</pre><pre>guidance builds upon the guidance in ASU 2011-08,&nbsp; entitled TESTING GOODWILL FOR</pre><pre>IMPAIRMENT.&nbsp; ASU 2011-08 was issued on&nbsp; September&nbsp; 15, 2011,&nbsp; and feedback&nbsp; from</pre><pre>stakeholders&nbsp; during the&nbsp; exposure&nbsp; period&nbsp; related to the&nbsp; goodwill&nbsp; impairment</pre><pre>testing&nbsp; guidance&nbsp; was that the&nbsp; guidance&nbsp; also would be&nbsp; helpful in&nbsp; impairment</pre><pre>testing for intangible assets other than goodwill.</pre><pre>&nbsp;</pre><pre>The revised&nbsp; standard allows an entity the option to first assess&nbsp; qualitatively</pre><pre>whether&nbsp; it is more&nbsp; likely&nbsp; than not&nbsp; (that&nbsp; is, a&nbsp; likelihood&nbsp; of more than 50</pre><pre>percent)&nbsp; that&nbsp; an&nbsp;&nbsp; indefinite-lived&nbsp;&nbsp; intangible&nbsp;&nbsp; asset&nbsp; is&nbsp; impaired,&nbsp;&nbsp; thus</pre><pre>necessitating that it perform the quantitative impairment test. An entity is not</pre><pre>required to calculate the fair value of an indefinite-lived intangible asset and</pre><pre>perform the quantitative impairment test unless the entity determines that it is</pre><pre>more likely than not that the asset is impaired.</pre><pre>&nbsp;</pre><pre>This Update is effective for annual and interim&nbsp; impairment&nbsp; tests&nbsp; performed in</pre><pre>fiscal years&nbsp; beginning&nbsp; after&nbsp; September 15, 2012.&nbsp; Earlier&nbsp; implementation&nbsp; is</pre><pre>permitted.</pre><pre>&nbsp;</pre><pre>OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS</pre><pre>&nbsp;</pre><pre>Management&nbsp; does&nbsp; not&nbsp; believe&nbsp; that&nbsp; any&nbsp; other&nbsp; recently&nbsp; issued,&nbsp; but not yet</pre><pre>effective accounting pronouncements, if adopted, would have a material effect on</pre><pre>the accompanying consolidated financial statements.</pre> <!--egx--><pre><b>NOTE 3 - GOING CONCERN</b></pre><pre>&nbsp;</pre><pre>The accompanying&nbsp; consolidated&nbsp; financial statements have been prepared assuming</pre><pre>that the Company will continue as a going concern, which contemplates continuity</pre><pre>of&nbsp; operations,&nbsp; realization&nbsp; of assets,&nbsp; and&nbsp; liquidation of liabilities in the</pre><pre>normal course of business.</pre><pre>&nbsp;</pre><pre>As reflected in the accompanying consolidated financial statements,&nbsp; the Company</pre><pre>had an accumulated deficit at December 31, 2012, a net loss and net cash used in</pre><pre>operating&nbsp; activities&nbsp; for the interim&nbsp; period then ended.&nbsp; These&nbsp; factors raise</pre><pre>substantial doubt about the Company's ability to continue as a going concern.</pre><pre>&nbsp;</pre><pre>While the Company is attempting to generate sufficient&nbsp; revenues,&nbsp; the Company's</pre><pre>cash&nbsp; position&nbsp; may not be&nbsp; sufficient&nbsp; enough to support&nbsp; the&nbsp; Company's&nbsp; daily</pre><pre>operations.&nbsp; Management&nbsp; intends to raise additional funds by way of a public or</pre><pre>private offering.&nbsp; Management believes that the actions presently being taken to</pre><pre>further implement its business plan and generate sufficient revenues provide the</pre><pre>opportunity&nbsp; for the Company to continue as a going&nbsp; concern.&nbsp; While the Company</pre><pre>believes in the viability of its strategy to generate sufficient revenues and in</pre><pre>its&nbsp; ability&nbsp; to raise&nbsp; additional&nbsp; funds,&nbsp; there can be no&nbsp; assurances&nbsp; to that</pre><pre>effect.&nbsp; The ability of the Company to continue as a going&nbsp; concern is dependent</pre><pre>upon the Company's&nbsp; ability to further &nbsp;implement its business plan and generate</pre><pre>sufficient revenues.</pre><pre>&nbsp;</pre><pre>The consolidated&nbsp; financial statements do not include any adjustments related to</pre><pre>the&nbsp; recoverability&nbsp; and classification of recorded asset amounts or the amounts</pre><pre>and&nbsp; classification of liabilities that might be necessary should the Company be</pre><pre>unable to continue as a going concern.</pre> <!--egx--><pre><b>NOTE 4 - PREPAID EXPENSES</b></pre><pre>&nbsp;</pre><pre>Prepaid expenses consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>Prepaid research and development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 23,336&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $128,445</pre><pre>Prepaid rent&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21,250</pre><pre>Retainer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15,000</pre><pre>Other&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,680&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,179</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 26,016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $168,874</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre><b>NOTE 5 - PROPERTY AND EQUIPMENT</b></pre><pre>&nbsp;</pre><pre>Property and equipment,&nbsp; stated at cost, less accumulated depreciation consisted</pre><pre>of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Estimated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Useful Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Years)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>Property and equipment&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 7,925&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 3,036</pre><pre>Less accumulated depreciation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (762)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;--</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 7,163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 3,036</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre><pre>&nbsp;</pre><pre>DEPRECIATION EXPENSE</pre><pre>&nbsp;</pre><pre>The Company&nbsp; acquired&nbsp; furniture&nbsp; and fixture near the end of February&nbsp; 2012 and</pre><pre>started to depreciate as of April 1, 2012.&nbsp; Depreciation expense for the interim</pre><pre>period ended December 31, 2012 was $762.</pre><pre>&nbsp;</pre> <!--egx--><pre><b>NOTE 6 - ACQUIRED TECHNOLOGY</b></pre><pre>&nbsp;</pre><pre>On July 5, 2012,&nbsp; the Company&nbsp; acquired&nbsp; the rights to certain&nbsp; technology&nbsp; from</pre><pre>Technew&nbsp; Technology&nbsp; Limited in exchange for 3,000,000&nbsp; restricted shares of the</pre><pre>Company's common stock.&nbsp; These restricted&nbsp; shares were valued at $0.79 per share</pre><pre>discounted at 69% taking into&nbsp; consideration&nbsp; its restricted&nbsp; nature and lack of</pre><pre>liquidity and consistent&nbsp; trading in the market for a total value of $1,635,300,</pre><pre>which was recorded as acquired technology and amortized on a straight-line basis</pre><pre>over the acquired technology's estimated useful life of fifteen (15) years.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Estimated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Useful Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Years)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>Technology right&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1,635,300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Less accumulated amortization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (54,510)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1,580,790&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre><pre>&nbsp;</pre><pre>AMORTIZATION EXPENSE</pre><pre>&nbsp;</pre><pre>Amortization expense for the interim period ended December 31, 2012 was $54,510.</pre> <!--egx--><pre><b>NOTE 7 - WEBSITE DEVELOPMENT COSTS</b></pre><pre>&nbsp;</pre><pre>Website&nbsp; development&nbsp; costs,&nbsp; stated&nbsp; at&nbsp; cost,&nbsp; less&nbsp; accumulated&nbsp; amortization</pre><pre>consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Estimated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Useful Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Years)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>Website development costs&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; 5,315&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; 5,315</pre><pre>Accumulated amortization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,602)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (801)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp; 3,713&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; 4,514</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre><pre>&nbsp;</pre><pre>AMORTIZATION EXPENSE</pre><pre>&nbsp;</pre><pre>Amortization expense was $801 and $534 for the interim period ended December 31,</pre><pre>2012 and for the period from April 11, 2011&nbsp; (inception)&nbsp; through&nbsp; December&nbsp; 31,</pre><pre>2011, respectively.</pre> <!--egx--><pre><b>NOTE 8 - RELATED PARTY TRANSACTIONS</b></pre><pre>&nbsp;</pre><pre>RELATED PARTIES</pre><pre>&nbsp;</pre><pre>Related parties with whom the Company had transactions are:</pre><pre>&nbsp;</pre><pre>Related Parties&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Relationship</pre><pre>---------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------------</pre><pre>George Blankenbaker&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; President and significant stockholder of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company</pre><pre>&nbsp;</pre><pre>Leverage Investments LLC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An entity owned and controlled by the president</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and significant stockholder of the Company</pre><pre>&nbsp;</pre><pre>Technew Technology Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-controlling interest holder</pre><pre>&nbsp;</pre><pre>Growers Synergy Pte Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An entity owned and controlled by the president</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;and significant stockholder of the Company</pre><pre>&nbsp;</pre><pre>Guangzhou Health Technology&nbsp;&nbsp;&nbsp;&nbsp; An entity owned and controlled by</pre><pre>Development Company Limited&nbsp;&nbsp;&nbsp;&nbsp; Non-controlling interest holder</pre><pre>&nbsp;</pre><pre>ADVANCES FROM STOCKHOLDER</pre><pre>&nbsp;</pre><pre>From time to time,&nbsp; stockholder of the Company advances funds to the Company for</pre><pre>working capital purpose. Those advances are unsecured,&nbsp; non-interest bearing and</pre><pre>due on demand.</pre><pre>&nbsp;</pre><pre>LEASE OF CERTAIN OFFICE SPACE FROM LEVERAGE INVESTMENTS, LLC</pre><pre>&nbsp;</pre><pre>The Company leases certain office space with Leverage Investments, &nbsp;LLC for $500</pre><pre>per month on a&nbsp; month-to-month&nbsp; basis since July 1, 2011. For the interim period</pre><pre>ended&nbsp; December&nbsp; 31,&nbsp; 2012,&nbsp; the Company&nbsp; recorded&nbsp; $4,500 in rent&nbsp; expenses due</pre><pre>Leverage Investment LLC.</pre><pre>&nbsp;</pre><pre>FARM MANAGEMENT AND OFF-TAKE AGREEMENT WITH GROWERS SYNERGY PTE LTD.</pre><pre>&nbsp;</pre><pre>For the Period from July 1, 2011 through&nbsp; October 31, 2011, the Company&nbsp; engaged</pre><pre>Growers Synergy Pte Ltd. to provide farm management services on a month-to-month</pre><pre>basis, at $20,000 per month.</pre><pre>&nbsp;</pre><pre>On&nbsp; November&nbsp; 1, 2011,&nbsp; the&nbsp; Company&nbsp; entered&nbsp; into a&nbsp; Management&nbsp; and&nbsp; Off-Take</pre><pre>Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a</pre><pre>Singapore&nbsp;&nbsp; corporation&nbsp;&nbsp; owned&nbsp; and&nbsp; controlled&nbsp; by&nbsp; the&nbsp; president&nbsp; and&nbsp; major</pre><pre>stockholder&nbsp; of the Company.&nbsp; Under the terms of the Management&nbsp; Agreement,&nbsp; the</pre><pre>Company will engage GSPL to supervise the Company's farm management&nbsp; operations,</pre><pre>recommend quality farm management programs for stevia cultivation, assist in the</pre><pre>hiring&nbsp; of&nbsp; employees&nbsp; and&nbsp; provide&nbsp; training&nbsp; to&nbsp; help&nbsp; the&nbsp; Company&nbsp; meet&nbsp; its</pre><pre>commercialization&nbsp;&nbsp; targets,&nbsp; develop&nbsp; successful&nbsp; models&nbsp; to&nbsp; propagate&nbsp; future</pre><pre>agribusiness&nbsp; services,&nbsp; and provide back-office and regional logistical support</pre><pre>for the development of proprietary stevia farm systems in Vietnam, Indonesia and</pre><pre>potentially&nbsp; other&nbsp; countries.&nbsp; GSPL will provide services for a term of two (2)</pre><pre>years from the date of signing,&nbsp; at $20,000 per month. The Management&nbsp; Agreement</pre><pre>may be&nbsp; terminated&nbsp; by the Company upon 30 day notice.&nbsp; In&nbsp; connection&nbsp; with the</pre><pre>Management&nbsp; Agreement,&nbsp; the parties&nbsp; agreed to enter into an off-take&nbsp; agreement</pre><pre>whereby&nbsp; GSPL agreed to purchase&nbsp; all of the&nbsp; non-stevia&nbsp; crops&nbsp; produced at the</pre><pre>Company's GSPL supervised farms.</pre><pre>&nbsp;</pre><pre>Farm management services provided by Growers Synergy Pte Ltd. is as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interim Period&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>Farm management services received and</pre><pre> farm management services booked&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $180,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $180,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre><pre>&nbsp;</pre><pre>&nbsp;</pre><pre>Future minimum payments&nbsp; required under this agreement at December 31, 2012 were</pre><pre>as follows:</pre><pre>&nbsp;</pre><pre>Fiscal Year Ending March 31:</pre><pre>&nbsp; 2013 (remainder of the fiscal year)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 60,000</pre><pre>&nbsp; 2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 140,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $200,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre><pre>&nbsp;</pre><pre>CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW</pre><pre>&nbsp;</pre><pre>On&nbsp; July 5,&nbsp; 2012,&nbsp; Stevia&nbsp; Asia,&nbsp; entered&nbsp; into a&nbsp; Cooperative&nbsp; Agreement&nbsp; (the</pre><pre>"Cooperative Agreement") with Technew Technology Limited ("Technew"),&nbsp; a company</pre><pre>incorporated&nbsp; under the&nbsp; companies&nbsp; ordinance&nbsp; of Hong Kong and an&nbsp; associate of</pre><pre>Guangzhou Health China Technology&nbsp; Development Company Limited, and Zhang Jia, a</pre><pre>Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia</pre><pre>Asia and Partners have agreed to make Stevia Technew, a joint venture,&nbsp; of which</pre><pre>Stevia Asia legally and beneficially&nbsp; owns 70% shares&nbsp; (representing&nbsp; 70% of the</pre><pre>issued&nbsp;&nbsp; shares)&nbsp; and&nbsp; Technew&nbsp;&nbsp; legally&nbsp; and&nbsp;&nbsp; beneficially&nbsp;&nbsp; owns&nbsp; 30%&nbsp; shares</pre><pre>(representing 30% of the of the issued shares). The Partners will be responsible</pre><pre>for managing&nbsp; Stevia Technew and Stevia Asia has agreed to provide&nbsp; $200,000 per</pre><pre>month,&nbsp; up to a total of $2,000,000 in financing,&nbsp; subject to the performance of</pre><pre>Stevia Technew and Stevia Asia's financial capabilities.</pre><pre>&nbsp;</pre><pre>For the interim&nbsp; period ended&nbsp; December 31, 2012,&nbsp; Stevia Asia&nbsp; provided&nbsp; Stevia</pre><pre>Technew&nbsp; $230,000,&nbsp; all of which has been paid to Guangzhou&nbsp; Health and expended</pre><pre>and recorded as farm management services - related party.</pre> <!--egx--><pre><b>NOTE 9 - CONVERTIBLE NOTES PAYABLE</b></pre><pre>&nbsp;</pre><pre>On February 14, 2011,&nbsp; the Company&nbsp; issued a&nbsp; convertible&nbsp; note in the amount of</pre><pre>$250,000&nbsp; with&nbsp; interest&nbsp; at 10% per&nbsp; annum&nbsp; due one (1)&nbsp; year&nbsp; from the date of</pre><pre>issuance.&nbsp; On October 4, 2011, the note holder converted the entire principal of</pre><pre>$250,000 and accrued&nbsp; interest&nbsp; through the date of&nbsp; conversion of $15,890.41 to</pre><pre>1,000,000 and 63,561&nbsp; shares of the&nbsp; Company's&nbsp; common stock at $0.25 per share,</pre><pre>respectively.</pre><pre>&nbsp;</pre><pre>On June 23,&nbsp; 2011,&nbsp; the&nbsp; Company&nbsp; issued a&nbsp; convertible&nbsp; note in the&nbsp; amount&nbsp; of</pre><pre>$100,000&nbsp; with&nbsp; interest&nbsp; at 10% per&nbsp; annum&nbsp; due one (1)&nbsp; year&nbsp; from the date of</pre><pre>issuance.&nbsp; On October 4, 2011, the note holder converted the entire principal of</pre><pre>$100,000 and accrued&nbsp; interest&nbsp; through the date of&nbsp; conversion&nbsp; of $2,821.92 to</pre><pre>400,000 and 11,288 shares of the Company's common stock at $0.25 per share.</pre><pre>&nbsp;</pre><pre>On October 4,&nbsp; 2011,&nbsp; the&nbsp; Company&nbsp; issued a&nbsp; convertible&nbsp; note in the amount of</pre><pre>$150,000&nbsp; with&nbsp; interest&nbsp; at 10% per&nbsp; annum&nbsp; due one (1)&nbsp; year&nbsp; from the date of</pre><pre>issuance. On January 18, 2012, the note holder converted the entire principal of</pre><pre>$150,000&nbsp; and&nbsp; accrued&nbsp; interest&nbsp; through&nbsp; the date of&nbsp; conversion&nbsp; of $4,356 to</pre><pre>617,425 shares of the Company's common stock at $0.25 per share.</pre><pre>&nbsp;</pre><pre>Convertible notes payable consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>On November&nbsp; 16, 2011,&nbsp; the Company&nbsp; issued a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $250,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion&nbsp; price&nbsp; to&nbsp; be&nbsp; the&nbsp; same&nbsp; as&nbsp; the</pre><pre>private&nbsp; placement price on a per share basis</pre><pre>provided&nbsp; the&nbsp; Company&nbsp;&nbsp; complete&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp; On July 6, 2012,&nbsp; the note&nbsp; holder</pre><pre>converted&nbsp; the entire&nbsp; principal&nbsp; of $250,000</pre><pre>and&nbsp; accrued&nbsp; interest&nbsp; through&nbsp; the&nbsp; date of</pre><pre>conversion&nbsp; of $15,959&nbsp; to 319,607&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common&nbsp; stock&nbsp; at&nbsp; $0.83&nbsp; per</pre><pre>share.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250,000</pre><pre>&nbsp;</pre><pre>On January 16,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $250,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion&nbsp; price&nbsp; to&nbsp; be&nbsp; the&nbsp; same&nbsp; as&nbsp; the</pre><pre>private&nbsp; placement price on a per share basis</pre><pre>provided&nbsp; the&nbsp; Company&nbsp;&nbsp; complete&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp; On July 6, 2012,&nbsp; the note &nbsp;holder</pre><pre>converted&nbsp; the entire&nbsp; principal&nbsp; of $250,000</pre><pre>and&nbsp; accrued&nbsp; interest&nbsp; through&nbsp; the&nbsp; date of</pre><pre>conversion&nbsp; of $11,781&nbsp; to 314,586&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common&nbsp; stock&nbsp; at&nbsp; $0.83&nbsp; per</pre><pre>share.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250,000</pre><pre>&nbsp;</pre><pre>On&nbsp; March&nbsp; 7,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which &nbsp;the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000</pre><pre>&nbsp;</pre><pre>On&nbsp; May&nbsp; 30,&nbsp; 2012,&nbsp;&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$400,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $700,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre><b>NOTE 10 - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS</b></pre><pre>&nbsp;</pre><pre>(I)&nbsp; WARRANTS ISSUED ON AUGUST 6, 2012</pre><pre>&nbsp;</pre><pre>DESCRIPTION OF WARRANTS AND FAIR VALUE ON DATE OF GRANT</pre><pre>&nbsp;</pre><pre>On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares,</pre><pre>in the aggregate, of the Company's common stock to the investors (the "investors</pre><pre>warrants") and (ii) warrants to purchase&nbsp; 85,333 shares of the Company's&nbsp; common</pre><pre>stock to the placement&nbsp; agent (the "agent&nbsp; warrants")&nbsp; with an exercise price of</pre><pre>$0.6405&nbsp; per share&nbsp; subject&nbsp; to certain&nbsp; adjustments&nbsp; pursuant&nbsp; to Section&nbsp; 3(b)</pre><pre>Subsequent&nbsp; Equity&nbsp; Sales of the SPA&nbsp; expiring&nbsp; five (5) years&nbsp; from the date of</pre><pre>issuance.</pre><pre>&nbsp;</pre><pre>DERIVATIVE ANALYSIS</pre><pre>&nbsp;</pre><pre>The exercise price of August 6, 2012 warrants and the number of shares&nbsp; issuable</pre><pre>upon exercise is subject to reset adjustment in the event of stock splits, stock</pre><pre>dividends,&nbsp; recapitalization,&nbsp; most favored nation clause and similar&nbsp; corporate</pre><pre>events.&nbsp; Pursuant to the Section 3(b) Subsequent Equity Sales of the SPA, if the</pre><pre>Company issues any common stock or securities other than the excepted issuances,</pre><pre>to any person or entity at a purchase or exercise&nbsp; price per share less than the</pre><pre>share purchase price of the August 6, 2012 Unit Offering&nbsp; without the consent of</pre><pre>the&nbsp; subscriber&nbsp; holding&nbsp; purchased&nbsp; shares,&nbsp; warrants or warrant&nbsp; shares of the</pre><pre>August 6, 2012 Unit Offering,&nbsp; then the subscriber shall have the right to apply</pre><pre>the lowest such purchase price or exercise price of the offering or sale of such</pre><pre>new&nbsp; securities to the purchase&nbsp; price of the purchased&nbsp; shares then held by the</pre><pre>subscriber (and, if necessary,&nbsp; the Company will issue additional&nbsp; shares),&nbsp; the</pre><pre>reset adjustments are also referred to as full reset adjustments.</pre><pre>&nbsp;</pre><pre>Because these warrants have full reset&nbsp; adjustments&nbsp; tied to future issuances of</pre><pre>equity&nbsp; securities&nbsp; by the&nbsp; Company,&nbsp; they are subject to&nbsp; derivative&nbsp; liability</pre><pre>treatment under Section 815-40-15 of the FASB Accounting&nbsp; Standard&nbsp; Codification</pre><pre>("Section&nbsp; 815-40-15")&nbsp; (FORMERLY FASB EMERGING ISSUES TASK FORCE ("EITF") ISSUE</pre><pre>NO. 07-5:&nbsp; DETERMINING WHETHER AN INSTRUMENT (OR EMBEDDED FEATURE) IS INDEXED TO</pre><pre>AN ENTITY'S OWN STOCK ("EITF&nbsp; 07-5"))).&nbsp; Section&nbsp; 815-40-15&nbsp; became effective on</pre><pre>January 1, 2009 and the Warrants issued in the August 6, 2012 Unit Offering have</pre><pre>been measured at fair value using a Lattice model at each reporting&nbsp; period with</pre><pre>gains&nbsp; and&nbsp; losses&nbsp; from the&nbsp; change&nbsp; in fair&nbsp; value of&nbsp; derivative&nbsp; liabilities</pre><pre>recognized on the consolidated statement of income and comprehensive income.</pre><pre>&nbsp;</pre><pre>VALUATION OF DERIVATIVE LIABILITY</pre><pre>&nbsp;</pre><pre>(A) VALUATION METHODOLOGY</pre><pre>&nbsp;</pre><pre>The&nbsp; Company's&nbsp; August 6,&nbsp; 2012&nbsp; warrants&nbsp; do not trade in an active&nbsp; securities</pre><pre>market,&nbsp; as such,&nbsp; the&nbsp; Company&nbsp; developed&nbsp; a&nbsp; Lattice&nbsp; model&nbsp; that&nbsp; values&nbsp; the</pre><pre>derivative&nbsp; liability of the warrants based on a probability weighted discounted</pre><pre>cash flow&nbsp; model.&nbsp; This&nbsp; model is based on&nbsp; future&nbsp; projections &nbsp;of the&nbsp; various</pre><pre>potential&nbsp; outcomes.&nbsp; The features that were analyzed and incorporated&nbsp; into the</pre><pre>model included the exercise feature and the full ratchet reset.</pre><pre>&nbsp;</pre><pre>Based on these features, there are two primary events that can occur; the Holder</pre><pre>exercises&nbsp; the&nbsp; Warrants&nbsp; or the&nbsp; Warrants&nbsp; are held to&nbsp; expiration.&nbsp; The&nbsp; model</pre><pre>analyzed the underlying&nbsp; economic&nbsp; factors that influenced which of these events</pre><pre>would occur,&nbsp; when they were likely to occur,&nbsp; and the specific terms that would</pre><pre>be in effect at the time (i.e. stock price, exercise price,&nbsp; volatility,&nbsp; etc.).</pre><pre>Projections&nbsp; were then made on these&nbsp; underlying&nbsp; factors&nbsp; which led to a set of</pre><pre>potential&nbsp; scenarios.&nbsp; As the result of the large Warrant&nbsp; overhang we accounted</pre><pre>for the dilution affects, volatility and market cap to adjust the projections.</pre><pre>&nbsp;</pre><pre>Probabilities&nbsp; were&nbsp; assigned&nbsp; to each of these&nbsp; scenarios&nbsp; based on&nbsp; management</pre><pre>projections.&nbsp; This led to a cash flow&nbsp; projection&nbsp; and a probability&nbsp; associated</pre><pre>with that cash flow.&nbsp; A discounted&nbsp; weighted&nbsp; average cash flow over the various</pre><pre>scenarios&nbsp; was&nbsp; completed&nbsp; to&nbsp; determine&nbsp; the&nbsp; value of the&nbsp; derivative&nbsp; warrant</pre><pre>liability.</pre><pre>&nbsp;</pre><pre>(B) VALUATION ASSUMPTIONS</pre><pre>&nbsp;</pre><pre>The Company's&nbsp; 2012&nbsp; derivative&nbsp; warrants were valued at each period ending date</pre><pre>with the following assumptions:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; The stock price would fluctuate with the Company projected volatility.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; The&nbsp; stock&nbsp; price&nbsp; would&nbsp; fluctuate&nbsp; with an&nbsp; annual&nbsp; volatility.&nbsp; The</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; projected volatility curve was based on historical volatilities of the</pre><pre>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company for the valuation periods.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; The Holder&nbsp; would&nbsp; exercise&nbsp; the&nbsp; warrant as they&nbsp; become&nbsp; exercisable</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (effective&nbsp; registration&nbsp; is projected 4 months from&nbsp; issuance and the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; earliest&nbsp; exercise&nbsp; is&nbsp; projected&nbsp; 180 days from&nbsp; issuance)&nbsp; at target</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prices of 2 times the&nbsp; higher of the&nbsp; projected&nbsp; reset&nbsp; price or stock</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; price.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; The Holder&nbsp; would&nbsp; exercise the warrant at maturity if the stock price</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; was above the project reset prices.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; A 100%&nbsp; probability&nbsp; of a reset event and a projected&nbsp; financing&nbsp; each</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; quarter for 3 years at prices approximating 93% of market</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; The 1,066,667 Investor Warrants $0.6405 exercise price is projected to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reset from $0.87 to $0.192 at maturity; and the 85,333 Placement Agent</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants&nbsp; $0.6405&nbsp; exercise&nbsp; price is projected to reset from $0.87 to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.192 at maturity;</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; No warrants have been exercised or expired.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; The projected volatility curve for the valuation dates was:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 Year&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 Year&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 Year&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 Year&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 Year</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------</pre><pre>August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 129%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 178%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 218%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;252%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 281%</pre><pre>&nbsp;</pre><pre>September 30, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 127%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 211%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 244%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 272%</pre><pre>&nbsp;</pre><pre>December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 126%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 167%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 204%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 263%</pre><pre>&nbsp;</pre><pre>(C) FAIR VALUE OF DERIVATIVE WARRANTS</pre><pre>&nbsp;</pre><pre>The table below provides a summary of the fair value of the&nbsp; derivative&nbsp; warrant</pre><pre>liability&nbsp; and the&nbsp; changes&nbsp; in the fair&nbsp; value of the&nbsp; derivative&nbsp; warrants&nbsp; to</pre><pre>purchase 1,152,000 shares of the Company's common stock, including net transfers</pre><pre>in and/or&nbsp; out,&nbsp; of&nbsp; derivative&nbsp; warrants&nbsp; measured at fair value on a recurring</pre><pre>basis using significant unobservable inputs (Level 3).</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value Measurement</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Using Level 3 Inputs</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; warrants Assets</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Liability)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Total</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----</pre><pre>Balance, August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(411,805)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(411,805)</pre><pre>Total gains or losses</pre><pre> (realized/unrealized) included in:</pre><pre>&nbsp;&nbsp; Net income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;231,521&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 231,521</pre><pre>&nbsp;&nbsp; Other comprehensive income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp; Purchases, issuances and settlements&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp; Transfers in and/or out of Level 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>Balance, August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (180,284)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (180,284)</pre><pre>Total gains or losses</pre><pre> (realized/unrealized) included in:</pre><pre>&nbsp;&nbsp; Net income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 73,723&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 73,723</pre><pre>&nbsp;&nbsp; Other comprehensive income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp; Purchases, issuances and settlements&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp; Transfers in and/or out of Level 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>&nbsp;</pre><pre>Balance, December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(106,561)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(106,561)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =========</pre><pre>(D) WARRANTS OUTSTANDING</pre><pre>&nbsp;</pre><pre>As of December 31, 2012 no warrants have been exercised and warrants to purchase</pre><pre>1,152,000 shares of Company common stock remain outstanding.</pre><pre>&nbsp;</pre><pre>The table below summarizes the Company's derivative warrant activity</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012 Warrant Activities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Apic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Gain) Loss</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------------------------------------------------------&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reclassification</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative&nbsp;&nbsp;&nbsp;&nbsp; Non-derivative&nbsp;&nbsp;&nbsp; Warrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </pre><pre>Derivative warrant at</pre><pre> August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (411,805)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Mark to market&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 231,521&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(231,521)</pre><pre>Derivative warrant at</pre><pre> September 30, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (180,284)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (231,521)</pre><pre>Mark to market&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;73,723&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (73,723)</pre><pre>Derivative warrant at</pre><pre> December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (106,561)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (305,244)</pre><pre>&nbsp;</pre><pre>(II) WARRANT ACTIVITIES</pre><pre>&nbsp;</pre><pre>The table below summarizes the Company's warrant activities through December 31,</pre><pre>2012:</pre><pre>&nbsp;</pre><pre>SUMMARY OF THE COMPANY'S WARRANT ACTIVITIES</pre><pre>&nbsp;</pre><pre>The table below summarizes the Company's warrant activities:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weighted Average&nbsp;&nbsp; Fair Value at&nbsp;&nbsp;&nbsp;&nbsp; Aggregate</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Price Range&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intrinsic</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Per Share&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuance&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Value</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----</pre><pre>Balance, March 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ --</pre><pre>Granted&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,805&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Canceled&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Exercised&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Expired&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----</pre><pre>Balance, December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,805&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>Earned and exercisable,</pre><pre> December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,805&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----</pre><pre>&nbsp;</pre><pre>Unvested, December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;-------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----</pre><pre>&nbsp;</pre><pre>The&nbsp; following&nbsp; table&nbsp;&nbsp; summarizes&nbsp;&nbsp; information&nbsp;&nbsp; concerning&nbsp;&nbsp; outstanding&nbsp; and</pre><pre>exercisable warrants as of December 31, 2012:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants Outstanding&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants Exercisable</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Average&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Average</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remaining&nbsp;&nbsp;&nbsp;&nbsp; Weighted&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remaining&nbsp;&nbsp;&nbsp;&nbsp; Weighted</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contractual&nbsp;&nbsp;&nbsp; Average&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contractual&nbsp;&nbsp;&nbsp; Average</pre><pre>Range of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise</pre><pre>Exercise Prices&nbsp;&nbsp; Outstanding&nbsp;&nbsp; (in years)&nbsp;&nbsp;&nbsp;&nbsp; Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercisable&nbsp;&nbsp; (in years)&nbsp;&nbsp;&nbsp;&nbsp; Price</pre><pre>---------------&nbsp;&nbsp; -----------&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp; -----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp; -----</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </pre><pre>$0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.6405</pre><pre>-------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------</pre><pre>&nbsp;</pre><pre>$0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.6405</pre><pre>=======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ====&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ====&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =======</pre> <!--egx--><pre><b>NOTE 11 - EQUITY</b></pre><pre>&nbsp;</pre><pre>SHARES AUTHORIZED</pre><pre>&nbsp;</pre><pre>Upon&nbsp; formation&nbsp; the total number of shares of common stock which the Company is</pre><pre>authorized&nbsp; to issue is One&nbsp; Hundred&nbsp; Million&nbsp; (100,000,000)&nbsp; shares,&nbsp; par value</pre><pre>$0.001 per share.</pre><pre>&nbsp;</pre><pre>COMMON STOCK</pre><pre>&nbsp;</pre><pre>REVERSE ACQUISITION TRANSACTION</pre><pre>&nbsp;</pre><pre>Immediately&nbsp; prior to the&nbsp; Share&nbsp; Exchange&nbsp; Transaction&nbsp; on June 23,&nbsp; 2011,&nbsp; the</pre><pre>Company had 79,800,000 common shares issued and outstanding. Simultaneously with</pre><pre>the&nbsp; Closing of the Share&nbsp; Exchange&nbsp; Agreement,&nbsp; on the&nbsp; Closing&nbsp; Date,&nbsp; Mohanad</pre><pre>Shurrab,&nbsp; a&nbsp; shareholder&nbsp; and,&nbsp; as of the Closing&nbsp; Date,&nbsp; the&nbsp; Company's&nbsp; former</pre><pre>Director, President,&nbsp; Treasurer and Secretary,&nbsp; surrendered 33,000,000 shares of</pre><pre>the Company's common stock to the Company for cancellation.</pre><pre>&nbsp;</pre><pre>As a result of the Share&nbsp; Exchange&nbsp; Agreement,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; 12,000,000</pre><pre>common shares for the acquisition of 100% of the issued and&nbsp; outstanding&nbsp; shares</pre><pre>of Stevia Ventures&nbsp; International Ltd. Of the 12,000,000 common shares issued in</pre><pre>connection with the Share Exchange Agreement, 6,000,000 of such shares are being</pre><pre>held in escrow&nbsp; ("Escrow&nbsp; Shares")&nbsp; pending&nbsp; the&nbsp; achievement&nbsp; by the Company of</pre><pre>certain&nbsp; post-Closing&nbsp; business milestones (the&nbsp; "Milestones"),&nbsp; pursuant to the</pre><pre>terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig,</pre><pre>LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement").</pre><pre>&nbsp;</pre><pre>MAKE GOOD AGREEMENT SHARES</pre><pre>&nbsp;</pre><pre>(I) DURATION OF ESCROW AGREEMENT</pre><pre>&nbsp;</pre><pre>The&nbsp; Make&nbsp; Good&nbsp; Escrow&nbsp; Agreement&nbsp; shall&nbsp; terminate&nbsp; on the&nbsp; sooner&nbsp; of (i) the</pre><pre>distribution of all escrow shares, or (ii) December 31, 2013.</pre><pre>&nbsp;</pre><pre>(II) DISBURSEMENT OF MAKE GOOD SHARES</pre><pre>&nbsp;</pre><pre>Upon&nbsp; achievement&nbsp; of any Milestone on or before the date&nbsp; associated&nbsp; with such</pre><pre>Milestone on Exhibit A, the Company shall promptly provide written notice to the</pre><pre>Escrow Agent and the Selling Shareholder of such achievement (each a "COMPLETION</pre><pre>NOTICE").&nbsp; Upon the&nbsp; passage&nbsp; of any&nbsp; Milestone&nbsp; date set forth on Exhibit A for</pre><pre>which the Company has not achieved the associated&nbsp; Milestone,&nbsp; the Company shall</pre><pre>promptly provide written notice to the Escrow Agent and the Selling&nbsp; Shareholder</pre><pre>of such failure to achieve the milestone (each a "NON-COMPLETION NOTICE").</pre><pre>&nbsp;</pre><pre>(III) EXHIBIT A - SCHEDULE OF MILESTONES</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Completion&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Milestones&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Escrow Shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------------</pre><pre>I.</pre><pre>(1)&nbsp; Enter into exclusive&nbsp; international&nbsp; license agreement</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; for&nbsp; all&nbsp; Agro&nbsp; Genesis&nbsp;&nbsp; intellectual&nbsp;&nbsp; property&nbsp; and</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; products as it applies to stevia</pre><pre>(2)&nbsp; Enter into cooperative agreements to work with Vietnam</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; Institutes (a) Medical Plant&nbsp; Institute in Hanoi;&nbsp; (b)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; Agricultural&nbsp; Science&nbsp; Institute&nbsp; of Northern&nbsp; Central&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,000,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; Vietnam&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares only</pre><pre>(3)&nbsp; Enter&nbsp; into&nbsp; farm&nbsp; management&nbsp; agreements&nbsp; with&nbsp; local&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if and when</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; growers&nbsp;&nbsp; including&nbsp;&nbsp; the&nbsp;&nbsp; Provincial&nbsp;&nbsp; and&nbsp; National&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Within 180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ALL four (4)</pre><pre>&nbsp;&nbsp;&nbsp; &nbsp;projects;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; days of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; milestones</pre><pre>(4)&nbsp; Take over management of three existing nurseries&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Closing Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reached(*)</pre><pre>&nbsp;</pre><pre>II.&nbsp; Achieve 100 Ha field trials and first test shipment of&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within two (2)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; dry leaf&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; years of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,500,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Closing Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares</pre><pre>&nbsp;</pre><pre>III. Test shipment of dry leaf to achieve minimum specs for&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Within two (2)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; contracted base price (currently $2.00 per kilogram)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; years of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,500,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Closing Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares</pre><pre>&nbsp;</pre><pre>&nbsp;</pre><pre>*&nbsp;&nbsp;&nbsp; On December 23, 2011,&nbsp; 3,000,000&nbsp; out of the&nbsp; 6,000,000&nbsp; Escrow Shares have</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; been earned and released to Ventures&nbsp; stockholder&nbsp; upon&nbsp; achievement of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; First&nbsp; Milestone&nbsp; within&nbsp; 180&nbsp; days of June&nbsp; 23,&nbsp; 2011,&nbsp; the&nbsp; Closing&nbsp; Date</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; associated with the First Milestone.&nbsp; These shares were valued at $0.25 per</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; share or $750,000 on the date of release and recorded as compensation.</pre><pre>&nbsp;</pre><pre>COMMON SHARES SURRENDERED FOR CANCELLATION</pre><pre>&nbsp;</pre><pre>On October 4, 2011, a significant&nbsp; stockholder of the Company,&nbsp; Mohanad Shurrab,</pre><pre>surrendered&nbsp; another&nbsp; 3,000,000&nbsp; shares&nbsp; of the&nbsp; Company's&nbsp; common&nbsp; stock to the</pre><pre>Company for&nbsp; cancellation.&nbsp; The Company&nbsp; recorded this&nbsp; transaction&nbsp; by debiting</pre><pre>common stock at par of $3,000 and crediting&nbsp; additional&nbsp; paid-in&nbsp; capital of the</pre><pre>same.</pre><pre>&nbsp;</pre><pre>COMMON SHARES ISSUED FOR CASH</pre><pre>&nbsp;</pre><pre>On October 4, 2011 the Company&nbsp; sold&nbsp; 400,000&nbsp; shares of its common stock to one</pre><pre>investor at $0.25 per share or $100,000.</pre><pre>&nbsp;</pre><pre>COMMON SHARES ISSUED FOR OBTAINING EMPLOYEE AND DIRECTOR SERVICES</pre><pre>&nbsp;</pre><pre>On October 14, 2011 the Company&nbsp; issued&nbsp; 1,500,000&nbsp; shares each to two (2) newly</pre><pre>appointed&nbsp; members of the board of directors&nbsp; or 3,000,000&nbsp; shares of its common</pre><pre>stock in aggregate as compensation for future services.&nbsp; These shares shall vest</pre><pre>with&nbsp; respect to&nbsp; 750,000&nbsp; shares of&nbsp; restricted&nbsp; stock on each of the first two</pre><pre>anniversaries of the date of grant, subject to the director's continuous service</pre><pre>to the&nbsp; Company as&nbsp; directors.&nbsp; These&nbsp; shares&nbsp; were valued at $0.25 per share or</pre><pre>$750,000 on the date of grant and are being amortized over the vesting period of</pre><pre>two (2)&nbsp; years&nbsp; or&nbsp; $93,750&nbsp; per&nbsp; quarter.&nbsp; The&nbsp; Company&nbsp; recorded&nbsp; $187,500&nbsp; in</pre><pre>directors' fees for the period from April 11, 2011 (inception) through March 31,</pre><pre>2012. The Company&nbsp; recorded&nbsp; $281,250 in directors'&nbsp; fees for the interim period</pre><pre>ended December 31, 2012.</pre><pre>&nbsp;</pre><pre>COMMON&nbsp; SHARES ISSUED TO PARTIES&nbsp; OTHER THAN&nbsp; EMPLOYEES&nbsp; FOR ACQUIRING&nbsp; GOODS OR</pre><pre>SERVICES</pre><pre>&nbsp;</pre><pre>EQUITY PURCHASE AGREEMENT AND RELATED REGISTRATION RIGHTS AGREEMENT</pre><pre>&nbsp;</pre><pre>(I) EQUITY PURCHASE AGREEMENT</pre><pre>&nbsp;</pre><pre>On January 26,&nbsp; 2012,&nbsp; the Company&nbsp; entered&nbsp; into an equity&nbsp; purchase&nbsp; agreement</pre><pre>("Equity&nbsp; Purchase&nbsp; Agreement")&nbsp; with&nbsp; Southridge&nbsp; Partners&nbsp; II,&nbsp; LP, a Delaware</pre><pre>limited&nbsp; partnership&nbsp; (The&nbsp; "Investor").&nbsp; Upon&nbsp; the&nbsp; terms&nbsp; and&nbsp; subject&nbsp; to the</pre><pre>conditions&nbsp; contained in the agreement,&nbsp; the Company shall issue and sell to the</pre><pre>Investor,&nbsp; and&nbsp; the&nbsp; Investor&nbsp; shall&nbsp; purchase,&nbsp; up to&nbsp; Twenty&nbsp; Million&nbsp; Dollars</pre><pre>($20,000,000) of its common stock, par value $0.001 per share.</pre><pre>&nbsp;</pre><pre>At any time and from time to time&nbsp; during&nbsp; the&nbsp; Commitment &nbsp;Period,&nbsp; the&nbsp; period</pre><pre>commencing on the effective&nbsp; date,&nbsp; and ending on the earlier of (i) the date on</pre><pre>which investor shall have purchased put shares pursuant to this agreement for an</pre><pre>aggregate&nbsp; purchase&nbsp; price of the maximum&nbsp; commitment&nbsp; amount,&nbsp; or (ii) the date</pre><pre>occurring thirty six (36) months from the date of commencement of the commitment</pre><pre>period.&nbsp; the Company&nbsp; may&nbsp; exercise a put by the&nbsp; delivery of a put notice,&nbsp; the</pre><pre>number of put shares that investor shall purchase&nbsp; pursuant to such put shall be</pre><pre>determined by dividing the investment&nbsp; amount specified in the put notice by the</pre><pre>purchase&nbsp; price with respect to such put notice.&nbsp; However,&nbsp; that the&nbsp; investment</pre><pre>amount&nbsp; identified&nbsp; in the&nbsp; applicable&nbsp; put notice shall not be greater than the</pre><pre>maximum put amount and, when taken&nbsp; together&nbsp; with any prior put notices,&nbsp; shall</pre><pre>not exceed the&nbsp; maximum&nbsp; commitment&nbsp; The&nbsp; purchase&nbsp; price&nbsp; shall mean 93% of the</pre><pre>market&nbsp; price&nbsp; on such&nbsp; date on&nbsp; which&nbsp; the&nbsp; purchase&nbsp; price&nbsp; is&nbsp; calculated&nbsp; in</pre><pre>accordance with the terms and conditions of this Agreement.</pre><pre>&nbsp;</pre><pre>(II) REGISTRATION RIGHTS AGREEMENT</pre><pre>&nbsp;</pre><pre>In&nbsp; connection&nbsp; with the Equity&nbsp; Purchase&nbsp; Agreement,&nbsp; on January 26, 2012,&nbsp; the</pre><pre>Company&nbsp; entered into a&nbsp; registration&nbsp; rights&nbsp; agreement&nbsp; ("Registration&nbsp; Rights</pre><pre>Agreement") with Southridge Partners II, LP, a Delaware limited partnership (the</pre><pre>"Investor").&nbsp; To induce the investor to execute and deliver the equity&nbsp; purchase</pre><pre>agreement&nbsp; which the Company has agreed to issue and sell to the investor shares</pre><pre>(the "put shares") of its common stock,&nbsp; par value $0.001 per share (the "common</pre><pre>stock")&nbsp; from&nbsp; time to time for an&nbsp; aggregate&nbsp; investment&nbsp; price of up to twenty</pre><pre>million dollars&nbsp; ($20,000,000) (the "registrable&nbsp; securities"),&nbsp; the Company has</pre><pre>agreed to provide certain&nbsp; registration rights under the securities act of 1933,</pre><pre>as amended, and the rules and regulations&nbsp; thereunder,&nbsp; or any similar successor</pre><pre>statute&nbsp; (collectively,&nbsp; "securities act"), and applicable state securities laws</pre><pre>with respect to the registrable securities.</pre><pre>&nbsp;</pre><pre>(III) COMMON SHARES ISSUED UPON SIGNING</pre><pre>&nbsp;</pre><pre>As a condition for the execution of this agreement by the investor,&nbsp; the company</pre><pre>issued to the investor 35,000 shares of restricted common stock (the "restricted</pre><pre>shares") upon the signing of this agreement. The restricted shares shall have no</pre><pre>registration&nbsp; rights.&nbsp; These shares were valued at $1.50 per share or $52,500 on</pre><pre>the date of issuance and recorded as financing cost.</pre><pre>&nbsp;</pre><pre>MARKETING SERVICE AGREEMENT - EMPIRE RELATIONS GROUP, INC.</pre><pre>&nbsp;</pre><pre>On&nbsp; March&nbsp; 14,&nbsp; 2012&nbsp; the&nbsp; Company&nbsp; entered&nbsp; into a&nbsp; consulting&nbsp; agreement&nbsp; (the</pre><pre>"Consulting Agreement") with Empire Relations Group, Inc. ("Empire").</pre><pre>&nbsp;</pre><pre>(I) SCOPE OF SERVICES</pre><pre>&nbsp;</pre><pre>Under the terms of the&nbsp; Consulting&nbsp; Agreement,&nbsp; the&nbsp; Company&nbsp; engaged&nbsp; Empire to</pre><pre>introduce interested&nbsp; investors to the Company,&nbsp; advise the Company on available</pre><pre>financing&nbsp; options,&nbsp; provide&nbsp; periodic&nbsp; updates on the stevia sector and provide</pre><pre>insights and strategies for the Company to undertake.</pre><pre>&nbsp;</pre><pre>(II) TERM</pre><pre>&nbsp;</pre><pre>The&nbsp; term&nbsp; of&nbsp; this&nbsp; agreement&nbsp; were&nbsp; consummated &nbsp;from&nbsp; the&nbsp; date&nbsp; hereof,&nbsp; and</pre><pre>automatically terminated on May 30, 20 12.</pre><pre>&nbsp;</pre><pre>(III) COMPENSATION</pre><pre>&nbsp;</pre><pre>For&nbsp; the&nbsp; term of this&nbsp; agreement,&nbsp; the&nbsp; consultant&nbsp; shall&nbsp; be paid an&nbsp; upfront,</pre><pre>non-refundable,&nbsp; non-cancellable&nbsp; retainer fee of 27,500 restricted&nbsp; shares. For</pre><pre>the purposes of this&nbsp; agreement,&nbsp; these shares shall be&nbsp; considered&nbsp; to be fully</pre><pre>earned by March 31, 2012. These shares were valued at $1.39 per share or $38,225</pre><pre>on March 31, 2012, the date when they were earned.</pre><pre>&nbsp;</pre><pre>COMMON&nbsp; SHARES&nbsp; ISSUED IN&nbsp; CONNECTION&nbsp; WITH&nbsp; ENTRY INTO&nbsp; TECHNOLOGY&nbsp; ACQUISITION</pre><pre>AGREEMENT</pre><pre>&nbsp;</pre><pre>On July 5, 2012,&nbsp; the Company&nbsp; entered into a Technology&nbsp; Acquisition&nbsp; Agreement</pre><pre>(the&nbsp; "Technology&nbsp;&nbsp; Acquisition&nbsp; Agreement")&nbsp; with&nbsp; Technew&nbsp; Technology&nbsp; Limited</pre><pre>("Technew"),&nbsp; pursuant&nbsp; to which the&nbsp; Company&nbsp; acquired&nbsp; the&nbsp; rights to&nbsp; certain</pre><pre>technology&nbsp; from&nbsp; Technew in exchange&nbsp; for&nbsp; 3,000,000&nbsp; restricted&nbsp; shares of the</pre><pre>Company's common stock.&nbsp; These restricted&nbsp; shares were valued at $0.79 per share</pre><pre>discounted at 69% taking into consideration of its restricted nature and lack of</pre><pre>liquidity and consistent trading in the market or $1,635,300, which was recorded</pre><pre>as acquired&nbsp; technology and amortized on a straight-line basis over the acquired</pre><pre>technology's estimated useful life of fifteen (15) years.</pre><pre>&nbsp;</pre><pre>COMMON SHARES ISSUED TO A RELATED PARTY</pre><pre>&nbsp;</pre><pre>On July 5, 2012,&nbsp; the Company&nbsp; issued&nbsp; 500,000&nbsp; restricted&nbsp; shares of its common</pre><pre>shares to Growers&nbsp; Synergy Pte Ltd., a corporation&nbsp; organized&nbsp; under the laws of</pre><pre>the&nbsp; Republic&nbsp; of&nbsp; Singapore&nbsp; ("Singapore"),&nbsp; owned&nbsp; and&nbsp; controlled&nbsp; by&nbsp; George</pre><pre>Blankenbaker,&nbsp; the&nbsp; president,&nbsp; director and a&nbsp; significant&nbsp; stockholder&nbsp; of the</pre><pre>Company ("Growers&nbsp; Synergy"),&nbsp; as consideration for services rendered by Growers</pre><pre>Synergy to the Company.&nbsp; These restricted&nbsp; shares were valued at $0.79 per share</pre><pre>discounted at 69% taking into consideration of its restricted nature and lack of</pre><pre>liquidity and&nbsp; consistent&nbsp; trading in the market or $272,550 and included in the</pre><pre>farm&nbsp; management&nbsp; services - related&nbsp; party in the&nbsp; consolidated&nbsp; statements&nbsp; of</pre><pre>operations.</pre><pre>&nbsp;</pre><pre>SALE OF EQUITY UNIT INCLUSIVE OF COMMON STOCK AND WARRANTS</pre><pre>&nbsp;</pre><pre>ENTRY INTO SECURITIES PURCHASE AGREEMENT</pre><pre>&nbsp;</pre><pre>On August 1, 2012, the Company entered into a Securities Purchase Agreement (the</pre><pre>"SPA") with two (2) accredited&nbsp; institutional&nbsp; investors (the&nbsp; "Purchasers")&nbsp; to</pre><pre>raise $500,000 in a private&nbsp; placement&nbsp; financing.&nbsp; On August 6, 2012, after the</pre><pre>satisfaction of certain closing conditions,&nbsp; the Offering closed and the Company</pre><pre>issued to the Purchasers:&nbsp; (i) an aggregate of 1,066,667 shares of the Company's</pre><pre>common&nbsp; stock at $0.46875&nbsp; per share and (ii)&nbsp; warrants&nbsp; to&nbsp; purchase&nbsp; 1,066,667</pre><pre>shares of the Company's&nbsp; common stock at an exercise&nbsp; price of $0.6405&nbsp; expiring</pre><pre>five (5) years from the date of issuance for a gross proceeds of $500,000.</pre><pre>&nbsp;</pre><pre>At closing,&nbsp; the Company&nbsp; reimbursed&nbsp; the investor for legal fees of $12,500 and</pre><pre>paid Garden State Securities, Inc,("GSS") that served as placement agent for the</pre><pre>Company in the offering (i) cash commissions equal to 8.0% of the gross proceeds</pre><pre>received&nbsp; in the equity&nbsp; financing&nbsp; or&nbsp; $40,000,&nbsp; and (ii) a warrant to purchase</pre><pre>85,333 shares of the Company's&nbsp; common stock&nbsp; representing 8% of the Shares sold</pre><pre>in the Offering&nbsp; with an exercise&nbsp; price of $0.6405 per share&nbsp; expiring five (5)</pre><pre>years from the date of issuance (the "agent warrants") to GSS or its designee.</pre><pre>&nbsp;</pre><pre>The units were sold at $0.46875&nbsp; per unit&nbsp; consisting&nbsp; one common&nbsp; share and the</pre><pre>warrant to purchase&nbsp; one (1) common share for a gross&nbsp; proceeds of $500,000.&nbsp; In</pre><pre>connection with the August 6, 2012 equity unit offering the Company paid (i) GSS</pre><pre>cash&nbsp; commissions&nbsp; equal to 8.0% of the gross&nbsp; proceeds&nbsp; received&nbsp; in the equity</pre><pre>financing,&nbsp; or $40,000&nbsp; and (ii)&nbsp; $12,500 in legal&nbsp; fees and&nbsp; resulted&nbsp; in a net</pre><pre>proceeds of $447,500.</pre><pre>&nbsp;</pre><pre>The Company&nbsp; intended to use the net&nbsp; proceeds&nbsp; from the Offering to advance the</pre><pre>Company's&nbsp; ability to execute its growth&nbsp; strategy and to aid in the&nbsp; commercial</pre><pre>development&nbsp; of the recently&nbsp; announced&nbsp; launch of the Company's&nbsp; majority-owned</pre><pre>subsidiary, Stevia Technew Limited.</pre><pre>&nbsp;</pre><pre>ENTRY INTO REGISTRATION RIGHTS AGREEMENT</pre><pre>&nbsp;</pre><pre>In&nbsp; connection&nbsp; with the equity&nbsp; financing&nbsp; on August 1, 2012,&nbsp; the Company also</pre><pre>entered into a registration&nbsp; rights&nbsp; agreement with the Purchasers&nbsp; (the "rights</pre><pre>agreement").&nbsp; The Rights&nbsp; Agreement&nbsp; requires the Company to file a registration</pre><pre>statement&nbsp; (the&nbsp; "Registration&nbsp; Statement")&nbsp; with the&nbsp; Securities&nbsp; and&nbsp; Exchange</pre><pre>Commission&nbsp; (the "SEC") within&nbsp; thirty (30) days of the Company's&nbsp; entrance into</pre><pre>the rights agreement (the "filing date") for the resale by the Purchasers of all</pre><pre>of the Shares and all of the shares of common stock&nbsp; issuable&nbsp; upon&nbsp; exercise of</pre><pre>the Warrants (the "registrable securities").</pre><pre>&nbsp;</pre><pre>The&nbsp; registration&nbsp; statement&nbsp; must be declared&nbsp; effective&nbsp; by the SEC within one</pre><pre>hundred and twenty&nbsp; (120) days of the closing&nbsp; date of the&nbsp; Offering&nbsp; subject to</pre><pre>certain&nbsp; adjustments.&nbsp; If the&nbsp; registration&nbsp; statement is not filed prior to the</pre><pre>filing date, the Company will be required to pay certain liquidated damages, not</pre><pre>to exceed in the&nbsp; aggregate&nbsp; 6% of the&nbsp; purchase&nbsp; price&nbsp; paid by the&nbsp; Purchasers</pre><pre>pursuant to the SPA.</pre><pre>&nbsp;</pre><pre>WARRANTS</pre><pre>&nbsp;</pre><pre>ISSUANCES&nbsp; OF&nbsp; WARRANTS&nbsp; IN&nbsp; CONNECTION&nbsp; WITH&nbsp; ENTRY&nbsp; INTO&nbsp; SECURITIES&nbsp; PURCHASE</pre><pre>AGREEMENT</pre><pre>&nbsp;</pre><pre>On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares,</pre><pre>in the&nbsp; aggregate,&nbsp; of the&nbsp; Company's&nbsp; common&nbsp; stock&nbsp; to the&nbsp; investors&nbsp; with an</pre><pre>exercise price of $0.6405 per share subject to certain&nbsp; adjustments&nbsp; per Section</pre><pre>3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of</pre><pre>issuance in connection with the sale of common shares.</pre><pre>&nbsp;</pre><pre>ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION</pre><pre>&nbsp;</pre><pre>Garden State&nbsp; Securities,&nbsp; Inc. (the "GSS") served as the placement agent of the</pre><pre>Company for the equity financing on August 1, 2012. Per the engagement agreement</pre><pre>signed between GSS and the Company,&nbsp; in consideration&nbsp; for services&nbsp; rendered as</pre><pre>the placement agent,&nbsp; the Company agreed to: (i) pay GSS cash commissions&nbsp; equal</pre><pre>to 8.0% of the gross proceeds received in the equity financing,&nbsp; or $40,000, and</pre><pre>(ii) issue to GSS or its&nbsp; designee,&nbsp; a warrant to purchase&nbsp; 85,333 shares of the</pre><pre>Company's&nbsp; common stock&nbsp; representing&nbsp; 8% of the warrants&nbsp; sold in the Offering)</pre><pre>with an exercise price of $0.6405 per share subject to certain&nbsp; adjustments&nbsp; per</pre><pre>Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the</pre><pre>date of issuance (the "agent warrants"). The agent warrants also provide for the</pre><pre>same&nbsp; registration&nbsp; rights and obligations as set forth in the Rights&nbsp; Agreement</pre><pre>with respect to the Warrants and Warrant Shares.</pre> <!--egx--><pre><b>NOTE 12 - NON-CONTROLLING INTEREST</b></pre><pre>&nbsp;</pre><pre>Non-controlling interest consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contributed and</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paid-in&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Earnings and&nbsp;&nbsp;&nbsp;&nbsp; Comprehensive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non-controlling</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; capital&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; losses&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; interest</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>Balance at March 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Current period earnings and losses&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (97,338)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (97,338)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>Balance at December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(97,338)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(97,338)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre><b>NOTE 13 - RESEARCH AND DEVELOPMENT</b></pre><pre>&nbsp;</pre><pre>AGRIBUSINESS DEVELOPMENT AGREEMENT - AGRO GENESIS PTE LTD.</pre><pre>&nbsp;</pre><pre>ENTRY INTO AGRIBUSINESS DEVELOPMENT AGREEMENT</pre><pre>&nbsp;</pre><pre>On July 16, 2011, the Company entered into an Agribusiness Development Agreement</pre><pre>(the "Agribusiness&nbsp; Development Agreement") with Agro Genesis Pte Ltd. ("AGPL"),</pre><pre>a corporation organized under the laws of the Republic of Singapore expiring two</pre><pre>(2) years from the date of signing.</pre><pre>&nbsp;</pre><pre>Under the terms of the Agreement,&nbsp; the Company&nbsp; engaged AGPL to be the Company's</pre><pre>technology&nbsp; provider&nbsp; consultant&nbsp; for&nbsp; stevia&nbsp; propagation&nbsp; and&nbsp; cultivation&nbsp; in</pre><pre>Vietnam,&nbsp; and potentially&nbsp; other&nbsp; countries for a period of two (2) years.&nbsp; AGPL</pre><pre>will be tasked with developing stevia propagation and cultivation&nbsp; technology in</pre><pre>Vietnam,&nbsp; recommend quality agronomic programs for stevia&nbsp; cultivation,&nbsp; harvest</pre><pre>and post harvest,&nbsp; alert findings on stevia propagation and cultivation that may</pre><pre>impact&nbsp; profitability&nbsp; and&nbsp; develop a&nbsp; successful&nbsp; model in Vietnam&nbsp; that can be</pre><pre>replicated&nbsp; elsewhere&nbsp; (the&nbsp; "Project").&nbsp; The Project&nbsp; will be on-site at stevia</pre><pre>fields&nbsp; in&nbsp; Vietnam&nbsp; and will&nbsp; have a term of at least&nbsp; two (2)&nbsp; years.&nbsp; For its</pre><pre>services,&nbsp; AGPL could&nbsp; receive a fee of up to 275,000&nbsp; Singapore&nbsp; dollars,&nbsp; plus</pre><pre>related&nbsp; expenses&nbsp; estimated&nbsp; at&nbsp; $274,000&nbsp; as&nbsp; specified&nbsp; in&nbsp; Appendix A to the</pre><pre>Agribusiness&nbsp; Development&nbsp; Agreement.&nbsp; Additionally,&nbsp; the Company will be AGPL's</pre><pre>exclusive&nbsp; distributor for AGPL's g'farm system (a novel crop production system)</pre><pre>for stevia growing resulting from the Project. AGPL will receive a commission of</pre><pre>no less than 2% of the price paid for crops&nbsp; other than&nbsp; stevia,&nbsp; from&nbsp; cropping</pre><pre>systems&nbsp; that&nbsp; utilize&nbsp; the&nbsp; g'farm&nbsp; system&nbsp; resulting&nbsp; from&nbsp; the&nbsp; Project.&nbsp; All</pre><pre>technology-related&nbsp; patents&nbsp; resulting from the Project will be jointly owned by</pre><pre>AGPL and the&nbsp; Company,&nbsp; with the Company &nbsp;holding a right of first offer for the</pre><pre>use and distribution rights to registered patents resulting from the Project.</pre><pre>&nbsp;</pre><pre>ADDENDUM TO AGRIBUSINESS DEVELOPMENT AGREEMENT</pre><pre>&nbsp;</pre><pre>On August 26, 2011, in accordance&nbsp; with Appendix A , 3(a),&nbsp; the Company and AGPL</pre><pre>have mutually agreed to add to the current Project budget $100,000 per annum for</pre><pre>one, on-site resident AGPL expert for 2 (two) years effective September 1, 2011,</pre><pre>or $200,000 in&nbsp; aggregate&nbsp; for the term of the contract as specified in Appendix</pre><pre>C. In-country&nbsp; accommodation&nbsp; for the resident expert will be born separately by</pre><pre>the&nbsp; Company&nbsp; and is&nbsp; excluded&nbsp; from the above&nbsp; amount.&nbsp; The&nbsp; expert,&nbsp; Dr.&nbsp; Cho,</pre><pre>Young-Cheol,&nbsp; Director,&nbsp; Life&nbsp; Sciences&nbsp; has been&nbsp; appointed&nbsp; and&nbsp; commenced&nbsp; on</pre><pre>September 1, 2011.</pre><pre>&nbsp;</pre><pre>TERMINATION OF AGRIBUSINESS DEVELOPMENT AGREEMENT</pre><pre>&nbsp;</pre><pre>On March 31,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; and AGPL&nbsp; mutually&nbsp; agreed to&nbsp; terminate&nbsp; the</pre><pre>Agribusiness Development Agreement, effective immediately.</pre><pre>&nbsp;</pre><pre>LEASE OF AGRICULTURAL LAND</pre><pre>&nbsp;</pre><pre>On December&nbsp; 14,&nbsp; 2011,&nbsp; the Company and Stevia&nbsp; Ventures&nbsp; Corporation&nbsp; ("Stevia</pre><pre>Ventures")&nbsp; entered into a Land Lease Agreement with Vinh Phuc Province People's</pre><pre>Committee Tam Dao&nbsp; Agriculture&nbsp; &amp; Industry&nbsp; Co.,&nbsp; Ltd.&nbsp; pursuant to which Stevia</pre><pre>Ventures&nbsp; has leased l0&nbsp; hectares&nbsp; of land (the&nbsp; "Leased&nbsp; Property")&nbsp; for a term</pre><pre>expiring five (5) years from the date of signing.</pre><pre>&nbsp;</pre><pre>The Company has begun&nbsp; development of a research facility on the Leased Property</pre><pre>and has&nbsp; prepaid&nbsp; (i) the first year lease&nbsp; payment of $30,000&nbsp; and (ii) the six</pre><pre>month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon</pre><pre>signing of the agreement.</pre><pre>&nbsp;</pre><pre>Future minimum payments&nbsp; required under this agreement at December 31, 2012 were</pre><pre>as follows:</pre><pre>&nbsp;</pre><pre>FISCAL YEAR ENDING MARCH 31:</pre><pre>2013 (remainder of the fiscal year)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$ 15,000</pre><pre>2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,000</pre><pre>2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,000</pre><pre>2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $105,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;========</pre><pre>&nbsp;</pre><pre>SUPPLY AND&nbsp; COOPERATIVE&nbsp; AGREEMENT -&nbsp; GUANGZHOU&nbsp; HEALTH&nbsp; TECHNOLOGY&nbsp; DEVELOPMENT</pre><pre>COMPANY LIMITED</pre><pre>&nbsp;</pre><pre>ENTRY INTO SUPPLY AGREEMENT</pre><pre>&nbsp;</pre><pre>On February 21, 2012, the Company&nbsp; entered into a Supply&nbsp; Agreement (the "Supply</pre><pre>Agreement") with Guangzhou Health China Technology&nbsp; Development Company Limited,</pre><pre>a&nbsp; foreign-invested&nbsp; limited&nbsp; liability&nbsp; company&nbsp; incorporated&nbsp; in the&nbsp; People's</pre><pre>Republic of China (the "Guangzhou Health").</pre><pre>&nbsp;</pre><pre>Under the terms of the Supply Agreement,&nbsp; the Company will sell dry stevia plant</pre><pre>materials,&nbsp; including&nbsp; stems and leaves&nbsp; ("Product")&nbsp; exclusively&nbsp; to&nbsp; Guangzhou</pre><pre>Health. For the first two years of the agreement, Guangzhou Health will purchase</pre><pre>all&nbsp; Product&nbsp; produced&nbsp; by the&nbsp; Company.&nbsp; Starting&nbsp; with the&nbsp; third&nbsp; year of the</pre><pre>agreement,&nbsp; the&nbsp; Company&nbsp; and&nbsp; Guangzhou&nbsp; Health&nbsp; will&nbsp; review&nbsp; and agree on the</pre><pre>quantity of Product to be supplied in the forthcoming year, and Guangzhou Health</pre><pre>will be obliged to purchase up to 130 percent of that amount. The specifications</pre><pre>and price of&nbsp; Product&nbsp; will also be&nbsp; revised&nbsp; annually&nbsp; according&nbsp; to the mutual</pre><pre>agreement of the parties. The term of the Supply Agreement is five years with an</pre><pre>option to renew for an additional four years.</pre><pre>&nbsp;</pre><pre>ENTRY INTO COOPERATIVE AGREEMENT</pre><pre>&nbsp;</pre><pre>On February 21, 2012, the Company also entered into&nbsp; Cooperative&nbsp; Agreement (the</pre><pre>"Cooperative&nbsp; Agreement") with Guangzhou Health Technology&nbsp; Development&nbsp; Company</pre><pre>Limited.</pre><pre>&nbsp;</pre><pre>Under the terms of the&nbsp; Cooperative&nbsp; Agreement,&nbsp; the&nbsp; parties&nbsp; agree to&nbsp; explore</pre><pre>potential technology partnerships with the intent of formalizing a joint venture</pre><pre>to pursue the most promising technologies and businesses. The parties also agree</pre><pre>to&nbsp; conduct&nbsp; trials to test the&nbsp; efficacy&nbsp; of&nbsp; certain&nbsp; technologies&nbsp; as applied</pre><pre>specifically&nbsp; to the Company's&nbsp; business model as well as the&nbsp; marketability&nbsp; of</pre><pre>harvests produced utilizing such&nbsp; technologies.&nbsp; Guangzhou Health will share all</pre><pre>available&nbsp; information&nbsp; of its&nbsp; business&nbsp; structure&nbsp; and&nbsp; technologies&nbsp; with the</pre><pre>Company, subject to the confidentiality provisions of the Cooperative Agreement.</pre><pre>Guangzhou Health will also permit the Company to enter its premises and grow-out</pre><pre>sites for&nbsp; purposes of&nbsp; inspection&nbsp; and will,&nbsp; as&nbsp; reasonably&nbsp; requested&nbsp; by the</pre><pre>Company,&nbsp; supply&nbsp; without&nbsp; cost,&nbsp; random&nbsp; samples of products&nbsp; and&nbsp; harvests for</pre><pre>testing.</pre> <!--egx--><pre><b>NOTE 14 - COMMITMENTS AND CONTINGENCIES</b></pre><pre>&nbsp;</pre><pre>SUPPLY&nbsp; AGREEMENT - BETWEEN STEVIA VENTURES&nbsp; INTERNATIONAL&nbsp; LTD. AND ASIA STEVIA</pre><pre>INVESTMENT DEVELOPMENT COMPANY LTD.</pre><pre>&nbsp;</pre><pre>On April 12, 2011,&nbsp; Stevia&nbsp; Ventures&nbsp; International&nbsp; Ltd, the&nbsp; subsidiary of the</pre><pre>Company&nbsp; entered&nbsp; into a Supply&nbsp; Agreement&nbsp; (the "Supply&nbsp; Agreement")&nbsp; with Asia</pre><pre>Stevia Investment&nbsp; Development Company Ltd ("ASID"), a foreign-invested&nbsp; limited</pre><pre>liability company incorporated in Vietnam.</pre><pre>&nbsp;</pre><pre>(I) SCOPE OF SERVICES</pre><pre>&nbsp;</pre><pre>Under the terms of the Agreement,&nbsp; the Company&nbsp; engaged ASID to plant the Stevia</pre><pre>Seedlings&nbsp; and supply the Products only to the Company to the exclusion of other</pre><pre>customers&nbsp; and the Company is desirous&nbsp; to purchase&nbsp; the same,&nbsp; on the terms and</pre><pre>conditions&nbsp; as set out in&nbsp; this&nbsp; Agreement&nbsp; produce&nbsp; Products&nbsp; and&nbsp; the&nbsp; Company</pre><pre>purchase the Products from ASID.</pre><pre>&nbsp;</pre><pre>(II) TERM</pre><pre>&nbsp;</pre><pre>This&nbsp; Agreement&nbsp; shall come into&nbsp; force on the&nbsp; Effective&nbsp; Date and,&nbsp; subject to</pre><pre>earlier&nbsp; termination&nbsp; pursuant to certain&nbsp; clauses&nbsp; specified in the&nbsp; Agreement,</pre><pre>shall&nbsp; continue in force for a period of three (3) years ("Term") and thereafter</pre><pre>automatically renew on its anniversary each year for an additional period of one</pre><pre>(1) year ("Extended Term").</pre><pre>&nbsp;</pre><pre>(III) PURCHASE PRICE</pre><pre>&nbsp;</pre><pre>ASID and the Company shall review and agree on or before&nbsp; September 30th of each</pre><pre>Year on the&nbsp; quantity of the&nbsp; Products&nbsp; to be&nbsp; supplied&nbsp; by the&nbsp; Supplier to the</pre><pre>Company in the&nbsp; forthcoming&nbsp; year and ASID shall&nbsp; provide the Company with prior</pre><pre>written&nbsp; notice at any time&nbsp; during the year&nbsp; following&nbsp; the&nbsp; revision if it has</pre><pre>reason to believe that it would be unable to fulfill its forecast&nbsp; volumes under</pre><pre>this clause.</pre><pre>&nbsp;</pre><pre>SUPPLY&nbsp; AGREEMENT&nbsp; - BETWEEN&nbsp; STEVIA&nbsp; VENTURES&nbsp; INTERNATIONAL&nbsp; LTD.&nbsp; AND&nbsp; STEVIA</pre><pre>VENTURES CORPORATION</pre><pre>&nbsp;</pre><pre>On April 12, 2011,&nbsp; Stevia&nbsp; Ventures&nbsp; International&nbsp; Ltd, the&nbsp; subsidiary of the</pre><pre>Company also&nbsp; entered into a Supply&nbsp; Agreement&nbsp; (the&nbsp; "Supply&nbsp; Agreement")&nbsp; with</pre><pre>Stevia&nbsp; Ventures&nbsp; Corporation&nbsp; ("SVC"),&nbsp; a&nbsp; foreign-invested&nbsp; limited&nbsp; liability</pre><pre>company incorporated in Vietnam.</pre><pre>&nbsp;</pre><pre>(I) SCOPE OF SERVICES</pre><pre>&nbsp;</pre><pre>Under the terms of the&nbsp; Agreement,&nbsp; the Company&nbsp; engaged SVC to plant the Stevia</pre><pre>Seedlings&nbsp; and supply the Products only to the Company to the exclusion of other</pre><pre>customers&nbsp; and the Company is desirous&nbsp; to purchase&nbsp; the same,&nbsp; on the terms and</pre><pre>conditions&nbsp; as set out in&nbsp; this&nbsp; Agreement&nbsp; produce&nbsp; Products&nbsp; and&nbsp; the&nbsp; Company</pre><pre>purchase the Products from SVC.</pre><pre>&nbsp;</pre><pre>(II) TERM</pre><pre>&nbsp;</pre><pre>This&nbsp; Agreement&nbsp; shall come into&nbsp; force on the&nbsp; Effective&nbsp; Date and,&nbsp; subject to</pre><pre>earlier&nbsp; termination&nbsp; pursuant to certain&nbsp; clauses&nbsp; specified in the&nbsp; Agreement,</pre><pre>shall&nbsp; continue in force for a period of three (3) years ("Term") and thereafter</pre><pre>automatically renew on its anniversary each year for an additional period of one</pre><pre>(1) year ("Extended Term").</pre><pre>&nbsp;</pre><pre>(III) PURCHASE PRICE</pre><pre>&nbsp;</pre><pre>SVC and the Company shall review and agree on or before&nbsp; September&nbsp; 30th of each</pre><pre>Year on the&nbsp; quantity of the&nbsp; Products&nbsp; to be&nbsp; supplied&nbsp; by the&nbsp; Supplier to the</pre><pre>Company in the&nbsp; forthcoming&nbsp; year and SVC shall&nbsp; provide the Company&nbsp; with prior</pre><pre>written&nbsp; notice at any time&nbsp; during the year&nbsp; following&nbsp; the&nbsp; revision if it has</pre><pre>reason to believe that it would be unable to fulfill its forecast&nbsp; volumes under</pre><pre>this clause.</pre><pre>&nbsp;</pre><pre>CONSULTING AGREEMENT - DORIAN BANKS</pre><pre>&nbsp;</pre><pre>ENTRY INTO CONSULTING AGREEMENT</pre><pre>&nbsp;</pre><pre>On July 1, 2011 the Company entered into a consulting agreement (the "Consulting</pre><pre>Agreement") with Dorian Banks ("Banks").</pre><pre>&nbsp;</pre><pre>(I) SCOPE OF SERVICES</pre><pre>&nbsp;</pre><pre>Under the terms of the Consulting Agreement,&nbsp; the Company engaged the Consultant</pre><pre>to provide advice in general business development, strategy, assistance with new</pre><pre>business&nbsp; and&nbsp; land&nbsp; acquisition,&nbsp; introductions,&nbsp; and&nbsp; assistance&nbsp; with&nbsp; Public</pre><pre>Relations ("PR") and Investor Relations ("IR").</pre><pre>&nbsp;</pre><pre>(II) TERM</pre><pre>&nbsp;</pre><pre>The term of this Agreement&nbsp; shall be six (6) months,&nbsp; commencing on July 1, 2011</pre><pre>and continue until December 31, 2011. This Agreement may be terminated by either</pre><pre>the&nbsp; Company or the&nbsp; Consultant&nbsp; at any time prior to the end of the&nbsp; Consulting</pre><pre>Period by giving thirty (30) days written notice of termination. Such notice may</pre><pre>be given at any time for any reason, with or without cause. The Company will pay</pre><pre>Consultant&nbsp; for&nbsp; all&nbsp; Service&nbsp; performed&nbsp; by&nbsp; Consultant&nbsp; through&nbsp; the&nbsp; date&nbsp; of</pre><pre>termination.</pre><pre>&nbsp;</pre><pre>(III) COMPENSATION</pre><pre>&nbsp;</pre><pre>The Company shall pay the Consultant a fee of $3,000 per month.</pre><pre>&nbsp;</pre><pre>EXTENSION OF THE CONSULTING AGREEMENT</pre><pre>&nbsp;</pre><pre>On December 30, 2011, the Consulting&nbsp; Agreement was extended with the same terms</pre><pre>and conditions to December 31, 2012.</pre><pre>&nbsp;</pre><pre>SUMMARY OF THE CONSULTING FEES</pre><pre>&nbsp;</pre><pre>For the interim period ended December 31, 2012 and for the period from April 11,</pre><pre>2011&nbsp; (inception)&nbsp; through&nbsp; December 31, 2011, the Company&nbsp; recorded $27,000 and</pre><pre>$18,000 in consulting fees under the Consulting Agreement, respectively.</pre><pre>&nbsp;</pre><pre>FINANCING CONSULTING AGREEMENT - DAVID CLIFTON</pre><pre>&nbsp;</pre><pre>ENTRY INTO FINANCIAL CONSULTING AGREEMENT</pre><pre>&nbsp;</pre><pre>On July 1, 2011 the Company entered into a consulting agreement (the "Consulting</pre><pre>Agreement") with David Clifton ( "Clifton").</pre><pre>&nbsp;</pre><pre>(I) SCOPE OF SERVICES</pre><pre>&nbsp;</pre><pre>Under the terms of the&nbsp; Consulting&nbsp; Agreement,&nbsp; the Company&nbsp; engaged&nbsp; Clifton to</pre><pre>introduce interested&nbsp; investors to the Company,&nbsp; advise the Company on available</pre><pre>financing&nbsp; options and provide periodic updates on the stevia sector and provide</pre><pre>insights and strategies for the Company to undertake.</pre><pre>&nbsp;</pre><pre>(II) TERM</pre><pre>&nbsp;</pre><pre>The term of this Agreement&nbsp; shall be six (6) months,&nbsp; commencing on July 1, 2011</pre><pre>and&nbsp; continuing&nbsp; until&nbsp; December 31, 2011.&nbsp; This&nbsp; Agreement may be terminated by</pre><pre>either the&nbsp; Company&nbsp; or&nbsp; Clifton at any time prior to the end of the&nbsp; consulting</pre><pre>period by giving thirty (30) days written notice of termination. Such notice may</pre><pre>be given at any time for any reason, with or without cause. The Company will pay</pre><pre>Clifton for all service performed by him through the date of termination.</pre><pre>&nbsp;</pre><pre>On December 31, 2011, the financial consulting agreement expired.</pre><pre>&nbsp;</pre><pre>(III) COMPENSATION</pre><pre>&nbsp;</pre><pre>The Company shall pay Clifton a fee of $3,000 per month.</pre><pre>&nbsp;</pre><pre>SUMMARY OF THE CONSULTING FEES</pre><pre>&nbsp;</pre><pre>The financial&nbsp; consulting agreement expired on December 31, 2011. For the period</pre><pre>from April 11, 2011 (inception)&nbsp; through December 31, 2011, the Company recorded</pre><pre>$18,000 in financing cost under this Financing Consulting Agreement.</pre><pre>&nbsp;</pre><pre>ENTRY INTO ENGAGEMENT AGREEMENT - GARDEN STATE SECURITIES INC.</pre><pre>&nbsp;</pre><pre>On June&nbsp; 18,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; entered&nbsp; into an&nbsp; engagement&nbsp; agreement&nbsp; (the</pre><pre>"Agreement")&nbsp; with Garden&nbsp; State&nbsp; Securities&nbsp; Inc.&nbsp; ("GSS")&nbsp; with respect to the</pre><pre>engagement of GSS to act as a selling/placement agent for the Company.</pre><pre>&nbsp;</pre><pre>(I) SCOPE OF SERVICES</pre><pre>&nbsp;</pre><pre>Under the terms of the Agreement, the Company engaged GSS to review the business</pre><pre>and&nbsp; operations&nbsp; of the&nbsp; Company&nbsp; and its&nbsp; historical&nbsp; and&nbsp; projected&nbsp; financial</pre><pre>condition,&nbsp; advise the Company of "best efforts" Private&nbsp; Placement&nbsp; offering of</pre><pre>debt or equity&nbsp; securities to fulfill the Company's&nbsp; business plan, and contacts</pre><pre>for the Company possible financing sources.</pre><pre>&nbsp;</pre><pre>(II) TERM</pre><pre>&nbsp;</pre><pre>GSS shall act as the Company's&nbsp; exclusive&nbsp; placement agent for the period of the</pre><pre>later of; (i) 60 days from the&nbsp; execution&nbsp; of the term sheet;&nbsp; or (ii) the final</pre><pre>termination date of the securities financing (the "Exclusive Period"). GSS shall</pre><pre>act as the Company's&nbsp; non-exclusive&nbsp; placement agent after the Exclusive&nbsp; Period</pre><pre>until terminated.</pre><pre>&nbsp;</pre><pre>(III) COMPENSATION</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; agrees to pay to GSS at each full or&nbsp; incremental&nbsp; closing&nbsp; of any</pre><pre>equity financing,&nbsp; convertible debt financing, debt conversion or any instrument</pre><pre>convertible into the Company's common stock (the "Securities&nbsp; Financing") during</pre><pre>the&nbsp; Exclusive&nbsp; Period;&nbsp; (i) a cash&nbsp; transaction&nbsp; fee in the amount of 8% of the</pre><pre>amount received by the Company under the Securities Financing; and (ii) warrants</pre><pre>(the "Warrants") with "piggy back" registration rights, equal to 8% of the stock</pre><pre>issued in the Securities&nbsp; Financing at an exercise price equal to the investor's</pre><pre>warrant&nbsp; exercise&nbsp; price&nbsp; of&nbsp; the&nbsp; Securities&nbsp; Financing&nbsp; or&nbsp; the&nbsp; price&nbsp; of the</pre><pre>Securities&nbsp; Financing if no warrants are issued to&nbsp; investors.&nbsp; The Company will</pre><pre>also pay,&nbsp; at&nbsp; closing,&nbsp; the&nbsp; expense of GSS's&nbsp; legal&nbsp; counsel&nbsp; pursuant&nbsp; to the</pre><pre>Securities&nbsp; Financing&nbsp; and/or&nbsp; Shelf equal to $25,000 for&nbsp; Securities&nbsp; Financing</pre><pre>and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to</pre><pre>the Company,&nbsp; and $18,000 for a Securities&nbsp; Financing&nbsp; and/or Shelf resulting in</pre><pre>less than $500,000 of gross&nbsp; proceeds to the Company.&nbsp; In addition,&nbsp; the Company</pre><pre>shall cause,&nbsp; at its cost and&nbsp; expense,&nbsp; the "Blue sky filing" and Form D in due</pre><pre>and proper form and substance and in a timely manner.</pre> <!--egx--><pre><b>NOTE 15 - CONCENTRATIONS AND CREDIT RISK</b></pre><pre>&nbsp;</pre><pre>CREDIT RISK</pre><pre>&nbsp;</pre><pre>Financial&nbsp; instruments&nbsp; that&nbsp; potentially&nbsp; subject&nbsp; the&nbsp; Company to&nbsp; significant</pre><pre>concentration of credit risk consist primarily of cash and cash equivalents.</pre><pre>&nbsp;</pre><pre>As of&nbsp; December&nbsp; 31,&nbsp; 2012,&nbsp; substantially&nbsp; all of the&nbsp; Company's&nbsp; cash and cash</pre><pre>equivalents&nbsp; were&nbsp; held by major&nbsp; financial&nbsp; institutions,&nbsp; and the&nbsp; balance&nbsp; at</pre><pre>certain&nbsp; accounts&nbsp; exceeded the maximum amount&nbsp; insured by the Federal&nbsp; Deposits</pre><pre>Insurance Corporation ("FDIC").&nbsp; However, the Company has not experienced losses</pre><pre>on these&nbsp; accounts and&nbsp; management&nbsp; believes&nbsp; that the Company is not exposed to</pre><pre>significant risks on such accounts.</pre><pre>&nbsp;</pre><pre>CUSTOMERS AND CREDIT CONCENTRATIONS</pre><pre>&nbsp;</pre><pre>One (1)&nbsp; customer&nbsp; accounted&nbsp; for all of the sales for the interim&nbsp; period ended</pre><pre>December&nbsp; 31, 2012 and&nbsp; accounts&nbsp; receivable&nbsp; balances at December&nbsp; 31,&nbsp; 2012. A</pre><pre>reduction in sales from or loss of such customer&nbsp; would have a material&nbsp; adverse</pre><pre>effect on the Company's results of operations and financial condition.</pre><pre>&nbsp;</pre><pre>VENDORS AND ACCOUNTS PAYABLE CONCENTRATIONS</pre><pre>&nbsp;</pre><pre>Vendor&nbsp; purchase&nbsp; concentrations&nbsp; and&nbsp; accounts&nbsp; payable&nbsp; concentration&nbsp; are&nbsp; as</pre><pre>follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Payable at&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Purchases</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interim Period&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; March 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------</pre><pre>&nbsp;</pre><pre>Growers Synergy Pte. Ltd. - related party&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42.5%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16.4%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49.8%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --%</pre><pre>tevia Ventures Corporation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 54.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.3%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --%</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 46.2%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70.5%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --%</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======</pre><pre>&nbsp;</pre> <!--egx--><pre><b>NOTE 16 - SUBSEQUENT EVENTS</b></pre><pre>&nbsp;</pre><pre>The Company has evaluated all events that occurred&nbsp; after the balance sheet date</pre><pre>through the date when the financial&nbsp; statements were issued to determine if they</pre><pre>must be&nbsp; reported.&nbsp; The&nbsp; Management&nbsp; of the&nbsp; Company&nbsp; determined&nbsp; that&nbsp; there no</pre><pre>reportable subsequent events to be disclosed.</pre> <!--egx--><pre>BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION</pre><pre>&nbsp;</pre><pre>The accompanying&nbsp; unaudited interim financial&nbsp; statements and related notes have</pre><pre>been prepared in accordance with accounting principles generally accepted in the</pre><pre>United States of America ("U.S.&nbsp; GAAP") for interim financial&nbsp; information,&nbsp; and</pre><pre>with the rules and&nbsp; regulations&nbsp; of the United&nbsp; States&nbsp; Securities&nbsp; and Exchange</pre><pre>Commission&nbsp; ("SEC") to Form 10-Q and Article 8 of Regulation&nbsp; S-X.&nbsp; Accordingly,</pre><pre>they do not include all of the information&nbsp; and footnotes&nbsp; required by U.S. GAAP</pre><pre>for complete financial&nbsp; statements.&nbsp; The unaudited interim financial&nbsp; statements</pre><pre>furnished&nbsp; reflect all&nbsp; adjustments&nbsp; (consisting of normal&nbsp; recurring&nbsp; accruals)</pre><pre>which are, in the opinion of&nbsp; management,&nbsp; necessary to a fair&nbsp; statement of the</pre><pre>results for the interim periods&nbsp; presented.&nbsp; Interim results are not necessarily</pre><pre>indicative of the results for the full fiscal year.&nbsp; These financial&nbsp; statements</pre><pre>should be read in conjunction&nbsp; with the financial&nbsp; statements of the Company for</pre><pre>the period&nbsp; from April 11,&nbsp; 2011&nbsp; (inception)&nbsp; through&nbsp; March 31, 2012 and notes</pre><pre>thereto&nbsp; contained in the Company's Annual Report on Form 10-K as filed with the</pre><pre>SEC on June 29, 2012.</pre> <!--egx--><pre>PRINCIPLES OF CONSOLIDATION</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; applies&nbsp; the&nbsp; guidance&nbsp; of Topic 810&nbsp; "CONSOLIDATION"&nbsp; of the FASB</pre><pre>Accounting&nbsp; Standards&nbsp; Codification to determine&nbsp; whether and how to consolidate</pre><pre>another&nbsp; entity.&nbsp; Pursuant&nbsp; to ASC&nbsp; Paragraph&nbsp; 810-10-15-10&nbsp; all&nbsp; majority-owned</pre><pre>subsidiaries--all&nbsp; entities&nbsp; in&nbsp; which&nbsp; a&nbsp; parent&nbsp; has a&nbsp; controlling&nbsp; financial</pre><pre>interest--shall&nbsp; be consolidated&nbsp; except (1) when control does not rest with the</pre><pre>parent,&nbsp; the majority&nbsp; owner;&nbsp; (2) if the parent is a&nbsp; broker-dealer&nbsp; within the</pre><pre>scope of Topic 940 and control is likely to be temporary;&nbsp; (3)&nbsp; consolidation by</pre><pre>an investment company within the scope of Topic 946 of a&nbsp; non-investment-company</pre><pre>investee.&nbsp; Pursuant&nbsp; to ASC&nbsp; Paragraph&nbsp; 810-10-15-8&nbsp; the usual&nbsp; condition&nbsp; for a</pre><pre>controlling financial interest is ownership of a majority voting interest,&nbsp; and,</pre><pre>therefore,&nbsp; as a general rule&nbsp; ownership by one&nbsp; reporting&nbsp; entity,&nbsp; directly or</pre><pre>indirectly,&nbsp; of more than 50 percent of the outstanding voting shares of another</pre><pre>entity is a condition&nbsp; pointing toward&nbsp; consolidation.&nbsp; The power to control may</pre><pre>also exist with a lesser&nbsp; percentage&nbsp; of&nbsp; ownership,&nbsp; for example,&nbsp; by contract,</pre><pre>lease,&nbsp; agreement&nbsp; with other&nbsp; stockholders,&nbsp; or by court&nbsp; decree.&nbsp; The&nbsp; Company</pre><pre>consolidates all&nbsp; less-than-majority-owned&nbsp; subsidiaries,&nbsp; in which the parent's</pre><pre>power to control exists.</pre><pre>&nbsp;</pre><pre>The Company's consolidated subsidiaries and/or entities are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date of incorporation</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or formation</pre><pre>Name of consolidated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State or other jurisdiction of&nbsp;&nbsp;&nbsp;&nbsp; (date of acquisition,</pre><pre>subsidiary or entity&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; incorporation or organization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if applicable)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attributable interest</pre><pre>--------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------</pre><pre>&nbsp;</pre><pre>Stevia Ventures&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Territory of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100%</pre><pre>International Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; British Virgin Islands</pre><pre>&nbsp;</pre><pre>Stevia Asia Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hong Kong SAR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 19, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100%</pre><pre>&nbsp;</pre><pre>Stevia Technew Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hong Kong SAR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 28, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70%</pre><pre>&nbsp;</pre><pre>The consolidated&nbsp; financial statements include all accounts of the Company as of</pre><pre>December&nbsp; 31,&nbsp; 2012,&nbsp; for the interim&nbsp; period then ended and for the period from</pre><pre>June 23, 2011 (date of acquisition)&nbsp; through December 31, 2011;&nbsp; Stevia Ventures</pre><pre>International&nbsp; Ltd. as of December 31, 2012,&nbsp; for the interim&nbsp; period then ended</pre><pre>and for the period from April 11, 2011&nbsp; (inception)&nbsp; through&nbsp; December 31, 2011;</pre><pre>Stevia Asia&nbsp; Limited as of&nbsp; December&nbsp; 31, 2012 and for the period from March 19,</pre><pre>2012&nbsp; (inception)&nbsp; through&nbsp; December 31, 2012; and Stevia Technew&nbsp; Limited as of</pre><pre>December&nbsp; 31, 2012 and for the period from April 28,&nbsp; 2012&nbsp; (inception)&nbsp; through</pre><pre>December 31, 2012.</pre><pre>&nbsp;</pre><pre>All inter-company balances and transactions have been eliminated.</pre> <!--egx--><pre>RECLASSIFICATION</pre><pre>&nbsp;</pre><pre>Certain amounts in the prior period financial&nbsp; statements have been reclassified</pre><pre>to conform to the current period presentation.&nbsp; These&nbsp; reclassifications&nbsp; had no</pre><pre>effect on reported losses.</pre> <!--egx--><pre>USE OF ESTIMATES AND ASSUMPTIONS</pre><pre>&nbsp;</pre><pre>The preparation of financial statements in conformity with accounting principles</pre><pre>generally&nbsp; accepted in the United States of America requires&nbsp; management to make</pre><pre>estimates&nbsp; and&nbsp; assumptions&nbsp; that&nbsp; affect&nbsp; the&nbsp; reported&nbsp; amounts&nbsp; of assets and</pre><pre>liabilities&nbsp; and disclosure of contingent&nbsp; assets and liabilities at the date of</pre><pre>the&nbsp; financial&nbsp; statements&nbsp; and the&nbsp; reported&nbsp; amounts of revenues&nbsp; and expenses</pre><pre>during the reporting period.</pre><pre>&nbsp;</pre><pre>The Company's&nbsp; significant&nbsp; estimates and assumptions&nbsp; include the fair value of</pre><pre>financial&nbsp; instruments;&nbsp; the carrying&nbsp; value,&nbsp; recoverability&nbsp; and impairment of</pre><pre>long-lived&nbsp; assets,&nbsp; including the values&nbsp; assigned to and the estimated&nbsp; useful</pre><pre>lives of&nbsp; website&nbsp; development&nbsp; costs;&nbsp; interest&nbsp; rate;&nbsp; revenue&nbsp; recognized&nbsp; or</pre><pre>recognizable;&nbsp; sales returns and&nbsp; allowances;&nbsp; foreign&nbsp; currency&nbsp; exchange rate;</pre><pre>income&nbsp; tax rate,&nbsp; income tax&nbsp; provision,&nbsp; deferred&nbsp; tax&nbsp; assets&nbsp; and&nbsp; valuation</pre><pre>allowance of deferred&nbsp; tax assets;&nbsp; expected&nbsp; term of share&nbsp; options and similar</pre><pre>instruments,&nbsp; expected&nbsp; volatility of the entity's shares and the method used to</pre><pre>estimate it, expected annual rate of quarterly dividends, and risk free rate(s);</pre><pre>and the&nbsp; assumption&nbsp; that the Company will&nbsp; continue as a going&nbsp; concern.&nbsp; Those</pre><pre>significant&nbsp; accounting&nbsp; estimates or assumptions bear the risk of change due to</pre><pre>the&nbsp; fact&nbsp; that&nbsp; there&nbsp; are&nbsp;&nbsp; uncertainties&nbsp;&nbsp; attached&nbsp; to&nbsp; those&nbsp; estimates&nbsp; or</pre><pre>assumptions,&nbsp; and certain&nbsp; estimates or assumptions&nbsp; are difficult to measure or</pre><pre>value.</pre><pre>&nbsp;</pre><pre>Management&nbsp; bases&nbsp; its&nbsp; estimates&nbsp; on&nbsp; historical&nbsp;&nbsp; experience&nbsp; and&nbsp; on&nbsp; various</pre><pre>assumptions&nbsp; that are&nbsp; believed to be&nbsp; reasonable&nbsp; in relation to the&nbsp; financial</pre><pre>statements taken as a whole under the&nbsp; circumstances,&nbsp; the results of which form</pre><pre>the&nbsp; basis&nbsp; for&nbsp; making&nbsp; judgments&nbsp; about the&nbsp; carrying&nbsp; values&nbsp; of&nbsp; assets&nbsp; and</pre><pre>liabilities that are not readily apparent from other sources.</pre><pre>&nbsp;</pre><pre>Management&nbsp; regularly&nbsp; evaluates the key factors and assumptions used to develop</pre><pre>the estimates utilizing currently&nbsp; available&nbsp; information,&nbsp; changes in facts and</pre><pre>circumstances,&nbsp; historical&nbsp; experience&nbsp; and reasonable&nbsp; assumptions.&nbsp; After such</pre><pre>evaluations, if deemed appropriate, those estimates are adjusted accordingly.</pre><pre>&nbsp;</pre><pre>Actual results could differ from those estimates.</pre> <!--egx--><pre>FAIR VALUE OF FINANCIAL INSTRUMENTS</pre><pre>&nbsp;</pre><pre>The Company follows&nbsp; paragraph&nbsp; 820-10-35-37&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification&nbsp; ("Paragraph&nbsp; 820-10-35-37")&nbsp; to&nbsp; measure&nbsp; the&nbsp; fair&nbsp; value&nbsp; of its</pre><pre>financial&nbsp; instruments&nbsp; and&nbsp; paragraph&nbsp;&nbsp; 825-10-50-10&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting</pre><pre>Standards&nbsp; Codification&nbsp; for&nbsp; disclosures&nbsp; about&nbsp; fair&nbsp; value&nbsp; of its&nbsp; financial</pre><pre>instruments.&nbsp; Paragraph 820-10-35-37&nbsp; establishes a framework for measuring fair</pre><pre>value in&nbsp; accounting&nbsp; principles&nbsp; generally&nbsp; accepted&nbsp; in the&nbsp; United&nbsp; States of</pre><pre>America (U.S. GAAP), and expands disclosures about fair value&nbsp; measurements.&nbsp; To</pre><pre>increase&nbsp; consistency and&nbsp; comparability in fair value&nbsp; measurements and related</pre><pre>disclosures,&nbsp; Paragraph&nbsp; 820-10-35-37&nbsp; establishes a fair value&nbsp; hierarchy which</pre><pre>prioritizes&nbsp; the inputs to valuation&nbsp; techniques used to measure fair value into</pre><pre>three (3) broad levels.&nbsp; The three (3) levels of fair value hierarchy defined by</pre><pre>Paragraph 820-10-35-37 are described below:</pre><pre>&nbsp;</pre><pre>Level 1&nbsp;&nbsp;&nbsp; Quoted market prices available in active markets for identical assets</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or liabilities as of the reporting date.</pre><pre>&nbsp;</pre><pre>Level 2&nbsp;&nbsp;&nbsp; Pricing inputs other than quoted prices in active markets included in</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Level 1, which are either directly or indirectly observable as of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reporting date.</pre><pre>&nbsp;</pre><pre>Level 3&nbsp;&nbsp;&nbsp; Pricing&nbsp; inputs&nbsp; that&nbsp; are&nbsp; generally&nbsp;&nbsp; observable&nbsp;&nbsp; inputs&nbsp; and&nbsp; not</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; corroborated by market data.</pre><pre>&nbsp;</pre><pre>Financial&nbsp; assets are&nbsp; considered&nbsp; Level 3 when their fair values are determined</pre><pre>using pricing models,&nbsp; discounted cash flow&nbsp; methodologies or similar techniques</pre><pre>and at least one significant model assumption or input is unobservable.</pre><pre>&nbsp;</pre><pre>The&nbsp; fair&nbsp; value&nbsp; hierarchy&nbsp;&nbsp; gives&nbsp; the&nbsp; highest&nbsp;&nbsp; priority&nbsp; to&nbsp; quoted&nbsp; prices</pre><pre>(unadjusted)&nbsp; in active&nbsp; markets for&nbsp; identical&nbsp; assets or&nbsp; liabilities&nbsp; and the</pre><pre>lowest&nbsp; priority&nbsp; to &nbsp;unobservable&nbsp; inputs.&nbsp; If the inputs&nbsp; used to measure&nbsp; the</pre><pre>financial&nbsp; assets and&nbsp; liabilities&nbsp; fall&nbsp; within&nbsp; more than one level&nbsp; described</pre><pre>above, the categorization is based on the lowest level input that is significant</pre><pre>to the fair value measurement of the instrument.</pre><pre>&nbsp;</pre><pre>The carrying amounts of the Company's financial assets and liabilities,&nbsp; such as</pre><pre>cash,&nbsp; accounts&nbsp; receivable,&nbsp; prepayments&nbsp; and other&nbsp; current&nbsp; assets,&nbsp; accounts</pre><pre>payable,&nbsp; accrued expenses, and accrued interest,&nbsp; approximate their fair values</pre><pre>because of the short maturity of these instruments.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company's&nbsp; convertible&nbsp; notes payable&nbsp; approximates&nbsp; the fair value of such</pre><pre>instrument based upon management's best estimate of interest rates that would be</pre><pre>available to the Company for similar financial arrangements at December 31, 2012</pre><pre>and March 31, 2012.</pre><pre>&nbsp;</pre><pre>The Company's Level 3 financial&nbsp; liabilities&nbsp; consist of the derivative&nbsp; warrant</pre><pre>issued in August 2012 for which there is no current market for these&nbsp; securities</pre><pre>such that the&nbsp; determination&nbsp; of fair value&nbsp; requires&nbsp; significant&nbsp; judgment&nbsp; or</pre><pre>estimation.&nbsp;&nbsp; The&nbsp; Company&nbsp;&nbsp; valued&nbsp; the&nbsp;&nbsp; automatic&nbsp;&nbsp; conditional&nbsp;&nbsp; conversion,</pre><pre>re-pricing/down-round,&nbsp;&nbsp; change&nbsp; of&nbsp; control;&nbsp; default&nbsp; and&nbsp; follow-on&nbsp; offering</pre><pre>provisions using a lattice model, with the assistance of a third party valuation</pre><pre>specialist,&nbsp; for which management&nbsp; understands the&nbsp; methodologies.&nbsp; These models</pre><pre>incorporate transaction details such as Company stock price,&nbsp; contractual terms,</pre><pre>maturity,&nbsp; risk free rates,&nbsp; as well as&nbsp; assumptions&nbsp; about&nbsp; future&nbsp; financings,</pre><pre>volatility,&nbsp; and holder&nbsp; behavior&nbsp; as of the date of issuance&nbsp; and each&nbsp; balance</pre><pre>sheet date.</pre><pre>&nbsp;</pre><pre>It is not,&nbsp; however,&nbsp; practical&nbsp; to&nbsp; determine&nbsp; the fair value of advances&nbsp; from</pre><pre>president&nbsp; and&nbsp; significant&nbsp; stockholder,&nbsp; if any,&nbsp; due to their&nbsp; related&nbsp; party</pre><pre>nature.</pre><pre>&nbsp;</pre><pre>FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS</pre><pre>&nbsp;</pre><pre>LEVEL 3 FINANCIAL LIABILITIES - DERIVATIVE WARRANT LIABILITIES</pre><pre>&nbsp;</pre><pre>The Company&nbsp; uses Level 3 of the fair value&nbsp; hierarchy to measure the fair value</pre><pre>of the derivative&nbsp; liabilities and revalues its derivative&nbsp; warrant liability at</pre><pre>every&nbsp; reporting&nbsp; period&nbsp; and&nbsp; recognizes&nbsp; gains or losses&nbsp; in the&nbsp; consolidated</pre><pre>statements of operations and&nbsp; comprehensive&nbsp; income (loss) that are attributable</pre><pre>to the change in the fair value of the derivative warrant liability.</pre> <!--egx--><pre>CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS</pre><pre>&nbsp;</pre><pre>The Company has adopted paragraph&nbsp; 360-10-35-17 of the FASB Accounting Standards</pre><pre>Codification for its long-lived assets. The Company's&nbsp; long-lived assets,&nbsp; which</pre><pre>include property and equipment,&nbsp; acquired&nbsp; technology,&nbsp; and website&nbsp; development</pre><pre>costs are reviewed for impairment&nbsp; whenever&nbsp; events or changes in&nbsp; circumstances</pre><pre>indicate that the carrying amount of an asset may not be recoverable.</pre><pre>&nbsp;</pre><pre>The Company assesses the&nbsp; recoverability&nbsp; of its long-lived&nbsp; assets by comparing</pre><pre>the projected undiscounted net cash flows associated with the related long-lived</pre><pre>asset or group of long-lived assets over their remaining&nbsp; estimated useful lives</pre><pre>against their respective carrying amounts.&nbsp; Impairment,&nbsp; if any, is based on the</pre><pre>excess of the carrying amount over the fair value of those assets. Fair value is</pre><pre>generally&nbsp; determined using the asset's expected future discounted cash flows or</pre><pre>market value, if readily determinable. If long-lived assets are determined to be</pre><pre>recoverable,&nbsp; but the newly&nbsp; determined&nbsp; remaining&nbsp; estimated&nbsp; useful&nbsp; lives are</pre><pre>shorter than originally estimated,&nbsp; the net book values of the long-lived assets</pre><pre>are depreciated over the newly determined remaining estimated useful lives.</pre><pre>&nbsp;</pre><pre>The Company considers the following to be some examples of important&nbsp; indicators</pre><pre>that may trigger an impairment&nbsp; review:&nbsp; (i)&nbsp; significant&nbsp; under-performance&nbsp; or</pre><pre>losses of assets relative to expected&nbsp; historical or projected&nbsp; future operating</pre><pre>results;&nbsp; (ii)&nbsp; significant&nbsp; changes&nbsp; in the&nbsp; manner&nbsp; or use of assets or in the</pre><pre>Company's&nbsp; overall&nbsp; strategy&nbsp; with&nbsp; respect to the manner or use of the acquired</pre><pre>assets or changes in the Company's overall business strategy;&nbsp; (iii) significant</pre><pre>negative industry or economic trends; (iv) increased competitive pressures;&nbsp; (v)</pre><pre>a&nbsp; significant&nbsp; decline in the Company's&nbsp; stock price for a sustained&nbsp; period of</pre><pre>time; and (vi) regulatory&nbsp; changes.&nbsp; The Company&nbsp; evaluates&nbsp; acquired assets for</pre><pre>potential&nbsp; impairment&nbsp; indicators at least annually and more frequently upon the</pre><pre>occurrence of such events.</pre><pre>&nbsp;</pre><pre>The key assumptions&nbsp; used in management's&nbsp; estimates of projected cash flow deal</pre><pre>largely with&nbsp; forecasts of sales levels and gross margins.&nbsp; These&nbsp; forecasts are</pre><pre>typically based on historical&nbsp; trends and take into account recent&nbsp; developments</pre><pre>as well as management's plans and intentions.&nbsp; Other factors,&nbsp; such as increased</pre><pre>competition&nbsp; or a decrease&nbsp; in the&nbsp; desirability&nbsp; of the&nbsp; Company's&nbsp; products or</pre><pre>services,&nbsp; could lead to lower&nbsp; projected&nbsp; sales levels,&nbsp; which would&nbsp; adversely</pre><pre>impact cash flows. A significant change in cash flows in the future could result</pre><pre>in an impairment of long lived assets.</pre><pre>&nbsp;</pre><pre>The&nbsp; impairment&nbsp; charges,&nbsp; if any,&nbsp; is&nbsp; included&nbsp; in&nbsp; operating&nbsp; expenses in the</pre><pre>accompanying consolidated statements of operations.</pre> <!--egx--><pre>FISCAL YEAR END</pre><pre>&nbsp;</pre><pre>The Company elected March 31 as its fiscal year ending date.</pre> <!--egx--><pre>CASH EQUIVALENTS</pre><pre>&nbsp;</pre><pre>The Company&nbsp; considers all highly liquid&nbsp; investments&nbsp; with&nbsp; maturities of three</pre><pre>months or less at the time of purchase to be cash equivalents.</pre> <!--egx--><pre>PROPERTY AND EQUIPMENT</pre><pre>&nbsp;</pre><pre>Property and equipment is recorded at cost. Expenditures for major additions and</pre><pre>betterments are&nbsp; capitalized.&nbsp; Maintenance and repairs are charged to operations</pre><pre>as&nbsp; incurred.&nbsp;&nbsp; Depreciation&nbsp; of&nbsp; furniture&nbsp; and&nbsp; fixture&nbsp; is&nbsp; computed&nbsp; by&nbsp; the</pre><pre>straight-line&nbsp; method&nbsp; (after&nbsp; taking into account&nbsp; their&nbsp; respective&nbsp; estimated</pre><pre>residual values) over the assets&nbsp; estimated useful life of five (5) years.&nbsp; Upon</pre><pre>sale or retirement of property and equipment,&nbsp; the related cost and&nbsp; accumulated</pre><pre>depreciation&nbsp; are removed from the accounts and any gain or loss is reflected in</pre><pre>the statements of operations.</pre> <!--egx--><pre>INTANGIBLE ASSETS OTHER THAN GOODWILL</pre><pre>&nbsp;</pre><pre>The Company has adopted paragraph&nbsp; 350-30-25-3 of the FASB Accounting&nbsp; Standards</pre><pre>Codification for intangible assets other than goodwill.&nbsp; Under the requirements,</pre><pre>the Company&nbsp; amortizes the&nbsp; acquisition&nbsp; costs of&nbsp; intangible&nbsp; assets other than</pre><pre>goodwill&nbsp; inclusive of acquired&nbsp; technology and website&nbsp; development&nbsp; costs on a</pre><pre>straight-line&nbsp; basis over their relevant&nbsp; estimated useful lives of fifteen (15)</pre><pre>and five (5) years,&nbsp; respectively.&nbsp; Upon becoming fully&nbsp; amortized,&nbsp; the related</pre><pre>cost and accumulated amortization are removed from the accounts.</pre> <!--egx--><pre>RELATED PARTIES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; follows&nbsp;&nbsp; subtopic&nbsp;&nbsp; 850-10&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification for the identification of related parties and disclosure of related</pre><pre>party transactions.</pre><pre>&nbsp;</pre><pre>Pursuant to Section&nbsp; 850-10-20 the related&nbsp; parties include a. affiliates of the</pre><pre>Company;&nbsp; b. entities for which&nbsp; investments in their equity securities would be</pre><pre>required,&nbsp; absent the&nbsp; election&nbsp; of the fair value&nbsp; option&nbsp; under the Fair Value</pre><pre>Option Subsection of Section 825-10-15, to be accounted for by the equity method</pre><pre>by the investing entity; c. trusts for the benefit of employees, such as pension</pre><pre>and&nbsp; profit-sharing&nbsp; trusts&nbsp; that are&nbsp; managed&nbsp; by or under the&nbsp; trusteeship&nbsp; of</pre><pre>management; d. principal owners of the Company; e. management of the Company; f.</pre><pre>other&nbsp; parties&nbsp; with which the&nbsp; Company&nbsp; may deal if one party&nbsp; controls&nbsp; or can</pre><pre>significantly&nbsp; influence the management or operating policies of the other to an</pre><pre>extent&nbsp; that one of the&nbsp; transacting&nbsp; parties&nbsp; might&nbsp; be&nbsp; prevented&nbsp; from&nbsp; fully</pre><pre>pursuing its own separate interests; and g. other parties that can significantly</pre><pre>influence the&nbsp; management or operating&nbsp; policies of the&nbsp; transacting&nbsp; parties or</pre><pre>that&nbsp; have an&nbsp; ownership&nbsp; interest&nbsp; in one of the&nbsp; transacting&nbsp; parties&nbsp; and can</pre><pre>significantly&nbsp; influence&nbsp; the&nbsp; other&nbsp; to an&nbsp; extent&nbsp; that&nbsp; one&nbsp; or&nbsp; more&nbsp; of the</pre><pre>transacting&nbsp; parties&nbsp; might be&nbsp; prevented&nbsp; from fully&nbsp; pursuing its own separate</pre><pre>interests.</pre><pre>&nbsp;</pre><pre>The financial&nbsp; statements&nbsp; shall include&nbsp; disclosures of material&nbsp; related party</pre><pre>transactions,&nbsp; other than compensation&nbsp; arrangements,&nbsp; expense&nbsp; allowances,&nbsp; and</pre><pre>other similar items in the ordinary course of business.&nbsp; However,&nbsp; disclosure of</pre><pre>transactions&nbsp; that are eliminated in the preparation of consolidated or combined</pre><pre>financial statements is not required in those statements.&nbsp; The disclosures shall</pre><pre>include: a. the nature of the relationship(s)&nbsp; involved; b. a description of the</pre><pre>transactions, including transactions to which no amounts or nominal amounts were</pre><pre>ascribed, for each of the periods for which income statements are presented, and</pre><pre>such other&nbsp; information&nbsp; deemed&nbsp; necessary to an understanding of the effects of</pre><pre>the&nbsp; transactions&nbsp; on&nbsp; the&nbsp; financial&nbsp; statements;&nbsp; c.&nbsp; the&nbsp; dollar&nbsp; amounts&nbsp; of</pre><pre>transactions&nbsp; for each of the periods for which income&nbsp; statements are presented</pre><pre>and the effects of any change in the method of establishing&nbsp; the terms from that</pre><pre>used in the preceding&nbsp; period;&nbsp; and d. amounts due from or to related parties as</pre><pre>of the date of each balance sheet presented and, if not otherwise apparent,&nbsp; the</pre><pre>terms and manner of settlement.</pre> <!--egx--><pre>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</pre><pre>&nbsp;</pre><pre>The Company&nbsp; accounts&nbsp; for&nbsp; derivative&nbsp; instruments&nbsp; and hedging&nbsp; activities&nbsp; in</pre><pre>accordance&nbsp; with&nbsp; paragraph&nbsp;&nbsp; 810-10-05-4&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies</pre><pre>to recognize all&nbsp; derivative&nbsp; instruments as either assets or liabilities in the</pre><pre>balance sheet at fair value.&nbsp; The&nbsp; accounting for changes in the fair value of a</pre><pre>derivative&nbsp; instrument&nbsp; depends&nbsp; upon:&nbsp; (i)&nbsp; whether&nbsp; the&nbsp; derivative&nbsp; has&nbsp; been</pre><pre>designated and qualifies as part of a hedging relationship, and (ii) the type of</pre><pre>hedging relationship.&nbsp; For those derivative&nbsp; instruments that are designated and</pre><pre>qualify as hedging instruments,&nbsp; a company must designate the hedging instrument</pre><pre>based upon the exposure&nbsp; being&nbsp; hedged as either a fair value&nbsp; hedge,&nbsp; cash flow</pre><pre>hedge or hedge of a net investment in a foreign operation.</pre><pre>&nbsp;</pre><pre>From time to time, the Company may employ foreign currency forward&nbsp; contracts to</pre><pre>convert&nbsp; unforeseeable foreign currency exchange rates to fixed foreign currency</pre><pre>exchange rates.&nbsp; The Company does not use derivatives for speculation or trading</pre><pre>purposes.&nbsp; Changes in the fair value of derivatives&nbsp; are recorded each period in</pre><pre>current earnings or through other comprehensive&nbsp; income,&nbsp; depending on whether a</pre><pre>derivative is designated&nbsp; as part of a hedge&nbsp; transaction&nbsp; and the type of hedge</pre><pre>transaction.&nbsp; The&nbsp; ineffective&nbsp; portion of all hedges is&nbsp; recognized&nbsp; in current</pre><pre>earnings. The Company has sales and purchase commitments&nbsp; denominated in foreign</pre><pre>currencies.&nbsp; Foreign&nbsp; currency&nbsp; forward&nbsp; contracts are used to hedge against the</pre><pre>risk&nbsp; of&nbsp; change&nbsp; in&nbsp; the&nbsp; fair&nbsp; value &nbsp;of&nbsp; these&nbsp; commitments&nbsp; attributable&nbsp; to</pre><pre>fluctuations in exchange rates ("Fair Value Hedges").&nbsp; Changes in the fair value</pre><pre>of the&nbsp; derivative&nbsp; instrument are generally&nbsp; offset in the income&nbsp; statement by</pre><pre>changes in the fair value of the item being hedged.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; did not&nbsp; employ&nbsp; foreign&nbsp; currency&nbsp; forward&nbsp; contracts&nbsp; to convert</pre><pre>unforeseeable foreign currency exchange rates to fixed foreign currency exchange</pre><pre>rates for the interim period ended December 31, 2012 or 2011.</pre> <!--egx--><pre>DERIVATIVE LIABILITY</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; evaluates&nbsp; its&nbsp; convertible&nbsp; debt,&nbsp; options,&nbsp;&nbsp; warrants&nbsp; or&nbsp; other</pre><pre>contracts,&nbsp; if any, to determine if those&nbsp; contracts or embedded&nbsp; components&nbsp; of</pre><pre>those&nbsp; contracts&nbsp; qualify&nbsp; as&nbsp; derivatives&nbsp; to be&nbsp; separately&nbsp; accounted&nbsp; for in</pre><pre>accordance&nbsp; with&nbsp; paragraph&nbsp; 810-10-05-4&nbsp; and&nbsp; Section&nbsp; 815-40-25&nbsp; of&nbsp; the&nbsp; FASB</pre><pre>Accounting&nbsp; Standards&nbsp; Codification.&nbsp; The result of this accounting treatment is</pre><pre>that the fair value of the embedded derivative is marked-to-market&nbsp; each balance</pre><pre>sheet date and recorded as either an asset or a liability. In the event that the</pre><pre>fair value is recorded as a&nbsp; liability,&nbsp; the change in fair value is recorded in</pre><pre>the&nbsp; consolidated&nbsp; statement of operations&nbsp; and&nbsp; comprehensive&nbsp; income (loss) as</pre><pre>other&nbsp; income&nbsp; or&nbsp; expense.&nbsp; Upon&nbsp; conversion, &nbsp;exercise&nbsp; or&nbsp; cancellation&nbsp; of a</pre><pre>derivative&nbsp; instrument,&nbsp; the&nbsp; instrument&nbsp; is marked to fair value at the date of</pre><pre>conversion,&nbsp; exercise or&nbsp; cancellation&nbsp; and then that the related&nbsp; fair value is</pre><pre>reclassified to equity.</pre><pre>&nbsp;</pre><pre>In&nbsp; circumstances&nbsp;&nbsp; where&nbsp; the&nbsp; embedded&nbsp; conversion&nbsp; option&nbsp; in&nbsp; a&nbsp; convertible</pre><pre>instrument&nbsp; is&nbsp; required&nbsp; to be&nbsp; bifurcated&nbsp; and there are also&nbsp; other&nbsp; embedded</pre><pre>derivative&nbsp; instruments in the&nbsp; convertible&nbsp; instrument&nbsp; that are required to be</pre><pre>bifurcated, the bifurcated derivative instruments are accounted for as a single,</pre><pre>compound derivative instrument.</pre><pre>&nbsp;</pre><pre>The classification of derivative instruments, including whether such instruments</pre><pre>should be recorded as&nbsp; liabilities&nbsp; or as equity,&nbsp; is&nbsp; re-assessed at the end of</pre><pre>each&nbsp; reporting&nbsp; period.&nbsp; Equity&nbsp; instruments&nbsp; that are initially&nbsp; classified as</pre><pre>equity that become subject to reclassification&nbsp; are reclassified to liability at</pre><pre>the fair&nbsp; value&nbsp; of the&nbsp; instrument&nbsp; on the&nbsp; reclassification&nbsp; date.&nbsp; Derivative</pre><pre>instrument&nbsp; liabilities&nbsp; will be&nbsp; classified&nbsp; in the balance sheet as current or</pre><pre>non-current&nbsp; based on&nbsp; whether&nbsp; or not&nbsp; net-cash&nbsp; settlement&nbsp; of the&nbsp; derivative</pre><pre>instrument is expected within 12 months of the balance sheet date.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; adopted&nbsp; Section&nbsp; 815-40-15&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification&nbsp; ("Section&nbsp; 815-40-15")&nbsp; to determine&nbsp; whether an instrument (or an</pre><pre>embedded&nbsp; feature)&nbsp; is indexed to the&nbsp; Company's&nbsp; own stock.&nbsp; Section&nbsp; 815-40-15</pre><pre>provides&nbsp; that an entity should use a two-step&nbsp; approach to evaluate&nbsp; whether an</pre><pre>equity-linked&nbsp; financial&nbsp; instrument (or embedded feature) is indexed to its own</pre><pre>stock, including evaluating the instrument's&nbsp; contingent exercise and settlement</pre><pre>provisions.&nbsp; The adoption of Section&nbsp; 815-40-15 has affected the&nbsp; accounting for</pre><pre>(i)&nbsp; certain&nbsp; freestanding&nbsp; warrants&nbsp; that&nbsp; contain&nbsp; exercise&nbsp; price&nbsp; adjustment</pre><pre>features and (ii) convertible bonds issued by foreign subsidiaries with a strike</pre><pre>price denominated in a foreign currency.</pre><pre>&nbsp;</pre><pre>The Company marks to market the fair value of the embedded&nbsp; derivative&nbsp; warrants</pre><pre>at each&nbsp; balance&nbsp; sheet&nbsp; date and&nbsp; records&nbsp; the&nbsp; change in the fair value of the</pre><pre>embedded&nbsp; derivative&nbsp; warrants&nbsp; as other&nbsp; income or expense in the&nbsp; consolidated</pre><pre>statements of operations and comprehensive income (loss).</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; utilizes&nbsp; the&nbsp; Lattice&nbsp; model&nbsp; that&nbsp; values the&nbsp; liability&nbsp; of the</pre><pre>derivative&nbsp; warrants based on a probability&nbsp; weighted discounted cash flow model</pre><pre>with the&nbsp; assistance of the third party&nbsp; valuation&nbsp; firm. The reason the Company</pre><pre>picks the Lattice&nbsp; model is that in many cases&nbsp; there may be&nbsp; multiple&nbsp; embedded</pre><pre>features or the features of the bifurcated&nbsp; derivatives may be so complex that a</pre><pre>Black-Scholes&nbsp; valuation&nbsp; does not consider all of the terms of the&nbsp; instrument.</pre><pre>Therefore, the fair value may not be appropriately captured by simple models. In</pre><pre>other words,&nbsp; simple models such as Black-Scholes may not be appropriate in many</pre><pre>situations given complex features and terms of conversion option (e.g., combined</pre><pre>embedded&nbsp; derivatives).&nbsp; The Lattice model is based on future projections of the</pre><pre>various&nbsp; potential&nbsp; outcomes.&nbsp; The features that were analyzed and&nbsp; incorporated</pre><pre>into the model&nbsp; included the exercise&nbsp; and full reset&nbsp; features.&nbsp; Based on these</pre><pre>features,&nbsp; there are two primary events that can occur; the Holder exercises the</pre><pre>Warrants or the Warrants are held to expiration.&nbsp; The Lattice model analyzed the</pre><pre>underlying&nbsp; economic&nbsp; factors that influenced which of these events would occur,</pre><pre>when they were likely to occur,&nbsp; and the specific&nbsp; terms that would be in effect</pre><pre>at the time (i.e. stock price, exercise price,&nbsp; volatility,&nbsp; etc.).&nbsp; Projections</pre><pre>were then made on the&nbsp; underlying&nbsp; factors&nbsp; which&nbsp; led to&nbsp; potential&nbsp; scenarios.</pre><pre>Probabilities&nbsp; were assigned to each scenario&nbsp; based on management&nbsp; projections.</pre><pre>This led to a cash flow&nbsp; projection and a probability&nbsp; associated with that cash</pre><pre>flow. A discounted&nbsp; weighted&nbsp; average cash flow over the various&nbsp; scenarios&nbsp; was</pre><pre>completed to determine the value of the derivative warrants.</pre> <!--egx--><pre>COMMITMENT AND CONTINGENCIES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company &nbsp;follows&nbsp;&nbsp; subtopic&nbsp;&nbsp; 450-20&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification&nbsp; to report&nbsp; accounting for&nbsp; contingencies.&nbsp; Certain&nbsp; conditions may</pre><pre>exist as of the date the consolidated financial statements are issued, which may</pre><pre>result in a loss to the Company but which will only be resolved when one or more</pre><pre>future&nbsp; events&nbsp; occur or fail to occur.&nbsp; The Company&nbsp; assesses&nbsp; such&nbsp; contingent</pre><pre>liabilities, and such assessment inherently involves an exercise of judgment. In</pre><pre>assessing&nbsp; loss&nbsp; contingencies&nbsp; related to legal&nbsp; proceedings&nbsp; that are&nbsp; pending</pre><pre>against the Company or&nbsp; unasserted&nbsp; claims that may result in such&nbsp; proceedings,</pre><pre>the&nbsp; Company&nbsp; evaluates&nbsp; the&nbsp; perceived&nbsp; merits&nbsp; of&nbsp; any&nbsp; legal&nbsp; proceedings&nbsp; or</pre><pre>unasserted claims as well as the perceived merits of the amount of relief sought</pre><pre>or expected to be sought therein.</pre><pre>&nbsp;</pre><pre>If the assessment of a contingency indicates that it is probable that a material</pre><pre>loss has been incurred and the amount of the&nbsp; liability&nbsp; can be estimated,&nbsp; then</pre><pre>the estimated liability would be accrued in the Company's consolidated financial</pre><pre>statements.&nbsp;&nbsp; If&nbsp; the&nbsp; assessment&nbsp; indicates&nbsp; that&nbsp; a&nbsp; potential&nbsp; material&nbsp; loss</pre><pre>contingency&nbsp; is not&nbsp; probable&nbsp; but is&nbsp; reasonably&nbsp; possible,&nbsp; or is probable but</pre><pre>cannot&nbsp; be&nbsp; estimated,&nbsp; then the&nbsp; nature&nbsp; of the&nbsp; contingent&nbsp; liability,&nbsp; and an</pre><pre>estimate of the range of possible losses, if determinable and material, would be</pre><pre>disclosed.</pre><pre>&nbsp;</pre><pre>Loss&nbsp; contingencies&nbsp; considered&nbsp; remote are generally not disclosed&nbsp; unless they</pre><pre>involve guarantees, in which case the guarantees would be disclosed.&nbsp; Management</pre><pre>does not believe,&nbsp; based upon&nbsp; information&nbsp; available&nbsp; at this time,&nbsp; that these</pre><pre>matters&nbsp; will&nbsp; have a&nbsp; material&nbsp; adverse&nbsp; effect on the&nbsp; Company's&nbsp; consolidated</pre><pre>financial position,&nbsp; results of operations or cash flows.&nbsp; However,&nbsp; there is no</pre><pre>assurance&nbsp; that such&nbsp; matters&nbsp; will not&nbsp; materially&nbsp; and&nbsp; adversely&nbsp; affect&nbsp; the</pre><pre>Company's business, financial position, and results of operations or cash flows.</pre> <!--egx--><pre>NON-CONTROLLING INTEREST</pre><pre>&nbsp;</pre><pre>The Company&nbsp; follows&nbsp; paragraph&nbsp; 810-10-65-1&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification to report the&nbsp; non-controlling&nbsp; interest in Stevia Technew Limited,</pre><pre>its majority owned subsidiary in the&nbsp; consolidated&nbsp; statements of balance sheets</pre><pre>within the equity section,&nbsp; separately from the Company's&nbsp; stockholders' equity.</pre><pre>Non-controlling&nbsp;&nbsp; interest&nbsp; represents&nbsp; the&nbsp; non-controlling&nbsp; interest&nbsp; holder's</pre><pre>proportionate&nbsp; share of the equity of the Company's&nbsp; majority-owned&nbsp; subsidiary,</pre><pre>Stevia&nbsp;&nbsp; Technew&nbsp;&nbsp; Limited.&nbsp;&nbsp; Non-controlling&nbsp;&nbsp; interest&nbsp; is&nbsp; adjusted&nbsp; for&nbsp; the</pre><pre>non-controlling&nbsp; interest holder's proportionate share of the earnings or losses</pre><pre>and other comprehensive income (loss) and the non-controlling interest continues</pre><pre>to be&nbsp; attributed&nbsp; its share of losses&nbsp; even if that&nbsp; attribution&nbsp; results&nbsp; in a</pre><pre>deficit non-controlling interest balance.</pre> <!--egx--><pre>REVENUE RECOGNITION</pre><pre>&nbsp;</pre><pre>The Company follows&nbsp; paragraph&nbsp; 605-10-S99-1&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification for revenue recognition.&nbsp; The Company recognizes revenue when it is</pre><pre>realized or realizable and earned.&nbsp; The Company&nbsp; considers&nbsp; revenue&nbsp; realized or</pre><pre>realizable and earned when all of the following criteria are met: (i) persuasive</pre><pre>evidence of an&nbsp; arrangement&nbsp; exists,&nbsp; (ii) the&nbsp; product has been&nbsp; shipped or the</pre><pre>services have been&nbsp; rendered to the customer,&nbsp; (iii) the sales price is fixed or</pre><pre>determinable, and (iv) collectability is reasonably assured.</pre> <!--egx--><pre>RESEARCH AND DEVELOPMENT</pre><pre>&nbsp;</pre><pre>The Company&nbsp; follows&nbsp; paragraph&nbsp; 730-10-25-1&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification&nbsp; (formerly&nbsp; Statement&nbsp; of&nbsp; Financial &nbsp;Accounting&nbsp; Standards&nbsp; No.&nbsp; 2</pre><pre>"ACCOUNTING FOR RESEARCH AND DEVELOPMENT&nbsp; COSTS") and paragraph&nbsp; 730-20-25-11 of</pre><pre>the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification&nbsp; (formerly&nbsp; Statement of Financial</pre><pre>Accounting&nbsp; Standards&nbsp; No.&nbsp; 68&nbsp; "RESEARCH&nbsp; AND&nbsp; DEVELOPMENT&nbsp; ARRANGEMENTS")&nbsp; for</pre><pre>research and development&nbsp; costs.&nbsp; Research and development&nbsp; costs are charged to</pre><pre>expense as&nbsp; incurred.&nbsp; Research&nbsp; and&nbsp; development&nbsp; costs&nbsp; consist&nbsp; primarily&nbsp; of</pre><pre>remuneration&nbsp; for research and development&nbsp; staff,&nbsp; depreciation and maintenance</pre><pre>expenses of research and development&nbsp; equipment,&nbsp; material and testing costs for</pre><pre>research and development as well as research and development&nbsp; arrangements&nbsp; with</pre><pre>unrelated third party research and development institutions.</pre><pre>&nbsp;</pre><pre>NON-REFUNDABLE&nbsp; ADVANCE&nbsp; PAYMENTS&nbsp; FOR&nbsp; GOODS OR&nbsp; SERVICES&nbsp; TO BE USED IN FUTURE</pre><pre>RESEARCH AND DEVELOPMENT ACTIVITIES</pre><pre>&nbsp;</pre><pre>The research and development&nbsp; arrangements usually involve specific research and</pre><pre>development&nbsp; projects.&nbsp; Often times, the Company makes&nbsp; non-refundable&nbsp; advances</pre><pre>upon signing of these arrangements.&nbsp; The Company adopted paragraph&nbsp; 730-20-25-13</pre><pre>and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging</pre><pre>Issues Task Force Issue No. 07-3 "ACCOUNTING FOR NONREFUNDABLE&nbsp; ADVANCE PAYMENTS</pre><pre>FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES")</pre><pre>for those non-refundable advances.&nbsp; Non-refundable advance payments for goods or</pre><pre>services&nbsp; that will be used or&nbsp; rendered&nbsp; for future&nbsp; research&nbsp; and&nbsp; development</pre><pre>activities&nbsp; are deferred and &nbsp;capitalized.&nbsp; Such&nbsp; amounts are&nbsp; recognized&nbsp; as an</pre><pre>expense&nbsp; as the&nbsp; related&nbsp; goods&nbsp; are&nbsp; delivered&nbsp; or&nbsp; the&nbsp; related&nbsp; services&nbsp; are</pre><pre>performed.&nbsp; The management&nbsp; continues to evaluate whether the Company expect the</pre><pre>goods to be&nbsp; delivered or services to be rendered.&nbsp; If the&nbsp; management&nbsp; does not</pre><pre>expect the goods to be&nbsp; delivered or services to be&nbsp; rendered,&nbsp; the&nbsp; capitalized</pre><pre>advance payment are charged to expense.</pre> <!--egx--><pre>STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; accounts&nbsp; for its stock&nbsp; based&nbsp; compensation&nbsp; in which the Company</pre><pre>obtains&nbsp; employee&nbsp; services&nbsp; in&nbsp; share-based&nbsp; payment&nbsp;&nbsp; transactions&nbsp; under&nbsp; the</pre><pre>recognition and measurement&nbsp; principles of the fair value recognition provisions</pre><pre>of section 718-10-30 of the FASB Accounting Standards Codification.&nbsp; Pursuant to</pre><pre>paragraph&nbsp; 718-10-30-6&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification,&nbsp; all</pre><pre>transactions in which goods or services are the&nbsp; consideration&nbsp; received for the</pre><pre>issuance of equity&nbsp; instruments are accounted for based on the fair value of the</pre><pre>consideration&nbsp; received&nbsp; or the fair&nbsp; value&nbsp; of the&nbsp; equity&nbsp; instrument&nbsp; issued,</pre><pre>whichever is more reliably&nbsp; measurable.&nbsp; The measurement&nbsp; date used to determine</pre><pre>the fair value of the&nbsp; equity&nbsp; instrument&nbsp; issued is the&nbsp; earlier of the date on</pre><pre>which the&nbsp; performance&nbsp; is&nbsp; complete&nbsp; or the date on which it is&nbsp; probable&nbsp; that</pre><pre>performance&nbsp; will occur.&nbsp; If shares of the Company are thinly&nbsp; traded the use of</pre><pre>share&nbsp; prices&nbsp; established&nbsp; in&nbsp; the&nbsp; Company's&nbsp; most&nbsp; recent&nbsp; private&nbsp; placement</pre><pre>memorandum&nbsp; ("PPM"),&nbsp; or weekly or monthly price observations would generally be</pre><pre>more appropriate&nbsp; than the use of daily price&nbsp; observations as such shares could</pre><pre>be artificially inflated due to a larger spread between the bid and asked quotes</pre><pre>and lack of consistent trading in the market.</pre><pre>&nbsp;</pre><pre>The fair value of non-derivative&nbsp; option award is estimated on the date of grant</pre><pre>using a Black-Scholes&nbsp; option-pricing valuation model. The ranges of assumptions</pre><pre>for inputs are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected term of share options and similar&nbsp; instruments:&nbsp; The expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life of options and similar instruments&nbsp; represents the period of time</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the option and/or warrant are expected to be outstanding.&nbsp; Pursuant to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paragraph&nbsp;&nbsp; 718-10-50-2(f)(2)(i)&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp; Standards</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Codification&nbsp;&nbsp; the&nbsp; expected&nbsp;&nbsp; term&nbsp; of&nbsp; share&nbsp;&nbsp; options&nbsp; and&nbsp; similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; represents&nbsp; the period of time the&nbsp; options&nbsp; and&nbsp; similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments are expected to be outstanding&nbsp; taking into &nbsp;consideration</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of the contractual&nbsp; term of the&nbsp; instruments&nbsp; and employees'&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exercise and&nbsp; post-vesting&nbsp; employment&nbsp; termination&nbsp; behavior into the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fair&nbsp; value (or&nbsp; calculated&nbsp; value) of the&nbsp; instruments.&nbsp; Pursuant&nbsp; to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paragraph&nbsp; 718-10-S99-1,&nbsp; it may be&nbsp; appropriate to use the SIMPLIFIED</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD,&nbsp; I.E.,&nbsp; EXPECTED TERM = ((VESTING TERM + ORIGINAL&nbsp; CONTRACTUAL</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TERM) / 2),&nbsp; if (i) A&nbsp; company&nbsp; does&nbsp; not have&nbsp; sufficient&nbsp; historical</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exercise&nbsp; data to provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected term due to the limited period of time its equity shares have</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; been publicly traded; (ii) A company&nbsp; significantly&nbsp; changes the terms</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of its share&nbsp; option&nbsp; grants or the types of&nbsp; employees&nbsp; that&nbsp; receive</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; share&nbsp; option&nbsp; grants such that its&nbsp; historical&nbsp; exercise&nbsp; data may no</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; longer&nbsp; provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term; or (iii) A company has or expects to have significant structural</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in its business such that its historical&nbsp; exercise data may no</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; longer&nbsp; provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term.&nbsp; The Company uses the&nbsp; simplified &nbsp;method to calculate&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term of share options and similar&nbsp; instruments as the company does not</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have sufficient historical exercise data to provide a reasonable basis</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; upon which to estimate expected term.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; volatility&nbsp; of the&nbsp; entity's&nbsp; shares and the method&nbsp; used to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; estimate&nbsp; it.&nbsp; Pursuant&nbsp; to&nbsp; ASC&nbsp; Paragraph&nbsp;&nbsp; 718-10-50-2(f)(2)(ii)&nbsp; a</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinly-traded&nbsp; or&nbsp; nonpublic&nbsp; entity&nbsp; that uses the&nbsp; calculated&nbsp; value</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; method shall&nbsp; disclose the reasons why it is not&nbsp; practicable&nbsp; for the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company to estimate the expected&nbsp; volatility&nbsp; of its share price,&nbsp; the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; appropriate&nbsp; industry&nbsp; sector index that it has selected,&nbsp; the reasons</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for&nbsp; selecting&nbsp; that&nbsp; particular&nbsp; index,&nbsp; and&nbsp; how it&nbsp; has&nbsp; calculated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; historical&nbsp; volatility&nbsp; using that index. The Company uses the average</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; historical&nbsp; volatility of the&nbsp; comparable&nbsp; companies over the expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; contractual&nbsp; life of the share options or similar&nbsp; instruments&nbsp; as its</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected volatility.&nbsp; If shares of a company are thinly traded the use</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of&nbsp; weekly or&nbsp; monthly&nbsp; price&nbsp; observations&nbsp; would&nbsp; generally&nbsp; be more</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; appropriate than the use of daily price observations as the volatility</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calculation&nbsp; using&nbsp; daily&nbsp;&nbsp; observations&nbsp; for&nbsp; such&nbsp; shares&nbsp; could&nbsp; be</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; artificially inflated due to a larger spread between the bid and asked</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; quotes and lack of consistent trading in the market.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; * &nbsp;&nbsp;&nbsp;Expected&nbsp; annual rate of&nbsp; quarterly&nbsp; dividends.&nbsp; An entity that uses a</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; method that employs&nbsp; different&nbsp; dividend rates during the&nbsp; contractual</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term&nbsp; shall&nbsp; disclose&nbsp; the range of&nbsp; expected&nbsp; dividends&nbsp; used and the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weighted-average&nbsp; expected&nbsp; dividends.&nbsp; The expected dividend yield is</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; based on the Company's&nbsp; current dividend yield as the best estimate of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; projected&nbsp; dividend&nbsp; yield for periods within the expected term of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; share options and similar instruments.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Risk-free rate(s). An entity that uses a method that employs different</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk-free&nbsp; rates shall disclose the range of risk-free rates used. The</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk-free&nbsp; interest rate is based on the U.S.&nbsp; Treasury yield curve in</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effect at the time of grant for periods&nbsp; within the&nbsp; expected&nbsp; term of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the share options and similar instruments.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company's&nbsp; policy is to&nbsp; recognize&nbsp; compensation&nbsp; cost for awards with only</pre><pre>service&nbsp; conditions and a graded vesting schedule on a straight-line&nbsp; basis over</pre><pre>the requisite service period for the entire award.</pre> <!--egx--><pre>EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR</pre><pre>SERVICES</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; accounts&nbsp; for&nbsp; equity&nbsp; instruments&nbsp; issued to&nbsp; parties&nbsp; other than</pre><pre>employees for acquiring&nbsp; goods or services under guidance of Subtopic&nbsp; 505-50 of</pre><pre>the FASB Accounting Standards Codification ("Subtopic 505-50").</pre><pre>&nbsp;</pre><pre>Pursuant to ASC Section&nbsp; 505-50-30,&nbsp; all transactions in which goods or services</pre><pre>are the&nbsp; consideration&nbsp; received&nbsp; for the&nbsp; issuance&nbsp; of equity&nbsp; instruments&nbsp; are</pre><pre>accounted for based on the fair value of the consideration&nbsp; received or the fair</pre><pre>value of the equity instrument&nbsp; issued,&nbsp; whichever is more reliably&nbsp; measurable.</pre><pre>The measurement&nbsp; date used to determine the fair value of the equity&nbsp; instrument</pre><pre>issued is the&nbsp; earlier of the date on which the&nbsp; performance&nbsp; is complete or the</pre><pre>date on which it is&nbsp; probable&nbsp; that&nbsp; performance&nbsp; will&nbsp; occur.&nbsp; If shares of the</pre><pre>Company are thinly traded the use of share prices&nbsp; established&nbsp; in the Company's</pre><pre>most recent private&nbsp; placement&nbsp; memorandum&nbsp; ("PPM"),&nbsp; or weekly or monthly price</pre><pre>observations&nbsp; would&nbsp; generally be more&nbsp; appropriate&nbsp; than the use of daily price</pre><pre>observations&nbsp; as such&nbsp; shares&nbsp; could be&nbsp; artificially&nbsp; inflated&nbsp; due to a larger</pre><pre>spread&nbsp; between the bid and asked quotes and lack of&nbsp; consistent&nbsp; trading in the</pre><pre>market.</pre><pre>&nbsp;</pre><pre>The fair value of&nbsp; non-derivative&nbsp; option or warrant&nbsp; award is&nbsp; estimated on the</pre><pre>date of grant using a Black-Scholes&nbsp; option-pricing&nbsp; valuation model. The ranges</pre><pre>of assumptions for inputs are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; term of share options and similar&nbsp; instruments:&nbsp; Pursuant to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paragraph&nbsp; 718-10-50-2 of the FASB Accounting&nbsp; Standards&nbsp; Codification</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the expected term of share options and similar instruments&nbsp; represents</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the period of time the options and similar instruments are expected to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; be outstanding&nbsp; taking into&nbsp; consideration&nbsp; of the contractual term of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the instruments and holder's&nbsp; expected exercise behavior into the fair</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; value (or&nbsp; calculated&nbsp; value) of the&nbsp; instruments.&nbsp; The&nbsp; Company&nbsp; uses</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; historical data to estimate holder's expected&nbsp; exercise&nbsp; behavior.&nbsp; If</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the Company is a newly formed corporation or shares of the Company are</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinly&nbsp; traded the&nbsp; contractual&nbsp; term of the share options and similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; is used as the expected term of share options and similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; as&nbsp; the&nbsp; Company&nbsp; does&nbsp; not&nbsp; have&nbsp; sufficient&nbsp; historical</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exercise&nbsp; data to provide a&nbsp; reasonable&nbsp; basis upon which to&nbsp; estimate</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected term.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; volatility&nbsp; of the&nbsp; entity's&nbsp; shares and the method&nbsp; used to</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; estimate&nbsp; it. An&nbsp; entity&nbsp; that uses a method&nbsp; that&nbsp; employs&nbsp; different</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; volatilities&nbsp; during the contractual&nbsp; term shall disclose the range of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; expected&nbsp;&nbsp; volatilities&nbsp;&nbsp; used&nbsp; and&nbsp; the&nbsp;&nbsp; weighted-average&nbsp;&nbsp; expected</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; volatility.&nbsp;&nbsp; A&nbsp; thinly-traded&nbsp; or&nbsp; nonpublic&nbsp; entity&nbsp; that&nbsp; uses&nbsp; the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calculated&nbsp; value&nbsp; method&nbsp; shall&nbsp; disclose&nbsp; the&nbsp; reasons why it is not</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; practicable for the Company to estimate the expected volatility of its</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; share&nbsp; price,&nbsp; the&nbsp; appropriate&nbsp; industry&nbsp; sector&nbsp; index&nbsp; that&nbsp; it has</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; selected,&nbsp; the reasons for selecting that particular index, and how it</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; has calculated&nbsp; historical&nbsp; volatility&nbsp; using that index.&nbsp; The Company</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uses the average&nbsp; historical&nbsp; volatility of the&nbsp; comparable&nbsp; companies</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; over the&nbsp; expected&nbsp; contractual&nbsp; life of the share&nbsp; options or similar</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; instruments&nbsp; as its&nbsp; expected&nbsp; volatility.&nbsp; If shares of a company are</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinly&nbsp; traded the use of weekly or monthly price&nbsp; observations&nbsp; would</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; generally be more appropriate than the use of daily price observations</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; as the volatility calculation using daily observations for such shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; could be artificially&nbsp; inflated due to a larger spread between the bid</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and asked quotes and lack of consistent trading in the market.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Expected&nbsp; annual rate of&nbsp; quarterly&nbsp; dividends.&nbsp; An entity that uses a</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; method that employs&nbsp; different&nbsp; dividend rates during the&nbsp; contractual</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; term&nbsp; shall&nbsp; disclose&nbsp; the range of&nbsp; expected&nbsp; dividends&nbsp; used and the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weighted-average&nbsp; expected&nbsp; dividends.&nbsp; The expected dividend yield is</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; based on the Company's&nbsp; current dividend yield as the best estimate of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; projected&nbsp; dividend yield for periods within the expected&nbsp; contractual</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life of the option and similar instruments.</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp; Risk-free rate(s). An entity that uses a method that employs different</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk-free&nbsp; rates shall disclose the range of risk-free rates used. The</pre><pre> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;risk-free&nbsp; interest rate is based on the U.S.&nbsp; Treasury yield curve in</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effect at the time of grant for periods within the contractual life of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the option and similar instruments.</pre><pre>&nbsp;</pre><pre>Pursuant to&nbsp; Paragraphs&nbsp; 505-50-25-8,&nbsp; if fully vested,&nbsp; non-forfeitable&nbsp; equity</pre><pre>instruments&nbsp; are&nbsp; issued&nbsp; at the date the&nbsp; grantor&nbsp; and&nbsp; grantee&nbsp; enter&nbsp; into an</pre><pre>agreement&nbsp; for goods or services&nbsp; (no&nbsp; specific&nbsp; performance&nbsp; is required by the</pre><pre>grantee to retain those equity instruments), then, because of the elimination of</pre><pre>any obligation on the part of the counterparty to earn the equity instruments, a</pre><pre>measurement&nbsp; date has&nbsp; been&nbsp; reached.&nbsp; A&nbsp; grantor&nbsp; shall&nbsp; recognize&nbsp; the&nbsp; equity</pre><pre>instruments&nbsp; when they are issued (in most cases,&nbsp; when the agreement is entered</pre><pre>into). Whether the corresponding cost is an immediate expense or a prepaid asset</pre><pre>(or&nbsp; whether&nbsp; the&nbsp; debit&nbsp; should be&nbsp; characterized&nbsp; as&nbsp; contra-equity&nbsp; under the</pre><pre>requirements&nbsp; of&nbsp; paragraph&nbsp; 505-50-45-1)&nbsp; depends&nbsp; on the&nbsp; specific&nbsp; facts&nbsp; and</pre><pre>circumstances.&nbsp; Pursuant to ASC&nbsp; paragraph&nbsp; 505-50-45-1,&nbsp; a grantor may conclude</pre><pre>that an asset (other than a note or a&nbsp; receivable)&nbsp; has been&nbsp; received in return</pre><pre>for fully vested, non-forfeitable equity instruments that are issued at the date</pre><pre>the grantor and grantee&nbsp; enter into an agreement&nbsp; for goods or services&nbsp; (and no</pre><pre>specific&nbsp; performance is required by the grantee in order to retain those equity</pre><pre>instruments).&nbsp; Such an asset&nbsp; shall not be&nbsp; displayed&nbsp; as&nbsp; contra-equity&nbsp; by the</pre><pre>grantor of the equity instruments.&nbsp; The transferability (or lack thereof) of the</pre><pre>equity instruments shall not affect the balance sheet display of the asset. This</pre><pre>guidance is limited to transactions in which equity&nbsp; instruments are transferred</pre><pre>to other than&nbsp; employees in exchange for goods or&nbsp; services.&nbsp; Section&nbsp; 505-50-30</pre><pre>provides&nbsp; guidance on the determination of the measurement date for transactions</pre><pre>that are within the scope of this Subtopic.</pre><pre>&nbsp;</pre><pre>Pursuant to Paragraphs&nbsp; 505-50-25-8&nbsp; and&nbsp; 505-50-25-9,an&nbsp; entity may grant fully</pre><pre>vested,&nbsp; non-forfeitable&nbsp; equity instruments that are exercisable by the grantee</pre><pre>only after a specified period of time if the terms of the agreement&nbsp; provide for</pre><pre>earlier exercisability if the grantee achieves specified performance conditions.</pre><pre>Any measured cost of the&nbsp; transaction&nbsp; shall be recognized in the same period(s)</pre><pre>and in the same&nbsp; manner as if the entity had paid cash for the goods or services</pre><pre>or used cash rebates as a sales discount&nbsp; instead of paying with, or using,&nbsp; the</pre><pre>equity instruments. &nbsp;A recognized asset, expense, or sales discount shall not be</pre><pre>reversed&nbsp; if a stock&nbsp; option&nbsp; that the&nbsp; counterparty&nbsp; has the right to&nbsp; exercise</pre><pre>expires unexercised.</pre><pre>&nbsp;</pre><pre>Pursuant to ASC paragraph&nbsp; 505-50-30-S99-1,&nbsp; if the Company&nbsp; receives a right to</pre><pre>receive&nbsp;&nbsp; future&nbsp;&nbsp; services&nbsp; in&nbsp; exchange&nbsp; for&nbsp; unvested,&nbsp;&nbsp; forfeitable&nbsp;&nbsp; equity</pre><pre>instruments,&nbsp; those equity&nbsp; instruments&nbsp; are treated as unissued for&nbsp; accounting</pre><pre>purposes until the future&nbsp; services are received (that is, the&nbsp; instruments&nbsp; are</pre><pre>not&nbsp; considered&nbsp; issued &nbsp;until&nbsp; they&nbsp; vest).&nbsp; Consequently,&nbsp; there&nbsp; would&nbsp; be no</pre><pre>recognition at the measurement date and no entry should be recorded.</pre> <!--egx--><pre>INCOME TAX PROVISION</pre><pre>&nbsp;</pre><pre>The Company&nbsp; accounts&nbsp; for income&nbsp; taxes&nbsp; under&nbsp; Section&nbsp; 740-10-30&nbsp; of the FASB</pre><pre>Accounting&nbsp; Standards&nbsp; Codification,&nbsp; which requires recognition of deferred tax</pre><pre>assets and liabilities&nbsp; for the expected future tax&nbsp; consequences of events that</pre><pre>have been&nbsp; included&nbsp; in the&nbsp; financial&nbsp; statements&nbsp; or tax&nbsp; returns.&nbsp; Under this</pre><pre>method, deferred tax assets and liabilities are based on the differences between</pre><pre>the financial&nbsp; statement and tax bases of assets and&nbsp; liabilities&nbsp; using enacted</pre><pre>tax&nbsp; rates in effect&nbsp; for the year in which&nbsp; the&nbsp; differences&nbsp; are&nbsp; expected&nbsp; to</pre><pre>reverse.&nbsp; Deferred tax assets are reduced by a valuation allowance to the extent</pre><pre>management&nbsp; concludes&nbsp; it is more&nbsp; likely&nbsp; than not that the assets&nbsp; will not be</pre><pre>realized.&nbsp; Deferred tax assets and&nbsp; liabilities&nbsp; are measured&nbsp; using enacted tax</pre><pre>rates expected to apply to taxable income in the years in which those&nbsp; temporary</pre><pre>differences are expected to be recovered or settled.&nbsp; The effect on deferred tax</pre><pre>assets&nbsp; and&nbsp; liabilities&nbsp; of&nbsp; a&nbsp; change&nbsp; in&nbsp; tax&nbsp; rates&nbsp; is&nbsp; recognized&nbsp; in&nbsp; the</pre><pre>consolidated&nbsp; statements of income and comprehensive income (loss) in the period</pre><pre>that includes the enactment date.</pre><pre>&nbsp;</pre><pre>The&nbsp; Company&nbsp; adopted&nbsp; section&nbsp; 740-10-25&nbsp; of&nbsp; the&nbsp; FASB&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification&nbsp;&nbsp; ("Section&nbsp;&nbsp; 740-10-25").&nbsp;&nbsp;&nbsp; Section&nbsp;&nbsp; 740-10-25&nbsp;&nbsp; addresses&nbsp;&nbsp; the</pre><pre>determination of whether tax benefits claimed or expected to be claimed on a tax</pre><pre>return should be recorded in the financial statements.&nbsp; Under Section 740-10-25,</pre><pre>the Company may recognize the tax benefit from an uncertain tax position only if</pre><pre>it is&nbsp; more&nbsp; likely&nbsp; than&nbsp; not&nbsp; that&nbsp; the tax&nbsp; position&nbsp; will&nbsp; be &nbsp;sustained&nbsp; on</pre><pre>examination&nbsp; by the taxing&nbsp; authorities,&nbsp; based on the&nbsp; technical&nbsp; merits of the</pre><pre>position.&nbsp; The tax benefits&nbsp; recognized in the financial&nbsp; statements from such a</pre><pre>position should be measured based on the largest benefit that has a greater than</pre><pre>fifty (50)&nbsp; percent&nbsp; likelihood&nbsp; of being&nbsp; realized&nbsp; upon&nbsp; ultimate&nbsp; settlement.</pre><pre>Section&nbsp; 740-10-25&nbsp; also provides&nbsp; guidance on&nbsp; de-recognition,&nbsp; classification,</pre><pre>interest&nbsp; and&nbsp; penalties&nbsp; on income&nbsp; taxes,&nbsp; accounting&nbsp; in interim&nbsp; periods and</pre><pre>requires increased disclosures.</pre><pre>&nbsp;</pre><pre>The estimated future tax effects of temporary&nbsp; differences between the tax basis</pre><pre>of assets and liabilities are reported in the accompanying&nbsp; consolidated balance</pre><pre>sheets,&nbsp; as well as tax&nbsp; credit&nbsp; carry-backs&nbsp; and&nbsp; carry-forwards.&nbsp; The&nbsp; Company</pre><pre>periodically&nbsp; reviews the&nbsp; recoverability of deferred tax assets recorded on its</pre><pre>consolidated&nbsp; balance&nbsp; sheets and provides&nbsp; valuation&nbsp; allowances&nbsp; as management</pre><pre>deems necessary.</pre><pre>&nbsp;</pre><pre>Management makes judgments as to the&nbsp; interpretation&nbsp; of the tax laws that might</pre><pre>be&nbsp; challenged&nbsp; upon an audit and cause&nbsp; changes to&nbsp; previous&nbsp; estimates&nbsp; of tax</pre><pre>liability.&nbsp;&nbsp; In&nbsp; addition,&nbsp;&nbsp; the&nbsp; Company&nbsp;&nbsp; operates&nbsp;&nbsp; within&nbsp;&nbsp; multiple&nbsp; taxing</pre><pre>jurisdictions&nbsp; and is subject to audit in these&nbsp; jurisdictions.&nbsp; In management's</pre><pre>opinion,&nbsp; adequate&nbsp; provisions for income taxes have been made for all years. If</pre><pre>actual&nbsp; taxable income by tax&nbsp; jurisdiction&nbsp; varies from&nbsp; estimates,&nbsp; additional</pre><pre>allowances or reversals of reserves may be necessary.</pre> <!--egx--><pre>UNCERTAIN TAX POSITIONS</pre><pre>&nbsp;</pre><pre>The Company did not take any uncertain tax positions and had no&nbsp; adjustments&nbsp; to</pre><pre>its income tax&nbsp; liabilities&nbsp; or benefits&nbsp; pursuant to the&nbsp; provisions of Section</pre><pre>740-10-25 for the interim&nbsp; period ended December 31, 2012 or for the period from</pre><pre>April 11, 2011 (Inception) through December 31, 2011.</pre><pre>&nbsp;</pre> <!--egx--><pre>LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL</pre><pre>&nbsp;</pre><pre>Pursuant to the&nbsp; Internal&nbsp; Revenue&nbsp; Code Section 382&nbsp; ("Section&nbsp; 382"),&nbsp; certain</pre><pre>ownership changes may subject the NOL's to annual limitations which could reduce</pre><pre>or defer the NOL. Section 382 imposes limitations on a corporation's&nbsp; ability to</pre><pre>utilize NOLs if it&nbsp; experiences&nbsp; an&nbsp; "ownership&nbsp; change." In general&nbsp; terms,&nbsp; an</pre><pre>ownership&nbsp; change may result&nbsp; from&nbsp; transactions&nbsp; increasing&nbsp; the&nbsp; ownership&nbsp; of</pre><pre>certain&nbsp; stockholders&nbsp; in the stock of a corporation&nbsp; by more than 50 percentage</pre><pre>points&nbsp; over&nbsp; a&nbsp; three-year&nbsp; period.&nbsp; In&nbsp; the&nbsp; event&nbsp; of&nbsp; an&nbsp; ownership&nbsp; change,</pre><pre>utilization of the NOLs would be subject to an annual&nbsp; limitation&nbsp; under Section</pre><pre>382&nbsp; determined&nbsp; by &nbsp;multiplying&nbsp; the&nbsp; value&nbsp; of its&nbsp; stock&nbsp; at the&nbsp; time of the</pre><pre>ownership change by the applicable&nbsp; long-term tax-exempt rate. Any unused annual</pre><pre>limitation may be carried over to later years. The imposition of this limitation</pre><pre>on its ability to use the NOLs to offset future&nbsp; taxable&nbsp; income could cause the</pre><pre>Company to pay U.S.&nbsp; federal income taxes earlier than if such&nbsp; limitation&nbsp; were</pre><pre>not in&nbsp; effect&nbsp; and&nbsp; could&nbsp; cause&nbsp; such&nbsp; NOLs&nbsp; to&nbsp; expire&nbsp; unused,&nbsp; reducing&nbsp; or</pre><pre>eliminating the benefit of such NOLs.</pre> <!--egx--><pre>NET INCOME (LOSS) PER COMMON SHARE</pre><pre>&nbsp;</pre><pre>Net income (loss) per common share is computed&nbsp; pursuant to section 260-10-45 of</pre><pre>the FASB Accounting Standards&nbsp; Codification.&nbsp; Basic net income (loss) per common</pre><pre>share is computed by dividing net income (loss) by the weighted&nbsp; average&nbsp; number</pre><pre>of shares of common&nbsp; stock&nbsp; outstanding&nbsp; during the&nbsp; period.&nbsp; Diluted net income</pre><pre>(loss)&nbsp; per common&nbsp; share is&nbsp; computed&nbsp; by&nbsp; dividing&nbsp; net&nbsp; income&nbsp; (loss) by the</pre><pre>weighted&nbsp; average number of shares of common stock and&nbsp; potentially&nbsp; outstanding</pre><pre>shares of common stock during the period to reflect the potential&nbsp; dilution that</pre><pre>could occur from common&nbsp; shares&nbsp; issuable&nbsp; through&nbsp; contingent&nbsp; shares&nbsp; issuance</pre><pre>arrangement, stock options or warrants.</pre><pre>&nbsp;</pre><pre>The following&nbsp; table shows the&nbsp; potentially&nbsp; outstanding&nbsp; dilutive common shares</pre><pre>excluded from the diluted net income (loss) per common share calculation as they</pre><pre>were anti-dilutive:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potentially</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Outstanding Dilutive</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interim Period&nbsp;&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>MAKE GOOD ESCROW SHARES</pre><pre>&nbsp;</pre><pre>Make Good Escrow&nbsp; Agreement shares issued and</pre><pre>held with the escrow agent in connection with</pre><pre>the Share Exchange&nbsp; Agreement&nbsp; consummated on</pre><pre>June 23, 2011 pending the&nbsp; achievement by the</pre><pre>Company&nbsp; of&nbsp; certain&nbsp; post-Closing&nbsp;&nbsp; business</pre><pre>milestones (the "Milestones").&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,000,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,000,000</pre><pre>&nbsp;</pre><pre>CONVERTIBLE NOTE SHARES</pre><pre>&nbsp;</pre><pre>On&nbsp; March&nbsp; 7,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 426,667&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>On&nbsp; May&nbsp; 30,&nbsp; 2012,&nbsp;&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;426,667&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>WARRANT SHARES</pre><pre>&nbsp;</pre><pre>On August 6,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued (i)</pre><pre>warrants to purchase 1,066,667 shares, in the</pre><pre>aggregate,&nbsp; of the Company's&nbsp; common stock to</pre><pre>the investors (the "investors&nbsp; warrants") and</pre><pre>(ii)&nbsp; warrants to purchase&nbsp; 85,333&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common stock to the placement</pre><pre>agent (the "agent warrants") with an exercise</pre><pre>price of $0.6405 per share subject to certain</pre><pre>adjustments&nbsp;&nbsp;&nbsp; pursuant&nbsp;&nbsp; to&nbsp;&nbsp; Section&nbsp;&nbsp; 3(b)</pre><pre>Subsequent&nbsp; Equity&nbsp; Sales of the SPA expiring</pre><pre>five (5) years from the date of issuance.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>TOTAL POTENTIALLY OUTSTANDING DILUTIVE</pre><pre>COMMON SHARES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,005,334&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,000,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre> <!--egx--><pre>CASH FLOWS REPORTING</pre><pre>&nbsp;</pre><pre>The Company adopted&nbsp; paragraph&nbsp; 230-10-45-24&nbsp; of the FASB&nbsp; Accounting&nbsp; Standards</pre><pre>Codification&nbsp; for cash flows&nbsp; reporting,&nbsp; classifies&nbsp; cash receipts and payments</pre><pre>according&nbsp; to&nbsp; whether&nbsp; they&nbsp; stem&nbsp; from&nbsp; operating,&nbsp;&nbsp; investing,&nbsp; or&nbsp; financing</pre><pre>activities and provides&nbsp; definitions of each category,&nbsp; and uses the indirect or</pre><pre>reconciliation&nbsp; method ("Indirect method") as defined by paragraph&nbsp; 230-10-45-25</pre><pre>of the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Codification&nbsp; to&nbsp; report&nbsp; net cash flow from</pre><pre>operating&nbsp; activities&nbsp; by adjusting&nbsp; net income to reconcile it to net cash flow</pre><pre>from&nbsp; operating&nbsp; activities by removing the effects of (a) all deferrals of past</pre><pre>operating&nbsp; cash&nbsp; receipts&nbsp; and&nbsp; payments&nbsp; and all&nbsp; accruals of&nbsp; expected&nbsp; future</pre><pre>operating&nbsp; cash receipts and payments and (b) all items that are included in net</pre><pre>income that do not affect&nbsp; operating&nbsp; cash&nbsp; receipts and&nbsp; payments.&nbsp; The Company</pre><pre>reports the reporting currency&nbsp; equivalent of foreign currency cash flows, using</pre><pre>the&nbsp; current&nbsp; exchange&nbsp; rate at the time of the cash&nbsp; flows&nbsp; and the&nbsp; effect&nbsp; of</pre><pre>exchange&nbsp; rate&nbsp; changes&nbsp; on cash held in foreign&nbsp; currencies&nbsp; is&nbsp; reported&nbsp; as a</pre><pre>separate item in the reconciliation of beginning and ending balances of cash and</pre><pre>cash&nbsp; equivalents&nbsp; and&nbsp; separately&nbsp; provides&nbsp; information&nbsp; about&nbsp; investing&nbsp; and</pre><pre>financing&nbsp; activities&nbsp; not&nbsp; resulting in cash receipts or payments in the period</pre><pre>pursuant&nbsp; to&nbsp;&nbsp; paragraph&nbsp;&nbsp; 830-230-45-1 &nbsp;&nbsp;of&nbsp; the&nbsp; FASB&nbsp;&nbsp; Accounting&nbsp;&nbsp; Standards</pre><pre>Codification.</pre> <!--egx--><pre>SUBSEQUENT EVENTS</pre><pre>&nbsp;</pre><pre>The Company&nbsp; follows the guidance in Section&nbsp; 855-10-50&nbsp; of the FASB&nbsp; Accounting</pre><pre>Standards Codification for the disclosure of subsequent events. The Company will</pre><pre>evaluate&nbsp; subsequent&nbsp; events through the date when the financial&nbsp; statements are</pre><pre>issued.&nbsp; Pursuant to ASU 2010-09 of the FASB Accounting Standards&nbsp; Codification,</pre><pre>the Company as an SEC filer considers its financial&nbsp; statements issued when they</pre><pre>are widely distributed to users, such as through filing them on EDGAR.</pre> <!--egx--><pre>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</pre><pre>&nbsp;</pre><pre>FASB ACCOUNTING STANDARDS UPDATE NO. 2011-08</pre><pre>&nbsp;</pre><pre>In September&nbsp; 2011,&nbsp; the FASB issued the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Update No.</pre><pre>2011-08 "INTANGIBLES--GOODWILL AND OTHER: TESTING GOODWILL FOR IMPAIRMENT" ("ASU</pre><pre>2011-08").&nbsp; This Update is to simplify how public and&nbsp; nonpublic&nbsp; entities&nbsp; test</pre><pre>goodwill&nbsp; for&nbsp; impairment.&nbsp; The&nbsp; amendments&nbsp; permit an&nbsp; entity&nbsp; to first&nbsp; assess</pre><pre>qualitative&nbsp; factors to&nbsp; determine&nbsp; whether it is more&nbsp; likely than not that the</pre><pre>fair value of a reporting&nbsp; unit is less than its carrying&nbsp; amount as a basis for</pre><pre>determining&nbsp; whether it is necessary to perform the two-step goodwill impairment</pre><pre>test described in Topic 350.&nbsp; Under the amendments in this Update,&nbsp; an entity is</pre><pre>not required to calculate&nbsp; the fair value of a reporting&nbsp; unit unless the entity</pre><pre>determines&nbsp; that it is more likely than not that its fair value is less than its</pre><pre>carrying amount.</pre><pre>&nbsp;</pre><pre>The guidance is effective for interim and annual&nbsp; periods&nbsp; beginning on or after</pre><pre>December 15, 2011. Early adoption is permitted.</pre><pre>&nbsp;</pre><pre>FASB ACCOUNTING STANDARDS UPDATE NO. 2011-11</pre><pre>&nbsp;</pre><pre>In December&nbsp; 2011,&nbsp; the FASB&nbsp; issued the FASB&nbsp; Accounting&nbsp; Standards&nbsp; Update No.</pre><pre>2011-11 "BALANCE SHEET:&nbsp; DISCLOSURES&nbsp; ABOUT&nbsp; OFFSETTING&nbsp; ASSETS AND LIABILITIES"</pre><pre>("ASU 2011-11").&nbsp; This Update requires an entity to disclose&nbsp; information&nbsp; about</pre><pre>offsetting and related&nbsp; arrangements to enable users of its financial statements</pre><pre>to understand the effect of those&nbsp; arrangements on its financial&nbsp; position.&nbsp; The</pre><pre>objective of this disclosure is to facilitate&nbsp; comparison between those entities</pre><pre>that prepare&nbsp; their&nbsp; financial&nbsp; statements&nbsp; on the basis of U.S.&nbsp; GAAP and those</pre><pre>entities that prepare their financial statements on the basis of IFRS.</pre><pre>&nbsp;</pre><pre>The amended guidance is effective for annual reporting&nbsp; periods&nbsp; beginning on or</pre><pre>after January 1, 2013, and interim periods within those annual periods.</pre><pre>&nbsp;</pre><pre>FASB ACCOUNTING STANDARDS UPDATE NO. 2012-02</pre><pre>&nbsp;</pre><pre>In July 2012, the FASB issued the FASB Accounting&nbsp; Standards&nbsp; Update No. 2012-02</pre><pre>"INTANGIBLES--GOODWILL AND OTHER (TOPIC 350) TESTING INDEFINITE-LIVED INTANGIBLE</pre><pre>ASSETS FOR IMPAIRMENT" ("ASU 2012-02").</pre><pre>&nbsp;</pre><pre>This&nbsp; Update&nbsp; is&nbsp; intended&nbsp; to&nbsp; reduce&nbsp; the&nbsp; cost&nbsp; and&nbsp;&nbsp; complexity&nbsp; of&nbsp; testing</pre><pre>indefinite-lived&nbsp; intangible&nbsp; assets other than&nbsp; goodwill for&nbsp; impairment.&nbsp; This</pre><pre>guidance builds upon the guidance in ASU 2011-08,&nbsp; entitled TESTING GOODWILL FOR</pre><pre>IMPAIRMENT.&nbsp; ASU 2011-08 was issued on&nbsp; September&nbsp; 15, 2011,&nbsp; and feedback&nbsp; from</pre><pre>stakeholders&nbsp; during the&nbsp; exposure&nbsp; period&nbsp; related to the&nbsp; goodwill&nbsp; impairment</pre><pre>testing&nbsp; guidance&nbsp; was that the&nbsp; guidance&nbsp; also would be&nbsp; helpful in&nbsp; impairment</pre><pre>testing for intangible assets other than goodwill.</pre><pre>&nbsp;</pre><pre>The revised&nbsp; standard allows an entity the option to first assess&nbsp; qualitatively</pre><pre>whether&nbsp; it is more&nbsp; likely&nbsp; than not&nbsp; (that&nbsp; is, a&nbsp; likelihood&nbsp; of more than 50</pre><pre>percent)&nbsp; that&nbsp; an&nbsp;&nbsp; indefinite-lived&nbsp;&nbsp; intangible&nbsp;&nbsp; asset&nbsp; is&nbsp; impaired,&nbsp;&nbsp; thus</pre><pre>necessitating that it perform the quantitative impairment test. An entity is not</pre><pre>required to calculate the fair value of an indefinite-lived intangible asset and</pre><pre>perform the quantitative impairment test unless the entity determines that it is</pre><pre>more likely than not that the asset is impaired.</pre><pre>&nbsp;</pre><pre>This Update is effective for annual and interim&nbsp; impairment&nbsp; tests&nbsp; performed in</pre><pre>fiscal years&nbsp; beginning&nbsp; after&nbsp; September 15, 2012.&nbsp; Earlier&nbsp; implementation&nbsp; is</pre><pre>permitted.</pre> <!--egx--><pre>OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS</pre><pre>&nbsp;</pre><pre>Management&nbsp; does&nbsp; not&nbsp; believe&nbsp; that&nbsp; any&nbsp; other&nbsp; recently&nbsp; issued,&nbsp; but not yet</pre><pre>effective accounting pronouncements, if adopted, would have a material effect on</pre><pre>the accompanying consolidated financial statements.</pre> <!--egx--><pre>The Company's consolidated subsidiaries and/or entities are as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date of incorporation</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or formation</pre><pre>Name of consolidated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State or other jurisdiction of&nbsp;&nbsp;&nbsp;&nbsp; (date of acquisition,</pre><pre>subsidiary or entity&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; incorporation or organization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if applicable)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attributable interest</pre><pre>--------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------</pre><pre>&nbsp;</pre><pre>Stevia Ventures&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Territory of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100%</pre><pre>International Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; British Virgin Islands</pre><pre>&nbsp;</pre><pre>Stevia Asia Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hong Kong SAR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 19, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100%</pre><pre>&nbsp;</pre><pre>Stevia Technew Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hong Kong SAR&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 28, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70%</pre><pre>&nbsp;</pre> <!--egx--><pre>The following&nbsp; table shows the&nbsp; potentially&nbsp; outstanding&nbsp; dilutive common shares</pre><pre>excluded from the diluted net income (loss) per common share calculation as they</pre><pre>were anti-dilutive:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potentially</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Outstanding Dilutive</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interim Period&nbsp;&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>MAKE GOOD ESCROW SHARES</pre><pre>&nbsp;</pre><pre>Make Good Escrow&nbsp; Agreement shares issued and</pre><pre>held with the escrow agent in connection with</pre><pre>the Share Exchange&nbsp; Agreement&nbsp; consummated on</pre><pre>June 23, 2011 pending the&nbsp; achievement by the</pre><pre>Company&nbsp; of&nbsp; certain&nbsp; post-Closing&nbsp;&nbsp; business</pre><pre>milestones (the "Milestones").&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,000,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,000,000</pre><pre>&nbsp;</pre><pre>CONVERTIBLE NOTE SHARES</pre><pre>&nbsp;</pre><pre>On&nbsp; March&nbsp; 7,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 426,667&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>On&nbsp; May&nbsp; 30,&nbsp; 2012,&nbsp;&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;426,667&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>WARRANT SHARES</pre><pre>&nbsp;</pre><pre>On August 6,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued (i)</pre><pre>warrants to purchase 1,066,667 shares, in the</pre><pre>aggregate,&nbsp; of the Company's&nbsp; common stock to</pre><pre>the investors (the "investors&nbsp; warrants") and</pre><pre>(ii)&nbsp; warrants to purchase&nbsp; 85,333&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common stock to the placement</pre><pre>agent (the "agent warrants") with an exercise</pre><pre>price of $0.6405 per share subject to certain</pre><pre>adjustments&nbsp;&nbsp;&nbsp; pursuant&nbsp;&nbsp; to&nbsp;&nbsp; Section&nbsp;&nbsp; 3(b)</pre><pre>Subsequent&nbsp; Equity&nbsp; Sales of the SPA expiring</pre><pre>five (5) years from the date of issuance.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>TOTAL POTENTIALLY OUTSTANDING DILUTIVE</pre><pre>COMMON SHARES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,005,334&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,000,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre> <!--egx--><pre>Prepaid expenses consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>Prepaid research and development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 23,336&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $128,445</pre><pre>Prepaid rent&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21,250</pre><pre>Retainer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15,000</pre><pre>Other&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,680&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,179</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 26,016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $168,874</pre> <!--egx--><pre>Property and equipment,&nbsp; stated at cost, less accumulated depreciation consisted</pre><pre>of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Estimated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Useful Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Years)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>Property and equipment&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 7,925&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 3,036</pre><pre>Less accumulated depreciation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (762)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;--</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 7,163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp; 3,036</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Estimated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Useful Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Years)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>Technology right&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1,635,300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Less accumulated amortization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (54,510)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1,580,790&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre> <!--egx--><pre>Website&nbsp; development&nbsp; costs,&nbsp; stated&nbsp; at&nbsp; cost,&nbsp; less&nbsp; accumulated&nbsp; amortization</pre><pre>consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Estimated</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Useful Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Years)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>Website development costs&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; 5,315&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; 5,315</pre><pre>Accumulated amortization&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,602)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (801)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp; 3,713&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; 4,514</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ==========</pre> <!--egx--><pre>Related parties with whom the Company had transactions are:</pre><pre>&nbsp;</pre><pre>Related Parties&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Relationship</pre><pre>---------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------------</pre><pre>George Blankenbaker&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; President and significant stockholder of the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company</pre><pre>&nbsp;</pre><pre>Leverage Investments LLC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An entity owned and controlled by the president</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and significant stockholder of the Company</pre><pre>&nbsp;</pre><pre>Technew Technology Limited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-controlling interest holder</pre><pre>&nbsp;</pre><pre>Growers Synergy Pte Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An entity owned and controlled by the president</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;and significant stockholder of the Company</pre><pre>&nbsp;</pre><pre>Guangzhou Health Technology&nbsp;&nbsp;&nbsp;&nbsp; An entity owned and controlled by</pre><pre>Development Company Limited&nbsp;&nbsp;&nbsp;&nbsp; Non-controlling interest holder</pre> <!--egx--><pre>Farm management services provided by Growers Synergy Pte Ltd. is as follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interim Period&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>Farm management services received and</pre><pre> farm management services booked&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $180,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $180,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre><pre>&nbsp;</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</pre> <!--egx--><pre>Future minimum payments&nbsp; required under this agreement at December 31, 2012 were</pre><pre>as follows:</pre><pre>&nbsp;</pre><pre>Fiscal Year Ending March 31:</pre><pre>&nbsp; 2013 (remainder of the fiscal year)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 60,000</pre><pre>&nbsp; 2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 140,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $200,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre>Convertible notes payable consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;December 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>On November&nbsp; 16, 2011,&nbsp; the Company&nbsp; issued a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $250,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion&nbsp; price&nbsp; to&nbsp; be&nbsp; the&nbsp; same&nbsp; as&nbsp; the</pre><pre>private&nbsp; placement price on a per share basis</pre><pre>provided&nbsp; the&nbsp; Company&nbsp;&nbsp; complete&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp; On July 6, 2012,&nbsp; the note&nbsp; holder</pre><pre>converted&nbsp; the entire&nbsp; principal&nbsp; of $250,000</pre><pre>and&nbsp; accrued&nbsp; interest&nbsp; through&nbsp; the&nbsp; date of</pre><pre>conversion&nbsp; of $15,959&nbsp; to 319,607&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common&nbsp; stock&nbsp; at&nbsp; $0.83&nbsp; per</pre><pre>share.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250,000</pre><pre>&nbsp;</pre><pre>On January 16,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $250,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion&nbsp; price&nbsp; to&nbsp; be&nbsp; the&nbsp; same&nbsp; as&nbsp; the</pre><pre>private&nbsp; placement price on a per share basis</pre><pre>provided&nbsp; the&nbsp; Company&nbsp;&nbsp; complete&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp; On July 6, 2012,&nbsp; the note &nbsp;holder</pre><pre>converted&nbsp; the entire&nbsp; principal&nbsp; of $250,000</pre><pre>and&nbsp; accrued&nbsp; interest&nbsp; through&nbsp; the&nbsp; date of</pre><pre>conversion&nbsp; of $11,781&nbsp; to 314,586&nbsp; shares of</pre><pre>the&nbsp; Company's&nbsp; common&nbsp; stock&nbsp; at&nbsp; $0.83&nbsp; per</pre><pre>share.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250,000</pre><pre>&nbsp;</pre><pre>On&nbsp; March&nbsp; 7,&nbsp; 2012,&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which &nbsp;the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000</pre><pre>&nbsp;</pre><pre>On&nbsp; May&nbsp; 30,&nbsp; 2012,&nbsp;&nbsp; the&nbsp; Company&nbsp; issued&nbsp; a</pre><pre>convertible&nbsp; note in the&nbsp; amount of&nbsp; $200,000</pre><pre>with&nbsp; interest&nbsp; at 10% per&nbsp; annum due one (1)</pre><pre>year&nbsp; from&nbsp; the&nbsp; date of&nbsp; issuance&nbsp; with&nbsp; the</pre><pre>conversion price to be at $0.46875 per share,</pre><pre>at which&nbsp; the&nbsp; Company&nbsp; completed&nbsp; a&nbsp; private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000&nbsp; on August 6, 2012,&nbsp; the same as the</pre><pre>next private&nbsp; placement&nbsp; price on a per share</pre><pre>basis provided the Company complete a private</pre><pre>placement&nbsp; with&nbsp; gross&nbsp; proceeds&nbsp; of at least</pre><pre>$100,000.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$400,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $700,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre>The table below provides a summary of the fair value of the&nbsp; derivative&nbsp; warrant</pre><pre>liability&nbsp; and the&nbsp; changes&nbsp; in the fair&nbsp; value of the&nbsp; derivative&nbsp; warrants&nbsp; to</pre><pre>purchase 1,152,000 shares of the Company's common stock, including net transfers</pre><pre>in and/or&nbsp; out,&nbsp; of&nbsp; derivative&nbsp; warrants&nbsp; measured at fair value on a recurring</pre><pre>basis using significant unobservable inputs (Level 3).</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value Measurement</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Using Level 3 Inputs</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; warrants Assets</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Liability)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Total</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----</pre><pre>Balance, August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(411,805)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(411,805)</pre><pre>Total gains or losses</pre><pre> (realized/unrealized) included in:</pre><pre>&nbsp;&nbsp; Net income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;231,521&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 231,521</pre><pre>&nbsp;&nbsp; Other comprehensive income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp; Purchases, issuances and settlements&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp; Transfers in and/or out of Level 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>Balance, August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (180,284)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (180,284)</pre><pre>Total gains or losses</pre><pre> (realized/unrealized) included in:</pre><pre>&nbsp;&nbsp; Net income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 73,723&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 73,723</pre><pre>&nbsp;&nbsp; Other comprehensive income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp; Purchases, issuances and settlements&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp; Transfers in and/or out of Level 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>&nbsp;</pre><pre>Balance, December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(106,561)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(106,561)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =========</pre> <!--egx--><pre>The table below summarizes the Company's derivative warrant activity</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012 Warrant Activities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Apic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Gain) Loss</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------------------------------------------------------&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reclassification</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative&nbsp;&nbsp;&nbsp;&nbsp; Non-derivative&nbsp;&nbsp;&nbsp; Warrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </pre><pre>Derivative warrant at</pre><pre> August 6, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (411,805)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Mark to market&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 231,521&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(231,521)</pre><pre>Derivative warrant at</pre><pre> September 30, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (180,284)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (231,521)</pre><pre>Mark to market&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;73,723&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (73,723)</pre><pre>Derivative warrant at</pre><pre> December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (106,561)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (305,244)</pre><pre>&nbsp;</pre> <!--egx--><pre>The&nbsp; following&nbsp; table&nbsp;&nbsp; summarizes&nbsp;&nbsp; information&nbsp;&nbsp; concerning&nbsp;&nbsp; outstanding&nbsp; and</pre><pre>exercisable warrants as of December 31, 2012:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants Outstanding&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrants Exercisable</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------------------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Average&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Average</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remaining&nbsp;&nbsp;&nbsp;&nbsp; Weighted&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remaining&nbsp;&nbsp;&nbsp;&nbsp; Weighted</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contractual&nbsp;&nbsp;&nbsp; Average&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contractual&nbsp;&nbsp;&nbsp; Average</pre><pre>Range of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Life&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise</pre><pre>Exercise Prices&nbsp;&nbsp; Outstanding&nbsp;&nbsp; (in years)&nbsp;&nbsp;&nbsp;&nbsp; Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercisable&nbsp;&nbsp; (in years)&nbsp;&nbsp;&nbsp;&nbsp; Price</pre><pre>---------------&nbsp;&nbsp; -----------&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp; -----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----------&nbsp;&nbsp; ----------&nbsp;&nbsp;&nbsp;&nbsp; -----</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </pre><pre>$0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.6405</pre><pre>-------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------</pre><pre>&nbsp;</pre><pre>$0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.6405</pre><pre>=======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ====&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ====&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =======</pre> <!--egx--><pre>The table below summarizes the Company's warrant activities:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weighted Average&nbsp;&nbsp; Fair Value at&nbsp;&nbsp;&nbsp;&nbsp; Aggregate</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Price Range&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intrinsic</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Per Share&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuance&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Value</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -----</pre><pre>Balance, March 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ --</pre><pre>Granted&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,805&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Canceled&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Exercised&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Expired&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----</pre><pre>Balance, December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,805&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;</pre><pre>Earned and exercisable,</pre><pre> December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,152,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6405&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,805&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----</pre><pre>&nbsp;</pre><pre>Unvested, December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ --</pre> <!--egx--><pre>Completion&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number of</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Milestones&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Escrow Shares</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------------</pre><pre>I.</pre><pre>(1)&nbsp; Enter into exclusive&nbsp; international&nbsp; license agreement</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; for&nbsp; all&nbsp; Agro&nbsp; Genesis&nbsp;&nbsp; intellectual&nbsp;&nbsp; property&nbsp; and</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; products as it applies to stevia</pre><pre>(2)&nbsp; Enter into cooperative agreements to work with Vietnam</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; Institutes (a) Medical Plant&nbsp; Institute in Hanoi;&nbsp; (b)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; Agricultural&nbsp; Science&nbsp; Institute&nbsp; of Northern&nbsp; Central&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,000,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; Vietnam&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares only</pre><pre>(3)&nbsp; Enter&nbsp; into&nbsp; farm&nbsp; management&nbsp; agreements&nbsp; with&nbsp; local&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if and when</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp; growers&nbsp;&nbsp; including&nbsp;&nbsp; the&nbsp;&nbsp; Provincial&nbsp;&nbsp; and&nbsp; National&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Within 180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ALL four (4)</pre><pre>&nbsp;&nbsp;&nbsp; &nbsp;projects;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; days of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; milestones</pre><pre>(4)&nbsp; Take over management of three existing nurseries&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Closing Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reached(*)</pre> <!--egx--><pre>Non-controlling interest consisted of the following:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contributed and</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paid-in&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Earnings and&nbsp;&nbsp;&nbsp;&nbsp; Comprehensive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non-controlling</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; capital&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; losses&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; interest</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>Balance at March 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; --</pre><pre>Current period earnings and losses&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (97,338)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (97,338)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>Balance at December 31, 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(97,338)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $&nbsp;&nbsp;&nbsp; --&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(97,338)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ========</pre> <!--egx--><pre>Future minimum payments&nbsp; required under this agreement at December 31, 2012 were</pre><pre>as follows:</pre><pre>&nbsp;</pre><pre>FISCAL YEAR ENDING MARCH 31:</pre><pre>2013 (remainder of the fiscal year)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$ 15,000</pre><pre>2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,000</pre><pre>2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,000</pre><pre>2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --------</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $105,000</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;========</pre> <!--egx--><pre>Vendor&nbsp; purchase&nbsp; concentrations&nbsp; and&nbsp; accounts&nbsp; payable&nbsp; concentration&nbsp; are&nbsp; as</pre><pre>follows:</pre><pre>&nbsp;</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Payable at&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Purchases</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ---------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ----------------------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Period from</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; April 11, 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interim Period&nbsp;&nbsp; (inception)</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; through</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; March 31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; December 31,&nbsp;&nbsp;&nbsp; December 31,</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------</pre><pre>&nbsp;</pre><pre>Growers Synergy Pte. Ltd. - related party&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42.5%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16.4%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49.8%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --%</pre><pre>tevia Ventures Corporation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 54.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.3%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --%</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ------</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 46.2%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70.5%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60.1%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --%</pre><pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ======</pre><pre>&nbsp;</pre> 79800000 33000000 12000000 6000000 0.2040 0.7000 0.3000 2000000 2000000 3000000 6000000 426667 426667 1152000 5005334 6000000 23336 128445 0 21250 0 15000 2680 4179 26016 168874 7925 3036 -762 0 7163 3036 1635300 0 -54510 0 1580790 0 -1602 -801 762 54510 801 534 2500000 2500000 100000 100000 0.1000 0.1000 15890.41 2821.92 1000000 400000 63561 11288 0.25 0.25 0 250000 0 250000 200000 200000 200000 0 400000 700000 0 0 0 0 0 1152000 0.6405 0.6405 411805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1152000 0.6405 0.6405 411805 0 1152000 0.6405 0.6405 411805 0 0 0 0 0 0 1152000 4.60 0.6405 1152000 4.60 0.6405 1152000 4.60 0.6405 1152000 4.60 0.6405 0 -97338 0 -97338 274000 0.0200 30000 15000 45000 15000 30000 30000 30000 105000 0.0800 25000 500000 18000 500000 3000 0.4980 0.0000 0.1030 0.0000 0.6010 0.0000 0.4250 0.1640 0.0370 0.5410 0.4620 0.7050 100000000 0.001 33000000 12000000 6000000 3000000 3000 400000 0.25 100000 1500000 3000000 750000 0.25 750000 93750 20000000 0.001 35000 1.50 52500 27500 1.39 38225 500000 1066667 0 1066667 1 500000 12500 0.0800 40000 85333 0.6405 0.46875 447500 292218 207782 0.27 0.18 120000 140000 260000 0 -97338 0 -97338 0 0 0 0 0001439813 2012-04-01 2012-12-31 0001439813 2013-01-18 0001439813 2012-12-31 0001439813 2012-03-31 0001439813 2012-10-01 2012-12-31 0001439813 2011-04-11 2011-12-31 0001439813 2011-10-01 2011-12-31 0001439813 us-gaap:CapitalUnitsMember 2011-04-10 0001439813 us-gaap:CommonStockMember 2011-04-10 0001439813 us-gaap:AdditionalPaidInCapitalMember 2011-04-10 0001439813 us-gaap:RetainedEarningsMember 2011-04-10 0001439813 fil:StockholdersEquityDeficitMember 2011-04-10 0001439813 us-gaap:NoncontrollingInterestMember 2011-04-10 0001439813 fil:TotalEquityDeficitMember 2011-04-10 0001439813 us-gaap:CapitalUnitsMember 2011-04-11 2012-03-31 0001439813 us-gaap:CommonStockMember 2011-04-11 2012-03-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2011-04-11 2012-03-31 0001439813 us-gaap:RetainedEarningsMember 2011-04-11 2012-03-31 0001439813 fil:StockholdersEquityDeficitMember 2011-04-11 2012-03-31 0001439813 us-gaap:NoncontrollingInterestMember 2011-04-11 2012-03-31 0001439813 fil:TotalEquityDeficitMember 2011-04-11 2012-03-31 0001439813 us-gaap:CapitalUnitsMember 2012-03-31 0001439813 us-gaap:CommonStockMember 2012-03-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0001439813 us-gaap:RetainedEarningsMember 2012-03-31 0001439813 fil:StockholdersEquityDeficitMember 2012-03-31 0001439813 us-gaap:NoncontrollingInterestMember 2012-03-31 0001439813 fil:TotalEquityDeficitMember 2012-03-31 0001439813 us-gaap:CapitalUnitsMember 2012-04-01 2012-12-31 0001439813 us-gaap:CommonStockMember 2012-04-01 2012-12-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2012-04-01 2012-12-31 0001439813 us-gaap:RetainedEarningsMember 2012-04-01 2012-12-31 0001439813 fil:StockholdersEquityDeficitMember 2012-04-01 2012-12-31 0001439813 us-gaap:NoncontrollingInterestMember 2012-04-01 2012-12-31 0001439813 fil:TotalEquityDeficitMember 2012-04-01 2012-12-31 0001439813 us-gaap:CapitalUnitsMember 2012-12-31 0001439813 us-gaap:CommonStockMember 2012-12-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001439813 us-gaap:RetainedEarningsMember 2012-12-31 0001439813 fil:StockholdersEquityDeficitMember 2012-12-31 0001439813 us-gaap:NoncontrollingInterestMember 2012-12-31 0001439813 fil:TotalEquityDeficitMember 2012-12-31 0001439813 2011-04-10 0001439813 2011-12-31 0001439813 2012-07-05 0001439813 2011-06-23 0001439813 2011-10-11 0001439813 2011-02-14 0001439813 2011-10-04 0001439813 fil:NumberOfWarrantSharesMember 2012-03-31 0001439813 fil:ExercisePriceRangePerShareMember 2012-03-31 0001439813 fil:AverageExercisePriceMember 2012-03-31 0001439813 fil:FairValueAtRateOfIssuanceMember 2012-03-31 0001439813 fil:AggregateIntrinsicValueMember 2012-03-31 0001439813 fil:NumberOfWarrantSharesMember 2012-04-01 2012-12-31 0001439813 fil:ExercisePriceRangePerShareMember 2012-04-01 2012-12-31 0001439813 fil:AverageExercisePriceMember 2012-04-01 2012-12-31 0001439813 fil:FairValueAtRateOfIssuanceMember 2012-04-01 2012-12-31 0001439813 fil:AggregateIntrinsicValueMember 2012-04-01 2012-12-31 0001439813 fil:NumberOfWarrantSharesMember 2012-12-31 0001439813 fil:ExercisePriceRangePerShareMember 2012-12-31 0001439813 fil:AverageExercisePriceMember 2012-12-31 0001439813 fil:FairValueAtRateOfIssuanceMember 2012-12-31 0001439813 fil:AggregateIntrinsicValueMember 2012-12-31 0001439813 fil:WarrantsOutstandingNumberOutstandingMember 2012-12-31 0001439813 fil:WarrantsOutstandingAverageRemainingContractualLifeInYearsMember 2012-12-31 0001439813 fil:WarrantsOutstandingWeightedAverageExercisePriceMember 2012-12-31 0001439813 fil:WarrantsExercisableNumberExercisableMember 2012-12-31 0001439813 fil:WarrantsExercisableAverageRemainingContractualLifeInYearsMember 2012-12-31 0001439813 fil:WarrantsExercisableWeightedAverageExercisePriceMember 2012-12-31 0001439813 fil:ContributedAndAdditionalPaidInCapitalMember 2012-04-01 2012-12-31 0001439813 fil:EarningsAndLossesMember 2012-04-01 2012-12-31 0001439813 fil:OtherComprehensiveIncome1Member 2012-04-01 2012-12-31 0001439813 fil:TotalNonControllingInterestMember 2012-04-01 2012-12-31 0001439813 2011-10-14 0001439813 2012-01-26 0001439813 2012-08-01 0001439813 2012-08-06 0001439813 fil:ContributedAndAdditionalPaidInCapitalMember 2012-12-31 0001439813 fil:EarningsAndLossesMember 2012-12-31 0001439813 fil:OtherComprehensiveIncome1Member 2012-12-31 0001439813 fil:TotalNonControllingInterestMember 2012-12-31 0001439813 fil:ContributedAndAdditionalPaidInCapitalMember 2012-03-31 0001439813 fil:EarningsAndLossesMember 2012-03-31 0001439813 fil:OtherComprehensiveIncome1Member 2012-03-31 0001439813 fil:TotalNonControllingInterestMember 2012-03-31 shares iso4217:USD iso4217:USD shares pure EX-101.SCH 6 stev-20121231.xsd 000260 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:definitionLink link:calculationLink 000450 - Statement - CONVERTIBLE NOTES PAYABLE (Details) link:presentationLink link:definitionLink link:calculationLink 000390 - Statement - ENTITY'S ASSETS (Details) link:presentationLink link:definitionLink link:calculationLink 000150 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:definitionLink link:calculationLink 000600 - Statement - SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details){Stockholder's Equity} link:presentationLink link:definitionLink link:calculationLink 000290 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000640 - Statement - COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) link:presentationLink link:definitionLink link:calculationLink 000530 - Statement - ENTRY INTO SECURITIES PURCHASE AGREEMENT (Details) link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - ACQUIRED TECHNOLOGY link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - Consolidated Statement of Equity (Deficit) {Stock Holders} link:presentationLink link:definitionLink link:calculationLink 000540 - Statement - GARDEN STATE SECURTIES INC (Details) link:presentationLink link:definitionLink link:calculationLink 000610 - Statement - OUTSTANDING AND EXERCISABLE WARRANTS (Details) {Stockholder's Equity} link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - ORGANIZATION AND OPERATIONS link:presentationLink link:definitionLink link:calculationLink 000480 - Statement - COMMON SHARES ISSUED FOR SERVICES (Details) link:presentationLink link:definitionLink link:calculationLink 000060 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 000620 - Statement - NON-CONTROLLING INTEREST (Details) {Stockholder's Equity} link:presentationLink link:definitionLink link:calculationLink 000350 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Tables) link:presentationLink link:definitionLink link:calculationLink 000270 - Disclosure - ACQUIRED TECHNOLOGY (Tables) link:presentationLink link:definitionLink link:calculationLink 000400 - Statement - AMORTIZATION AND DEPRECIATION EXPENSE (Details) link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - Consolidated Balance Sheets Parentheticals link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - WEBSITE DEVELOPMENT COSTS link:presentationLink link:definitionLink link:calculationLink 000210 - Disclosure - CONCENTRATIONS AND CREDIT RISK link:presentationLink link:definitionLink link:calculationLink 000460 - Statement - CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES (Details) link:presentationLink link:definitionLink link:calculationLink 000240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 000420 - Statement - RELATED PARTY TRANSACTIONS FUTURE MINIMUM PAYMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 000280 - Disclosure - WEBSITE DEVELOPMENT COSTS (Tables) link:presentationLink link:definitionLink link:calculationLink 000310 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 000320 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 000380 - Statement - GOING CONCERN (Details) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 000470 - Statement - SHARES AUTHORIZED AND TRANSACTION (Details) link:presentationLink link:definitionLink link:calculationLink 000660 - Statement - CONCENTRATIONS AND CREDIT RISK INSTANT (Details) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 000220 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000340 - Disclosure - RESEARCH AND DEVELOPMENT (Tables) link:presentationLink link:definitionLink link:calculationLink 000190 - Disclosure - RESEARCH AND DEVELOPMENT link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:definitionLink link:calculationLink 000250 - Disclosure - PREPAID EXPENSES. (Tables) link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - PREPAID EXPENSES link:presentationLink link:definitionLink link:calculationLink 000170 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 000300 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 000330 - Disclosure - NON-CONTROLLING INTEREST (Tables) link:presentationLink link:definitionLink link:calculationLink 000160 - Disclosure - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS link:presentationLink link:definitionLink link:calculationLink 000180 - Disclosure - NON-CONTROLLING INTEREST link:presentationLink link:definitionLink link:calculationLink 000200 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 000230 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 000650 - Statement - CONCENTRATIONS AND CREDIT RISK DURATION (Details) link:presentationLink link:definitionLink link:calculationLink 000360 - Statement - ORGANIZATION AND OPERATIONS (Details) link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 000370 - Statement - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) link:presentationLink link:definitionLink link:calculationLink 000630 - Statement - RESEARCH AND DEVELOPMENT PAYMENTS (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 stev-20121231_cal.xml EX-101.DEF 8 stev-20121231_def.xml EX-101.LAB 9 stev-20121231_lab.xml Other Comprehensive Income Contributed and additional paid-in capital Fair Value at Rate of Issuance Average Exercise Price Per common share Per common share Gross proceeds received in the equity financing Gross proceeds received in the equity financing Common shares purchased Common shares purchased Fiscal Year Ending March 31: Technology right estimated useful life 15 years Technology right estimated useful life 15 years SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE Contribution per month Contribution per month Common shares held in escrow Common shares held in escrow Related parties with whom the Company had transactions Tabular disclosure of Consulting services. PREPAID EXPENSES. Proceeds from sale of common stock, net of costs Cash received from reverse acquisition Changes in Accrued interest Changes in Accounts receivable Adjustments to reconcile net loss to net cash used in operating activities Net loss, The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Common shares issued for conversion of accrued interest at $0.25 per share on January 18, 2012 Number of shares issued during the period as a result of the second conversion of convertible securities. Make good shares released to officer for achieving the first milestone on December 23, 2011 Common shares issued for conversion of accrued interest at $0.25 per share on October 4, 2011 Total Equity (Deficit) General and administrative expenses Directors' fees Preferred Stock, shares outstanding Website development costs Statement [Line Items] Entity Current Reporting Status Entity Common Stock, Shares Outstanding Consultants fees per month Consultants fees per month Future Minimum payments for the fiscal year 2016 Future Minimum payments for the fiscal year 2016 Future Minimum payments for the fiscal year 2013 Future Minimum payments for the fiscal year 2013 Six month lease payment Six month lease payment Aggregate Intrinsic Value Number of Warrant Shares Common stock price Common stock price Debiting common stock at par Debiting common stock at par Shares surrendered for cancellation Shares surrendered for cancellation Other. Other prepaid expenses Common shares issued for acquisition of 100% of issued and outstanding Common shares issued for acquisition of 100% of issued and outstanding Fair Value Of Derivative Warrants CONVERTIBLE NOTES PAYABLE. Prepaid expenses consists RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Disclosure of accounting policy for recently issued accounting pronouncements. EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR Disclosure of accounting policy for Equity instruments issued to parties other than employees for acquiring goods or services COMMITMENT AND CONTINGENCIES NON-CONTROLLING INTEREST Issuance of common stock for conversion of accrued interest Issuance of common stock for conversion of accrued interest CASH FLOWS FROM OPERATING ACTIVITIES: Common shares issued for future director services on October 4, 2011 Net loss attributable to the non-controlling interest Income tax provision Loss from operations Stockholders equity number of shares par value and other disclosures Accrued interest Accounts payable Entity Registrant Name CONCENTRATIONS AND CREDIT RISK INSTANT COMMITMENTS AND CONTINGENCIES COMPENSATION First year lease payment First year lease payment. ENTRY INTO AGRIBUSINESS DEVELOPMENT AGREEMENT Warrants Outstanding Average Remaining Contractual Life (in years) Issuance of gross proceeds Issuance of gross proceeds Share value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. COMMON SHARES ISSUED FOR OBTAINING EMPLOYEE AND DIRECTOR SERVICES Common shares authorized to issue The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Convertible notes issued On November 16, 2011 Convertible notes issued On November 16, 2011 AMORTIZATION AND DEPRECIATION EXPENSE Retainer RESEARCH AND DEVELOPMENT (Tables) NON-CONTROLLING INTEREST (Tables) RECLASSIFICATION ACQUIRED TECHNOLOGY {1} ACQUIRED TECHNOLOGY GOING CONCERN {1} GOING CONCERN NON-CASH INVESTING AND FINANCING ACTIVITIES: NET CASH USED IN OPERATING ACTIVITIES Depreciation expense Accumulated Deficit Additional paid-in Capital Consolidated Statement of Equity (Deficit) Salary and compensation - officer Farm field lease Stevia Corp stockholders' equity (deficit): Acquired technology, net The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Statement [Table] Amendment Flag Aggregate security deposit Aggregate security deposit Range of Exercise Prices 0.6405 Range of Exercise Prices 0.6405 Range of Exercise Prices 0.6405 warrants Range of Exercise Prices 0.6405 Common shares value to issue and sell Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Common stock value Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. CONVERTIBLE NOTES PAYABLE {2} CONVERTIBLE NOTES PAYABLE Website development costs Net The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Prepaid research and development The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Consulting services Tabular disclosure of Consulting services. SUBSEQUENT EVENTS {2} SUBSEQUENT EVENTS CASH FLOWS REPORTING Disclosure of accounting policy Cash Flows Reporting. NON-CONTROLLING INTEREST {2} NON-CONTROLLING INTEREST Disclosure of accounting policy for Non Contolling Interest. INTANGIBLE ASSETS OTHER THAN GOODWILL BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION WEBSITE DEVELOPMENT COSTS {1} WEBSITE DEVELOPMENT COSTS The entire disclosure for all or part of the information related to website development costs. PROPERTY AND EQUIPMENT SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: Cash at beginning of period Cash at beginning of period CASH AT END OF PERIOD Common shares issued for director services earned during the period Common shares issued for notes conversion at $0.25 per share on October 4, 2011 OPERATING EXPENSES: COST OF REVENUES Common Stock, par or stated value TOTAL EQUITY (DEFICIT) EQUITY (DEFICIT) NON-CURRENT LIABILITIES: Entity Voluntary Filers Current Fiscal Year End Date Accounts Payable at Growers Synergy Pte. Ltd. - related party Accounts Payable at Growers Synergy Pte. Ltd. - related party FUTURE MINIMUM PAYMENTS Warrants Outstanding Number Outstanding SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES Exercise price Exercise price Stock price value Stock price value Common shares held in escrow. Common shares held in escrow. Common shares authorized to issue par value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Accumulated amortization. The aggregate expense charged against earnings to allocate the cost of acquired intangible assets. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method. Convertible note issued on March 7, 2012 Convertible note issued on March 7, 2012 Common shares surrendered for cancelletion Common shares surrendered for cancelletion Non-controlling interest consists Tabular disclosure of Non-controlling interest. Schedule of Milestones CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS PRINCIPLES OF CONSOLIDATION RELATED PARTY TRANSACTIONS {1} RELATED PARTY TRANSACTIONS PROPERTY AND EQUIPMENT {1} PROPERTY AND EQUIPMENT Interest paid Changes in Accounts payable Common shares issued for cash at $0.25 per share on October 04, 2011 OTHER (INCOME) EXPENSE: Farm management services - related party Non-controlling interest in subsidiary CURRENT ASSETS: Percentage of stock issued Percentage of stock issued as of date. Future Minimum payments total Future Minimum payments total Future Minimum payments for the fiscal year 2014 Future Minimum payments for the fiscal year 2014 OUTSTANDING AND EXERCISABLE WARRANTS Percentage cash commission Percentage cash commission Aggregate common shares Aggregate common shares Common shares issued for acquisition of 100% of issued and outstanding. Common shares issued for acquisition of 100% of issued and outstanding. Commons shares for conversion of principal Commons shares for conversion of principal Amount Amortization expenses on websited development costs Amortization expenses on websited development costs Convertible note issued on August 6, 2012 Convertible note issued on August 6, 2012 WEBSITE DEVELOPMENT COSTS (Tables) SUBSEQUENT EVENTS {1} SUBSEQUENT EVENTS Net loss for the period Statement, Equity Components [Axis] Common Stock, shares authorized Preferred Stock, shares issued Additional paid-in capital TOTAL NON-CURRENT LIABILITIES Derivative liability Security deposit Entity Central Index Key Warrants Outstanding Weighted Average Exercise Price Expired Warrants expired during the period. Share par value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Restricted shares for non cancellable retainer fee Restricted shares for non cancellable retainer fee Financing costs The cash outflow for loan and debt issuance costs. COMMON SHARES ISSUED UPON SIGNING AND COMPENSATION Convertible notes issued On January 16, 2012 Convertible notes issued On January 16, 2012 Convertible note amount WEBSITE DEVELOPMENT COSTS {2} WEBSITE DEVELOPMENT COSTS GOING CONCERN {2} GOING CONCERN Property and equipment {1} Property and equipment STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES STOCKHOLDERS' EQUITY {1} STOCKHOLDERS' EQUITY ACQUIRED TECHNOLOGY Common shares issued for services-related party Common shares issued for services rendered by a related party. Restricted common shares issued for farm management services to a related party valued at $0.79 per share discounted at 69% on July 5, 2012 Restricted common shares issued for farm management services to a related party valued at $0.79 per share discounted at 69% on July 5, 2012 Common shares issued for future director services on October 4, 2011. Common Stock, $0.001 Par Value Amount Research and development TOTAL CURRENT ASSETS Entity Filer Category Securities financing Securities financing as of date. Gross proceeds Gross proceeds as of date. LEASE OF AGRICULTURAL LAND Percentage of commission not less than AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated Balance NON-CONTROLLING INTEREST Balance NON-CONTROLLING INTEREST Balance NON-CONTROLLING INTEREST Balance NON-CONTROLLING INTEREST Total non-controlling interest Unvested Unvested Warrants unvested as of the date. Granted Warrants granted during the period. Per common shares Per common shares Reimbursed legal fees Reimbursed legal fees CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES Accrued interest through the date of conversion Accrued interest through the date of conversion Total future payments Total future payments Depreciaton expenses on Property and equipment Depreciaton expenses on Property and equipment Prepaid rent Vendor purchase concentrations STOCKHOLDERS' EQUITY (Tables) Website development costs, stated at cost Company Acquired The Rights to Technology Tabular disclosure of amortizable intangibles assets, in total and by major class, including the gross carrying amount and accumulated amortization. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) RESEARCH AND DEVELOPMENT {2} RESEARCH AND DEVELOPMENT DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS {1} DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS RELATED PARTY TRANSACTIONS WEBSITE DEVELOPMENT COSTS Income tax paid Common shares issued for notes conversion at $0.832143 per share on July 6, 2012 Common shares issued for notes conversion at $0.832143 per share on July 6, 2012 Net loss. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Common shares issued for notes conversion at $0.25 per share on January 18, 2012 Number of shares issued during the period as a result of the second conversion of convertible securities. Total STEV Stockholders Equity (Deficit) TOTAL OTHER (INCOME) EXPENSE Foreign currency transaction gain (loss) Accumulatd amortization The accumulated amount of amortization of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. ASSETS Document Fiscal Period Focus Gross proceeds to the Company Gross proceeds to the Company as of date. Securities for financing Securities for financing as of date. Earnings and losses Another shares surrendered Another shares surrendered Total potentially outstanding dilutive common shares Total potentially outstanding dilutive common shares Percentage owned by Technew Percentage owned by Technew Percentage owned by Stevia Asia Percentage owned by Stevia Asia Future minimum payments PROPERTY AND EQUIPMENT (Tables) CONVERTIBLE NOTES PAYABLE SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES {1} SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES CASH FLOWS FROM FINANCING ACTIVITIES: Common shares issued for financing services upon agreement at $1.50 per share on January 26, 2012 Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. NET LOSS ATTRIBUTABLE TO STEVIA CORP Gross margin TOTAL STEVIA CORP STOCKHOLDERS' EQUITY (DEFICIT) Document and Entity Information Balance NON-CONTROLLING INTEREST {1} Balance NON-CONTROLLING INTEREST Balance NON-CONTROLLING INTEREST Range of Exercise Prices 0.6405. Range of Exercise Prices 0.6405. warrants Range of Exercise Prices 0.6405 Common stock exercise price Common stock exercise price Restricted common stock issued Restricted common stock issued SHARE EXCHANGE AGREEMENT Shares surrendered for cancellation Total of convertible notes on various dates Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Total prepaid expenses Make Good Escrow Agreement shares issued and held with the escrow agent Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"). Percentage of shares represented of the issued and outnstanding Percentage of shares represented of the issued and outnstanding Warrants Outstanding CONVERTIBLE NOTES PAYABLE {1} CONVERTIBLE NOTES PAYABLE ORGANIZATION AND OPERATIONS Net change in cash Proceeds from issuance of convertible notes Website development costs. Proceeds from disposal of property and equipment Changes in Prepaid expenses Common shares cancelled by significant stockholder on October 4, 2011 Number of shares of stock cancelled during the period by a significant stockholder. Professional fees Farm expenses REVENUES Website development costs, net Acquired technology Sum of the gross carrying amounts before accumulated amortization as of the balance sheet date of all intangible assets having statutory or estimated useful lives. The aggregate gross carrying amount (including any previously recognized impairment charges) of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Total Accounts Payable Total Accounts Payable Total Net Purchases Total Net Purchases CONCENTRATIONS AND CREDIT RISK DURATION Current period earnings and losses Current period earnings and losses Warrants Exercisable Weighted Average Exercise Price Canceled Warrants Cancelled during the period. Balance; Balance; Balance; Outstanding warrants balance Exercise Price Range Per Share ENTRY INTO SECURITIES PURCHASE AGREEMENT EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT Common shares sold to one investor Common shares sold to one investor Subsidiaries of the Company Tabular disclosure of subsidiaries of the Company. NET INCOME (LOSS) PER COMMON SHARE REVENUE RECOGNITION PROPERTY AND EQUIPMENT {2} PROPERTY AND EQUIPMENT CASH EQUIVALENTS COMMITMENTS AND CONTINGENCIES {1} COMMITMENTS AND CONTINGENCIES RESEARCH AND DEVELOPMENT {1} RESEARCH AND DEVELOPMENT NON-CONTROLLING INTEREST {1} NON-CONTROLLING INTEREST STOCKHOLDERS' EQUITY GOING CONCERN ORGANIZATION AND OPERATIONS {1} ORGANIZATION AND OPERATIONS Changes in fair value of derivative liability. Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Common shares issued for future director services on October 4, 2011 earned during the period. Changes in additional paid in capital related to exercise of share-based payments awards (such as stock options) and the amount of recognized equity-based compensation during the period (such as nonvested shares). Loss before income taxes and noncontrolling interest TOTAL COST OF REVENUES Preferred Stock, par or stated value Convertible notes payable Advances from president and significant stockholder Percentage of commission not less than Percentage of commission not less than Warrants Exercisable Average Remaining Contractual Life (in years) GARDEN STATE SECURTIES INC Commons shares par value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Common stocks per share Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Common shares for convertible notes Common shares for convertible notes Amortizaion expenses on acquired technology Amortizaion expenses on acquired technology Property and equipment net Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. CONCENTRATIONS AND CREDIT RISK (Tables) Future minimum payments {1} Future minimum payments Summary Of The Warrant Activities CONVERTIBLE NOTES PAYABLE (Tables) UNCERTAIN TAX POSITIONS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) SUBSEQUENT EVENTS RESEARCH AND DEVELOPMENT PREPAID EXPENSES {1} PREPAID EXPENSES Text block that explains the prepayments of the entity. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET CASH PROVIDED BY FINANCING ACTIVITIES Purchases of property, plant and equipment Common shares issued for outside services Warrants issued to placement agent in connection with the sale of equity units on August 6, 2012 Warrants issued to placement agent in connection with the sale of equity units on August 6, 2012 Common Stock, $0.001 Par Value Number of Shares Salary and compensation - others Common Stock, shares outstanding TOTAL LIABILITIES AND EQUITY (DEFICIT) TOTAL LIABILITIES Accumulated depreciation Prepayments and other current assets Accounts receivable Document Fiscal Year Focus Entity Well-known Seasoned Issuer Net Purchases Stevia Ventures Corporation Net Purchases Stevia Ventures Corporation Future Minimum payments for the fiscal year 2015 Future Minimum payments for the fiscal year 2015 Earned and exercisable Earned and exercisable Warrants Earned and exercisable as of the date. Relative fair value of the common stock and warrants Relative fair value of the common stock and warrants Amortized value over per quarter Amortized value over per quarter Amortized value over the vesting period Amortized value over the vesting period Restricted stock shares Restricted stock shares 2014 2014 mInimum Payments. RELATED PARTY TRANSACTIONS FUTURE MINIMUM PAYMENTS ACQUIRED TECHNOLOGY RIGHTS GROSS, NET Less accumulated depreciation The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement. ACQUIRED TECHNOLOGY (Tables) RELATED PARTIES Disclosure of accounting policy for Related Parties. FAIR VALUE OF FINANCIAL INSTRUMENTS NET CASH USED IN INVESTING ACTIVITIES Commissions and legal fees in connection with the stock sales on August 6, 2012 Commissions and legal fees in connection with the stock sales on August 6, 2012 Common shares cancelled in reverse acquisition Number of shares of stock cancelled during the period pursuant to acquisitions. Common shares deemed issued in reverse acquisition Non- controlling Interest Interest expense Common stock at $0.001 par value: 100,000,000 shares authorized, 63,555,635 and 58,354,775 shares issued and outstanding, respectively Accrued expenses CURRENT LIABILITIES: Document Period End Date Document Type Accounts Payable at Stevia Ventures Corporation Accounts Payable at Stevia Ventures Corporation Common stock in aggregate as compensation for future services Common stock in aggregate as compensation for future services COMMON SHARES SURRENDERED FOR CANCELLATION AND COMMON SHARES ISSUED FOR CASH SHARES AUTHORIZED AND REVERSE ACQUISITION TRANSACTION Convertible notes issued On March 7, 2012 Convertible notes issued On March 7, 2012 2013 (remainder of the fiscal year) 2013 (remainder of the fiscal year) Common shares issued and outstanding Common shares issued and outstanding. Potentially Outstanding Dilutive Common Shares FISCAL YEAR END CONCENTRATIONS AND CREDIT RISK {1} CONCENTRATIONS AND CREDIT RISK COMMITMENTS AND CONTINGENCIES DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS Issuance of common stock for conversion of convertible notes Changes in Accounts payable - related parties Common shares and warrants issued for cash to two investors at $0.46875 per unit on August 6, 2012 Common shares and warrants issued for cash to two investors at $0.46875 per unit on August 6, 2012 Preferred Stock, shares authorized Preferred stock at $0.001 par value: 1,000,000 shares authorized; none issued or outstanding Accounts payable - President and CEO Property and equipment, net Net Purchases Growers Synergy Pte. Ltd. - related party Net Purchases Growers Synergy Pte. Ltd. - related party Warrants Exercisable Number Exercisable Balance., Balance., Outstanding warrants balance Shares value Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Convertible note issued on May 30, 2012 Convertible note issued on May 30, 2012 PREPAID EXPENSES Warrants issued to investors in connection with the sale of equity units on August 6, 2012 Warrants issued to investors in connection with the sale of equity units on August 6, 2012 Restriced common shares issued for technology rights valued at $0.79 per share discounted 69% on July 5, 2012 Restriced common shares issued for technology rights valued at $0.79 per share discounted 69% on July 5, 2012 Interest income Financing cost Common Stock, shares issued TOTAL CURRENT LIABILITIES Accumulated amortization NON-CONTROLLING INTEREST {3} NON-CONTROLLING INTEREST Common share for a net proceed Common share for a net proceed Price per unit Price per unit Common stock per share Equity impact of aggregate cash, stock, and paid-in-kind dividends declared for all securities (common shares, preferred shares, etc.) during the period. Financing for private placement Financing for private placement Convertible notes issued On May 30, 2012 Convertible notes issued On May 30, 2012 Less accumulated amortization Accumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations. Property and equipment estimated useful life 5 years Gross amount, at the balance sheet date, of long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. RELATED PARTY TRANSACTIONS (Tables) LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL Disclosure of accounting policy for limitation on utilization of nols due to change in control USE OF ESTIMATES AND ASSUMPTIONS Advances from president and stockholder Changes in operating assets and liabilities: Common shares issued for compensation Common shares issued for compensation Amortization expense Common shares issued for future director services on October 4, 2011 earned during the period Common shares issued for future director services on October 4, 2011 earned during the period Common shares issued for conversion of accrued interest at $0.832143 per share on July 6, 2012 Common shares issued for conversion of accrued interest at $0.832143 per share on July 6, 2012 Balance Balance Balance Net loss per common share- Basic and diluted: NON-CURRENT ASSETS: Cash Exercised Warrants exercised during the period. Common share for a net proceeds Common share for a net proceeds Common shares issued to two new members of BOD Common shares issued to two new members of BOD Interest rate on convertible notes Interest rate on convertible notes Net technology right estimated useful life 15 years Net technology right estimated useful life 15 years PROPERTY AND EQUIPMENT {3} PROPERTY AND EQUIPMENT Total contribution Total contribution Warrant Activities DERIVATIVE INSTRUMENTS OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS Disclosure of accounting policy for other recently issued, but not yet effective accounting pronouncements. INCOME TAX PROVISION DERIVATIVE LIABILITY CONCENTRATIONS AND CREDIT RISK CASH FLOWS FROM INVESTING ACTIVITIES: Changes in Accrued expenses Common shares issued for consulting services at $1.39 per share on March 31, 2012 Number of shares issued in lieu of cash for consulting services contributed to the entity. Number of shares includes, but is not limited to, shares issued for consulting services contributed by vendors and founders. Weighted average common shares outstanding - Basic and diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). Net loss before non-controlling interest Change in fair value of derivative liability TOTAL OPERATING EXPENSES Accumulated deficit LIABILITIES AND EQUITY (DEFICIT) TOTAL ASSETS Property and equipment XML 10 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
ENTITY'S ASSETS (Details) (USD $)
Dec. 31, 2012
Mar. 31, 2012
Property and equipment estimated useful life 5 years $ 7,925 $ 3,036
Less accumulated depreciation (762) 0
Property and equipment net 7,163 3,036
Technology right estimated useful life 15 years 1,635,300 0
Less accumulated amortization (54,510) 0
Net technology right estimated useful life 15 years 1,580,790 0
Website development costs 5,315 5,315
Accumulated amortization. (1,602) (801)
Website development costs Net $ 3,713 $ 4,514
XML 11 R54.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONCENTRATIONS AND CREDIT RISK INSTANT (Details)
Dec. 31, 2012
Mar. 31, 2012
Accounts Payable at Growers Synergy Pte. Ltd. - related party 42.50% 16.40%
Accounts Payable at Stevia Ventures Corporation 3.70% 54.10%
Total Accounts Payable 46.20% 70.50%
XML 12 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details)
Number of Warrant Shares
Exercise Price Range Per Share
Average Exercise Price
Fair Value at Rate of Issuance
Aggregate Intrinsic Value
Balance; at Mar. 31, 2012 0 0 0 0 0
Granted 1,152,000 0.6405 0.6405 411,805 0
Canceled 0 0 0 0 0
Exercised 0 0 0 0 0
Expired 0 0 0 0 0
Unvested at Dec. 31, 2012 0 0 0 0 0
Earned and exercisable at Dec. 31, 2012 1,152,000 0.6405 0.6405 411,805 0
Balance., at Dec. 31, 2012 1,152,000 0.6405 0.6405 411,805 0
XML 13 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
ENTRY INTO SECURITIES PURCHASE AGREEMENT (Details) (USD $)
Aug. 06, 2012
Aug. 01, 2012
Financing for private placement   $ 500,000
Aggregate common shares 1,066,667  
Common stock per share $ 0  
Common shares purchased 1,066,667  
Common stock exercise price $ 1  
Issuance of gross proceeds 500,000  
XML 14 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
NON-CONTROLLING INTEREST (Tables)
9 Months Ended
Dec. 31, 2012
NON-CONTROLLING INTEREST (Tables)  
Non-controlling interest consists
Non-controlling interest consisted of the following:
 
                                      Contributed and
                                        additional                           Other             Total
                                         paid-in        Earnings and     Comprehensive      non-controlling
                                         capital           losses            Income           interest
                                         -------           ------            ------           --------
 
Balance at March 31, 2012                $    --          $     --           $    --          $     --
Current period earnings and losses            --           (97,338)               --           (97,338)
                                         -------          --------           -------          --------
 
Balance at December 31, 2012             $    --          $(97,338)          $    --          $(97,338)
                                         =======          ========           =======          ========
XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 16 0001165527-13-000168-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001165527-13-000168-xbrl.zip M4$L#!!0````(``]T3D*&=<=`+4L!`/8]"P`1`!P`B=C_H'EI MST2,;(+@67U,J'QT>*=*RTX^]^O7^[\1[3PACMWA4'T[[+[@.NZ9]FWVTMWKLSSH5\_>,F[9/)M M(,!_E0SGGK=\NV/F)0_9U9LO2FQ)VM'0@5T'LKYB>T.T6I1?/$WQ6?JZ1&?D M"H0#_^V&..*X)XZ&A?OH1=-"O]B0LL[67YZ0?O1?WU&K?4JRMKE%LT%F\$]4 MZO/&,W(9Z2W#+=]Y/0EF9X,SC(YI+-]NHA]PB)*[\GM`S^. M4O22WM*[+H"N&1KXYZ9K_0"TX4_?G15OV9%S0S2*IY?1],)+ZP521D/R%X*\ MV)R$-_DC\M64?GT5>O-:N3,O3-!:9.ZF-U&741JDK[=H'B0I]J)T["WJF=YE MPVUP3L;;6FZ9A(+X8P]'&KPS=)5$HHJQ(M%'-VEL?_ONTNJ/O:1&_WWZ5>2MQ\'>9O*,GI52JA`/-+ M'*ZBU,-K+O7RQS$KOG!G0>ZO*`S_$<7/T1WRDCA"T^LD61%[\,NOD+`SWM\[ MT17YI%X#,N)A?JP7[JZ0OO8(S?)_*I7.W)W)WTP-G\Z]Y/&]&_]\=Y'OPY=` MW^F_IFL[WYVQ`@0E_@1V9`+30XC&*-UT+D'ZQ%R6 MZ;YCU8E6Q*%$8:T%@1N,EEXPO7Q9HBA![;37+0U8[]BE(F5!R]K7A.2B7(432]_7P5+.CI_ MQ'&2"*IGN[K)FK).M#(6)>I##5JM>)`>OUJL0C+I3"_0$A.I7DI6"N3G$-$? MR-VC!9TP_L@^KY0L:+>A;>FY8:>$Q`$T:_0GZA6KO(KX*M'N"RS(T6V(8$4, MVG?=+0>R]"1F)9]B-+U'_F,4A_'\5=0KD9@/:J2ARJ6U!BKO#8T@FTZ2ZPNB M`\HT3/"&5290"J].L0:PHM[BO128CF:[E8:L[QEMNF0CU+:W7@5$,OH2/)%P ME`2_T3P@(<-ZZF&&ODRS`DMC'*4X7J=T2TPW=#0@S9<:_U?TD)![+]`3"N/, M`YS'29J(]QYHTR"_7J0T:HDER'@TN'"WQB*S0DRN2];V&<>1WS+BTC1F"JJ2 MJ@"Z=/$@#K[^4E1+VW0A<(L!G[#@$AUTS0;Z3BA9NOZX\5[I(J%=:&SI)'HL M6?WDA4KCEFD(;=UQ9)!O439R;SPR<%'+I8%!5B+5ZI@C!H;QP`#,/,\2@7JP*\Q`RFH6FBZ,3#(XR25&I0Z`Y@4QKE,J5A M2SV7J0,AX(L5NH\GLUG@(YQ,<)8Q?(S#*?FMI>Y`AXSNS?*5TBFSB0LD")W' MT1,)Y>F4/XY3).")1')/B+E05$O-,BW`1A$E,F51ZQ?NS9#,Y^U#M8*BI3)E4>L5%8(4 M3N]"6S/*P=I!B/7/8O)TAHAVT\QM_>*%*R2HCL9F*7:$R8'5-U(3'//(JHUB M%C1-BW5H>6D24&61A4/0.,%&TVE`%X5>>.,%9`5Y[BV#U`M%IPZ=A'0.&TR5 MBY6'+IM"#=NP32`&?HM2+XC0]-+#41#-DUP:D4R_@7"Z%5J6I>E,UK\90BFC MLDR!#G72%4!K3FS\0=.$J6@6T`*N!1C7L2M0"J],9]O5M3TJHQD^HHFDH/O)WD39-\A60X$CY";)@4 M)RWI6!'KW<6S]-G#J,T#11,"IBF;A"MD4C95*^%23/RVS>#RB5;&HC*CVX)' M/GZ[\3!=/--I+0MY;H@A::$1PR>9;C_D"$M/-3;ESH?5&;VR>4$QP755UFB5 M/I(YY@\TK2_]*E]W%=;P]0`JN92%B(K99(51+:S2P&`M5A6ZR()'")^[)K"% M"8J5@*IXB!NCB@FSG.K6S7``=4.LV<%(4%/F6O()PDKYRGA4NQ4E3-JZ%)I9 M6-?7-HA6`E^1;3!L6Y:`E%/A,`+'<%;B53C,447E%CVA:%6;H"N4OY94>[K0 M99?[:XFB,+\1U8P=Z0XP='G9%P!H!B`J@'(5(#N MU3YO:&BN(OBZT]T^EH1<%IDY@&'#?-BGK'M`% MMMZ&QIT7>CA`R:_>/'OHMJTRI$^:R,5->Q$:N@S35#Q`*IDU]IU]$VKH2;:9 MG^3W;Z]2MZ.*%;DVNT?&_6BNH^]2V4IN"UO>44P7:*9Z,/X5N#KU&M;>M4`_ MH@AA+Z3;):>+(,I.N:#%F=*3"?G28C=A-P`I(E6Q1'@(DUM'V M;YZRO@(,QW+:49DL$?TRFF^^E!G^FF6;!L-C1W9KY/)>00(NDRU_4(?7&%@: MP&!W::O4M'3-8),ULR&,=QWY\0)]J2]P:4H)`,NQ@5FF[+MX"?B*'(%A:]`J MTU@):&/.(#N`HD.=2Y,(@"S)RINY`O5'+XCHAY/HO2C_.B+#/3M2A=;:W&"4 M>B\2K0\U,T>)%U(USXIN8D-;AX=GQQ\T',Y^#4%&*V+94X%Q',4%?R0QB5B` M/3:D"D"617EWTAW-[AZ[:7)Q8X^L,GRZ MS-AVJ<]H1JZYE_%#`+*AJ`!D!U0KMDQ;VA<96B[( M*\AMB5G1>S0`-=50#3U!-P$[=ZI2KW2!8EK\ZCV1;^B*QPOS@E($*W('9M%41QMW/_Z.C() MH.3R)<5>C*=!Y.'7ZQ0M$N&-1(VKX>SPU]QI")W1[($YJE;GFFNR'>JXC="8 M+8`:U(W_H#Y1D;TPS=SIF?NU`KE_XT4^HPA)5<%H11UV9$OBKS='TYSW;(;\=#([?_2B.>EJFU.+Z(9/'$1^L`QE M`HR:V4`5N\,I+^S[/[[*$I[^XRLO[M<[T7F,TG<$R6WA3>.W<`B`,'1GQ*O& MGI$[U;P_?/FGEOYP;IR.Y*BNRS]E'[Y!@RYB\V5E:ZGB8!6="EJ&I0$U$,(. M5$X?/H=5@;$]2V6[\_&SEP0^K<<*PE7*[JFKW'/9U'K:*5NUT("GF%M%8Q-* MX%"4FCH'X08/9Z[2OB3>@NM3;8/Y(SV]]XFL=.9HO%H\(#R99?ANWQ+&70,[[V=>4;? M-$+BX;5%=CV1Z7;.!6\.&4,;-U=;D]@%@80Y3PAEYPE-UX>;E>W@[YA+E(OP MMELT]FZ2-":]09TMJ('7N_HO5I@NP;(7+FU./*!G^B=9;TPXG:*N00CJ1['M M.L5AS$MB']1K1G_&O)^TN;T&(#JPQYGW20DA=],CWOQ>BNX]U/MJ_A8.KD?L M.?RBI/5I9+0Y`B2[X)R^S#0,Z9%F=/\M:7OF%G7^<@CA-NX18M`UYQI'N:;< M+[Z\'K*'U'G\8I_X\OO#GA'G]X!]8LWA^5HQYO*28_2K3CVVQMOOM5PIP8_S]YI0O?U3V;G M[^\WN4,^N33_F@99SPB$7&,CL8/I6.-*`;\O[:U^W*&FX?`[W]YJJ\Q9]U9# M?N<.BWOO/Z2^BB>#WNK),7D!8D#>EU#EI9;ZXZ7!86DK=HV=\^6)CUO9MS*=\/GU+IA'`<'R MHI1Y'XC*A&AC/K2*Q#ZHU^9%>TN;.V;MK0926=(#\E:3+3V@`@JRI@=D+YD] MK67.Y5-OB;%PX*>;=U:,GCT\+;R#2-9COCE,.4)[UZG&E<(/J`^OC[4-^P-J MIRSV[(U&_)YYY\R]#Z&?XF"V-WIQN/0.&FPT_==JO:D]N8\KWER:R7OPDO5K MX;:G+XZBZ>4+PGZ0H,DL@Y@L"P40U77US:Z2?3F]>H[]L0%W#52Q\8_:*B)N M^:@-(5"E]1_50<1G@:,V!T\=V;[Z1W'5L9Z@KF)\M4I7^.U<^.W[5R;1A/SZ M@+"A:P#0O2G;V>S^$:TG-/7>%#C4&KLK)'FN!S=!FXS"$:@ME)H]UK9OG]0X M`N7YLL9=-CU77)[]^[GH4@^:.ZFA=`"]U.1/>J53)SF47FFH+(_2*ZTZRJ7T M2D?%^91>Z:8ZI]*D')U7Z@4@PG:ZQ^([BWGHJ(+9`=6LW^%Z#"IRKUX,US@. MC7D7*Q];2X&UB7DLPU5L*?*Q=>59>735L*7+&/;VD>_C%=TPLVZ!4:KIYO;D MCTGT/UZT\O`K<,C*1E=8\VT;]/Q[U01[H'5=%;A]C!KS3DH&I*]^/S[]I?)I M'U9K_BG+R-Z)>7P64)!+^["ZWU,YL66U]70:Q-<=^Z%Z7?:N;T3^XWKRSG*D;UA&;0>[ATQ^$`]R&16K?595=CO5=/X%MNX[>E&/IN[)JUEA]UY)G MQVX7;3E&W.=<<]7C,C+;8W#7N^I0AZ8)%,$VN@W%>,+[HZ01.<=2M9XMC_B\ M!/I/#=&#Z4#3L'.[I(L8"AC4=%Y*H%MT_D=WMF&;H%,N`GV]0Q8BE?/4B;YXM.+;3QGT\ND6A1VZZ\7#Z M*G)8>\,89PH-5#`[H)IUCN0X5.3U5KJM:^91:,R[;/C86O+[7-*RYG&TK-@: MXF/KRC&!=-VP%;+ND?\8Q6$\?[VE;V%(?B'SA-B[0#@+FMM2V:,>C07,_=>! M.YRU2"3Y,502G`%ZJH5`*9D%S0_2-*U<>$]UX:D%4]8RI?>,XY0]U4V=#[8T MS3'K,N4%Y`YIUM8"@SY0Y"Z;U?\X*TMQ[ MX\KSZ%.I86LJA12&C^1/RWK4/;&O"QIAGYGSYQ)LK67%V'X4Z:K0]M^Z6' M1.`JJ$C^VOOW*ZXCXK,CY-/A^FN0/MX_HCO":3*[S&C]3-WH)!JMYJLD+10E M-KQ2G:.I\5#5)T0W>A)Z_WF(P)__T*R*1Y'9XG?EC$\W4C",U`J_K/#K%10*5(VY_ M,3=]=.KS./<]-']Y14_I\87*0U1.W&ZYT=DM8X/%"'^W= MV<&HW=+F>8H@:>[-#A"@U$ELA4J@\`YO=8C-R1<`#=VPH3)$@8!"-33O;B'7 MAM!1ALHS=P(#N@X`)9CM]UXTU#5!TS0MV.$&E/J")0)O=8C-_0!)UW7-Z=(* M'.E-R[(TW>B0`_^8LX!KT2.].J,B.`8[X\%UVH&NVRXO!S)JKXEJ"]2X@Y'U M#C6NH%1P2\C-IDE0`0DUJ!M;4(#L"MKV2MJ6_@[$BVV'5:J=Q((T6 M,4Z#/[(O)K/KB+3OG!X].$H2E$HTIFE"MB7K850QJK6&"0TA/EF$]4@^IZFY M*R_`63'N9':!W MO)^@W-Y>]45`[PB*N-1:QS8;ZB)W"&U[WVW^75V7+_0RU-XJVT5!O7Q9"K7& M<*'-R:#27-NU2OEV*6&;,!NCN.$4$^0:7$+V[>Q\-4-#!W3_!Y MZ`4+"2_.M*@08D=<>6<[":Z1CY&7H`NT_O\Z&OE^O")WWB(?$8]'Y@B9"$?7 M+).)JWC@U/+C-J$\LQN,Z`I$VKL!0\_VH?`BJ:-5'SL:K@YJVU*(UM:\-]XK MM>T]]J82-H.N9K%A+1^>:HKU]H-65H[9)47&?P8"B;C=R008%M>P+<7MC'.M M?8$)3*X!W9(S+5#>QGY2QK4T]@`,'BRUY&JM"$&3#<6X;4NZ-T8GR\WVAC,T MZ-8.H%TPM>SJ+0?=>J_=P([\3HLR;W#\%$SI.\Q_3FA%_&2)L$=/QAKY9/4A MV?6&EFD8,+_\YP3M@FN]OS0UU]%-::[$W-N70/J_KP*,B`!R2_IZ$Y((B;[K MD7RZI)=(V-5P',9?\D-VP90WY&G+$L<^0M/D"L>+]1?/TF>R/%)CO2KI"C@T#%\(3%$>='QO.B,9V9F7D]D: M3^!Q0B4>C07.WPX_V`0)U%9KV?-25HTF>) MI4$#[RD7X@]8W\ZS:(';&>?ZB,NQ@2['>=LX$SSWHDT%";DGB<-@FOU"G-<- MN9HTSZ:Z9!-R>.$=^23;"Y!ZO)^/!:'PQF-QHOEM]%#LJRZX.[^\I?KT>!\3VZ^7ME]\& MU^/[R]N;V\G@ZV@\^O'RZ^7X?GW-7]L"949?XOC]PL'[X:6#\Q@OF6_^\LWO MJYBY)_OMKX-G+V$N"H@/PLL8T^49\_$JFB(\2!_1(/2>DT$\HS]7:4];D%XR M1D_>U!O$$2'U.M#!WP8D^+1/!UL&@UGLKTC`2:^8KA,\M#;/B\@GLQFB;X$= M/*.'"I@'^LKQ0;+-.:6/7DIU(9*28!Z1K])X\("(-"(^#/Z?O7=M;AM)UH0_ M[T;L?\!&].S*YY4\NEBV>^:\\DT"L0;?XO&93"K5ZC,LB3`(929YS51 M>@,G`)]#J/E_A?.L^#M=N6@*:8)1.KXG-\N;/*NN;X)Y$J:IGIPX2'&9X?1@ M12=AG-Q[WIY)/[4X.N2A8FE#\N=(>6Q>DWM#\5S(K`E3.IJ).%'B`,5IQ38W M+NG3Q8KOX=J2>WJ5?5MA7%5SL94PIQ"<206FV,)P!V5T&X?!5['FXCC3MR$M MI*',Q0W.RLEKH(;_K,1^'1[M>MYWN']P\'K5,W,!Y)B/;X(W0(\'![OV:(`R M0T$>PB""I0DZPAH?0ZUK-F5?U0=%#)T^`W9XC,E@$\\(X*&I>`-0J%H9.*JO MFV=5?BJO!?GATLJ_].:J0PPO%00HR+N"DQN$P=&Q.%YY<.`9P\[!WXZ.7\%7 MQ+Z*8X1&>C%/XA+)*TG@/S#0&--MY*$D";0%YN+`EV0:M^;FS2>[#*6W2JGE`+5>8-(%SW9GG<1+`F?,?;(^L(;PMRG/@ MG_><)<(//D`C\.*&?/`USJ_CE$ZJ$*QX4C3'_^%K;P%%ZAD&V5U:!&.A9X:" MQ'($H17;GV!`$3:]D,>V?H5@*9-J;',*L3I)!:>)W%-/]8P@+$"V02"8"I[O MXC&%(#OZPDIP.,'$Z9,AK5[09V'Q*B'8G(\MJOD\H6L]00^(F[S_XB/Y0YX'NM'J9-"MIF>$TB^J$%&+8!%`>V`C*],,!4S:#;?(#I M]BBGZEDW*2IP:/5/VYZF%H-J1?>2NH5LNK88B%HBNG(.[B=^3?[Z%`GMSS?> M#X*E?(O24?@MRG=Q%TA%#?`FLTI$$II[@_J[ZXK$WFP636)!'.S@"J8+ND-F M+<,2ZSNLMYLR6Z*@U7=M7# M>%8EXJ\HJXKD'HG0\QIKT^4ATI+B(<2UR^?N?*YU..E/OF3BR:%/&1S<5'D> MCI@&:9]/11R,-MD/M)1<8C3.H]"T9H1B.!.O=(]9%\[N!F#$QQ-KC8;@U!:D MG>/N#<#)#5R'?D5\G(.&G8LM/CJ"[4<2,%JE?TNM(1NJ01U+*5R:P$`!'H/U MEB2HQ:PND(2**20\M!MS^#XN9DJ,\&RP`[V]_^B MAUX?+4K8]2&SR:_P&:_HD+;!X9W$""&NI MXNT-V?W%?.Z0UU1FPJB$NCTS1_F+D";!IRSS,8ZNG+R3R$91>0=&"IDJ_?B3 M^$DZBO)K8/"54&!W@[.SRUW@(VI)PVN_G@>'&AYK)4B$&; ML/2`.F5L."VET<(U[J*:S4)]!@W;:%>,_(*3:!7,]FE79,3LYDEDC;?,,CJI M[%9R:]M>R)*$,2,^P5$&O@,OMYXH,2'M<^)VT\)*'4+T&A%^M4$V3>>#*QZP MDZ[FR-9%GL2;*&U?54+D]&@)]NL97*N_@=P3I`QEEXP-"T8ASEA4V,J^$-'7 MC!;4P7?;!+C![:8M^:$P'P/T=)1"G..YDJL+CG_.9\W&42\BZ&6M"S@!*SV( M*&LW4?NF"J:IES3T:2`2/8%9AWI_TJ@$_P)4)3<,(;)L>E]?!7Y[=!SF>2R& MH9V6EK:'CTP`*;!)):Y#)882E_?BA3Y!)WX8@P(I8^K!+0;N1Y%X?=2@+L*\ M^-JZ26<.64S@,"_C)/Z75\2A^U(N+N,:>36&9;09J9ZM6F_X,R'U'63]/>^[ MNXG'-ZA^"U]$7E4B:$OK*P@K"@##]> M?%3NK*`S$/\ZZWWI#;NG:\I[ZZZ)H?)#72S_^@ MS^OT]7!;6>EEE,W!Y2D-R7XTKT9)/(;?G-P(8:V??=D_T;J[$(!W0N8G]WO9 M'808BVHDS-]8&+<;)8-A]^3S>?<7ZK)4-$$FKL/*Y-[G;O\B&'9.ALU?OOKK MR84*<7_U.C0_];L8E5Z#]*2'__"]Y1DZW&7BR7*/(X%9O@=*CI\C%N(>BI-' M9RC)U^=!H1OF._)F&^E#FG&(S_\`VMIE#Q<,D_DU1H"@([@4XT4J'AB0R%][ M-`9[W$5W>F[6@52?.@PHZ^>`GY-."F"!TW`,<@`F'X9JG*8_7S`/\S+E"O(G8?!>_TN8>)YA?(["1+Q!GL"ZU1_U M:,E4`97B(+F:@P8R7>)%-K*$ZEC/BW%?X(5[YV)IZ^=\B+,]YS@L![&95V-! MPNE4++U8>7I3[Z%U1[[$/4(U2;K?E]JU^Y^5L'6/*<.?J"P,L4PY"*Z2'J&3 M3"W/K<=AM11URA"?BGF"M@$>W30S^EY.U8\U`O9DB#!/\N?Q.GPFPI0EE@F1 M0O1B^76B_'A1.(,\JN$#D:=*+VM-"/;YYP>?<3PT\^$\>IPE"_)Z+']!F,:, M6H4NB.8K_1XP1`BN@#17D40ZH*+(`$LI\FM:YL@$ZQUZ?/G_!18;_&<<[GK- M%'A\5`B-6M#COX1ANU-FU\*$$PM`EW^79%E<2OYE8MK482=U945C/G^$."PP M./TY7LF?C=#5-3YC+DBHAUL`P_&<<[F"M37?F[& MXU-!A9W9'&1`AB.=I`%XM7-8WE$>A8+_*/LTPY_.$6RIC4,(VSO-RF!<0>`- MN)Z8R=&^T!7N4<$5G\5(`X)"X.'X#K9Y=>+UIG-[.6)C?)VBNRHM:P_7I7C% M6%#3AM.!#X.]8'#UY4NG_RO:8+U/Y[V/O9/.^3#HG)Q<7)T/>^>?@LN+L]Y) MK[N![.`/PLH?P)LN^]V!L+:D];<77)UWKD[!5I.)*[TOP>>?\I-, MG;C.40*'&\I.SL*J-*PFJ&<@X&8\6Y08!%QX=&Z!H`PEW9A$XDK3N=/5Z M0(7`IT[G4HMUB)FVS3Q.D3TZ,CU]?C1M).55(M,3F3EU726NI%[X@9P%]^5R MPV$0B=.+7)4/I0XJ>;0?TU'%X>CI:A<'L+N/8K+!P?[>/_&Q*OTU>`]#[)NQ MTQ'M_1==V0YNK]C-Y-YG1XB9W@>3#'F1S(*+=,XI"O%ZO:TY3K.L1()CZRF+ MVH$7PB;+K?4$82`C0,7#%A"YK3$\])#X1E#E:5S<1)PBI'M2+`&=+V:8RF>1 M'8.H8HR%Y9)CBX5*V+,$>>1VG&.<5V%2^.H,C-MW5SLX(1-?1BUIO,-$\.@I M2"/P9(?"QD0U9!HR7[%9CW97G`S:U=D+>HGG6"])YS_7<5ZZ/SWU=?T8\&`# M;>FQ^1/LXW2"09%;XTRWAS*M!&%.A;P20O<^"G.++HI%=.1U,V=5,I&:9XBL M36SL;U5JAX4,*UG`DBTGNU^%50J?6%;JZ*,#Z9#`HRN/K7=,><0<%"#9$1=;4Z25]M-)4T'1X+3-\A*RLC33 M^@?$*:=QHO2;MCJ5[DF=RJ9\Y2LKJI?]GI#4EV==E.PG%^<#H2^/M;M**!*8 MQB22ZC$+DMY(RQR]2MF=LIAT'K_/A9FB'LQ=/'%YSSQFRH2GRY8%G<$)_4Z8 M"T,MG%.*%BL&X=D#"-+236`L>Q;^E@G9O*2W66S>WAY_`(Z7;RH+*-O^9I9D M+K@>FQ<:G-:94L#J].@;ON+CD+*P;V\/32YFTOMJ*Z+OP"6"G8-7L)&I?K,0 M^9$T0+!"<<'YE/-II#RH)>8^A"BGM+IS^"J();W*AT#,D95,Y=FW*-^;1&'" MR$591"T9.&-AB];'Z.1\U/O":)OT':D;0:!7,&GUM^ST9W](IO2FTZ M"17&2]J"$`!0!F6ITN+)>(/&R-[:=6)IEN[5S]A;Y"^$+T;19H_.>VLS*_$\ M'D1.)W:H'.2P-_&@IFCB>=`4"]N!M(&!"U@-0SW!;::R->17+;6^16_-,?YO M9=^&VEI!A=\F37R]4$ZSE$=5?"D)].$RAPK<=CYY#AJ,_([E*9S)/`5!.LY`4F6`QL68AX.PL"G:0U73#:R[]7#MC96^)!X=@'[!TRGM3/>.CC`1P M/!A5.&($.%I;1-'F&Y;S"-];Y?01$\BFCJS%VUVK!8W9TF@3)T_3)^#I-*-`"Y'Z% MD;.#C#-@N!(;WA%A!Z&C8`SEO:\V_OA.*:.8V%-!:].>]=MS_+/"*UV/6>-Y M#WK;(S]>OV5%'<1;RO]L_``T,U.OWZC)>$E7M??3\GF^I*L`RO@\F]]$4GG$ M<2B@!06O8$`5UJ-;=S+R$Z]PG=($:<3/ON-KS87G@3__@!Y*TLL2CI4MNZ6. M!S"\P_X[LJ-JA M[7@(W@'="%O+ M6$(%WFSH7R"OJE@YN.U5DHU^@*J)S>T$(4,\(^,E>>8:'?Z?Y?LW4=3ZEAQR*]NGYJDF6GE+[4,P`UL(@0PK5X91@ M%"80=)4Y4J1.3.7^8C)4E,0J&W#E%_>[)V>=P0`3U=8),I\H%"L+,TU"QNBM M6(R4)N>51^,$L*2FL?=02J_D-AL6:HB,()LDZPHUDA2O1IT(>C?'0Q[7SK#[@#Q1,7F7'VYK`%%5Q1; M<\R;,Q`"'G&EUQ0",_Z4.L]K3*(=64$KY2[P)M>IY"NZ^@Q?$U/;V]@+4)_T2;BC[O!EG8T)?$3NY`R+1%,WZ0CQU+0L?,.)JRFQ6 MY=B"A>>A'T])KJRNU;4Z_JBC2V-QGD9K9,LN!8P;JL#3JC&Y2'9F]%'/I#)` MIB:BJ<[R!N,Y=*YU:C"Y:VA)5J(XZ4:K=9A-%<:YJNCVKKL[%53C2C/($UFH M+0O%R6U\P2[G6@"UH9I!6RL=BQG'N4J6\Q&AL#WVDO@VFC2(RPDMB"/#813\ M!P8C5Q>-ZQ5DY4%%-*U\B2$P"DN%N8M&0JFD)#>IZW;(72@69^MG/(=DJ<18 M_LZ6#LG36DQ!"_]B0_;&R?6WP5-)GUN$D**;1T*93>U4W1!B@BC.Z2\@`4`L M'YT/RC"&_*O!\]0\?+%[0'RG=!1^QQ]8>YE!R6CXG2K!T+*CL!*2)]$TRGE% M&_^5)!0ONP4Z:7/=F^4`=N%^F7K%W]E*S*,QIRO(]\(J`PM$*Y-G%FFR$#I2 M$OJS'LPYW&U_UVT&":=X!.8D MYLK&^KT*!;/-DWLA'Z"]2CHI9*E:'A??A'X;2=K8*5[YR*/)P6O&9LE#9IM" M31,[;1+S666J9!;B:"8V-+=TK:SP9D`YV:\37J7FR9#"4[-DH2R&4M?'E0"1 M*8_*I&JIC+:D8&B)_-#2`!A=,2JC_"U5Z%](+YGO<;2@TD*3,Y,JDM(5QQ8%WZ)[Y&$:'8VR1R5[M.[D MWR["$R20$(+927N:FW.WH9"E-I$ZBYHD*T:C$L;79A!Y*<\-XN,YN>XC1-:# MU18AS!X4)_HDL]%AA+"-IP:Y"C`!A24,JI7DV=1B@`PP#><>UM5+JWN%`(8_ M,8=OC)4>P)C%V)'TK!&L#A[3Z?6#KYVS*W1`T'+!P;!_!5`N:SD?ZF(2S(VC MZJ.WG'3VA0.D(UL+Q;P.*M(X0#YV8XIUF\?4P,CFDER)2N] M?@2KL`FY%I]F["_Z:K?@WP2?`[N]>L,K'VJ/ M2$,@/'A)EQ>=9$E9WKI>11^)`E+8*(&J/!"UTSR<17=9_@U=TI(L,,$<1MNB M1C6A_QH$3GQQ]DI%_;X#4Q!KJB1?[6H7#X3OZ:XIX5V[29HG MI5DEZ5/=8]7OD%L=4,4(1G,#=W0&9"\])%(,+1@#+4?V>:GJF>VZ*&,Q&[-H MQ#6FFUCL8SZ^:2_!1]Y_KY]1R%_8_U>=Z2%?>QDT8* MP`S'(_BUT'#N5DZZ/H,A!@N2=8)_"KX?`0!M_BTJX0QB>$:K1+(B'2M`Y3=D MZ2>BFH,*HS70A4-\M"L+2(G`O=<>5_`@KZQ&R&5-5W$9(8RZY]P'82'DV4BU-1K= M:\XB-F7UGCBE:@2B/F/`Z+FV`J.#>3R.`X!=RN6/JHE`.7"*X6-Z>PUJ&$"N*R M$0WQR'$044$=4(%6I34=K1-M6EXG-?+/21C0",Q?D'T37]^P&`?7#.VR M5F:=2!;+?S#V`V55J39H7[%3I3@SW;9:YM%O:NG7I$;V/7],U,\J!=GP2(]S M[J1>B>YR@T9.-A(@7+<&45]?)0EVZ[*8X$P@>52UZ MU+1^Y#LQH^PVVE51QS*Z%LLGRP?@4,C&F*H1HUQL^0)U;M`U)KY'/?D>C3&S M8Z5$[:[!6K31M5:\U\!LDXBT`_>A3H!P1]0YRAE(>=\9`1[&O.XJT8_)VW$4 M(]FQKAV0DG'OBK;;I9W*%=>@(.=K/=9">&^_/Y0-=TU@7MIP^JZSHKGNB-$4 M#IX7CZ)Q*,Y-C1](*NOMKE6^2P7H#_V/9VSGF7$#"3ZEE5'T"3F=!KQ(&S1-0= M3M;'I!02I9!MG>I:B#R940BK9HJ2<\"%!&!:G6NF%#:5[2F=]*^3["[=RP6[I$#/]&%V4QWF"E7%YG]G M>S8-JX0Q:";;I>-[S]I/V9K:Z]Y1B1G@ID%Y%B1AB;"*J,KNUHA.D(4CHR<2 MG$*H"/E$@3@N2L4H)&9^S!E]3?4S5U@*PX>(^U!8Q,N4]R;"E30&_-X]#2W, M.H"(`R%86J'%L&%HLE4;ZJ^[]O:$,G*"C;!\!*&%$,NK8BD57,`6P5T$B?Q6 M`I0K?F[[IRL+"=V`J7H'5V>;V!']1M^F4703WL9,G:X].SI1'[A;V(R9`2XG M?91,.O;1RDTDK=/5;:1>*3DHH[8;H5O>R@93'D%H.* M=.G]-0YSW830>X[=C+5PMW""BEG>+TWFI33ZH&B7,YD^G%W/*%,@V]5WP!?J MZPP&W:%,.3[K=3[TSGK#7G<0?.EV!E?][FEP<8Z-;$^N^GV`,47PT94=1]VO MW3,AWNNWTU?N!:?=?N\K=I@(?NGT^X"@2KZP$3V#VG2UOJ$.S0*O//&86]]V MO[A-)V'^6`P_*%<+M'AHTV+,+^_]C8?@5/%6-HZ68#:$GPTRJG(C6:0I%!HM M>I,QX9U[!JP\#5HNY6$K#'Q0831GC1Q*B.?DT8TP5?AZJ+3&'1C+JSI?(R0% MY>UFJ6GHYF`@?-^::[_R,3P1=/TK'"0\BKO8//IKMR^)_%<\AKTOE^*L0O`= M3NK9Q?FGO3-Q)$[54=W`,9#(;I,,,_1=H?BCMSK@IP%QM2-N(0"%"J2LIU%4IYNOYQXE18\%(&W9VJ,WJUU&\(.6I'6)<041 M7[]*+0N2LM]DEJU08FM'-'27,\[HHFXZ48-_&IQJ,@B/:8RK)_;I6I@8B!?7 MH%[9)U.Z4/)H)MBI.^-UHC+G`\R1][T/V7%I'@-6QG2\^CY4^:C8;);'UV+6@*-N'FYGB<(I&F79-QTN4I31 M6"$?(>.ZB3_4T3,4A,M`E]1,V7-2-L*D=(!,)EI*$[YNY%"`TJ$P_G"F,4!T MEMPR4`PWR_V`Q:%DM$)9N;Y&G%JW0)`BXV_DSDY,0S)NRP0-]3W2EF,9WX]4 MZD@IF\Q!OD7;Q5$846=I`M,S#+9A_]:=M+R'`?,<_\XFN<0LE3QL4T/%Y%/> M[#@/E%>Z;C+5BMCJ54WP_+(@#?8;C%C;(:N-K6+2VD4K1T?&5.J&GWF[E+'4 M`5>@0PTO,)W&]>BL98Y?+1'(2:-K20F"L*NB5`!6XJ!DLW@,#7[320%/NWT5 MZ%RM"8KE"$`2;[$,M<#L*?;V6Q^@?+AP[R?1.!'SMM&ELT@BP0:%F$!H ML5)5.^ROH(QGD50`=V[%@JD.#!DSLM1VV/E03`M&P=42C.$[^71JFL[5.);+!F0K43 M1TDH"4(F-OV-AVJERYGY+L^7C(I#PR_994Y:8AACM$Z&,4C\ M92O:I>D(1LV34%708??'1@K]!68\J=H#1[BTY@!>>TCQ!>X6A[.)Z+0\T;/! MTB=1$;M-A7*Y.*"@DTDU+EN40$@6B*V:!)F$GT"O!;'Z$!;/^3,;TH\23\-L ME>$\R@$FV$/;WVA"S&9,C97708&%,1R#E+<>DU%KHIH,R9@ M1OL:)WX1VQ+3$.>R:'>HQESHR^Q`=HM2AE$_".-0L>]VV4_;'5F(P![?U>KN MV=[@I',6_-KM](/N^&R62&^IP+9Y-D"UU+Q+`OUD['?"D,_@<=/]Y MU?O:.=M0Q8CE2)3:.&@SD`(E^&42"W')-USCTE/*L%B["OS$VD+)(]_&8Y,\ MZ>D$U4DY34`+0$%3B0457$I9!'CA_IZ M*C^^A"A7,&PI/=_`!:3U+`\_<4EP(BEI/F;0@C-7-!UN9?PN)8,JE*%.83R-?I,+*-D M"@%_HQ5OTBXBI\?`:YS%$XBI2MO^56V=-RHK'3;Y-)*H,\($V#E^A3R'*1-7 M=\T^]#V=='>&[&'[N]H/AY\YY M\.GBXO27WMG9DX02CO?WCO;W#H_WCCR1!/+EA\<44O&+ZUAFV$O#N"XKN,ZR M"4`9,((SO;Q5_HR"@/!OC:-QT@RB:?]JN+$)*![C"]*88-Q*C[KISZ['[W.+ MJEG9&E"A>I"UQC.6"&(T1IYZVZ?X&!?6?G-?MU"#W8`[W($GN87@^>#8 MZQ\`O#?&5':=?"ZYMYF-$-B"46,Y7F65S*E=;7@WVRO#-(NAC$4_2])I*^-8 M`\#MK`.]/B\[_36#XRZ;B=BQ5NDN,_A&)30+: MS9/L/H)L;>UG`0NV!6N)%X+GF7@0=&"S6GO*-[*3V0`OD3XBKMBBT]J!)H+/ M$\.\B>?\['L,+>-^$D+HM:YOAH@"ME>RDO@%.;RF\(#VIU/?";03Z]61L4S% M.N&WE25"V`;\BN"7@.(+F;3%+%;($^4(/L(:\BJZM1.'":0XG0IB!3-)Q0K, MM//:IQ',55-KTYE+Z@^`R^9Y7_2]C%(;_`AGTO"A&>[&4X<:JS<#+8#21\1H M#_W$/#($V7C4^$J\CJ\Y,$>TQK`%? M89_CBZQV@_@;ZT[GQW=@V>7SNQ^MLDC$1PT9!]2]Q[A.:2/@Q>EZNXHX4JN3 MK5?*99+R\$"-L+A<9W4%VJ3J8805-#-.8\T#-/QF-U\)1:$9^;643-%D.,6/B.#4:L%& M+@\KS*IL7GL?,A'69L@*&AQ(RP\[8,MNFW/8?`-;G!%\B=$3R-.+%2PH:/(: M",92Q"'``&4KVD?@S>[6@7'%(\;1Q)79_7?.#D&[UN0.Y0@2P0X5Q88A[#.L MK=(27%55.1+(&A&S5-@$%Q1D8#=(UW%\L) M82,A/08/J'5H^KW/H+[9/!UGU_RMEP!-!3M*N^_SS`+#&$6<%\&C95,73?:> M"BOX'LNU,?`P_C7'V*"Z@(V$'&32X1[R6#30>AU/6ST]`V4RQ/\A=5/\=Y?5 MV(-+2'KHS#LUI#O<:/8QQTK5P@]6K;`*F",3GEQ$$=;X-]["X.)1\9W&WZ5S MDGW1ZQ.B/_?D,`KU+)(&1,7(62I3$'.I$M.45,QPTE+E7.6"?/B;3MJX$WD; MLQ.C.IL!]1&5R>F5>+J"/PISR"-''JR[5DG;L+W>;+?![U#)3C4S6X*-@A56 MGW`Z&YLQ>31R2PD@/$K]:J&"[)<8PJ)$-9;/'VERBRVP>)%2R^KX2_`9Z4>K9,NP@%:+9'D=##?*55>43:<%"A`5 MF_%9A'ZTRE;="A\JGB!%I!*,F\:[(>ZH"2+<$;\9RB9.S&M1/",+C:SCLU7E%7+!3;OQ1TL$J#]^3;ZLHP-6WZH3=OA'NN;AWX="04' MXON0DO4`B]T][@5)7)2::SO=UBYE/KIDDT(U(C9KF4>A4N=;"^G<#%<34_1\Z"V9$1^;%Q-;VMQR)(5O22X'(2#W^_8\(M; MXIEQ*!4C:F29VFP2,:.(HA1]C_)Q7'B?.P:J2!('/->*GA/;";K`NV)(%T5D MO:U+M0"D,%ETJ>24EYJH,C72&D2@F8HT7:*LFS;YQ,I2S)E9/='5#X;@E&]6 M9R=V2$PE&EGH>NAU7*.L]R]P9SXI&XIO8O8*201@1\2&^]51[M*1R/B68^4=I2/&MAC?G!B"C+[N(8W+3FHIPXC:$HEJEA MA,]X98O*V,/G8&IP!&FMOZDB;;M),#U M6L8JR[OJOT_KP_P`GN0F&4A%Y[R(]'"FW6!I&^NFOTJC<`]\RT]]U/+%M!R;++QC(:8-!(F&;`V%HZHJRJ6,9UJJ^ M6V0UJMJ,90R"@X<8!/6?&PSAD9\IKU';8!W]F)SX@,8UFU)7T`XP.V^.9%,1 MF$:8T<)R5T#L3:+O\O1[\D8;N!&0!0:H!*^7W!./!QUP0B=1DQFF*J$X4"(` M?/5A4-YE>T49T8Q!1#@&BP>4,.5;<*Y:*^N$VH]O?*%:FU7ANAO33"^JM90J M6\XGVV#UJ&S43=L4'A#E7@X0:-5UA! M@+#A/=P(,A#87X5L2H\H4>U^![?\<&R,QR=4^E!:B?0"^6$)>@>0(_?%6&IZ M.PKB\ORQ?8Z$<`I'HALJ7L`8I/&^<3Q)[H+@CH='$[VRIV9+0X\S">Q,[B!0 MLO^D*GPM_A2C=38UF`?88<"?*;VS*BFA,=_R%K7ACRIB4?\]M0V!G"2=5A-8 M_3DL"HJ((H99*BQQ<*>VN0N#.^!Z#)Z&_MP44;%5\8Q#TX*/[\0F^`G]>U*S M'4P"FE6K'4K*C13L1*^O7^\N2NAN9;G%*ULK.:.@\0S848'!*,@:''&I#.S*+()M8H#\[B9*)@JE+\Z=019.#F8'_._#+/+$ M:K6M(=_H`JHFU(IIJMJ?BU"+(LE!<`9_?3;<@NY?$D@C5+\'4=O6K MAG\3,X_`A*0[@:>-]4W!S`14O_T*5ZE17G;BU]%KUFF@-A<:G0?!\4X\DM#BPFTG4=/$X]T1M`+/<>,EN@D;5@O-;C*,4#KJW\NC2*`.6 M`PAIOH!\)N70!YM2/\[ALW'WEB#LR"\_XD)-!G(:'3WDZH?(DGR/!M.$^0TE MLI;OK(NW`-Q6K?`XU"'Z?,!>O(Z(5F1`4YK,U"P\4\:\7:=0MI2ZP;L.J,M' MMX*7KUY2=G+QY4MOB(#DD"1_',,I?(OR)&% M;F1P>?OM?8=[PDY1.VF8^Z8S#JHM/J7A.S1'LMJ"8(285I,Y:\70JX[V^:[I M">-[C0KAH^6-R#=6#RK`-5:P=^`NSM+D7H8F"JS]DFTGL58UER6(I0+A,C-!9CE2DBHF/%BE)(-Z@%"; MJNBM0&^="<).3:NF%NU6/I"+`%AR'Q$Q5X`L](%(173-N+_@D^,("XD68`&H MC%??X.JL1[/WC+ZK%,:?/5->]=`D=(_IS#5-WFMD6FT3Q!@SD9(Z43T* MPKKFV'/:@,N`1Q4J0`S\FU$)Z\58["L!G5S,WX=NW@;;58,8U:$_HV_6'169 M8T+!K+H9\$+7EAO@KN>75?B] M1I[RV7)BR=F0&@"SRHCG:Z-KQ@R+216$Z02CT>LX0($;7%H7?JDM&,_B:0?:"'CQ+6_R8`JIV(ETU7J;II[T7BGS)+$* MR1;6;1X+\72Q]7;LGOPI@4;:S[B"*:;G`VWJIK':UH=UD2N_5DC%CU')M?#= MH%^`Y>5'C!T#CDR^[@!L*.N>GGXUJ\I#&\5$K+"EDK@7U6)K>AUYDC"'I33P MS^2>]%9PSNZS/9APT;@5NX%C)57BZA)KN.*Y/[\XWP,CL7]Q=@;5U+WS8;?? M':R,9.M6V1L68EN&]-OCO8,&:U[&_GM8!;*Q]6S9`$DL$A8JX8\WG7X%-QJ4 MT6TK\@@$:L'!8T8WDI7B^5 M3&HI:[PSA9?&O.TF+[[&/&QOTB`;*1;RTP59H>>^]72L+&,<J>HZG5P`46QTRENOH;%G.^(C<[CW<;NX141OOHQ9)6\Z% M4O3F_$S1H%OK7'$7F#8GTPCL2HFE>-X2AXIM4,"VPMH`4@ZJFAMZY()NT]X6 M439FB#7$>F!2%_)W3[?S>W5)'L^I*XMZ%HV6C.`;D84V7*]73^**AA(';`U; M\MH%PQ-6FW=VBHVL@6WZM7M^U<7FB)_.>\/>Q?D&9,>2$N/M/B(]#G[^^4E$ MQA0AKL5>59&NH77%;_0, M(#5.]\7V`(O1HP)>4A;)T^`/W#:%MB'&Z3R?R_7ULRO=5$2JV=83H,-+ ME)L\PF`LF*+@)[DU)H5((6NC9>937*AZ2>^:4Q-00UO<0C96`MBJVFV!U4': MLL:6//D:II]0][J=_LEG#!B<0MO?B[6:&:RC`KX[DOBY3Z("TOT"BP[B=?Q1 M93/;F/SQT>CK]K\]/.A[,N/6FG7SOG)_3.9>=7>>X()[[HD[^@9<8@ M8+<&W?[7WDF7_F9X$7SH!E>#[FG0.P\^7@VO^MT'2L@-8<\]$\C-R%_B*SS$)4+S%$"Q$TC$^^L/_-TW!IPE[6&`0VMX3KPFZ!B MQ0\CW\!B;O9UMPO$<3?X9-B*0!,8OK8-9U#;XQV[Z6^_J=HC-\U?9WZ:\=C0 M=`Y;!Z):-E&.-7CP MJ!QGP@]I0$C31^S\]-K]X`RLPXI"<3"\./G'WH<.\*N3BR^7W?-!!QQ+R"`O M/@P[O7-@E]TOEV<7OW:[M71?70@SHV4Y*%CITP-W.+F/`4-&BD[0=!//7%P& MD8T@F8QY"U5_D?;#%'.OA]BB/7MP:OO(^A"2<$,T8UJK13D^]=4XR*2F'87@ MIVAH'MA%)*EK*4BI`7U$7=/G6Z>ICFT$[P[>@Q?A:/]AHITE`-=M?GPLR:5\ MZ!?OO?4Y#1Z\S!AQJC&-JRKJ_U^G>::KC9+68G%?AWF22QA MP$TNJ[?_D:N7CY+X5EB_T<43\JN;.ZI>IT'CK:PD1^92"X2[>R`R-]9.6!5R M'CFMW0Q)G:HX9=L+L*NJ#*8J6@"!\)&<9W)6;V#J_8V5E\SWF&56$';<8->W M/#8Z3\)Q6W;-+!+4+1A817L(:?3ORR_*PK!RP>ZBZ%MR+S.,TQ*Z"$L'>C8" M/J42(&3:3YUQY,V.PN-%:L3XOJ=D`P3AQ/IE=$3TM:$J2%,;C7VZ/2^&Q,(< M.]G%RF"?2K\*H/IC800VM@<\WAR:E8^B\BZ*%/I&+"T&83U&@(B=E:UQ3BB- MTYU'XJ)$V#*)ZFNZ&F`=]'J]:AB[`*//69ZJ2N5"`*1$B`V3>:E8N>Y*<`T9 M7#[O`.1-BQ7RE4+*E^S!5L$7366DK)I2I:82YA,"2X)-S>9M]3P2\V]>:4%4 MZ(C%WU9=,9=:Y52U_FW!YUV3_"L8.C96D('D>5TRK9KDN"4K174?2CAP?-Z: MXW[XE6DR[!BZ!S2H3@/1"=6Q;,T!CJFGGP",09-W.ODKL"I9L2/[`O$L[4P0 MD\)X>)AJ^8@3N&SM$*'T5RC+V9F^VCE\Q7$L-J;(/OFTW8$H[VS,"7%^59Q" MWZ)8HKK!K_RXB_H$/_G2+#IW%O7S$VBMVX\PR04GE4Z7=&RO;W/[XLEGHA1+ M#9);L8Q?+2#XKOA[TIA.I5(3=)V`)Y\@A?JA>J;03/=4&U;Z;9R!C5$HQU3Y]^2E^ZP\\7IW3@O=?=U_3O[G]= M=D^@V?>PV_\2_$>PL_.U.\#H#M[X_X*+?N]3[[QS1J43)&!W3H97XNZ33PF& M]2KX:W#(C+!XBME;'4J93?#ZS`H$EI@P11E^-07KAQ_/&V&@9$)O]Z9W/`%W MH;,(RQ#H2Z&TL:H*DV;%RIQ"86+)[CK*"_UEGATIC%W7OR<6-9X+P:)?$XN5=>$976UW%0G:^9K>[J4&KDE4U2B=!SG^B\^E1/EY M!DLU$[3$VI!OF#LTC^TS6+/BE*"_3::KFL.&>;.FZAA#B)@(2TX>`/U!)YG\ M.9@XZ=\"QTU74'&*:Z>S+74]"77Y,G@J#:!$V;K@>1*>N;ZK6K%"WQJM%[^8 MN:W@B=.X`/J<+8CX/^($Y'DVVADY+-81H8H1(4E)B$\_;D;YAMZYZK.RCWOI M42SKL26W:N`IKB]8CB>$`W94W4G]3-6K MV+'L+5_?UG7W$N(`>40A#NF]@@NQ<2,@"V%LR;7V'()'G)*62)2;E#1(LO@( MU[5]#;BY9YF2.]09IY-*"")F244`1R?!O`V^"S9TC!*H#^+3BVN7+NND1QDW50B/ M8KJOG7J7AKU[<3-Q(;',P)'(V85I_5VC]3V?,NCVQ>M8)Q8!,C41TJW:M$1* MH`4:S\_G2JIWQIOG4K>LKK-@]Y*[(NRVVBD2%S-ML"N1`:<2]C`@8X"$4D[54!L[AZ/6`,*,)?$806F8 M8]<4J3+UP5D-!T@(LM7K'19E(=`_`(][!J:*E;A>H@'693.!:VE_JH2QH!C? M1),JB62O)+$T(0A7Z(?7#*Z!1\'S8ND#^[V*BQA0R>0P=%J%=5;_AKT#L?#/M76/`=]`:#*\@KN@@N.WVHS@XNAI^[_6#XN7-N:B$' M6"/9.1$_[T/2D<%"<+_F>2HGZ8E:KG>L*C/BG3'`5N(U`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`/F*9%;I2'IGP#W=@8_E0' MU[B>;V]I#B3YO,.FN,EZ`+ZPMCQZ\H5H*46H_VX(8\#U.H M8&)[BZH%K$SF9\G==<+%^=%>'U@MP+\3??=3K*PE>(;YMQIJ M`54CH$Q;K`=X>I--J,S.H[9&%0#YC-0#//W<&@4(2\_NH94!3S\W78K0*DR7 MK1:@SVW6#;P8$\FJ[6^MFEJN@N!%F>0Z,N0+6)%-:@M2/?F4&K&PE2H#GG[< MC5($6AF@N)H<+:M@0)9>@W(^@V9D&HFWQ_26S.1_AH5O"0V^A$S^!9]O,_FW MF?SV5G*M8YO)O\DI_?$S^9?+WW\I!XJJCS4^[3:=?Y-K_#3I_`M*UM:Y^M.E M\],32P/HZK0\3]#RD8XGS9NI7V@26BA;5IF^A\=[[RW(QVD%)@,DS7/W"21? MB76=1G%IF=LJ_].3ZNG-PB5OQ710^G%9YW]RE07WEWF@N'L9/X^LH$G$/5:@ M>_L(5JQ49*02.@ M0'9<:^0,%Z^P2U^Z*^3J.%2&'8HJ0'],52C<1_-@>V>C)+Y6WY-G!MQB=0(* MY$?GLA[7BVY)>&88VTT6BZ'4,#!E/-6PK`U2E3@A M8RML\129K*ORFG?B%+MH",-52+%=Q]<#0V?8'`$9L,_B`X(5\O$7TKILG`FE MJIAGF%8D2V<@_R$-XMDLFL0:#0MZO$*-@U!RHGD(R9]%$?FD)D^&48W2O$LU MB48,)J6X:>:V0CP>OV'SFEKV0V85?CH,]%=.SD<[=PQW'^;B:02:8U1/1*LI8?O2L1$.3/Z(9 MBB4=)]7$W_1'L%=!*T@,P4Y=,`,)-)E,G.>A?BAI`)Y/%\S15MW4/@CR%XRJ MRGU,5O9?)&+&%BX.AB)50'+(B(SP3C0RZP*BUB,;M$0(5N+]\&`O?&2[+'!( M`#U&6,(LQQ/@9/J+>=0KNZ.DV7*;12)F,V\B&!?S)+Q_^*%=+,8R4]S1W&+; MV,6B(Z'IZY;W@D-)=Q10;)1-35J>^WT.&JKG&TKM$6W0,,'=*&ZBJ-1SUZ/$ M%0-=W6MAFZHPL9L:9!ER&YT54PN;G^DY^\6!>#:I<2.T;.K:Q-NB[Q(?E;=4 M)1NO*)D1B;\]`WVI)>1.I,S6BB80&&UQR%-4:Y$3[OHMPIC/3 M=PI?CV00$>3[Y,EBZ"FL\C7*>;!1/L;:;-V1MH)/CV;!]X;5M8ZDYZ,L!]ZV5 MSZ@S)CV+\7T>YU@[K+^X>B6X7;G;HAH>N1IKL)SGIL8&I&$FZ%MJB33O\FC8 MK;0=XQL7,@`8;Y-]M,L,5##I.WD3-<@IJ[L<03"/"L%X(>ZV4 M4SZ)L"X3\@C2*I]G!1)+&2>R+L+N3\ZZLQI5>T?F=Q2[_OH$R^WB'@%/5M:% M*/QHR:G5=W"PG#'0%8.-8UKHB7BJ6-<(>C98#(7-U"[J'$5^#9MU&"[=VH54 MT8&WYO>UH8K<2*C8JY_*WOG)Q9=N,.S\5W#9O_C:&_0NSE=]UM!Y/GU-I]-Q MQN1(&7YG9\SNT-Q4[=Z]V9==BIGM;"K;?")TW=[$4@M61D_!FCM##D(D-5^8 MCT^6@MQ0D>E8:@H\V]8@<.A(F3Q(^$A.X$B*8YE](@2)UID\+T:P=,O@C:6= MW2RTIN,1NF\*N0#T*)>"+!N>B]P:HS2AF8I^I9PB7F-$ADMVV4H&[C5#/L(\ M_3JN`FNBDA%:+.O6B*$?'0>!^MR!DI4Y?E@E?)0SX2S^%H(2EF:/7+'6O*?.8 M4K]?0S/CS:2;!Y#I"ES+5&J_]V&MG=RS))Y86;`U!\44:[EIP',@B3"/;H11 M$=^:W=Q)LJ)XI3=5FFMM+@;%UU71&I"5428V#:15K_Q$6"E\CCZA?7CLVS[. MS9;HQ^H4X^X)+&R?JD&+[&$[)Z"AC!S?:M-;VA>#+>=$*!B%IT*E!?/!]E?= MZ;`+"+,HC::`]#].PG@FSZUUILTGX$UOX40HVQW*J"92(UT)J3`;BGTA1!M'9QD! M0_[D1HA52J`&2N[H05GBB%L.]5]%5$F.%R7L>^AJ'WJOA\%5X+`2HB%' MSDJU7:I=,;$QODFM'/>98$KE`E@@/=^&GYR0II/M-HC*S4EQZS&%UA>[-610 M$Z[QJ#%5$C-;B])0%;+5&_1!7:.YW`K1-HVGX.X_WJHXKQYS`I3`6MQU%.%=!HC]A$ ME)8$8RD*8E-Y8\68RN/5`>9"G"6V!I!Z+$H68G29?M!\#=X8S_A&8>*-/QAJ M[#_Q6D@GPGQ&3)P2E+065B6!]JGM/J5$R=-E5#:GUL^2L)7]XC6VF%73,*WR M2+RHK`\?+"`R8+Z$5,'1H2A?-!$"5'Q3BN`N$@HX."FY?2M.)(O/C\,\O]\; MA>-O?OU0?D=83(C`N1C6PL,C%(+J52?N+ M>9%XYS=!8;]5D^NZG5S6\/Z!*QOBQFXD&5C;)+Q30:(9N'X]+[83.I(D$D:! MS4HQMEP)BI,Z.*0>-0P)"QIV#@2152Y8KL(:L%>+TD?.4Y/;8ULXF=@\U:LX M-[1S.J!Y9!D[3/V`N*3SHQG(F'EB\5B_2_BW*H\+<8P:,',IXB86U>@W#&!G M:N$EEV'KSA[!"J]22KFM8(#9/$XM211.!/NV0`'A&!4$K`S-+I0A@7&I@OH$C?W5^TNT/.[USZ6"^&/2&O8OS=5!ZC04PB2?2K2-8 M28`MH9S*O@)W"C'!A2[3;T*3MMV77A\8J+4U02QV1^0N779.`F#\K!+2`UA> MI9.YAV+T,^,6]&DOPNH'>7,J=G$V$LKJT<%N<+A_<`C#T[_5D,]`61YW^3R/ MD^!`_O8@V.F)9<90Y"OQ@#RKKF\:;SA8F5[.>E]ZPP[02"#^=S7LG?7^K_KS M8W!^<38(3J^Z@!Q]\KES_JD;",+"GO,72_2;7QR5Y)O2@V5-V?'M@XN]XEQ6 ML`-MP1Z]/US"E8!?:Z*)*N+UL;"[5)S3FWAN!!&<4<-`Q4Z*U=$`6)@)ELH$ M\5EM[5RX5&/W8UW2"03R343[Z:'04$*BJ9@6-5HZ\)ZR" M,LE_X?LPD8`I?N"?$!S0UEWHHLH5-G'^]J.]3?>FV>Q%1FZ9<&\D$TTCZ(]D*4-%L8%OG=Q,/+% M%\9#)O[]\UFCDC!9ZA?2Z)UV'E`M)E4'CTD(?4ZHODD]7YX7'IM5:8<3A"D:[5*A@?@>8@<)N;H7 M?1>6K2SA@5HJD.FJXC'U5Z/5"ZSU%K`!(;5*XAAD08*^&J6L@0Z!/"RNMS2F M[,PW+=FCO69D6'1NR`$R&J=32$9N)#THI8^?=U`E)"^610[^]210+7,Q/ZN4 M:1H!UF;"U56=C(;'53!3"]/929)WD+_@'@&H63SCQ8Y06C:XE?M@VU+6<&#] MN!+&.'_,%E-2!.75*,LXT?NS]'0-B<*RTJZ]3*X1#F5EY>6\.PQ4.L7.V<5@ M\"JX[/:%?O+EB]!?!I\[_>[*3XY**PPDV".$B6;HQI0)Y1@VJKC?@*J<*A03 M'+Y%!?+-\8I='KCV8[QYE"@_"%DV%N:#?]1>[Y`U%V`>6,D*0V@^4+$679A, M*;)1HIQ6H*/ZW6`UC(<:HI\KNO%PG>7I33EV&BC_(Y6Q)"7WI%=K>#5^#L*8GX]/[5$<+=!H<&_4=QD#3?IXEVU5_\V M8CS.Y]Z)OLL,)KD',@G(/F)>ODEA662:K,\G#`)2$&H9[^G1/3IT_?9J>^6[ M"B[)>=J2V?:J02"NFQ[51RCN1$G;P/"!FVZN7>A7L^?_9 MDLGVZH>["CZV-NA;X8'//Z?MU1_QZG)AH/?YQ[B]>@E7AJ(;"EKC_E ME4R7B&>!9#0+OKP3FRR2+;W()7G^(;S,JV[*BE,?<0>T(WY+D-LK11(TL^TA M7]V2T/9J*0*#?,RG?^562?MS7CF5#.*"6^?1BQQY7SK_Z`:?+BY.@^[@I'_Q MB\R(63D5_`ND?7_*A$G;+<9Y=D=&TC&PI"HA0(,M>FNY;@`%&NH>9+$T/C`( MKQ'9-(5P?*IR9^`[+3DSZ/`.NDT\H(X#4PQ*?:J9;N'N>>I_5FD4'!ZIY&N` M]VRFF"A0,9QQ:X9&LV";)4HVLT;G65'NG219X:NW'@%J051XD3SB)"K*3'P# M,'XBE:3[Q=Q=KH+Z1[P*CG;W]_?A_QMZWEOSO!4/S,G%^==N?]C[<-8-SB^& MW37/WP6EDR]ASC+ZWM'\/!!Q_JYM39IL`FE[TV_26T&R,4^G0?37!H)-.$,\ M-D;O/QVVKBB>=3(L1U5J&1SL_P5R2NC--*UFV!Y'4'BP<^`S<*U\9SM1G$.Z M-'J_F.2?^I8UWE8X"BCZ`7XF6R7)JG\QFY_V7[]Y^_[=,:;)(//TJ;+BR^TH M-,U]A:RT)+(2Q"BSR>-;/P[N/`G'-@>U9GR=9P6KM\FS<11-K$H\,?(D"@M? M3M=/!_:QA>J&3G5=%:4XA"YJE@"*,GG(ET$;?2_-!,D('9-2W:N@HL+L@N>I MLE6Q*O^<4'@\L]B(F_V2UO4/R.O_'%?!F\.WNV_?OGL!(UDF6+R4U*+LZ6B_ M16AMQ==6?&W%UU9\;<77([/VQWOT'T%\_=+I]SOGP[5-MYHA^$7>DH(NV(E] M(D+7&&#E6B4LQ+"(@H/=_;>X$`'ZSG/DGS$W*4]1BQ9>T$\>O'#^DBT`^?G^\>W1T1&Z8&A;_ MJ%V[LF`)9)F+X96^M08/$ED(><.>.OK)PG01=+@2!%.0RF_?[!.A3"MFVZO> MG2@-SC.E"]W<*EOFO-T&S'>T,_*1]:`:*01H\OVN#;4]0"!X1:F#RXZL9/37 M+DVAVF7G^)6"ZZQ+6:3N9#2F)Q%`XI0>'!]NSGOUZ.QR>_4GN0K6B58$"[.- MAQ?#SEEP>3'LG@][G;.S7X.+J^%@V#D_[9U_"DY[9U?#WE=?&2^M]!T\_U+] M>:^"8\&Z0+"^6>LI#W"Y;Z_^)%?!?YA_UOOQBKK[PB^<=`:?@X]G%[\,@G[W M\J(_%(QKU6=1N*TFM+.K?\OAD<(6V#LD9X\U9:CO+FC$X(MANA"<$<]*]AE* MLCL.(`L(EE;W'XU#RNJI5:>A<13/-;!B>"]U3X]V.@9$1ZO\F8)7./M/4B6Q M*"/J-;.<:!*ECP^=?"S-%&MFK&6+@LKUZIP`1'2KP#[=.)*32#Q#X:A!AXD0 M$*2$1GJ=Y?<<+VDBFUU+HVH2YPCX[D-;`"Q,,;`DMK=1= MA1R71(=80(;'GB&L1)+U/0\9LNV7I$=N0#FZ(=*V5'RS\W2)S6:1F]!H`6VD M!IJ#`83)`KW:$71,$'^S8?C,$0\I.@<$P\BCF:`>!;-`L&IWPE<(E2@A4170 MX-SO:'.]"0;+UE6>44Y_C#/=-YH&"0+EG73%ZX(JOJP@#\D]3:XU;L*OYIDI`OD@LWR+*%GX6QP[G:P7$GG MJL689K?05!W@B"F[`\3D6V$78R0#6'847Z?FBX1_[\IN&$NY0.3/.5I<(_\& MF\);7=;AVEH66WA@`QB.--98;)^CQC,*.G*)Y$F*8P#(M/)K^+)\7RR'_R*?OA20$:0C-EIW.]:5;;RR0DBNJ<"OC MSPRN/@RZ_[P2=GK0_2K^O0E,6:9/`K2-Y&EU<]S4T83L_?$QZ!K'OB9DSF7S MS$DO'%,O#%9K#2\O\"L$"R7V"! M.'\+YJ:"'WHI?*)1]OF=""8&NU?F\:A2;5:$MIP+.2<[5=2++(:BE*@92(/N MZ:=.?^4STN^>B)-Q]FO0&PRNNJ=!Y^3DXNH<+$+H]7=^`>C,7]8Y.W);ZJ>B MIZS3/QT$5Y>GG2$D&K[&S-6]_?>KOJ,'ATZ8G@C>1E1\\50[D(W#43NSCG)_ M-4!6(G@8OBYV_];,.P.<'G, M9Q\O^D'ORV6GUX?E5\BTRN@1U-_^UF;2+';VUJ..,=14Q+-Y$D_O@QMA:M7PEJ%B#&&]N:P":H#BW(;C7,6V2QC*5WHDK51NC^ MU@M6F!\B;,AF",=-+BAUZN'86^_5K"5!*#)8"\^O5G0*9>A`4%(V0Y#%O6A& MVPC'JE<.=4L8\V-3-'1PK\/B@&^:)\CB"_@-)0L@0RC7ZW"XO MJI:ICO***CV;)205,^">2&8='"B9]:%SUA'2/QA\[G:'?R//.>T-3LXN!EYT/OK#?LB:?@^SR#JF6>6?MV MZ6:Z+M4\0)QNI1ESB&6_6>CS"`)\/AOV:H5$[=)0/=W5?#/&-`PXXQH%FY@84H\0XC%& MJ%&$C=:@H;CFO]P:=]AY!&"(:]Q8=CA]MZB6[#T@R10D],P8+& M_M3I7"H73N;O<*^&'-#!R2$Y-[/QTM['_F`MKHLB3YQ^/_=5S1Q[LC&/XO6Z!9KL!Z1V6`U%??;HW/AP;_]P#6[\GY60 M(YC7YK4/5N&PBT:VC%40[`PO+GLGH`F],@9"[_RT^[%WWAMV]\YZ7X7%5C_$ M\R[%)S_LTSOP=`"U>E$3?N6G` MG5K*\>=SJ*L85[27B//&N_L**KBV\O-5-[<,%6:K]:?1BY'P(KH*]3LV&)$V,]^CY'F=7@BXS:4)PWV_PXK-BES!K.,/3. M4*LJ+&H[L/6;V%Y3]Q,A]V^B9#ZM$MY[8=G!:;U=D7"3<,W,UY)>T`&OL-M: M(^^4#0>9IB:^KW1Z;;QKD[W^.3'3O<#&S<#ZPWK!DUL[5H?>N-AE91V^_JRT M'8[/AR^;Y+SB`^!,SR^927-2,-L38:;)"5UZQ&WP!N#YY":=92 M)\'OX,55^T=H%;DP]'2I+7?<"/=KG):[RUY/&VO5(/F6,,^RXVX:_[6'J"#& MO>E/6DL[$"^C4(8F"Y^8I7&Y:3CE8+5QBGU]+F`^A:HOH M4DDI?:)+P"%)M/PXI+*H*QO:\"'+SL:VB>?=AO5]"%)QL[SJN\&'JR%4U`>_ M=H=!]^/'[@GDB&[>V?Z%=+NLY6'6$H\<"!E6B;-F@_6 M'KPJD9[OO2D+-1W6[9C)D_[]KU6Q=QV&\[\-XNL4`TEI6=L&E^))$'4?1M_+#TDV M_O9__L=__V__KG]R%@M^-1%\X=38S^:+V,U#_-&/IO_QOT\/#O??[!_\OX/# M@\.C@__]?V`$_W-O+[K^OK=GTX.X',$%@C4V*9$:!R8L2\>.NH4/=VX])=*DN6!LNT`MAPDQY!VV:WEC.E MX)."N59Y@1),`ZBLS),ZA6YEX^[2O?@8V+[)]F0?Z*0*;>[&XVI6294:!/`8 MPC5EL]>H4*8PWPRZKZ#P,WA8B.7C4R]>]_:3ME*YM$^1W(+^O"!4!CQ'`/'0*)4YA9DXN.YE2ZY M9*G;)(R]AD)][.GF.R6I=%>@TQ.)@'12#J85?#(2G"J\EW$B%5+U^M=4U3+T M!(S`8G6_7DOH@JB#LCDH,-,"I:_X#FZI,(=3?S'CM,IE"$^K1>@BUMP%2O]2 M/'X.LC#$H+.K6OA7AGL$`;%[QQDDG0H=5,_EBZ3_^E:#I#TC,"NF>-VM;I^N M/?!%"?.[OO<<@GJV4A7VN85X9II\!?-D*59!OE1WWB9+`Y1CG3+L.I5B@VW6 MDEI(S3RT>MRBN\+;@$SJ1':V)EF0578%>,DD`J@QOX_!>*2\IY)P0$V;]:?+ M4JF7$3=V3748Y$8S:.?'VL!#6S=0S2E5C7R; M5,GHV`,D8*V"M^G3J'A/X^1OE_WN9:=WVOVOR^[YH#O8C)[]1NC9ZL&!?O+Z MJO8E:,;Q!+/+TT(JKT5<(/*?/*2FE=ZVI]SV:E$9V?*HQ"L\'+'\GAG$>`N& M_D-=/3V(\0+RP0%MV>3VJD$9FX`Z?OC+VK4"L/20Z8+2-Q$*;9+-N7'Z(UX% M/P%N\='1VZ=YV<'A^]TW;WS5GO52O_QEW0J_A5=//?S5O?^0UUM M2"-Y2;HW^WK[???_NS984MU=-ZE@=;VR=E[&X MC"/[%70 M++MU\FOQZ\U&Q%Q$+^_->!3N_0B+YJR=YUS:& MM;U2*_](9NH+BSVY=)SG7_P%LSI^XO?]1*[?[?Y\^"3O9V\]VMT_>NO9Q+,V MM?/Y=^OYKX*==V\/GT1^.-_>_O&VK\'VRD4U+TE,D-]L:75[U2`?+A\/WAX] M^5O;Y./S+]#VZAF)\]D=IP]AI*?=RW[WI-<9]B[.=>;Y.C4-34C;<"R+ZLFM M:96G<(7"D[I MV-U$="EZ0W!Q*"LI:.\W\GDTODFS)+MFU65^D)@A?#^Z(U\>NIYP%L]B51ZK M4=F1G(Y,@Y_ZN]`C-X^QFM:TXFLIB+/J/FG;O4:Y*7DV^4B]Y0[*PA#88J): MV;[[>6$'58!K@YH?^9NW/_\%R@0E_CB#6M+0Q@VL!*Q8<@PJ#?'\`R](0D&: M7I3[1%?JR(HE%>G@.!)Y.%&8Z+#_LS#_%I42DT)001DF-9['3P>[;X^.=X_$ MKGC>)PO!X1B36BA#:H2`)%3E#`#3_H6H1>)M4!H(U+>7Q*E",\+Q7\^>(X#XW>;'/^-W:U4>_96NU&%SVP1:>5*@RJRL^_HAL_'`=/%$8Q MVN2F'KCFSB\;QE%JZY\RC!/L'+_9/3[8?[:HS("0E@@;&#RD7Z)1$9?1:0T@<)(59;'A^,*[8"_X MI?MAT!/7I]VOW;,+S+H/3BX&PPT@):E)D&UW`B)@WGW13,DG-T+[Z_3;"<<< M)\HWO4O5'*_^@N7Z7T4%5'*C@O M8&V?/./=/8K=HTTYC9=\ET?KWWIIU]^`G8/=M_O/F):_\W[_X-664V^OF@QZ M+9:_=>.V+\_S#^%E7BT22$>[[PXVE%B_4/B!,VJ+0[*],@3Q9W3CHE]6*`F8 M0_K3\=&;Y1V[GM?H+'GS(/4`R&W6>?#2*WQ`EFHG3L<1]DOD/01SZ)E"[CB: MCK<.1;PICXJY[,J5W%N^YV5\R2RWO2]['ER&>7D_S,.T4#U,'BW'_7VP%_2[ M9YUA]S2X[``"S+#?.1]T3H`B-N"$IL_N=5=NV*;6)9B+A8&N"M!(.;B[R6:L M@0(T5"K)J@5A'JWL/-:OO)2O?'[^\>-@+*X0W8F;J\->?Y% M_Q&O%O1_6L@"SR)HJ"/(J)?>1KHMS]G9R89&5W>PS>Y2\`+)LIE'E511NK(=/78"L,]S](]31NJ*BN"G4VW'R+LNQ]',^=?N M8(@]M'=1HJ_*X\EZ)E&(_=AD*3*TZXS'45#,0_%OM-=*'*MZ9H-@;K$(E*XXW]\IL#R_(!UB:*OB`V#!9=*U\`Z^#CTY'A.?%Z)X@ MC_7X">J_EBOLUI6WY-9/;W;%_*'$-[?ZN^J.=X)?^A>_=/N#8/#K>;?_Z=?@_0#70X;R[&94:R`L6_W:L>I==BD7Q;[=,)@'_HMJ[3,)\% ML[KY;!'EMS&P!"R.MHC1_1HDS%TL4#_$ROG`$/?*:W:1,NY^:Y.H7A=.EPZ# M@:X5L#%*H%`0S\Z>LP0GWHW:D5_[-+@\4S\0Z^QY]4"PYG">Y>W:_W)YRBSO;.N MY3AE2/?>U:\50=\39^%O7JE%!"$=(1.)%$CA*IVHRGRQPS,-SN#>3;,!-NFX MA\*ZT.EL!O`JOU@%&Q=E>]_YFSCGO7ZS*3TNLWF2W4>L M\3#?0L5"Z#KF0E[R9S+(B9LHF3_@Q,ZBB#7C]K:QQ>7*H2MO2^I%4(;Y=<03 MA%5R#57"JC$TMIU6M&'S+)M$2>&;E5B'>7@=L@3E:84(.N[AAM=YK/L;TUQAOG%I)Y,I(]Z$!O?[5E>>Z@T3F3&[CA M]1N$@3*^"7D+=4$,RJ7*[1))JG1Q!!T7_&!.JK'$P5D:K0<'9%C[!$_"ZE@M M'WWJE2)O=)UXQ;_0]\-"E0\4V^*![=4?^DK;L5LRWE[](%?4IM^2[?;*YF2; M>9J5"_3'H;-M]N?"JY[RZ4I&L\(2TWRQ/P[E;*\V=@:[/"#P)._4'N\M0?X9 MK]8LZ%TFM_;Y)_EGNWJALOSEU`'_D12W[=6:]/#XV<*+NKAX/9.YX*[QK4S@ M\?S6'S4>9=FWI]8F-K1>/QV\MW#?-_^*!VS>GYI;O%!A\EQ7S\\MR&_^S'2Y MO=JRS.W5#W#U!'V>UN[NM/`+'S&)))C%:3RK9L$\O,=,4S*$/%*=2"J5`@41 M8Y."%I8N?,'(GY>R?JSY8UQ`&@H`/8%C";*%->C6XF?"`(^"G3R:A7%*LJ"G M\J&0U/&B$*!_G*O@I^"MY-3+[,&;YQ_P]NK/=Q4YVII2 MVZL_PQ4DSOYQ&?;VZL]RM;8A=](9?`Y.+KY\Z6$A8M`[%W^=GW<1>D;6E`T_ M=X.+RVX?\8D&4-LX&':_]CJR&VOWEXW42:E6K.2.7;LWL%.F.T4?V2R3%;\GPZH*#+9Z]C;.K51 MB'UR(U[B[F#;4CB]BR__O]#5-OA/LHC%X/'2A'[7%0"S\%ND M'E&_/@Q^RP0A!K=BKE7.JJ;%DN-K?55Q\DGXVB2ZAIH4?/TH2J-I/&X4J=RE M1?!N_R^J`R\EYAP:4!=0V,(*G.#+K8@O<5%4[I"8>@G%\>(55HU6QN0S-1G? M;\E]]U2M29,_C_;_TABC9VYL4>"'VF6C_B/GKNINI>F4'*/J=G-^Z?#(UQOQNIE MC9#D/[#O(^BU/`]CW'K#5,DO%'N%A<5R](FWBEJ6VM5]I;VQ[SWQM1K:S;)OYC M-,HK*#`\>.,LW7:4?RKFP2J\LO0VRDMD%?7=-"LCW4D\G$%9H?]@_71X;'=W M!TG'%1Z$NZ#D508'@K?-6?UBF*85/2,2^R(*=@XH0P>G-?G3+DELD1G`(&@= MH%A$#0OPAJ("X.P5;(A:'^!XXA-@RSF@\@A-)YXCOUJP*E)G&8_SRM8![251 M&9QL+O8^%8"?B1WW1[O';@X84:M8!\N(] MKK$)YBTQ5;#(<__UX3&6>.*C_*77'@C,!Y+[?U:"$@Z/+%W\07@%JY`_)4\\ M"$Q1\FW^P?[V2'A79?-'@BNO0H%X?WCP^N=#_]EX0T8BIGCX_CT_#S;VP`+: M7X>NZ^5^8LI>S-@/?BC&#K3[GV$J1>)[I3UMD'@;B\$MBX<0M"6H'T#:;W:/ MCM_ZZ?KMP;O=-X(RGX683VJ*PR4O(+X>PE_;_FU_\JL58G6;:E&V8&#;!F;; MJQ;R>!G%#LL,F.U5-H1"SIS%T+H[&Q(96A#.VSL52 M0Q!ON^5@7_,D'&M<-@#G0NA$HZ%*X$[OPQKNT`76$_D,HE))Q(;"7:URH)XW MZT'[M^$ZSPH+3VD<11,6!)L")0%@J@_R2=O1EMV.L?MLKVX_XN0G?G>N]M2\ M78",W,:YMSK!5B?8Z@1KZ`3$+[/5"5`G.-A]]_Z`4;G0"=[L'K]_N]4)MEH!.L'&RR?6U@G(V-`K2_Y^M[Z2P-CW8ZD+K=G;?P)U08EFP31'D0HMO7G[ M_MT2:0+BRS+7J'[CHGW5@IEO[4N5S/1':="IKJNB](EF4)D@,*;W;T8X42YTM-\B MF[92ZH\II1ZPKULIM9526RGU0UP]MY1:8<1;B)[M%:6&YT@!>'%(9UMDB!_@ MZJ;2OLMU><)AX?V:S]M804ZZHV3W6:5<&&2FY\&Q6==/(QC/.O M85)MNI3M8#_8"TZ[_=[7SK#W%1H$#X;]*VP0C%U?H1+_8Z?7#[YVSJZPR_#' MWGGG_*37.:/?Q6FN5?2VTZ/E`K]T^OT.C*$W&%QU3X.+\Z!S]>EJ,-3VRJJO M.>T.3OJ]2X0:$),Q[X&YTGF>!Z>=(<[W$WQAC6"X96[": MFSY'@AJM+FN'6IN=V#,-LJ_OCW>/CHY:2QC(MU4,S1,(HY-PF7SAM=58%F^0 M+UB3H)_$6.P:1-^A3V81:0O66T"R__KMF_UC\H3:SJWOJ,7K7-IN.> M_%:I+MGT@0HX@/]ZT.AN>+0S\KEG!M6HB'ZO^")T?Z_BDOHT!F%2;\W@LD,^ MBK[/[2:H4P"CV#E^A04^=+P/KE-;^4`;WM4Y[YS].N@-5GT4E-LW=MPZOS6! M`\ECJ+W"2@;HEVF#(.#D_'7ZV,C2O!"ZE=>E[P`34!)2T'5=T:WJ0BK)OY@G M,313E\%E]VLF,?A2T@GKE)I'JLF]:@%+/YME8K[3\#8#J,P4/P[&25@5LI%J M$<_B).2]214PB&<$.&C6N/22P&`@G4DZ1NH-:CI5U-F@R=T@;L.08.P5=NJ> M#O?5'M/CC.159[B(^15F#&VA__K!AD)AU!:57J5Q"YU_^>5*W$3)1#74]5%9O4X[XKCC44LCZ/(< MYO>>3'X)3H+'3?"L25QBI^7&$%[9D7WW"&S>)TZPH/LP*8`MBM7,)40)@$M4 MXK6-KZ\L2SX(IEC)!N7BWX9&D5#J5RT4U6*_<("RJW7-1_PG+;*%<+WQY*;: MMOJ&6GUK5>]QN6I90CZ=&)N"W$QBB87BI?P\"J4,DEA/FE>_/SC>>[._=W"L M:>]C9_`AZ(RQ4[4-/2,H*!J/9?]QCTD@%;.FCF/>W-3<=CY>]+]T M^V>_RM%TQ?6GWODG:4<,@F%G\(]`?.6DJP&QNKWA1ZW%XI<\@SF_>!WLO]L[ M_AMYV6EWV.U_Z9W#"W[YW!6V4E\H(<0N"G8N^F(,'[JGI\*(^=CM#*_Z77B/ M^,YI][_$O>&%C[^=!^(!O>&O4BT>!!>_G`>#X<7)/]C(Z\'`X-1$7KVBLK9M M_0AQ"=J?">DGV!4".@3>;3'9OF=`NZLZ`SJO@OKA7\3)NCB].+OXM/(#A\LE;1I:)?=XE6AM-)(= MS"!"'Y1Y.,$PO5#BPK&UH82ANTZ\\6AU7IBN M+TX.>P/+2T5Z72ZINUVV:!EAA.H(E!05$\ZSD?[:703*F/AD$AH0:=?\OV5TJ\"`P(N2D?U_4G--Q M4NF(NM%4U1L-"Y=*3EB.;X1&AI8WYN2U[74[%IE+@2FP?6;C?L^@X,$)5EID"A!P1U%FOS M&D?*/5RSGS`Q5*>2>RZH!%M/LUD\II0IN`GXYW!QXG0JCJ10)R"J,CM,64?WDMR2^%N4W(/NVOBF)A$`?`+%+2BC?*9)%1[N%>/` M$J5:`1(:GE'&0AKMQ*^CU\H@1Q-FU[*@Z-MOLT2L.G`(!K]:CE^_\E'H97U\ MZ81AFF@)S8!;:_HDWW#NBMH"MG*P^(DR10(P0;SJO8L)%.,H!<[!N$"GD`9I M5%1)J5EF$N;71KNB5'P;Y0A9>A=!644KLYPJK,))G%2HO(>X(>(XUBN+6RS% M$``DXKS0OI&&9;V<*_.$2\/HN6#:HX"OBZY37HV12M=/$[EI(JLPVV7L- M0>C;)#I!+D'J;78)G?J'UG%ADHW/3P+;^G8+W<^*%:KW,2JAPI&NHA2=]$V" M1,2LZ\<@T>!^MHLMUZ+>A99OOI'Z9MF:P"'BU%\\II5A.S/0I4AH)Y%[N$;- M6)DT=SY0C;,C#,$O&"1:RYGLU3,MG;)MQH5D6;A6$V/BU`BC8`A-_*Y714H$ ME0G(KYIAB_/5&Q>1+[1>!?^VX'-8)B(#I"@1I%J-RPH"!V;\VM.D3IM8BYIS MK;SKFYP&94E6J9==72GE)9$N>KKT.S($Q5B*L+NI"*$+P(>RWFP??N7@\1-E7S!3(4=CZ$]EOA@O/4C'#,9\)`G;'59M]$3HE1@ M/P4Y(@R^\$&2ZZT-E` M:_3)RT?E!+%T=0>'J.<7%B'>""7%]*I;,&7;W6Y"+6WASL>>VP_&$:C7!>AB M!G8X<&<90:7"]^D7%&1#.,I4'$Z1@`KH2$)Z_M7N!`?[^W]A5.!2ZJ%<0(U< MQNB-!=`@:P-[SYB$-R3XB.O_>Q7F0DM'\7&LW2TJ8>K2X&-TKOTF["..V^$A:R8]>?,9 M%7;&*)A>UXE,,YA##]OG9XS#FF6[]/ZF2@UF:@$\?PL,W+ZR!]@1>(4?'J[Z MPZ-5?_AFU1\>RQ_^J?=YU8*>'_"'[GWFN0%/<[8.?_[+IA[U[OVF'G5XL-ZC MB!/D\/AP8Z-Z?_"755GU`)(H)<;W_OK;*[;MW>:V[6ASVW:PL4>]>;.Q1[T[ M7'G;&CVJ-G;LWFYL_]YNC!0.]S>WZ$?'&WO4VZ.5]V_GY)55KT/RDG#B=5\*XV3F# M5*7@R!N^7TB,3Z$M;*]>ZE4`!9$!5D0&7R3-ML3VGW^\VZN7&$ULKY[H[-5%]UL*^,-?U:[V3E%$+TX0;*^>B`QV MSK1Y^6I#3USVBT/HB[XENS_E54#5C6=XLX?L/H0)9!/M!D_OFW_I5\%/.V\. M#G;?[Q]OB$\L>HG'"P=,(\!R18@'J\I$]W>#G3P"C(=H\MOZFJ@.%TB M%EN/[3PJ=3'A#KQWX^OP)S%^#H\.=H\/#Y[K]8%^_P.V_@)1,ESEHX]$"L_( MEY]_$`\9[`,V\5)YJ(M=@DJ`F"Y162:1!63PTJ_^R#LUU/[_P'CZP;\/D03E MO?K!&>X?=^^V5W^CFRI,?+=#U'RDE]Z5?!3_M'.R_W3U^>_"XWG;SDBV#>)05?OXA+'OU'T_9 M*R+X#U>+")K)??JJ;D]P<34<##OGI[WS3ZORDPZF(3>829`N*#D$[=*)ZN]^ MC2OWF71PJT&X\V@F;&+0C@I`AXW3ZY53@>V\=)F,+FSGPI5V7:="UW7Q@#CA M1\!=.(#GI]WMU1.Q,SPSJAHZZ$BZ86AFVRO/RG7F%-5PXX_?^238R:O@#!H[ M;D_I(^]E6^YL^S]+OV+9+VY8K2=3VY+1]FI[]0>^"OK1.`&TT06-")Y_I-NK M[152K,P8WO1323$=K1I=^O<-QMQW3C`PC.FL@,&WK>]B@] M,DT\>3#L!3YLY==O?@";CD\^)`*YO=I>;:_^\%>!%_2K&1'S0:G\L*G'-2K3 MD[SM$03$TT[@"6H=GWP)'V.([F/R)/7SC+10F/_)DA/=Z)B4\ MZ)P,>U][PUYW8VC>[5G35JITC-_*L^KZAIU4S[O@_*[<]65P]>5+I_\K@)D/ M/W>#DXLOEYWS7^7`!B]H0;9M;9[K:)U72'^K))\L>'*WT=)JZ9_^HOHQ!QW9 MA=GY)9+Z$BZM&@>=Z^L\NO9W_7W^+?FC7#U6@DMPB8W1^I`W]4P$NL++^M"2 M>5.G+.BE91ZG13S>4O%C;]P3ILU<"D:,KWO,=_"&VH_XIIY"67C$5R#WW]@1 M^('J+9_VZEEJOQ_Y'4\ZFT>?S((Z^"]A/KYYD=X`SYP>\>$_;5_^8K;"'P3^ M!)HC;?W\9[MZ8B^3W9#X#_$J\E*5D?'TC,Q-WB?`EY,_,WVONZ[//HCM<'Z@ M(?I/HG8";(_B2]Z_'W47 M0,K/?O5"S:3VJZV8?]`;GDO,+V395^EM5)31Y`4!1O]YPU#;&-A+Y,\_XM7& M82%<-[?\^?'Y\_"&)!$%TRQ)LKLXO2;W,/?8^=XZ$]GY<9Q.LWPF$0Q=GX\S M82#F*7L;^9A`<).[XH9G)L0BJ)'!0S>\^#8G>EG:TA!-P85K.W[LJWIRW9IV M?OB-7P(%^9$?OQ6ZC[2S+2G[VZNU5G1+L!MQZA(FW!H&0EW,8?>Q9/G[], M::.36WM*KLFU9V?)LA6W";=`Z0]VXC2XC\)\^3:MZQ?),&5]HX-RK],2NG.P M_.=+#VFCBOIF![656MNK'_?*!S?YT[/$+3<2!0[>O'Z[W@-^6CEJN\X,UAXW MG8&:0"L3?^+-W9S#92/#>-H9K#WNYC!6]=INC_8?^&@_87=4,J:-=&4--O*` MU1ZRS@S6'G=S&'1S__VO5;%W'8;SO]707$4GG0`J"9:E#Z/OY8_@LA3*?[H1]/_^-^G M!X?[;_8/_M_!X<'AT<'__C\PD/^YMQ==?Q?\QN(SXG($%^<7PVYP[TNX.@"-+XSRJ-@L,C MNOZ'^P<'NYS$?`NHZ.@FG`3O?MY]+W?74)TD0Z09F>=)&S$'@WA6)>*O**N* MY#ZXB\L;SVOX;$\$`Q`/`/(&6EYB\IWK/(IF45KN\KD[GTONG(KUIS_YDHDG MASY'[^"FRO-P1'\0VG0N&1K]1CIA/RCTM!:/QAH]0PZSF(9XI7O,IW$>CZJ`'>KE\0R. MGQN8,XPO'`OQ5\0P;1BR8*-_T4.OCQ8E;&>JA7RHY\7B<8,RNHW#X*N89,5@ M?`!"*O@0KZ^GI#[R,>^9I="9*<1,B,\]O4VF,4G2QZ\-6\! MV58)&:9>`S\813!/]VMNH@0&$43%.,_NJ"SZ7[]76?GWKGU?01CAAU1&S2-[ M.?GFA^.;.+K%X9*[HWM&P]ZS,([R,HPI7Q8'HMQKO)+0K"ZPC@#@6S@646\:7SCV[PZ>+B-.A\ZG>[7[KGPT!J=*L^<:?W*CB]ZG=0 M.;CX&'0')_V+7^K';R;="S:)_`G;1;F:3>OU>C$FD224R@41Q"E@`+;(S2(3 MA$9EFB":G?A5"VU-XJ+,XU&E69IXJ28`I0T&@O?MQ.(A=K+7T_W\2CN`PZNXP5X3X+;5+\60K52US<"MD?W.5Q68JCG&8E M``>V\@=SZNB!'0CY#*K9H-9U#,\F:Q+L1"'<40<8P%;/NBW:LK#0>B==P]G'U@RQ._/O<^](9B>_:"P;3!TNN++%Z7R]WRZV`YMIA%TP1$4Q*E0_J+OXZ0J6'M[ M^*#V$Y'[B5!(TT)HP<;@7.^PH3Y>_\4M5F'59N3/3Y'@SK&OHJD4FG#D3<,$ MW7H>Y;3M>$O!TM*C%T^=5&-9S23,BW`^3[#11184Z(+S;<6A9RO&&8Q2=KPQ M2XS/N\OR;])<_!I'91K.UAUZ+RW*N*Q*<#N%KX(OT20>ATEPF3#P^OIKX'O[ M'*993!^R,UJB.4G[.,0FQ^,J*:N<$=I@'$<,1KL>";DG3)ESL/$$K9*[)Q&D MY"Y(Q]U>B94Z6N#$7OI!FBB??4I_Y*L755NQO9K_70?&TN3>Q^F/&IR>_`T\ MG_PY#7-R@H)9F(;7MM^QE@KD)H9;ZS^3;+SE?MY#%$_1>W9W$_DB6DL_2N@G M=U'NTTB$5N5-SV=^3G+_$ER`Z3CV:#$\.'C>T,_66IA?!!4)(7_P_A%QCX+. MV9G0^:H\V%FFKUD[$Q3:UV]"Y2M>`%5MKU["53`)[W6<\Q'?4D=L?5R?MO<- MAA!PS6Z%CE]S=#E(P5Q73I!#6"&:[/S; MRHT->ST:..JHX,7!_KZP4()I#)D"92YX:(&&2E`X_&S.(UGU2PHYM&XX+[2%4:]6:DU5H7O MT208A44$^L9OSEE-NK[97?S1. MN?`+_[;@]1=IG75X>+3;*(>H'>#UO:PJ&WRDSELF]UC4.;@);]=%*PI&D'P; MU5C:>20D0@&99YDKF[NHDVC)W8H/X)!1?YVY>#=H:RAC).ZE8RA M#A4KY/;BVI4&49,[I^LWN";I?74V.\ZWGB6U/83A,$CX?LTI_>':O<^=2DF,(J*C)1)#/.\@F,`*LPYE%:K%=EH0NK M9!WC$N,SBC;]01#<*@B*_3 M>!J/>3R2D+RIKE&)ZI0B97%/8,IXW"\F]2Z4!-(,(HH+N$1A=4ANL@QO%8^L MK[`GU9ZB2XIGZ)-8&0TC2T<1BR$-<33I>$IG/=GH/IA$H[CTEV2P(A]!\%#K M)U;A)UPN),:Q6%GY!+*\DTG@MN05D0X2&J='/S MRW;Q8=CIG??./P7=+Y=G%[]VNT'G_#0X[?6[)T/Q^:#;_]H[63V7ERSM0?O: M-JNUC-;>6%_,<8:C)ZVB((WNO-&\<#[/8MZA-9BA(Q% MY"VLA.^TC^!Q_X41%UY?Y]$U\'^+SV.IV;0"52$HHOP6$*2\$DO6#@"]^)+B M>611_$98HE!M1&XJH>2:$/]I*2Q$OGAR.EDJ=T$MH?+7WF6^74C3^%8L>0C. M6(JN%*5585>(\^[&N6YF@^'=%_-7C<6 MNDU@^-0%0NFW#$#`UV&WX2/QICB;M%1U*C=! M/6`TL1DYDS]^^OEH5PR,\G0F0W^OPKR,OX.S3`^[[ZR0 M$X@E9].(%&*JV4_S;!9TYGFO)D#C7'UX$ MEYW^L"=X.C&YAI^[_6#XN4-_IR4"_2+(#*RT[PN90>Y#"=<@N.A[QK2N&)'` M$,'E5?_D

*_4UA($BK?E?HLEWX[Z?>8*C*_/J]3Y^'@_5K_*!VT/OZ-<3B M?X:I.%WWP>%;RWPZ]-0CD;L1T!4C3LQ$#`5/1J0.>J`K<0A"QM06Y8'JXES[ M49?-1]DUGY8Q28E06.@W>3QAE6&7@KVD+!DCZ/7H]+$X59R-)+R#&G'W>)-X M%G,1-5?/O8GGY.[.T%&IVU.:EZ>XS6O)8GDN,T"8C)2BC'Z_S5`0HDWJU]SB M2*$J&JBJ4$"$@4@IA9K2_6,]^USL3/FNS6DQ$L@1@37#TD=6< M:Q_#.S$+JR+00BLYS82)E'N#]3\=UE@F+G5[MP8Q"38&5](IL7ZTC&=R?5$0 MX5^PR.*_5+VH\K:"=;%E@FC1OU/?O40QX?>>M(H1F'V4CA&80])+-)U"C?^M M769I;78@:^O-K\(\B:6AKHJ(E;+B$]FR!M-8,)((P;%F2&$BKDJM8/+J][BH MR1K%9NA[C5&>VYF;C&@H!7,6?H=0C&7&RW6GBS#+*@N;1%4_FYI@]YBR,41. M8/'$3/)2G,#X>[!S]/95(`BQO"D4A1!]3^T2]>S1,;E?(_?]M?O44[,F9$)" M(]*&N/P2#(&20I2`2GZ/];GX%5F[NASR3`UV1/:VO!$ZL44)KCTB)(!5K>H1 MXMLC;\EZ)&OA(7)U+_2OVW@BUSU2+W3N*0;AXFE<,]%ZGGI%/&ON(RWT,-8V M53T!^52Z2Y^SNTBL,%]0L4)\'\CP/92/4Z&_`)@8G!5[C(V)`84-8X[K2Z1L$.BL$1C(TQ;5D4=*'R,6F$`T,'$S*`,OT5,8&;7D>64P\4#'BJ! ME.K1,/RIML)K&&_T?1S)RFY&_$N==:X#^';9'DPPB\2Z_'STEW;7UBS,OT5E MR\-`/`%R`&?(`9-\R$_],F#QB)F?8:](@WMCDB'7Z#]%U+1`KHLB[U/=VWW!3J5>J M/+-%KP&OPP:>RZ'K`5-!'8`B2I?ONQ_1EX_P:#N6;B]7J];CC?8..KNEJ0=* M)Z>:N$3*\>SE(EU\F(EUF53CB'!\B<0FQ-P82IV`0)5(DWJ,UQ+RZ1?-U7/# M2^`W)S4:GZ5J,P'HCZ,2`)U:@NJE=FFTW+[QZ+84EV>Q4[)IM8'"0NF7*+=: M/:,$UU3)G,+8*&5H"`2E5/\]/%2:`L%$&0"$EIG23R:J#P@7=86@BURP*R<& MD[6G;32!.ZUA/II04?1TJC,95!"?PG?4@PC",6I\!S\?'?D\4D!<,_0'[1JT MD+Q*HD)%":\K&38J^$SR"%]H*;!H$8IC*%81A(Z0L877/5F4H56EMS/.L#93 MG*>$A>GD8O)YZ066CDRC=P3P6+8&@COXUMK6JW#N]<:2IZP)7.*,A5Q=PJW> M)PB%K&P>`K2=D9'&"2@9E$):LBP>A5`6.\QP91F@D/`$C23(F\UUCHXY`"#Q MXO.(%#M!QM'O(1#&GBH%^R/CO1H*DLY,^E7)FUGP`JW#U!G<1I*,WN<%:NK/5\Z_7]TAQ!X4[Y1XM/< M`]=KK]^5CDVA$@V"3_V+*R%A>^BPWO1XI7!I_RK)J+M4O'KPWP('YG?2"D M5\'@Y.(2<8_6=7%?&9E!D?_8NCN6<"5@S"B]#J_9?JDU*WU'4NPG5LVKD`;V MH&X(_2PO+-A0YFF:W((S@@$RID%X&PH!Y6\4:4X;E6T8Y^&(Q5(\-WQE\9AY M(>%P%]K1):O]0:Y@X%T<<_T4WQH44KJCO@?\2?`I$NS1LQ)+@.(8S.'UK*)A MM_]EU0<,&]YJNH)31BWQ(BL">*M]F&%)9OP1L3,Z`67W?/!6EE1'YEKO!DQT(+2 MM=[^$ZR89]@*%3F*,"&':^C57.P*/-KG3$GW\F@JR!6.(!T`?*(3E;A:#0C$ ML3#I(-()TSG$V*XG50!%\^O@HU?QE"ZY?)X54?&`Q;&S(4;V MOD6.:-.!8')#*;\]^J63B_/SKH1.KV_^TAM^IN+B?-C_5?QL>$&UL>[)Y_.+ MLXM/OU+Y5*.R^[3F3<12*\$9CIWN%[^ZHI248!B-;](LR:[I=SHUYK-+VK;8 M]`U3R?7\![QI46`5'Q_=V7?L"9VI(*EGX&2HXEE^S&)^HHQ_I%7=0/QLZS2R MGRBKF84(M:'M81NN*5H"2$T&\:>;B.(\)].5X=7"T=J]P"VPZDWKI>TMS62C M=X35^`(E<3$&Q[S\S=N?_P)^>="6%5B1Y(VA-DC!S43,-"%9(0D-5)PDA#0O M7Z91$HM-%9;NO?8,%\)F`Y-6*$83^3H5@@.7N$QBW'TK;-,CL="*<.["HDZT M\7M$'.1CME]Z'.J$J122D,40@*+V$B&GH,Y)&*8FD\H\;3%AR>V#S"NIZE2% M$)5)D,13%'S3>%I"ZO_.P?$KF6:UV?3,X470,:DMD++SZY-QR$8N9C,3<\'I M6)P4J2*&&9AG')`C&-P+_4+L[:40B0!WOXM^%:$D-'P"67X=IE:7E-KY!MZF MU@X(U!4>S:M1PNP%IB4/!$T+BF!ZL.*:]4=-OIG=I5:>.OT+R_'`ST9OCNA. M?(K$%'U'_4,2IM^B="0,#=MUQ&PC1V,)G<`FSP_=PD49_&R!EDA^5XODW67' MHF%V+.538&+IO-C`=+L0FII^JGL(FHZX4?H'Y<&V`HS$RWU6^1*@1V:_]J#4)6PF:-TW0]8P\"R))Z&=<2QNV/A)WE51:'SB M42OSXT%'8EFKO+^K\]X07&]G5X/>5_R`-B["%,1?.OU^YWRX>H*CT:B#0??D MJM^#!,W-)AQVJNNJ*`-F=>A#:JG$@]ICKP.AM4:ZV$4WN.PPCYQ.TP_'LK;$ M\AU)B$"[NJ3V*3FU:CVNW-$MQ.O&$GJ!F,E/2IIA2C[$IFZMK")QZFQJ-GXH MRCWJ1=6AWR"#^4!2S0W&JMJS#K';4OIB.HTPU0B^JDH- MJ?1>)D90+]K?J!B+7T'J:%V=`%&JW?VW;W??OGW'-5Z[/LK]4D^ME&2?;]Z^ M?W=,5]N8SC`CR+JBMDZ80X)\P3>7F25VF-Z,O%WQ<,^'LB)>)P6YM8WVYG5@ ML]$34WQ['N?^.JPIP(7N:,VQF2AFX@\8=074LJ(`!R5DON#H-16OD\VHJ&ZQ M0IA'\6P$6$>6$5='G6"8B2"?1&;`PP`/9+C%[]E#?]6G4*C_:3#`4&'->-!? MOZN5A\%`,Q1,H`+9(J,QYJRJSC7*&;M`)U$R,--'"D[`."QN9,I046#8(/J] M"C&F__YUW?")[X./S43C2&QO,SNKF93@]&^S$HTW,N;-=4B9G1CJ\X$1ZO;T MAO?"\CHZ:C_-;NIG9`#*)"2?B45[;Q9%%5-C=9S/=\YXF.7-6/)P$;6K>AA@EKU\(@ MX9M-!<\BFS1R5*D:SNH_%2XBXH_=.7C%&HQ1IL0VS,6>B+OQ(>W(N&15)P<7 MHCZW5(5!9@('&9B%YS7BB%M$K@X[)2COL7?,E)V-!8?>)P<4`["R-]2Y=QQ[ MRAP4BQ4O0MY+&4LDLT:XR5XEMO(EMC&-O(G'=$/?O$%/_UH4[W`U",T3"Z`@ M;*;B@ZF50]E8:W.,C5($:NOD%D_RLHXYNK2C.`'J(NED<#(!*I3Y6E743WJ= MX)7QQ&7$S&;`RT)?"NLDNHV2;-YL3B537L:(Q,,V/A7&Y)AM7!**.S<+^?@L M_"T3\O1^3_HA/!I1-1+V:`Q])7470NT[55[CE?>*YG.AMF$ENU2@( MD\)G9%BVU(.S-^LA$QN':.LD:Z'SOVL;[KZT>41>DL+.\`] MC9/(GIN'N+3M;DVA8=!Y4E0'YO?.0(AU]FK]T>MS,]U%O3Q""07WF@OKG-JV M+!50%8'L'.V_HJBF_N.)F/>IS*KPD1,R!95XP$QP-2"Q%<``,<"N!J8S$L3& MA8FNTMI:NH_*8^S\?FO*EO7=Y4Y70#8T1;D=2X:CC7?.DY M?O)CQL*:&$;,M^:L3>.`*,IB]VD_FKO[K7<*]-'*72PC>*"4._>+CW9&KX*! M4&4%#P#F(DMZ@D&8U/X.<5B:#@./!Z[%H:I$=N`R6U'B$O$H,Z#6/6$0<]"' M"0+#P\_=X/*L%E^NJ5" MAR:#7FYEG7G=4--?!Y>Z[`=S6]6;VK-UT(,S,?VSP;MC.=5WV5'@@3MJ29#P M))-_*E#IK2]QK(S7X-"E*']#O@+2#09L>RUM1X9?Q/F]FL:5P1T8P0)7Q6Z+ MIQ?=E;):BOG1J,:B/&K,T^ET<-:?NYR:#[7]EW!UTC>:-7.$)M")9[DZ??Y( MV^^Y>7[I>;'BHL&F^*7/R?%0!ZNL&.$?H9EM:J_:??L`*[=8^<0+VZLG`C6&K8U'52EMV^W&O.`K)^CGG_=">JXB5+>)'CIWZ=<$&\I[X>XT@C, M3_(NH5\63]WY##P.V6P%@E[A55KWW-+^#W&E.ZT_X;N>98)/N9:^AO7D-^XO M?`@3B9Y06M6.ST\GSOG^M'`]GN_E3S2,1UZ-I3LV/F@U/,X^V<]*`T9'1(%Z M'JGU1/NV\_.[W:.C]X_8LNL'F/M66O\(5X\OK6L9]@>;SOHBN0$VO];`UOGQ M\\K=Q^>7SZQ8;)GB#W45_(?\Y_'?\(BO>)[I.&-I2T3%6!2M'Q416"NG=89V M)YV`*ZT2#QADTQ+`31\OMG84[`7][J#;Z9]\EGV8NE^[9Q>7)E=IK=A:YU._ M]^%JT#OO#@;TR0QY3EQ?!)^ZXCN]07`I!G4V/-U$^O?BEZ^1C(7H!@=O=1\Z M?V5K"D'<>%05<1H514#V>2EL%Q6_IL\@M.A^&BV$%7>SX%,D?A<7!MU`5\AW M/EV>F6)X]Q@8#$(-?M"$/)`!;`5I`'\;C((ZGN]OU@2UNIYZ*07XN#)%N%'N MO#!V?O"Z`)9+H3HM79CJA(U1Z06L19\+<(LCQDCT./Z8>7AMYQM8A?F`WW=K M?\>+\I"I`U(,-$^80%LJ+-<)Q7%* MLYF@J-,E+4FH3.(:'1/N=5K0@;)9-H@1R6]32LH,F1C86 MS-';?2&/$-.7%X]%21'=W7!H0'>M?IYA-QQW(8K^M+ZKB2U+]XJX1(M%[:E[ M=-,X2EA]&$N0:LX7=@;>P6CA%@I:-$:?>"-T9V7X&>[6:G0V'U52FR=!264( M[EHG#DYJPNOT,/U.#$=![$G4[,-WQU9%H`N31L%F,^RNI/)7*MO('$(\1"ES MD-4(2'0)Z=+\=/CNC5VLR/+B=!,.WQ9UYG-H0O,]Z+07`"P6O/2A=6L"BWI#.=5$U>=->K/ M=DXS<0X*;.R2!H*45AJG M?T\-E?X&W4V%^HL5G@`>Y5/^!07H.O#Z!8Y$9Y/*KL]#_1FD)6*'2IE'*5'0 MH/$G5F0O2-"L5+-KX&1SNAMU3#(9D!^YQ.$X%-K`7:9-"5,2 M%PRB>2G=CZI[I\_<07`J@]5#I8NC#$L7"]0PNY'$5X.^"Y#?2SM!Z?7VQ8]> M!SU(?P$-FB-98K;XQ%4`H`HNY5*H5=!G=)3E@J%'\Q#*Q\7&>$^IIY"':2X, M(!6=LM:O)S>9;Z=^%4^^WCNYB;*$_5ZA MS+&6CO&4U96,8^B'1N<$/59&$6LEY6KB;&.>R<9J])ZW5JA!@:L7CW;[7WKG MLJC]XN/CLI2ZGVT]15?#H44$)#62VC!0[(*=+\4XF-6F@+>MMRW6U-R.D5W" M$6*Q=Y,8S\;*.W'6!:`TM00Z4$+FW.B4<-#&JP>V M+?I53+WB/:5/G-"6&ERRS?`Q#VO4QEL@!&TYNF`$H/@!C@5*W:JXIU4>8N-P?I@W?ZR']=.0#PY$UEUY!CFTX MY9/9\PYDCQPL^\&ZQGNQ"H+>8\&6L*+MV``$&E0\A#'PV":T#0YIU+OREGVL M$`)4,%S9;E$.G5L&JM1=^WY97R%7C%=V M"?]6O7G^06ZOMES#?^+*2WX( MLQ]<75Z>_0HYP&08)Q<7EUU`4/[:)7=)]BZY^^FJ<_[I_WZ^N"+W/G<[9PQ; MT=FRTB^B,2_)H*6='IG$GKSPR%#+H_#I."@@1"> MMQ!W(8U)EJ)&X2V+/>V8?$G(`G-$]72^&2-4%J8UR^@9IEQ<;,E+`C"0W"BC M3W8(8[=)O[@T"]J-\-[$>D+U'9GH9O6]O:21P4(:YE9OE0`$''&[Z9`PO MM:(#+M&$V1E+=RX\8;B2DNE@V;KD@JI8ZU9$VX:QJ(B;9[B_0S04XW)3O;8J M%;X`\HYKZ$9$M!.G&J)3L`P(TMC84L]K3!XN(.4I5&6-82MS4@^.,&%H;"`] MH5.23#/!W%Z5=#.6,'LM\4*-?MA*-#@>A`0<1=8J%E9J2-I(:<#<*TXZ*B-* M)D`LH@R3^P@4"$VMAU:RD]C(/#AHO8/0X)1!&6 M5\NO4TL#4$FQ]#`@BV&[$'V?)YDW/FQ*3FCQ!CPWC?+B)IX7==8H-G21J:%9 M/@N3^%\R8Q3S5(-;F9OA2W_+9*Z'+.F90?6%$!2S&%OCF3?'JBV!SB_2AU'- M4Q(;3M'[&J;RI!:;*5&,(W<`Y$F^F-$4V-F85=Y0KM4$:*7CIGM00%8;\&I? M4H'FG8DE[=M[2IBL*UGP$4*#J211.,SD>[(!:%,%].:"JSJ8PLANE7&-]3_5 M^,8S92J^W:J$ZE'ES9D.;\,XL7I*Q"E2E]T.>&J!"CN*!8HR%]O--LH>\.!\:Z^ M3&:'A1!K(T;:D--BVRU**VQ?<[J]MAD'VP;SI">>5W/E8K0LO[\0EPH%615D M^-O)F%/ASY8&+F+G;]4URBO7'+/*99F/ATE"^&O$K8[2L2#AQRM7?A/L82?< MWA"TAP%6+`,L<._\4_?\!%HR).O6+$O'@-O;$7SH#G_I=J$-;_=KKQ-\%7>O M^JP1!`(3R_3<#LUYA:)F'&YG('XH?^\90>_\:W>`$V0)O<8'LD9Y-)0)",4W M"4!=LC-)E\DJD]9#QT=UBN=3I1R8NJL![U376<--7:+?2;N(1C_B?::,%\)J;1< MF3YV>J^"P8E0U"&M>=#M?^V==%=NUK+!RFNQ@&@+)IB3"Z9/6SKN((HF`"%J M\5#%J755#W)98?4F=KMV_:?R?M!+&25CQLEM6L,3'3@ZM1WV[ MX0ZX,2H$%7:MD>O1``6X`9-PYTAGH2MF.83\=65`JT,D5#=HO^XST\LQBB:\I+NNEKI:+_$GI^P>I[W M_8J^3IM@J,.P4;UJ,Y#2\J]IGV*;KW8@O[.@@1OOO\W/J'93VGY;K%B"1;1I M6K<%X5Y[L4#82<[GTLRA:H4>O#0K8XF*AL(F9EU$)I7I,PR#82-6[2>\O!;= MDB"O8K!*L2+"/29I"\EE%VMX&TD_JOC-'2`#@`>V2K'I(73>K)(I6'RQ-#FB M,4W]631]60^Z]=F M7+8M1%@PIC]ZAML'/#","^LTP#X5S#W5BCMH?*_7WX`\7%=_H[E0@M?X-;@1 MXC4$.V]?!8C.P)94H?BH'L_T\/JT$0#9U+I/)?Z;-(`/#B`[A`X)0#@1RU0C MV@!L6A#%+1:'4\<.%-P9_<"!&TO$C)13QMY))ZXLGP6,YE(J3V+$U_&ME%1Q M+N3]SM'^JV`2WA>!$GA:S,$K:GWUM1#@0C-3G_GA2,7ZB.>+I]#A2U7N7D7O M=^4!%/=4C#T8HX`)AC=6'NW<^QKGBO&T`ZX,#"2*)E4/HAQR02RM9=&N"'4X MJZYOO*)\PI&.O%DQ=&G74TU`:6R MAMOTRY>.4'6:R_2QN[K\UKG#'OH(,`'C.8<@_';Z3\#Q>M\M/!^\U0`_1W`19%P0+ MW:F_Z`;=F$2_.CY/[[QS?@+[YM.*.U][I\')6>_CF MQ$X@>9[M/&"7FY1+]XNG0N2AFD9%Y%PR3)G.+]5[R5[B<5#-0:`6VJVJZFD* M1(>DO_!.M)!`L>A6EK:`AK:W/,EX_LOPV^J&[@^M#3=]@GR74$=NX\X<']3M MEG5JT)XQ2;UZ83$-4_DTX3],=1XO8D'S/Y;JK!8)GXS%:J@9U_HP3/0FGFF1 MC`NG,04WH;8RQ8S)=L4>PL0M-A#Y<(U2BJ&/^S-M4:H.K=K@`AW0:'Z+M3TC>#"+FX(??C2?N/2^3=1,=<\_ M=3YU&QV3/G7ZIYB$W!EVA99Q2%#.V$J;&%/9I)Q?GP8# MSUN4HM\>IZ@G#>=(CUOX*,_CI/PK$"UKR&?UMJQTM64*GIXW+8 MJBFK6!5\P[A-E]$Q5.4*CW\[5&,GD#F+18DS+'1!""MZ7:QS"5G/TJ;(]1E#S%4TA3J6\],%E#CU\6"Q-$P2;]33*)0JL9RR3:%2"S`?H M5E9S51AZI_&>Y.O?UG;%U9/+&((<14\]0BJ_)QM'J!Z=J: M,U"CE,/J#+:N@:O]BN^HTD"XCQE`/PXH%)?PQ&_WI4ZH\9C9B\6&-6O/]-D3 M4X@B.EO8=(-6#,OM;P]BU+):50-[J2:0>K>(]=W5*Q%(]["VG`.SH+[3O,0R MIUFZM\Q28]8`/JKK^/9EFT8A/?>U.?$R5,-V#@9\%<\KNE@S7&JA\6/B@SC" M"3=IA'J4XV)Q#2W)"LN*G@;^]!W).&H2X,:BL/;S$D\T,IKZ6_)O^0697R5M M$6%5EWG5TO.0/A,5AB:=H)&*#="@KHQ6^[ADN%'2M!-(1MM]IX'G\WB)BIXT M.+FAL*8*YMK/P[0([2)%4.X53(+$+(#%?_^7=AZAOJG:*$U4?H1AJK7WL9Y_ M/6N"6WX7YF)07F9-%O(7_4WJ-Y-_S./K:V&(A^-O2E+))CJJ/Z3LK;,+X@8* MM[-Z;G*W?+Z6HJAJ`(GV;90F+O##?`P25<(XF!=*I[1T0K5#PZCEX#P6G\GD M/X_\L#I4*TNEG?H\?@?^C.;K6NABP3K%4\%&S:8'4/"LUIFELAF/G=TDC_H$ M?)2)-<`A]^Z536;CMQM4[S>E"3<%01)=6_9E);[.4G54"AQ]19OZO?0VB7/S M5[95@YLHF=:4]M.A1.SGH<,%C_"^X>EZG(6_'2L MNA2)E;O.LP)KY,=1-"G\OEN?/U8P"&WORA2^!ZZ18^`^=<=T=FN,GRO=>B;< MYJ&6FKWK[&*NWST_`PX&:DBK@[G=/>\.@WQO\`V>W5OFV_;`5 M'O'1X=BJ%9>6?H#N-KDJVW>1[X2S9>SO`5`<;9I2O6]PC(2V)TZ$D,$%[A?D M!H%`F85YG*"U"2J*--O@`C2[VS"!&:W>V\Y"9G`T+VIO'J7(O;%F<$C]-KTM M)=C$6A19-5WJMN&]9`4?0_UJ%O[&N+K+U0D4$9>5*T?+&OMUR:!X"^0F>Y^LXS8,3U, MKX+%G`5/;#H057ZK?4[M6@TUI*R0&I%'7-3'$`^6[+P,,1D]HM636Z\&PXLO MW3[C@9P[KN[+C8*=`^J>U/4KS27EKBT5V-$Z>YB0B*?*]:#\CF1]>(;BY@@F M*Z2=T*7)8^'PJ--4T(Y#K?SF=>"KT1/'0[6^%8)6319<+V+"0*#8"0OVVK%Z M,FE:]7#60(S M*.+KG)Q<7`&17_, M>+PW0W[==E3D"]NK/^!5T-%"Z%*2'K-U7_I5L_V>&^OME<_])4*?:*)_`<_SC]X;[OMU4N] M^F@7<"Y-D3SY]0]^_K97VZO5KB3463S3R5^NK]#$\>TYVEX](74^_Q`V?=7% MX,_CK9BN[MT>U#_F%2O46?#5+]"U8/'W'N/5[*M;6OPS7F$P^0_UHA<\H*V5 M\V>["AXG+/5(CWTQKP^6#9]YRI_R["[*BV!PGT;Y]7UP64:O`1;Z=;`7Y`#[ M%4VPR]G]QL?]YO#U\5\><5T.WKY^\XC/7WZ>/[]^_VSC$-3Q%V_A%^!A:#AL M-PCV2[_:D#UU]/K=8U+B\9O7!R^!$@_V7Q^]1$I\_J797CW*AF_E^>HOV!Z5 M/_=5\.;MZ\/'E$KO]A]5_UIZ'&_WGU$Z;J72G^PJ^`_\YP=Y[(MYO7[!0ZQ, M6IVXN,20U20.JE$!G7G3L@OMNXM-%R*^%=;MX.K#H/O/*T!4ZD*SI@VTCAU: M54_1;9A4:$)#44V$4Y&U2-EX7.4<'JG&LE`5+A+30\("^PIZ+9BUNYLHY7!H MY`4%0!YA!2.6O=75X,$DDC@8$12-BY_[BF=G55'R]@UY)(Q&1,^H[W$8BR^N M$JTEX'K,F'CCF="JHQ3S2'W%6W)PF*E?&((RVP"-$(*))$0+_J.F7"\A,G+] M$!9Q<3%5]0$2*FPE,OW0&?0&@,QTV>\.!$UB_8V@U:OSSM5I;]@]E8W*>E\( M.FOO_.-%_\O:F'1088-[8(,WAM4DEDVH9&!]`6E!G9)V'*49`'!"D93GQ:-( MT*NXGH<2]Q5'D4]JJ/VP7M)Y'HO78I=L!=R?W,/GT,K$]+-QO^8JQ1D@YA?6 M575F$>`^Z6K&J]<#UC.^T[G4T!=0_-8V<](5W@;J=X_%H$+G51+9]8QY=%TE M'G"K0,Z"W)?SH3=<=?NP(=WOXYLPO6YIG3(3W,#=_ZRK"SWAR&!9^\'^WC]E MD\2\C,?B=+V'(?;-V.F(]OZ+]<_#[16[F=S[HFC`?H))AN698L.3"EHVU"6) M9+VM.4ZSK$2"8^OY>Q6K(EC89+FUOO*O'-LJ)X+Q+"!R&RKCH8?$-X(J3V/! M]#E%3!,H%>20].'DMTHVH::SW5%5WQ(13*R@6*B$/0N$CH7@,![G59@4ODR8 MNYL8BEWS:%?#LV3S.)45Y^0Q=2$N/05I-(X*[,V$@,[3,,Y=Z]$.OL6$1C.^D$6 M4'O]P8K@[":(7T/#RV/K'5,>,6@$!)T#Q4!3I%4_VTE3`$WIH_2'&EO-M/X! MN&/3."'8_)Z7"J8G\8^%2G3XLP.!O]80&K+?!M(,.Z%%?C^[5UV&)!'`BB&PI6,0[>'^R3VPIM MG0T:;S7EWHQN(L2+!DJ\R>ZP MEY[9-C]VBVP763\FPB9HE`5<.J&).H,3^ITP#Z_S<$Y/B%BQ/?C?\1Y;.BX" M$*)"O'`ONTN]U?>FF:O8O+T]_@`<+]]4!CR!G)^^GG):P479O,#:":TSFF<( M94I9R0+D3`TIO[=G-V03O)#L"X(&+SKN8DJ98[)S2ZL[A*V4TJ44!:`FZ$J,\^Q;E>Y,H3#B`@!A1J]):C+-Y5!^C MG]_L&\A-F)]X31)_BV1K4P1>'\+K]GHSMZQ3>E9D9^^/0P5:!@*)O'!@9, MCS=HC.PM8@A2P9_I=KCPC+UQ*R23ZIL;;?;HO+NE$*<[EX:89J,>F`S95Q).E'._YEDL;<,RNQ.,WT?JMKH^ MAY0'Q>;Q+/F!]1'A+OH>:Q82!@!AQ@ZRFJY0?]F:N'9FUZ*UZ'L(]@:]+?8. M1Q6.O8U8DRBTP,L),E$S$ M%\VN"TMTP1+N`;7L64*,C)0(+MX93\HEPG#;41X;>XV;N3IJS["I;U+!Q`:N MX?&TI$7;`U30/SC0R!\PR_W/<76J\)_KYO/`;W],(MQ>_;&O0&C5KD`WC9Y# MXST`/G2:#DN_"?VL\#Z4I\%O51X7DWACI/F!'82.@C&$7%YM_/&=LLSC424#.EJ;]JS?9@!O/%`U MCP2@$SSIXY>&W?%XR'CZZ`O@!Z"9#:-$<(.A6SQ1QS'!XAH%3?!USB_%NI_KX`>VDL`F+72;:<0_SJ+9_%* M$F%#,_N<"=/U'_"O0:?__#N^UERD5_]`^EE"6<8C6_2Z.[Q:>MLV>H*2>%WF M"_I;KQHL=:S.0KE&5T!R*45!S<=RJFGOU6TXO&<$_&2O/,-#FDKM0UF_D7LG4>$&'4XA2-@`.5\W')(I5P$F5T5)[&IPQ7(S MO1%J%LKN1^,D+`H33BU6C5_WNR=GG<&@][%WLE;0^D1BY2OD^T)G`\BNO7IK MVS,CZG7*S>R\AUPZD;%3AVI,@CF<::E?IO)/7#&'@H=CK)4DG]V$$W]"8PT; MKO,N%9"^9V\;6\8V]*J(+J;=HHQGZ*-?<3>O!MA*LCL8]KYTAET%*#X87'VY M7`L\'`,UF!EH&EQX!*C>%0@5^9,&/:\QJ81D#ZRDPL";/JC2R^C^U8E00"2S M\)L7`EXO/'TQQSPOBFHVMPG$2H$-D238YZ[\7/J+F8VD#D):4)'JKN`).L7A M*$Y'I#G!*HG@U(4_'%0EP[E/,_6R)9="AAW#FG! M56-RJON/CWID+SF5&Z9BK(H;;##"1.=*VL+4=PTMX9C==*,53TE MT`2O05R[C:GJC<%A%/P'8A5EYKLB$[."],%5$4TK7ZH*C,)2JNZBD5!S*]LZ9`\K<44M/`O-F1OY%Y_&WRG]+FRZ44> M"?4ZM9.10XA2HH)!?P$I"6+YZ'Q0"HY9\V>5;ZSFX&-*;)YW>FC$%I;$OKS,,PYW&U_UVT&*=EPW+11J6,),G:M,C'T M,9A%Y8U09*K6GCCZK`1QN6O>*1Z!69>YLOI^KT+!;//D7LB'VW@BC*="M@S& M]E33/)*TL5.\\I%'DX/7C,V2A\Q:QGZ%]+2!0*HBE3N3<1Z%+4-R2UO+O'U; MW.PW=&4CUCP9DHIJEBS4S5!:'[@2(#+E49F(,;:U[J-G,+1$?K,JA@XO=_K! M@RI5W::X4*>_+,MPS//1629NB4OEF/,R+(FLB=T^J]D%R[>:?)J"UJ9B=ZI$ M*E]1*+42WPA0,JPLIYV%32-LKD'8%V_[0>)8DKXXM$UD(%W>RARG\-)]``,)RK!%79X@I#V>MV7W>>`5G$ ME#.32E="RK[?WZ)[Y&%9WM!8M>S1NI-_NPA/J$#$_0OK[J1%SLVYVU#(4IM( MG65;DA6C40GC:S.(O)3G.L/>D^L^0F0]6/445HA"1S*?9#8ZC!"V,6@I8F\F ML/-Y)BQA4*TDSZ86`^2D83D1?+.NSUK=3S4N41%0AV^,M2S`F*'-J6QLST;@ M\5UP[P1S7'P4AL)7.#<74].JLU>K1-*)M:H_XV.GUP^^=LZNT*U!RRP'P_[5 M%U,HO)YEIW,`J5+K2F<^Q'3FH^.]HW?<8#<%$H0\VHLB/$XT4B!!?J:*_YPI MUG1,LC+0IQ\H">SU3E@%8<@+^33][2D7V*=>`>E89C8Y*+K8.][GI1KZ"-1<;P%4X-J1A#@TSR<17=9 M_@U=[Y(L,)$>1MNBG`6N5JB7#]+?DY^K+K MY]=SG$13K&OTEN:XCYTT?:)BG,-0OS M;Q%VF<8PE%:T9"4_5L[*;\B267`#E*`8:;UVX1`?[0I;O%)7M`FZUWY<\$NO MK`7)95R0ZA!R>Z9>\^>,K^IT&+:DT.L49(V M2^O\N/$J+B.$J?B<^R#LCCP;0:9RI#JP(V<1FQ*NO"D?'2JB#D7E#3R.". MS9+L.I:>+^46)H*KQ7D:E@&4BD&\.**!(SD.8F3*(RJH`RKMJK2FHW5B6,OK MI$;^.0GC.K9;N?/?7M^PR`G7#.WR76:=2!;+?S#VKNA.E6HS^14[58HSTVVK M91[]II9^36IDW_-'6OVL4I`-CQ\YYT[JLN@N-W@$@\^8$CV*W+?T)6N#EC?9 M2.!YT1),>16A+$BFRVZ*4('@4=6B1TWK1[X3,\INT3T"LBV[7+Q98O4.<&'6[B>S0^X-$8,SL"2]3N&N1&&UUK19&UNY'&N1UX&75: MA3M.3QD6.)_\'=2!AS%??K-KNU`#HAC);I>1:S0/[UTQ?+N$53GX&A3D?*W' M6I#=NZU?Y("%IL/]TH;3=YV5V^!3^R[C8`WAX'GQ*!J'XMSH;2AN`)]$/*'* MZ_A<07=_K3)5,EAO.H$0?+>14'\X%Y"P76J9W'.V[2R64=#FHJPGIPY5-1?' M:D;\R)(H1W#$3*01:Q)5I7VNW,CBQ-TIG!S?D3;VB#IU!`''B%)"_7D.WE]E M_Y;-S,066Z M!LP_S)R$53/%UX@?*"C%Y,`IA4VE5C+'1%'#DGFB/A4^-+3C)5J_LNUV9C\S MYM+(QW)';'7`AAF$/J>Z)$*>TT=^N``[QU9\.)RA6U4/JS*#5XX]JK)"0O!$ M">6A+EJJ"_-H3^FD?YUD=^E>+MCEQ-D!245$V-KS5T%1_=_9GDW#*F$,FLEV MZ?C>L_9S&N5^EZE)]P`W#4,9CX"05/H+00HAE:[%$#2Y@`4$4"A:LM"I75-[V3UKAO!YG.[@=DQ+DRKIDP.)[<8JJ1+[Z_E$/\I MT&#QGF,W8R4((RR+"Y!>.-A,I:4RLPVURYE,'YO/N$>9`MFNO@.^4%]G,.@. M92+S6:_SH7?6&_:Z@^!+MS.XZG=/@XOSH!/TNR=7_7[O_%.`H*TK.XZZ7[MG M0KS7;Z>OW`M.N_W>U\ZP][4;_-+I]SOG0_J%C>@9U*:K]0UU:!9XY8G'W/JV M^\5M.@GSQV+X0;E:8J&/M6DQYI?W0FWS27%QJNX9H34AD1K0AS8XJ\JX9)&F M4&BTZ$W&1'SN&;"R/VA9F(>M,-#&3`PH-#F![$DS\8,;8:KP]5#)DCLPEE=U M%DA("N?;S5*5BJ;RWCD#X?O67'M/''^I8#T+[_=,)O!%?AH70@T.DXOI699> MGT'J;P?MO0UA*9Z(,_4K'&)D`[MPJB^^=OOR@/V*+*#WY5+P"0C\`YT,FO!VPF*5$,!:$^Y M]C@I(/T:SX5@,'%T%\EZL#K_G$TI2H%SD%L*/AS`@DVR$#V:-"W(NQ@(+!O5 MN:N6IT8BH\DE!G`RS.-".%B50+^>:Y84EA:`9F9KKMX\?9D]$+2DX4L<,8@V M^]5Y6:25_2;SAH4"73O!4S%?XPB'J%R1C6,,"=2PV0I;G`S"8Y;CZHE]NA;F M#6+R-:@W@&DJ]TT>S00K=^?P3E0M0(!9_[[WH2@HS>/`G$!.:;OAF'O54)U# M7;(]CS[1]AV0C#5?:)"2FF*#FT,2EC[T'TFT^R&54G4`1%EFR@:+C!_'Y(=+ MQ=\9\2C\QK?R*LA2$E@7G M>:;-3DT+`7$M"\I*J-YS*^-)7EL#ZI947#C+XVLQ:\"^-P^W\U[A%(VR[)L. M52G*:*R0CY!QW<0?ZN@9"L)EH$MJINPY*1MA4CHX)U-'I?M`8CX"2RQ`X5$X MBCC3>(9-'Q@;5PPWR_T@TZ%DM$)1NKY&+&"W0)`BXV_DSDY,PT%NJPB=!'M" M\&'2J863["-]J5"2XCR957V+=I.CU*/..P6F9QALP_;6:J67/ZO,S;^S22XQ M2R4/VU1@,?F425,Q4N41-Z&P]E8.7M4$SR\+$!70<":ZI@<7I`C;3632VCTL M1T?&A-Q,ZR,M4L92!UQ!%C4\P5($GP1VK4=G+7/\:HD@4AI=2TH0A%V)!TF0 M,'%0LED\%C0,U3;PM-M7@=L_(!U5$FTW*,0$0HN5JGIJ?TUH/(ND`KAS*Q9,=,R(??9'Z@CCEB?-,Z&<8@\1?B:'>J(Q`V3T)5$P@1L+11%'"!V5:JFL(1 MJJTY@-<>4GR!N^3A;"(",$\R;;#T253$;E.A7"X&*>AD4HW+%B40$A5BJ\I" MEA4DT!]#K#Z$Y'/^S(;TH\33,%ME*)%R@`G$4")__QF'I_4*AXF7H&"/5\NI9A:M="D-SCIG`6_=CO] MH'M^N@E5.4HDP]71:#S^(+[J%C4`8^3,=B0>.S(YWLQ$$'(GG_`VX(D;?`ZZ_[SJ?>V<;:C(QO*]2B,"E##(&A-L/HG%+#B=ZI8%E*`MB:1B M9;$VK/+(1Z\SL1(WTCD,&I_R]8#R@O*Q$ILDF*LR9)!+1/6R^N!ZEMD#MFN7 MRN5V*01)*7[:U5ZWC;6CN;CL]I6S%#;P$GREJV[?I=-!")X0L-%S1"4K$4+A M==`%KC&)9?]Z+"P!.'G!NF5XO*UZ;Q258,7*5(^KRRGK-*[`+I3BPXU3:XG?S`3+H\C:V(JA5OC[]; MG\<\660VK[B@'+&L07]_$F'`B'-4[B4\]"CCWM2NP,Z6])E8/\OT)OY&*R2H M/6E.QXK7AHTG$/:6+I!7M1.C45+K<%U,(PDW)"REG>-7R#>9SG4U]R<1B`,) M)SX7*E6=U+?8[4U=FT#=-A:'T/9G56LYCIM:I)][EH&VH*HOHQIH$+/@!EL#Q.[RW(B'@U*2Z%(08::%,L?8ZC10CF]7J%G[WS8 M.?_4^W#6U0'?B^'G;C\8?NZOP^3[6:E:V4%JJ57VN(:8FX4F/DJ;=KD(])(L``#S\(R\2- MZL1]JI(S"8X:I<'.P;'790,PAXR![3IY:G)O,S:AC`BA@-69E55!J7:UX7!N M+Q34[(PR,?TL2:>M3,JGPR_B"\A%IG'RM[XRTY_ MS40,EXU,_!96F3@S\$KFP&ZV9CH,`-(KO+IES)O<-]1NK$UZ`F8)!\7P,H7YS$VA&V MT)E-5W?TNFX79%(/W2:*,I8%\P`^+1:CSK-=E!FM^^*R>/JH0-1"1AIH43:2 M;[V)09F-SF0P6V2(\6M+:M"%K$7"CMNZMX;>#EV7?W"\J\PEQ1U4\'YT+[&M MY#HH#=2C^=^K$@M81PQ=(2"6X.6O!355!6GO.HK2:!JC`A?-YDEV'T%E@/:K M@<>B!2V,@P[DF7@0=#6TVN_*-[*3V8#?D3Y!KJ%CD,*!AX//$\.\B>?\['LL M5.-N%!+NM:ZEAP@2MBRS"D8$.;RF`)?VIU/?";2+.-21L6SL.KF\E25"F`[\ MR."'@D(?F2#(3'W(2>885,*L\VKLM=..2;LXG0IB!7M/Q8;,M//:AQ7,09S$ M=9!5*2>`+.AYGQ`V46K#=^%,&CY3P]UXFEIC]6:@8E#ZB!CM85R`1P(A\Y-: MD8G7T3D'YHCF6HDM#@6704S6N@5+(4,QUZ_5Y#5#Q'F)90WX"OL`B1G#(.*#NY\<55AO#,4[7VU5$0EN=;+WBWCZ-DEBI M,]9!H/3WJ16_)KN5,<[5*OP>1-S+D71#8_42KY<*%4FO%41;&J06N]QJQ8$: M&P0T!+IKAH!+;[5RK[4GWY&BNM&NO?_2_L/8C_A2PVE05T+9`),I"P?5&*%6 M:EZ;)#"U5T)AGYF@"`)/0<,KZ$,IX^\Z6$Y-E,_-#'FF-BZQ&`YQ2W#2:QQQ M!C[-X@T@4++9J*7RVXU5K3L2J^@RO@GRL.KOV/%J2@JR*;*/0!I"M`X2-^Z`[Q*G[M4%NWNRGZIH7B6FI+,$2!*LLY^)NL-&SN7H.SP M"#]9HDYG\T6"$<<<`8"I1FZD$:3?`>$B(R450;`>&G458;I;@(0\(H)3JP5\ MNCPP-JOH>NU]R$18FR$KGG%@A3_L@"V[;$MY)`)T(H'C&.)JXJ@K]S=@C:M29W*'V1&(RH*#8,89]A M;94QX:JJ*J5`UB.9I<+&TJ`@`[M!NKZ+(=US[FQT[MM17`Y,35&)45,A/\LR MB1J5Z?_^UX6.%N;4/35U!$5?%V)<3.N['?!-@2FWHG>&5,T0W#Z,4'WNGGZ" MA/_.B?CX$8IH'#7O%HZ;JY+%BUP7W$23:TY@H5R._-L_N3;%Q"-C@)1O@Z<'YJBH-51WM_-3*>257J8W6N7K1WX!=0 M^$=U8B"M:VK-;^"'.:106%S;/4G\^ M[-U-9%L;5O:0X\TW+$@*[5F\XP8K*%0,#S#'$VC@@ML`[%36`*L3Q)0@"?`` M::V2\]_/6W1'UP/HAGQ$?Q'H<0OIP^B;?.B>%\L)80,P/08/]'L8Z*9`,ZC7 M-T_'V35_ZR5`@\B`$O7[/+/`7481YT7P:-F,29.]IV(0OL?RMPSO!D6Y#\D9D`XL_KO+,"/`[22]@.:=NO$!W+@3 M',QV0B&"L!<[4&%O,&?<+I;&S&Y-'Z+26` M\"CUJX5*N%]B"*L5564^=]3"I-6'*5+PEH+GBCA;CL2IP>3QT)W:!E9:B$%Q MF9$)\S.Y4&+]9W$C`VL229-16>>Z!4G;]H\MT(6/R[0M:3O'0(<:]$KR)%+P MY0NSQ,4WG\K4`-:(6XP[!X`:`?.R53$+%=:UHJPDF+H"?>Z,I`(8"6G6BRVP M>)%2R^H83_`9Z4>K9,NP@%:K9WD=##?*5:N63:<%"A`5__%9G7[TU5;="A\J MGB!%I!*,F\9O(BZO"2(V$M\O4 M\D"V+&V`-@'WA\:9GC2"92U1G_FZH70"8K!J>(=?'XMV7`4O'!3<#0LVB4;, MBPZR M/TNC9;U:OJ>3>TI+9U+>R:^L(\5"&CHP84.6RR"WY5#;M+'O,?%Y#-N1&7$@ MO@^):P]P"[C'O2#5C5)S[0RP55A92"%YL="_B&%+E.D)(ZXYG\?9``BI=&*=W%Q;4AH``$MQ:IB-H*>LLUN9KA&V M:2`4QKQ@;Z$U?>;A=F)7[43U/*@M/90?&U='[%KFLO11+PDNAWOB=Z`V'/R6 M#L`XE`IV-?)^;3:)0&M$&XN^1_DX+KS/'0-5)(D#TVY%]XSMS5W@PC&DBW*X MWM:ENG%2;#FZ5'+*2TU4V3-IC7[1S*F:+H%'0#OV8DDT)O^L#L?E1_%PRC>K MR9J5-N62.WKE&B+49P2$C9]+D>R+`#HWF]EOS;Q72PR-XJDPQ6RC5>X8(`G! M_Y."HH_9A\I,?25:-A[21G_IMQ>NK=S>W$,VQ/ M!L@7`!SA.S)"X:A2ST/7`_AEW9VY#X5Y"DF`5CLQ,.1)PPX^.:4R":GP<(@. M'HV0*R-/I+=0,(_V%`#-1#.?*&VI^K8`^OP(7I1E=W$,;EIS40YD$<>6Y4CX MC%>VJ-1#?`XF4$>0G_N;0A>P.W[3PR7]6XR5+8%GIE45VRW`)Y2082]CDO(@W9Z1SD6>6ADL+`T'JSNM(LW6N"1^M*;\[9 M+9:&*0OT5VE4[H$#F^GO.C#:M@.3Y1<,Y+0!SY%8YX&P9G5-X=2Q#&O!42ZR M&E4%RS(&P<%##(+ZSPW&"<-V-::87U5I*E?;G MDVVP>E0VZOZ)"LB*8#+>M=V"@.(,WQA/&\=]<^RGHR M].!'C0[)+!CL&0&/T#9[[0+FK\Y?HOO8].A8B:&P)E;;WJ8MA-@OC*]`4XV6 M!5-;6]016Z(1!J,,L#@48/FHCLT)X5O$DSC,L1H"LLM#@-R)O_DXK\2DL2(- M8<-%N1%(*["_T`VJX,W:_0YN^>'8&(]/J/1!&Q/I!?+#$O0.]%/NB['4]';H MT.7Y8_L<">$4CHP]5+R`,4CC?>,@K-P%P1T/CR9Z97O;EBXX9Q(-G=Q!=''_ M257`BO++5[96LD9[;3`$$D5BI'"6L)QM[(+W8V> MZ`(.\+2L*H&G-K0CLPBR\PMZH](PN?^7RJ#B4D`U3_"M`4)/8%ZPQ2=-6T69 M_]307K"LNDJPO363F'IX=-@?"'9KX?70JQ_N-G@#>`:$N@T:TPS2RQ7RL"FK M0@0XZ:?_C(C[9L!%RR[\HOFS8A?F;WC=391,%+QDG#N#+)PL/4=M+C3:=;@;743E^#4[ ME9?U@?--/9)X_,!N)E'3Q>/<$[4!S'+CM<<)&E4+SF\QCE(XZ-X2JDNC#%@. M(*3Y`I*FE$,?;$K].(?/QMV0A;`CO_R("S492)QT-%ZL'R*!"SP:3!.?.I20 M<+ZS+MX".'&UPN-0A^CS`33T.B):D8&Q:3)3L_!,&?.V:D/94LI%J`/J\M&M MB/\^0`9_4@0'$:OSD0#'2IO1X\U!,YQ6?WA`/=;P4*"5SI+DWL9`2FP M5DZVA,7:WER6O'J.N]WK2`HONMD@BN`I0H=-C&Q:C%FK@?L9E3%>7?NG/(.C M#1ZEYTIJLO!@E5X-6@A"T:HBP0*=@B;6.S5MU%J4:/E`+FE@R7U$Q#P.LC`* M`B+1-1,R@AV/(RR\6H"=H+)W?8.K,SC-WC/ZKE(8?\ZY\C@)8ZT4@*)?4Y.U M!V24+?!)K::_*U>+_V8NMB.R>C',!"NV\YNHND/?L-S2>IV)]0KI=2%HMJ4L M^)/C4Z,RN-JFTX78YSB:"ONS`A0#CRV6U\$0#?P.7Y>J'5O-)B"OC]"5 M>)!O<&'*A\$<2%ZZL!9:%H@W77U.$>*@2-N`\H=W2!-7S/9!/S&`(JI%4*VS ML%Z5MO50I:=RWW8701JI0ODU+-BF M7O\$"MS@N@I!Y4;19/^^E&P(MO>1,4 M4Q3&3J2K-MXTW*7W2IF.B155MK!N3K#H"+LNZWZU>SJCRT45_$ M"ELJB7M1+;:FUY'G(G,\4@./3NY)IPCG[#[;@PD7C?.Q&SA64N7'+K&&3K-T M>7O3``:>9^F)!)%*Q'=["A-F0];I^<7Y'IBD_8NS,ZA#[YT/N_WN8&7`9+>! MT+!'V]*^WQ[O'30$P3+6YL-JMXUE:4LBR,RIUYMQ&=7S6_"^01G=QF$P!*#. MZ"XXB\6N@I#S,-"RD&C0V%G]#CQ*)B)\OR`J2&PJ%@EDR39>UYO,U"EK-#J% M9L=""";9OX:[;&^9(ENJ%O+3!:FNY[[U=*PL8U-S"1_AMS46[Q1ESZHYKYR/ M)XR69ZKND.>,`%!>'0>7Z\C1YIKKI+=[#[>;^U_4QONH1=*6&+SMU^[Y51?[H7XZ[PU[%^<; M$%!+BJ6W^PCV.?CYYR>12U.$:\>%U"7.KLB7GD/=!MC\"OV!<4MUD3`"L:.` M1(:':V/@P.'BVKI;HIL.%HPP\?W%/9(T@J5!E8S!T08(M1\\C.'Y9#%1C"\@FGEUI@48(@L79E3E2 MZZ'H"]6UV^F??,90RRDT,[]8J__'.NKLNR.)U/PDZBPE"["%(:#*'U4VT\') M'Z89-HDB+5T&>9Y1AG'H6VQ,;.ZWTZ_ MWSG_U$5,LF;RN3]Q-U?'6`+*^1L2T%'WE_R-UP5VND`P36\@.W@6;5:GR%O`5#I982V']3:<6&(QIL:*A2DW29?^9G@1?.@&5X/N:=`[#SY>#:_Z7<_@?`QW0PB$#]S$H"IDRU'M8M9) M3^Q!7CW&]7B5+,.[4DY+B#C$,_!R^M9# M9@!2AAC8!F05^!*9J4]_;VO%0X3:48N-J[YV)+[FZ=A3RY.`XQ=JX15TQ7^N M_:'I'J0R%,$P++X!=I%0,_$.R*1@_]W>4>`4[N(@M)V#FOK=+X5':/HW5.^D M=:\:0:E:B3:/S]R`YG$2,!M/]^_<^16QA?>2J.%AT/5GB2:BS'L":7VR[E!B M.V6\\5AJAWG@/8VLCOPALLY#5"Y(3PD3.(U,I+C^S-.D;L"=_1IP-K2&ZT#Q M@I(B?\."!NJW73K0K.#'W>"382L"O8SXVC8<6VV/=^RFO[&O:KS>M+*="83& M^T3KV4P5&^5E,B.AQ>"4)&F[J\SDP5HU-JG,:M`T1T?:LP.SSF'K$%[+)LJQ M!@\>E>-,^#$G"&GZB)V?7KN%HL'=\!B^"TU99OH.P`6(B=@G!.M>]IH1S^BE MT*Y93!QZTA7KF<*#X<7)/_8^=(!1GEQ\N>R>#SK@.$/.?/%AV.F=`Y_N?KD\ MN_BUVZW5BM6E/[.6ED,BEHY1B"F0^QCC96?`V1?`A*`7%\AD(\C_8RY7U4*G M_13'W*LC-F_/'IRB&[(^A!;=*.28\&R1K$]O-AX5J>)'(?AA&BH/-LI)ZBH; M4H1"'U%7>_K6::H#1,&[@_?@OCC:?YA.P5+#ZTY6/E[HTGKTB_?>^KP5#TY$ M76C1L_P1;UL#UD[`D)\6]36?"G.[<8SVE]HT#(CMF(XV;?450BJIKB:+6C`D M')@@(U+VL70AY*+A,D%IGDSN+D1_:)D%O2E3:'W135A^R$Y`%*$,H2L@(XB9 MX_+(@*+6D+?.PX1)OAI:LZZ[]SN4FFNZVBQEC1[[=9@GL42Z-^G'WA9?KG95 M2M6P,C$:'7E3E6< MLNT%U%]5(%45+5!1^$C.,SFK-YT8_+WBETS1F656)'O<8->W/,`\3\)Q6T+4 M+!+4+1A81=MD:?#YRR_*M+'2]^ZBZ%MR+Y/"TQ(ZC,L`038"/J5R5F2F5ITD MYDUHP^-%J@?YOJ=D`P3AQ/IE=$3TM:$J550;/891>%X,N:`Y-FN,E:=@*ATZ MT+@"2V824-8`#CJ/0L@Z*^^B2.&RQ-)4$69K!(#L6=D:+(:B2=U<)RY*!+23 MH-*F<0=6R*_7CHFQ"[`VG87+JH@R!#Q4!%\QR;**E>O&&]>0=.=S2T"JNU@A M7Y&L?,D>;!5\T=3,RGHZ580L468A<";8U&S>5NDET2#GE19$A0Z5_&W5%7.I M54Y5Z]\6?-XU^=J"H6/O$!F-G]?%]*H/E%NRTJ8"0XE&C\];<]P/OS(-P1U# M]\!)U;DT.@<^EMUGP"/V]!.`,6CR3B=_!58E:[EDZRN>6)\)8E+H'P]3+1]Q M`I>M#4J4_@J55#O35SN'KSC"R<84V2>?MCL"YIV-.2'.KXI3Z%L42U0W^)4? MD5.?X"=?FD7GSJ)^?@*M=?L1)KG@I-+IAM]4OE%&/8;,OGCRF2C%4L,G5RQ) M6PL(OBO^EDBF&:_4!%TGX,DG2$&@J)XI--,]U6F8?AMG8*-7RAP1RP`<13?A M;8QB7F&#/?G_+Y5GO8Z][^O13^M(=?KXXI0/OO>Z^IG]W_^NR>P+][(?= M_I?@/X*=G:_=`8:5\,;_%UST>Y]ZYYTS*IT@B[US,KP2=Y]\2C"L5\%?@T-F MA,53S$[K4,IL]D[(K`ADB0EAE.%74[!^^/&\$09*)O1V;U[)$W`7.HNP#(&^ M%'X?*X0Q:62L,BT4)I9L[J0\%Q1405L[SS$W:B.@.E^_9MU4I-2(2,\BG$VV-+UM@U-? M,^`8Z$=4<#V2".::A?,,:^7/?/I)+CL[])*H0E\Z#W+\%Y]+B?_T#)9J)FB) MRN5-9Z-=D8.BW5$J&)$2%(2XM./FU&^H7>N^JSLXUYZ%,MZ;,FM M&I*,ZPN6XPF!HAVEBU(_TP5?\EC092G:DHT?<3\<'"TQ&@$&]/:FTTIVE'"#-4JG>.G::/"DL77S1[Q!X^MDJ=BRHD3=S M5E`)$I4">40A#NF]0GBQH3X@"V%LR;7V'()'G)*62)2;E#1(LO@(UP62#2#" M9YF2.]09IY-*"")F244`5"AAW@TD#_83C1*'X^ M5U*],]X\E[IC>IWE8N6V/(MORVUI9+3`UP@[>?HCI'@K=R15%MPASL"]W>Z]LL0&3^J7%,S.,=]9 M;T+18V[@1O*%GG[<,D$I>))4I*4']6]!^Q<<9EJ8IH*-8WMESD-^K\366,6R MDQAK\R1U<%+ST;UEIY4N6K?XQ%U MS^)TX>?7:8707Q"4/(=T-R/)S?;>QX!- M_QS.&Y;/[8>)4PWHK`$K*34"Y!>"A/@,86U9I>E:9L]D6R(70B'L9$S#H2R@B:1<3F,75ZP%C0#G6*=RKPR!.-F)8/8,] M([$J:4,)G7],CRAEO^:PMC->=8"?)Q7U<0^PIRS.YM=S6>L')2#4L6NJ8YGZ MX*R&`P@&V03X#HNRL`4$8,5[!J:*E;A>HC'Q99N):VE_JH2QH!C?1),JB607 M+;$T(0A7Z)38#*Z!1\'S8ND#^[V*BQB@W>0P=%J%]X:]![WPP[%]A M\7O0&PRN(-7I(KCL]*%2/;@8?N[V@^'GSKDISQQ@V6;G1/R\#WE0!A?"O<;/ M4\Q)#_ERC8Y5Y1-OXR*W@-S)5*US2U]3M4OR`(RAW3:W>ILU>EB$&5Q7\407 MU@T:G3&"X_WCO>/]Q8!"RV`MJ,ZOZB7JT:IT9V7V0O+@(0KDZ-0IW[-WM&^5 M.`9+%C-Z7OSP$D=.*W82IBIPI+O>7NI(9^/U$CVD%')QC28M=72_CW?,E&EA MK86-1%8^M)C1>W(?5-CH68NVPD7WBQ]6Q!@\I%S1%"FV`^JM5K"XZ/46S/?" MJAOV'B$RW7U(Y`6RY)GZ:&CDJJ8BTH<:0>1)M!HR^1 MKA7S*OK(9\-EC^3]BPH@Z^HPNL*J*I*?$58?VS8/Q(%R0+R\$A'P6R[7A`%O*E&6:S5P7J#W+!)IU M<(L&;Q>>/8/_=8E*MR6TXF8)VO-Z0=@:B[7G>/F$S^JU-QF.C9*P-@7Y$6?Q M6(5@BVSARH]`_XBS);FF.L7T_V_O6[L:U[$%/]]_H0_5JZE9P,F#`-5S^JZ5 M@E`G?2E"0Z@S9[[,,HD@[N/8:3^@Z%\_VI)L2[;D.+;S`IUUIT<5$FEK:VN_ MM!^)0U\NI:_PMRD2!>)3E%7;[=!BK"O;X(]V\2LTIJ`5TU#<2IEK!MHZ(=N` M6UN81.8&Q1FG!2)VXUO2N6SXFUZPH@S:E0U87.9^>)=]#DZ>U&GM[V MG]<^>K`ZZKN*30G7+/O`F/FC^.."0(O-*Q7Q(Z32NHXBE%[Q0;N_"K+#- M#+F)/-25#U!=KD,??:&":WMG*X9E"G_O2UML,D5!1FQ6'FT<$079$>F_<]>V M7.A03KYDDQJV$'J2Y$XDSXW+$A@RP=5;"2=65K#35[Y=,8%!_@[^J:=8EMZP MA?T7YU/0LTR2&IC$21,8>-H"-VUIBL+F33:B,BNO6HW$!.%O0HK"YO>6RXDH MO;M5DQ4VO[4>PNKE*RP>;ASV1%BL@+G:@Q:*:F"LO2T3N@6-*.D'7WQFU[)Y((M M(+[@:7`7D@N6_-TD%YCD@NQ1REJ'22YH(#.K\MVWFT7-/U%.-FT@63@!:1+?-(WT[OZ#Q3 MA?(I`I,!XOAE]PD$7Q&\/F$[S)C;//Y3$^JIC<(55J7AH.*?PS3^4U99Z/E* M'BC9O4S_CC./)ECV6('NK2-8@BF<#6\46[2I&O\!CZ$V$6/>Y7,QP\)EV+'0/B5R=6-RPHZ(*"E*Z_"E<1_-@ M>WN/COW,O\?N#+C%T@`4B(_V65],<']:OJN.7@X.M5IR0<"Q7/XCU^7:@IP2 M23DO)(RL1JG*C\EX:E8G9-I]G,S"@G5Y7/.![=+&'L1P)5+L4/%UE-`9[==` M&;#.X@.")?+Q=Z&-V\0C2E6P\&A8$AV09J.HA<\9WTCMJ?Y;VL\C8"UXV%TUQL9_(]K+%U]7@3FQ_$LTA M$BS3'S*3E%$>>BE%(R9_6F"1H'3B1%-]'R+"7@FM4&)`!VG"#`30>"QP7G[J MAY0&X/DBPA2=[)/U@X5AOJU_:Y6+,2Y([\D><-79ITA'1]*U'Y@8D'(JYHX!BL?>4A.6IUU/0 M4+I?BVF/U`:U''H:P0SC,-Y[#"7%&.CJ6@L[R0HCIQG7?8;81F7&U-)^;/&> M]>*`S"WDN`FTG.2UD=7P3U:R56XO*QP\IV2)2/3I8!I0>&"02!EICASO/(2% MW@`Q4@45@`E^^K0J]C\LXEP$2X).'TR\!==SR`'$&7.-Y,@M4YRU2FCZG2^' M5C[6A3)I;J@`%]2`LKH*KN:7/+*+%1&5N(QF84@$)A<$6*,52SU%,7-VEK3P M=W);%!PTCA[3-WR/L[X20-EUYPO$')%H?S9^`4M;A"CAI6E"LN[L^]##FU'> ME.E,N==$@09S7/(1IQKD-/9]!]8\CDP_"'3]HD%$"-\79B:@NX#E(-XL)Y"9 M!4V^B<)&%,A9$GA0-MV2?(,Z.^F/??Q(?0[0)IDL#WT_P4D!FGR&#<$;!,'( MPGH#I1*NV"&B4Y%_EBNQJ&#I@BNC+^*/\M7#6$NE"\G`R;))IP.^8%\.-K*? M:+JYW",V5S"=WHVL+SRU;3)J#O7E@/LV$\\81TQJD/%S8?LT=SC^XK2QS-T" MU;"KZO4AQ3SG-38@C62#.E2SXO0W?BS?'8^ME078CAS<7H^P"-^_\'W=Z-?@SOAZ.;JIQEK.0+NO[;="/B MR5D_I;N=;5:=5RG/3EJL8;-DLR<9=3K17;=-,].^N;$52'VN(?8!,XT;]J.3 MX2"O^(NXS304.S[ M?(*W"`_1N5V(01!92$BN0\YCXF=@9*:[9!H\<&>,U@ABSS2'$B:1&F>4?TDO M#/%[#N"$!T$46/2%&V,/O&1M6"!N1,J!$+ZO/D(66H)=JR#$.(,JJEJ!O47- M204YO&'JVV<$J/>FI1C(<&M15.93;?5JDZ&2I)I-&'^!TM(5;8@ MP9@JUCQ/C_"I@I[#EFL]9Q7_V`TE"?\PKE@AG<:?V,F$/;M4\XOU-`ZP>*'M MYC$S$%HC68N%0%SKY$37,&&N-S02@&L%K M0%42$3_$UO=\R]=I-N*%4C1?!.[W`L*=V1)AZ,A8HH$&S#]"**$T<]2:PVJ< M2IY:T=^8TPCEOMKY"RCI*+)VR\T-[62%3>V)M)YFHF]3#DI#N]FA`<^!X$4? MSX@Q8[\DIWG@>$'P.3Y49B86N38X7^?)]0)[4Y/ M=WPR-RO1FE8IQM4;6-I)-BZ6E`5;N8&XA)+B6T5Z2S$R)'1.B8(1:#)C"FI- M9/UDK_%S#P@S[.(G:'HP<2Q[SNYMYDXG?P$O?@$GHK)=H03'1)I(5X'4\YH` MQT^*B\,"@1WG2X#7*[F2S'>4[@T]^=X<7-01X5H^\W>3OQ*KB&MIX).R=4^7 MV?H]902,\$_9^,FD,'!`A4]BH#+B2+98TG\%40#[D5.!M-7)?EJJ3JIO,1BR M"FQ%1#3XE+.*VJZH74EB8S)S,['U<\*4PB7EB.+]YOSS`FDJV6Z.J-2[*?X)FAUQ(?N@C; MGLB*#24G>^9)&4X$@X]8/IU8`Q$UAH5<;]W)Y40R(T;%\K5$E\6?+"9+, M78V#7E1`\9%@$XFT1!A+$`@VE?:-FH80:76`!1%G3E8#<#46I?2TJ3+]H`\= MK&C/Y8.B`3_Z1]C$_B/+0A@3C:.D`5N$DFJ5[11*"J5V'U>BV.U*5#:EUB\% M?W/[16ML259-SK3R,5DH3"\?()`R8!F%HH(3/X'I7C'A84P^E`"]8J*`@W-4 MMF_)C93B`B:6[[\=/5J3/_7Z(?L.L9AH,=+EY30T/((>/[`W1W9QOMCX-5MH MCJO`\5-#Q@<0HS<1CIY;D,:G415CG`I7F^*1'IKB8B:VEW2)N1662;@1["V= M.H'G`7(Q^65`B*XR:7]/%B)K_DDH[%_1]#GMK.?EO([@0H?W:G4%&\"M8[WR MQZDYN)PU"V<#21P'$Z,@RTKIFW9$*([IX!#RE#,D,E5R%T`07J0J!Q9D`-9J M4?&5T^0"#Z4CG$ZS/%6K..>T^ARC_-0<8LG`R/U;NB_Q7Y M=D"N4:Z\G4OK-0;1X[_HP[G'$<^XC(1W:0HIXP"*&WL-V,)+*FA'UG MBA'"-0J$(FG4[*(R!"6.,[(F>WZDE4RI:7VL+U>3S\Z7+710Q226)^Y6NLX^ M<&30;52D=J@@$6W0>,H&0/-GSATBWVEH,89W`1SP9NZ:*Y\60M;YHM4.ZX=8 M&0?IPGY1U6G]<',QN!OWAS?,;SVZ'XZ'HYLZ18<3PV)J3YFWB'`H1)MN*6T( M7JO*HO$Z(O;_113TK%=4ZUH#;3FEL^5>#E^E(B^$]SR9!0@4#56&N:JG!B51 M^Q)OHTXI0M@%,79)B&/^2'3@;OL0=5KM#H`7_S8NJ@T$J_'"+WS;06WVVS8Z M@*K9]&7U,YG`]Z+G66Z%]FJ21T&G"A),*G-?0[@-J^3M/D"NX'_8/YYN/">X MC/#8NZ`B8.A>0,"2YS3T`',]_#X<]X%^$?F_A_'P>OA_^3^OT,WH^AY=/@R@ M2/?%;_V;;P-$B/YB=#.^&UTW\0`L$\P0CMR5.-8=O"I$LF`A'#`VVKOGG1+> M$_JU?.%6?A@ZKOWJ$M8TLQ>)[`6VE,@,0F4$.W&M,1ITY[)8_/@<`^[Q9+F4 MS#>M6\MG.EL\[;&X063/V8.J.#7UC0A5P?+)2K$^J+W]$:4RNAZ-V9!T77#) M$*:?5==$I#*,)FC**2O'[`L@*7GZKF2_^W-9<"P]A]P"W`L3$*U`^%M&2DFA M6*)V1ZVF;!M(*0-:L;`VX#RF)=$I0&XEJT@G+\R"9^"O<:ZX<(JBFX3F.=/W M@UXK-MWU;1<7GIUY#'N1WB\M::,^QD>@/N38JZSC:)%#'_MDQ&C(1']^.@,\ M2ME?K&Q3&GV-_26BXN;RBR=)K_B>B"JVZ.S3+"QSDZ14^%0^EO1?7!]]*Z*B M;#D97D4E0R98M M!6EKH&_PY%)7G_B7(CA6U<#LA2@V5C+"0PYU3W']%/0;RL/L]$AMD9WIMD4M M58&1T?S^A!P@>/3I">*^<_$E7,^5[SNH.8P7LWP2/3Z%JC@+LK],UM@3AK*F MCJRAQW%_]+H29IHIGZTDR5<(%5%#`"J@'%R4?93-N!TR8299\S$##N!/5A`E MSF]+R&04(?)J*LMDHM<'1,;I.KQL6.S-]!B.*"B*J)6ZZI!D`PPLWR7K![?8 MI\U3&E*=;@9CQ.-7#JY']_>?T>W@CFA'W[\3[>G^M_[=H*J*=(/#S+L;8<[P M+C>G?F.6.4#?Z2+942,JX_SM"W5.J6I]TJO8SD/6O1+WJ7@EOA)).B'VFAYJ MK3LNLQ=@731E&4#(3\@96YR!+MZ'7"ZZ&X'VKO<[IO5:.(AZGJPN?*RL0Y"7 MHI>V0W>6[D8#$]NC/)<"-HXRZ?;G".$Q5PU"AMW%88X[BIJTB&X-N/I#X*A' M"B1SQ2?C4/<@'B-;8T1$>@'UY"<7BA1R0Y`FGCPYL>*>K"?AB)R239]>M/%+ M3'K03ACLH4=].-E&/[GN&]2^E,Z/7CE9HU)/I?=LTV8!S!UU&*N7::$EWDN@ MWL,`*]6?K?X-#J5@YN7\TLM/-8O]%RSQ.)T_#?]D(6/L#%C45?:*:?FF6'^' MQ4/KG/`@G@FAAO91#-W:>Q28D1GI1NA6N$^&S,PH1R"J#TH^CVZ5/X-N' MT8QV893PM++?EV,G#'5]R!$+UK#GB#&:)5\^L)/X&D,O#"7;!V$W1P-7R@9> MXPG$CGA#D&;$24*,^5OEJX:$S*@4@4&DZN:7-$K:QQPIE0S!!5=GZF6.O._] M_QF@;Z/1)1K<7]R-?F<1,96#Y+]#0/PWCYBT@V#B>Z\")/VD_BP/"(BK:FJ3 MYV90[AL235AV.IT06<^TA*T+S_$NCYV![Q3$S%"'-QKD"S_U%<7C(+E0QW7?(@)KQY'=UP8H9'/D)?"-/,QJPLO"(\N'"_0);@_ M0ID('&A+I]@.#D*/?`.*.6$>(OP]^;1?KT>H)O1>%#S_HU$.OEN^5(\X9D8'0@B3M^>+T^3^8KIVO`;]X60 MK"V'T]`RO[F20=:<%MZ3Z/U3IQ"C]*X+8"G2@$/4;OT%8DK$#UTWFM,^2(3" MT4%;9^!FHJVS8>IR#9U(2G-P)D!,9#:^_:(O>+QPK$F6@V9V_.Q[@92) MY'L3C*>9U$<"N8.M0!?3]:F=O;:06]&/GJ,@))=01=T\/3T[,= M@*3,8W$IJ26RIVZK0&@9\67$EQ%?1GP9\;5FUKZ^J=^#^/J]?W?7OQG7-MU2 MAJ`7>24%'3JP=2(BSC&@>7,1L1"M`*/V8>N4'@1WSAS&PD[#J)^???Q,[K\( MF9>I^9WKRRAF?VCSG5E1`:CD[/F2?R+Y4.0I?"_<8U'@2SJP[<^*'XI($/Y\ MWCOL=KO"!TD.BQYJU:DL00%+"X(GD`J MGYZT!*$LYNL6Y]PKZU>:EOX?N#;$WU M>UKQGU/J_6V?Y5'J>(-OEH/>9UT=-4UF8[I1H3!L10.26MGN=YKQ7:V>7 M9O1!1JC.:P5:&FT\'HW[U^AV-![C\62"JM#+6D,$%2 M'.K""F97CO<:W-&"F.0G[)L-%3*XZ-__AJZN1[_?H[O![>AN3)A?56-#+&:6 MK\>M:O;3Z?+Z!$<=X?Y*G3323Y=TS]"]@ZK*;M-J8:PI%:!6^(,?8UE5/%;* MR>9MJ2;87L35,*TWIK]J--P)E.',I%"+Y3>4S4I%13,(L>AYRSCB6&E%&73A MS\S4R>Q,ZN_#ZQMK]58HI?3"*[2JBW].,9F#5ZF#MB`6U,`B6NVSY[_)%9^F MK#,Z,\RFMD^K].LJ-D`!4P*88V>/D;=5Y\6_AO%$[./$?@L87*S"Q!(R[&E` MJ$22Z6<:,I2.GY&>\`&DM"=$6A3.GYR\B.+DL(0/H3L&M;-R%2&2DC8>BK&- MH&5W5*8_B3.]Y3I,$0*5VRZ3V^M'#![A4T4W$UZ1:#5PU8R$_H-8IQ0C=@BU M<-/VL;QY#OA47&TWY/A4X5=33V@9NN2P-"C4("Y;4;VXPC&C<]Z/+F:W:!+Y M4$-:9'=0YOJ%V-;T-018-K:?W>2+`O\^9"U,2KE1V,_E>G>Y&!Z?]MMB%4.$ M&EQ9M&2%!^W:(]=*RR%;Y^S10"%"SFH1BI.Y#`DTIHG0`4=1;K<3NZB["*NS M+6XCT#YD!1CX)SQ;$6J,"]K)[)F5D'^V75!O*$IX)!.O),V*M@#8!6VF93RG MA*"_Q#%D4L41A8BR7=IK,UNA^M&+Y*HX7%AFUM,Y=&+!N83_RAT:6/U"0(WM M9K@`44\2)E"F[TK>)Z;SA"GDG_#7D3GE"&D=H?$:2)I,4W4W;#[#B;C%V>6.X8U$JL"8C&B;(JL?+ MY>L4+MBDWQPKUYLX3XD&7:I5A_ZADKUTZ#O;/\#;2>NH]47$Y"JUT\JTF`$& M3`YT<$'VX=`J1JR/94"+(B[9&W^KB5&AD\*L__24\$LXO="W'R/>AH`:7W_IWFNKX0GMI'__,+A$_8N+T<,-6+W0A/)F!/6]O]>YM(P>TEFI1[%_ M=WF/'FXO^V,(R#RF$;Y'K?.J:PSAMA/SFA:Y$\P8,FOVP9^"PTFBC@'SL*`7 M[,;351'C6^+/2<,;LNUO$(!Z?W0$D>"_#Z^O$<$$&HU_&]S]#8T']Q0]R=^N M1G=H^/VV/[P#]//ZP=RP(]>N>-5\<#%M=1]#;=,GN<">+QS[Z0W-B#6UB!X) M/65T"-=SV>UIDF2G(/70*#9?NL+XZD-(NJ`_GS-&N1 M+*`@;8@4?=@EF4^NJ2]'_D`7+YUH_3>Q:&BM3;$E,GHBN@N\DTK6:5(2-^^P M*&J'F&^"J-.A"%I8Q5Q6&CFQ#(0I(Y>MY)`=\7*KT$T,^JYDE"\60T4;)K'0 M$WW;]GAC\@SRUI)V!/1IE[5K9\;!JW<4A'B!XH,7#EC'Z*&QTQ02#^Q'9KZ- MO04AQ6Y/C#A)>I5B@1R8*IC0M>Q1B9NN:_OMP"'PUD&4S\?E\'"&990^B&HR86*NQ2<[-%KK0=&$)P,:M4]3#6L@!MS\'C+NG2P M)&CJ*LC6H>9-G$372V(2@8GD$S,\U%8H3?(+VSW>?@`-+-_A7E50O""8BC*$ ML$8[]O*BJDP6F594Q;LI(:DD(W5#,JO=YC+K:_^Z3Z0_NO]M,!C_39CG^E#_Z^AA+/Q[='5U/QA3_[GPI7ORV3T5?-?#_M?A]7`\)+/0]31` MI3(OP7VQ=$O:@:4\@-QNKI++A;#UIJ_.ZPE%ML/8D/>QD^D.)50>I3(6N[0F M*%4A>;US92]&'6_T6+%V6K=.<`TR95O>C;0TKQ>N4HTU;?]T.Z;A*G#'XUKE M@FW#]`@B'FTJ-27G#*CNOAT00-(>:`3@5'_0J?T6A%N"\R+#AVV%:[Y$&VQF M_S"A1[:0*6#^K=^_Y6XJ3QO.$X.,1.`82,K#S"TZO+J[K\5UJ<@CMU_/?7G+ M#95L6LI[=181<&3T#XM,3`0]*W'2/60=HSBOCWOSL495_(0Y*/QO:^?&G:-6 MIP8W_D=$Y`B-_]/:!U4X[#+(RE@%Z&`\NAU>@";T.3$0AC>7@ZOAS7`\.+H> M_B`66SJ)9BW.K427XLD M3U66>:S'9=]`GS">0E-)D=/KG_D"Z`R6;RNCK$6/?RZHS,KQ18G:J#C/-V-2 M6+&ES!J98<0G(UI55I#:@87?I'U?XZXOPN(D?ND%$6N%AOYR2<)]QD MY[6D%[1F#++]UBGO9)TP)4V-?)_K]+'Q'IOLZ<\%,UU;`#H?/%!@E'.&_^IAR@0C'O-,GJ3GWH\*)`$'?&AU)+.@A=0J4,*"IZ:I\AR M,^.4`VQ1%.O\6L1\L'B_3I5**M(G=0DH)$DL/SJB+!JPMD,RR*SE=M;$TQZ# MVH?`WM4JN>43I_X(F)$\Q=@Q\)5\4ON(@W2AI=AM_['-LY)XJH=3Q& M(;UK;]J0D?2.I#W+X2%=.)]#:'/%(_P.N92F?6HM!#5.?#`/8\-==R_"3$]O MN9.WRLQ4T&B35):0+KQ>V5.;-KX=/1&!SI_EQN#:J$V4TJ,NZR`I[3P05@?6 M]`MA5(E!#G:X%<1/P.^V)XDID+BGH\LX@\D5.UON)Q&:T?L>\:;1\R(:O;%8 M[)_(H2NL=!_2>^%S2U-LM2[Y999,C7X M2JRVYNE+]_)0?^$^Q"^VA7X0THRD9G=;XP>@F8VQ[]NA![?F:97"Z!L&-5.& M?>L`*8%LMUI_T;Y#T&[OP$2(BG\=3M>8ZHR^DA.U@QGZ8?O$YD;#P"%J=8E6 M185TVP_(_]!.M9NI6*WL9O^!_[GOG^W_1.OM1=:5Q"UOQQNH4YN$R1= MEG#&>#)S\>OZ:>==40=C>)WS7:8.`=RS%3/*.1[D0/;)#$\C!X^>^D3% MBYN5WN-)Y%./P8#W2[WRO?D%;17,>VEGTT\;\6N8)K'OU"%C1KL_,DUBS:B8 M0%0?FB:Q9K1^RC--8LU(21A%WC%#)F:T;R/3)-:,]F-DFL2:T8H\K>SW39-8 M,S)-8NOB;_L@[.;(-(DUHZU=2M,DUHS62F"F2:P9;?#L51\V$T%FFL2:)K'Y MM"_3)-8TB35-8I73FRY["]-ESW39,Z,]&9DFL49\&?%EQ)<17SO#DM_?R#2) M+11?IDEL?%U-DUCY5$R36-,DMD$699K$FM%.CDR36#-:?LZF2:P9K8FTUMHD MMOGT7BE[^)(V6<33"R\(@PMK88>68_\'3V^AY+<][;M36F"M3\ND7B9UT&OG M"O/Y:?=$%]J`T@9'`7WX9`I2DDEL4FK-:-DM*A^456%R5I=BNS%<)A9TKT:[ M5J*"!949-FE&.O?1:H3?TM%F[J_R<#KMPXZVVO\=!E^N^)QL1N][ MA+9(BNU>@6]F)!=+-Z/W/4*=P]/S77BL.#ELGWTQNO>[&C6DD>R2[BW\QM"J M&>7(AQ@OIX>M]J:,E]/SP_.S$[5/O*[36O*`W_K>`OOAVZUCN2'Y*3S;4V.S M`1\WFYE:L3B>5HQ:H9U-IA!H!GW]#EEK8VLRB>81Z\LVQ62NB/[-B&-^W4TX-KD)O<=>I>-L'_E+=M7;\'J?A/'9X9?.1M:75NT>MKJG MFD.\+E([MW]:VQ^A@[/3SD;DAW+UXC^;8%@S4E'-+HD)X3>&5LTH1SZR?&R? M=C>^:I%\W#Z"S&B+Q%D]NK?.8DK/YW)G9=+#N,^:Q=-F4Y[C/3?4O'C[Y_'^ M1L8WN#E4[X9OT'@$MTL%'\\CN*H?T,3<-39JU`ZKE>VX;$)-!F2B0B#??I[M MO'>O`@[:&W+(M0]/N[W#;F,E`#_5^K7VQ',.06ON^>&:>G[O^@@=]$X.>^W6 MUOQ_JYW=]F&KL)OM@[#?H\T+!>%7[X<.S:@FV1`!USMO'9Y]V7$!MWU4F='& MB;-.GOZR"25O70GWFZ:%]Y7MVB&^ME_P=.B&EOL,I2!9'./7M^_6OSS_PK&" MH+87[W?\&-A2X3YEEAT-2PSR$8O"!U;VZ^*W(9Y1_&ZJ48J?BKJEMKZC*0ZP M^R/CQ]PNQ_@$E$X^('&:D88@-N:;K.]S3"(,[S#5T&XM'PJ1_FZ'L]]G MWGP\P[P$_6_6=.Q;;F#1FNI!,_&'?%&T8*NRTO.O,UX:/6X6,K.F*!361I:/ M*[L*XR7Y1K=/+?LS0A1W<`(S>Z%![Y'\W_:!WI\1DA"G1N\W[/G/&'UU+/=/ M[#Y:?VZO"!*Z]7%@3\'NAG3!P'YV[2=[8D%;5NA*,?.<*?:YC]](QR8Q'W<% MJ<@"K_$+]BU"1D/:"(6VWT#7UQ<-0==W$9G1#M^0]^JRMKQ4/OB>XY!_L@ZV M:!%3CR&-)DEC^56L2SWT$12_(B&0\-J>V](S8&EP;SSW**8-:'P<=[%##.2J M,'[SO5?L!^C^S<4^`?`VQ.@ZG#;46\50^'IIN/C/ZZ?P;Q'1F_\S\R+T&[8< MHI&FI-X2%:.AJ"_FO/.:.I@.(# MVYW@!>B^Y@GC#93*5!;(K,@R#>%^ M\%$NK&%90()4MN'!)4J[YT_Q],&=>.[4!G>OY=Q&_F1F!7CTZ-C/+/A5T8.J M3(H>FT MZ!7[NO??!B(AKLCN+0=!JC*X/2&^)$X;7SXG`-A%!SZ>6[8K!.P\L4G?R*0[ M59AK?T;H$SIM%?1+E<_@9/L`F]''&Z'V23D:W<>1L;<_S,@8^F;T$4;H4Z?U M?AFV&7V4T9(^'+5,/TWMOTO\S_DZLV!?LAY#'BUPOA+AWZPUF1J:0W@DTM0$V`G&4_$CHB$32G*P%>C2L3^UF:TK)(DC<7*8M!FB7L8QD;[L1>6(X,_9*+!(%F`G8G$S^2EE+< MK#B`?-F%6('``2_ M.&^>=Q5Q;J,3&)W`Z`0U=`+!+V-T`JH3M`_/SMM9G>#DL'=^:G0",]KUT0HZ M0>-1`+5U`@$VZI45_GU67TF0V/>ZU(7"1\@/H"YPT4R8YB.&W1">=7)Z?M9+ MY;3.STZ^_#JS)S.!+)>=:RR8Y:/=5@Y"D*=:`:5"8I!Z5'NXI\A M*M"19#3DM"7-K%2'2JM5B:5M8V3#+#N%5R/G]F"$.ME+L*7UFQ%.(A?JM@ID MDY%2[U-*K7"N1DH9*66DU%Z,MBVE*D!L\B#-2*2&;80`[%PZN4EPV(/1IY-M M,%OTZND'H1S1%=^A.G&@* M39;&O@59L/T)^88-]=-K1WR/B>H=T@CO1^QXK[%.'A#U.XCFCHC@\?EH_9AN]@0P(K'!RD+;LX9&VE MGHC]JEF+[(P@X!=/W)<7A:+-)EG293Q`;(42N]PA%I"CEV.XB"@-T`+U>'-3]?+PK6H09[=,(70%Q_J#$^9W1 M[-QT-#&C)53S0)D3YSUH2'G1CM&,L68V-#HJ^&_':,*,-G3W4I7:4,"['R7Z M+V)]:,V1?\@1L45B\[*A&D^E1?C8"RW'D-V''(E==;>QLH;LOEH.O+@?9AZ# MMX^O[8_0IX.3=OOPO-5;8RTX<1'U"5&F@9XMVPV0YR/'(\)+)[N@I)WEV/_! MTU\B-QY^YKXF/"6#$A494MAN<`B_]>88'<"ZC>/A@Q@_G6[[L-=I;VMY%*^_ MPM&/PAGV:<"%CV?8#8B*O%Y2V")?WCX0JP"[PB'&E6."PR2T*F"=F7$8.CA3 MXW/71^_YI,:Q_Q\EGG[P[\-+`O=>[3G#?;]G9T;O9X0VJJ*C9?Y'HYR7P>(! M="[HG)]L1"415OMXZOI'&Z&S[N%9IR'1VP0@1H%7W=F9T?L>[9@J+_QHB:Z?:Z2R?5QN!(.?#MJMT\/>:7N]WO9D$<,@ MUH+A[8-0=O3W30:&H[^7CP>O&.:]2MAXX['A+"".@S"0Q3;P M9N*!S6C)U:'=Q'[G=),2_O8AV_41ZB_LR1JG/_AFV>YG=`V9U.:6KODLB^)7 MB_\KO439+S:L6@M;,V1D1F;TCD?H#D\<*PAHLACTLC$WWHQV>H18U&[3LPH) M;6+F9NG?7]#L5_`[5_JYO+RY@PV>[*4B]W;)3VX\]TB5LJO\,K>$=G0O:YQ& M/:&AW373P#U-:M^[I38(=]$U;1P`=)VOCM#0?.8JK9DF-OX@M8.355Z^>0": M?B-_Q(N31 M=:U=D:9&2JZVVD;S?79SA)9="B,+S6B?1TH9LRO96+LT0@<,*XU(QYT./3=B M-1.++>SYR7,<[Q7*-J>?T4AM)8;2N&WEGVWWR?/G+%!']7<"\03[ MKK2:\&^"?V)W9`X\J3:GT6+:B=XTTE4J.-$Y[B.R8X M-%(=QWZ/TLT-4MK9^X,O$>R[YNG-"]::3K;_@GWKN:$X&#,2,&H(MD&DWN&Y M9>ODNIH18]!FQ$:(2WZP_5VFHQK;-617F]@NB-[K6Y,P6A9GN\_K&E7.^K-TF3FZN])=7FU*00_QG=0G]5M0FW M1.E'![:+H&UO^8I`;+4F]J4U2RL#I<93"=UY67UF5/QG_4]JX6EM0!FI94;[ M.])%57UJ'9^>M'H;!J81ORXZ.3ZM-\$G5'7W=790&VYQ!WP#A4Q\PX?;G,.E M$3`VNX/:<.?!J.JU-5?['5_M[79HK;4N:F2":I/4V4%MN/-@+'M#6_$YC#ZJ M/=G.WRX'=\,?_?'PQV!X_@^N!G?;Z9P4:9:D8T#\^RTI1&WT=?@^*CA M0DC<@$6>*3'9VBH=C(7ZS\\^?K9"X]E>.VFM*:6:^200==AMB4`K+'9'2*ZQ M6X:&;NC;;F!/#!6O^^`VF*A]2Q@Q76Z=:]3U,I:G45Y;>XU+4.[?V!78J;>S M71IMSD6PB?K"]1W(*^]F[9M94OWXN^5/9CL9?ZK9TQHG_V06WYFCT*<=?@/- ML7S8P_L;;3BN>7-^P`TN)2S*\]W8/NC'0-G)T`T_;S6B-D-.7[>QPIK M7V.CW<&,Y=[HHCMFN0O?UN@SEN_B*>TG*B3>'IKJ`+M$7X:4=TS,[ZB95#PR M8GZE%;8EYI>R[`?W!0J1VA12(ZG2PKHK)&G&6QBSNOF#; M&@/Y;CN$J7FN:>E8$8&7$"2ZK<4'P<3W7N/@LWTB\PUKQC#/7':EXV].0)&>_(0,E*)28HIO.] M>OZ?Z-4.9^B'C4/7FM<%'4K(V6$4$G`/K,_H.Y[:$\M!MXX4@YY^#;J\_6:Y MGBU.T(WGAS-"J\*G%QB*7#3> M+N_]C5`7G%74857S%&.BW/J6WO-H+[T^[WD44'T3>:ZCZUMVT,UQ>N'?P/.% M?SY9OG"#T-QRK6(ON)OC:\SG#=OK^(Z">O MV-=I)$2KTA:\"6?J++U;WWLAO[0U6@RH+.F_;G+Z62W$_$ZHB`CY]OD:GR]0 M__J:Z'R1CP[*%,0M9H)$^_H74?F"':`J,]J%$9I:;[10K^9Z-;3*//45:;B^ MV!<"C:T_,?)>B(Z?N%X`4"R7E<.\K$% MWMB#__59]N2NP5>;I._?L._ZGN.0[P]!#I,CI#\*PF`,;\ZU';S00'F2+L)L M:+(*S`?+X"DGS;0\MDGDWYL1*YUH/T8A"U0!>1C-#$6MCA9A@V(IINL&E-&PW=B3??3#6)6/76VLH&-XG+ MRO%M/,X=6>%>5(+8DPBQ#27LK`4;I1]>5L*&)M<]\GUP$"VP;WM3A`4%:CM2 M:T/G=O#E[+#;/=^I3G$;W[N1UOLPVF`,^'O;3GV1W&SR69T?;U?NKI]?;EFQ M,$QQKT:H@3K6Y5;82(GN36XGE\^PRFN5)LWA*@HC'W^W77L>S>^(0FDYM]8; M#1RY\OP1BS)TGZ^Q133*9MZ_V))HSM9$"[Z$@XO7W#[YF=%:+W>?$R&Z9:2W0D^_[8_0#0[1+;^` M^U6NQ8QJ'OV1ZK_=@F8?"D":D1F9T8JWG2BG-#/87&\S,J-]'D'O5XB.?O*] MNH6P=GVTYX\D9K2KHU@:KDZ1_85O.ZC-0K3:[_S^F9$951LA&KAIS[FP4G[E MP'8G>`%.0A/G;$8;I<[M@]#T:.!.U]D9#PHV>='SS%S4=SJ2PL^7?#7)#-[\ MTM)7#2U^Q-'&TM%W+N]]"P`9*^>CC=94K6(KE3=HK`?W`+L05!>C"\Q=>-G1FUT<-V5/=X[-U4F+OY+B]"Y38 M;AUW=Y$2MX\:,UK+@1MY7GT!BJ,K&G:G5D>Y9,4EEJ9^2R&%7(.DB8"%]Y\[KFLR>0P""(\[;O3410& MH>5"IQ<4N3;+3&#?^:N4K3!LMUNGG>Y?T11/[+GE!.2CFZN__O?9E_,6_,=* MORQ;0PG,/:T9.,4^GEYY_@64RG)8J]EJ('6[+0U(^I4*L$2^*?1L&#VU6ZW1 M4W,(;'=TT*ZXO'(+OV%G.G1Y@]%*\)WJP!.G3M:^Q3Y0I?6,1T_L:W>84'%` M/L/3T=-XAD70W3SJ;HD-70ZPUC'DSS"X*BZK`OO5Q=.O;_?4J.\'Q+`O!*W3 M.FOU%*"=)2@KF%J__!A/9BY^K;9V5[\VGU<@%=X5@I`6^?)W\L]9NNC#_66Y M-3,DG)\S69`6TQ>_47>UW(3)4M^M/_$WSYLR"NW'A9HRS`FH&%I'$1*)OPC5 MG`JO2B9S*\=_1/CJ0+&1K;1;)VVRE;9R*Z>-;X4R*_ER*4/ MDF>T9E8=U)]T3D]/SQ(Z+%YI.4QOW=9F0.(++8.H'SU'07A:&Z9VN]<1[^N2 MM>3;>TN^Y(:VY3AO@O2YM)T(&K^*$J(6C+U6J]?MG@BWO/S"ZP*X_%VI"O"M MCZ&%Q1T174"GY#Y=XA?L>(NY=)5SO'+0[N3Y9+?;/>6"H&C:)A;_IX+(.N1G:G& M,JK3Z5%:+5P,3H[VWEF5\$[/^36@OUYE+@6D)^VS+]G9,JGY^=%*[$+@EK\DUNQX`H_/1N#(*0S$24V(<`/T7.M?V$ M>W^0.Q2LN->S+YWD*JZPRCI@4R"HVTH9517HKFF7O4DTC^@[ZR7H_A/;6J)? MJO!T=';:89`4S%E_704.6N6752$)DI)7)(GV:5>/=#)?O?56/F9Q16JG>([W M_'9G/\]4%-"N=`W(EGO=1$:77:1IL/2GOSI(&7KISSVBROVG$NGW3GIM-16* ML]9?N33Q*YY4H+K@/.0DNN%YN=%>",=;R,51W$ ME4Z*W%WM5J=]DE=3>]RN7#)U_>7;K;;"[MG8\FKW^.8VW\KC?I75@6#B8O=W MA$N-W.RWEWFY5:??.FXG3H7BV1L"0NUJ7QD(PJW]"$_C;X]9\LEXAJ$]-WV] M(K\+ECF`U21)Y/27UO%)*A?*K=0\;`J*Z9QWVL=?.E5!$YU"\$2E/3S-$XX: M7[HG',4*#4*BP,Y)94""S!<#^AAVZ]ONQ%Y83C7$$&O@M"U"LV25QF%2L9QV MY_R\.DSWH3?Y,[C%/OV50,#!-/ZP'&Y:Q[''0#5Q(ZLJ=E]Z59E88J?UC?=" MDXO:X+=NK^Y[*S]WHZ"HW(V]ELY#7Q6B?UAN9/EO[*NO@G]B?V`&QP^T))BL]8V)[!TS0-+Z819!D/6-IS34L\V39_HOE M1-B"L"[L/=F$7N''Z]C2\[./G\DJ-H1.N($]H2N77>D;'"YMA57ZA;M7G-+EZ.;AAF MI\8VNQI%J99=\-:/:R,HND"M!:L04_U55R.D^NM5(*(&-KDJ`.I"Q(N,J@N#!?<'!4J.@/$GR->-I*ZRSNL2KL=@J M@J[&,BO+MSI;6HTZ4(_.3[=&LBO&$*$\'1EKK@A4''* M:-CQ"Q_LQ/$+\.S+\0L@;^?X2^A*Z[S^[;6!N$8*6!_0:Z"!AH%=!Q-8'XC[ M0P3K903"DS--K`Y9J6C0(0E6`J)%7GM!4/A2E3&S)W$B)X'3G5K3*4UZMAQ( ME[#=B;6P0\O1^@$+@6@<5LQ_2@!UZ$_SL:M?SKK=\ZT`YT&JS,2;+WP\PT2O M>R%42?Z)]4^EFX4OA/='UW/I@7ODVKC/-H^2:@*-_6^WUQ=>Y$SO\`23S?>O M,"'AA\78ZYQ!^,`]L/*%Y^-+LO;J@>*=LY.$`:VZE#)5'H)=B)I/:/W&"R$* M?CRSA.BS?*2>,D;CN-519'ZK)T_`N++]((1@<=KPDG?"7!$?W?1A63E=LMB] M_9/F@]=8BR>NZ69+22`V;>[Q)/+M\*U:0MY)NIQNQA258F=1H:?H>(:O[&!B M.8"73JO=K;[ETDNL#-1)C3,ON\3*0/76#U1O9:!.UP_4:3%0-'IC52)J+:$B M.JF2.]$@/!8[4X$GG:MXDC!ERAS8M;)IK..5[5KN1"H-4HXU"^Q!.9_PPDUD MQJWO33">KBH`>D(HC32/:C,5=](^5^VD>!MCCU`2X?<+RRU*)5EI2^*<8LA6 M$#DAZ)A$W@6KAEJF)4JR$XFI5$F355Y;EY?6O0WQ=4C$+4T%NH62ND54N20G MI75\\B7.5EYER37`69B30BY2@K/:<+(2-''%6J%@;2U$MEM=!8#:M9J$K!+J MED-&6:+XDUKX.6W%"5JY>:NN6'K?^A7C7LP\E:4?UB%BM0@XH943*BVV-C!5 M0:/'[=.3Y@&M1-(:6=H]T\&WG)@;`TR)NMY)NSIHE#HSOZM`9J<=D=HS\]59 M3+GCLU:OS')BFDL_"F>>;_\'3\<>57Z6>G)TN3RJ))K<[.5@(.3[`QY]2F1M M:*BRU2X!3+Q,JB'I2_)EJ+!Z\;]E:R@QM&+=O>7NN/PA-E7SKZW<@%B9KP)T MI2K^I2OW7>ILRJ%Z^?D1EJ$VEA*+6S.UD//]2%#D/@O)0OV04%JY#"0M`'&2 MMWIR)<[O/8=0^LC%0_I&ZOG5MJ]+D,M-KTK`HJ[9&EM7)E_1256KT=MQ-:F+?8_\%W.75P%35,5UMW?0U@1`-.4BBK=`9RI0[TT%U)N1? M*:=-.7Q"/V4%C&[-E#(S\+-&X>*O+%RB` MA7SAGQ%1$PO+7^F@^-(]ZVF!2&=6WASZ/2Z!B>BX)X*O$`)(BCK5I'6I+HQB M?G62[`I:A@Z*G*:1F5I![.*ER?BORDK#;D]![;EY9:VFCC[5/NZ)RHN\L\3] MLZS"A=+#`[ZQV$LOSJ/B$G'.\8WGQ@H3T6I9F3CL7^$*JBM]#\GQC:4+R:BM MJ:VVC[M?!.QJE-+L"J5<6N>=A$>ED^1/CFR5L*\7PKMO'6N"E[R`P%TX;RFK M8[9RAZF8.O\<4K[>)5L[?P^)XIV6-%7.JU1.5DD.5R^R6OLM9W;JS1SLO20!P>.GC3^[%6V+%*59F*!5]CSQ\@G:+@F MY^^`\W95!W='X`>YR10O$1=6,$L?,YMYBI#G5'O5^GY65+@ M,IU/A3HPKL$36NWEY^0DE6+Z29>ON^JSUI=.IWV^9%GA;H)[XP5?63:3;[0$ MOFC'NM/?>8C0RAG^9V?GG?C6EE]&O,["!BH?>.)OO_SR^OIZ'.#)\;/W\LO%\'\(!*U6 M^Z3[Y;Q-]+7T9VS.7X1)?UTD'BCRCR"T_!`JN/PW.%*.6B='X#=)/V7?PNXT M_0[YOVX;IIPFW_CUEW327W_A6\QM=]CNMMKM\ZWLTZ:-?$+809=L\0B$=?Q9 M^1V`R-HR]`G^*T'_S^U0F01_JUL1_C\(_">[<$O:K37>DDRDQM:WVP:FT"[> M;KOZ=O]HMW?A4-LE#K7&+OG[UO_C??;*,8W5]KU$.'^J2;)Q=A+3E'?,/&>*_0#3[4SQ$X"U5RA/ M'L#Y3MBW+ME.=A+O&DMKGY`>?^U&VDI:M&!:QO<"169`W[BA^'T1=WYS",W@76CH&X&ST;CW`;6C0JY>9P;G7#= M>,X6]S-J7['RO>90K5RM1:,E[LQA&*5R#P[)Z*`[>2Q&9=V#0S(:[LX?D5&( M=^-8:#J3T96+C9(Z`?-&]5TC;HTFNWF<&\5T$U@V>N;F<6[4QDUCW&B!Z\9R M7!=O;6A=>_3KH+WUE,-V'?QW6F>MWK9W0*R(LR,HC5*-@J#XZ=;/H'5ZU.E6 MW$&[M1-4U*+A+M7.H-/>3I:C?`:$%9U4/H/6#NP`LC0K[8`_GBJ;C>Z;T+JA MNQ@]\8(YK,[,3CWG\1(3^I:K^X9RJ1X5;7,6EP;:0;PK^[;M&\;[;!,2XG<0 MU_H6O/N&\*0T5S^\(U]F5<1A)SN(=5TSXGW#>5(2 M$*:-&-X"=1NINE%\QW+22YNT<1&:?K!WR(^+N`N=Y[A$33_8AY/@K-ZG%=;) MO^E[O#4)(\MQ["=R1=ZPY>^?=J,X'BX/[N*=7J0[O28[';I047[W-"#%F;UB M^WD&!;??@YA6G-3O?'][(<'C\^&G`)V:&'<3/MC;0QFD>V#<3?A@'T[BG7,W MX33VG+L)9_8NN9MP4GO#W7+)D64Z/>S;`5VDN^J[TW>;IY?O@K%O!Q7'0)-3 MNJ8[V/]#T7<#V;?#&<%.+L2=#-E.]O^0BKJC[-LQT2A@Z"KZ+G+UXN;`:SN% M50(F*X8;LK:^6]Y!!SK%=$ZK[@":L6Y_!^>4TJKN8!?.@.R@TAF4[_6V;_QJ MD\I9@V]61M=:.XZ-ZK2E-"BC"6T:[Z6;+.[;&6R-N]<-]S?\?0-8-AQ^:Q4` M#8]?.^:AB@E%^[T8/3;'5A#Y^+]92-FOO\3_IC^/XN;MR6^AGZO\0SOP3CKM ML[^1ORS_M=#VF\TRM5_(R?"]P?=NHCGVK=#CQ[1\G?_B*V5^2">[Q*XWMUW5 M=(K]QC-E?_7K+RF4JEW=1LEVXMD6Y'_4V&`$0`;_'U!+`P04````"``/=$Y" M$GKYXCX"``#J"```%0`<`'-T978M,C`Q,C$R,S%?8V%L+GAM;%54"0`#S3L= M4`L``00E#@``!#D!``#-5M%JVS`4?6ZA_Z"E#WZ2%24K-"%9Z<(& M@[2,A,'>BB+?Q&*R920Y\?Y^DF-USN:D'0R:ESBZ.O><>^^1A2=W52;1%K01 M*I]&-.Y'"'*N$I%OII$P"M_>WHPPC>X^7%U.WF&,'D'-)-.E01B)ST("6I;" M0N!`[^/!D%*$,/894N0_QOYGQ0P@IY6;:2^UMA@3LMOMXFJE9:STA@SZ_2$) MP-[5Y<5%#1Y71APD[(8!3LGWA_F2IY`Q+')C6*Q M1"3Z::9RHZ1(F(7D(Y.>>ID"6--#=2-C^[.`:<^(K)`08JF&M8LY;AP8O0W7 MIPG)[Y(YD[R4]:&8N_6!%%06\@22(.9+_5\]^0J:$J3B;=E(^D.J=-1N,6I[ MMF9F5?M0&KQAK/#"E("T)D3\,"CNT^947C?AIWMCG/BLU!IR&P0D6X&<1MT8 M\D:%A,D(*9V`;B[G'8A-:O>+-S)KQDQZ MQ)1ZZ^R'OV^@>\B#,QGR5PT%$\FGJH#`@`5`!P`&UL550)``/-.QU1S3L=475X"P`!!"4.```$.0$``.U= MWW?;N+%^;L^Y_T-N^Y`G;^QDL]W=T[T]C$0Y;&52I>BDZFH(DW*5)7Y!T MXOWK+T!1%B4")"B!U,#E2[N1\6/F^T!@,!@,_OJW;_?AJT=$$AQ'O[R^^N[R M]2L4!?$"1ZM?7N,DOOCQQ_<_75R]_MO__-O;!2/0I]DR:N+5WB" M0_1JGN$4;=MX]?UW;]]=7;UZ=7'!:H0X^NUG]C]W?H)>T;ZBY)<_K=/TX>3U9NWEY?OWFP+_NF__OB'/^2%?_Z6X+T*7]]MBU^]^=?- M=!ZLT;U_@:,D]:.@J)C@GY/\]VD<^"E3K+G+5\(2[%\7VV(7[*>+J[<7[ZZ^ M^Y8L2H(N<;C739*B1^P',7GX+HCO:5-7;Z\H,J4:K,V68%2J%'!<_?333V_R MOY9+T^86Z7/Q%`:UXCS##&E]0\;7GT2D#A$+EJ^*O[SUK6J_>$H M?;/`]V^*,F_\,/S3JUS8G].G!_3+GQ)\_Q"B[6]K@I9".;:",Q[>,P;^S%I[ M<[),:RH(";([=$%_11$;R0IEY+5^NLS/;5TLT-+/PE2AQ-6VEI>NR4YMT(>2E@SF;S))<4+\NLX#C(*0;K]?R-:F%&* MTR=>I^A;BJ(%6FR[9?)W MH&@NRQN.,(K0'L51$H=XX:=H\<$/V;0X7R.4)L="+&ZP+US%$C`!"@G"."AW M^SIDZVM,7I2TH].;,HE):D$7_,VD2=U?P3"(;24*I->Z2 ME/A!*A#WH%!9U-U0-,B^T'3ZW#97S*3[,C=.M=O:2Q+?UT*W[3862OPJ2VCO M\0.3TP]?OXK)`I&-D7M6W$<9(6SJDH'_L.Q96>`/FRH#%07!$3'RD[4`]_Q/ M`&`6C)(RVALMP(%K!$&<16GBH@#A1S8UVR@MU!$-]KHJ>I!1KS6?I+?G(VE& MT(./%^:W!VHYHWIV^&7UH$6@)Y^/=T"6!IDE01/\#_3BX_[]N7&WXRAHL2IS MB@-@HYD&GIH`9Z;X`9'T:49W(?G^[O\R_,!LOVL2)R+;NJ$2`';$0VQ_NJI7 M'N)BG]UG(=LWCM$#00'.]^#TOT.48QPMC/N8I/CW_'>A?F+#0$WSVHP`=8#J M\V532ZGM=\VJ:,-IO>(*;9&J>VF)0SJD:'\$+3P4K*,XC%=/!V@+"H''5Z2< M0BM#A&CQD>Y]BUQ4N04U09:O)!_=]UV.U^H$(2ZG";9<%?G0_G"^*7O"X$-3 M_(@6H_C^(4L1FG(JS1(?*9_!,FTV*1JJ/02&*R92W\Z'UO4A(\33,?7@9("GH3%M6%( MK+!@&WMY;C]0K==''^"WR@A@/J.[8(K].QQ2W%!"]T'S-`Y^6\Z+T MJ<'])EU=@]-*>2C`;>1+HLL=9M94."M3;8>C@#_X!Y[;TZF9_\2.IN1.XPX* M0V&JQ6'7%1;G;.?%)25(XE?E5].1-``6XNI&*3#"VJNHII$Y37BRN1 MTN!.5NGF`!&4I%)3GZ"P1M2(U`5W\CK.D!<[RR4.Z'+KD/+B6\^11$6-^)*! M0:''55'\5!P](CHQLRB7.$5R9D5#)8TX:U(?G!M7>G72>UF27X_.Z)XM"2D= M=E)?!PI#IVRAM`A-&2."'_T4/Z*2Y$+W':\L%*ID'7AN11$6-").!00,; M0MIVT(D;GIK@/+DW.(I);OQL#!H!$Y5BP'A0;;M580&W.*D!H=/]W$L?):HH M`+>Z-FV!CPS/TG=?WPR(W,RN5FD_#$5#7R8"[3#)2B'SY7?O:>D\;]'/;+BB M;ZD9YN5^>9V@%>]RV9NSI=R9^@^;/GH[G0)XA.8^LJ)4/ M`6QRGGT'!26(S-=T$$@Y9X25-0B/E84!G.MF7_!*I6TXZNJ-CC[F2>PE219*XZ*"IKRLU47G/W)$];)4I:"E!G7+0@J MU]*4I3W%P3ES2F[D11)@P*?/ZS!E/D3A5PCHA1G*3.LA"P(4J+7U8# M_`5*@O,V;.2<(_*(`^'`/RAT5OAK1T^5@9UFX+X#)UTC(H4_KZ0>)'!U!/<1 ME.[T/C%AQ0O`83D]6.#H!\ZUMJ>,S&J@"?8'>H'SD^79PF8D7@HCT\HE-%AY M]Q0"-\R+'42T*C)_-[UV(2ZO`14URH+[#NPXPD7@2R'M&!,4T-Z2"1*NS$VU MSDI2XU@K<]6H/SC[B7WC*$ER>6HHJA33AY.JA@!-IP11]==&M!C3-2Z,\_S! MA7)",ZJNCC[T-.@.;NV9^Z%/,$H^^ZL\7&R;W8$E$*4BUZ7BZF'S$[#<&=4%ZCB"H4LGSWBWL*)5.&746OG_.::NE#4:/^ MX`XM*^K)VMH:L<+1$=Q)Y;.,5A3$]V@JSM/-*ZG3?J>L(+@)C%KZ\;Z@Q9AI MV(HVU].`(@GEP:>\;+2M?;#\+B^I$FUAS<[G82$X17T29I5_#D$9]N#@(FWW;D M?4!+6L83?GQM6M"/RE;X@-L/6_O^+@&#AZ7T8ZFB)[B-K14]4OG8G+U1JN$6 MJ+"XCMR(--?';FQK+VI(4XWNX,S%W>9C0A4?Q1$5.J-R[X+7-I/RIAR=FE%B M?J.:4\EQY).GW'9N=2N[RQXUV%-T"CBX7?RS%L47\`%%2'QX+"JM#:T<1<&] MM[0;@)N!5AU=1K08;1*P,$_=P6*[I5W>IZ0H:-].QJ,@"/`@?>4U"8FIL;K6BJ@`2=E=>`]*+5- M?+6]:O?!3W#`#HIQF*7""U--M32@I5%Q`5='>7GX[[1^1GBU9J\D/E+[:X7L MC.GD+'-Q2C>%ZBDYH2'`+)T"CX"X0P?.<+%*X<4J9[G)XU,DSLVJKI^S7KJJ$VRX@B4KZ@9#%MT21^Q@Q/B&&V]C<>MT]Z&O:4T29'?H@OY* MMUNE6"3!A[^'/_>CYZLM/@IJFA+.94OLJS'.%P&1!<$MV^&*M"7K8K$GEH"S MNH&X9T7P509WBG]4,.6OI9F';)#M5$OT^K2"1\2S%/;O:LJL.K)]6" M9S7S:@?>WOT3CH;@/J/2A?YZ%BKE-"&AJA^XLVY!CNU:/NKKZ,%-@][@3JT/ M4VO7$B0HK`:W]'&JKP.9( M3FN%A]'\3\.+Z=PH]TT(B\(&NEY+A<>Q?("W[KC//B%^E&[R&PDQKBL-'^9: M716>LO*1-K\A$N`$S0@.D,O.ZK8^:R'-Y3Q(AY#6% MX8-=IZG*`T(^SA,?DSS?HY&.Z0[?6;(<=BQGMQ#LIAKP$6_46>51H6!XKU8$ MK6CG='$F.$IPD`LD'N&UY>%#WJ!O#^=]F^6CG`6P6%EV/PC1;U$9/A5MD)`\ MSE/+2S$ANHA)3__-@N58S&7FAU.\I"/H"_*)V-PYM44M&6R'F8!6A;MCCH@' M1\IR*_MQ[6A)H0P^`N*.VF#7$U=TSX[/-K-#Z8=&MB0JZT.1#!("7A3NJ3G2 M*)HGCVU12P:5S),*=_(<$4^:)]NUHR6%)\R3"AT#^,9$)>%#+M11<&2HT&-0I.N\?R!HS2(''HL[ M*U="F)MJP(>[461QAEP=^-!+Z"T`7Z'WH.0Q+_+F"8SXR<6.` M*3X5)G"I-XS%_V:;_$V)%POXE:>QC;#?!*3299FY/E9A>U[2$[DT']2E+YG0XPY?[??A+=&F\^B M8=)7T`'@@=`%G/"2<]1.B-M$"OOC^^B5HZXYP`/A=*BZC_VKEPT%<;1HN[M2 MUBQ@:M5!UWVT(73IZD?6L.S$ M?FSSP"E7"V7W`8W\90A'=)]"Q^MV!;I]H!"O",IU-]*K]Y<5D=_^T(;]$WK0 M<0"<`FCWT8^B,9MD85J2F8KY[J>=F#<4MO6[JY;?O'R;.O+<#K3NPR-MQ$N. M5OX+<)2?%>@^9'&W1>=_PCZYO_$C?Y4+O*67[M_*+Y%R@%;2+'"6U$#7??AB M(:=`3`\%ZR@.X]63RT+VDCR:@+=1/:H9/2AL"4T?@8L<<>PX+9]-R"X_A]6` M4R*G>O'ZR]F+O:[S)SQ\3GEEP M1",:424+2_?AD?MB>+O.+18Y&*'\P9'/.%U[:S3W0[3-&9CG/'(B(UME22K: M<2EL'#BY*F'L/BR3#468)7)ZLS''$!!9]HZV;`4[D<="H#.F4 M^TYGH1]L]NRK_'T3]1_KJ3T`)UHYH((QT+5[A']2<]JI%G3N6@$AX$6]<^-* M[-WH-!&E0O>&,,WDVT/_QI")6F$FZL19,NMO$L9?U::>WFOXK+FF]R09DDN_ MO`L9=`9A!,](_(@7+*SL-F';SN=G>PVZEC[F!XE-3^&V;PCPY'H*/.#N?.P] MU2*F#\K#TL'[-`!)V0OBU%ZOY-#OIZ@4,D6XH`)?%>(P> MJ'&-?<[E(6Z1LS+;Y6=1YGX?%'BSPWU,4OQ[+IZSM*+4CU8LKL=($I0*PV'K M*_U'\-H$7/?W^/(G[A(K>KY0["QW+[%/L7^'0\P]Z96M^:)Y;`6APCN`K8ZN M=E&4\F=5I3HOG\!FV,!=_SNX85'_CK.@\(LFM@DHA1?Y6GR,6X=A0Q2-?-T7 MS6%+&.&]XUWDY"@NKY3.8TLZ.&04^ECH>VG7QHL>#D?""NZ&(86#(#]!8[3Y M?PH`NZBZ0R$W_MC!8&$[8'85/6W8-I_:Z@O8(9\,++@L#56-BK>HZ=07(&IB MBGW,4E7/2KJB[Z!^!/#P`K=_KHH](^C!QXMZNZZQVLNG]Q`G<.XL\8B<^4_Y M`^3$7[3_AO7B!V\;+;TY.#C9X<92WP0[< M1ET@_";L6D&T25U#^D:;U,(#SCZG,\\V-0W+UT@058<.SO1I%OI1RC+0T%\? M-E%\7&Y;-`#1Q2(QF,NBW;:X_$N@4@P&N&TT4[>87JBBYK<`)0D=>H=3SXEK7M?"`VXJ M+UL0Y=/Z,;J3L;$J52!^LQ(#5F1452$!;3274K9)$GA8XX7Q5P$$GA%&)4"<,#-J/*:G[Q:O@2*V\`%SAK.[?EHP?Z/;;0?Z1:< MG8+E:34/G;5UNR#9)C2PBMI!H@FC!AVCA#S1X9C'C[>B\K"NMAQ60`"W89EG M#P^;J]U^N+UG;$7+F-QOTI77[U)D:VM`H#00X,[R=@>.>%%W.KM?ZKR4M!MU M^P>N!]J"VUUL0H,]_QM*F)#BT_*]4OKR<:`MN.V"'4THA]]1^,E-]<.*8>.2SDTQDD0QDE&D.->&[;U M;\.S'-NPQ\[,=//_GA^;=$BFZ;[2#LG(TA_4\]N;&\/]XDSFUK5M3:R187O& M:.3"D0YK9X# M5HX8_6%KC&BGKCGVS-%'VYDZUU].1Y;39O^XYY9EC\Y,Y=7)* M1\[<4S`-B!KN'U^1)/V![)I3@PHP,^C7X[F&/3=&BFPT8KY MBI:3N>.9\97PSZWZ?#+&JX?Y1%DO0'\MATK4_4^/YD6O;<3BA[_ZI.D'8'CRHM["H65&Z[YUA.N8+TN9C>W%C>=M)B;%.F35N-CZ.N\7,LJF)I M>K5>1E2$PK'%!*&;`LMSK?D_E%@PPL;/8L4(I>G3H?>!+0U4$/J!*;%/*BV> MPTEW(`(T!^DL#G&`T=%9\8_N#ZK#]%E`:$SEYR"]\53T!I6E0KRS.695D<%O M]NQ.VC/`6_5FJL-8V#8,MVWO:%=]G*JP%K8,P9';.\X"7Z]3%>X-[<-Q]O:.O,`?J@KX^N;!N'][AYWKVU0%>EWC0-RXO0->=6''/L'KR7)WJULZ:UJ'X=<^Q;HH\<`K7SH8N0#D> M>Z)`&,DX1JF/PZ-Q;VRW+[`;!3G3=;+AJ!G%17>T17-[E%* M\%W&>J!BW-!_KKDS.Z<8<%3YJO$1_5$=HE[,+MF7^N;`62T#'$N.4GP@?QKN MIBIQ<,B%4]@F_=?(N3&GSGP^,UT6@N?8\X^&:Y[H"%'6?U\.$V4"#XX5^(Z5 M&_\W=!W'BXV9;JP(ROLY<#LP4_XS3M?41MP6K*9)/[DYX#/W:5#UX*QYSD9I MQVEARSO1#<5@_1=6FF^,--0!SHF$TCUX9P0R/+V[;(O[MHJNL#^KW(,SA2N" MD:VR)/VA'>[E2GHBOZ=VYZZ6W(:=T>ZC%%-#\JGD1AOCD%JUCZCL"!*9[2U: M`,Y*:T#D7"J#R7^W\\'JU,'JW#S.6'Z7T4Q2?,_>&+I-T#(+IWB)WG^A M=AIO2]ZN/N`)\`@P.G?.3E&2&$&0W6?YDT]C%G@18%]PJ%E7&CCPM8IV[HKE MT5Y-]%]7$CB\0@4[-SVKETE=Z_JC-[]VG3D[#!2DAF]5%3CX\A!T[X%E82UQ M&*^>7+Q:\Z:V*^%$+U\7.!\M0.@\A.U@WC/N8Y+BWR4G^+W2P$&O5;3S$#8Z MUYTR]%M5!TY$.R@Z#W\37'VO61:::@#'OU%AA?%Q:C8I$P8AFN)'M!C%]P]9 MBLCV'?!K$@N?TFZL!I@H>=7E@O!.,:"D5P=-5X:6J\+5I<+)!]TEE-_2R<,H M3M*$;_K7%`:.<)V:`I`/]["#?^\X_YYQX[C>[A;IV)RYYLC*_UFDC#K1Z2?? M05^>0'F)!O<@?/?@LR.X$SHPI7Q?X!-H"A,Y=@MLU$I=ER>\J M$K386?8\^T"R)G`RI`'HW&U8-E=VHA2K[>)PN:UA1+(!38B1A4/.]SA8'L=9 M'J+49I-;[]8U;RS;NKF]F1E?\CQ0)QHA1_75ESURE'"#:0+?-)G@)/!#YJ@R M\Y#9/'K_W56-ZZBI!O`)ME'ASHT/%S$U:*OYO>^=/!RLA46!@RQ6L7-[8I*E M&4$W%)'[['[F/S$Y>68#OQQP7`7*=7X`FR&Y&P]5"Z]:"_&J[EW,['!OVQFXT( MOX\S;TOX0@V;%$B;%*D,',DV%X4=/^:STA5+1W'%G2JE*H*?/.74[SOQS[,@ M?_>CS"=/5Y+)4`3U-&7A0/F^DP`EQZ1?XE72%/[F!$S=I0)*CLC`Q*FC+?(- M.9A4YP':;D-WHCC1)Y_@.$O8+E7HI&^L!YP`2>6':]>=)O=D^2;GQJWWT7&M M?YMCPQZ70@-.S=PIU7AO:3FEI!D,9QT,YYUCR2'[4%_KJ MK'+G1G&^3IO_8B_J79O&-?UO%I!8$\S64`$ZX@WJ]N6?/^;-'[YSZH3F@'-U M&E2=7^X6/1[41--^68TX.%"R^R=*=CGZY_-;US7ML>F:XXGCC@Q[9$ZGV[M> MY8(6+5J4H3^(IS&%C4.G4"&,G3^B8D0QR[M761AY81.BHL#Y$*O8^:7N,;JC M6$2KTDFJDU]C&WV]R>>>Q%E^<,92 M>VYN13VFR$;U^W)YL[G:BHS5BJ`5E=U(6.8C%"6Y(XQN_#=7CN:(/-*%L29^ MMV4[>K#4%IS.7>0N-?.HA9*B12Z;\.4$,T1PS/4D-%<"#K2,VIV[MJM"T*[_F?DD MY;X"45M<.[S+JG;N>C;_>6MY7V:W[NBC,2\=8]ACU[RVYIZ;N_0VZ7YESG1. M:P\X5R>"U<-+W#M#+!].Q8&W$2WF*!1?F!'7`$Y(H\*=>YGW+NLT1E4'"^P-'R;TP:Y@QGI9J!39^1 M;P9K;?EJ:>`$U"K:O:LZ_Q:%-OWNC\!1+*O1O6-Z@B,_"O*C''X:NX,"P,$[ M5$?2'ZUFC[Z]E6K'T3:^Z(XY>]F3<(A,$&]DOX4EWT==Q51N9AE,K^*=6SV8$7<)F!#_2?F:A'R!!+NS:XL!GQWI5N\]X MO3UM*?LK>'Y,;CG@V`J4Z^MJ17XN()6=1,/D)$VY23K*LICU%.I?D-D0`G2"+`;+^H'M!R5.S\E(AY7=B^RUGF3QG-2!P@M."F MI!.4!(ZM4,$A4U&7]OVUX8Y->^ZQO#S,U&66KF6/3C3I&UKMRXIO$&,PW.$; M[B["]W<9H4O8E!I>X00)XF6JI8#/=US%.K?.J9$54*G\%1KYR9JM9S@1Y-<4 M%@4.K%C%SLWTO97+10%B3Q%:D;=&[,VA].EY:\:!6[XNT<3'FX.__-V:\JW+:/'9)\3G/WS2JCIP&MI!T7D< M%IW(2@.#;P^7"P!']U"=[J.B]GODC=[#$EI!*-Z=#:\O*TKS=WMS8[A?G(GW MT62A?8;]9?[9<%W#]O+\=Y_R8]C">9//$.LXI-K,-_N*HQ,`GMAM;ZD!3Y1S M\';)BKH!C-T5BR/V4)?Q#3-,-!ZH,V().*L;B&4*!2HK]"8"H>;7 M3E,H[,A!2S\+TR[9^;4V:3S03VOD/^#4#]F&/[G9LZT.'Q^K%CRKL5<[\/:> M'N-H".XS*NV1ZEFHE-.$A*I^"EWW:C@P%@N\D6;FXX45%0.GEH_Z.GIPTZ"W M0H^^&IZ*"/6%Z9,(1ZOZ:4M06`]F1)IVGPMUM]=(-M*.*4@!3KE8R]2`#;B4 MS@H/$M1\"'8<,6N"HD";7FT?&ZS]'&JKP.9(3NO.SRSRYR/DO@EA4=A`UVO9 M^8&%G;&.G&7A*-YXZH08UY6&#W.MKIV?7.P=E+I^M$+;@%TAW(U5X&/>K'7G M!Q/&(R+^"NU)(H2\IC!\L.LT[?[\XOD"HP0'N4#B$5Y;'C[D#?IV?T%\>Z9:ROM>K"R['X3HMZ@,GXHV2'1_ M[YPC33$ANHA)G]^!C_(D%YD?3O&2CJ`OR"=B<^?4%K5DL!UFW=]9YXCX&>'5 M.D6+5BO[<>UH2:$,/MU?E]\*5G3/CL\VLT/IAT:V)"KK0Y$,$I+7\=7RHFB> M/+9%+1E4,D\JW,ES1#QIGFS7CI84GC!/*LT*QPS9NRS-7Q-JM@>Q1`99G&25+C&1.5A`^Y4$?!D:%"CX'#'J1AXA&T9I$#CW36#.)[ M="6$N:D&?+@;=1;`KM!CD+N;61XJR>,,N3KPH9?06P"^RO1R.X^1V]I+QJT! M'_A&G06PG_'8&\#-W0]^R##BC(CM7X#'?S\KT/FMW&MFV7$OV6S_`ARJ9P6Z MSX23)Q_D7TC:_@DX6#L5.K__NMT2\.#:_0TX7B4E>KC;^H#Y[R9N_P(>K$*! MSF^R%M,C[^&SYS\!!VNG0O=O#]!M2KXI+.W?!?NP2C'@*/)5ZSSTXS9_-)'[ MK3[_"3AR.Q7DPC>&FV7'W2QS;KTY>[EBDS;>_)?ICJRY\6%J;N]/*;]4=D*/ M?=TG.T'$X2K9<)6L=DH8KI(-5\F`4S-<)1NND@U7R8:K9,-5LG-Q,UPE@\K, M<)6LQ].EX2H9;(Z&JV1]GW$/5\F&JV0'<`]7R8:K9,-5,LB(#U?)^A_DPU4R M*%0,5\E>RA6)X2J9MHO^<)5,&XJ&JV2ZSY/#53+MY\GA*AE@DH:K9/U[:(:K M9,-5LN$JV7"5;+A*!NLJ6>XM=Y9[5DER^!P:','N] M%OTAS%X;BH8P>]WGR2',7OMY<@BS!TS2$&8_A-D/8?9#F/T09C^$V?^GA]D7 MZ?#Y8:HU>?Y%%8`'@C>IVWG(?:T`;>'6&NT^'H[)"*'RS1#!\:)B@O#LW/H* MP.%N4EXZ'#<10E!CEIAJL,\)=_XWHV'<59N'!1@.@VP9@@:CG=/GCQV[^\O[R\G-,IQ'^( M"1I34]8GO#FS=1/`9]'VD'1N--`9/:`B^^P.&PN[Q0D+@+?C=(J2Q%O[A]'Y M6`[L336`@]ZH<.?/ MUTTP25+FU9XB/T$S_VFSF%/43&+BK=$$)X$?L@F+UGK'`UZZ+G02Y$'H M/(A75I;O3R#D^Y="R/<]!/?*RL)+32)?]X40(DY7PL@/ M?40(9:<\-SW+L$SVM+7OIR^7:4JS!]PK?]UIV<.4W5=F!-?=M:U%)X'.E4,'. M':;%CA4CMAQ.<.1'`8Y6/(\'OR!P8$7J=>X/O29QDLQ('""TX)T%[/\=.(H' MRG3NV2RQ)CF<;E7%CBT-4IV[N(:[/:(FJQN;IOFAJMKCBW/M>;_&-^Z M:LQUZ1[Z,]6E11K,=/AFNHW264:"M9^@A$['7Q%)YD\1(JNG68JFZ<)%(>UZ M,?-)REMZ6E4'/GVV@Z)S*[\LSCS_*C]1Z3."DA'].F/BIZ6$FP)*Q/4TXJ)& M^`L` M`00E#@``!#D!``#L76V3V[B1_KRIRG_`;>YNO%76S,BS=JV=W:1D#$>9:GLW=Q4]GW/_;'/_SV-S_^6Z=# M1LSK.U1L?-(A_(8[C$PW/&`Q#?+]^:NK;I>03@=J.-S]Y1W\7EU<7<<%O?_N;;[Y1A=\]^GROPL-57+Q[ M\:?;X=1:LA7M<-"K3O=5YZI[ M_NC;"4'GW-ECXP?LGE/+$^MSRUM)4MU77:F91`V@65$91U4B=73?OGU[H7Y- MEI;D[&!;/$G]]47XXT%IGB/.5L6R6[_Y47@.F[`Y43S?!4]K]M.W/E^M'?9M M]-U2L'DZ.4>("ZA_X;(%#9@-.GT+.NV^`9W^+OIZ2.^8\RV!DI\F@TS)WN[1 M"BM=-"7CF`GNV89;3]B#V@U+/0VH"!!R)^HW)OE,3C*LELR)FLU)ZP74J2?M MKF8H;3B/PA=#^6E/:/88,-=F=BPVT,D9QXJ-FBF`<$S9LY(TSQR8.#UQEM3$ M&4^V4<][/9K!DHN^MUH(MF>OS>S:0Z\>*=6_9ZHYM22C9?SHK4^,B M*1A4VQ--,-_;"(L=$);_^[F".$I)9P5*`LIGL&A))K`<,K?S:7KV!\6"[/$@ M(9,?+W8B'3:B)RSB"9N):)5-MHD**_Y"?BR0+2IQ87ER-EX'G5A,57TNO%4Y M+<<">.5U=Z$',7W/#02_VTB<]UR[9]L7B,W4VK!=,Y%1K MS@>^OX&-32;BBFJ@4%92'`RR@`51/`@-"'`AWIS$?-J$II+*2"*H4N?41TU/ MFC=TP8Q')BSNL['@.8#)*8S"2K$0&)A$U$E,GBCZ;8)'TM88HCF<609D@.:YS!L9M()8ABTKH&!%KN(O#7D+]Y MZRA'!_MV4"%N$!8/]RWJ?&54&"ZS9.U6ZICYF9LQ:NI[C+9XF?+$,##_@*SB8 M_.2S^<89\CGKO@8A_!3TE*^+PE%E$3&(VC$C`K@1%K,C&\6/.)(AZ;XF3\!2 MUR1ZDC863:P:V]KT@*JLK^30JHG;^H-L^NGVMC?Y:MY,!Q]&@YM!OS>:]?I] M\]-H-AA]&)O#07]@3$>&_*MOWAI#!]>5?IGNZ1( MT4#J;40F8O18D!^9(ZU5PY?"/Q08D7M%M=F1:0+H,R67DCH<03!%_Q3V9%WY MJYF4Y=OQG'9EFBZR3,ML--4']H0YRB>$BH`S_PL/EE^6WFJV9'"13-VGC]2> M">KZ<@&02O=G],YA,_88O)<\?DE!/XX>:HAH:0IF'$4"D'4H`7F0(I`'*8,Z MSHND($MJDR`AAZX1UECS"PT0>K=QI.EN2UO7\?R-4!>6ID&I17W)D:MQ)""N%SRI\#ZT7+B*@Y]C=.04QET@%`J!N@>;&./>X)H8 M?QH;HZDQ;16JBIN^=S!>L@/*X"'I-CJG_IT2?>-W%I2NP9VU>\&1T M.Y?=R#'V=]'7/\>G]#>R1?'5O#F/%J7@>`DH7Z\VHBJ+A@)7?#D#74I\ZJBY M++[$!"XOBLER=ZFH`"P8^/DS0H&;K[RUVH;8 MFHHZQ"^J@YM#\\"U!*,^NV;A_P?NP`V8Q%,@18458,0.5^I*5=&XK2(@"JQ+ M^9?<,TN#K6=98J.NP4-&;4-H%94!LY7,([>A"O-!93JIX` MB]D"ZL.B8A#-H\"A_7#,UDHQ'(OZK3DX]NR_;OP@FJZE.%(37(V/T*M]Z/GR M>YCFY5;EGMO,?O_TR8?)WEPS0<'0[$G+ZIZ#]95A])R4%1KNIU0`RM-T)Q<) M/!@9H61J(^R`2Y/\%CY;L`'9^*%'DQ<+1>A6JK8-I5-J_'#HG1YS]4\-I!3` MOYMR1K#]"74B<,@``\=1A+J7N@[2Z@A7>":V9&3M"77)(FW%M?#F7%J-(APO M<_D!C@C7*C)O:U%RA002T$?FOR0/2VXM"?<)#<)K#IB<8:BIFE1([JTZ^CA4 M8_*@(QU%>JYGP%IE]HTG^IX;136;\VA/&6^V>L'EJ]=C)E0-T_TOZFZH>.K^ M`(0+KG30Y+5=`^EJJ+ZK(ZXD4G"VMC(!DNG!EAXB6?[]\OS5:W7CJ&H363(2 MCW1_>$E`PE-`90T+X"[8V`A7(W)1`JA[U<:>$$'8K#+SZL M&?:!HL._`@Y3@RP@Z<#ZT*IYX12=D75CIG>P-K?W52=LH?#7"@M1S+9JE/KW M/;B8PDT"'+T1*-+,`>,'!L636\^ MYY8<>S!746O)V7T\XN9-*EYL/- MJ1[`M&2\J+CH.B,CK'C:,;`G7'M68M,*/`#\]_^`>-]3:25DIW0XP@<;DD"$ M`2W73$XV/,B,.,TLBO.P+A``Y5`-M$E(G+R(R'_7%IB4:?V>ZW`I_3VOK,>(3I-NL0MJ@6>B(K*18J_"]D$:502#(A+.32ND.C MDEHYG(@J]59ST!MY;KPT1))<<\'D:B#\&\:R-IA%M=#0*RD6!GI;@O])UY[_ M>S)G[<-:234<8JU2]S3I7,+F3`AFJT4Y6H(W`20JLX\CGLO6TN!84DHLG%M) MQ(),0Q^2:-OF[=BT#7HEM7+L1U*AMYJ#WHV<<0,V!,\(,&(V@J]9-39JI-&"@[B%W MV4!^S#ZP.2JHP0S-8HX*RHJIDC\#7:((_Z5M0,IN^[%]F*_YJF#QF76^\.XO M;,9#G,@/A_"07_ULN(&T/OH;`?`HR+8",U4ALCHS)BF,NE.$J%96^H2T9DU MI'^&",U4#1Q$9^8@!9$>91-L!+N5.[[59A7[]]YX8K9DNV0;LM:;%/26KXM+ MF5)51%3R%,6,1-S(.F*W]3&9A\E5(/<#'.V_T34*3M+(HN&AL[&-9X^IJK"] M/#+UD'OZ87:%&&97S0RSJV<89E=-#[-*C=0\S'(;V]9A=H499E>ZAMF4/ZJ\ M!4-P5(@8IHRHU&*X3"\YC%'G`_PQW*\0Y7L18T?7<,"*783\&N(WGCTF1P5[ MB6`*,8/(K[Q8"/7TP0!2<+@^MU12Y^P4R[GE<5F6RXB"^F6R_<(PJ]<^3N:\R]4"&D(A(9K)DCR2N.\SXO%0#FD;[TZ(P;1,42; M\%%"!7O^VF6[`NW"#0<:*M=WZF'#01$=KM1'#'4X80%1LBY*P-Z4M&7SYI23 M^IG\A8]:GN+SFX&,^J"\9G<\4#D9MO1[P9BFS5:915$@+1(`Y?`0T=Y+9P#^ M@&LJ=,%6A_Q%\*W;CJ:!7*2+)*#+H0EA9X2>O.JJ0FH@])&''`^.$ZOYR.8H MJH*S/TH*A+)%PML`?\-?GH`;63AB3V=GE7S'GW M\C)\[TB]GI5]1XNEIC_@L%HS3A+5D,A@`Y:6%.(_5,AL6`+N8(/7#\0"@G^P+6 M21'4W@O^S\K&J9,RWOE,7_-0MS:[M_3,.=F)$I_4M&:=.H'>CCS==./B>0;+ M79";D[94%:WPSA((M0R:H\_&9#9X/S3(R)P94S+N?>W)OUH3V5U%$WE(S.^; MYB!V';FM]\$O.GK)E/^-V>-P8PN+!NP6>[[/`O]ZF^FV"(9HLFBHZFH8,OQA MSSJ`&%6?M]`!79>R#A&O%P:8[-^6G.N=IV@G%.;^@J!8X;GRHZ4\H?VQYW#K M*3_K=QTZR&S?"-$QX)T8?6,T&WXE@^GTDW&]]_[(Q!S)SWWC5I:8ZDOL?>*6 M%AZP[B7RIEL!R%KQ5*:'B(3<&AN)4GMRMF;%0JMV/]DW>@#4'\5AY')R[Z:D MF'E1[G$UE\R6U#56:\=[8JS$B,;31(UN;4U"N93_SZ?!3([ST70V^:2&=#SF M9Z;<@,G]F-R(F;./QH3,/O9&Q+@=#\VOAOSRQIS(>4%6G\"T\,$TKV7!B:X) MH5'EZ)@E-/Y*;H?E%FD,3\Y:88V/24\J.O_4@I9_0QR@CWGKELSG,>FTHMK>-- MGSPQ4.;&]OD$N(*XYWZ+'&%+-C_EO9[B;F@.0]O-S`[R&?A)*XG&3@Y[#&Z& MZDD.>"XO>K.FX)'>Y\!-3M,/,5.H^H9WFDO/D;KRPY/M.+`LW`N,J5#.6?'] M]^YNH^4(I]Q"U=W+[L'FUN%= MHVI3=Z2QS"4\MK&$%SQ,"%6G=TB.PBBNA_].F%)RPA76$B0)WA`E0;@M`BEI^G`DP3^>(\"5S!&YN<&)KCJ:]T75_ M8EP/9I/!]+_!'Z8WFF7LR"I6Q@4G5182Z82=X!;>W2M^!!B2B&-;@%1//WM1 M-#5[$0.ZV#-"L4LZ1LB?QH:4`F3)15XU"DCXU1)7C^_(]-AYA"2YM@N'M12U M#T9$QR+2WL%C8)#DJR`A5WHY7#J[/-:H("CUP)E*UG:2G%QHP0O3T64TH%6N MQ;E:V,LQ5PP=A&NPG+^_#D8SL_=A,GC_:3H8&=/IM?'9&)IC&$SR:T-YJ^?, MJ=5IX%Q_ZXJ,VA0"4W"!,DF2+4GP)5O&;8)9;6WM>9GB>K@^/..PRT0`;N^> M";I@$[:BW%494%S%$YJ"Z[Q\*S&+,/KT_R2FKR`$QEK\O+ M;P'$X?9-4=?OQ%=;^"J.>N4;\7Q^>*F*2/>URT$1,I^4.B9/07#B1WR.J#TF MJ&L2]=;I?5'FSM,+6+C=I1*'=`4G@"KV!5ZHL:/+FT,_TNTCKK\GB_"!0>>) MN%Y`N)SIK##70?1^^!QR(:RH^(4%$;%MY59MI(^5>I09*@5;N$,(#B=&?F9.I,?D\Z!O3@F,)'$WT0866)F&/ M+LP1":6(`^D@4&XKR#:`3AUMQ+*06)@V@5*;1@_/.#2B1$_NJMXF6'H"@M-G MGO+A2X-W;GEM^:O%3$[N*_JH4O7O[OVM MO7;*J7[%@R!LYAV+W5;OG@B$7ZI[A?`95)]8LD8@:8"?P-V30Q_:%<)=2JU9 MR:$*P(IZ.DD:%0&_<]C("^(L5*8[\NZ5&=%]`U=MJ4.I5$7L,TL5A,,-KBTG MV(7L_*--E\3<2/=-L1/T\S:OQ"M->IK9_."IHJJ#YYPJXQ3QOL"M.9D-_C<\ MXI?KGS&6"^!`_6G\"0[_C9S-5X7*N)<'*@N)\G!(<`OW2PE^)&+8)JQ55\_> M^P0U.[$YCYH)"RAWZ8)=,[EP9GI2'Q5#>]%D,48EN5$T66OR9Q>U]=!C)E_+ MF(1)/I/B+GNN?;U[/5FE+,N9@(Y%,_M'P>$A*K,05.I:K@'4BH(=HH4!*W$4Q6E[+V=4KF[ MFERS+(?Z/I^KLT'/S0K?."ZG8=7*8(V;H/K#WG0ZN!GT6^4$4]CHX_4K5^&- MNIA+!<,VOVJJRS(U=3B?EQ4/M=E6N;P@\9?1_S@RA^:'K^3OW?_38;&>J"5R MEO'9L'QSVC92*J@CQ=&^&O":&TU#_NN&VSQX*C^,-X-1;]1O>RJ5JHI*2^%5 MHU/;F!0H"[;E"328!$@+<(T94<#]-)7;C,$H-?M/ZQ!;647UD_X\7U[[M6`6 M3WOD+;6(AGSSQPPQR$K2BQ/(MPU(:6T^3@&?I>6FCZR9;5`!?H_I7K4%A34= M7V<)@0P"W:PVCG*7NF;2E.:M"R'.;WSZJ79^%S080FS;ZC4EZHPIE[-<](Y! M+HCRZ^`#BLN(A(+4E@&!AQHZW"41C[8AJY0JC@*-RW=/DUE#Y`B&0WAS?IRK MH3`O2)FZ&C)_5!`1Z5#A>PZWU9RVY0K^/5&.]1?11->:H_-:*CK.T5&Y&QO$ M)W6HD%NZ+W3!(,>U.9<](*7K>RO8G>1MM4I5Q:.S@H`HCVK@\Z01PB9).9@`PK20^+UU3<*A4K,N?, ML<.PS[:A*:?91SFYBM3^G#FY*J?:.F4&+;V)L=@]IZ3OB748+A%Q"CU=XU19 M+^QH!6W=B5J==5/?8IGAF:<>9V'VC%E+UW.\Q=.(I3KAI9;#^=OEL<;9C2%A M$FPIOR0NTQ8@CQ:\C`(((T&W\$"4K^E=(5\Q= M'K".P^_#E%O1'1JA<(E&U'7T2SGQ0J+7A%U-5YX(^-_"A1Y6?NH^$;Z2QI%0 M.U/P'I<+Y#GI16P4(<)]M47P?$D"7B@^8.?#.T`!/&$/SNE2\LU:N:HOF$I4 M=\0K+I?CEX3QL,`3_,8%<:G*P>PEOH**TFR#$*A=?L=0 M$2"2E+]5_NVY8-GSD"P>8<]@LRD_ER+C+"RDSPK;8XI;,6(+Z\^*YE_:@HS\ M)F>:3RF*/E7>L)[D9P//&X<>OFA__#LJ4U@J*]0"$!,D0+$M?9[9U&1.L!RU M(A;Y>"V9,FLCX.HXU<4YMRANJ2\0`-79NX4R(D[LD+JV]5Z#]$5+?KU6-+Z8 M%6AB;STKA22$*[=4'S/GQB,3%O?96(`5=OGF^\O7*;#.*8QSW"X4`N4."=35 MX6!$GX0,R.4YL-#V0*V61JS#1R$"*H+A/T][#-?^IVA-T?SS$.>=0;2J\0B! M0LWL!0:4G`+TA%VKE`914&K/M:?,<5*FI:(:VD*O<\31%WP=FJ1QW+6R)GW) MZ!0!V,CVE%^-(<]Z2M*.*#[4]5QIL3&V4F^F[&7R>*%>A$M\D2CH2QD<:?D& MD14;1&_&P5^*LOCNG,R6TLB6%OU*6KN6L[&E@@/!J+\13UN*:ZFN)?7#R&^H M'89^GQ.(Z7Q'F!.^6ZV>,]J%DJ=+K?3ZLB"Q/(F&I*_,=@Y'!F$1N6M1K7B0 M!CQWLX_G6F6;ET145O1YX8A%3R6@1<4E/=3\L(R.Z>*8I8X)0N%5:ZX>E+C_ M&O__&O]Y&$H9\5G##)6B^[,QF0W>#XV1.3.FX][7GOR-1\HJ8*9$C(!;.DF)'"`%^8'7;."MHZTFQC$[,;6JU#AQB-O/OS` MUXADQ]X)*1P'\$Z#T\9^ZF_<@/V>IP<]9O[N/\,4D/(E9_1"V5H7%JST*_D] MC+X&U'ND?(G)G>V)>9MPZV3/6BT^$03@YLPQMWL0D9L8IBF7-[>+(V^_$82< M(H+GZOB;#>93T5I6?._P=_?_/@#+[0:NV$"D]\1%EN?,QMS+<0"^]@[ M-K5%F4WAUVQCP)3@2_RSKA7Z(G[?65_R]4G,E%#,*_2R$LF)&_"I\+CUR%GG MF.FOB,>K!?/?,CS"M`YM\W/5;!KG_'5US@"R_XOM*]A70FR!\L8$S!@P"L,* M,^T>>.Z2:)M^A2E\O\NKV.XB'_K+IF@&+SXQ;YY\^L*;RV_;.1BW;'_E/_@! MZ\A5%@<)DMR`3V?\*P;?*J!RA9>%31_VB1^"B9@*#WXH@`RG8.';W'AY1PCL MND2GG]P7(!MC;3.E0\'LFE6<9K8;U0=#:3(I?C-:S-`HBKYD'\`XY"%X_':\ M+A];Z14L+9^20MCX<2'C4(Y<(^V>-O6E7PWW@:WV2@<+S"LK.C%`;51$10FMKU?F7]=` MA&7>\]),FHXC>NM)X\'$67?&XD.=S'$6"]4>?(AOC)L\W031UV29+U]4_*3- MF[@O3COU4!\>2`:_F=F?5V1I+H#+<7ZK[WJ)W-2I^D+M#4S9(G]R"U]WK@R>O!>VJ)\C2>>VOO3.-'IJY'H^T- M=D:`O1Y3BE=>$DJ17*M130RM#"?G.41/"OW0V-WPH^49G"P+#6N6JO+WM%/8 MU:J&F4"8>QGS6W[79*Q6)ENBVLXGMNYRRRIBQG]S8R[M1TG/6VN@48)+QT7ZKV;3.D;[2QPVGUM7-9_-Z MQV"O81^LA#-3=D<:536UOQM@3E>L9.)AGJYK"61L_MPX"?KSOQNDA M]"ADOW@6Y]Q:42^UEUCCVK=HVI5A;O-BZ]V%C'<(Z>O"S:6J1%ZD/K+ MU9.D=LO?0W^&E%5#W9(N@6[.^<+)$LV_KJW%F,KVMC;%Z=>GY3`->2B\VXF0 M03?(3PFLXZ0@(Q90?%O#P7`K-7%'PXO%3)1.GI&IM9K,[-5Z:<*2J7`B5E@2 MC8]TH)VQSH];.PSJ<(@%E9@'P1_@12]N`&?"1CK)@I*J2IJV>Q>-UE8JHHYH MXR;:F\+Q?FRY.EZ#FIDHWHHG]"=Z@7EHI3CYJ`#?$'^[?V['S\>*V43 M]E.;>0)DQOP\KOJ.>@U!\%^S!UX]<;/V`N[6!I+YOJ/*&&SE0DDF%4[#,[DD$TR8 MY'>$R7Y'WAXBP"!"[%4?=7Z//9>R>O5E@<%I>+M:L]63OKI7EG MS:V[]=W"^`+1-:L&UJOFYU&.J*0*QNF$`)))(+F(,8%)R09%X+08#T0@=<9' M:^_3)'4Y&<:<$]@5?E!9J;#ER[C@ZM9*HL*L0NM$R"O^:$S8:F^@4GAN MQV'LCKK5^N[.6'ZQ;YQ/YL1FX)Y_67TVEDL#$'ZH>]PP5[5L`(6^;LKBHB&Y M1+A88C))+I3D4D=8&[J[H8I(Q`QK=S26J*HKP%;^/0I+E:)0N]VI: M/G964[8T5%=W:/!6=KF(S084("9"?ML%+59%T%8]@9O*JL6AYBI.DKO:<-^%+5]#F!>Q!UK"=Q8";OPR6T]$WF'CO'Y-F-?Z=IUMCAY=$ZG=3>=0ZHB'/4 M>7+.16P4J(BK3XTKG\2>#3>)1YX`5[(L:_O&:-"]'=\L%:&D!S)1]]'UPR3E MV0R4`'(IET/ M2%`?7.:J3$A(P3&9`U,@2@W)Q@TV8`C.3`KM`-6J[XE"#6_V"9?\0Y$N&DA$ M'[,T;)&>09XI@[HW*A>6C/#)^;+<.U#TGWE<.A2[$*'L=G@'A*._PM.5WTO9 M.U@"4#65<-_)@Q">X)`G/+`/!Q=$?N5I##]JI`75URGY^A'?N0NP@JH9Z(06 MM`T2]2PM5_PFEEF&>C=1/'%9MX*`UGS<%%_4MKB4*Z=O=9D<9?%$H4U!6A^+ M2SU]:[?YZMK'2RX*Y7:J6Q6J(E0WC2'0^_I`&2*CGF[U>@^DALV*HF+AHO!M M(2R1$\2#1$B\XR+[I03$=ZP;675=MT>U7.MB,CDGH`IJ!PSIWCQ1;Q]0>WN= M$?$;L+A/?+ZNOGXM_`OZPOK!>7Y8%[QL\2WEN]8H`1_,K;^[J&/V3!UPB3L_ M8.B(PF9.^HO$<^LWVEDP=U\@&9!D\U!DR8ZG?K*+$C>PM[,H?.34BX*+48TB MOE-3>"I.1`=0JTMCN?P"V;KWQFQM7I&E.;'OS:6("QW[[=F;=F].,SG-L#H.QY!F;)QH+0V9WA@G3Q.,.J0;UQEC$GJ_LF34=);NGBBG.71A``.@LC3F/L&'`U,4FVG/'&LE%ZWLW-F_K8)US M]IV.,!T!TZ:Z,[9JHC_^S9[!+CN*1WL_55B,2Z3-TF@!M[8X%33WPH&_GH[#PF*#92\IU,J_K3"DZP5 M]EGQZOA6%%_6`*$V2J+VF4_L7\!Q%I)#+M-.R!@?SMH8Y1Q^[8=N)#Q^<_J5 M_ZH37]_QY7YY^W5N#?VV2LK0V<>^^_1]*],^NU(M>K&>/AX#N/PBCG M8K-XS$K&R"8A;9"_AP:MLFH8O(K*.6^L^<2^,W_(&?9&Q]V@;(M3]+4XEPMSMJQ+]@^)[_EN/#K0U%GB%#/-8S`<9,2UPD2) MCJCZ631X&E5`K;@RZB%Q=S2Z+U=COT_QHF#[[D$[;-VU@/[-=,=@Y<:+4#2K0W?`PCC]#J@1J?<5;)UGS<-+! MVR^MG5=17OJO? M"9I4[,,GX+R%YX()YK!78`X#F;VZ";:37;VF2V='X4A-!I/ZE1RYW=W,7CLK MQYA/K?DM^Z_Y-W,YL5;&]!1W('M9$QH M:VV<(MHZ#J".93F4A8+S8[;JJTY#J7U4T\*\6@%-*W-^`+XYM*Y_9=Y=^Q9+ M\Q:]N-QRO-H2U>OQ)B0A\H;SK-1B7DH%HJN?P^4,-XE&90P?,FTWQ4L>;?G" M6+VEC(_M]1\\H[;)!J5\6CEN]*0)BGTJ6VT40M;M[8?W[^VM^)41>@4&-AD+ M2^OFM*44=NU(+Y>A[E$'.-E@6OP[_)D?=X0>B8ZJ],+ZTJPTT`BE(!$RD(AN$7LAQM_5WF^I/:>!L=65`WOP4F.51[(<"PA M"'5G/S.T5KG3M8*Y`B5H,%RHN\X)T=?J8/S)FI M-Z4O-(AX"&;517B'!G#KQT[*HA:6!8DYQTH"@4%?,Z'$.TKEK"WZ%IV]=5:Z M&M7;Z<%7JIT,5UK"(C"MG2G&V#_ND_27=E0QQ9?ZX(JI4`KW+:OE4Q&2R"^# ML,5T[!:"+D:]>R/ABZDPD0)A3"T>$'R@M4P5%C["^7IE_70.HH!*OHSV)48OVC6E29UT8BS\HF^`L/%L- M3`-&9--4!.K.HJ0N*+;\##[2NDHD*JJ1IB1@;1TN9W<\YGUL8*GL]UD$=;VM MA\PR<5,>5RQ*0[+=ZRX*`:[&-[\^N:3I'0TY)0HJH:;+7,`5$2+(40;YWR#E M_XP-4$HV.4\041ZGBU0V/Z7:K8%;TQLZ*YG7J:/AH#ZK8'Y&.STVF"E8HZ%N M>?/H#)EN3[>LG$),'Z5XFRUQFB_.<#BM[&A_UWZP&ZM3TT#3/+7_K`]$T;WUL>)(8 MX2P)0&4P+ES2N@9'U<_V4\):!X898W!_LX30L8'G^:^GR-(913ZJHDNRK%/F+S8#:S0H]_^0D_+ M7-<_AZJ&WB@:@Q#1,,E:)KQIPMH>"U*DG2_60%:.P^ MTE*)P#95^?>X,J95HE#+),Z7I+WP76<]_U7@KKE$:I5=2P52Z['6 M'>!+FJ1L;F:6/H0V0MT&40,%0AB6-'5]9N$;6H7_5J^CW*.+HACO.MZ@WQK:[HBKU'WE"8K1/MT'TE0,\B-R0YXIX]"'E-RPPYJ)+ MH_I`5-NEE/G=`!=$"*Q]=V?/5Y^,I;FR5JNU.5TOV+^MV[G(^66_!Q(\3OO? M$.G7J1E"&]^YMD'<73MYX3CN M9D,UA'*K('30`C@EY3*^Y9K+A[JG=92]:5)#:TZ$.ZH4-T4+5!2ZD8\$XHQ9 M1,D7@N1YC'Q35H#D#=RYL9HZ_>0%_/-'+1'7MMK,SR60JYL9?$OG8,BQ^UF'>+F?W%-,G*7-Y;D_&%*2+,=Y89@AW^@.$_]?3W%<-JHBD;U)WLV-9>K/[B[*/F-5Y=SOFC/_>RC M5\VYH'5=&YU'MC5-90F?]N`Y/;-O1P?43C8Y!2MB'#53!JZR$CC%RC&5A_2J M[^HG`VQ244-"X3G%75X6Z*UR4:"+][$SG=^A!%),0^9([*" MUXA#*E, M*ZI_3B<]B+ZTH#(I"/N>O'__@;`ID/"`[9&1X4HMT4`(TC6/1UJ`%KWW2\] MH[?BIP[4"+:&R;YBPLE! M.O&$^"NR"_;)X1S_4`J%)JG_##_25NNE1[M(J[US:SYK?6W#&7YLJI*FPH>0'EQ&K*8%PVDR#8'X\R2"Y$ ME]OIZXE@KEFE;IS._IMUR@R]_SY=DDV&F!X-/:&I6:4X?;69%;I/5DZ4N@$0 M6D1AROK!GG^TPI2R,4YK.=WD[Z"F+&654&>@(`1(3-YNCF*(G\D9$W*4S5$$ M3\LAZHZ?=?C"VJRD6SO\"H6&4P&80<_;TC75==%-.D^/04EE7KA]UGAVZ@&\ M6J,[^3@U0-%/JC&*.79SPVIOR'^#/&HK-8\[9.--Z3M=:ZV9,L@>1=LC)Q\\ ML4#Y:*UB[+N#;$'CJKKN!;"=/H$"78TX5)(DCKI@B-!5X2Q,7>>AP5?3 M[R((&S&!B1[VGQ_V<4*]&7UT`[;'K@)DU5/(V-Y:L;B`BKQ9$D"[<+:B#9Q( MG>4QL"UU'SX:M;;_Y>!2"58PE&7S>W/I6-%S< M84,AKI]RD=I.\OOHH_0(7U]?!S^5;VNOTG%\-]PBC[9N>/CXPGWEH=%UAUDG M3^&/KZK%X@^LLFCX7=:P+D=`ZBSE5VVK^T7.V*K[?W:JUH25[F"=TEU,-SY[ M/,PB7!,[S*E)BJPD%1!6?Q<%[-8J8N!>$':\JF1_;\]&<_$NRKQ#7U>'=IO6 MYBHZ4T?4#EI7%`HB+NL#O8M/Z*@<>BH.=<0BFH.6\/0TW=7'X.Z>AEX4 MDQW3[LE-@"^]('LT'WT-1CHC=\$.,B)&';*O/A5Y91S@:4T:3C*DK^"BUQ45 M0H6RUS(BO1'"?A@+V-I8I!0>WFJ,AI\8[>V-'_HIG?DO](PCYOKUSOVO*)X$ M;I*HSH\=&M0V37;O#`;$G^E#PH06<_=$A8FKO,Z1*WXP%BSK,UO=_(D%`>)4 MCOE83#V';I["*(@>A;O5@5?E#=P)G)HZR-3DG1N^$F,C9!&HA+*$2GV<%>,H M6MN)F[X^20\=W(=]X,:LXW!: M`9NNAU?R#'`C&\`;_'(3[+W\#OJ1YWULW#A^Y:E(HD(9O.=NF&I[$6>;"P0M MWQ&CV"#Q$[A19)\N]AS3[:A/I@Y$UZ=098D\<''['7LPC1XI$Q^SGVW-;7P3L?;:/S^[\:N]7?F/H;_U-\`BN^$4,0P5G$S3IXE\/=:E M&=P:#:$X:MVVOKLSEE\@1887?;FQ)@:D(4\F]GKN0/SFPIY9$\M03K])4+'J@B>J^I^XTZ]?1'M964=3) MO[FT[@W'NC>)-5\YRS7@<<4!^LFF*UY^N^--3?F$\N8E9[53-:M ML]>-WPE\UT?LJ8VF:_!0!2@/N48[4BLZL1LF;+T(>SH)6[?T-0VK,S7%<$NS MF>&84[(PELX7XBR-^0J^$?9\=+!3M<;Y*J;-."%JLHD#R<)*B=>,;:K))GD# M5Y--31W4$>QW4<9,S0ZE,F9MQF6X>>=9->*D'N(6S+&2JC+9!^;?T4+E9` M<0[K8W;B%0E9C_B]3OZAH,D5^?KD;Y[@ZL=-T]A_V*?\+BJ-Q)LNQ&N-ZNKE MQ(I%'%SBNG_U'O-VEH^\B\?+X'B@1PW;*ISA*0(>T=2D])41H1XLB;3."XKEC5S'(&,M5A&FZS.X_"++H"^%=@%=#,1U__/'H# M+%4%A3+.*&X[G\PE>6/-)_:=^0,Q_P:U5\VQ($O9$*<[9,5!&0Y5;+-`_<=0 M\)YOBL>!MZX?PHKLFK*O.FSJ:W#6I@4T\CJHB\%B)HYL,GDD/0HDCTPB>0.+ M]=',>`@SG2*U\["B,IE%J)MG%`+=*CZD-0]BQ:**`(6_Q6_B,B<;ACPDS1IJ9\, M7>Y$B=2*:)[S]L:!$R0C%(BB*`Z&IIH03L4],EC]0\;FO?U9? MK8DJ%3"H."GDD!W)9@)Z*4/1M0_)=5*BHLDQMM8IZ?&FI^Q/%BJ5_ MB@_JJOY3(1P5?5^HHB,6?;T5`>JH>9LZ0,4>C!76S1:I*0=4BZ3N@#;=.&3- M0=0:[`1I4GOF6?(G4E;+EM6\#3@[57%W\'M#O*)-%1 M*/$RJ?T0\O;87376,7W=O@@I67O3G1&6=44VBJ`Z*QMF?PVI=_W*DW#IUPK? MJWT42UG=J`"*6*E0$PT:AS/)K'F-+-9H]=N4=FO1C:&=0&:*$X9K!2QIA/6* M/>:[1N*[*L@N/*T7W.=JZ,:WD$!`1&\8[]:++C!7[,W%H7YND4:TU^%KN-N" M=1C3#9C,6X<0U^/#H+`/4,8%9C\$_J.XJ9D>2#EDJ8.X-M%W$5JZA+K.%JRI MSW[H/^^?1\>>JM5.IU,>M74%)*Z3P47L)]`Y250GT*EO;"A(PZR/,$ MZV4'(AX2'.:OOX^-B;KJW=T;-[6SE!G#((= M(#M@+#!-)V[RQ#XY+[X'Z_5U`OR&AWN>C-K#KUU7(!K"1P]W5A[UE3!6G\C- MS/Z\(C=+^RXGEB@QP/QY;!CN;JJSP&/D0&O.WCW(7='XQ=_09+V+0N,QIA26 M34;ZX>/[17;.;X=9JM"/OT#;%0MDW1+TYP3CN]M+JM;QOCO)]"+['61LY9KQ MW*T/[SZ^K\[=^G&(?.)A;-#3/<_+8O[%S7HP)B\'#&F9/%25Q\W` MZ7GZ^HZ7@E+YPV75QA;]FG"Q)9 M1A7&T-,X2].B=[D8"RCK+7!>2Z+:WL-!(H]68VK48*+X!!H4%>+P<9'/;OSH MCZ8<64-73X>_UK0#[L3/TA/K=MWG#^)WV+7"\2E_A7F!-!1DF)IL#VHYHSDQ ME)OF;&\I&1A$Y:]L%0-GD'RA885LH?#,%S4-)\Q*K^'J?;503$LP/JQ]A"12 M$#46S+0U2:G65>O!ZHZG:Y=9=T/G]GQBSYVE/9NQ#;,U=\REN7(J@-3\/`I! M2JI@H),)($S"VX((DLO0=9"GM3.-9W>R'HVN-[)-&*9#0[NWDE&*?MW"=Q`5 MUIDYJ;TUO]%XXR=T$<,NZ/TO/[__^*'"G9N>QE5/.RM=M0KH.+*$Q@G-T;&#YC4?-J+45R4L;-F-"YW'U9JBXF!- M@B7$%XJR):R_2:E7D"1.\*J^4`U/X[Y08<8X1<;JK;3[7TPD9 MRKMW9O!97&Z0TBRNBBY$:N@G8VF:?YM\,N:WIG'+_@YA44W%G9I?P*6**BF# MBIL`"20700XRM*6,:NN!-'7T+*F*W\EL8`T?!*,[;5`S3"F#M`70D!E7):8^ MSEUKA_IJH;/J3IA=A0TFFPN?1'2>#*RWE0JG7V3 MN8M5*G(8U5AI!>#/[!=@1JBWZ6=Z6!\UM4[A[#2EYI6[,N8#H*Q!M%BB` MF.S-ZP8J.VY)$+'5?)S3[68<1/3;Y@E6^<+O79+LZ,;?^B5^)!#!?ODH4/Y@_7,%]N]`A9U2"?_'O*%<3_B4.CD=UG]L*36V\>,B[ M5UXVOIEE\>0A#7>P54(U9&R*=AEJ><.CB_FO[O?Y[6N]M;M_@^[H@'*`8/&*'WB0;>9S]]2&,H?LVZ?)+!!KQ#PII()^\O`,[P\Q ML\]1H7'V<`*506%CQBL?L*_1CS_QD*T/A'G0X7/L;IY\^B)>$JQX!WX?6)6P MJ1FH+G=1DKZ=!%$"KSWLV1\4KO+]@.V2V(<./FOLQ3_\?1^EO]T=?BK^_<.H MOE"T)I5LA>$G9I)^PGU'/WC*A!T7L?1KFJ=L5\U?7EG0EHG91 M7U>2ZB$<+SY*+RW#A)-&!15Z2&+MRP)M$EPU6^*"";!=K%F3'-O='P:,#]H\ M46\?@+)G<2:PNOZAB+`C79J"S MT"0]@WVIW$9Y[=CJIS5G-VK%86UZH_X"L.@^-(:C?*=YF@I57!5`-9Q'V/&C M&V94SQ.V`X@"WQ/!8:&W$)\M_D][FX7#N\&*_82O6&7I8GK:1GN;UBYB?--> MWAISZS\-*`_+$]LAQ]T89;%8K38[=8$><#&'-,3_H`/W8L;@%:"\]@* M-S%U$SJEXL\:OVC5!!K^711&97(`9[\X7(`C""9V;.#N8I%3#''0'+Y`M>?3]6_H2!B2J8/:F.>6OB'>M;,X@EZ7BR)I7- M<(8JM2&YS!2VW,US8.MAG?0NO.EY8`5*MT52U_349E>23'4>01?"4+".EF, M_%)9U1P5=>Q;#)0>:HR)"!SCY(M'[IG"*5S%34V[][716BBKJH^T8I.+A/O) MY"A4!,X(J7#':6_2"'@5?A:WG'T04VCM?6O:"?@;#ZX]6N2\DO`#!#[56&DT M2YK.=JVC>6CI`<.2.-`DX7R3-_0LG+'V,2V$#E6"D2N40YMD2\H.F,H/X8^0*H5B<''CQL^C70A4=_?L!*C!R,/A8&^%@F'7Z,Q<"H(E<]BWIOS]?A(`$_[>#KDU=8S3 M(LK'TLG2_(8@J*B(_.2^<.X^IMB>P>45,@1HDOHBXG.?T.T^(%"#.7E'>`WG MQ\>8/D*3E6J2-_XA20-"/WRY;=CS3Y MX5^5GP>K_%P'XW+5YV9O1R9K972XR<)]!7;SBNFF\C%\*E:-8'QN1-XPR5K6 MFF2%T%JM*%4;[2^2&%1C@;,\H$;$($'+OKAYI8?:;,+2,WBX5HG$8Q7NX@_- M:@5J5WW54*JL]T4@6M7W,WS6XP-Q`FS/)^;<8BR-RVJ[.[V7Z(J670?5I8#VIOUT=U8G` MJ1%*LV9 MSQ;2\\B!63([1AV3JYYTO8+Z59>CEKXXG(DRKVI1NW:1OH)R;56%,#Y?7FMD MU*),C*!'&!,05*U11$B[\4%`A^U!OUASQUZ9D_62%\5:K)>33\9*B9RNU>LX M2'50%`4OD`=$TS8Y2B2Y2#4BN\&!UL%&)=!U'DT$`'F5AW,Q\^G2O+56V0G) MTKK]Y*R4$(EJ#P=1'5U!8594S#@'*3]1*RI!A!8CA;$..Y9PK0\3>F)_5U'@ M.9$=4BM\`=H<6:SO^?/:8GMK5=$7RYLP$<#/!^1X?B:ECT!=5%=4F9V[=>F2 M<;:U9JF+JY6@#<%]NW](?,]W8Y\FG$B3BM%40D\2R"I8?M"V`3"5FC!MX3__%$KF50? M/6IDEZKNUMA\K*U9*I*6.D#RXEPZ2NZF]FY?[#GZ'6UBK#YQ)-X;,P;%T>7& MM#*$(EO.2%#(=J]^*LBEF(Y1"'3^--RP-;DZ5V#+1C2DY'51&A=F=W=G.3!- M9C%V]MRQYK?F?`)GVYK9!?OKGH1TL*&/H_/(3C8Z3V/L#MPA-P0)9:9YFAY3 MP+BVS[L]&]"P*;F.Q,HWEY!-']Y3M,F9VMJ#3Z[^#=++1 ME>MZ.C8O1EOJ?'^E!=K#^?:='T8QKTS-]*-)"X)>E3?1_MI"/=214\^%I'OJ M3J,/CKWR<@>;G'I;:P@.>'S+>;@E'+TG#^$/9RN%HBX\''ORET_V;&HN5W]P M=U'R&Q%7LF-#4777STY<&PS>_7+L-F*KM@GH&(<-\0V5CZ$NOIH$8T;]UH8) M@R>Z+$=S]BGK_K0-["`Z_[67[+[C0N#_RE, MZ"T6$OTZ#R+R2!`X6N&-Z\?W4%_3WDYI[+\P;5[HS'T-)`C^ M`)R)0"Y2Z+`?LD\;;RTI\7Z$Q_S"LYR8JYSA)'6_$;K=TLV(N),[V+P4"M4% M]'KB`D5=J9LHOMD#=)BJ3)*B?6 M*T!;Y*&^SNH+56.TCIU[/NPFS0N\CBENI[' M@P&@^BRP!//:$3L?V"!B*DB0THC0/&\CYSA]^^`"$]`N(RXG[E.J7=G/T-?%?NJ>(`;EZ(Z>*62*9P454C_<,\7L`\_3-?]DB><<]QM-S&]L M3\?&DJW&XE>++<22.1L+]B8;%Z;?8WXB5+-9ZE.B#F;POLV!F79!L7P-X7,5 M8"E!DT.%^*-8(`CCIS,>^'&=LQWRAY?CN>1KC5@ M47Q90PQ?&R51$7RY),)%7;&U4@RTA@D7)W:Q8P-;.^NQ^$%4L>\Y#RGBM!.8*,YHD#MOF5YPMR=]!'1X@%&2Q1J98[+2+^6]-GU0W%? MS"^*]VXP\[=L(_:%NG'2AD.N58NZV>2Z=`?C?)6\ M094?QH1>30:5\,UU!P@B.L583LWYRC$(-9\T!:I(WL#%K*BI@PI? MX2((ET$.0B"G=$R(4S1$*:RESG)0/$/(5`ER&\1N7'8U%1W\CCS1D4TX0O/*% M@Q]Z;,'-[XZSE'Y^F?[LQK_3-&OL\/(([U)J['M^)=((2O2-+Q@YJ3G+JGU, MQ^UKI6`==ZB\X>/0:[[\[*SVOYQ"Y8*QTKP5UX0->-03!'$3Q:=',9*HAJHW MM(4I-*BC+^X``@Y:U;B_4&_:L22U[M4E[]8;+%-W62[%':+,5U8MBIDYJT&< MV*%:[2_%-W$%P=JIASK].XHZE)OD46P]5@_3WSMIP)Z>7@[M0"TM5:I:U06G MB-/-C$BAR*%P7G&QZ4G<26:S>-SMH&B:GX?3O'%97<6!E9?3AU64@(/J;D\T M$/6MF5^$J<^Z"5^50AVW71QY^PV/\8+%VWZW8RLRM@1[C")/A)/DD7M7_%4X M,G<#3MX'Y>+83R'8C_W?]9[]T(=-,%_%[?8QE*A+LH"S3!WPS4T6R<8DO_@> M^QESDNC9WY`'MB+<^BEO[9E'QSXQM8$C$(ZJ?N.QN%!KKE`5T*.[F&Y\;I9W MQ/SF/N\"'DT'A?DH83:"6-N]'P#=-=/UV=T\^6S=>3+:5_R?O$,$AI23K6WW M<>CS(,8R,@Y5_Z#E5)P%^\^^Z!4S![]L*+9=;FCK?X._)T+F)LM*+;3/;9XE MJ8YJI2O!<>E(6642P*QW0SBQSF)V(+F737I^NO23WSEQ7-)4!$KY7>0:N*6* M.&:*Q@)0;X3$49WUMK9/>179:0R'NW9>;9ZHMP^HO16!H'=L:GS>/R_YY+G( M0G79^C<+/`L?9Q3*I#4R>>IM&WUYK;6+&/`+\>19R#\&0FM.)1N\OXWY8S6= M'HN']V*TT[O]'ARA^R=I:BZM>S;_WIO6?.4LUYQ"I^+S4_T+Y_ M?G;96LG>\GK(V5T:,=AR\<5/_7$=1C1:H?CQ4!@!U,JD=*"ALAQI>@&[!E%0 M!KGPN#>7CG4],\G<=J#$@_'%@'^-=,VA8(^3A8;RZ`R=J^&XW]:07)^Z?@C. M*,CD:A8-C:]HRI9H5@@#LS60(#B&-2>.\3>RL%?6*#.E5S;Z*7!;(#+A0`#?K<]HP9^':0]+,:^@*ZINXOKLSEE\@46%E MW/X;91$$1Q6KU?F7]?`;@.C5)5U_FS%KS0,PY,R&J%7 M))MKQI+D)6WTBLU*87#UO3$+-ENBCCY097P0%RI+!"U)=">MY6><1Z"N]VJ'?4O(`1Q7B&H5^VP5LE9AD MMS?T<-Z5Q%&;-5^'@\8ZL!7HL&T$!LKRP&F%!Z MB-<"6"SM>S8E3,GU%W)CS8WY!%!I3!SKGA?7'!LNVYOI%*==!W7`U/+L:^-$ M6:Q);86-&MRV:`"?8MY:6=1ZB&GSY"8B>&"72;HB.Y!5#B$8&W#;V^DLX;SC MJ`YX9IHD>TB#M;<\!)>IE*<&W13X>>()6UL]U\VY[=K`GZIV45E?4&V!S"O: MIY`T?`@%&AN`.UGJ["2V^^CB4R(%<903,7_9<$9+XY']QP(BS)#R\*S/?OKD M/-&5"Q>>@D-Y'?HI1/WM'_=)^@NT7;&-U"U!2\JDYNYJ2:',\`Z1:;E6Q'T4 M$5\0AYTI1KXRS?A.*V&ZP5PO6-/('M2#H%.A(/F%L]O]J&N+>4'3R;:HES3A MI7)4-0]#5%'C!KPX,/\PU_,U`A& MG;E`FZ^'P-\#N^;;+)AZ;("IL\'9O4RC]8ID"NF;D+*%>W24,39`J=BCJCZ;V@@-![2TH*J6V M)@%M;!#6;;.*6[4>T#$H32X0[6?IL\UTD-7/ZB#!K5&TT1@7%K6Q`!@\;2)9T0_T7B!&'F[Q&0#6^HBMTH%$AY!3(VX?B$9F` ML:%)Q00U<0(*@](66PG=O'N,7OZ71WT!*_:74S2Q'_W?:7;4>N,G&S<`)KH; M]I/3%5[3DYVQHR`>`YF\:2+:)M`XX:V/!3D*!L@!HSP`?>'$Y%%>GVD0_"6, MOH8KZB912#U^9'QZSBI_'H49)54PR!$""$AX^SN((+D,(H2,"4!*UBC"J,7( M=+]F9-/8(3QAQ9[PW7N&7*`AF$3Q+HKSFYWB^*J_A[H2;*4:*JZ(IN08HR%$ MD5P6*0C3=6.GO6>R>S@M/1SZ0JV5E8K79!VPV=V!2AG&A=QBYXD>YW_VUL<* M)U)_%^5(K574D'1_=YIT#]$BG+U/?.2!N`6N<#_J\JE>.BEE.-38V:'=J[7! MBB[6$;G=W4R41(/#@2-?6XE.IN0/'"+&G"<]-Q<2TUF:;HH7)/Z.Z,2Z@ZZ;_00B%7YOB%Z[A" MB%R%D[9Z'>6\711%Y;]E\DZJ(`.02FRW@+>OF5Q=/M-77V6^I+O/0SM4%[L5 M':T[FM$LIEG9+ON%Q@L:_W7OQFEE,8S&QW7PE38J@CI.S-O/@<4D<+KGOPL9 MFIE)T?U0I"/MU)^A'4/%)A7$HPHHTPE\YFOW-.$97'6%NA5>TNP$=4II=P68 M95^$I*S\@>E4)[]HU[G+NT>=@9J=I!F+F$5:DL8^<*H6(J0J5V-5SR&7 M70VB<>NKO.%L49%(PVD'U5N^5FJM__#+H08;E-<]4MQH/E53/4'KX;1,!WA9 M)W_N];1+)U)!6?)LB7.M7,"H-L*-)I">56F;96?-K;OUW<+XPKD$&YBSNK6#FZ4QJN-88KA@PB63HF@B9)-,.,FE MCPEW*+.5)E#\D",6TI._KJVE.77,R:>Y/;-OORRMVT_.ZG9IKU9STVF`JO*K MN$5U2P512^M,%CD*(T(:X>*N"!,X)@RV-4YI!=II^+HC#6J%U@0$5H"KZ6D4 MGA34P$`(FJ\M0*#KJZ^I#U)B(3BZ$T+@7"^OX+4M]>D*_B7".?G1GEL(Z"1O M8BJL(*HYU!,>'"LE'(HG\-H,/PA*HR MD9`I0S)M1C5C*AGJ[-I%#6S#A7L7[H`R:B8WL$+FE7SLFHFXU=Y%!X"W4A$5 M"&182W)OS-8F,,EE-%W&C!2X]<<"P$ZV.0T1[S!^%V>5L\+L?+TKJUQ5`WVQ MRC4HBXK^S%GEUBLV_UMS]K][<^5\EXQR#2929)23#BBN%JV?)%EAIAE]=(,; M2I,JVA)^H.P&M05J6S>#KEK;57%L#G\FE^^:`I!,MI37L:MFS1&7"J!`?WQ# M?9M#I1;N0&89>A6$,>UI,5VF/^KO: MRE`KJ:B!B2.CX-CDX@"KL1`HBM$*B7W4IM;616F:P8'F*"</' MJU]^^LAW91__>/73QY^O?OWUXPEM-"<=.1*U7;&O:`*UW_T7&KR.#9!UEFZ@ MHJL8XT'Y1F)FY`(!E91LI.9Y'4PCS:H@:4:@\7P>&TT$I7+G*PA&5`;B(BQR MF2:2@C<-+^CDF*M1!C7UK9=+*(57()W[\]@`);=``PE=XWCT35BSR%-)IVYZ M.L;USVDAJZD4C4'*@:I&M$Q8TP3:'@M:I)VOHJEI,'S?V'!8LPV0X+_6@H2B M("T`@`;'..K%CE8-]KE)$3%%&2G6PGV%^!,C;4,@T^)E7*11:R61ZQ)!?Y:) M@Y7T`(0R_712FK2EK[.#!UVU-E@I_JHC=M&7*OPL+C0>'V/ZR"9K@XDZDL7? M1+%(=UH_9"XN6R@=RBQ[$-PU%90N:@4,AI5[U5N M2WNQPH5N8+I9LN(V!N,#"$>V[^[L^>J3L317*[[OF)I+)T]>7'A5;9 MDZM/HW(([58N>4E/6.KN.D*$L78^V4OK/\TID[TT[\WERN2AWBL+%"HD4C4X M2N>F4&Z![0#&"3(X'X5SK&?B24%^,1]O3&C'&J^(;3W#CUG-A2\T3GV@$8Y2 MFM7SLL,[9HNG7VO*]2F\A%RGJ2J%6Y0=I$#:S_%:P`X)ET1^U1VMIK-;\M66 MANX-O[)2-5%Y&=4.CY@\E&?7#YD].+/2D5^PPDEJ'T5FGS0K@&0%^`GRY3() M.756@3FR,5MIZ&XH\`9@NC-\VDFS2 MH@M6=+./^7V8^0URC:EWPWH/N_Z]&$9["Z293.]D06/>J[ILQQX%X0,D>^L\ MQL\7;(G`U'&#X)44$$*FF7XD+U@X*D*D_FUZ%F[9,Z(&S(7D'\A*4K[*1_"9 MC14"40F,UFIBS,@7TU@2E5Z54,TG;J"N'/(^<2$8P5!=<3/&I?FU'+(TEK]A?SSP__3L=#IJU)PTW[+-QU%(2Q=6N#2V1K*U5 MQEX&6`[//L].^^>0ZFO.)R/,\NUDG:K0U(XCVGTO.V6?G!=.'U1(@6?B/U'O ML91")S:=VS6?/>+/(B<&0ZGTSR'7$HH$Q8W%0BAWVX MZ79*'U)Q"`J)MMEQ*.3UY5H;G#CK0\U,J_PZ>I)MJR@JPR2!7,X-9Z$IT?]# M=,'FH(3X],J]I$U,WH5,J_K3"D\"F,L=.#8[;MJ(A M+ZJ3VJA5PQ/[E^`7.`2][;*@M[YTG72'&6<^I>*&2ACAN MO(EB(#%Q(N=K))A+HK@A[*U-(]I.SMLIK>\LO5AO)3^`YI,PDPVI]NG7B.$Y M$Y]E?/W\RQ]__Q#/^V70J0_^[0[FQ_:3I<\V&]GZ[JC_BX>-&CQ]BV- MXQ(MO7'(4ZSYB$E>TE'.74$IU`%[+H%P$5?G*9IC`64[FU24=U<>J4N!KBD; MN.I)S?#2EA-\Q%136G!]4O!O;%T?TGQ297.JXJ7NY='8F.PK'<)!\WWKEV#2 MU%_YJSJR@)45U))XH5`'Y*H-OZ=6U5Z5451;']E$JW9Q)))I(PF>\(D_KNY!BB MD4AC#-UM5[%>2[>'WGAU,5U=&?MVF.[NAOF^KE`T6)#Z%7Y02:W5\F64"[97 M$N.`QUK1A0+1&=.AJ5;Z>FCDM3=0$7==A[$[ZJ[=`.X,3F]*2K]"(>94``8/ M65OOKG1-L5V4D]9G'X66LDF^&`AX.()[$(+&Y$^G?2]Z2S5`$5EN?!-==8)P M^EM<+MJY&%1ZF=CZ\R,!78CKJ**4M>"0``V'&%$L2@AYQ\KEV7%%&(5LBT_I M,Y_P2W>9;_A=9N$'A0<3ID/P"D$>?)3XB?TN>L M[!$S70J7*OOX]=#B+OOV>^3AE;\-\;/IZSL"V39_)C3@98\2?E8='HAWJ[7F MEKPZGMJ(2'36:$R\8^&0S`L2PI[FJ>*A>"0I\&G[69>?HH#Y7_('=QTR(D'2["`0EL^.WE@)@SO&BL*HJ@0L9$";_JJQ#/TWL4%RP M_E(SD6IL7,O65%\GM6Q=LYDK+=YDU]7*8%K!0D)\TOG]=H^U1"YC+]G,?QF[ M7>J40)_MJTX1='LD)HV<%ZRGWGG:XDT4'XLI+OW'IU0L#4_#!3HW@TP_[ZXX M9OHXR"WO(XI!,NE!.(FY=+&_\+*KXE__Q(-D^'M\IP%W5NRWO_SIW\$W_F// M=DH?],QFC#I])W-WPYS1[K7T-&T,*D!G"P>#GBG)B^YI:S]G$- M,;'-BJ!"NO.B`:+D\E@PI]KU\SA6E4$8#D,VG+',HQ#N6%W(S6DN,U'[.!I# M,D50N;2B(F;XR&;%\14JD?7\%$)J8W"10A3%Z;(&075/ZRQ+4:6&AM#F@J(^2$?W4BG!LQYB1"I+_L2%'O5K$>,I$L(G= M3^G,?X&\II29' M-'$+;8\-CMVMP(6.*2F# M"A:SYV\+(D@N@_SS)RWD$GI[T4@I4=>5L7B)NBE*,5TMX*4E9XYMF0T()(NC M#:T\SJI_5E<&7+4*NA+=^(F*"Z&V9":H21=K M0A7B-A&.B!8TAN/BJBO$XJ]Q]X85@G"QXJR]0^J@+JQVU5(&3W5M![_8K.AQ MZ3:S%@%:JG#D-&OU,VKI*5T5-$[%ZIA%>;S1X<2YA\(77926`5-<%A'_><>^ MFW#O=JQK`8F[5Z);5SS0:>?ZWEL_?/N[S_[A^2^0%.1!.>=-X,;9F;P;!!#G ME+'LD3>GD5/'3+CL)S3=O/OAO)KYJ&*@&L:@IB!&-6"[>\SAW(]]!1:B.X,#7(5DQ31KHZQ M/@C^E6,!*][IB=Z_QVC`,OU][^&`N$[AN/V_BX#`>@.I,?MK#@FC' MR@Z#V8:+U.!B5K"9I/XS"%PG=+L/9OZ6?H0Z"57$3.W>1V[D.ZBJ/RL<("9D MDCT72@(FE7SDM3&TE1WLK;.R">(VCF"VX\1V5[G'9RE=;.]$:4H\IL,5.&D0 MA8]O`[@5(+NGU\2'"B$NOQ4`TW@0:0EOAU'\S'[#?,/;B[W>PY[Y+I]50R^; M+%(VJV1;.68:-Z!9DLW�]3"5/"NV(O^P%DG+$)X=G=/+&&XK/$_6-Z#%B; MSRC;?1SZO#AB>3A%XZP]:#GEV@3^LY_RL%'HYA9.4`IMEQO:^M]XS5`A<\,9 MW9G88_OPXR3:IE_9KFQ4DU$GB)5/:#K[/B8(])@T[;`O1.+R0-3$@7RI)C9: MQ1>1@9YME$.%=IHSPS&G9&$LG2_%DF\K\D9(&UF9GC:&*4<3MA\VQ((6/%\4 M9`C7J1]D7UM[.X^"9+JG3B28)'D,=,IZOH@"?_-:QX.OI4GPI9#1NN=I;2`(J/R>EU6;VT M)-;J3<.%V;#/H;W-/XYU3+PG#Z'#8ZJ%8EQYO>)$YN;*L>[8]T<0G1NKU?IN MP3\^8X%?LP5.PUN:[#XHZQ9II/X( MMM4>V,4[=0MUBGYD&S]$F.<;8P!W<)3\Y[&A6Y/YY.3C"%CH+-$)U,=LTT[9 MQJ+FV%K^CN8BG34JZ0JX*I-D%P3U5Z83T:-.=3K;].R2=-Z-UFDNU-F(P0'Y M:PMGTO;V-#BXYALA>0G/6:ND%&KI4KPZH2)Y:"P@:V>%,U[:%F.C>1Z^V<-) MZM2/Z88ULZ+QB[\YVRNU?5O_W-RL9B^S]):+)%XFDR294#@=L-E/@#OJ9WYY M_8%0-P[9:V>!3;W.[GB;=)[G^[;-*+X/S?:5?BE4?$/[HBJOFV1OC01ZK.NB MVS*(E5S/%AJ%BRM866%%J.@Q`Y9RYQI6U*$_61.>/XK&Z>R[4EG.?3L6EY5V^JP&?#.6AW.^TYKRUV[B;XS0FT)9^EI^`=E; M:,=45`N52$E3$D`D"WP0BKD`;PF7QL_A/"%O=&=PBO8YA5VK<1OPB(#O'.>L MVR+377*`7/LX_EA`H@@Z<3=C*#!6*]-9C0Y5LNZ?G00H#<2`)"EN\E2#&?XK M//U)00!JJ<_:&=O@%_MVQF!R9KWN>\&LQ$!EIO+Q=ZC=VYD(S%@=&M.U@^JD MG3*?);:PH[U=`*7,S^: M^LMJ!E'*FN_QK(T7;9W3KZ*B2V)OK^VIT@E;Y8N:S]6:E--^FI;5^@WI5_(L MY,%Y$9/8W^D8MG^=SL0Z]?/R9UQ-MFH^V9(CM;M#Y>=C2S>E=GB:.5?A2)(7 M4`ZDI@S&<0Y,+- M6Y'+\:$V$:S5Z]@"CJT5Q1XEG3(^UR2!?="Z M>M!(;U?=C3%Y@8H9RN5C5"'5'>5.E+H!S\SP'_8U\9;GSZ#P7"L2`V+>J,BY MR5K5!5Z4NK)YO9W:0P.VMNM%E$K0,>#%]N:)>GNH>S*EG(7&?Z%6R-R%CT!2 MEQ+8^G7\-7A+13%^D1U4$F/#I/`@[K$`K*LUSNYV.XU;]QES:BZM>\.Q[DUK MOG*6:YB5FVJO-3^/FDF55,&@YRB`%"2,!4'*)BA.5RV&HSM&>"K%DFX8`(-7 M<61RO4_9[O`+3,ZL@8;%4&=N`P'J:6?_`X9J6O6VSAU M_1"V,Y+@M>9WT,!24@EUKVK/82VS-`25$)QM39;FU'+(TEK]96PH4S+'*=!: M#-%P6)O3%**PV#<:R*V]Z]=U`J'[HM0=I$9(.F/_4PV0?@!'FFHY%^^.E/>5@\ M\"#'FZ>?/M3R>&/;["4YL767^LI6S!0Y)MI"`MZ'=S_]J9Q\QS4B/WT8)D&Q M%^M(K\GW$(\$AQIE0S$'#WRZAU]`+8M:PQTN8K*@+LZMG/KIZSMRWK3@0$W$ MF8B?G!&5JHU54>3#*WFAH1?%@I5F&^U#-LN,ZQ!%VWBKY$YV]/#NT]=G"L$% MU#->:.P^4C'H]E8(/*:/-:=M(1I"350XY5&W3)EDX@K1)Y7:HZ-P4I'NI6LJ MZK__4C+WK/OAZ601B7)/A]F`TR$7K)(^L3D;YNF"0]U^H.!FVMSE-9O&`F'UC_%U05[B\!T&:CFW[Z+R6Y-,'KA3[5(=O M,W[6`#PLIRX8B_OT;\WJX^/^L#2<^]VZ?@C]L,/*>`">`D)3]UN-4RF_CG:5 MMHKB=[KP8=FZ?DQ>W&#/[_Z\@^0#!^+KV)R@K9U.H=UM1(<#[(%RT?X<&H*UHE&A>+PZ/(0N&OSTS_S;PIROQE<:'9LN%(WQ-E-2,MA&@YYA9-"M@Y8 M';F@$U$V5'()HOPZ&H5M%<5@,;_LM3+:=0C2=KZ0-U/SQII8SFCJ?72US2D\ MNXWBT+PF-1#41F6JC;)4?"<%-\G8H"*A).U(/:J-EI]7.5HP:Z;%4D>\4E;- M\$M>TD'-KZ`4*DVGLOC9V("C9H<*-G[IZ!1[.F-_8S_+?\3^\^`FE/WD_P-0 M2P,$%`````@`#W1.0LTDW&64,```K2X#`!4`'`!S=&5V+3(P,3(Q,C,Q7W!R M92YX;6Q55`D``\T['5'-.QU1=7@+``$$)0X```0Y`0``[5U;=^,VDGZ>/6?_ M0^_L0S]UNIU.,DG.S.ZA)=K-C2QJ1;I[>EYR:`J2L$.1&E[<=G[]`B0ED11N MI$`1D/V2N&T`K/H^W*H`5/WUOY\VP9M'$"TM M3*)W/__\XR_OKM[^]W_]^[_]]3_>O7LS!=$H\.(L>?/N#;R!`7CC9#`%NS;> M_/#=]Q^OKMZ\>?<.UPA@^,]?\7\>O`2\0=\*D[_]>9VFVU_?O__V[=MW3P]Q M\%T4K]Y__^'#Q_>[@G_^]W_[TY_RPK\^);!6X=O'7?&K]W^_FSC^&FR\=S!, M4B_TRXH)_#7)?S^)?"_%BO$_^89:`O_KW:[8._RK=U??O_MX]=U3LJ@(NH1! M[3-)"AZAYT?Q]CL_VJ"FKKZ_0LA4:N`V6X)Q5*6$X^J77WYYG_^U6AHUMTCW MQ:NM__B^^&.C-&2(LX<8T?JG@M4A`NP&+W8:Q!#ZIB:4IQ@LBO2O`V MP-TXBM]6-7][K#GJ@;^S/F$\)&GL^>FNG]]6Q&K'2X#_W2IZ M?+\`$"-TA7_`XE^]^W!5#J;_1+_ZO?C\'*P@_FJ83KT-:`A,+585L$JI$=>% M]6)_UR3Z,>?S+;7?ER7>;[T8M??.7\-@L:N]C*--"P!W0D0,'=YD"9(FVN** M7O#V310O0%Q,S&?!?Z>(BYHEX%[[LV9XUU4CX_S]N7&>@1A&2(?%V$M9@-?+ M:8I\0UDR!1_/18&!1%I@L6X";T6`OOYWS2!O*$>&^H=S05V(/4+BQ%Y@H=7T MZ3?P3)W6F^4T@YZB+)F"'\]%P2B+L:(W,/&]X"OP8OJ<0RVJ&1%TE-E$_L+,5[;&Q[T<<&JY)F_(C`0&;J+^=E"INY\0CUG%44 MTZ>M>BDMN6@H2@;_YS,/DV(4S\$VBE/4)QR$8Y;0!PBYN)9TT%0G\_++>7GY M'`49`C$N.@V=D&8Y+9DX4I9BIGTX+P=?0!#\%D;?0@=X212"A94D&8BI7-#* M:\D)57D*-V>WH0\;CQOT&]((H974C`^JPA0FSFYE%X(5YJ<8%]6R6K-14YK" MQ][D_NM[HC]4DLMW%(5)%,`%VE\LKKT`>Y.=-0!ITM7/2V_P?,Y=N@RG=/"E MESSD?25+WJT\;UOTXWS>Y>_OIWO$<`N9O+>PB:UAVET$EC48*HB!9@ MH1^;PY)1<*`QR489CT"6!=Z*`>OX?L1LIV2.?`! M?,33Y12DI3JT#L^JH@L=;+U[.G[J3M,L!EL/+LRG+0@3P.:'7%878BB:]G0: M)6F)$%D:M&&@H5E/AU.G(C^-0K_%^DPHK@0??")(BBHX/T5;$*?/,V1BY>;P MOS*XQ?O`VSA*:(8#IY(2_-"[67W28JNOXK*?;;(`F\5C@,#U80XM^CD`.<;A MPMA@M_8?^>^I^M&W"'*:UZ@/R(-4G]&-]DQMQS:NHA&K;-4E[DK(-P8-'WTO M!@L7^.LP"J)5\X"34D@#A&GJ2=QOT#`M!VIM/!)Q)1;4!ENRFA)ONHCVV>-I M@EY.&W2)2O9T=:7[U'T#0YB""7P$BU&TV68IB)UHF7Y#0+"V9MQJ&M`D#D%/ MUUBDL&8A8,,5?`A`:3`N$AO1D5ABFGF[-],(U?7O%J709'#)FU)-O MTW3G"VWHHP2B'M90DL(4M;A&'-%5[NNBS:G>(:8O2"?H=^KT=6NF.]`3Z#W` M`*80),@NRF^(KJ,`B95@&RE]YKCEA*MK<:(I#H9RQGU%=+$#3T:%@;EJVR4I M#*I_*+H[O9IYS_CH2NR\KE%8':Y:'--[9H:BMW^HI,!8#P3(4F0$IAKPX`VYD M+Y?01\NN'5<7839+`A6U8DP$B)Y>'9YPVRH*'P&:GO%]F"@%8AL,3B6M6.,! MH)R#5WB5TGUY$E^7!G3<5H04OJ#"KJ,.1Z>85%I<8AF# 2/:-P99,.MG!77VIVOL@._ MCZ'![@T*NXYGJ"V`5I.BQW_V@HSV#)%44CDN.4\)CE55CI!*A!46&T?%M*+B M6$GE=C+&8@$+:68>7%CAR-O"%(M&]OE22FO%"E5EY?8WK7$/W"$EN'PHDG/E]H*`]LQR5 M-4BA[P7R0_@TFE<@H$]#(E6FYVFV>0"QO2R"9R(A<_,'=24;R1J/8>('49*A M/[7VK[1O>>A`0AUC'BFQAG3FD1AUJ$1".5_$:\RGH1FH^ZQ0/\,W1_!DE_>W M&8CS#BCDL:-65H6IHTY&=][1@5"`\2FD;ELH*VC*T4U@Y8X0D+#T&NV@M;7D2B+L^H(>OXM]ON6:)U-2"-"$( ME',&'L7WYRY5K!JZ$26Z2`UXO_-(6N8*12NM)S'LM6G`:YXMDH,(5=&3'H$E MZ>?SN\'VRB3VTMZ"./^6%`\8I>5AG%\48?1T\;RZ.%Z0BV,.'D&84>^+[O^L M"MK,2?&@C'(XCZ(DM9>E@!SW,KFL%@Q0U%3.VU#(Z8#X$?K4SM\H-#`!S!YT MS,%!-^7&0NZE%V*`5%(7&HA:*C<0*L_`G[&P](6@64X7'@@:*N=>JRDCLBIH M@WY#,^5\97G0N5D<+:F7%JLEM%B#:RHIU]5+\RA6?M]/):D,%05[FQ M,(U"6-Z'*J4=PQCXZ&O)#:"NT;Q:`]/$[6]5MK@(*+>7PN,<)$DN#X.DHV(Z ML7*LHX+;J`0@[==&N!BCM2Z(\K#4I7+4+16KCDX$<;17;@URO,"+(4B^>*O\ M)N$N,`B.2(M$9L5P%:JJ$W=B6"BW5NW$1A+GDG/HVA?3D9J#CLJ=6-Z"$"D4 MX'0*BPT,(58&1S!@SWR\6CJ1Q$5`N4/,(_5$=]Y:\4+04KF3R[V,5NA'&S"A MAX`GE=3+_JFJJ-PTAO;]45W0LM=PC%-^/2U($E!?N5GLUH,A[DUV>(B;8X5( MW#RA,PY7/HM!ZCW1EB#1Z@,3*-PS:VN2,#;*V;.YU[RJ-'LG02VN(VUTW96S M=V^B&,!56,1^\Y_=V$.F@H_EV_6]:[!$95SJ`&S3@HYDMD)(.0O9JGO!*!PV M2^G(TY&FRIFZ5OB(Y,,S=Z$4Y^$PM;B>[-!TUV3)$; MI/@H"I'0&9+[<'.OF)J+B"15<[[E]&N!@5\7NP_VZY!'YJ+T=K M+URA?EFF3\!A)6(8^G!+O5K;PXI7T[6O2!#O"H ME[6LN#O#\,96"FC!2E4A]7*7[:*G[1[F77L)]/%1,@RRE/JXBE=+"V*XJE/8 MZN3Y(2<(_@+@:HT33H%(`IU'P=\A&4OB_@I M97#"_/78IR*PBM0G6:SO#/Q`BR7:P&^@4)]J'^A9I.[0C[MT"C74@@L]@PD5 MNN#;/5&(#X.,)\A]=$>LHPI5_/=W9)65HZ@,^'L?PC2Y`WB5H?!"**@*&:S> M57L60-!5/4(.;ZS9?!R5TXZ.8TV5.W*DQ,=F,L.NHQM+'`24.T1LAL=F4D4I MK!M'-)TEGBJ2[;CC_4JYQ26B+E)#%^B%M%?QN)#@#F,.$6857=@2TU_BF2%Y MN+@1FCG%Q@FUJ"Z0L_55[O3L-2C(T%LMT3!*FL9.$@Z8A&V/-]M=_+])H3Q5 MS$)&$,,(NYOB-"^O'86_7VE*(A*<,9(ZT6B&BV%)Q+N:(N[:.(OQR6C1NXI` M>3Z:S9/<(*!/D*+U]:!<'`Z)MA!Y_U!:S/FG1SCP?1``9)+A0`=Q`BK"$#84 MXG65IJ4E#,K=JV1VIRGXEO^IT]`Z5%::P+9`*&=#,04ODL?C5^/VLI)(W@$^ M*LI(D7MBH_HS+@"<:EPYP*'=CDMFGYB!)8^BG95QTXYL7+_+(0UT&&KTQI4D^%2CE M;C<:B__+BN<6B1M1CAMRK1Z\!"RJ(2*,<&$^@=B'"2C/SNTMRS3IXTM:])5> M()9YAY(_M1<]_2:*;[(TB_4[@M]`*K>O4[FK+B[[ECOXIT7$%9S2G>%T\'J_XHH6S;@1^&BK;$EK5FE MR94''N\R:4\3?%4RP_?C##MWRIRLZ8?O?]S=6[;#__'"S(N?KW[M.[UV; M5YYTN6!2R)=X>8"\&,$0&2VHQ^[6H?LM@G@5@UQW([WZ\<.1R-__U(;_$[Z@ M9QS%FSLO]%:YP#N"D3E7C35.@%I*L\KS M)`<\"LF=W&%,DBEBNL!?AU$0K9[G^/U/DN>.(QFNG9K1A<26X%!(Z^31:K%& M3:.T>FPAN@PUJRE/BICRE$L0?3N#&-M;"?:`IN0P0:$0U]\4)6!5A[DFR MYOD>D<"T<=JZ&>6I[`8.A32)+I-F%YL%GE]8\2N`HY7)'["G?D%YJJ5#2ND% M?;M,R**R@HS,AW>%S1/1Z*7W2N*T$!;._S&":E+]XFW031-^D9 M?0\-#QPOHB:+GG$47I_NG/OISH"'[FC&P/UU%D>/<(%OF]TGV.3V:X[-]'P:@ M)K4;R1F>O7SJ(CI)/R0H]T9S#!!#/F3E*JL5&9C;/H=&E?TZ+.K-$)LH3N$? MN7CVTD(C/,3+WMYR*\R M@=X##"#QW%>TYH4SV0K$L[[@K)S74#-`BM5Y"13R@5/NK6?C$08W,2NI\(53 MRX-*XNO/%@-RYS+DW*P1KWOA++8$4KF'G%A>_%2N?.%2.9NMZ&#'H\"#5.=2 MNS8NO$-T!%:YJ$`(CAAX"1B#XO\(`/RJ]8!"O@W$1X3E'@+BM^LIQXP^M=6+ ML)A/AE:YR(/'&I79)=#TYP.TV:0[TH6J#DR[I+'`[@,DQ)2SIX_%GL5@Z\$% M+W$=I]I+(+B)E'(N+GJ?G'G/>5*1V%NT'\>URB^!:#)J&DW:I>"5K2L]?$O; M5EY@!VCBJ)RU3M0`WYVM@-"&_F;5%\+Y$6+*!7`Z%GMW.[KLJDAM8:()55\" MT23$E#/KQ0V5DZ\C7"#I;=!3SG"G"%](B%'9;-*"FTT6@0]=R\K4`3#FS&\GJ`[#( MD_D6E[!;T]VBA;4K3:K(9VWVDR`E)O0JSN)ZFG^&#R([+:.JJ@Y;@4Z+6U[=0R*TAOH M2L@W00J;-2Z.P2-(U-L05Z0]7*VHY%$4H)%<[^+(I,"CW+PJKOG)J^9ED-P& M,.5VQOG>/ES@_V'#^Q&9Y/B$+`_.V73ALFPBT2:TV!^U`T433@W42^/X&77( M_+YY*S*;=35F\0@&NOFB::J#*,395C_T-<+I@GP9I50+&792?T@D/(+L[B)Z?M@9:+ MDX0_\.VBSG,=T-W4TC\S\.PEM3]5ER;Y?$A+19_B%,P5>_Q8VP'NK)$%$U]V6S4Q\`Y:F+_&Q;46&&D_FQ@C-,CFYM@U1Y^F]L2^_7KZ M7$)HXIDO&E%I.;`LTDG M%AOG_'QTM)]0OIC7CN6:8_.S.;'SU7MD.ZX$`X#6\!!3"TT629FEP$,"4U"^ M+,1KSRA*J*<:(C5DI;PB?X8VN(6J#&A"".*\ST[%U5[[P3LW)P;JUC,#;<#= MN3%UC)&DTTYJRT,,7ZHP0\4F/CQ78+D%0-K/*2-[^AD9]-;UQ)S:KNG,C*\&^OGT*876\!`S"DV6X:Z4 M"5L6E,(#WH83GRAHI0>>%-CX-R^V7>:P'YMSZ[/A6I]-:^JX\WN\27:,Z=C] M9-X8UORS,;DW[9L;:VI,1Y8QJ10Z?68XX=M#3!XGB"MG7W_(OW&X48D#E'T" MBY5(U(!N;0PVP^P$Q>+MLY#PIQI.M0$-F<[\U:CT&#)2E&W7D(V8`BRG!O ME:(P16(&^*E`><5?X($2H])`,\8=#*,8#8Z=/.)SA4A-!1YX\'FJSAI"<&@_ M7Z"A8QKST2>T(Z\X_&6X1(GM#N,0)8HRE/\P`:C7X@?L%5\[UQG*K#1F&O:KLVAHJ7(B(D;TYJ MV0;: M0L#DG[BGW>,7!:D'0X'HK>PZ@TTV2!ID7N0D8@G;3#$"58?>X8CP5)](1/#0 M?OIP[J^Q0Q(-*F182#G=.6IQF`>>#2&&"GCUD(!_94AE\U'@Y3NU^&#QNNKR M<#VNU/)#AZGA\%"/S$55^@)&N\B[Y]V[U',]`=]_3]VGX'L1Y9SH.MEFX\7/ M]I+Y+G@6X!_R@P'4U6DNEM/;&VAVN?82F.2Q94HY*;/*<;D!SW*E,%>=;@@H M*!=@KA8X(]?Q66!/2*]R2?RQL5$N,MT<^(&7)+GF^:U&JBNS6>Z22".@H%RX M\_L$V$LS2>'&2ZDAS1N%+HFCIO[*1;/>W\&IQ`ZJ7/`IY@(*;V)U+XE.0;24 MR]EC;;9(3J)P-8&/8%&\%1-;$SLU=4E]H!N6RB7+O4'& M@Q<44?=IX[M:Y)(HK.NN7'!J2H($L2VK4-U+(E,0+>5B\E*#`(@1+5S]DK@6 MQXQ,]R^G>[F&?_&.=AXP!?EBP]R>\>M=4M<00(GBDO@@+W!SY=4=EIXYD/GE M+X$>`50HM`SH*JH\4YB#;11CG>WEX;?E8P?:P!.N?@D$M\>,PO>`_J2*[&*+ M+Z/"A7(J.FJ'S$%-OS4CZNX5;N"26&Z#&X7U3@XL\A(ZS4-<-V^(\Y=2L7J7 MP%L+E"AT=4B_-OPV>`X>09B!.?`CA)_X(0Z_WB5TBA8H43K%@+XH\LUM\VD+ MP@0P;1R1FI=%KP!2%(+_HN.H=]8(X&LO`?FU?*1ED>A@6V8_L/+[;6B#@CT" M[-.*+BU=4M?IA"2E*W5RFY'7^^(E:.40!:?R`0LW*LU%.UV#V%U[H;G9!M$S M$#&K3V_S$HB7A"ZE"_RB0*I`P1,K6O%+()F/">7V1B>OEV3^:O>8.;Y,1I6+ MY)&(#85+B:GG)A#9@L7*$-ZG,"BS#MG+:10DXPRXT0C-%BM@[>P/_FQ\U+O4M`?/;"$$ M?^R*UKP$PEHA12%MP)M$$%"D=HY,3C4QO;IK5I;O.TFF4?@6IN5P"OSA5 MZ\JZU.8OI3/(Q9S21_8WR]1Z,.5Z#\'YGDN57U/WL50IX#F?2A6?//F%5*,9 M2=,17C#A`GHQ]AHMW37`7D0O?,Z_QIIH!"LJ/X60V=G-'*+P*/4_Z'-.XS?<*O M2%[[1EH\6>L+N5D%4C5*73&J*3ZYZP*C\&`WJ@K3*,]>,O*V,/4"^`?`V7/"Z<#R%EIADPE*6\JH+:M2EI)J9/"[OI[]>8[ M=W(0J*3:"XC.;Q^4&.CB+`D];;BDT!W'Z1)E3074EM7("BEU&C!0UT!,N\!? MAU$0K9ZY6<`3S4?5ET_WWG_%\4C''M"W.9OW:!R.1O%K/CVP"DR M+]#R%K40$O$QUVS!2OV\G+Q"TS77];1YN#'_.0MCH00?]G8 MMKT!!W\[OLA/'%O#)]$K3+D!@CZ:!=@UZ8#X$?J`SR"WBG8D\4%0+M+5?1@# M'XN!8[Y&X0(6HLVRV%][";`?`K@J@C^).]%.:U,KUB7!R`FK-7"64UDK-+MY MA3*>2EV?T:3P"-"LC9K$Z:CXZS*GPN!;=YSNDSFY"U49<)B+,4+>?I.45V2# M3SFV\Q!XG./5J`SM!2N5BSAXY!SC3Z MQ8N1T9`F=CR'JW6;T=.V/1V8E8`:)YCM<^Y`7D3Q?8V7ZK"U01X">>H3&[;@YZN"+--N?IP"J;:7VUD M9/64>$##^81BZ4QE']0<QIQRII[FF%VJ#;%7M^:TRM?^1C!0T5_%Z@&#=CD'HP MZ#Q)<-L]W\S`%668$6;'*R\L(^[4TIVA/C>K(%+)[..@WQ1/NSDI3^6T/=34 MLY,D'V^T6:5>:.!,J%*YK$TH#2S4.Q#:"8@&+K#0C[2<:H2"0Z>O)?8S(OH5 MY75AP_VLO/@$&]- M*\Y:0R7QP)1/Y"<0+*S03)#NWS@LU8IJ14%=28FY-2G/;T&,;0QOA0]+=]"L+A^=G)#QDB@QR;HJ+1.)!RK M*C$1I2#0^9-(0)J%J$7U@WBOI,1LDE0_6!K#APQ_`8EQA_ZY)KN\CHLICRM9 M.8FY&\F8NE'J!=5O$P`]+J,\F@2UZ'D1S^#]$HN\-C71OT;VG3FQ'6=FSM&/ M=_;4^63,S1.]9-*^?SYOFC21)=T2.E4OGK07[4F[ M\_X);J-H4=ACQBH&N0@-+Q.VV?#[6&0*[`JB0H3IX*3F5&&(NC2?!M8YW@M7 MWV`5`MGA';X@\!=E/[9"O5M(5^YKBO?O6*YW1OYH]EF+%I3G MI34D'!]:O[;=K8TVC?E=H/GT1#.-U-3Y+"[2UR7%=*VTS(KF2BHV]"Y9#Y.& MA?"K=?*BK9,R<"[YEBO)-\TLKPK&U,6#HZYR'7XO[Q$9I!)*PT]42;G(0G.\ MM(7>"HS!-DH@#?6C8EI`?ZQ<[^9#'HZ;,(\4OU<:M8KX$O?Y4N>%,L,U>VK8 M%5(:;)IB@V[>S:EKN5\=PW%,]]2KR,2VSK=])WY>TA:"$-^=%7B=57SH?:4> M^WD1Q%_W]2]\7W\<;=],4KC!H0+O$[#,@@E<@A^_HGTPR6W4KKXJ'##V_:W@ MZ)V>21X@P,\V61Z[<8QO@_G0H]RQ8)56'GJFJKT?&Y"(GP+1A""XI/(`4U7L M?7-_G-!A;MU^W@$W)6Z@71JLK#+PY"_Z<%^RP+>5`BP@1W19WPQ>LJ MST@+&'J_7]N8_8P-3I_]A^!$7RNM/.Q,57N_7XMFO%.Z?ZOJRE/1#HS>[^92 MQ$R_0;@O$VCA*:+<>MIC3) MXLIS[A9+V(8)KR_:KBTMUY6K#Q(G+V+:FX1L1#`**X\Q2U$*S&<*#V'C5>' M[XMV^.[]:E%8'IXE=DAR#1%&KWA=5;"G+F(M8.B=DMU.!59ER9_%US)BDJ93 MP9K*TR$,0>^.X.JV\2!*N>=9-#<]#$X$&]"&&E%`!LWV1,M)>'/OWL_-.VMJ MW=W?S8RO>5SW$S>#G;YUOGUA)_$D13YM\VE6+-1.[0R]5=%CXW@21Z][R!>] MA[R!B>\%V"MLYN\I\@=>'Z\8(YE70Q609^#C0=QD*L\#LQ!'M*\ M22NJ/,QT)7O?^-7B+^\B+Y.Z,K&<\LA2U.O][#]_AE5\G`$JJ93RD!)5&S2K M#R7CYXD;74ZKY]O2<@21])"5_!%6>&Q.C:'W/7IL2`5Q?]UZOI"MIQP&FMEP MT43-&`VTTJIP05R*N*KVOC7=I;B9(S'ML"D'8<;D5%`:;A&%^_=2^GZS&(8^W.(/4Z#GU=.$`*[ZO=]>+3L"SH>8S$"A$&7)+E37-'H$FP<07^%H75?$=4NHHBJH,U8R,0`&8^)_O##S MXNN MJ9P:R5ZH\3.&J1>21T[?)WQK;J*]M&/F+Y0="W^R\G56R/FN30V]I=;#QCF5 MJ5=SYX6;.P?OK)&EZRB&?X"%&^4++L<=?5Q>%8QY;CJ:NL/"/?/BSU[0'O9] M/;WA/Z@_0#K&UX2DY\B>R,C$27MES*VB/.Y\I7LW9?)-@OGWT2=C>FL:M^AG M3EP]3@7U,>X_95^[AC6UD+UW-YO87TT31[JQYN;(/8@AN$GLUN;0/G$]SBNDVV,A5PJQHBJHMW":D`$X%Q-XT;5"8[6*P0K) M;B0X@B4(DQRUFR@NWL`Z('Y$>QS&2X>6[>C"4UMX>C\#F:-=.]INIF"1RT;- M^4DNISSL%/7Z/^+8[^-I9WG-$LI#>:12[^<593@IL,@_:#^"V%V#SXA19.?/ M0`PCHHN(7TEYJ$44[_WLXE@(].G_S;PX)69?8Q;7$/&JLKV?+>"42^[7V?U\ M],EP*B=5^!;/K>6X\]Q?6R2!$#FX.ZT]Y=DZ$:[^SS$JF[*\0Y5W&XQPX8"` M_LB07D-Y2K@J]WZ,4'O@R+U$TRRG"G!LJ=_/T+^M6VRH%R=(.':P MP;G_V:D9]4GI!$[_)Q*';6_5[LC-0^;>_KBT\A0P5>W_+"(?C]0]_N&/RN-8 M5:3_DX<;&'JAGY_7D4/C-@HH#U]3(=Z!@U3+??>F?QJ%NRME#_BX`J=F!O$- M(/7-5M65A[\=&!1R9%ZUPU(P-B'UORL/;T,="GX2C<_*1I*&7J(3=@D;N3/% M@D!6T/RK-75MQQRARJYE.D=&U.DYJ84_<;Y3R3922;+H!;[(,N#;5!_Z-$N/ M(\+K[HT\7]I@YM)V8Q?$0BS`+/!Y2<)\SBJB#,W\$2E>T_L\GN3*SJ M22+YF8GEE$>7HMZYWCCE9S="T;:T#+;%B[754^R^61;[:R\A.E7(Y70!M:G> MF:+SY62:3R#V80($[G;6B^H"+D')WD_SL$<,6\/V,D\A.HLC'X`%,>`JI:3R MZ%)5'#3^WJTQ'YM3Q\5!QO#&$^\[K>GH1#.+T^KY+"N.('(Z+^4C#/N)5V/H M+;H>)I,@[J]6THNVDN8`;AZR&.T3)FB'&]P`R@6RXU*JX$E=4HBJ]0XHVLWZ M&(H5&'G)&F\:8$()T$TMJCRT="5[MXEJVX,Y\`'.M&Z%[AK@5)[I\]X2)BTL MPG659Z`%#*]6E9Y6%<^4TLQ^.K?1E'\'353W(21M,FM_5AZ\NC+G#)>`PSA, M05I>@Y;QK6/]X&9(TQ/L.]PCG``7H>P8T'B_/O/-]@]9UYN/CB MQ;%'3E?7JKKR1+0#H_?+B6@ZJW0-\OZX6D!Y?)L*]7]5L/Y%4@]NEM`,1+K% M=G4>#Z!S?W=GS+_:-^XG$U\(-:9?G2_&?&[@;,DCU_J+LANK.CID2RZ,WX1&H7H MGXGQ!+G.26(=569HOI^2K'+O'K9IAM]&V\MRJU*L$\6#:<+`9I56!6I6W]FM MBTRM>\>\9KS/O7`%=J?V5."Y571"GZ]__ZD@'T'LK4!-$BKXC,(ZP<[2N7>W MYMY,,HK\G\O=&345=5X-G:#G:M__"_+=K2LK3&,8)M#/Y:'W>69YG;#G:"[1 M=?IZ+"OQ6%;B9'_M!7BL$7KY[B^JX$8UY/A?[/5O-7 M<.0C@=V?E(?KH,39#DU)@!W^ICQB%35Z/R@UG[:0'+%Y]Q<-X"I5Z/UDM)QF M2<%6]W]2'JZ#$O0S3B66"M.+PSQ=0#D>"%Y/:C'E62`K1S\258*1^SQ4-'&V MV/])>>0/2M`/.26@W>_)E'WO.CAJ4A&LQ/R[.1]9#LZ-O?.P2S^4.N&+YSN/ M.D%(.2.$*P#C%$J\[M"6OAX'4*VY>#U[4F+F5O;L:7<]II*^J#R8.?R"ZJ!L M45D5(D2\E6TP&8*@\A!A#C8>#/,@/V$^YC,OF,`EL,*OP(OI!XBGMJ@YE>W0 MZ]TQ2I#P"X"K-=K-M3H@Z]:.YER*(-6[1VLG5\7J*::+RB^XM`E4UI$K$4QZ M=Z$1A)$TA79M47,J94RA$OU]!`E/FD+;M:,YE]VGT$Y.R-?S637/9_,K0/:R M1G_RX:^K.[9DZ% MH3KB5Q5!_]24K,14KZTO.S4#XD*7Y(;"Q6,#B6S,/+JQPY&UAZ@54ZZM- M;56H$+&Y6J'2_[L'+\86>X)$F41)PGAG0BNI$_94;7NWIVR<7QT+%X,U"!/X M"*P0K;/@BHHWKX9.N'.U[]TIZT9H5.&@^WCT10$JO[+"%"#<4BH#_#HZ<2"` M@$3/ZZM?1TV_3GDSCKS!8USZHU50!66J/?%Q&PE;9M0A0GJ\M@>E#/&2[:7AT#"TRB=@"1QUQX[ M<#*MCO),"*C=N[$[,0W'M&_PQ#JZG[CW=J[*_4<5@7&2 MX@M?$^`E8.8]4_-1DP^W?).E60SN8`@WV:8<13C7L+L&-S#QO0!/6ZC61Q+TPG75IT$]&$KHUV`EAGD6%>:G$SCYZ7(X^8D?-+HG M3O)#9%$2BL)ZHEXJ2H%Y;Z/VZP\?V7=WEEML(Z9C[/"WIK?F=&29#HXV;$X= MP[7LZ8F.\99?.9^'O*5@DD[QQ#[*V,6V;6%HCZP>;O*.O+PZR5^TD[SJA6IN!YN/$IW/-0+=J$BJM/7"9U[?K)55'ER&FKW[HD=1F&1! MBE]CXT2NI-M+1T64!_18J4&SG:-=XPA?M\AWBODV-UM_:B=VN&[T<9LK%GWG,>CB_ML&5K MWX8J7%"7L@ZPG)^J-CNX%I7U(V?PO5Q#(MIVKEE,>:3)RG7>U)5_P?]Y0/M# M])O_!U!+`P04````"``/=$Y"65J$KBX:``!R'@$`$0`<`'-T978M,C`Q,C$R M,S$N>'-D550)``/-.QU1S3L=475X"P`!!"4.```$.0$``.P]77/C-I+/>U7W M'WAY."S"0S-[-;M$3;W,BD0E*><5Y2M`19J%"DP@][O%OWWZ\!?HL@ M",JVR%SQR1;1:*#1Z`\`C<:G?WS;.-(#\@/LN9^/1F].CR3D+KPE=N\_'^'` M._[YYW^\R9`BS?WWL,)%)RCX[>CHP1\A9T,_/'Q\4T0H@=L+SQ_^V;A;4B%L]$9`;?#T,=W48@N/'\S M02L[(71$FART`:Y80F@4!S:_CT*-7N#@JV]0&+-TEZ60!_? MOO'\>P`Y'9U\O9Z:E/B4G&\.=O]@@8\^?/AP0DM3T`HD':T$]=L34GQG!RC# M#*68`X_=(+3=10E^&999D0"_.XD+4]`H.+ZW[6T&N[*#.PJ;%##8YD8;=E^6 MH7\2/FW1"4`@'R^R"IXK4,=SC]-Z,+'^]LEV72^T0YARY"?\WFZQN_+HC[]] M(D/T,1TG`ZTD.KX?":K/WP5XLW70=\FWM8]6\`VX?)SR]O>MC]Y`YU(0WW.@ M6NWXDN(3J!+`#*,]FN8-IRAL?U'!4N$_(/&VR`\Q"C(F?W?R,B0MT:HM25`% MN[BO!#GV75N"H`IR^DC+PG;:T@)5%I'SRM.-X+"`!HG\,S?4$KX:Q1AW#R_] MWR$/EH9N@SQ;!N96VB_#I79]>*9EGVG8."[R2\_/R=,'3Q2@I>[^G?Z_*]Q)S02D MKE99?L3J[+"542GYE++FY=@UUK4;&"WU?*IHNJ68,_E6AO\G*+2Q4V!4`QR' M13^^(RPR81RI-8;_"[@DBDQ*L$G?)_@&+I6Y!!-8M6Y-V305RZSPAEG*X\X2^:;R)ZQKGG(& M/A<1A[WO3W>E,&E,TB\D:$Y*VY/2!J6\Q5PX_UUH-1;@0(H;_]]A4M3(K:%, M94N9S&1P$RP86LI*73/KO9.&&CP/Y4-%BA-D$L4F%=$-7DJ-E^*Y@>?@)4$@>2LI1SGP:\>KO+Y6+>)WF^"% M@]6R5.U2T<:@N8A64V#"D_G.\#);U>-IURH?<]QT:5#"+A71#YY/O1MJW*J: MI9O*&"H30S2;&^,KV53D2T-1R."RO%/A2AR&OGO+<%K!6!+,4HY:2G%+&?*! MG0):]=QVR&ZAN48HK%&F91">#CWCZM`$CQ0C&GA2XZ3(XU_GJJ%,+&5\I>E3 M_?*6Y9@PH'A+BK.*,Y(BD'(,`TN:G0]]%3O9$Z!E@4/JA%]1)[S)%>'5Y`E5 M=1N%Z9@0OR1N@.@]VL0/4KQ(D))FAH5!F<&7LC$!VV^!4TX-";$CJC:N6+(& M.)[QJG@C,2Z)(I,R;&#-QH.YJF&3/K=@N+0).&UDD_BK8HQ5DVQ^I.MC@?7\ M,W#PG,W1+GL+[<3[T'E+^7(^8[0T+.+;VT?=`!:JOU&/'8:8;/K3_TV6F:P' MYJGZ82K&C3I6JEO80M"\0X:? M6K;E9LO8#M87CO2@_+$ZWV+K1:"4:(H!VZ5 MN*7I&MG),/3I%(P-K(85F.^6@"EL6Y%G_RH+/D!^7,`NI>@'F_?<`Z62'S$*J`+]Y+HQ@E@G+8PFZ_L*_G72TL[\2A MZK8P%OD#G]A\DJ]U6(IEGN)$F1G*6*4_E:]DB[@:&R%>A>?!5(X#BVBIE!41 M2PGFP8MIN[DYLWT@?HU"#+T3V>KF0<.W:J*4K,O!+ M)-0/OLJ&JL_-"=G7%`W\8]?BV;?J:J\V#!#,6X)=HN@'(]:NJ% M.I8U2QZ/]3D]Y)[I4Y4<<]<[FJWJ\X3TQXJ0%L*:"LBE'+N4HA]\4C:;ZZ*/ M+N;6W%"N54V]GE^#\-#@AHH$[U6;)\F5U3XGH"EN1$I:D=)F!HG>U^^I%V%^ M!9[,_BSN`PTBVL2WB6*H-^"0W"BJ9EK&G,[W>J[QP'G[,E5G*,2^B,79CZF%Y;&J&G111!/O?4HQMH%;-4?T.O@)U-LWJE&# MK$(>/RIG112!E&`83-,+.9O[NYG.EJ])T,-1>6Y=Z8;ZFS*! M]7/!>:O(F1@XSW/\J7+E(3Z>S7'2-7P!ZR"-]:OYNDT48OUE1B2N>!7>61]K M'<\[#TI0#XQL5*M%.\92GJ5RGHJL7CDI6;B!`;5V[9QX=3"98=FCL?>8*S"\ MA17#\\NJ2W']@1EE9GB+B.B5]*_L+A4WQ.&3ZJX\?T/[5&"+"#1/4N)55%*[ M^*_M+J48E53`-3"K]D:=JX=L9-F#)RIY8PRD]5)$H/!V=UC M`_)7!7;5N7RHQK@5KNA.C"F M7>X2;A@IIP+/9ZN*#R<#T*#:^'QCAVW7LXT+S^-:-3"J/JA[8-H>9X)D^_1* MN9!5XT:>SA7]XD+59&VLRM,"D/"1H1@VGE:MIE*K.5&D6[17BD0:DVAK9.L] M:Z\(.\R(5F(L+L!<3E:/2.I$=^!/K7FLS43"-H[UX#QOGV4:.6E*!G8]ZT1R MYCEX@9\3`)=AX#&U:CG;A,"E30S65/C`:S(WZO()"=?A'7FQ,ECRCKQ2W,.9 M5]U5_KKKV!4.-D+R7-C*427G^O;`J[W3YK5)F,?U6UB;^W61I0.7V!DON>9+ M4^`7>!C*5#=-F/J%:_?5:(^7PLB3T&I`B+BEA*:EN&WI>]+Z#Q*T7[KW/\AT M;4`YZSR'$T$N`LZSH)6+<;6G=O^?(\0_G10>+(`?I=<,/N'-UO-#*7X]8^HM M:`GGA0?RZSA]YN&8?#H>G1V_';WY%BR/))?YKD7-&Q$G;3NP^ZP#:?X#:7[T M7JCYRK,0S^B!YVK/[43AG8G6'2D\H$$Z\*ZN:>:+&R*MT8K,-SA.D!,&Z9?C M_%6.NBYP'_(0[LKN`R[D'X'&N8^_Q(TG#[9(+G8+5(XF^MG`40P2AC]U[%90,@3HB^NMHA9W?>>$A\AW4LA?A MD60G_Z6M$A(^'XG5#2+X%X<1^7KI>]$V[1*&SHB1=Q??#@;:T!T.643'XAJ6 M:=YX+NA)_ZE*M;SX,\(^6EIHL78]Q[M_2FEBE;PD!0O`_4(DP.`3/;N4-S`M M\;\2IJ=DL$O_&LS04%C/#UKX`G0(R,S:!JM9[?`7A._7(5K*#\BW[Q&HV#OD MZRN3@.M12(@G[T6=VP%>@&Q,L!.%:)E2M&_M3DD>>QM@(.UC,";L=QRT5%T# MD6>N$&52@(L3L$6%_A%V_F3B>Q>O\`*F<2$7#Y>X^DJ'T1]LNNO%#N1HZ@5! M2E/VL]>]'>UT=_3JTR=^C>OCTMO8V*WVJ\#HH)2\]!H1N4Z[VPC6+146.-L. MI_OUY?V<+44!58,@0LL+S[^(0G)""-9D$7J^B?P'O$"![NKP$VCYD3A=BNV[ M:#F)B+-DK=&,]H$E]B^!M5/%1V=D3$7'KV#LB,S;;[3]N-8":. M?B8;"MSYLC?._@W/!79!<('=Z:R?;\'QO_<1[8,]\X0L]!V[]! M(FF.(BV$:7#CJ\9BV@TJCT+YN?\=!T-'= MPS?N*]6DVP0G<5`I,81/SY39>'#VPOPR>W$OPOJ4L/&][D;WI0>? M8<`7R&_D".MR5-C+T@#)HH::QVF'V'$'T+SQVR M2!0ES$IK-%!2@.N$/[O#GBVOH\T&!$Q?%38%0<2]R"4>?!K(-G/(/T^$'>"\ MA\)L29;=SVOC]7E;D&_2$=J/"F,;@#J?H)I'3'CH>XY#.)_HYQIB!($[)RK> MRU-=F`OT""_1S9:7L$$/U\BWUK:K;+:.]X1JN?<"B#H?C"G>X#C80'?G(7:2 MTS)]I7E.,(F0Y8V!@'NDIKRM&8OGX^E\*`RT`-3.4\S%@C+Q/1?^7<2O3M1* M\EZ5.R>:SM%RY\^C$%:AMRA45BOBO#^@EF/QLCC_@J8MOO?T*A9M%_7KSQ`3 M.H^7V/:)1EO!&@[B/,I)5(,V>LZE##CH'+X1((W0(=3CVIW8-D^ MI4C-'OK*^[G*'9-4)X/R;E3$7N+6B.7U)8O=A;8BU8CE=2=<<1UK^;8;V'2_ MIZ*HV!-/M';G=K+LJ9/=K"]K;Y,KL"M[6>E_@[O?&DGG@U`]AF'3V0S7*X52 M.).EV^][Z9,F)`?V4PK/Q\;+E/U\DD8TKZM;;8-`U4Z)H]NDP`=:A1Q]C.F&O(&#/\3F M:`L$+TPH,TY5_!@0NEJ(U]Q[/WP7S<&H,"/?1RZHM>24+HYC%(K)K-+"0W9@ MOD#[A?A2?34Z/=57+\JR%BTX!V'EZL_L-5'W4$S$FK'P MC`OL>Y0$/0<&2FXGH25=#Q='TFW)K+VQ'XCD1Y=&"M-;:'*`[?9D53%TXEU+9^\,NU][J1+-?V M'^C2\Y:Q,LL"!W=L+E%X24!&"HALZMV]CIPTH3VW(:\5%T8]NF*`BRFX`()@)X0@LL=A4P.=+D8>A(1JJG#R)7`NO/ M+FCM`V_?5]ZN-M3+*\N\-,!J@@EMNX\OC*X3ENU$*2M`T(;,IGF`5I$SQ2LT M>G<+VDK8%HGCZX7OG M3,U^3!-M9O83#=C*^,,N[",==$$?]W>7"F;1ZYZ]M-L^I5X#>JS=',W* MNST98V>%;SP/:ZK6(2?28U8#K+_N[A[W9]==&J#ZFD^G>/_&6D/'[LG6W810 ML:I>76Q1X2`^6]- M3-X?7U_"".0H7'L^_A>Y+D$/#9@W:JM`/5`G[*[-;)_>0!>B(P?NDA^*O(E_%_>?^:($*=67P2E9=3%B#7_VN/H"_7%T`PF:3L` M'=OO[+S7-.>&H6@3Q5`F%[HQEK6Q,IVFZI?Z?D.4GO1V=N8YR.,L7\_7E?1$GTW/`!.DN2M-1,,/9JD`] ML+ID-&FKF>3?5;12&Y MOE5#&5LZ.)O&C3H669$\&W%?Y">]X&L]>AIZC/,`!OKJ7)_4FUTV=`\HHHGK M7/G^WD?WL$:2`W(+!;D!G3-9!I.:9"=M*W=);YY&*TX_DT3I[.;8*A5VJ?%R MG59:450^]U+?)6PB7JID\7Q1'40@OIYZ)M)=\+NIRRL9D]0ZK)1/6 MOBR5SP3KWGL*XMZQ]R@JA3US0^8S^$WB;K7+>&5#WE:61;;)]L/5#U-5M+/4 MCZA-"ED$Z=1LD<]EBU7XTDL)S]*MEL()=K_V8T+$4DI31+KI[ANT8Y#G<%SD M7R#$<&D$ZG0^97:UTL['7DZ<@K8O[Y+V0862)PAO5,:+&4_F&_`4.4-WVTDYYEZ.<9].$EH-@YGL+A)9Y]$%= M<:?ZZ%(V)N!F6>3DF6@3HDQ4;=R8B;*I6A]#BPR$-W>1#],[2X.;FV5&42]" MBTB6XCR';S6T:+>\CP-?FO`D^1A^(`$JY/X935R1:?IL>HE7Z%)/,9730342 MOW^T"S!5YB[.K&KY6Q]G2\$@D6-1#86[JI0'\9>BJ)&@GKIO-%D2R.2%C>.E M0)HO+CM;R_.MEQ(L"=?I5&R07V!(0>66OO:GAP&[BZ_O6C2\WI1YPBJYC>X& M>$'Y7G["J0&H6PJRN2J'5M5OSBVP8,KFX,K;4 M&[H'T1C5U1)+I\^.7!(6Y`8Z^]GM6RATF[#@-F2_.^U6*GO+76'LOF-;[!>[ ME?SLD-9=>D-Y4;:VZ'IW2C$9K/PH9'@VAK]H*T0[=M^ M3K>LW#N*$RG9Z>FC"*]M;ST034MIT_0]J^7B_.'>,W(>-31(G\EP6*Y]M M#6"GGL=4D4U%OR!3;CR?6G-#GD[!@VB:JXW5>GD<WQ3909H;(P^C M81;VDA`3?Z-)=UETL,MZJ2G2(PT3+2(?AT\3M/6"_`BVOKS;W#_[)#GJJ*_&?')M<7]U`:Q>&`:)5N)$:DK[:-& M8`:$O7P8V*NR@#/^?Z'!M[S\22><&1/GF:H7JGL,9:):AFK^,ID; M@KJK!8K7WD'A*2X2\I($GP;0]B/R`_/)1?[]TRQ$TW!9?I([R]/9HDY?J(M? M2+@!N,A'P=CSP?$R>2#$M!U8*\11UR1D.-!=.;J/@O#]V>GH;/>4ZB4P_C7&++N)1-]. M>;&!>S;:?HY>_+X\S(9"\.\$T3M=^`%-L7V''2Q@6A)-(HJMFSS9S.Q>Q10< MPDT"GZ$']%\ MQ_3UIN4]B0(`K?!`E]\M^;`'WMX<,?O' M[7S7L:7E'*VQPM%=FLG]IZ+)$@#L)R%/;T^%Z,C@^D@&PX<0@>SCOASKS2/& M0RNMGFYIB?.P&EV^U@U+_2W-`SE1P,*,5?HS,3)MWU=J@;`;7RA[F*OX^`>+ M2<+&2QA?MX^DX&(':6I7<*;S5X5$&2R*[6#I`Z@+VC)Q?M6=96(Y``W!3O,D M9D%?S4!\%WAK-Z>#8J1FJL?556*L\KBFYD#S'FB4UXA8A.9\EDS34HNL7Z3^ MTW8CJ#`2LWU\2G=P]8O0%CX7G\HBHKZ1*.J.-5&8X3G]"GT4ZG.DZ(3J^:ZJO_&\KFBF(#,Q,#4R(3+#X#!LCEQ-8.>$T8 MD"X%UGNN@#4TROU=P%+`F$@?DF#>H/:O"97]:S+(_4MLYB/!O$'M7S,J^]=L M,/D7//U)B0>A!@Q8PZ:X-`>DHQATJA0)+6\T;70[R)_8"[(S9%$3($Y#4;_>+DC-3<1"`3`%!+`0(>`Q0````(``]T M3D*&=<=`+4L!`/8]"P`1`!@```````$```"D@0````!S=&5V+3(P,3(Q,C,Q M+GAM;%54!0`#S3L=475X"P`!!"4.```$.0$``%!+`0(>`Q0````(``]T3D(2 M>OGB/@(``.H(```5`!@```````$```"D@7A+`0!S=&5V+3(P,3(Q,C,Q7V-A M;"YX;6Q55`4``\T['5%U>`L``00E#@``!#D!``!02P$"'@,4````"``/=$Y" MCPVK-5DH``!TW@(`%0`8```````!````I($%3@$`&UL550%``/-.QU1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`#W1. M0K6T7*S#;```%;H$`!4`&````````0```*2!K78!`'-T978M,C`Q,C$R,S%? M;&%B+GAM;%54!0`#S3L=475X"P`!!"4.```$.0$``%!+`0(>`Q0````(``]T M3D+-)-QEE#```*TN`P`5`!@```````$```"D@;_C`0!S=&5V+3(P,3(Q,C,Q M7W!R92YX;6Q55`4``\T['5%U>`L``00E#@``!#D!``!02P$"'@,4````"``/ M=$Y"65J$KBX:``!R'@$`$0`8```````!````I(&B%`(``L``00E#@``!#D!``!02P4&``````8`!@`:`@`` &&R\"```` ` end XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
PREPAID EXPENSES. (Tables)
9 Months Ended
Dec. 31, 2012
PREPAID EXPENSES.  
Prepaid expenses consists
Prepaid expenses consisted of the following:
 
                                                  December 31,         March 31,
                                                      2012               2012
                                                    --------           --------
Prepaid research and development                    $ 23,336           $128,445
Prepaid rent                                              --             21,250
Retainer                                                  --             15,000
Other                                                  2,680              4,179
                                                    --------           --------
 
                                                    $ 26,016           $168,874

XML 18 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
NON-CONTROLLING INTEREST (Details) (USD $)
Contributed and additional paid-in capital
Earnings and losses
Other Comprehensive Income
Total non-controlling interest
Balance NON-CONTROLLING INTEREST at Mar. 31, 2012        
Current period earnings and losses $ 0 $ (97,338) $ 0 $ (97,338)
Balance NON-CONTROLLING INTEREST at Dec. 31, 2012 $ 0 $ (97,338) $ 0 $ (97,338)
XML 19 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONVERTIBLE NOTES PAYABLE (Details) (USD $)
Oct. 11, 2011
Oct. 04, 2011
Jun. 23, 2011
Feb. 14, 2011
Convertible note amount $ 2,500,000 $ 100,000 $ 100,000 $ 2,500,000
Interest rate on convertible notes     10.00% 10.00%
Accrued interest through the date of conversion $ 15,890.41 $ 2,821.92    
Common shares for convertible notes 1,000,000 400,000    
Commons shares for conversion of principal 63,561 11,288    
Common stocks per share $ 0.25 $ 0.25    
XML 20 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details)
9 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Make Good Escrow Agreement shares issued and held with the escrow agent 3,000,000 6,000,000
Convertible note issued on March 7, 2012 426,667  
Convertible note issued on May 30, 2012 426,667  
Convertible note issued on August 6, 2012 1,152,000  
Total potentially outstanding dilutive common shares 5,005,334 6,000,000
XML 21 R52.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) (USD $)
Dec. 31, 2012
Percentage of stock issued 8.00%
Securities for financing $ 25,000
Gross proceeds 500,000
Securities financing 18,000
Gross proceeds to the Company 500,000
Consultants fees per month $ 3,000
XML 22 R47.htm IDEA: XBRL DOCUMENT v2.4.0.6
GARDEN STATE SECURTIES INC (Details) (USD $)
Dec. 31, 2012
Reimbursed legal fees $ 12,500
Percentage cash commission 8.00%
Gross proceeds received in the equity financing 40,000
Common shares purchased 85,333
Exercise price $ 0.6405
Price per unit $ 0.46875
Common share for a net proceeds 447,500
Common share for a net proceed 292,218
Relative fair value of the common stock and warrants $ 207,782
Per common share $ 0.27
Per common shares $ 0.18
XML 23 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
GOING CONCERN
9 Months Ended
Dec. 31, 2012
GOING CONCERN  
GOING CONCERN
NOTE 3 - GOING CONCERN
 
The accompanying  consolidated  financial statements have been prepared assuming
that the Company will continue as a going concern, which contemplates continuity
of  operations,  realization  of assets,  and  liquidation of liabilities in the
normal course of business.
 
As reflected in the accompanying consolidated financial statements,  the Company
had an accumulated deficit at December 31, 2012, a net loss and net cash used in
operating  activities  for the interim  period then ended.  These  factors raise
substantial doubt about the Company's ability to continue as a going concern.
 
While the Company is attempting to generate sufficient  revenues,  the Company's
cash  position  may not be  sufficient  enough to support  the  Company's  daily
operations.  Management  intends to raise additional funds by way of a public or
private offering.  Management believes that the actions presently being taken to
further implement its business plan and generate sufficient revenues provide the
opportunity  for the Company to continue as a going  concern.  While the Company
believes in the viability of its strategy to generate sufficient revenues and in
its  ability  to raise  additional  funds,  there can be no  assurances  to that
effect.  The ability of the Company to continue as a going  concern is dependent
upon the Company's  ability to further  implement its business plan and generate
sufficient revenues.
 
The consolidated  financial statements do not include any adjustments related to
the  recoverability  and classification of recorded asset amounts or the amounts
and  classification of liabilities that might be necessary should the Company be
unable to continue as a going concern.
EXCEL 24 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U M.3!A83,W9&8B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E!215!!241?15A014Y315,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E=%0E-)5$5?1$5614Q/4$U%3E1?0T]35%,\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E9%4E1)0DQ%7TY/5$537U!!64%"3$4\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E13/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.5#(\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E!23U!%4E197T%.1%]%455)4$U%3E1?5&%B;&5S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-43T-+2$],1$524U]%455)5%E?5&%B;&5S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]21T%.25I!5$E/3E]!3D1?3U!%4D%424].4U]$93PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-534U!4EE?3T9?4TE' M3DE&24-!3E1?04-#3U5.5#,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D-/3D-%3E12051)3TY37T%.1%]#4D5$251? M4DE32S,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I3='EL97-H M965T($A2968],T0B5V]R:W-H965T3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%? M8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@ M8VAA2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3`M43QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^3F\\2!796QL+6MN;W=N(%-E M87-O;F5D($ES'0^ M3F\\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#DR-3QS<&%N/CPO2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQAF%T:6]N/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@U-"PU,3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S2P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4X,"PW M.3`\6%B;&4@+2!0 M2`H9&5F:6-I="DZ/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\F5D M+"`V,RPU-34L-C,U(&%N9"`U."PS-30L-S3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U M.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q M8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%RF5D/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`\3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F M,V0U.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W M838Q8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA'!E;G-E2!A;F0@8V]M<&5N M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S"!P3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F M8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA2`H1&5F:6-I="D\8G(^55-$("@D*3QB2!S:6=N M:69I8V%N="!S=&]C:VAO;&1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!R:6=H=',@=F%L=65D(&%T("0P+C2`V+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XV,#`L.#4X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW M-C(\3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9? M9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N)W,F;F)S<#L@ M969F:6-I96YC>29N8G-P.R!T:')O=6=H('!L86YN:6YG(&%N9"!M;VYI=&]R M:6YG('1H92!D86EL>3PO<')E/CQP29N8G-P.R!D:7-C M;VYT:6YU960F;F)S<#L@:71S)FYB29N8G-P.R!S:&%R93PO<')E/CQP29N8G-P.R!P2PF;F)S<#L@&-H86YG929N8G-P.R!!9W)E96UE;G0L)FYB M&EM871E;'D@,C`N-"4@;V8@ M=&AE(&ES29N8G-P.R!A9G1E&-H86YG929N8G-P.R!!9W)E M96UE;G0@=&AE/"]P2!U<&]N(&%C<75I2!A;F0\+W!R93X\<')E/E9E;G1U2!A;F0@=&AE(&%S2!O9B!696YT=7)E2!T:&4@0V]M<&%N>2!I;B!T:&4@=')A;G-A M8W1I;VXN/"]P2!F;W)M960@4W1E M=FEA($%S:6$@3&EM:71E9"9N8G-P.R`H(E-T979I82!!2UO M=VYE9#PO<')E/CQP2PF;F)S<#L@=6YD97(@=&AE(&QA M=W,@;V8@2$L@4T%2+"9N8G-P.R!W:&EC:"9N8G-P.R!S=6)S97%U96YT;'DF M;F)S<#L@8VAA;F=E9"!I=',@;F%M92!T;SPO<')E/CQP2!P87)T;F5R+"9N8G-P.R!'=6%N9WIH M;W4\+W!R93X\<')E/DAE86QT:"!#:&EN82!496-H;F]L;V=Y)FYB29N8G-P.R!A;F0F;F)S<#L@1W5A;F=Z:&]U)W,F;F)S M<#L@869F:6QI871E2!,:6UI=&5D("@B M5&5C:&YE=R(I+"9N8G-P.R!A(&-O;7!A;GD\+W!R93X\<')E/FEN8V]R<&]R M871E9"9N8G-P.R!U;F1EF5N("AT;V=E M=&AE2!O=VYS(#2!A;F0F;F)S<#L@8F5N969I8VEA M;&QY)FYB7,@;V8@;F]T:6-E M(&]F('-U8V@@8G)E86-H+CPO<')E/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`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`@<&5R8V5N=&%G93PO<')E/CQP2!U;G5S960@ M86YN=6%L/"]P2!B92!C87)R:65D(&]V M97(@=&\@;&%T97(@>65A2!5 M+E,N)FYB&5S(&5A2!D:79I M9&EN9R!N970@:6YC;VUE("AL;W-S*2!B>2!T:&4@=V5I9VAT960F;F)S<#L@ M879E29N8G-P M.R!O=71S=&%N9&EN9SPO<')E/CQP29N8G-P.R!O=71S=&%N9&EN9R9N8G-P.R!D:6QU=&EV92!C;VUM;VX@&-L=61E9"!F3PO<')E/CQP29N8G-P.R!O9B9N8G-P.R!C97)T86EN)FYB'0@<')I=F%T929N8G-P M.R!P;&%C96UE;G0F;F)S<#L@<')I8V4@;VX@82!P97(@29N M8G-P.R`S,"PF;F)S<#L@,C`Q,BPF;F)S<#LF;F)S<#L@=&AE)FYB'0@<')I=F%T929N8G-P.R!P;&%C96UE;G0F;F)S<#L@<')I8V4@ M;VX@82!P97(@29N8G-P.R!I&5R8VES93PO<')E M/CQP29N8G-P.R!S=&5M)FYB2PF M;F)S<#L@86YD('5S97,@=&AE(&EN9&ER96-T(&]R/"]P2!A9&IU2!R96UO=FEN9R!T:&4@969F96-T6UE;G1S+B9N8G-P.R!4:&4@0V]M<&%N>3PO<')E/CQP M2!C87-H(&9L;W=S+"!U6UE;G1S(&EN('1H92!P97)I;V0\+W!R93X\ M<')E/G!U2!H;W<@<'5B;&EC(&%N9"9N8G-P M.R!N;VYP=6)L:6,F;F)S<#L@96YT:71I97,F;F)S<#L@=&5S=#PO<')E/CQP M6EN9R9N8G-P.R!A M;6]U;G0@87,@82!B87-I6EN9R!A;6]U;G0N/"]P2`Q+"`R,#$S+"!A;F0@:6YT97)I;2!P97)I;V1S M('=I=&AI;B!T:&]S92!A;FYU86P@<&5R:6]D2`R,#$R+"!T:&4@1D%30B!I2!T:&%N(&YO="!T:&%T('1H92!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/"$M+65G>"TM/CQP6EN M9R9N8G-P.R!C;VYS;VQI9&%T960F;F)S<#L@9FEN86YC:6%L('-T871E;65N M=',@:&%V92!B965N('!R97!A3PO<')E/CQP6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T M871E;65N=',L)FYB2=S(&%B:6QI='D@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C M;VYC97)N+CPO<')E/CQP2!I2!O9B!A('!U8FQI8R!O2!B96EN9R!T86ME;B!T;SPO M<')E/CQP2!O M9B!T:&4@0V]M<&%N>2!T;R!C;VYT:6YU92!A2!T;R!F=7)T:&5R("9N8G-P.VEM<&QE;65N="!I M=',@8G5S:6YE29N8G-P.R!A;F0@8VQA2!B93PO<')E/CQP'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/"$M+65G>"TM M/CQP'!E;G-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!A;F0@97%U:7!M96YT+"9N8G-P.R!S=&%T960@870@8V]S="P@ M;&5S29N8G-P.R`R,#$R(&%N M9#PO<')E/CQP'!E;G-E(&9O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W M7S1B9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F M+U=O'0O M:'1M;#L@8VAA2!A;F0@8V]N M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'!E;G-E('=A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9? M9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA2!H860@=')A;G-A M8W1I;VYS(&%R93H\+W!R93X\<')E/B9N8G-P.SPO<')E/CQP2!T:&4@<')E2!,:6UI=&5D)FYBFAO=2!(96%L=&@@5&5C:&YO;&]G>29N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R!!;B!E;G1I='D@;W=N960@86YD(&-O M;G1R;VQL960@8GD\+W!R93X\<')E/D1E=F5L;W!M96YT($-O;7!A;GD@3&EM M:71E9"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R!.;VXM8V]N=')O;&QI;F<@ M:6YT97)E2`Q+"`R,#$Q('1H6YEF%T:6]N)FYB2!' M3PO<')E/CQP2!,:6UI=&5D+"!A;F0@6FAA;F<@2FEA+"!A/"]P2!A;F0@8F5N969I8VEA;&QY M)FYB29N8G-P M.R9N8G-P.R!O=VYS)FYB'!E M;F1E9#PO<')E/CQP3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B M9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O M'0O:'1M M;#L@8VAA29N8G-P.R!I29N8G-P.R!I65A2`Q-BPF;F)S<#L@,C`Q,BPF;F)S<#L@=&AE M)FYB29N M8G-P.R!I29N8G-P.R!C;VUP;&5T M960F;F)S<#L@829N8G-P.R!P65A2!C;VUP;&5T92!A('!R:79A=&4\+W!R93X\<')E/G!L86-E;65N M="9N8G-P.R!W:71H)FYB3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%? M8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`P M+#`P,"!O9B!S=6-H('-H87)E&AI8FET($$L('1H92!#;VUP86YY('-H86QL('!R;VUP=&QY('!R M;W9I9&4@=W)I='1E;B!N;W1I8V4@=&\@=&AE/"]P&AI M8FET($$@9F]R/"]P2!H87,@;F]T M(&%C:&EE=F5D('1H92!A65A2!L96%F('1O(&%C:&EE=F4@;6EN:6UU;2!S<&5C2`D,BXP,"!P97(@:VEL;V=R M86TI)FYB7,@;V8@2G5N929N8G-P.R`R,RPF;F)S<#L@,C`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`S,"P@,C`@ M,3(N/"]P29N8G-P.R!!8W%U:7-I=&EO;B9N8G-P.R!!9W)E96UE M;G0\+W!R93X\<')E/BAT:&4F;F)S<#L@(E1E8VAN;VQO9WDF;F)S<#LF;F)S M<#L@06-Q=6ES:71I;VXF;F)S<#L@06=R965M96YT(BDF;F)S<#L@=VET:"9N M8G-P.R!496-H;F5W)FYB29N8G-P.R!F2!A;F0@8V]N2!0=&4@3'1D+BP@ M82!C;W)P;W)A=&EO;B9N8G-P.R!O2`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`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/"$M+65G>"TM M/CQP2`Q-BP@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E M9"!I;G1O(&%N($%G65A2!I;CPO<')E/CQP65A'!E;G-E&-L=7-I=F4F;F)S<#L@9&ES=')I8G5T;W(@9F]R($%'4$PG7-T96TI/"]P MF4F;F)S<#L@=&AE)FYB7-T96TF;F)S<#L@2UR96QA=&5D)FYB2PF;F)S<#L@=VET:"!T:&4@ M0V]M<&%N>2`F;F)S<#MH;VQD:6YG(&$@"!!("P@,RAA*2PF;F)S<#L@=&AE M($-O;7!A;GD@86YD($%'4$P\+W!R93X\<')E/FAA=F4@;75T=6%L;'D@86=R M965D('1O(&%D9"!T;R!T:&4@8W5R'!E65A&-L=61E9"9N8G-P.R!F'!E29N8G-P M.R!A;F0@04=03"9N8G-P.R!M=71U86QL>29N8G-P.R!A9W)E960@=&\F;F)S M<#L@=&5R;6EN871E)FYB65A#PO<')E/CQP65A2`R,2P@,C`Q,BP@=&AE($-O;7!A;GDF;F)S<#L@96YT97)E9"!I;G1O M(&$@4W5P<&QY)FYB29N8G-P.R!C;VUP86YY)FYBFAO=2!(96%L=&@B*2X\ M+W!R93X\<')E/B9N8G-P.SPO<')E/CQP2!W:6QL M('-E;&P@9')Y('-T979I82!P;&%N=#PO<')E/CQP&-L=7-I=F5L>29N8G-P.R!T;R9N8G-P.R!' M=6%N9WIH;W4\+W!R93X\<')E/DAE86QT:"X@1F]R('1H92!F:7)S="!T=V\@ M>65A2!T:&4F;F)S<#L@0V]M<&%N>2XF;F)S<#L@4W1A M65A65AFAO=2!(96%L M=&@\+W!R93X\<')E/G=I;&P@8F4@;V)L:6=E9"!T;R!P=7)C:&%S92!U<"!T M;R`Q,S`@<&5R8V5N="!O9B!T:&%T(&%M;W5N="X@5&AE('-P96-I9FEC871I M;VYS/"]P29N M8G-P.R!A8V-O2`R,2P@,C`Q,BP@=&AE($-O;7!A;GD@86QS;R!E;G1EFAO=2!(96%L=&@@5&5C:&YO;&]G>29N8G-P.R!$979E;&]P;65N M="9N8G-P.R!#;VUP86YY/"]PFEN9R!A(&IO:6YT('9E;G1U29N8G-P.R!O9B9N8G-P.R!C97)T86EN)FYBFAO=2!(96%L M=&@@=VEL;"!S:&%R92!A;&P\+W!R93X\<')E/F%V86EL86)L929N8G-P.R!I M;F9O2!P2PF;F)S<#L@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/"$M+65G>"TM/CQP29N8G-P.R!! M9W)E96UE;G0F;F)S<#L@*'1H92`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`H M-BD@;6]N=&AS+"9N8G-P.R!C;VUM96YC:6YG(&]N($IU;'D@,2P@,C`Q,3PO M<')E/CQP2!E:71H97(\ M+W!R93X\<')E/G1H929N8G-P.R!#;VUP86YY(&]R('1H929N8G-P.R!#;VYS M=6QT86YT)FYB2!T:6UE('!R:6]R('1O('1H92!E;F0@;V8@ M=&AE)FYB2!G:79I M;F<@=&AI2!W:6QL('!A>3PO<')E/CQP2!S:&%L;"!P87D@=&AE($-O;G-U;'1A;G0@82!F964@;V8@)#,L,#`P('!E M'1E;F1E9"!W:71H('1H92!S86UE M('1E2X\+W!R93X\<')E/B9N8G-P.SPO<')E/CQP2`Q+"`R,#$Q/"]P29N8G-P.R!O2!T:6UE('!R:6]R('1O('1H92!E;F0@;V8@=&AE)FYB M2!G:79I;F<@=&AI M2!W:6QL('!A>3PO<')E/CQP2=S M)FYB7,@9G)O;2!T:&4F;F)S<#L@97AE8W5T:6]N)FYB2!T;R!'4U,@870@96%C:"!F=6QL(&]R)FYB2!T:&4@0V]M<&%N>2!U;F1E&5R8VES929N8G-P.R!P2XF;F)S<#L@26X@861D:71I M;VXL)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/"$M+65G>"TM/CQP29N8G-P.R!A;&P@;V8@=&AE)FYB29N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R`T,BXU)29N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`Q-BXT)29N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R`T.2XX)29N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R`M+24\+W!R93X\<')E/G1E=FEA(%9E;G1U'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M/"$M+65G>"TM/CQP2!H M87,@979A;'5A=&5D(&%L;"!E=F5N=',@=&AA="!O8V-U7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6EN9R9N8G-P.R!U M;F%U9&ET960@:6YT97)I;2!F:6YA;F-I86PF;F)S<#L@&-H86YG93PO<')E/CQP2P\+W!R93X\<')E M/G1H97D@9&\@;F]T(&EN8VQU9&4@86QL(&]F('1H92!I;F9O3PO<')E/CQP2!F M;W(\+W!R93X\<')E/G1H92!P97)I;V0F;F)S<#L@9G)O;2!!<')I;"`Q,2PF M;F)S<#L@,C`Q,29N8G-P.R`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`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`H-3`I)FYB&5S+"9N8G-P.R!A8V-O=6YT M:6YG)FYB"!B87-I6EN9R9N8G-P.R!C M;VYS;VQI9&%T960@8F%L86YC93PO<')E/CQP"9N8G-P.R!C3PO<')E/CQP"!A M2X\+W!R93X\<')E/B9N8G-P M.SPO<')E/CQP#PO M<')E/CQP&EN9SPO<')E/CQP&%B;&4@:6YC;VUE(&)Y('1A M>"9N8G-P.R!J=7)I"!P;W-I=&EO M;G,@86YD(&AA9"!N;R9N8G-P.R!A9&IU'0^/"$M+65G>"TM/CQPF4@3D],'!E2!R97-U;'0F M;F)S<#L@9G)O;29N8G-P.R!T2!M;W)E('1H86X@-3`@<&5R M8V5N=&%G93PO<')E/CQP2!U;G5S960@86YN=6%L/"]P2!B92!C87)R:65D(&]V97(@=&\@;&%T97(@>65A M2!5+E,N)FYB&5S(&5A65A2!C;VUP;&5T92!A('!R M:79A=&4\+W!R93X\<')E/G!L86-E;65N="9N8G-P.R!W:71H)FYB65A2!C;VUP;&5T92!A('!R:79A=&4\+W!R93X\<')E/G!L86-E;65N M="9N8G-P.R!W:71H)FYB2=S)FYB29N8G-P.R!386QE2!A9&]P=&5D)FYB2!P M87)A9W)A<&@F;F)S<#L@,C,P+3$P+30U+3(U/"]P6UE;G1S)FYB29N8G-P.R!E<75I=F%L96YT(&]F(&9O'0^/"$M+65G>"TM M/CQP'!O2!D971E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/"$M+65G>"TM/CQP2!O'0^/"$M+65G>"TM/CQP65A2!C;VUP;&5T92!A('!R:79A=&4\ M+W!R93X\<')E/G!L86-E;65N="9N8G-P.R!W:71H)FYB65A2!C;VUP;&5T92!A('!R:79A=&4\+W!R93X\<')E/G!L86-E;65N="9N8G-P M.R!W:71H)FYB2=S)FYB29N8G-P.R!386QE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@ M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM M96=X+2T^/'!R93Y02!A;F0@97%U:7!M96YT+"9N8G-P.R!S=&%T M960@870@8V]S="P@;&5S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!!8W%U:7)E9"!4:&4@4FEG:'1S('1O M(%1E8VAN;VQO9WD\+W1D/@T*("`@("`@("`\=&0@8VQA2!R:6=H="9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R`Q-29N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`D,2PV,S4L,S`P)FYBF%T:6]N)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO<')E/CQP2!0=&4@3'1D+B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R!!;B!E;G1I='D@;W=N960@86YD(&-O;G1R;VQL960@8GD@ M=&AE('!R97-I9&5N=#PO<')E/CQP'0^/"$M+65G>"TM/CQP2!0=&4@3'1D+B!I6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M(2TM96=X+2T^/'!R93Y&=71U65A7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M M+65G>"TM/CQP65A2`Q-BPF;F)S<#L@,C`Q,BPF;F)S<#L@=&AE)FYB29N8G-P.R!I29N8G-P.R!C;VUP;&5T960F;F)S<#L@829N M8G-P.R!P65A2!C;VUP M;&5T92!A('!R:79A=&4\+W!R93X\<')E/G!L86-E;65N="9N8G-P.R!W:71H M)FYB3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A M83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-? M.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M29N8G-P.R!A;F0@=&AE)FYBF5D*2!I;F-L=61E9"!I;CH\ M+W!R93X\<')E/B9N8G-P.R9N8G-P.R!.970@:6YC;VUE("AL;W-S*29N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`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`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6UE;G1S)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/"$M+65G>"TM/CQP29N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R`T,BXU)29N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`Q-BXT)29N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`T.2XX)29N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R`M+24\+W!R93X\<')E/G1E=FEA(%9E;G1U'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!3=&5V M:6$@07-I83PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'!E;G-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!A;F0@97%U:7!M96YT(&5S=&EM871E9"!U2!A;F0@ M97%U:7!M96YT(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!R:6=H="!E65AF%T:6]N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U-"PU,3`I/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O M:F%V87-C3X-"B`@("`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`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%SF5D('9A;'5E(&]V97(@=&AE('9E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A7V)F8C9? M9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5R8VES92!0&5R8VES92!0&5R8VES86)L92!A="!$96,N(#,Q+"`R,#$R/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$U,BPP,#`\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A83,W9&8-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-?.#1A-U\T8F9A M7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&5R8VES92!0'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R M8VES92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!0&5R8VES86)L92!! M=F5R86=E(%)E;6%I;FEN9R!#;VYT&5R8VES92!0&5R8VES92!0'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F,V0U.3!A83,W M9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W838Q8V-?.#1A M-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R65A"!M;VYT:"!L96%S92!P87EM96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PP,#`\2!D97!O6UE;G1S(&9O65A M6UE;G1S(&9O3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P8S=A-C%C8U\X-&$W7S1B9F%?8F9B-E]F M,V0U.3!A83,W9&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&,W M838Q8V-?.#1A-U\T8F9A7V)F8C9?9C-D-3DP86$S-V1F+U=O'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!0=&4N($QT9"X@+2!R96QA=&5D('!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@870@1W)O=V5R6YE XML 25 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES (Details) (USD $)
Dec. 31, 2012
Mar. 31, 2012
Convertible notes issued On November 16, 2011 $ 0 $ 250,000
Convertible notes issued On January 16, 2012 0 250,000
Convertible notes issued On March 7, 2012 200,000 200,000
Convertible notes issued On May 30, 2012 200,000 0
Total of convertible notes on various dates $ 400,000 $ 700,000
XML 26 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS (Tables)
9 Months Ended
Dec. 31, 2012
RELATED PARTY TRANSACTIONS (Tables)  
Related parties with whom the Company had transactions
Related parties with whom the Company had transactions are:
 
Related Parties                               Relationship
---------------                               ------------
George Blankenbaker             President and significant stockholder of the
                                Company
 
Leverage Investments LLC        An entity owned and controlled by the president
                                and significant stockholder of the Company
 
Technew Technology Limited      Non-controlling interest holder
 
Growers Synergy Pte Ltd.        An entity owned and controlled by the president
                                and significant stockholder of the Company
 
Guangzhou Health Technology     An entity owned and controlled by
Development Company Limited     Non-controlling interest holder
Consulting services
Farm management services provided by Growers Synergy Pte Ltd. is as follows:
 
                                                                     For the
                                                                   Period from
                                                   For the        April 11, 2011
                                                Interim Period      (inception)
                                                    Ended            through
                                                 December 31,      December 31,
                                                     2012              2011
                                                   --------          --------
Farm management services received and
 farm management services booked                   $180,000          $     --
                                                   --------          --------
 
                                                   $180,000          $     --
                                                   ========          ========
 
 
                                                 
Future minimum payments
Future minimum payments  required under this agreement at December 31, 2012 were
as follows:
 
Fiscal Year Ending March 31:
  2013 (remainder of the fiscal year)                                $ 60,000
  2014                                                                140,000
                                                                     --------
 
                                                                     $200,000
                                                                     ========
XML 27 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
WEBSITE DEVELOPMENT COSTS (Tables)
9 Months Ended
Dec. 31, 2012
WEBSITE DEVELOPMENT COSTS (Tables)  
Website development costs, stated at cost
Website  development  costs,  stated  at  cost,  less  accumulated  amortization
consisted of the following:
 
                                   Estimated
                                  Useful Life      December 31,       March 31,
                                    (Years)           2012              2012
                                    -------        ----------        ----------
Website development costs              5           $    5,315        $    5,315
Accumulated amortization                               (1,602)             (801)
                                                   -----------       ----------
 
                                                   $    3,713        $    4,514
                                                   ==========        ==========
XML 28 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHARES AUTHORIZED AND TRANSACTION (Details) (USD $)
Dec. 31, 2012
Jun. 23, 2011
Apr. 10, 2011
Common shares authorized to issue 100,000,000    
Common shares authorized to issue par value $ 0.001    
Common shares issued and outstanding   79,800,000  
Shares surrendered for cancellation   33,000,000  
Common shares issued for acquisition of 100% of issued and outstanding. 12,000,000    
Common shares held in escrow. 6,000,000    
Another shares surrendered     3,000,000
Debiting common stock at par     $ 3,000
Common shares sold to one investor     400,000
Common stock price     $ 0.25
Common stock value     $ 100,000
XML 29 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONVERTIBLE NOTES PAYABLE (Tables)
9 Months Ended
Dec. 31, 2012
CONVERTIBLE NOTES PAYABLE (Tables)  
CONVERTIBLE NOTES PAYABLE.
Convertible notes payable consisted of the following:
 
                                                 December 31,          March 31,
                                                    2012                 2012
                                                  --------             --------
On November  16, 2011,  the Company  issued a
convertible  note in the  amount of  $250,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion  price  to  be  the  same  as  the
private  placement price on a per share basis
provided  the  Company   complete  a  private
placement  with  gross  proceeds  of at least
$100,000.  On July 6, 2012,  the note  holder
converted  the entire  principal  of $250,000
and  accrued  interest  through  the  date of
conversion  of $15,959  to 319,607  shares of
the  Company's  common  stock  at  $0.83  per
share.                                                   --             250,000
 
On January 16,  2012,  the  Company  issued a
convertible  note in the  amount of  $250,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion  price  to  be  the  same  as  the
private  placement price on a per share basis
provided  the  Company   complete  a  private
placement  with  gross  proceeds  of at least
$100,000.  On July 6, 2012,  the note  holder
converted  the entire  principal  of $250,000
and  accrued  interest  through  the  date of
conversion  of $11,781  to 314,586  shares of
the  Company's  common  stock  at  $0.83  per
share.                                                   --             250,000
 
On  March  7,  2012,  the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                           200,000             200,000
 
On  May  30,  2012,   the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                           200,000                  --
                                                   --------            --------
 
                                                   $400,000            $700,000
                                                   ========            ========
XML 30 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
DERIVATIVE INSTRUMENTS (Tables)
9 Months Ended
Dec. 31, 2012
DERIVATIVE INSTRUMENTS  
Fair Value Of Derivative Warrants
The table below provides a summary of the fair value of the  derivative  warrant
liability  and the  changes  in the fair  value of the  derivative  warrants  to
purchase 1,152,000 shares of the Company's common stock, including net transfers
in and/or  out,  of  derivative  warrants  measured at fair value on a recurring
basis using significant unobservable inputs (Level 3).
 
                                                    Fair Value Measurement
                                                     Using Level 3 Inputs
                                                 ----------------------------
                                                 Derivative
                                               warrants Assets
                                                 (Liability)            Total
                                                 -----------            -----
Balance, August 6, 2012                           $(411,805)          $(411,805)
Total gains or losses
 (realized/unrealized) included in:
   Net income (loss)                                231,521             231,521
   Other comprehensive income (loss)                     --                  --
   Purchases, issuances and settlements                  --                  --
   Transfers in and/or out of Level 3                    --                  --
                                                 ---------           ---------
Balance, August 6, 2012                            (180,284)           (180,284)
Total gains or losses
 (realized/unrealized) included in:
   Net income (loss)                                 73,723              73,723
   Other comprehensive income (loss)                     --                  --
   Purchases, issuances and settlements                  --                  --
  Transfers in and/or out of Level 3                     --                  --
                                                  ---------           ---------
 
Balance, December 31, 2012                        $(106,561)          $(106,561)
                                                  =========           =========
Warrant Activities
The table below summarizes the Company's derivative warrant activity
 
                                                  2012 Warrant Activities                              Apic          (Gain) Loss
                                  ----------------------------------------------------------         ---------        ----------
                                                                                                  Reclassification
                                                                  Total         Fair Value of      Change in of      Fair Value of
                                Derivative     Non-derivative    Warrant           Derivative       Derivative        Derivative
                                  Shares           Shares        Shares             Warrants         Liability        Liability
                                  ------           ------        ------             --------         ---------        ---------
                                                                                                      
Derivative warrant at
 August 6, 2012                  1,152,000           --         1,152,000           (411,805)             --                 --
Mark to market                                                                       231,521                           (231,521)
Derivative warrant at
 September 30, 2012              1,152,000           --         1,152,000           (180,284)                          (231,521)
Mark to market                                                                        73,723                            (73,723)
Derivative warrant at
 December 31, 2012               1,152,000           --         1,152,000           (106,561)                          (305,244)
 
Summary Of The Warrant Activities
The table below summarizes the Company's warrant activities:
 
                                 Number of         Exercise      Weighted Average   Fair Value at     Aggregate
                                  Warrant         Price Range       Exercise           Rate of        Intrinsic
                                  Shares           Per Share          Price           Issuance          Value
                                  ------           ---------          -----           --------          -----
Balance, March 31, 2012                 --          $    --          $    --          $      --          $ --
Granted                          1,152,000           0.6405           0.6405            411,805            --
Canceled                                --               --               --                 --            --
Exercised                               --               --               --                 --            --
Expired                                 --               --               --                 --            --
                                 ---------          -------          -------          ---------          ----
Balance, December 31, 2012       1,152,000           0.6405           0.6405            411,805            --
 
Earned and exercisable,
 December 31, 2012               1,152,000           0.6405           0.6405            411,805            --
                                 ---------          -------          -------          ---------          ----
 
Unvested, December 31, 2012             --          $    --          $    --          $      --          $ --
Warrants Outstanding
The  following  table   summarizes   information   concerning   outstanding  and
exercisable warrants as of December 31, 2012:
 
                         Warrants Outstanding                     Warrants Exercisable
                  ----------------------------------       -----------------------------------
                                 Average                                  Average
                                Remaining     Weighted                   Remaining     Weighted
                               Contractual    Average                   Contractual    Average
Range of            Number         Life       Exercise       Number        Life        Exercise
Exercise Prices   Outstanding   (in years)     Price       Exercisable   (in years)     Price
---------------   -----------   ----------     -----       -----------   ----------     -----
                                                                     
$0.6405            1,152,000       4.60       $ 0.6405      1,152,000      4.60        $0.6405
-------            ---------       ----       --------      ---------      ----        -------
 
$0.6405            1,152,000       4.60       $ 0.6405      1,152,000      4.60        $0.6405
=======            =========       ====       ========      =========      ====        =======
XML 31 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Dec. 31, 2012
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION
 
The accompanying  unaudited interim financial  statements and related notes have
been prepared in accordance with accounting principles generally accepted in the
United States of America ("U.S.  GAAP") for interim financial  information,  and
with the rules and  regulations  of the United  States  Securities  and Exchange
Commission  ("SEC") to Form 10-Q and Article 8 of Regulation  S-X.  Accordingly,
they do not include all of the information  and footnotes  required by U.S. GAAP
for complete financial  statements.  The unaudited interim financial  statements
furnished  reflect all  adjustments  (consisting of normal  recurring  accruals)
which are, in the opinion of  management,  necessary to a fair  statement of the
results for the interim periods  presented.  Interim results are not necessarily
indicative of the results for the full fiscal year.  These financial  statements
should be read in conjunction  with the financial  statements of the Company for
the period  from April 11,  2011  (inception)  through  March 31, 2012 and notes
thereto  contained in the Company's Annual Report on Form 10-K as filed with the
SEC on June 29, 2012.
 
PRINCIPLES OF CONSOLIDATION
 
The  Company  applies  the  guidance  of Topic 810  "CONSOLIDATION"  of the FASB
Accounting  Standards  Codification to determine  whether and how to consolidate
another  entity.  Pursuant  to ASC  Paragraph  810-10-15-10  all  majority-owned
subsidiaries--all  entities  in  which  a  parent  has a  controlling  financial
interest--shall  be consolidated  except (1) when control does not rest with the
parent,  the majority  owner;  (2) if the parent is a  broker-dealer  within the
scope of Topic 940 and control is likely to be temporary;  (3)  consolidation by
an investment company within the scope of Topic 946 of a  non-investment-company
investee.  Pursuant  to ASC  Paragraph  810-10-15-8  the usual  condition  for a
controlling financial interest is ownership of a majority voting interest,  and,
therefore,  as a general rule  ownership by one  reporting  entity,  directly or
indirectly,  of more than 50 percent of the outstanding voting shares of another
entity is a condition  pointing toward  consolidation.  The power to control may
also exist with a lesser  percentage  of  ownership,  for example,  by contract,
lease,  agreement  with other  stockholders,  or by court  decree.  The  Company
consolidates all  less-than-majority-owned  subsidiaries,  in which the parent's
power to control exists.
 
The Company's consolidated subsidiaries and/or entities are as follows:
 
                                                             Date of incorporation
                                                                 or formation
Name of consolidated      State or other jurisdiction of     (date of acquisition,
subsidiary or entity      incorporation or organization         if applicable)         Attributable interest
--------------------      -----------------------------         --------------         ---------------------
 
Stevia Ventures              The Territory of the                April 11, 2011                100%
International Ltd.          British Virgin Islands
 
Stevia Asia Limited             Hong Kong SAR                    March 19, 2012                100%
 
Stevia Technew Limited          Hong Kong SAR                    April 28, 2012                 70%
 
The consolidated  financial statements include all accounts of the Company as of
December  31,  2012,  for the interim  period then ended and for the period from
June 23, 2011 (date of acquisition)  through December 31, 2011;  Stevia Ventures
International  Ltd. as of December 31, 2012,  for the interim  period then ended
and for the period from April 11, 2011  (inception)  through  December 31, 2011;
Stevia Asia  Limited as of  December  31, 2012 and for the period from March 19,
2012  (inception)  through  December 31, 2012; and Stevia Technew  Limited as of
December  31, 2012 and for the period from April 28,  2012  (inception)  through
December 31, 2012.
 
All inter-company balances and transactions have been eliminated.
 
RECLASSIFICATION
 
Certain amounts in the prior period financial  statements have been reclassified
to conform to the current period presentation.  These  reclassifications  had no
effect on reported losses.
 
USE OF ESTIMATES AND ASSUMPTIONS
 
The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period.
 
The Company's  significant  estimates and assumptions  include the fair value of
financial  instruments;  the carrying  value,  recoverability  and impairment of
long-lived  assets,  including the values  assigned to and the estimated  useful
lives of  website  development  costs;  interest  rate;  revenue  recognized  or
recognizable;  sales returns and  allowances;  foreign  currency  exchange rate;
income  tax rate,  income tax  provision,  deferred  tax  assets  and  valuation
allowance of deferred  tax assets;  expected  term of share  options and similar
instruments,  expected  volatility of the entity's shares and the method used to
estimate it, expected annual rate of quarterly dividends, and risk free rate(s);
and the  assumption  that the Company will  continue as a going  concern.  Those
significant  accounting  estimates or assumptions bear the risk of change due to
the  fact  that  there  are   uncertainties   attached  to  those  estimates  or
assumptions,  and certain  estimates or assumptions  are difficult to measure or
value.
 
Management  bases  its  estimates  on  historical   experience  and  on  various
assumptions  that are  believed to be  reasonable  in relation to the  financial
statements taken as a whole under the  circumstances,  the results of which form
the  basis  for  making  judgments  about the  carrying  values  of  assets  and
liabilities that are not readily apparent from other sources.
 
Management  regularly  evaluates the key factors and assumptions used to develop
the estimates utilizing currently  available  information,  changes in facts and
circumstances,  historical  experience  and reasonable  assumptions.  After such
evaluations, if deemed appropriate, those estimates are adjusted accordingly.
 
Actual results could differ from those estimates.
 
FAIR VALUE OF FINANCIAL INSTRUMENTS
 
The Company follows  paragraph  820-10-35-37  of the FASB  Accounting  Standards
Codification  ("Paragraph  820-10-35-37")  to  measure  the  fair  value  of its
financial  instruments  and  paragraph   825-10-50-10  of  the  FASB  Accounting
Standards  Codification  for  disclosures  about  fair  value  of its  financial
instruments.  Paragraph 820-10-35-37  establishes a framework for measuring fair
value in  accounting  principles  generally  accepted  in the  United  States of
America (U.S. GAAP), and expands disclosures about fair value  measurements.  To
increase  consistency and  comparability in fair value  measurements and related
disclosures,  Paragraph  820-10-35-37  establishes a fair value  hierarchy which
prioritizes  the inputs to valuation  techniques used to measure fair value into
three (3) broad levels.  The three (3) levels of fair value hierarchy defined by
Paragraph 820-10-35-37 are described below:
 
Level 1    Quoted market prices available in active markets for identical assets
           or liabilities as of the reporting date.
 
Level 2    Pricing inputs other than quoted prices in active markets included in
           Level 1, which are either directly or indirectly observable as of the
           reporting date.
 
Level 3    Pricing  inputs  that  are  generally   observable   inputs  and  not
           corroborated by market data.
 
Financial  assets are  considered  Level 3 when their fair values are determined
using pricing models,  discounted cash flow  methodologies or similar techniques
and at least one significant model assumption or input is unobservable.
 
The  fair  value  hierarchy   gives  the  highest   priority  to  quoted  prices
(unadjusted)  in active  markets for  identical  assets or  liabilities  and the
lowest  priority  to  unobservable  inputs.  If the inputs  used to measure  the
financial  assets and  liabilities  fall  within  more than one level  described
above, the categorization is based on the lowest level input that is significant
to the fair value measurement of the instrument.
 
The carrying amounts of the Company's financial assets and liabilities,  such as
cash,  accounts  receivable,  prepayments  and other  current  assets,  accounts
payable,  accrued expenses, and accrued interest,  approximate their fair values
because of the short maturity of these instruments.
 
The  Company's  convertible  notes payable  approximates  the fair value of such
instrument based upon management's best estimate of interest rates that would be
available to the Company for similar financial arrangements at December 31, 2012
and March 31, 2012.
 
The Company's Level 3 financial  liabilities  consist of the derivative  warrant
issued in August 2012 for which there is no current market for these  securities
such that the  determination  of fair value  requires  significant  judgment  or
estimation.   The  Company   valued  the   automatic   conditional   conversion,
re-pricing/down-round,   change  of  control;  default  and  follow-on  offering
provisions using a lattice model, with the assistance of a third party valuation
specialist,  for which management  understands the  methodologies.  These models
incorporate transaction details such as Company stock price,  contractual terms,
maturity,  risk free rates,  as well as  assumptions  about  future  financings,
volatility,  and holder  behavior  as of the date of issuance  and each  balance
sheet date.
 
It is not,  however,  practical  to  determine  the fair value of advances  from
president  and  significant  stockholder,  if any,  due to their  related  party
nature.
 
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS
 
LEVEL 3 FINANCIAL LIABILITIES - DERIVATIVE WARRANT LIABILITIES
 
The Company  uses Level 3 of the fair value  hierarchy to measure the fair value
of the derivative  liabilities and revalues its derivative  warrant liability at
every  reporting  period  and  recognizes  gains or losses  in the  consolidated
statements of operations and  comprehensive  income (loss) that are attributable
to the change in the fair value of the derivative warrant liability.
 
CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS
 
The Company has adopted paragraph  360-10-35-17 of the FASB Accounting Standards
Codification for its long-lived assets. The Company's  long-lived assets,  which
include property and equipment,  acquired  technology,  and website  development
costs are reviewed for impairment  whenever  events or changes in  circumstances
indicate that the carrying amount of an asset may not be recoverable.
 
The Company assesses the  recoverability  of its long-lived  assets by comparing
the projected undiscounted net cash flows associated with the related long-lived
asset or group of long-lived assets over their remaining  estimated useful lives
against their respective carrying amounts.  Impairment,  if any, is based on the
excess of the carrying amount over the fair value of those assets. Fair value is
generally  determined using the asset's expected future discounted cash flows or
market value, if readily determinable. If long-lived assets are determined to be
recoverable,  but the newly  determined  remaining  estimated  useful  lives are
shorter than originally estimated,  the net book values of the long-lived assets
are depreciated over the newly determined remaining estimated useful lives.
 
The Company considers the following to be some examples of important  indicators
that may trigger an impairment  review:  (i)  significant  under-performance  or
losses of assets relative to expected  historical or projected  future operating
results;  (ii)  significant  changes  in the  manner  or use of assets or in the
Company's  overall  strategy  with  respect to the manner or use of the acquired
assets or changes in the Company's overall business strategy;  (iii) significant
negative industry or economic trends; (iv) increased competitive pressures;  (v)
a  significant  decline in the Company's  stock price for a sustained  period of
time; and (vi) regulatory  changes.  The Company  evaluates  acquired assets for
potential  impairment  indicators at least annually and more frequently upon the
occurrence of such events.
 
The key assumptions  used in management's  estimates of projected cash flow deal
largely with  forecasts of sales levels and gross margins.  These  forecasts are
typically based on historical  trends and take into account recent  developments
as well as management's plans and intentions.  Other factors,  such as increased
competition  or a decrease  in the  desirability  of the  Company's  products or
services,  could lead to lower  projected  sales levels,  which would  adversely
impact cash flows. A significant change in cash flows in the future could result
in an impairment of long lived assets.
 
The  impairment  charges,  if any,  is  included  in  operating  expenses in the
accompanying consolidated statements of operations.
 
FISCAL YEAR END
 
The Company elected March 31 as its fiscal year ending date.
 
CASH EQUIVALENTS
 
The Company  considers all highly liquid  investments  with  maturities of three
months or less at the time of purchase to be cash equivalents.
 
PROPERTY AND EQUIPMENT
 
Property and equipment is recorded at cost. Expenditures for major additions and
betterments are  capitalized.  Maintenance and repairs are charged to operations
as  incurred.   Depreciation  of  furniture  and  fixture  is  computed  by  the
straight-line  method  (after  taking into account  their  respective  estimated
residual values) over the assets  estimated useful life of five (5) years.  Upon
sale or retirement of property and equipment,  the related cost and  accumulated
depreciation  are removed from the accounts and any gain or loss is reflected in
the statements of operations.
 
INTANGIBLE ASSETS OTHER THAN GOODWILL
 
The Company has adopted paragraph  350-30-25-3 of the FASB Accounting  Standards
Codification for intangible assets other than goodwill.  Under the requirements,
the Company  amortizes the  acquisition  costs of  intangible  assets other than
goodwill  inclusive of acquired  technology and website  development  costs on a
straight-line  basis over their relevant  estimated useful lives of fifteen (15)
and five (5) years,  respectively.  Upon becoming fully  amortized,  the related
cost and accumulated amortization are removed from the accounts.
 
RELATED PARTIES
 
The  Company  follows   subtopic   850-10  of  the  FASB  Accounting   Standards
Codification for the identification of related parties and disclosure of related
party transactions.
 
Pursuant to Section  850-10-20 the related  parties include a. affiliates of the
Company;  b. entities for which  investments in their equity securities would be
required,  absent the  election  of the fair value  option  under the Fair Value
Option Subsection of Section 825-10-15, to be accounted for by the equity method
by the investing entity; c. trusts for the benefit of employees, such as pension
and  profit-sharing  trusts  that are  managed  by or under the  trusteeship  of
management; d. principal owners of the Company; e. management of the Company; f.
other  parties  with which the  Company  may deal if one party  controls  or can
significantly  influence the management or operating policies of the other to an
extent  that one of the  transacting  parties  might  be  prevented  from  fully
pursuing its own separate interests; and g. other parties that can significantly
influence the  management or operating  policies of the  transacting  parties or
that  have an  ownership  interest  in one of the  transacting  parties  and can
significantly  influence  the  other  to an  extent  that  one  or  more  of the
transacting  parties  might be  prevented  from fully  pursuing its own separate
interests.
 
The financial  statements  shall include  disclosures of material  related party
transactions,  other than compensation  arrangements,  expense  allowances,  and
other similar items in the ordinary course of business.  However,  disclosure of
transactions  that are eliminated in the preparation of consolidated or combined
financial statements is not required in those statements.  The disclosures shall
include: a. the nature of the relationship(s)  involved; b. a description of the
transactions, including transactions to which no amounts or nominal amounts were
ascribed, for each of the periods for which income statements are presented, and
such other  information  deemed  necessary to an understanding of the effects of
the  transactions  on  the  financial  statements;  c.  the  dollar  amounts  of
transactions  for each of the periods for which income  statements are presented
and the effects of any change in the method of establishing  the terms from that
used in the preceding  period;  and d. amounts due from or to related parties as
of the date of each balance sheet presented and, if not otherwise apparent,  the
terms and manner of settlement.
 
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 
The Company  accounts  for  derivative  instruments  and hedging  activities  in
accordance  with  paragraph   810-10-05-4  of  the  FASB  Accounting   Standards
Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies
to recognize all  derivative  instruments as either assets or liabilities in the
balance sheet at fair value.  The  accounting for changes in the fair value of a
derivative  instrument  depends  upon:  (i)  whether  the  derivative  has  been
designated and qualifies as part of a hedging relationship, and (ii) the type of
hedging relationship.  For those derivative  instruments that are designated and
qualify as hedging instruments,  a company must designate the hedging instrument
based upon the exposure  being  hedged as either a fair value  hedge,  cash flow
hedge or hedge of a net investment in a foreign operation.
 
From time to time, the Company may employ foreign currency forward  contracts to
convert  unforeseeable foreign currency exchange rates to fixed foreign currency
exchange rates.  The Company does not use derivatives for speculation or trading
purposes.  Changes in the fair value of derivatives  are recorded each period in
current earnings or through other comprehensive  income,  depending on whether a
derivative is designated  as part of a hedge  transaction  and the type of hedge
transaction.  The  ineffective  portion of all hedges is  recognized  in current
earnings. The Company has sales and purchase commitments  denominated in foreign
currencies.  Foreign  currency  forward  contracts are used to hedge against the
risk  of  change  in  the  fair  value  of  these  commitments  attributable  to
fluctuations in exchange rates ("Fair Value Hedges").  Changes in the fair value
of the  derivative  instrument are generally  offset in the income  statement by
changes in the fair value of the item being hedged.
 
The  Company  did not  employ  foreign  currency  forward  contracts  to convert
unforeseeable foreign currency exchange rates to fixed foreign currency exchange
rates for the interim period ended December 31, 2012 or 2011.
 
DERIVATIVE LIABILITY
 
The  Company  evaluates  its  convertible  debt,  options,   warrants  or  other
contracts,  if any, to determine if those  contracts or embedded  components  of
those  contracts  qualify  as  derivatives  to be  separately  accounted  for in
accordance  with  paragraph  810-10-05-4  and  Section  815-40-25  of  the  FASB
Accounting  Standards  Codification.  The result of this accounting treatment is
that the fair value of the embedded derivative is marked-to-market  each balance
sheet date and recorded as either an asset or a liability. In the event that the
fair value is recorded as a  liability,  the change in fair value is recorded in
the  consolidated  statement of operations  and  comprehensive  income (loss) as
other  income  or  expense.  Upon  conversion,  exercise  or  cancellation  of a
derivative  instrument,  the  instrument  is marked to fair value at the date of
conversion,  exercise or  cancellation  and then that the related  fair value is
reclassified to equity.
 
In  circumstances   where  the  embedded  conversion  option  in  a  convertible
instrument  is  required  to be  bifurcated  and there are also  other  embedded
derivative  instruments in the  convertible  instrument  that are required to be
bifurcated, the bifurcated derivative instruments are accounted for as a single,
compound derivative instrument.
 
The classification of derivative instruments, including whether such instruments
should be recorded as  liabilities  or as equity,  is  re-assessed at the end of
each  reporting  period.  Equity  instruments  that are initially  classified as
equity that become subject to reclassification  are reclassified to liability at
the fair  value  of the  instrument  on the  reclassification  date.  Derivative
instrument  liabilities  will be  classified  in the balance sheet as current or
non-current  based on  whether  or not  net-cash  settlement  of the  derivative
instrument is expected within 12 months of the balance sheet date.
 
The  Company  adopted  Section  815-40-15  of  the  FASB  Accounting   Standards
Codification  ("Section  815-40-15")  to determine  whether an instrument (or an
embedded  feature)  is indexed to the  Company's  own stock.  Section  815-40-15
provides  that an entity should use a two-step  approach to evaluate  whether an
equity-linked  financial  instrument (or embedded feature) is indexed to its own
stock, including evaluating the instrument's  contingent exercise and settlement
provisions.  The adoption of Section  815-40-15 has affected the  accounting for
(i)  certain  freestanding  warrants  that  contain  exercise  price  adjustment
features and (ii) convertible bonds issued by foreign subsidiaries with a strike
price denominated in a foreign currency.
 
The Company marks to market the fair value of the embedded  derivative  warrants
at each  balance  sheet  date and  records  the  change in the fair value of the
embedded  derivative  warrants  as other  income or expense in the  consolidated
statements of operations and comprehensive income (loss).
 
The  Company  utilizes  the  Lattice  model  that  values the  liability  of the
derivative  warrants based on a probability  weighted discounted cash flow model
with the  assistance of the third party  valuation  firm. The reason the Company
picks the Lattice  model is that in many cases  there may be  multiple  embedded
features or the features of the bifurcated  derivatives may be so complex that a
Black-Scholes  valuation  does not consider all of the terms of the  instrument.
Therefore, the fair value may not be appropriately captured by simple models. In
other words,  simple models such as Black-Scholes may not be appropriate in many
situations given complex features and terms of conversion option (e.g., combined
embedded  derivatives).  The Lattice model is based on future projections of the
various  potential  outcomes.  The features that were analyzed and  incorporated
into the model  included the exercise  and full reset  features.  Based on these
features,  there are two primary events that can occur; the Holder exercises the
Warrants or the Warrants are held to expiration.  The Lattice model analyzed the
underlying  economic  factors that influenced which of these events would occur,
when they were likely to occur,  and the specific  terms that would be in effect
at the time (i.e. stock price, exercise price,  volatility,  etc.).  Projections
were then made on the  underlying  factors  which  led to  potential  scenarios.
Probabilities  were assigned to each scenario  based on management  projections.
This led to a cash flow  projection and a probability  associated with that cash
flow. A discounted  weighted  average cash flow over the various  scenarios  was
completed to determine the value of the derivative warrants.
 
COMMITMENT AND CONTINGENCIES
 
The  Company  follows   subtopic   450-20  of  the  FASB  Accounting   Standards
Codification  to report  accounting for  contingencies.  Certain  conditions may
exist as of the date the consolidated financial statements are issued, which may
result in a loss to the Company but which will only be resolved when one or more
future  events  occur or fail to occur.  The Company  assesses  such  contingent
liabilities, and such assessment inherently involves an exercise of judgment. In
assessing  loss  contingencies  related to legal  proceedings  that are  pending
against the Company or  unasserted  claims that may result in such  proceedings,
the  Company  evaluates  the  perceived  merits  of  any  legal  proceedings  or
unasserted claims as well as the perceived merits of the amount of relief sought
or expected to be sought therein.
 
If the assessment of a contingency indicates that it is probable that a material
loss has been incurred and the amount of the  liability  can be estimated,  then
the estimated liability would be accrued in the Company's consolidated financial
statements.   If  the  assessment  indicates  that  a  potential  material  loss
contingency  is not  probable  but is  reasonably  possible,  or is probable but
cannot  be  estimated,  then the  nature  of the  contingent  liability,  and an
estimate of the range of possible losses, if determinable and material, would be
disclosed.
 
Loss  contingencies  considered  remote are generally not disclosed  unless they
involve guarantees, in which case the guarantees would be disclosed.  Management
does not believe,  based upon  information  available  at this time,  that these
matters  will  have a  material  adverse  effect on the  Company's  consolidated
financial position,  results of operations or cash flows.  However,  there is no
assurance  that such  matters  will not  materially  and  adversely  affect  the
Company's business, financial position, and results of operations or cash flows.
 
NON-CONTROLLING INTEREST
 
The Company  follows  paragraph  810-10-65-1  of the FASB  Accounting  Standards
Codification to report the  non-controlling  interest in Stevia Technew Limited,
its majority owned subsidiary in the  consolidated  statements of balance sheets
within the equity section,  separately from the Company's  stockholders' equity.
Non-controlling   interest  represents  the  non-controlling  interest  holder's
proportionate  share of the equity of the Company's  majority-owned  subsidiary,
Stevia   Technew   Limited.   Non-controlling   interest  is  adjusted  for  the
non-controlling  interest holder's proportionate share of the earnings or losses
and other comprehensive income (loss) and the non-controlling interest continues
to be  attributed  its share of losses  even if that  attribution  results  in a
deficit non-controlling interest balance.
 
REVENUE RECOGNITION
 
The Company follows  paragraph  605-10-S99-1  of the FASB  Accounting  Standards
Codification for revenue recognition.  The Company recognizes revenue when it is
realized or realizable and earned.  The Company  considers  revenue  realized or
realizable and earned when all of the following criteria are met: (i) persuasive
evidence of an  arrangement  exists,  (ii) the  product has been  shipped or the
services have been  rendered to the customer,  (iii) the sales price is fixed or
determinable, and (iv) collectability is reasonably assured.
 
RESEARCH AND DEVELOPMENT
 
The Company  follows  paragraph  730-10-25-1  of the FASB  Accounting  Standards
Codification  (formerly  Statement  of  Financial  Accounting  Standards  No.  2
"ACCOUNTING FOR RESEARCH AND DEVELOPMENT  COSTS") and paragraph  730-20-25-11 of
the FASB  Accounting  Standards  Codification  (formerly  Statement of Financial
Accounting  Standards  No.  68  "RESEARCH  AND  DEVELOPMENT  ARRANGEMENTS")  for
research and development  costs.  Research and development  costs are charged to
expense as  incurred.  Research  and  development  costs  consist  primarily  of
remuneration  for research and development  staff,  depreciation and maintenance
expenses of research and development  equipment,  material and testing costs for
research and development as well as research and development  arrangements  with
unrelated third party research and development institutions.
 
NON-REFUNDABLE  ADVANCE  PAYMENTS  FOR  GOODS OR  SERVICES  TO BE USED IN FUTURE
RESEARCH AND DEVELOPMENT ACTIVITIES
 
The research and development  arrangements usually involve specific research and
development  projects.  Often times, the Company makes  non-refundable  advances
upon signing of these arrangements.  The Company adopted paragraph  730-20-25-13
and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging
Issues Task Force Issue No. 07-3 "ACCOUNTING FOR NONREFUNDABLE  ADVANCE PAYMENTS
FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES")
for those non-refundable advances.  Non-refundable advance payments for goods or
services  that will be used or  rendered  for future  research  and  development
activities  are deferred and  capitalized.  Such  amounts are  recognized  as an
expense  as the  related  goods  are  delivered  or  the  related  services  are
performed.  The management  continues to evaluate whether the Company expect the
goods to be  delivered or services to be rendered.  If the  management  does not
expect the goods to be  delivered or services to be  rendered,  the  capitalized
advance payment are charged to expense.
 
STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES
 
The  Company  accounts  for its stock  based  compensation  in which the Company
obtains  employee  services  in  share-based  payment   transactions  under  the
recognition and measurement  principles of the fair value recognition provisions
of section 718-10-30 of the FASB Accounting Standards Codification.  Pursuant to
paragraph  718-10-30-6  of  the  FASB  Accounting  Standards  Codification,  all
transactions in which goods or services are the  consideration  received for the
issuance of equity  instruments are accounted for based on the fair value of the
consideration  received  or the fair  value  of the  equity  instrument  issued,
whichever is more reliably  measurable.  The measurement  date used to determine
the fair value of the  equity  instrument  issued is the  earlier of the date on
which the  performance  is  complete  or the date on which it is  probable  that
performance  will occur.  If shares of the Company are thinly  traded the use of
share  prices  established  in  the  Company's  most  recent  private  placement
memorandum  ("PPM"),  or weekly or monthly price observations would generally be
more appropriate  than the use of daily price  observations as such shares could
be artificially inflated due to a larger spread between the bid and asked quotes
and lack of consistent trading in the market.
 
The fair value of non-derivative  option award is estimated on the date of grant
using a Black-Scholes  option-pricing valuation model. The ranges of assumptions
for inputs are as follows:
 
     *    Expected term of share options and similar  instruments:  The expected
          life of options and similar instruments  represents the period of time
          the option and/or warrant are expected to be outstanding.  Pursuant to
          Paragraph   718-10-50-2(f)(2)(i)  of  the  FASB  Accounting  Standards
          Codification   the  expected   term  of  share   options  and  similar
          instruments  represents  the period of time the  options  and  similar
          instruments are expected to be outstanding  taking into  consideration
          of the contractual  term of the  instruments  and employees'  expected
          exercise and  post-vesting  employment  termination  behavior into the
          fair  value (or  calculated  value) of the  instruments.  Pursuant  to
          paragraph  718-10-S99-1,  it may be  appropriate to use the SIMPLIFIED
          METHOD,  I.E.,  EXPECTED TERM = ((VESTING TERM + ORIGINAL  CONTRACTUAL
          TERM) / 2),  if (i) A  company  does  not have  sufficient  historical
          exercise  data to provide a  reasonable  basis upon which to  estimate
          expected term due to the limited period of time its equity shares have
          been publicly traded; (ii) A company  significantly  changes the terms
          of its share  option  grants or the types of  employees  that  receive
          share  option  grants such that its  historical  exercise  data may no
          longer  provide a  reasonable  basis upon which to  estimate  expected
          term; or (iii) A company has or expects to have significant structural
          changes in its business such that its historical  exercise data may no
          longer  provide a  reasonable  basis upon which to  estimate  expected
          term.  The Company uses the  simplified  method to calculate  expected
          term of share options and similar  instruments as the company does not
          have sufficient historical exercise data to provide a reasonable basis
          upon which to estimate expected term.
 
     *    Expected  volatility  of the  entity's  shares and the method  used to
          estimate  it.  Pursuant  to  ASC  Paragraph   718-10-50-2(f)(2)(ii)  a
          thinly-traded  or  nonpublic  entity  that uses the  calculated  value
          method shall  disclose the reasons why it is not  practicable  for the
          Company to estimate the expected  volatility  of its share price,  the
          appropriate  industry  sector index that it has selected,  the reasons
          for  selecting  that  particular  index,  and  how it  has  calculated
          historical  volatility  using that index. The Company uses the average
          historical  volatility of the  comparable  companies over the expected
          contractual  life of the share options or similar  instruments  as its
          expected volatility.  If shares of a company are thinly traded the use
          of  weekly or  monthly  price  observations  would  generally  be more
          appropriate than the use of daily price observations as the volatility
          calculation  using  daily   observations  for  such  shares  could  be
          artificially inflated due to a larger spread between the bid and asked
          quotes and lack of consistent trading in the market.
 
     *    Expected  annual rate of  quarterly  dividends.  An entity that uses a
          method that employs  different  dividend rates during the  contractual
          term  shall  disclose  the range of  expected  dividends  used and the
          weighted-average  expected  dividends.  The expected dividend yield is
          based on the Company's  current dividend yield as the best estimate of
          projected  dividend  yield for periods within the expected term of the
          share options and similar instruments.
 
     *    Risk-free rate(s). An entity that uses a method that employs different
          risk-free  rates shall disclose the range of risk-free rates used. The
          risk-free  interest rate is based on the U.S.  Treasury yield curve in
          effect at the time of grant for periods  within the  expected  term of
          the share options and similar instruments.
 
The  Company's  policy is to  recognize  compensation  cost for awards with only
service  conditions and a graded vesting schedule on a straight-line  basis over
the requisite service period for the entire award.
 
EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR
SERVICES
 
The  Company  accounts  for  equity  instruments  issued to  parties  other than
employees for acquiring  goods or services under guidance of Subtopic  505-50 of
the FASB Accounting Standards Codification ("Subtopic 505-50").
 
Pursuant to ASC Section  505-50-30,  all transactions in which goods or services
are the  consideration  received  for the  issuance  of equity  instruments  are
accounted for based on the fair value of the consideration  received or the fair
value of the equity instrument  issued,  whichever is more reliably  measurable.
The measurement  date used to determine the fair value of the equity  instrument
issued is the  earlier of the date on which the  performance  is complete or the
date on which it is  probable  that  performance  will  occur.  If shares of the
Company are thinly traded the use of share prices  established  in the Company's
most recent private  placement  memorandum  ("PPM"),  or weekly or monthly price
observations  would  generally be more  appropriate  than the use of daily price
observations  as such  shares  could be  artificially  inflated  due to a larger
spread  between the bid and asked quotes and lack of  consistent  trading in the
market.
 
The fair value of  non-derivative  option or warrant  award is  estimated on the
date of grant using a Black-Scholes  option-pricing  valuation model. The ranges
of assumptions for inputs are as follows:
 
     *    Expected  term of share options and similar  instruments:  Pursuant to
          Paragraph  718-10-50-2 of the FASB Accounting  Standards  Codification
          the expected term of share options and similar instruments  represents
          the period of time the options and similar instruments are expected to
          be outstanding  taking into  consideration  of the contractual term of
          the instruments and holder's  expected exercise behavior into the fair
          value (or  calculated  value) of the  instruments.  The  Company  uses
          historical data to estimate holder's expected  exercise  behavior.  If
          the Company is a newly formed corporation or shares of the Company are
          thinly  traded the  contractual  term of the share options and similar
          instruments  is used as the expected term of share options and similar
          instruments  as  the  Company  does  not  have  sufficient  historical
          exercise  data to provide a  reasonable  basis upon which to  estimate
          expected term.
 
     *    Expected  volatility  of the  entity's  shares and the method  used to
          estimate  it. An  entity  that uses a method  that  employs  different
          volatilities  during the contractual  term shall disclose the range of
          expected   volatilities   used  and  the   weighted-average   expected
          volatility.   A  thinly-traded  or  nonpublic  entity  that  uses  the
          calculated  value  method  shall  disclose  the  reasons why it is not
          practicable for the Company to estimate the expected volatility of its
          share  price,  the  appropriate  industry  sector  index  that  it has
          selected,  the reasons for selecting that particular index, and how it
          has calculated  historical  volatility  using that index.  The Company
          uses the average  historical  volatility of the  comparable  companies
          over the  expected  contractual  life of the share  options or similar
          instruments  as its  expected  volatility.  If shares of a company are
          thinly  traded the use of weekly or monthly price  observations  would
          generally be more appropriate than the use of daily price observations
          as the volatility calculation using daily observations for such shares
          could be artificially  inflated due to a larger spread between the bid
          and asked quotes and lack of consistent trading in the market.
 
     *    Expected  annual rate of  quarterly  dividends.  An entity that uses a
          method that employs  different  dividend rates during the  contractual
          term  shall  disclose  the range of  expected  dividends  used and the
          weighted-average  expected  dividends.  The expected dividend yield is
          based on the Company's  current dividend yield as the best estimate of
          projected  dividend yield for periods within the expected  contractual
          life of the option and similar instruments.
 
     *    Risk-free rate(s). An entity that uses a method that employs different
          risk-free  rates shall disclose the range of risk-free rates used. The
          risk-free  interest rate is based on the U.S.  Treasury yield curve in
          effect at the time of grant for periods within the contractual life of
          the option and similar instruments.
 
Pursuant to  Paragraphs  505-50-25-8,  if fully vested,  non-forfeitable  equity
instruments  are  issued  at the date the  grantor  and  grantee  enter  into an
agreement  for goods or services  (no  specific  performance  is required by the
grantee to retain those equity instruments), then, because of the elimination of
any obligation on the part of the counterparty to earn the equity instruments, a
measurement  date has  been  reached.  A  grantor  shall  recognize  the  equity
instruments  when they are issued (in most cases,  when the agreement is entered
into). Whether the corresponding cost is an immediate expense or a prepaid asset
(or  whether  the  debit  should be  characterized  as  contra-equity  under the
requirements  of  paragraph  505-50-45-1)  depends  on the  specific  facts  and
circumstances.  Pursuant to ASC  paragraph  505-50-45-1,  a grantor may conclude
that an asset (other than a note or a  receivable)  has been  received in return
for fully vested, non-forfeitable equity instruments that are issued at the date
the grantor and grantee  enter into an agreement  for goods or services  (and no
specific  performance is required by the grantee in order to retain those equity
instruments).  Such an asset  shall not be  displayed  as  contra-equity  by the
grantor of the equity instruments.  The transferability (or lack thereof) of the
equity instruments shall not affect the balance sheet display of the asset. This
guidance is limited to transactions in which equity  instruments are transferred
to other than  employees in exchange for goods or  services.  Section  505-50-30
provides  guidance on the determination of the measurement date for transactions
that are within the scope of this Subtopic.
 
Pursuant to Paragraphs  505-50-25-8  and  505-50-25-9,an  entity may grant fully
vested,  non-forfeitable  equity instruments that are exercisable by the grantee
only after a specified period of time if the terms of the agreement  provide for
earlier exercisability if the grantee achieves specified performance conditions.
Any measured cost of the  transaction  shall be recognized in the same period(s)
and in the same  manner as if the entity had paid cash for the goods or services
or used cash rebates as a sales discount  instead of paying with, or using,  the
equity instruments.  A recognized asset, expense, or sales discount shall not be
reversed  if a stock  option  that the  counterparty  has the right to  exercise
expires unexercised.
 
Pursuant to ASC paragraph  505-50-30-S99-1,  if the Company  receives a right to
receive   future   services  in  exchange  for  unvested,   forfeitable   equity
instruments,  those equity  instruments  are treated as unissued for  accounting
purposes until the future  services are received (that is, the  instruments  are
not  considered  issued  until  they  vest).  Consequently,  there  would  be no
recognition at the measurement date and no entry should be recorded.
 
INCOME TAX PROVISION
 
The Company  accounts  for income  taxes  under  Section  740-10-30  of the FASB
Accounting  Standards  Codification,  which requires recognition of deferred tax
assets and liabilities  for the expected future tax  consequences of events that
have been  included  in the  financial  statements  or tax  returns.  Under this
method, deferred tax assets and liabilities are based on the differences between
the financial  statement and tax bases of assets and  liabilities  using enacted
tax  rates in effect  for the year in which  the  differences  are  expected  to
reverse.  Deferred tax assets are reduced by a valuation allowance to the extent
management  concludes  it is more  likely  than not that the assets  will not be
realized.  Deferred tax assets and  liabilities  are measured  using enacted tax
rates expected to apply to taxable income in the years in which those  temporary
differences are expected to be recovered or settled.  The effect on deferred tax
assets  and  liabilities  of  a  change  in  tax  rates  is  recognized  in  the
consolidated  statements of income and comprehensive income (loss) in the period
that includes the enactment date.
 
The  Company  adopted  section  740-10-25  of  the  FASB  Accounting   Standards
Codification   ("Section   740-10-25").    Section   740-10-25   addresses   the
determination of whether tax benefits claimed or expected to be claimed on a tax
return should be recorded in the financial statements.  Under Section 740-10-25,
the Company may recognize the tax benefit from an uncertain tax position only if
it is  more  likely  than  not  that  the tax  position  will  be  sustained  on
examination  by the taxing  authorities,  based on the  technical  merits of the
position.  The tax benefits  recognized in the financial  statements from such a
position should be measured based on the largest benefit that has a greater than
fifty (50)  percent  likelihood  of being  realized  upon  ultimate  settlement.
Section  740-10-25  also provides  guidance on  de-recognition,  classification,
interest  and  penalties  on income  taxes,  accounting  in interim  periods and
requires increased disclosures.
 
The estimated future tax effects of temporary  differences between the tax basis
of assets and liabilities are reported in the accompanying  consolidated balance
sheets,  as well as tax  credit  carry-backs  and  carry-forwards.  The  Company
periodically  reviews the  recoverability of deferred tax assets recorded on its
consolidated  balance  sheets and provides  valuation  allowances  as management
deems necessary.
 
Management makes judgments as to the  interpretation  of the tax laws that might
be  challenged  upon an audit and cause  changes to  previous  estimates  of tax
liability.   In  addition,   the  Company   operates   within   multiple  taxing
jurisdictions  and is subject to audit in these  jurisdictions.  In management's
opinion,  adequate  provisions for income taxes have been made for all years. If
actual  taxable income by tax  jurisdiction  varies from  estimates,  additional
allowances or reversals of reserves may be necessary.
 
UNCERTAIN TAX POSITIONS
 
The Company did not take any uncertain tax positions and had no  adjustments  to
its income tax  liabilities  or benefits  pursuant to the  provisions of Section
740-10-25 for the interim  period ended December 31, 2012 or for the period from
April 11, 2011 (Inception) through December 31, 2011.
 
LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL
 
Pursuant to the  Internal  Revenue  Code Section 382  ("Section  382"),  certain
ownership changes may subject the NOL's to annual limitations which could reduce
or defer the NOL. Section 382 imposes limitations on a corporation's  ability to
utilize NOLs if it  experiences  an  "ownership  change." In general  terms,  an
ownership  change may result  from  transactions  increasing  the  ownership  of
certain  stockholders  in the stock of a corporation  by more than 50 percentage
points  over  a  three-year  period.  In  the  event  of  an  ownership  change,
utilization of the NOLs would be subject to an annual  limitation  under Section
382  determined  by  multiplying  the  value  of its  stock  at the  time of the
ownership change by the applicable  long-term tax-exempt rate. Any unused annual
limitation may be carried over to later years. The imposition of this limitation
on its ability to use the NOLs to offset future  taxable  income could cause the
Company to pay U.S.  federal income taxes earlier than if such  limitation  were
not in  effect  and  could  cause  such  NOLs  to  expire  unused,  reducing  or
eliminating the benefit of such NOLs.
 
NET INCOME (LOSS) PER COMMON SHARE
 
Net income (loss) per common share is computed  pursuant to section 260-10-45 of
the FASB Accounting Standards  Codification.  Basic net income (loss) per common
share is computed by dividing net income (loss) by the weighted  average  number
of shares of common  stock  outstanding  during the  period.  Diluted net income
(loss)  per common  share is  computed  by  dividing  net  income  (loss) by the
weighted  average number of shares of common stock and  potentially  outstanding
shares of common stock during the period to reflect the potential  dilution that
could occur from common  shares  issuable  through  contingent  shares  issuance
arrangement, stock options or warrants.
 
The following  table shows the  potentially  outstanding  dilutive common shares
excluded from the diluted net income (loss) per common share calculation as they
were anti-dilutive:
 
                                                           Potentially
                                                      Outstanding Dilutive
                                                          Common Shares
                                                   ---------------------------
                                                                    For the
                                                                  Period from
                                                     For the     April 11, 2011
                                                 Interim Period    (inception)
                                                     Ended           through
                                                   December 31,    December 31,
                                                      2012            2011
                                                   ----------       ---------
MAKE GOOD ESCROW SHARES
 
Make Good Escrow  Agreement shares issued and
held with the escrow agent in connection with
the Share Exchange  Agreement  consummated on
June 23, 2011 pending the  achievement by the
Company  of  certain  post-Closing   business
milestones (the "Milestones").                      3,000,000        6,000,000
 
CONVERTIBLE NOTE SHARES
 
On  March  7,  2012,  the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                             426,667              --
 
On  May  30,  2012,   the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                             426,667              --
 
WARRANT SHARES
 
On August 6,  2012,  the  Company  issued (i)
warrants to purchase 1,066,667 shares, in the
aggregate,  of the Company's  common stock to
the investors (the "investors  warrants") and
(ii)  warrants to purchase  85,333  shares of
the  Company's  common stock to the placement
agent (the "agent warrants") with an exercise
price of $0.6405 per share subject to certain
adjustments    pursuant   to   Section   3(b)
Subsequent  Equity  Sales of the SPA expiring
five (5) years from the date of issuance.           1,152,000              --
                                                   ----------      ----------
TOTAL POTENTIALLY OUTSTANDING DILUTIVE
COMMON SHARES                                       5,005,334       6,000,000
                                                   ==========      ==========
 
 
CASH FLOWS REPORTING
 
The Company adopted  paragraph  230-10-45-24  of the FASB  Accounting  Standards
Codification  for cash flows  reporting,  classifies  cash receipts and payments
according  to  whether  they  stem  from  operating,   investing,  or  financing
activities and provides  definitions of each category,  and uses the indirect or
reconciliation  method ("Indirect method") as defined by paragraph  230-10-45-25
of the FASB  Accounting  Standards  Codification  to  report  net cash flow from
operating  activities  by adjusting  net income to reconcile it to net cash flow
from  operating  activities by removing the effects of (a) all deferrals of past
operating  cash  receipts  and  payments  and all  accruals of  expected  future
operating  cash receipts and payments and (b) all items that are included in net
income that do not affect  operating  cash  receipts and  payments.  The Company
reports the reporting currency  equivalent of foreign currency cash flows, using
the  current  exchange  rate at the time of the cash  flows  and the  effect  of
exchange  rate  changes  on cash held in foreign  currencies  is  reported  as a
separate item in the reconciliation of beginning and ending balances of cash and
cash  equivalents  and  separately  provides  information  about  investing  and
financing  activities  not  resulting in cash receipts or payments in the period
pursuant  to   paragraph   830-230-45-1   of  the  FASB   Accounting   Standards
Codification.
 
SUBSEQUENT EVENTS
 
The Company  follows the guidance in Section  855-10-50  of the FASB  Accounting
Standards Codification for the disclosure of subsequent events. The Company will
evaluate  subsequent  events through the date when the financial  statements are
issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards  Codification,
the Company as an SEC filer considers its financial  statements issued when they
are widely distributed to users, such as through filing them on EDGAR.
 
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
 
FASB ACCOUNTING STANDARDS UPDATE NO. 2011-08
 
In September  2011,  the FASB issued the FASB  Accounting  Standards  Update No.
2011-08 "INTANGIBLES--GOODWILL AND OTHER: TESTING GOODWILL FOR IMPAIRMENT" ("ASU
2011-08").  This Update is to simplify how public and  nonpublic  entities  test
goodwill  for  impairment.  The  amendments  permit an  entity  to first  assess
qualitative  factors to  determine  whether it is more  likely than not that the
fair value of a reporting  unit is less than its carrying  amount as a basis for
determining  whether it is necessary to perform the two-step goodwill impairment
test described in Topic 350.  Under the amendments in this Update,  an entity is
not required to calculate  the fair value of a reporting  unit unless the entity
determines  that it is more likely than not that its fair value is less than its
carrying amount.
 
The guidance is effective for interim and annual  periods  beginning on or after
December 15, 2011. Early adoption is permitted.
 
FASB ACCOUNTING STANDARDS UPDATE NO. 2011-11
 
In December  2011,  the FASB  issued the FASB  Accounting  Standards  Update No.
2011-11 "BALANCE SHEET:  DISCLOSURES  ABOUT  OFFSETTING  ASSETS AND LIABILITIES"
("ASU 2011-11").  This Update requires an entity to disclose  information  about
offsetting and related  arrangements to enable users of its financial statements
to understand the effect of those  arrangements on its financial  position.  The
objective of this disclosure is to facilitate  comparison between those entities
that prepare  their  financial  statements  on the basis of U.S.  GAAP and those
entities that prepare their financial statements on the basis of IFRS.
 
The amended guidance is effective for annual reporting  periods  beginning on or
after January 1, 2013, and interim periods within those annual periods.
 
FASB ACCOUNTING STANDARDS UPDATE NO. 2012-02
 
In July 2012, the FASB issued the FASB Accounting  Standards  Update No. 2012-02
"INTANGIBLES--GOODWILL AND OTHER (TOPIC 350) TESTING INDEFINITE-LIVED INTANGIBLE
ASSETS FOR IMPAIRMENT" ("ASU 2012-02").
 
This  Update  is  intended  to  reduce  the  cost  and   complexity  of  testing
indefinite-lived  intangible  assets other than  goodwill for  impairment.  This
guidance builds upon the guidance in ASU 2011-08,  entitled TESTING GOODWILL FOR
IMPAIRMENT.  ASU 2011-08 was issued on  September  15, 2011,  and feedback  from
stakeholders  during the  exposure  period  related to the  goodwill  impairment
testing  guidance  was that the  guidance  also would be  helpful in  impairment
testing for intangible assets other than goodwill.
 
The revised  standard allows an entity the option to first assess  qualitatively
whether  it is more  likely  than not  (that  is, a  likelihood  of more than 50
percent)  that  an   indefinite-lived   intangible   asset  is  impaired,   thus
necessitating that it perform the quantitative impairment test. An entity is not
required to calculate the fair value of an indefinite-lived intangible asset and
perform the quantitative impairment test unless the entity determines that it is
more likely than not that the asset is impaired.
 
This Update is effective for annual and interim  impairment  tests  performed in
fiscal years  beginning  after  September 15, 2012.  Earlier  implementation  is
permitted.
 
OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS
 
Management  does  not  believe  that  any  other  recently  issued,  but not yet
effective accounting pronouncements, if adopted, would have a material effect on
the accompanying consolidated financial statements.
XML 32 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Dec. 31, 2012
STOCKHOLDERS' EQUITY (Tables)  
Schedule of Milestones
Completion            Number of
                           Milestones                                Date             Escrow Shares
                           ----------                                ----             -------------
I.
(1)  Enter into exclusive  international  license agreement
     for  all  Agro  Genesis   intellectual   property  and
     products as it applies to stevia
(2)  Enter into cooperative agreements to work with Vietnam
     Institutes (a) Medical Plant  Institute in Hanoi;  (b)
     Agricultural  Science  Institute  of Northern  Central                              3,000,000
     Vietnam                                                                            shares only
(3)  Enter  into  farm  management  agreements  with  local                             if and when
     growers   including   the   Provincial   and  National        Within 180          ALL four (4)
     projects;                                                     days of the          milestones
(4)  Take over management of three existing nurseries             Closing Date          reached(*)
XML 33 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
AMORTIZATION AND DEPRECIATION EXPENSE (Details) (USD $)
9 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Depreciaton expenses on Property and equipment $ 762  
Amortizaion expenses on acquired technology 54,510  
Amortization expenses on websited development costs $ 801 $ 534
XML 34 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONCENTRATIONS AND CREDIT RISK DURATION (Details)
9 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net Purchases Growers Synergy Pte. Ltd. - related party 49.80% 0.00%
Net Purchases Stevia Ventures Corporation 10.30% 0.00%
Total Net Purchases 60.10% 0.00%
XML 35 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Mar. 31, 2012
CURRENT ASSETS:    
Cash $ 5,978 $ 15,698
Accounts receivable 120,659 0
Prepayments and other current assets 26,016 168,874
TOTAL CURRENT ASSETS 152,653 184,572
NON-CURRENT ASSETS:    
Property and equipment 7,925 3,036
Accumulated depreciation (762) 0
Property and equipment, net 7,163 3,036
Acquired technology 1,635,300 0
Accumulatd amortization (54,510) 0
Acquired technology, net 1,580,790 0
Website development costs 5,315 5,315
Accumulated amortization (1,602) (801)
Website development costs, net 3,713 4,514
Security deposit 15,000 15,000
TOTAL ASSETS 1,759,319 207,122
CURRENT LIABILITIES:    
Accounts payable 627,929 237,288
Accounts payable - President and CEO 41,689 20,220
Accrued expenses 11,445 5,400
Accrued interest 28,178 15,521
Advances from president and significant stockholder 21,238 19,138
Convertible notes payable 400,000 700,000
TOTAL CURRENT LIABILITIES 1,130,479 997,567
NON-CURRENT LIABILITIES:    
Derivative liability 106,561 0
TOTAL NON-CURRENT LIABILITIES 106,561 0
TOTAL LIABILITIES 1,237,040 997,567
Stevia Corp stockholders' equity (deficit):    
Preferred stock at $0.001 par value: 1,000,000 shares authorized; none issued or outstanding 0 0
Common stock at $0.001 par value: 100,000,000 shares authorized, 63,555,635 and 58,354,775 shares issued and outstanding, respectively 63,556 58,355
Additional paid-in capital 4,222,085 1,474,751
Accumulated deficit (3,666,024) (2,323,551)
TOTAL STEVIA CORP STOCKHOLDERS' EQUITY (DEFICIT) 619,617 (790,445)
Non-controlling interest in subsidiary (97,338) 0
TOTAL EQUITY (DEFICIT) 522,279 (790,445)
TOTAL LIABILITIES AND EQUITY (DEFICIT) $ 1,759,319 $ 207,122
XML 36 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMON SHARES ISSUED FOR SERVICES (Details) (USD $)
Dec. 31, 2012
Jan. 26, 2012
Oct. 14, 2011
Common shares issued to two new members of BOD     1,500,000
Common stock in aggregate as compensation for future services     3,000,000
Restricted stock shares     750,000
Stock price value     $ 0.25
Amortized value over the vesting period     $ 750,000
Amortized value over per quarter     93,750
Common shares value to issue and sell   20,000,000  
Commons shares par value   $ 0.001  
Restricted common stock issued 35,000    
Share value $ 1.50    
Financing costs 52,500    
Restricted shares for non cancellable retainer fee 27,500    
Share par value $ 1.39    
Shares value $ 38,225    
XML 37 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Dec. 31, 2012
Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss for the period $ (1,439,811) $ (1,303,241)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation expense 762 0
Amortization expense 55,311 534
Changes in fair value of derivative liability. (305,244) 0
Common shares issued for compensation 0 750,000
Common shares issued for director services earned during the period 281,250 93,750
Common shares issued for services-related party 272,550 0
Common shares issued for outside services 0 0
Changes in operating assets and liabilities:    
Changes in Accounts receivable (120,659) 0
Changes in Prepaid expenses 142,858 (49,219)
Changes in Accounts payable 390,641 (36,067)
Changes in Accounts payable - related parties 21,469 15,150
Changes in Accrued expenses 6,045 310
Changes in Accrued interest 40,397 33,958
NET CASH USED IN OPERATING ACTIVITIES (654,431) (509,825)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property, plant and equipment (4,889) 0
Proceeds from disposal of property and equipment 0 0
Website development costs. 0 (5,315)
Cash received from reverse acquisition 0 3,198
NET CASH USED IN INVESTING ACTIVITIES (4,889) (2,117)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Advances from president and stockholder 2,100 200
Proceeds from issuance of convertible notes 200,000 750,000
Proceeds from sale of common stock, net of costs 447,500 100,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 649,600 850,200
Net change in cash (9,720) 338,258
Cash at beginning of period 15,698 0
CASH AT END OF PERIOD 5,978 338,258
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Interest paid 0 0
Income tax paid 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common stock for conversion of convertible notes 500,000 350,000
Issuance of common stock for conversion of accrued interest $ 27,739 $ 18,712
XML 38 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONCENTRATIONS AND CREDIT RISK (Tables)
9 Months Ended
Dec. 31, 2012
CONCENTRATIONS AND CREDIT RISK (Tables)  
Vendor purchase concentrations
Vendor  purchase  concentrations  and  accounts  payable  concentration  are  as
follows:
 
                                                 Accounts Payable at                  Net Purchases
                                                ---------------------             ----------------------
                                                                                                 For the
                                                                                               Period from
                                                                                 For the      April 11, 2011
                                                                              Interim Period   (inception)
                                                                                  Ended          through
                                              December 31,    March 31,        December 31,    December 31,
                                                 2012           2012               2012            2011
                                                ------         ------             ------          ------
 
Growers Synergy Pte. Ltd. - related party         42.5%          16.4%              49.8%             --%
tevia Ventures Corporation                         3.7%          54.1%              10.3%             --%
                                                ------         ------             ------          ------
                                                  46.2%          70.5%              60.1%             --%
                                                ======         ======             ======          ======
 
XML 39 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENTS
9 Months Ended
Dec. 31, 2012
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS
NOTE 16 - SUBSEQUENT EVENTS
 
The Company has evaluated all events that occurred  after the balance sheet date
through the date when the financial  statements were issued to determine if they
must be  reported.  The  Management  of the  Company  determined  that  there no
reportable subsequent events to be disclosed.
XML 40 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
ORGANIZATION AND OPERATIONS (Details) (USD $)
Jul. 05, 2012
Jun. 23, 2011
Common shares issued and outstanding   79,800,000
Common shares surrendered for cancelletion   33,000,000
Common shares issued for acquisition of 100% of issued and outstanding   12,000,000
Common shares held in escrow   6,000,000
Percentage of shares represented of the issued and outnstanding   20.40%
Percentage owned by Stevia Asia 70.00%  
Percentage owned by Technew 30.00%  
Contribution per month $ 2,000,000  
Total contribution $ 2,000,000  
XML 41 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Dec. 31, 2012
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)  
Subsidiaries of the Company
The Company's consolidated subsidiaries and/or entities are as follows:
 
                                                             Date of incorporation
                                                                 or formation
Name of consolidated      State or other jurisdiction of     (date of acquisition,
subsidiary or entity      incorporation or organization         if applicable)         Attributable interest
--------------------      -----------------------------         --------------         ---------------------
 
Stevia Ventures              The Territory of the                April 11, 2011                100%
International Ltd.          British Virgin Islands
 
Stevia Asia Limited             Hong Kong SAR                    March 19, 2012                100%
 
Stevia Technew Limited          Hong Kong SAR                    April 28, 2012                 70%
 
Potentially Outstanding Dilutive Common Shares
The following  table shows the  potentially  outstanding  dilutive common shares
excluded from the diluted net income (loss) per common share calculation as they
were anti-dilutive:
 
                                                           Potentially
                                                      Outstanding Dilutive
                                                          Common Shares
                                                   ---------------------------
                                                                    For the
                                                                  Period from
                                                     For the     April 11, 2011
                                                 Interim Period    (inception)
                                                     Ended           through
                                                   December 31,    December 31,
                                                      2012            2011
                                                   ----------       ---------
MAKE GOOD ESCROW SHARES
 
Make Good Escrow  Agreement shares issued and
held with the escrow agent in connection with
the Share Exchange  Agreement  consummated on
June 23, 2011 pending the  achievement by the
Company  of  certain  post-Closing   business
milestones (the "Milestones").                      3,000,000        6,000,000
 
CONVERTIBLE NOTE SHARES
 
On  March  7,  2012,  the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                             426,667              --
 
On  May  30,  2012,   the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                             426,667              --
 
WARRANT SHARES
 
On August 6,  2012,  the  Company  issued (i)
warrants to purchase 1,066,667 shares, in the
aggregate,  of the Company's  common stock to
the investors (the "investors  warrants") and
(ii)  warrants to purchase  85,333  shares of
the  Company's  common stock to the placement
agent (the "agent warrants") with an exercise
price of $0.6405 per share subject to certain
adjustments    pursuant   to   Section   3(b)
Subsequent  Equity  Sales of the SPA expiring
five (5) years from the date of issuance.           1,152,000              --
                                                   ----------      ----------
TOTAL POTENTIALLY OUTSTANDING DILUTIVE
COMMON SHARES                                       5,005,334       6,000,000
                                                   ==========      ==========
XML 42 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 43 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
ORGANIZATION AND OPERATIONS
9 Months Ended
Dec. 31, 2012
ORGANIZATION AND OPERATIONS  
ORGANIZATION AND OPERATIONS
NOTE 1 - ORGANIZATION AND OPERATIONS
 
STEVIA CORP. (FORMERLY INTERPRO MANAGEMENT CORP.)
 
Interpro  Management Corp  ("Interpro") was  incorporated  under the laws of the
State of Nevada on May 21, 2007. Interpro focused on developing and offering web
based software that was designed to be an online project management tool used to
enhance an organization's  efficiency  through planning and monitoring the daily
operations  of a  business.  The Company  discontinued  its  web-based  software
business upon the acquisition of Stevia Ventures  International Ltd. on June 23,
2011.
 
On March 4, 2011,  Interpro amended its Articles of  Incorporation,  and changed
its name to Stevia Corp.  ("Stevia" or the "Company") and effectuated a 35 for 1
(1:35) forward stock split of all of its issued and outstanding shares of common
stock (the "Stock Split").
 
All shares and per share amounts in the consolidated  financial  statements have
been adjusted to give retroactive effect to the Stock Split.
 
STEVIA VENTURES INTERNATIONAL LTD.
 
Stevia Ventures  International  Ltd.  ("Ventures") was incorporated on April 11,
2011 under the laws of the  Territory  of the British  Virgin  Islands  ("BVI").
Ventures owns certain rights relating to stevia  production,  including  certain
assignable  exclusive  purchase  contracts  and an assignable  supply  agreement
related to stevia.
 
ACQUISITION  OF  STEVIA  VENTURES  INTERNATIONAL  LTD.  RECOGNIZED  AS A REVERSE
ACQUISITION
 
On June 23, 2011 (the  "Closing  Date"),  the Company  closed a voluntary  share
exchange  transaction with Ventures pursuant to a Share Exchange  Agreement (the
"Share  Exchange  Agreement")  by and among the  Company,  Ventures  and  George
Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder").
 
Immediately  prior to the  Share  Exchange  Transaction  on June 23,  2011,  the
Company had 79,800,000 common shares issued and outstanding. Simultaneously with
the  Closing of the Share  Exchange  Agreement,  on the  Closing  Date,  Mohanad
Shurrab,  a  shareholder  and,  as of the Closing  Date,  the  Company's  former
Director, President,  Treasurer and Secretary,  surrendered 33,000,000 shares of
the Company's common stock to the Company for cancellation.
 
As a result of the Share  Exchange  Agreement,  the  Company  issued  12,000,000
common shares for the acquisition of 100% of the issued and  outstanding  shares
of Ventures.  Of the 12,000,000  common shares issued 6,000,000 shares are being
held in escrow pending the  achievement  by the Company of certain  post-Closing
business milestones (the  "Milestones"),  pursuant to the terms of the Make Good
Escrow Agreement,  between the Company,  Greenberg Traurig, LLP, as escrow agent
and the Ventures'  Stockholder (the "Escrow Agreement").  Even though the shares
issued only represented approximately 20.4% of the issued and outstanding common
stock  immediately  after the  consummation of the Share Exchange  Agreement the
stockholder  of  Ventures  completely  took  over and  controlled  the  board of
directors and management of the Company upon acquisition.
 
As a result of the  change in  control  to the then  Ventures  Stockholder,  for
financial  statement  reporting  purposes,  the merger  between  the Company and
Ventures  has been treated as a reverse  acquisition  with  Ventures  deemed the
accounting  acquirer and the Company  deemed the  accounting  acquiree under the
acquisition  method of accounting in  accordance  with section  805-10-55 of the
FASB  Accounting  Standards  Codification.  The reverse  acquisition is deemed a
capital transaction and the net assets of Ventures (the accounting acquirer) are
carried forward to the Company (the legal acquirer and the reporting  entity) at
their carrying value before the  acquisition.  The acquisition  process utilizes
the capital  structure of the Company and the assets and liabilities of Ventures
which are recorded at their  historical  cost.  The equity of the Company is the
historical  equity of Ventures  retroactively  restated to reflect the number of
shares issued by the Company in the transaction.
 
FORMATION OF STEVIA ASIA LIMITED
 
On March 19, 2012, the Company formed Stevia Asia Limited  ("Stevia Asia") under
the  laws of the Hong  Kong  Special  Administrative  Region  ("HK  SAR") of the
People's Republic of China ("PRC"), a wholly-owned subsidiary.
 
FORMATION OF STEVIA TECHNEW  LIMITED  (FORMERLY  HERO TACT  LIMITED)/COOPERATIVE
AGREEMENT
 
On April 28,  2012,  Stevia  Asia  formed  Hero  Tact  Limited,  a  wholly-owned
subsidiary,  under the laws of HK SAR,  which  subsequently  changed its name to
Stevia Technew Limited ("Stevia Technew").  Stevia Technew intends to facilitate
a joint venture  relationship with the Company's  technology partner,  Guangzhou
Health China Technology  Development Company Limited,  operating under the trade
name Tech-New  Bio-Technology  and  Guangzhou's  affiliates  Technew  Technology
Limited.  Prior to July 5, 2012, the date of entry into  Cooperative  Agreement,
Stevia Technew was inactive and had no assets or liabilities.
 
On  July  5,  2012,  Stevia  Asia  entered  into a  Cooperative  Agreement  (the
"Cooperative Agreement") with Technew Technology Limited ("Technew"),  a company
incorporated  under the  companies  ordinance  of Hong Kong and an  associate of
Guangzhou Health China Technology  Development Company Limited, and Zhang Jia, a
Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia
Asia and Partners have agreed to make Stevia Technew, a joint venture,  of which
Stevia Asia legally and beneficially owns 70% of the shares (representing 70% of
the issued shares) and Technew legally and  beneficially  owns 30% of the shares
(representing  30% of the issued  shares).  The Partners will be responsible for
managing  Stevia  Technew and Stevia Asia has agreed to contribute  $200,000 per
month,  up to a total of $2,000,000 in financing,  subject to the performance of
Stevia Technew and Stevia Asia's financial capabilities.
 
The Cooperative Agreement shall automatically  terminate upon either Stevia Asia
or Technew ceasing to be a shareholder in Stevia  Technew,  or may be terminated
by either Stevia Asia or Technew upon a material breach by the other party which
is not cured within 30 days of notice of such breach.
XML 44 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets Parentheticals (USD $)
Dec. 31, 2012
Mar. 31, 2012
Preferred Stock, par or stated value $ 0.001 $ 0.001
Preferred Stock, shares authorized 1,000,000 1,000,000
Preferred Stock, shares issued 0 0
Preferred Stock, shares outstanding 0 0
Common Stock, par or stated value $ 0.001 $ 0.001
Common Stock, shares authorized 100,000,000 100,000,000
Common Stock, shares issued 63,555,635 58,354,775
Common Stock, shares outstanding 63,555,635 58,354,775
XML 45 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS' EQUITY
9 Months Ended
Dec. 31, 2012
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY
NOTE 11 - EQUITY
 
SHARES AUTHORIZED
 
Upon  formation  the total number of shares of common stock which the Company is
authorized  to issue is One  Hundred  Million  (100,000,000)  shares,  par value
$0.001 per share.
 
COMMON STOCK
 
REVERSE ACQUISITION TRANSACTION
 
Immediately  prior to the  Share  Exchange  Transaction  on June 23,  2011,  the
Company had 79,800,000 common shares issued and outstanding. Simultaneously with
the  Closing of the Share  Exchange  Agreement,  on the  Closing  Date,  Mohanad
Shurrab,  a  shareholder  and,  as of the Closing  Date,  the  Company's  former
Director, President,  Treasurer and Secretary,  surrendered 33,000,000 shares of
the Company's common stock to the Company for cancellation.
 
As a result of the Share  Exchange  Agreement,  the  Company  issued  12,000,000
common shares for the acquisition of 100% of the issued and  outstanding  shares
of Stevia Ventures  International Ltd. Of the 12,000,000 common shares issued in
connection with the Share Exchange Agreement, 6,000,000 of such shares are being
held in escrow  ("Escrow  Shares")  pending  the  achievement  by the Company of
certain  post-Closing  business milestones (the  "Milestones"),  pursuant to the
terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig,
LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement").
 
MAKE GOOD AGREEMENT SHARES
 
(I) DURATION OF ESCROW AGREEMENT
 
The  Make  Good  Escrow  Agreement  shall  terminate  on the  sooner  of (i) the
distribution of all escrow shares, or (ii) December 31, 2013.
 
(II) DISBURSEMENT OF MAKE GOOD SHARES
 
Upon  achievement  of any Milestone on or before the date  associated  with such
Milestone on Exhibit A, the Company shall promptly provide written notice to the
Escrow Agent and the Selling Shareholder of such achievement (each a "COMPLETION
NOTICE").  Upon the  passage  of any  Milestone  date set forth on Exhibit A for
which the Company has not achieved the associated  Milestone,  the Company shall
promptly provide written notice to the Escrow Agent and the Selling  Shareholder
of such failure to achieve the milestone (each a "NON-COMPLETION NOTICE").
 
(III) EXHIBIT A - SCHEDULE OF MILESTONES
 
                                                                  Completion            Number of
                           Milestones                                Date             Escrow Shares
                           ----------                                ----             -------------
I.
(1)  Enter into exclusive  international  license agreement
     for  all  Agro  Genesis   intellectual   property  and
     products as it applies to stevia
(2)  Enter into cooperative agreements to work with Vietnam
     Institutes (a) Medical Plant  Institute in Hanoi;  (b)
     Agricultural  Science  Institute  of Northern  Central                              3,000,000
     Vietnam                                                                            shares only
(3)  Enter  into  farm  management  agreements  with  local                             if and when
     growers   including   the   Provincial   and  National        Within 180          ALL four (4)
     projects;                                                     days of the          milestones
(4)  Take over management of three existing nurseries             Closing Date          reached(*)
 
II.  Achieve 100 Ha field trials and first test shipment of       Within two (2)
     dry leaf                                                      years of the          1,500,000
                                                                   Closing Date            shares
 
III. Test shipment of dry leaf to achieve minimum specs for       Within two (2)
     contracted base price (currently $2.00 per kilogram)          years of the          1,500,000
                                                                   Closing Date            shares
 
 
*    On December 23, 2011,  3,000,000  out of the  6,000,000  Escrow Shares have
     been earned and released to Ventures  stockholder  upon  achievement of the
     First  Milestone  within  180  days of June  23,  2011,  the  Closing  Date
     associated with the First Milestone.  These shares were valued at $0.25 per
     share or $750,000 on the date of release and recorded as compensation.
 
COMMON SHARES SURRENDERED FOR CANCELLATION
 
On October 4, 2011, a significant  stockholder of the Company,  Mohanad Shurrab,
surrendered  another  3,000,000  shares  of the  Company's  common  stock to the
Company for  cancellation.  The Company  recorded this  transaction  by debiting
common stock at par of $3,000 and crediting  additional  paid-in  capital of the
same.
 
COMMON SHARES ISSUED FOR CASH
 
On October 4, 2011 the Company  sold  400,000  shares of its common stock to one
investor at $0.25 per share or $100,000.
 
COMMON SHARES ISSUED FOR OBTAINING EMPLOYEE AND DIRECTOR SERVICES
 
On October 14, 2011 the Company  issued  1,500,000  shares each to two (2) newly
appointed  members of the board of directors  or 3,000,000  shares of its common
stock in aggregate as compensation for future services.  These shares shall vest
with  respect to  750,000  shares of  restricted  stock on each of the first two
anniversaries of the date of grant, subject to the director's continuous service
to the  Company as  directors.  These  shares  were valued at $0.25 per share or
$750,000 on the date of grant and are being amortized over the vesting period of
two (2)  years  or  $93,750  per  quarter.  The  Company  recorded  $187,500  in
directors' fees for the period from April 11, 2011 (inception) through March 31,
2012. The Company  recorded  $281,250 in directors'  fees for the interim period
ended December 31, 2012.
 
COMMON  SHARES ISSUED TO PARTIES  OTHER THAN  EMPLOYEES  FOR ACQUIRING  GOODS OR
SERVICES
 
EQUITY PURCHASE AGREEMENT AND RELATED REGISTRATION RIGHTS AGREEMENT
 
(I) EQUITY PURCHASE AGREEMENT
 
On January 26,  2012,  the Company  entered  into an equity  purchase  agreement
("Equity  Purchase  Agreement")  with  Southridge  Partners  II,  LP, a Delaware
limited  partnership  (The  "Investor").  Upon  the  terms  and  subject  to the
conditions  contained in the agreement,  the Company shall issue and sell to the
Investor,  and  the  Investor  shall  purchase,  up to  Twenty  Million  Dollars
($20,000,000) of its common stock, par value $0.001 per share.
 
At any time and from time to time  during  the  Commitment  Period,  the  period
commencing on the effective  date,  and ending on the earlier of (i) the date on
which investor shall have purchased put shares pursuant to this agreement for an
aggregate  purchase  price of the maximum  commitment  amount,  or (ii) the date
occurring thirty six (36) months from the date of commencement of the commitment
period.  the Company  may  exercise a put by the  delivery of a put notice,  the
number of put shares that investor shall purchase  pursuant to such put shall be
determined by dividing the investment  amount specified in the put notice by the
purchase  price with respect to such put notice.  However,  that the  investment
amount  identified  in the  applicable  put notice shall not be greater than the
maximum put amount and, when taken  together  with any prior put notices,  shall
not exceed the  maximum  commitment  The  purchase  price  shall mean 93% of the
market  price  on such  date on  which  the  purchase  price  is  calculated  in
accordance with the terms and conditions of this Agreement.
 
(II) REGISTRATION RIGHTS AGREEMENT
 
In  connection  with the Equity  Purchase  Agreement,  on January 26, 2012,  the
Company  entered into a  registration  rights  agreement  ("Registration  Rights
Agreement") with Southridge Partners II, LP, a Delaware limited partnership (the
"Investor").  To induce the investor to execute and deliver the equity  purchase
agreement  which the Company has agreed to issue and sell to the investor shares
(the "put shares") of its common stock,  par value $0.001 per share (the "common
stock")  from  time to time for an  aggregate  investment  price of up to twenty
million dollars  ($20,000,000) (the "registrable  securities"),  the Company has
agreed to provide certain  registration rights under the securities act of 1933,
as amended, and the rules and regulations  thereunder,  or any similar successor
statute  (collectively,  "securities act"), and applicable state securities laws
with respect to the registrable securities.
 
(III) COMMON SHARES ISSUED UPON SIGNING
 
As a condition for the execution of this agreement by the investor,  the company
issued to the investor 35,000 shares of restricted common stock (the "restricted
shares") upon the signing of this agreement. The restricted shares shall have no
registration  rights.  These shares were valued at $1.50 per share or $52,500 on
the date of issuance and recorded as financing cost.
 
MARKETING SERVICE AGREEMENT - EMPIRE RELATIONS GROUP, INC.
 
On  March  14,  2012  the  Company  entered  into a  consulting  agreement  (the
"Consulting Agreement") with Empire Relations Group, Inc. ("Empire").
 
(I) SCOPE OF SERVICES
 
Under the terms of the  Consulting  Agreement,  the  Company  engaged  Empire to
introduce interested  investors to the Company,  advise the Company on available
financing  options,  provide  periodic  updates on the stevia sector and provide
insights and strategies for the Company to undertake.
 
(II) TERM
 
The  term  of  this  agreement  were  consummated  from  the  date  hereof,  and
automatically terminated on May 30, 20 12.
 
(III) COMPENSATION
 
For  the  term of this  agreement,  the  consultant  shall  be paid an  upfront,
non-refundable,  non-cancellable  retainer fee of 27,500 restricted  shares. For
the purposes of this  agreement,  these shares shall be  considered  to be fully
earned by March 31, 2012. These shares were valued at $1.39 per share or $38,225
on March 31, 2012, the date when they were earned.
 
COMMON  SHARES  ISSUED IN  CONNECTION  WITH  ENTRY INTO  TECHNOLOGY  ACQUISITION
AGREEMENT
 
On July 5, 2012,  the Company  entered into a Technology  Acquisition  Agreement
(the  "Technology   Acquisition  Agreement")  with  Technew  Technology  Limited
("Technew"),  pursuant  to which the  Company  acquired  the  rights to  certain
technology  from  Technew in exchange  for  3,000,000  restricted  shares of the
Company's common stock.  These restricted  shares were valued at $0.79 per share
discounted at 69% taking into consideration of its restricted nature and lack of
liquidity and consistent trading in the market or $1,635,300, which was recorded
as acquired  technology and amortized on a straight-line basis over the acquired
technology's estimated useful life of fifteen (15) years.
 
COMMON SHARES ISSUED TO A RELATED PARTY
 
On July 5, 2012,  the Company  issued  500,000  restricted  shares of its common
shares to Growers  Synergy Pte Ltd., a corporation  organized  under the laws of
the  Republic  of  Singapore  ("Singapore"),  owned  and  controlled  by  George
Blankenbaker,  the  president,  director and a  significant  stockholder  of the
Company ("Growers  Synergy"),  as consideration for services rendered by Growers
Synergy to the Company.  These restricted  shares were valued at $0.79 per share
discounted at 69% taking into consideration of its restricted nature and lack of
liquidity and  consistent  trading in the market or $272,550 and included in the
farm  management  services - related  party in the  consolidated  statements  of
operations.
 
SALE OF EQUITY UNIT INCLUSIVE OF COMMON STOCK AND WARRANTS
 
ENTRY INTO SECURITIES PURCHASE AGREEMENT
 
On August 1, 2012, the Company entered into a Securities Purchase Agreement (the
"SPA") with two (2) accredited  institutional  investors (the  "Purchasers")  to
raise $500,000 in a private  placement  financing.  On August 6, 2012, after the
satisfaction of certain closing conditions,  the Offering closed and the Company
issued to the Purchasers:  (i) an aggregate of 1,066,667 shares of the Company's
common  stock at $0.46875  per share and (ii)  warrants  to  purchase  1,066,667
shares of the Company's  common stock at an exercise  price of $0.6405  expiring
five (5) years from the date of issuance for a gross proceeds of $500,000.
 
At closing,  the Company  reimbursed  the investor for legal fees of $12,500 and
paid Garden State Securities, Inc,("GSS") that served as placement agent for the
Company in the offering (i) cash commissions equal to 8.0% of the gross proceeds
received  in the equity  financing  or  $40,000,  and (ii) a warrant to purchase
85,333 shares of the Company's  common stock  representing 8% of the Shares sold
in the Offering  with an exercise  price of $0.6405 per share  expiring five (5)
years from the date of issuance (the "agent warrants") to GSS or its designee.
 
The units were sold at $0.46875  per unit  consisting  one common  share and the
warrant to purchase  one (1) common share for a gross  proceeds of $500,000.  In
connection with the August 6, 2012 equity unit offering the Company paid (i) GSS
cash  commissions  equal to 8.0% of the gross  proceeds  received  in the equity
financing,  or $40,000  and (ii)  $12,500 in legal  fees and  resulted  in a net
proceeds of $447,500.
 
The Company  intended to use the net  proceeds  from the Offering to advance the
Company's  ability to execute its growth  strategy and to aid in the  commercial
development  of the recently  announced  launch of the Company's  majority-owned
subsidiary, Stevia Technew Limited.
 
ENTRY INTO REGISTRATION RIGHTS AGREEMENT
 
In  connection  with the equity  financing  on August 1, 2012,  the Company also
entered into a registration  rights  agreement with the Purchasers  (the "rights
agreement").  The Rights  Agreement  requires the Company to file a registration
statement  (the  "Registration  Statement")  with the  Securities  and  Exchange
Commission  (the "SEC") within  thirty (30) days of the Company's  entrance into
the rights agreement (the "filing date") for the resale by the Purchasers of all
of the Shares and all of the shares of common stock  issuable  upon  exercise of
the Warrants (the "registrable securities").
 
The  registration  statement  must be declared  effective  by the SEC within one
hundred and twenty  (120) days of the closing  date of the  Offering  subject to
certain  adjustments.  If the  registration  statement is not filed prior to the
filing date, the Company will be required to pay certain liquidated damages, not
to exceed in the  aggregate  6% of the  purchase  price  paid by the  Purchasers
pursuant to the SPA.
 
WARRANTS
 
ISSUANCES  OF  WARRANTS  IN  CONNECTION  WITH  ENTRY  INTO  SECURITIES  PURCHASE
AGREEMENT
 
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares,
in the  aggregate,  of the  Company's  common  stock  to the  investors  with an
exercise price of $0.6405 per share subject to certain  adjustments  per Section
3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of
issuance in connection with the sale of common shares.
 
ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION
 
Garden State  Securities,  Inc. (the "GSS") served as the placement agent of the
Company for the equity financing on August 1, 2012. Per the engagement agreement
signed between GSS and the Company,  in consideration  for services  rendered as
the placement agent,  the Company agreed to: (i) pay GSS cash commissions  equal
to 8.0% of the gross proceeds received in the equity financing,  or $40,000, and
(ii) issue to GSS or its  designee,  a warrant to purchase  85,333 shares of the
Company's  common stock  representing  8% of the warrants  sold in the Offering)
with an exercise price of $0.6405 per share subject to certain  adjustments  per
Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the
date of issuance (the "agent warrants"). The agent warrants also provide for the
same  registration  rights and obligations as set forth in the Rights  Agreement
with respect to the Warrants and Warrant Shares.
XML 46 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
9 Months Ended
Dec. 31, 2012
Jan. 18, 2013
Document and Entity Information    
Entity Registrant Name Stevia Corp  
Document Type 10-Q  
Document Period End Date Dec. 31, 2012  
Amendment Flag false  
Entity Central Index Key 0001439813  
Current Fiscal Year End Date --03-31  
Entity Common Stock, Shares Outstanding   66,555,635
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q3  
XML 47 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
NON-CONTROLLING INTEREST
9 Months Ended
Dec. 31, 2012
NON-CONTROLLING INTEREST  
NON-CONTROLLING INTEREST
NOTE 12 - NON-CONTROLLING INTEREST
 
Non-controlling interest consisted of the following:
 
                                      Contributed and
                                        additional                           Other             Total
                                         paid-in        Earnings and     Comprehensive      non-controlling
                                         capital           losses            Income           interest
                                         -------           ------            ------           --------
 
Balance at March 31, 2012                $    --          $     --           $    --          $     --
Current period earnings and losses            --           (97,338)               --           (97,338)
                                         -------          --------           -------          --------
 
Balance at December 31, 2012             $    --          $(97,338)          $    --          $(97,338)
                                         =======          ========           =======          ========
XML 48 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
REVENUES $ 8,142 $ 0 $ 120,939 $ 1,300
COST OF REVENUES        
Farm expenses 66,743 0 66,743 0
Farm field lease 6,250 0 21,250 0
Farm management services - related party 60,000 60,000 652,550 120,000
TOTAL COST OF REVENUES 132,993 60,000 740,543 120,000
Gross margin (124,851) (60,000) (619,604) (118,700)
OPERATING EXPENSES:        
Directors' fees 93,750 93,750 281,250 93,750
Professional fees 123,356 73,454 352,031 117,183
Research and development 0 39,172 118,669 144,369
Salary and compensation - officer 0 750,000 0 750,000
Salary and compensation - others 59,105 0 110,982 0
General and administrative expenses 69,302 14,868 204,616 36,160
TOTAL OPERATING EXPENSES 345,513 971,244 1,067,548 1,141,462
Loss from operations (470,364) (1,031,244) (1,687,152) (1,260,162)
OTHER (INCOME) EXPENSE:        
Change in fair value of derivative liability (73,723) 0 (305,244) 0
Financing cost 2,807 9,000 16,125 18,000
Foreign currency transaction gain (loss) 1 0 1,316 0
Interest expense 10,130 15,630 40,462 25,123
Interest income 0 0 0 (44)
TOTAL OTHER (INCOME) EXPENSE (60,785) 24,630 (247,341) 43,079
Loss before income taxes and noncontrolling interest (409,579) (1,055,874) (1,439,811) (1,303,241)
Income tax provision 0 0 0 0
Net loss before non-controlling interest (409,579) (1,055,874) (1,439,811) (1,303,241)
Net loss attributable to the non-controlling interest (44,978) 0 (97,338) 0
NET LOSS ATTRIBUTABLE TO STEVIA CORP $ (364,601) $ (1,055,874) $ (1,342,473) $ (1,303,241)
Net loss per common share- Basic and diluted: $ (0.01) $ (0.02) $ (0.02) $ (0.03)
Weighted average common shares outstanding - Basic and diluted 63,225,253 54,854,293 61,613,572 40,575,587
XML 49 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACQUIRED TECHNOLOGY
9 Months Ended
Dec. 31, 2012
ACQUIRED TECHNOLOGY  
ACQUIRED TECHNOLOGY
NOTE 6 - ACQUIRED TECHNOLOGY
 
On July 5, 2012,  the Company  acquired  the rights to certain  technology  from
Technew  Technology  Limited in exchange for 3,000,000  restricted shares of the
Company's common stock.  These restricted  shares were valued at $0.79 per share
discounted at 69% taking into  consideration  its restricted  nature and lack of
liquidity and consistent  trading in the market for a total value of $1,635,300,
which was recorded as acquired technology and amortized on a straight-line basis
over the acquired technology's estimated useful life of fifteen (15) years.
 
                                   Estimated
                                  Useful Life      December 31,       March 31,
                                    (Years)           2012              2012
                                    -------        ----------        ----------
Technology right                      15           $1,635,300        $       --
Less accumulated amortization                         (54,510)               --
                                                   ----------        ----------
 
                                                   $1,580,790        $       --
                                                   ==========        ==========
 
AMORTIZATION EXPENSE
 
Amortization expense for the interim period ended December 31, 2012 was $54,510.
XML 50 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
PROPERTY AND EQUIPMENT
9 Months Ended
Dec. 31, 2012
PROPERTY AND EQUIPMENT  
PROPERTY AND EQUIPMENT
NOTE 5 - PROPERTY AND EQUIPMENT
 
Property and equipment,  stated at cost, less accumulated depreciation consisted
of the following:
 
                                   Estimated
                                  Useful Life      December 31,        March 31,
                                    (Years)           2012               2012
                                    -------         --------           --------
Property and equipment                 5            $  7,925           $  3,036
Less accumulated depreciation                           (762)                --
                                                    --------           --------
 
                                                    $  7,163           $  3,036
                                                    ========           ========
 
DEPRECIATION EXPENSE
 
The Company  acquired  furniture  and fixture near the end of February  2012 and
started to depreciate as of April 1, 2012.  Depreciation expense for the interim
period ended December 31, 2012 was $762.
 
XML 51 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Dec. 31, 2012
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)  
BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION
BASIS OF PRESENTATION - UNAUDITED INTERIM FINANCIAL INFORMATION
 
The accompanying  unaudited interim financial  statements and related notes have
been prepared in accordance with accounting principles generally accepted in the
United States of America ("U.S.  GAAP") for interim financial  information,  and
with the rules and  regulations  of the United  States  Securities  and Exchange
Commission  ("SEC") to Form 10-Q and Article 8 of Regulation  S-X.  Accordingly,
they do not include all of the information  and footnotes  required by U.S. GAAP
for complete financial  statements.  The unaudited interim financial  statements
furnished  reflect all  adjustments  (consisting of normal  recurring  accruals)
which are, in the opinion of  management,  necessary to a fair  statement of the
results for the interim periods  presented.  Interim results are not necessarily
indicative of the results for the full fiscal year.  These financial  statements
should be read in conjunction  with the financial  statements of the Company for
the period  from April 11,  2011  (inception)  through  March 31, 2012 and notes
thereto  contained in the Company's Annual Report on Form 10-K as filed with the
SEC on June 29, 2012.
PRINCIPLES OF CONSOLIDATION
PRINCIPLES OF CONSOLIDATION
 
The  Company  applies  the  guidance  of Topic 810  "CONSOLIDATION"  of the FASB
Accounting  Standards  Codification to determine  whether and how to consolidate
another  entity.  Pursuant  to ASC  Paragraph  810-10-15-10  all  majority-owned
subsidiaries--all  entities  in  which  a  parent  has a  controlling  financial
interest--shall  be consolidated  except (1) when control does not rest with the
parent,  the majority  owner;  (2) if the parent is a  broker-dealer  within the
scope of Topic 940 and control is likely to be temporary;  (3)  consolidation by
an investment company within the scope of Topic 946 of a  non-investment-company
investee.  Pursuant  to ASC  Paragraph  810-10-15-8  the usual  condition  for a
controlling financial interest is ownership of a majority voting interest,  and,
therefore,  as a general rule  ownership by one  reporting  entity,  directly or
indirectly,  of more than 50 percent of the outstanding voting shares of another
entity is a condition  pointing toward  consolidation.  The power to control may
also exist with a lesser  percentage  of  ownership,  for example,  by contract,
lease,  agreement  with other  stockholders,  or by court  decree.  The  Company
consolidates all  less-than-majority-owned  subsidiaries,  in which the parent's
power to control exists.
 
The Company's consolidated subsidiaries and/or entities are as follows:
 
                                                             Date of incorporation
                                                                 or formation
Name of consolidated      State or other jurisdiction of     (date of acquisition,
subsidiary or entity      incorporation or organization         if applicable)         Attributable interest
--------------------      -----------------------------         --------------         ---------------------
 
Stevia Ventures              The Territory of the                April 11, 2011                100%
International Ltd.          British Virgin Islands
 
Stevia Asia Limited             Hong Kong SAR                    March 19, 2012                100%
 
Stevia Technew Limited          Hong Kong SAR                    April 28, 2012                 70%
 
The consolidated  financial statements include all accounts of the Company as of
December  31,  2012,  for the interim  period then ended and for the period from
June 23, 2011 (date of acquisition)  through December 31, 2011;  Stevia Ventures
International  Ltd. as of December 31, 2012,  for the interim  period then ended
and for the period from April 11, 2011  (inception)  through  December 31, 2011;
Stevia Asia  Limited as of  December  31, 2012 and for the period from March 19,
2012  (inception)  through  December 31, 2012; and Stevia Technew  Limited as of
December  31, 2012 and for the period from April 28,  2012  (inception)  through
December 31, 2012.
 
All inter-company balances and transactions have been eliminated.
RECLASSIFICATION
RECLASSIFICATION
 
Certain amounts in the prior period financial  statements have been reclassified
to conform to the current period presentation.  These  reclassifications  had no
effect on reported losses.
USE OF ESTIMATES AND ASSUMPTIONS
USE OF ESTIMATES AND ASSUMPTIONS
 
The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period.
 
The Company's  significant  estimates and assumptions  include the fair value of
financial  instruments;  the carrying  value,  recoverability  and impairment of
long-lived  assets,  including the values  assigned to and the estimated  useful
lives of  website  development  costs;  interest  rate;  revenue  recognized  or
recognizable;  sales returns and  allowances;  foreign  currency  exchange rate;
income  tax rate,  income tax  provision,  deferred  tax  assets  and  valuation
allowance of deferred  tax assets;  expected  term of share  options and similar
instruments,  expected  volatility of the entity's shares and the method used to
estimate it, expected annual rate of quarterly dividends, and risk free rate(s);
and the  assumption  that the Company will  continue as a going  concern.  Those
significant  accounting  estimates or assumptions bear the risk of change due to
the  fact  that  there  are   uncertainties   attached  to  those  estimates  or
assumptions,  and certain  estimates or assumptions  are difficult to measure or
value.
 
Management  bases  its  estimates  on  historical   experience  and  on  various
assumptions  that are  believed to be  reasonable  in relation to the  financial
statements taken as a whole under the  circumstances,  the results of which form
the  basis  for  making  judgments  about the  carrying  values  of  assets  and
liabilities that are not readily apparent from other sources.
 
Management  regularly  evaluates the key factors and assumptions used to develop
the estimates utilizing currently  available  information,  changes in facts and
circumstances,  historical  experience  and reasonable  assumptions.  After such
evaluations, if deemed appropriate, those estimates are adjusted accordingly.
 
Actual results could differ from those estimates.
FAIR VALUE OF FINANCIAL INSTRUMENTS
FAIR VALUE OF FINANCIAL INSTRUMENTS
 
The Company follows  paragraph  820-10-35-37  of the FASB  Accounting  Standards
Codification  ("Paragraph  820-10-35-37")  to  measure  the  fair  value  of its
financial  instruments  and  paragraph   825-10-50-10  of  the  FASB  Accounting
Standards  Codification  for  disclosures  about  fair  value  of its  financial
instruments.  Paragraph 820-10-35-37  establishes a framework for measuring fair
value in  accounting  principles  generally  accepted  in the  United  States of
America (U.S. GAAP), and expands disclosures about fair value  measurements.  To
increase  consistency and  comparability in fair value  measurements and related
disclosures,  Paragraph  820-10-35-37  establishes a fair value  hierarchy which
prioritizes  the inputs to valuation  techniques used to measure fair value into
three (3) broad levels.  The three (3) levels of fair value hierarchy defined by
Paragraph 820-10-35-37 are described below:
 
Level 1    Quoted market prices available in active markets for identical assets
           or liabilities as of the reporting date.
 
Level 2    Pricing inputs other than quoted prices in active markets included in
           Level 1, which are either directly or indirectly observable as of the
           reporting date.
 
Level 3    Pricing  inputs  that  are  generally   observable   inputs  and  not
           corroborated by market data.
 
Financial  assets are  considered  Level 3 when their fair values are determined
using pricing models,  discounted cash flow  methodologies or similar techniques
and at least one significant model assumption or input is unobservable.
 
The  fair  value  hierarchy   gives  the  highest   priority  to  quoted  prices
(unadjusted)  in active  markets for  identical  assets or  liabilities  and the
lowest  priority  to  unobservable  inputs.  If the inputs  used to measure  the
financial  assets and  liabilities  fall  within  more than one level  described
above, the categorization is based on the lowest level input that is significant
to the fair value measurement of the instrument.
 
The carrying amounts of the Company's financial assets and liabilities,  such as
cash,  accounts  receivable,  prepayments  and other  current  assets,  accounts
payable,  accrued expenses, and accrued interest,  approximate their fair values
because of the short maturity of these instruments.
 
The  Company's  convertible  notes payable  approximates  the fair value of such
instrument based upon management's best estimate of interest rates that would be
available to the Company for similar financial arrangements at December 31, 2012
and March 31, 2012.
 
The Company's Level 3 financial  liabilities  consist of the derivative  warrant
issued in August 2012 for which there is no current market for these  securities
such that the  determination  of fair value  requires  significant  judgment  or
estimation.   The  Company   valued  the   automatic   conditional   conversion,
re-pricing/down-round,   change  of  control;  default  and  follow-on  offering
provisions using a lattice model, with the assistance of a third party valuation
specialist,  for which management  understands the  methodologies.  These models
incorporate transaction details such as Company stock price,  contractual terms,
maturity,  risk free rates,  as well as  assumptions  about  future  financings,
volatility,  and holder  behavior  as of the date of issuance  and each  balance
sheet date.
 
It is not,  however,  practical  to  determine  the fair value of advances  from
president  and  significant  stockholder,  if any,  due to their  related  party
nature.
 
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS
 
LEVEL 3 FINANCIAL LIABILITIES - DERIVATIVE WARRANT LIABILITIES
 
The Company  uses Level 3 of the fair value  hierarchy to measure the fair value
of the derivative  liabilities and revalues its derivative  warrant liability at
every  reporting  period  and  recognizes  gains or losses  in the  consolidated
statements of operations and  comprehensive  income (loss) that are attributable
to the change in the fair value of the derivative warrant liability.
CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS
CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS
 
The Company has adopted paragraph  360-10-35-17 of the FASB Accounting Standards
Codification for its long-lived assets. The Company's  long-lived assets,  which
include property and equipment,  acquired  technology,  and website  development
costs are reviewed for impairment  whenever  events or changes in  circumstances
indicate that the carrying amount of an asset may not be recoverable.
 
The Company assesses the  recoverability  of its long-lived  assets by comparing
the projected undiscounted net cash flows associated with the related long-lived
asset or group of long-lived assets over their remaining  estimated useful lives
against their respective carrying amounts.  Impairment,  if any, is based on the
excess of the carrying amount over the fair value of those assets. Fair value is
generally  determined using the asset's expected future discounted cash flows or
market value, if readily determinable. If long-lived assets are determined to be
recoverable,  but the newly  determined  remaining  estimated  useful  lives are
shorter than originally estimated,  the net book values of the long-lived assets
are depreciated over the newly determined remaining estimated useful lives.
 
The Company considers the following to be some examples of important  indicators
that may trigger an impairment  review:  (i)  significant  under-performance  or
losses of assets relative to expected  historical or projected  future operating
results;  (ii)  significant  changes  in the  manner  or use of assets or in the
Company's  overall  strategy  with  respect to the manner or use of the acquired
assets or changes in the Company's overall business strategy;  (iii) significant
negative industry or economic trends; (iv) increased competitive pressures;  (v)
a  significant  decline in the Company's  stock price for a sustained  period of
time; and (vi) regulatory  changes.  The Company  evaluates  acquired assets for
potential  impairment  indicators at least annually and more frequently upon the
occurrence of such events.
 
The key assumptions  used in management's  estimates of projected cash flow deal
largely with  forecasts of sales levels and gross margins.  These  forecasts are
typically based on historical  trends and take into account recent  developments
as well as management's plans and intentions.  Other factors,  such as increased
competition  or a decrease  in the  desirability  of the  Company's  products or
services,  could lead to lower  projected  sales levels,  which would  adversely
impact cash flows. A significant change in cash flows in the future could result
in an impairment of long lived assets.
 
The  impairment  charges,  if any,  is  included  in  operating  expenses in the
accompanying consolidated statements of operations.
FISCAL YEAR END
FISCAL YEAR END
 
The Company elected March 31 as its fiscal year ending date.
CASH EQUIVALENTS
CASH EQUIVALENTS
 
The Company  considers all highly liquid  investments  with  maturities of three
months or less at the time of purchase to be cash equivalents.
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT
 
Property and equipment is recorded at cost. Expenditures for major additions and
betterments are  capitalized.  Maintenance and repairs are charged to operations
as  incurred.   Depreciation  of  furniture  and  fixture  is  computed  by  the
straight-line  method  (after  taking into account  their  respective  estimated
residual values) over the assets  estimated useful life of five (5) years.  Upon
sale or retirement of property and equipment,  the related cost and  accumulated
depreciation  are removed from the accounts and any gain or loss is reflected in
the statements of operations.
INTANGIBLE ASSETS OTHER THAN GOODWILL
INTANGIBLE ASSETS OTHER THAN GOODWILL
 
The Company has adopted paragraph  350-30-25-3 of the FASB Accounting  Standards
Codification for intangible assets other than goodwill.  Under the requirements,
the Company  amortizes the  acquisition  costs of  intangible  assets other than
goodwill  inclusive of acquired  technology and website  development  costs on a
straight-line  basis over their relevant  estimated useful lives of fifteen (15)
and five (5) years,  respectively.  Upon becoming fully  amortized,  the related
cost and accumulated amortization are removed from the accounts.
RELATED PARTIES
RELATED PARTIES
 
The  Company  follows   subtopic   850-10  of  the  FASB  Accounting   Standards
Codification for the identification of related parties and disclosure of related
party transactions.
 
Pursuant to Section  850-10-20 the related  parties include a. affiliates of the
Company;  b. entities for which  investments in their equity securities would be
required,  absent the  election  of the fair value  option  under the Fair Value
Option Subsection of Section 825-10-15, to be accounted for by the equity method
by the investing entity; c. trusts for the benefit of employees, such as pension
and  profit-sharing  trusts  that are  managed  by or under the  trusteeship  of
management; d. principal owners of the Company; e. management of the Company; f.
other  parties  with which the  Company  may deal if one party  controls  or can
significantly  influence the management or operating policies of the other to an
extent  that one of the  transacting  parties  might  be  prevented  from  fully
pursuing its own separate interests; and g. other parties that can significantly
influence the  management or operating  policies of the  transacting  parties or
that  have an  ownership  interest  in one of the  transacting  parties  and can
significantly  influence  the  other  to an  extent  that  one  or  more  of the
transacting  parties  might be  prevented  from fully  pursuing its own separate
interests.
 
The financial  statements  shall include  disclosures of material  related party
transactions,  other than compensation  arrangements,  expense  allowances,  and
other similar items in the ordinary course of business.  However,  disclosure of
transactions  that are eliminated in the preparation of consolidated or combined
financial statements is not required in those statements.  The disclosures shall
include: a. the nature of the relationship(s)  involved; b. a description of the
transactions, including transactions to which no amounts or nominal amounts were
ascribed, for each of the periods for which income statements are presented, and
such other  information  deemed  necessary to an understanding of the effects of
the  transactions  on  the  financial  statements;  c.  the  dollar  amounts  of
transactions  for each of the periods for which income  statements are presented
and the effects of any change in the method of establishing  the terms from that
used in the preceding  period;  and d. amounts due from or to related parties as
of the date of each balance sheet presented and, if not otherwise apparent,  the
terms and manner of settlement.
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 
The Company  accounts  for  derivative  instruments  and hedging  activities  in
accordance  with  paragraph   810-10-05-4  of  the  FASB  Accounting   Standards
Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies
to recognize all  derivative  instruments as either assets or liabilities in the
balance sheet at fair value.  The  accounting for changes in the fair value of a
derivative  instrument  depends  upon:  (i)  whether  the  derivative  has  been
designated and qualifies as part of a hedging relationship, and (ii) the type of
hedging relationship.  For those derivative  instruments that are designated and
qualify as hedging instruments,  a company must designate the hedging instrument
based upon the exposure  being  hedged as either a fair value  hedge,  cash flow
hedge or hedge of a net investment in a foreign operation.
 
From time to time, the Company may employ foreign currency forward  contracts to
convert  unforeseeable foreign currency exchange rates to fixed foreign currency
exchange rates.  The Company does not use derivatives for speculation or trading
purposes.  Changes in the fair value of derivatives  are recorded each period in
current earnings or through other comprehensive  income,  depending on whether a
derivative is designated  as part of a hedge  transaction  and the type of hedge
transaction.  The  ineffective  portion of all hedges is  recognized  in current
earnings. The Company has sales and purchase commitments  denominated in foreign
currencies.  Foreign  currency  forward  contracts are used to hedge against the
risk  of  change  in  the  fair  value  of  these  commitments  attributable  to
fluctuations in exchange rates ("Fair Value Hedges").  Changes in the fair value
of the  derivative  instrument are generally  offset in the income  statement by
changes in the fair value of the item being hedged.
 
The  Company  did not  employ  foreign  currency  forward  contracts  to convert
unforeseeable foreign currency exchange rates to fixed foreign currency exchange
rates for the interim period ended December 31, 2012 or 2011.
DERIVATIVE LIABILITY
DERIVATIVE LIABILITY
 
The  Company  evaluates  its  convertible  debt,  options,   warrants  or  other
contracts,  if any, to determine if those  contracts or embedded  components  of
those  contracts  qualify  as  derivatives  to be  separately  accounted  for in
accordance  with  paragraph  810-10-05-4  and  Section  815-40-25  of  the  FASB
Accounting  Standards  Codification.  The result of this accounting treatment is
that the fair value of the embedded derivative is marked-to-market  each balance
sheet date and recorded as either an asset or a liability. In the event that the
fair value is recorded as a  liability,  the change in fair value is recorded in
the  consolidated  statement of operations  and  comprehensive  income (loss) as
other  income  or  expense.  Upon  conversion,  exercise  or  cancellation  of a
derivative  instrument,  the  instrument  is marked to fair value at the date of
conversion,  exercise or  cancellation  and then that the related  fair value is
reclassified to equity.
 
In  circumstances   where  the  embedded  conversion  option  in  a  convertible
instrument  is  required  to be  bifurcated  and there are also  other  embedded
derivative  instruments in the  convertible  instrument  that are required to be
bifurcated, the bifurcated derivative instruments are accounted for as a single,
compound derivative instrument.
 
The classification of derivative instruments, including whether such instruments
should be recorded as  liabilities  or as equity,  is  re-assessed at the end of
each  reporting  period.  Equity  instruments  that are initially  classified as
equity that become subject to reclassification  are reclassified to liability at
the fair  value  of the  instrument  on the  reclassification  date.  Derivative
instrument  liabilities  will be  classified  in the balance sheet as current or
non-current  based on  whether  or not  net-cash  settlement  of the  derivative
instrument is expected within 12 months of the balance sheet date.
 
The  Company  adopted  Section  815-40-15  of  the  FASB  Accounting   Standards
Codification  ("Section  815-40-15")  to determine  whether an instrument (or an
embedded  feature)  is indexed to the  Company's  own stock.  Section  815-40-15
provides  that an entity should use a two-step  approach to evaluate  whether an
equity-linked  financial  instrument (or embedded feature) is indexed to its own
stock, including evaluating the instrument's  contingent exercise and settlement
provisions.  The adoption of Section  815-40-15 has affected the  accounting for
(i)  certain  freestanding  warrants  that  contain  exercise  price  adjustment
features and (ii) convertible bonds issued by foreign subsidiaries with a strike
price denominated in a foreign currency.
 
The Company marks to market the fair value of the embedded  derivative  warrants
at each  balance  sheet  date and  records  the  change in the fair value of the
embedded  derivative  warrants  as other  income or expense in the  consolidated
statements of operations and comprehensive income (loss).
 
The  Company  utilizes  the  Lattice  model  that  values the  liability  of the
derivative  warrants based on a probability  weighted discounted cash flow model
with the  assistance of the third party  valuation  firm. The reason the Company
picks the Lattice  model is that in many cases  there may be  multiple  embedded
features or the features of the bifurcated  derivatives may be so complex that a
Black-Scholes  valuation  does not consider all of the terms of the  instrument.
Therefore, the fair value may not be appropriately captured by simple models. In
other words,  simple models such as Black-Scholes may not be appropriate in many
situations given complex features and terms of conversion option (e.g., combined
embedded  derivatives).  The Lattice model is based on future projections of the
various  potential  outcomes.  The features that were analyzed and  incorporated
into the model  included the exercise  and full reset  features.  Based on these
features,  there are two primary events that can occur; the Holder exercises the
Warrants or the Warrants are held to expiration.  The Lattice model analyzed the
underlying  economic  factors that influenced which of these events would occur,
when they were likely to occur,  and the specific  terms that would be in effect
at the time (i.e. stock price, exercise price,  volatility,  etc.).  Projections
were then made on the  underlying  factors  which  led to  potential  scenarios.
Probabilities  were assigned to each scenario  based on management  projections.
This led to a cash flow  projection and a probability  associated with that cash
flow. A discounted  weighted  average cash flow over the various  scenarios  was
completed to determine the value of the derivative warrants.
COMMITMENT AND CONTINGENCIES
COMMITMENT AND CONTINGENCIES
 
The  Company  follows   subtopic   450-20  of  the  FASB  Accounting   Standards
Codification  to report  accounting for  contingencies.  Certain  conditions may
exist as of the date the consolidated financial statements are issued, which may
result in a loss to the Company but which will only be resolved when one or more
future  events  occur or fail to occur.  The Company  assesses  such  contingent
liabilities, and such assessment inherently involves an exercise of judgment. In
assessing  loss  contingencies  related to legal  proceedings  that are  pending
against the Company or  unasserted  claims that may result in such  proceedings,
the  Company  evaluates  the  perceived  merits  of  any  legal  proceedings  or
unasserted claims as well as the perceived merits of the amount of relief sought
or expected to be sought therein.
 
If the assessment of a contingency indicates that it is probable that a material
loss has been incurred and the amount of the  liability  can be estimated,  then
the estimated liability would be accrued in the Company's consolidated financial
statements.   If  the  assessment  indicates  that  a  potential  material  loss
contingency  is not  probable  but is  reasonably  possible,  or is probable but
cannot  be  estimated,  then the  nature  of the  contingent  liability,  and an
estimate of the range of possible losses, if determinable and material, would be
disclosed.
 
Loss  contingencies  considered  remote are generally not disclosed  unless they
involve guarantees, in which case the guarantees would be disclosed.  Management
does not believe,  based upon  information  available  at this time,  that these
matters  will  have a  material  adverse  effect on the  Company's  consolidated
financial position,  results of operations or cash flows.  However,  there is no
assurance  that such  matters  will not  materially  and  adversely  affect  the
Company's business, financial position, and results of operations or cash flows.
NON-CONTROLLING INTEREST
NON-CONTROLLING INTEREST
 
The Company  follows  paragraph  810-10-65-1  of the FASB  Accounting  Standards
Codification to report the  non-controlling  interest in Stevia Technew Limited,
its majority owned subsidiary in the  consolidated  statements of balance sheets
within the equity section,  separately from the Company's  stockholders' equity.
Non-controlling   interest  represents  the  non-controlling  interest  holder's
proportionate  share of the equity of the Company's  majority-owned  subsidiary,
Stevia   Technew   Limited.   Non-controlling   interest  is  adjusted  for  the
non-controlling  interest holder's proportionate share of the earnings or losses
and other comprehensive income (loss) and the non-controlling interest continues
to be  attributed  its share of losses  even if that  attribution  results  in a
deficit non-controlling interest balance.
REVENUE RECOGNITION
REVENUE RECOGNITION
 
The Company follows  paragraph  605-10-S99-1  of the FASB  Accounting  Standards
Codification for revenue recognition.  The Company recognizes revenue when it is
realized or realizable and earned.  The Company  considers  revenue  realized or
realizable and earned when all of the following criteria are met: (i) persuasive
evidence of an  arrangement  exists,  (ii) the  product has been  shipped or the
services have been  rendered to the customer,  (iii) the sales price is fixed or
determinable, and (iv) collectability is reasonably assured.
RESEARCH AND DEVELOPMENT
RESEARCH AND DEVELOPMENT
 
The Company  follows  paragraph  730-10-25-1  of the FASB  Accounting  Standards
Codification  (formerly  Statement  of  Financial  Accounting  Standards  No.  2
"ACCOUNTING FOR RESEARCH AND DEVELOPMENT  COSTS") and paragraph  730-20-25-11 of
the FASB  Accounting  Standards  Codification  (formerly  Statement of Financial
Accounting  Standards  No.  68  "RESEARCH  AND  DEVELOPMENT  ARRANGEMENTS")  for
research and development  costs.  Research and development  costs are charged to
expense as  incurred.  Research  and  development  costs  consist  primarily  of
remuneration  for research and development  staff,  depreciation and maintenance
expenses of research and development  equipment,  material and testing costs for
research and development as well as research and development  arrangements  with
unrelated third party research and development institutions.
 
NON-REFUNDABLE  ADVANCE  PAYMENTS  FOR  GOODS OR  SERVICES  TO BE USED IN FUTURE
RESEARCH AND DEVELOPMENT ACTIVITIES
 
The research and development  arrangements usually involve specific research and
development  projects.  Often times, the Company makes  non-refundable  advances
upon signing of these arrangements.  The Company adopted paragraph  730-20-25-13
and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging
Issues Task Force Issue No. 07-3 "ACCOUNTING FOR NONREFUNDABLE  ADVANCE PAYMENTS
FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES")
for those non-refundable advances.  Non-refundable advance payments for goods or
services  that will be used or  rendered  for future  research  and  development
activities  are deferred and  capitalized.  Such  amounts are  recognized  as an
expense  as the  related  goods  are  delivered  or  the  related  services  are
performed.  The management  continues to evaluate whether the Company expect the
goods to be  delivered or services to be rendered.  If the  management  does not
expect the goods to be  delivered or services to be  rendered,  the  capitalized
advance payment are charged to expense.
STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES
STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES
 
The  Company  accounts  for its stock  based  compensation  in which the Company
obtains  employee  services  in  share-based  payment   transactions  under  the
recognition and measurement  principles of the fair value recognition provisions
of section 718-10-30 of the FASB Accounting Standards Codification.  Pursuant to
paragraph  718-10-30-6  of  the  FASB  Accounting  Standards  Codification,  all
transactions in which goods or services are the  consideration  received for the
issuance of equity  instruments are accounted for based on the fair value of the
consideration  received  or the fair  value  of the  equity  instrument  issued,
whichever is more reliably  measurable.  The measurement  date used to determine
the fair value of the  equity  instrument  issued is the  earlier of the date on
which the  performance  is  complete  or the date on which it is  probable  that
performance  will occur.  If shares of the Company are thinly  traded the use of
share  prices  established  in  the  Company's  most  recent  private  placement
memorandum  ("PPM"),  or weekly or monthly price observations would generally be
more appropriate  than the use of daily price  observations as such shares could
be artificially inflated due to a larger spread between the bid and asked quotes
and lack of consistent trading in the market.
 
The fair value of non-derivative  option award is estimated on the date of grant
using a Black-Scholes  option-pricing valuation model. The ranges of assumptions
for inputs are as follows:
 
     *    Expected term of share options and similar  instruments:  The expected
          life of options and similar instruments  represents the period of time
          the option and/or warrant are expected to be outstanding.  Pursuant to
          Paragraph   718-10-50-2(f)(2)(i)  of  the  FASB  Accounting  Standards
          Codification   the  expected   term  of  share   options  and  similar
          instruments  represents  the period of time the  options  and  similar
          instruments are expected to be outstanding  taking into  consideration
          of the contractual  term of the  instruments  and employees'  expected
          exercise and  post-vesting  employment  termination  behavior into the
          fair  value (or  calculated  value) of the  instruments.  Pursuant  to
          paragraph  718-10-S99-1,  it may be  appropriate to use the SIMPLIFIED
          METHOD,  I.E.,  EXPECTED TERM = ((VESTING TERM + ORIGINAL  CONTRACTUAL
          TERM) / 2),  if (i) A  company  does  not have  sufficient  historical
          exercise  data to provide a  reasonable  basis upon which to  estimate
          expected term due to the limited period of time its equity shares have
          been publicly traded; (ii) A company  significantly  changes the terms
          of its share  option  grants or the types of  employees  that  receive
          share  option  grants such that its  historical  exercise  data may no
          longer  provide a  reasonable  basis upon which to  estimate  expected
          term; or (iii) A company has or expects to have significant structural
          changes in its business such that its historical  exercise data may no
          longer  provide a  reasonable  basis upon which to  estimate  expected
          term.  The Company uses the  simplified  method to calculate  expected
          term of share options and similar  instruments as the company does not
          have sufficient historical exercise data to provide a reasonable basis
          upon which to estimate expected term.
 
     *    Expected  volatility  of the  entity's  shares and the method  used to
          estimate  it.  Pursuant  to  ASC  Paragraph   718-10-50-2(f)(2)(ii)  a
          thinly-traded  or  nonpublic  entity  that uses the  calculated  value
          method shall  disclose the reasons why it is not  practicable  for the
          Company to estimate the expected  volatility  of its share price,  the
          appropriate  industry  sector index that it has selected,  the reasons
          for  selecting  that  particular  index,  and  how it  has  calculated
          historical  volatility  using that index. The Company uses the average
          historical  volatility of the  comparable  companies over the expected
          contractual  life of the share options or similar  instruments  as its
          expected volatility.  If shares of a company are thinly traded the use
          of  weekly or  monthly  price  observations  would  generally  be more
          appropriate than the use of daily price observations as the volatility
          calculation  using  daily   observations  for  such  shares  could  be
          artificially inflated due to a larger spread between the bid and asked
          quotes and lack of consistent trading in the market.
 
     *    Expected  annual rate of  quarterly  dividends.  An entity that uses a
          method that employs  different  dividend rates during the  contractual
          term  shall  disclose  the range of  expected  dividends  used and the
          weighted-average  expected  dividends.  The expected dividend yield is
          based on the Company's  current dividend yield as the best estimate of
          projected  dividend  yield for periods within the expected term of the
          share options and similar instruments.
 
     *    Risk-free rate(s). An entity that uses a method that employs different
          risk-free  rates shall disclose the range of risk-free rates used. The
          risk-free  interest rate is based on the U.S.  Treasury yield curve in
          effect at the time of grant for periods  within the  expected  term of
          the share options and similar instruments.
 
The  Company's  policy is to  recognize  compensation  cost for awards with only
service  conditions and a graded vesting schedule on a straight-line  basis over
the requisite service period for the entire award.
EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR
EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FOR ACQUIRING GOODS OR
SERVICES
 
The  Company  accounts  for  equity  instruments  issued to  parties  other than
employees for acquiring  goods or services under guidance of Subtopic  505-50 of
the FASB Accounting Standards Codification ("Subtopic 505-50").
 
Pursuant to ASC Section  505-50-30,  all transactions in which goods or services
are the  consideration  received  for the  issuance  of equity  instruments  are
accounted for based on the fair value of the consideration  received or the fair
value of the equity instrument  issued,  whichever is more reliably  measurable.
The measurement  date used to determine the fair value of the equity  instrument
issued is the  earlier of the date on which the  performance  is complete or the
date on which it is  probable  that  performance  will  occur.  If shares of the
Company are thinly traded the use of share prices  established  in the Company's
most recent private  placement  memorandum  ("PPM"),  or weekly or monthly price
observations  would  generally be more  appropriate  than the use of daily price
observations  as such  shares  could be  artificially  inflated  due to a larger
spread  between the bid and asked quotes and lack of  consistent  trading in the
market.
 
The fair value of  non-derivative  option or warrant  award is  estimated on the
date of grant using a Black-Scholes  option-pricing  valuation model. The ranges
of assumptions for inputs are as follows:
 
     *    Expected  term of share options and similar  instruments:  Pursuant to
          Paragraph  718-10-50-2 of the FASB Accounting  Standards  Codification
          the expected term of share options and similar instruments  represents
          the period of time the options and similar instruments are expected to
          be outstanding  taking into  consideration  of the contractual term of
          the instruments and holder's  expected exercise behavior into the fair
          value (or  calculated  value) of the  instruments.  The  Company  uses
          historical data to estimate holder's expected  exercise  behavior.  If
          the Company is a newly formed corporation or shares of the Company are
          thinly  traded the  contractual  term of the share options and similar
          instruments  is used as the expected term of share options and similar
          instruments  as  the  Company  does  not  have  sufficient  historical
          exercise  data to provide a  reasonable  basis upon which to  estimate
          expected term.
 
     *    Expected  volatility  of the  entity's  shares and the method  used to
          estimate  it. An  entity  that uses a method  that  employs  different
          volatilities  during the contractual  term shall disclose the range of
          expected   volatilities   used  and  the   weighted-average   expected
          volatility.   A  thinly-traded  or  nonpublic  entity  that  uses  the
          calculated  value  method  shall  disclose  the  reasons why it is not
          practicable for the Company to estimate the expected volatility of its
          share  price,  the  appropriate  industry  sector  index  that  it has
          selected,  the reasons for selecting that particular index, and how it
          has calculated  historical  volatility  using that index.  The Company
          uses the average  historical  volatility of the  comparable  companies
          over the  expected  contractual  life of the share  options or similar
          instruments  as its  expected  volatility.  If shares of a company are
          thinly  traded the use of weekly or monthly price  observations  would
          generally be more appropriate than the use of daily price observations
          as the volatility calculation using daily observations for such shares
          could be artificially  inflated due to a larger spread between the bid
          and asked quotes and lack of consistent trading in the market.
 
     *    Expected  annual rate of  quarterly  dividends.  An entity that uses a
          method that employs  different  dividend rates during the  contractual
          term  shall  disclose  the range of  expected  dividends  used and the
          weighted-average  expected  dividends.  The expected dividend yield is
          based on the Company's  current dividend yield as the best estimate of
          projected  dividend yield for periods within the expected  contractual
          life of the option and similar instruments.
 
     *    Risk-free rate(s). An entity that uses a method that employs different
          risk-free  rates shall disclose the range of risk-free rates used. The
          risk-free  interest rate is based on the U.S.  Treasury yield curve in
          effect at the time of grant for periods within the contractual life of
          the option and similar instruments.
 
Pursuant to  Paragraphs  505-50-25-8,  if fully vested,  non-forfeitable  equity
instruments  are  issued  at the date the  grantor  and  grantee  enter  into an
agreement  for goods or services  (no  specific  performance  is required by the
grantee to retain those equity instruments), then, because of the elimination of
any obligation on the part of the counterparty to earn the equity instruments, a
measurement  date has  been  reached.  A  grantor  shall  recognize  the  equity
instruments  when they are issued (in most cases,  when the agreement is entered
into). Whether the corresponding cost is an immediate expense or a prepaid asset
(or  whether  the  debit  should be  characterized  as  contra-equity  under the
requirements  of  paragraph  505-50-45-1)  depends  on the  specific  facts  and
circumstances.  Pursuant to ASC  paragraph  505-50-45-1,  a grantor may conclude
that an asset (other than a note or a  receivable)  has been  received in return
for fully vested, non-forfeitable equity instruments that are issued at the date
the grantor and grantee  enter into an agreement  for goods or services  (and no
specific  performance is required by the grantee in order to retain those equity
instruments).  Such an asset  shall not be  displayed  as  contra-equity  by the
grantor of the equity instruments.  The transferability (or lack thereof) of the
equity instruments shall not affect the balance sheet display of the asset. This
guidance is limited to transactions in which equity  instruments are transferred
to other than  employees in exchange for goods or  services.  Section  505-50-30
provides  guidance on the determination of the measurement date for transactions
that are within the scope of this Subtopic.
 
Pursuant to Paragraphs  505-50-25-8  and  505-50-25-9,an  entity may grant fully
vested,  non-forfeitable  equity instruments that are exercisable by the grantee
only after a specified period of time if the terms of the agreement  provide for
earlier exercisability if the grantee achieves specified performance conditions.
Any measured cost of the  transaction  shall be recognized in the same period(s)
and in the same  manner as if the entity had paid cash for the goods or services
or used cash rebates as a sales discount  instead of paying with, or using,  the
equity instruments.  A recognized asset, expense, or sales discount shall not be
reversed  if a stock  option  that the  counterparty  has the right to  exercise
expires unexercised.
 
Pursuant to ASC paragraph  505-50-30-S99-1,  if the Company  receives a right to
receive   future   services  in  exchange  for  unvested,   forfeitable   equity
instruments,  those equity  instruments  are treated as unissued for  accounting
purposes until the future  services are received (that is, the  instruments  are
not  considered  issued  until  they  vest).  Consequently,  there  would  be no
recognition at the measurement date and no entry should be recorded.
INCOME TAX PROVISION
INCOME TAX PROVISION
 
The Company  accounts  for income  taxes  under  Section  740-10-30  of the FASB
Accounting  Standards  Codification,  which requires recognition of deferred tax
assets and liabilities  for the expected future tax  consequences of events that
have been  included  in the  financial  statements  or tax  returns.  Under this
method, deferred tax assets and liabilities are based on the differences between
the financial  statement and tax bases of assets and  liabilities  using enacted
tax  rates in effect  for the year in which  the  differences  are  expected  to
reverse.  Deferred tax assets are reduced by a valuation allowance to the extent
management  concludes  it is more  likely  than not that the assets  will not be
realized.  Deferred tax assets and  liabilities  are measured  using enacted tax
rates expected to apply to taxable income in the years in which those  temporary
differences are expected to be recovered or settled.  The effect on deferred tax
assets  and  liabilities  of  a  change  in  tax  rates  is  recognized  in  the
consolidated  statements of income and comprehensive income (loss) in the period
that includes the enactment date.
 
The  Company  adopted  section  740-10-25  of  the  FASB  Accounting   Standards
Codification   ("Section   740-10-25").    Section   740-10-25   addresses   the
determination of whether tax benefits claimed or expected to be claimed on a tax
return should be recorded in the financial statements.  Under Section 740-10-25,
the Company may recognize the tax benefit from an uncertain tax position only if
it is  more  likely  than  not  that  the tax  position  will  be  sustained  on
examination  by the taxing  authorities,  based on the  technical  merits of the
position.  The tax benefits  recognized in the financial  statements from such a
position should be measured based on the largest benefit that has a greater than
fifty (50)  percent  likelihood  of being  realized  upon  ultimate  settlement.
Section  740-10-25  also provides  guidance on  de-recognition,  classification,
interest  and  penalties  on income  taxes,  accounting  in interim  periods and
requires increased disclosures.
 
The estimated future tax effects of temporary  differences between the tax basis
of assets and liabilities are reported in the accompanying  consolidated balance
sheets,  as well as tax  credit  carry-backs  and  carry-forwards.  The  Company
periodically  reviews the  recoverability of deferred tax assets recorded on its
consolidated  balance  sheets and provides  valuation  allowances  as management
deems necessary.
 
Management makes judgments as to the  interpretation  of the tax laws that might
be  challenged  upon an audit and cause  changes to  previous  estimates  of tax
liability.   In  addition,   the  Company   operates   within   multiple  taxing
jurisdictions  and is subject to audit in these  jurisdictions.  In management's
opinion,  adequate  provisions for income taxes have been made for all years. If
actual  taxable income by tax  jurisdiction  varies from  estimates,  additional
allowances or reversals of reserves may be necessary.
UNCERTAIN TAX POSITIONS
UNCERTAIN TAX POSITIONS
 
The Company did not take any uncertain tax positions and had no  adjustments  to
its income tax  liabilities  or benefits  pursuant to the  provisions of Section
740-10-25 for the interim  period ended December 31, 2012 or for the period from
April 11, 2011 (Inception) through December 31, 2011.
 
LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL
LIMITATION ON UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL
 
Pursuant to the  Internal  Revenue  Code Section 382  ("Section  382"),  certain
ownership changes may subject the NOL's to annual limitations which could reduce
or defer the NOL. Section 382 imposes limitations on a corporation's  ability to
utilize NOLs if it  experiences  an  "ownership  change." In general  terms,  an
ownership  change may result  from  transactions  increasing  the  ownership  of
certain  stockholders  in the stock of a corporation  by more than 50 percentage
points  over  a  three-year  period.  In  the  event  of  an  ownership  change,
utilization of the NOLs would be subject to an annual  limitation  under Section
382  determined  by  multiplying  the  value  of its  stock  at the  time of the
ownership change by the applicable  long-term tax-exempt rate. Any unused annual
limitation may be carried over to later years. The imposition of this limitation
on its ability to use the NOLs to offset future  taxable  income could cause the
Company to pay U.S.  federal income taxes earlier than if such  limitation  were
not in  effect  and  could  cause  such  NOLs  to  expire  unused,  reducing  or
eliminating the benefit of such NOLs.
NET INCOME (LOSS) PER COMMON SHARE
NET INCOME (LOSS) PER COMMON SHARE
 
Net income (loss) per common share is computed  pursuant to section 260-10-45 of
the FASB Accounting Standards  Codification.  Basic net income (loss) per common
share is computed by dividing net income (loss) by the weighted  average  number
of shares of common  stock  outstanding  during the  period.  Diluted net income
(loss)  per common  share is  computed  by  dividing  net  income  (loss) by the
weighted  average number of shares of common stock and  potentially  outstanding
shares of common stock during the period to reflect the potential  dilution that
could occur from common  shares  issuable  through  contingent  shares  issuance
arrangement, stock options or warrants.
 
The following  table shows the  potentially  outstanding  dilutive common shares
excluded from the diluted net income (loss) per common share calculation as they
were anti-dilutive:
 
                                                           Potentially
                                                      Outstanding Dilutive
                                                          Common Shares
                                                   ---------------------------
                                                                    For the
                                                                  Period from
                                                     For the     April 11, 2011
                                                 Interim Period    (inception)
                                                     Ended           through
                                                   December 31,    December 31,
                                                      2012            2011
                                                   ----------       ---------
MAKE GOOD ESCROW SHARES
 
Make Good Escrow  Agreement shares issued and
held with the escrow agent in connection with
the Share Exchange  Agreement  consummated on
June 23, 2011 pending the  achievement by the
Company  of  certain  post-Closing   business
milestones (the "Milestones").                      3,000,000        6,000,000
 
CONVERTIBLE NOTE SHARES
 
On  March  7,  2012,  the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                             426,667              --
 
On  May  30,  2012,   the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                             426,667              --
 
WARRANT SHARES
 
On August 6,  2012,  the  Company  issued (i)
warrants to purchase 1,066,667 shares, in the
aggregate,  of the Company's  common stock to
the investors (the "investors  warrants") and
(ii)  warrants to purchase  85,333  shares of
the  Company's  common stock to the placement
agent (the "agent warrants") with an exercise
price of $0.6405 per share subject to certain
adjustments    pursuant   to   Section   3(b)
Subsequent  Equity  Sales of the SPA expiring
five (5) years from the date of issuance.           1,152,000              --
                                                   ----------      ----------
TOTAL POTENTIALLY OUTSTANDING DILUTIVE
COMMON SHARES                                       5,005,334       6,000,000
                                                   ==========      ==========
CASH FLOWS REPORTING
CASH FLOWS REPORTING
 
The Company adopted  paragraph  230-10-45-24  of the FASB  Accounting  Standards
Codification  for cash flows  reporting,  classifies  cash receipts and payments
according  to  whether  they  stem  from  operating,   investing,  or  financing
activities and provides  definitions of each category,  and uses the indirect or
reconciliation  method ("Indirect method") as defined by paragraph  230-10-45-25
of the FASB  Accounting  Standards  Codification  to  report  net cash flow from
operating  activities  by adjusting  net income to reconcile it to net cash flow
from  operating  activities by removing the effects of (a) all deferrals of past
operating  cash  receipts  and  payments  and all  accruals of  expected  future
operating  cash receipts and payments and (b) all items that are included in net
income that do not affect  operating  cash  receipts and  payments.  The Company
reports the reporting currency  equivalent of foreign currency cash flows, using
the  current  exchange  rate at the time of the cash  flows  and the  effect  of
exchange  rate  changes  on cash held in foreign  currencies  is  reported  as a
separate item in the reconciliation of beginning and ending balances of cash and
cash  equivalents  and  separately  provides  information  about  investing  and
financing  activities  not  resulting in cash receipts or payments in the period
pursuant  to   paragraph   830-230-45-1   of  the  FASB   Accounting   Standards
Codification.
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS
 
The Company  follows the guidance in Section  855-10-50  of the FASB  Accounting
Standards Codification for the disclosure of subsequent events. The Company will
evaluate  subsequent  events through the date when the financial  statements are
issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards  Codification,
the Company as an SEC filer considers its financial  statements issued when they
are widely distributed to users, such as through filing them on EDGAR.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
 
FASB ACCOUNTING STANDARDS UPDATE NO. 2011-08
 
In September  2011,  the FASB issued the FASB  Accounting  Standards  Update No.
2011-08 "INTANGIBLES--GOODWILL AND OTHER: TESTING GOODWILL FOR IMPAIRMENT" ("ASU
2011-08").  This Update is to simplify how public and  nonpublic  entities  test
goodwill  for  impairment.  The  amendments  permit an  entity  to first  assess
qualitative  factors to  determine  whether it is more  likely than not that the
fair value of a reporting  unit is less than its carrying  amount as a basis for
determining  whether it is necessary to perform the two-step goodwill impairment
test described in Topic 350.  Under the amendments in this Update,  an entity is
not required to calculate  the fair value of a reporting  unit unless the entity
determines  that it is more likely than not that its fair value is less than its
carrying amount.
 
The guidance is effective for interim and annual  periods  beginning on or after
December 15, 2011. Early adoption is permitted.
 
FASB ACCOUNTING STANDARDS UPDATE NO. 2011-11
 
In December  2011,  the FASB  issued the FASB  Accounting  Standards  Update No.
2011-11 "BALANCE SHEET:  DISCLOSURES  ABOUT  OFFSETTING  ASSETS AND LIABILITIES"
("ASU 2011-11").  This Update requires an entity to disclose  information  about
offsetting and related  arrangements to enable users of its financial statements
to understand the effect of those  arrangements on its financial  position.  The
objective of this disclosure is to facilitate  comparison between those entities
that prepare  their  financial  statements  on the basis of U.S.  GAAP and those
entities that prepare their financial statements on the basis of IFRS.
 
The amended guidance is effective for annual reporting  periods  beginning on or
after January 1, 2013, and interim periods within those annual periods.
 
FASB ACCOUNTING STANDARDS UPDATE NO. 2012-02
 
In July 2012, the FASB issued the FASB Accounting  Standards  Update No. 2012-02
"INTANGIBLES--GOODWILL AND OTHER (TOPIC 350) TESTING INDEFINITE-LIVED INTANGIBLE
ASSETS FOR IMPAIRMENT" ("ASU 2012-02").
 
This  Update  is  intended  to  reduce  the  cost  and   complexity  of  testing
indefinite-lived  intangible  assets other than  goodwill for  impairment.  This
guidance builds upon the guidance in ASU 2011-08,  entitled TESTING GOODWILL FOR
IMPAIRMENT.  ASU 2011-08 was issued on  September  15, 2011,  and feedback  from
stakeholders  during the  exposure  period  related to the  goodwill  impairment
testing  guidance  was that the  guidance  also would be  helpful in  impairment
testing for intangible assets other than goodwill.
 
The revised  standard allows an entity the option to first assess  qualitatively
whether  it is more  likely  than not  (that  is, a  likelihood  of more than 50
percent)  that  an   indefinite-lived   intangible   asset  is  impaired,   thus
necessitating that it perform the quantitative impairment test. An entity is not
required to calculate the fair value of an indefinite-lived intangible asset and
perform the quantitative impairment test unless the entity determines that it is
more likely than not that the asset is impaired.
 
This Update is effective for annual and interim  impairment  tests  performed in
fiscal years  beginning  after  September 15, 2012.  Earlier  implementation  is
permitted.
OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS
OTHER RECENTLY ISSUED, BUT NOT YET EFFECTIVE ACCOUNTING PRONOUNCEMENTS
 
Management  does  not  believe  that  any  other  recently  issued,  but not yet
effective accounting pronouncements, if adopted, would have a material effect on
the accompanying consolidated financial statements.
XML 52 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
RESEARCH AND DEVELOPMENT
9 Months Ended
Dec. 31, 2012
RESEARCH AND DEVELOPMENT  
RESEARCH AND DEVELOPMENT
NOTE 13 - RESEARCH AND DEVELOPMENT
 
AGRIBUSINESS DEVELOPMENT AGREEMENT - AGRO GENESIS PTE LTD.
 
ENTRY INTO AGRIBUSINESS DEVELOPMENT AGREEMENT
 
On July 16, 2011, the Company entered into an Agribusiness Development Agreement
(the "Agribusiness  Development Agreement") with Agro Genesis Pte Ltd. ("AGPL"),
a corporation organized under the laws of the Republic of Singapore expiring two
(2) years from the date of signing.
 
Under the terms of the Agreement,  the Company  engaged AGPL to be the Company's
technology  provider  consultant  for  stevia  propagation  and  cultivation  in
Vietnam,  and potentially  other  countries for a period of two (2) years.  AGPL
will be tasked with developing stevia propagation and cultivation  technology in
Vietnam,  recommend quality agronomic programs for stevia  cultivation,  harvest
and post harvest,  alert findings on stevia propagation and cultivation that may
impact  profitability  and  develop a  successful  model in Vietnam  that can be
replicated  elsewhere  (the  "Project").  The Project  will be on-site at stevia
fields  in  Vietnam  and will  have a term of at least  two (2)  years.  For its
services,  AGPL could  receive a fee of up to 275,000  Singapore  dollars,  plus
related  expenses  estimated  at  $274,000  as  specified  in  Appendix A to the
Agribusiness  Development  Agreement.  Additionally,  the Company will be AGPL's
exclusive  distributor for AGPL's g'farm system (a novel crop production system)
for stevia growing resulting from the Project. AGPL will receive a commission of
no less than 2% of the price paid for crops  other than  stevia,  from  cropping
systems  that  utilize  the  g'farm  system  resulting  from  the  Project.  All
technology-related  patents  resulting from the Project will be jointly owned by
AGPL and the  Company,  with the Company  holding a right of first offer for the
use and distribution rights to registered patents resulting from the Project.
 
ADDENDUM TO AGRIBUSINESS DEVELOPMENT AGREEMENT
 
On August 26, 2011, in accordance  with Appendix A , 3(a),  the Company and AGPL
have mutually agreed to add to the current Project budget $100,000 per annum for
one, on-site resident AGPL expert for 2 (two) years effective September 1, 2011,
or $200,000 in  aggregate  for the term of the contract as specified in Appendix
C. In-country  accommodation  for the resident expert will be born separately by
the  Company  and is  excluded  from the above  amount.  The  expert,  Dr.  Cho,
Young-Cheol,  Director,  Life  Sciences  has been  appointed  and  commenced  on
September 1, 2011.
 
TERMINATION OF AGRIBUSINESS DEVELOPMENT AGREEMENT
 
On March 31,  2012,  the  Company  and AGPL  mutually  agreed to  terminate  the
Agribusiness Development Agreement, effective immediately.
 
LEASE OF AGRICULTURAL LAND
 
On December  14,  2011,  the Company and Stevia  Ventures  Corporation  ("Stevia
Ventures")  entered into a Land Lease Agreement with Vinh Phuc Province People's
Committee Tam Dao  Agriculture  & Industry  Co.,  Ltd.  pursuant to which Stevia
Ventures  has leased l0  hectares  of land (the  "Leased  Property")  for a term
expiring five (5) years from the date of signing.
 
The Company has begun  development of a research facility on the Leased Property
and has  prepaid  (i) the first year lease  payment of $30,000  and (ii) the six
month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon
signing of the agreement.
 
Future minimum payments  required under this agreement at December 31, 2012 were
as follows:
 
FISCAL YEAR ENDING MARCH 31:
2013 (remainder of the fiscal year)                                     $ 15,000
2014                                                                      30,000
2015                                                                      30,000
2016                                                                      30,000
                                                                        --------
 
                                                                        $105,000
                                                                        ========
 
SUPPLY AND  COOPERATIVE  AGREEMENT -  GUANGZHOU  HEALTH  TECHNOLOGY  DEVELOPMENT
COMPANY LIMITED
 
ENTRY INTO SUPPLY AGREEMENT
 
On February 21, 2012, the Company  entered into a Supply  Agreement (the "Supply
Agreement") with Guangzhou Health China Technology  Development Company Limited,
a  foreign-invested  limited  liability  company  incorporated  in the  People's
Republic of China (the "Guangzhou Health").
 
Under the terms of the Supply Agreement,  the Company will sell dry stevia plant
materials,  including  stems and leaves  ("Product")  exclusively  to  Guangzhou
Health. For the first two years of the agreement, Guangzhou Health will purchase
all  Product  produced  by the  Company.  Starting  with the  third  year of the
agreement,  the  Company  and  Guangzhou  Health  will  review  and agree on the
quantity of Product to be supplied in the forthcoming year, and Guangzhou Health
will be obliged to purchase up to 130 percent of that amount. The specifications
and price of  Product  will also be  revised  annually  according  to the mutual
agreement of the parties. The term of the Supply Agreement is five years with an
option to renew for an additional four years.
 
ENTRY INTO COOPERATIVE AGREEMENT
 
On February 21, 2012, the Company also entered into  Cooperative  Agreement (the
"Cooperative  Agreement") with Guangzhou Health Technology  Development  Company
Limited.
 
Under the terms of the  Cooperative  Agreement,  the  parties  agree to  explore
potential technology partnerships with the intent of formalizing a joint venture
to pursue the most promising technologies and businesses. The parties also agree
to  conduct  trials to test the  efficacy  of  certain  technologies  as applied
specifically  to the Company's  business model as well as the  marketability  of
harvests produced utilizing such  technologies.  Guangzhou Health will share all
available  information  of its  business  structure  and  technologies  with the
Company, subject to the confidentiality provisions of the Cooperative Agreement.
Guangzhou Health will also permit the Company to enter its premises and grow-out
sites for  purposes of  inspection  and will,  as  reasonably  requested  by the
Company,  supply  without  cost,  random  samples of products  and  harvests for
testing.
XML 53 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONVERTIBLE NOTES PAYABLE
9 Months Ended
Dec. 31, 2012
CONVERTIBLE NOTES PAYABLE  
CONVERTIBLE NOTES PAYABLE
NOTE 9 - CONVERTIBLE NOTES PAYABLE
 
On February 14, 2011,  the Company  issued a  convertible  note in the amount of
$250,000  with  interest  at 10% per  annum  due one (1)  year  from the date of
issuance.  On October 4, 2011, the note holder converted the entire principal of
$250,000 and accrued  interest  through the date of  conversion of $15,890.41 to
1,000,000 and 63,561  shares of the  Company's  common stock at $0.25 per share,
respectively.
 
On June 23,  2011,  the  Company  issued a  convertible  note in the  amount  of
$100,000  with  interest  at 10% per  annum  due one (1)  year  from the date of
issuance.  On October 4, 2011, the note holder converted the entire principal of
$100,000 and accrued  interest  through the date of  conversion  of $2,821.92 to
400,000 and 11,288 shares of the Company's common stock at $0.25 per share.
 
On October 4,  2011,  the  Company  issued a  convertible  note in the amount of
$150,000  with  interest  at 10% per  annum  due one (1)  year  from the date of
issuance. On January 18, 2012, the note holder converted the entire principal of
$150,000  and  accrued  interest  through  the date of  conversion  of $4,356 to
617,425 shares of the Company's common stock at $0.25 per share.
 
Convertible notes payable consisted of the following:
 
                                                 December 31,          March 31,
                                                    2012                 2012
                                                  --------             --------
On November  16, 2011,  the Company  issued a
convertible  note in the  amount of  $250,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion  price  to  be  the  same  as  the
private  placement price on a per share basis
provided  the  Company   complete  a  private
placement  with  gross  proceeds  of at least
$100,000.  On July 6, 2012,  the note  holder
converted  the entire  principal  of $250,000
and  accrued  interest  through  the  date of
conversion  of $15,959  to 319,607  shares of
the  Company's  common  stock  at  $0.83  per
share.                                                   --             250,000
 
On January 16,  2012,  the  Company  issued a
convertible  note in the  amount of  $250,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion  price  to  be  the  same  as  the
private  placement price on a per share basis
provided  the  Company   complete  a  private
placement  with  gross  proceeds  of at least
$100,000.  On July 6, 2012,  the note  holder
converted  the entire  principal  of $250,000
and  accrued  interest  through  the  date of
conversion  of $11,781  to 314,586  shares of
the  Company's  common  stock  at  $0.83  per
share.                                                   --             250,000
 
On  March  7,  2012,  the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                           200,000             200,000
 
On  May  30,  2012,   the  Company  issued  a
convertible  note in the  amount of  $200,000
with  interest  at 10% per  annum due one (1)
year  from  the  date of  issuance  with  the
conversion price to be at $0.46875 per share,
at which  the  Company  completed  a  private
placement  with  gross  proceeds  of at least
$100,000  on August 6, 2012,  the same as the
next private  placement  price on a per share
basis provided the Company complete a private
placement  with  gross  proceeds  of at least
$100,000.                                           200,000                  --
                                                   --------            --------
 
                                                   $400,000            $700,000
                                                   ========            ========
XML 54 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
WEBSITE DEVELOPMENT COSTS
9 Months Ended
Dec. 31, 2012
WEBSITE DEVELOPMENT COSTS  
WEBSITE DEVELOPMENT COSTS
NOTE 7 - WEBSITE DEVELOPMENT COSTS
 
Website  development  costs,  stated  at  cost,  less  accumulated  amortization
consisted of the following:
 
                                   Estimated
                                  Useful Life      December 31,       March 31,
                                    (Years)           2012              2012
                                    -------        ----------        ----------
Website development costs              5           $    5,315        $    5,315
Accumulated amortization                               (1,602)             (801)
                                                   -----------       ----------
 
                                                   $    3,713        $    4,514
                                                   ==========        ==========
 
AMORTIZATION EXPENSE
 
Amortization expense was $801 and $534 for the interim period ended December 31,
2012 and for the period from April 11, 2011  (inception)  through  December  31,
2011, respectively.
XML 55 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS
9 Months Ended
Dec. 31, 2012
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS
NOTE 8 - RELATED PARTY TRANSACTIONS
 
RELATED PARTIES
 
Related parties with whom the Company had transactions are:
 
Related Parties                               Relationship
---------------                               ------------
George Blankenbaker             President and significant stockholder of the
                                Company
 
Leverage Investments LLC        An entity owned and controlled by the president
                                and significant stockholder of the Company
 
Technew Technology Limited      Non-controlling interest holder
 
Growers Synergy Pte Ltd.        An entity owned and controlled by the president
                                and significant stockholder of the Company
 
Guangzhou Health Technology     An entity owned and controlled by
Development Company Limited     Non-controlling interest holder
 
ADVANCES FROM STOCKHOLDER
 
From time to time,  stockholder of the Company advances funds to the Company for
working capital purpose. Those advances are unsecured,  non-interest bearing and
due on demand.
 
LEASE OF CERTAIN OFFICE SPACE FROM LEVERAGE INVESTMENTS, LLC
 
The Company leases certain office space with Leverage Investments,  LLC for $500
per month on a  month-to-month  basis since July 1, 2011. For the interim period
ended  December  31,  2012,  the Company  recorded  $4,500 in rent  expenses due
Leverage Investment LLC.
 
FARM MANAGEMENT AND OFF-TAKE AGREEMENT WITH GROWERS SYNERGY PTE LTD.
 
For the Period from July 1, 2011 through  October 31, 2011, the Company  engaged
Growers Synergy Pte Ltd. to provide farm management services on a month-to-month
basis, at $20,000 per month.
 
On  November  1, 2011,  the  Company  entered  into a  Management  and  Off-Take
Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a
Singapore   corporation   owned  and  controlled  by  the  president  and  major
stockholder  of the Company.  Under the terms of the Management  Agreement,  the
Company will engage GSPL to supervise the Company's farm management  operations,
recommend quality farm management programs for stevia cultivation, assist in the
hiring  of  employees  and  provide  training  to  help  the  Company  meet  its
commercialization   targets,  develop  successful  models  to  propagate  future
agribusiness  services,  and provide back-office and regional logistical support
for the development of proprietary stevia farm systems in Vietnam, Indonesia and
potentially  other  countries.  GSPL will provide services for a term of two (2)
years from the date of signing,  at $20,000 per month. The Management  Agreement
may be  terminated  by the Company upon 30 day notice.  In  connection  with the
Management  Agreement,  the parties  agreed to enter into an off-take  agreement
whereby  GSPL agreed to purchase  all of the  non-stevia  crops  produced at the
Company's GSPL supervised farms.
 
Farm management services provided by Growers Synergy Pte Ltd. is as follows:
 
                                                                     For the
                                                                   Period from
                                                   For the        April 11, 2011
                                                Interim Period      (inception)
                                                    Ended            through
                                                 December 31,      December 31,
                                                     2012              2011
                                                   --------          --------
Farm management services received and
 farm management services booked                   $180,000          $     --
                                                   --------          --------
 
                                                   $180,000          $     --
                                                   ========          ========
 
 
Future minimum payments  required under this agreement at December 31, 2012 were
as follows:
 
Fiscal Year Ending March 31:
  2013 (remainder of the fiscal year)                                $ 60,000
  2014                                                                140,000
                                                                     --------
 
                                                                     $200,000
                                                                     ========
 
CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW
 
On  July 5,  2012,  Stevia  Asia,  entered  into a  Cooperative  Agreement  (the
"Cooperative Agreement") with Technew Technology Limited ("Technew"),  a company
incorporated  under the  companies  ordinance  of Hong Kong and an  associate of
Guangzhou Health China Technology  Development Company Limited, and Zhang Jia, a
Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia
Asia and Partners have agreed to make Stevia Technew, a joint venture,  of which
Stevia Asia legally and beneficially  owns 70% shares  (representing  70% of the
issued   shares)  and  Technew   legally  and   beneficially   owns  30%  shares
(representing 30% of the of the issued shares). The Partners will be responsible
for managing  Stevia Technew and Stevia Asia has agreed to provide  $200,000 per
month,  up to a total of $2,000,000 in financing,  subject to the performance of
Stevia Technew and Stevia Asia's financial capabilities.
 
For the interim  period ended  December 31, 2012,  Stevia Asia  provided  Stevia
Technew  $230,000,  all of which has been paid to Guangzhou  Health and expended
and recorded as farm management services - related party.
XML 56 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Dec. 31, 2012
DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS  
DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS
NOTE 10 - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS
 
(I)  WARRANTS ISSUED ON AUGUST 6, 2012
 
DESCRIPTION OF WARRANTS AND FAIR VALUE ON DATE OF GRANT
 
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares,
in the aggregate, of the Company's common stock to the investors (the "investors
warrants") and (ii) warrants to purchase  85,333 shares of the Company's  common
stock to the placement  agent (the "agent  warrants")  with an exercise price of
$0.6405  per share  subject  to certain  adjustments  pursuant  to Section  3(b)
Subsequent  Equity  Sales of the SPA  expiring  five (5) years  from the date of
issuance.
 
DERIVATIVE ANALYSIS
 
The exercise price of August 6, 2012 warrants and the number of shares  issuable
upon exercise is subject to reset adjustment in the event of stock splits, stock
dividends,  recapitalization,  most favored nation clause and similar  corporate
events.  Pursuant to the Section 3(b) Subsequent Equity Sales of the SPA, if the
Company issues any common stock or securities other than the excepted issuances,
to any person or entity at a purchase or exercise  price per share less than the
share purchase price of the August 6, 2012 Unit Offering  without the consent of
the  subscriber  holding  purchased  shares,  warrants or warrant  shares of the
August 6, 2012 Unit Offering,  then the subscriber shall have the right to apply
the lowest such purchase price or exercise price of the offering or sale of such
new  securities to the purchase  price of the purchased  shares then held by the
subscriber (and, if necessary,  the Company will issue additional  shares),  the
reset adjustments are also referred to as full reset adjustments.
 
Because these warrants have full reset  adjustments  tied to future issuances of
equity  securities  by the  Company,  they are subject to  derivative  liability
treatment under Section 815-40-15 of the FASB Accounting  Standard  Codification
("Section  815-40-15")  (FORMERLY FASB EMERGING ISSUES TASK FORCE ("EITF") ISSUE
NO. 07-5:  DETERMINING WHETHER AN INSTRUMENT (OR EMBEDDED FEATURE) IS INDEXED TO
AN ENTITY'S OWN STOCK ("EITF  07-5"))).  Section  815-40-15  became effective on
January 1, 2009 and the Warrants issued in the August 6, 2012 Unit Offering have
been measured at fair value using a Lattice model at each reporting  period with
gains  and  losses  from the  change  in fair  value of  derivative  liabilities
recognized on the consolidated statement of income and comprehensive income.
 
VALUATION OF DERIVATIVE LIABILITY
 
(A) VALUATION METHODOLOGY
 
The  Company's  August 6,  2012  warrants  do not trade in an active  securities
market,  as such,  the  Company  developed  a  Lattice  model  that  values  the
derivative  liability of the warrants based on a probability weighted discounted
cash flow  model.  This  model is based on  future  projections  of the  various
potential  outcomes.  The features that were analyzed and incorporated  into the
model included the exercise feature and the full ratchet reset.
 
Based on these features, there are two primary events that can occur; the Holder
exercises  the  Warrants  or the  Warrants  are held to  expiration.  The  model
analyzed the underlying  economic  factors that influenced which of these events
would occur,  when they were likely to occur,  and the specific terms that would
be in effect at the time (i.e. stock price, exercise price,  volatility,  etc.).
Projections  were then made on these  underlying  factors  which led to a set of
potential  scenarios.  As the result of the large Warrant  overhang we accounted
for the dilution affects, volatility and market cap to adjust the projections.
 
Probabilities  were  assigned  to each of these  scenarios  based on  management
projections.  This led to a cash flow  projection  and a probability  associated
with that cash flow.  A discounted  weighted  average cash flow over the various
scenarios  was  completed  to  determine  the  value of the  derivative  warrant
liability.
 
(B) VALUATION ASSUMPTIONS
 
The Company's  2012  derivative  warrants were valued at each period ending date
with the following assumptions:
 
     *    The stock price would fluctuate with the Company projected volatility.
 
     *    The  stock  price  would  fluctuate  with an  annual  volatility.  The
          projected volatility curve was based on historical volatilities of the
          Company for the valuation periods.
 
     *    The Holder  would  exercise  the  warrant as they  become  exercisable
          (effective  registration  is projected 4 months from  issuance and the
          earliest  exercise  is  projected  180 days from  issuance)  at target
          prices of 2 times the  higher of the  projected  reset  price or stock
          price.
 
     *    The Holder  would  exercise the warrant at maturity if the stock price
          was above the project reset prices.
 
     *    A 100%  probability  of a reset event and a projected  financing  each
          quarter for 3 years at prices approximating 93% of market
 
     *    The 1,066,667 Investor Warrants $0.6405 exercise price is projected to
          reset from $0.87 to $0.192 at maturity; and the 85,333 Placement Agent
          Warrants  $0.6405  exercise  price is projected to reset from $0.87 to
          $0.192 at maturity;
 
     *    No warrants have been exercised or expired.
 
     *    The projected volatility curve for the valuation dates was:
 
                        1 Year      2 Year      3 Year      4 Year      5 Year
                        ------      ------      ------      ------      ------
August 6, 2012           129%        178%        218%        252%        281%
 
September 30, 2012       127%        173%        211%        244%        272%
 
December 31, 2012        126%        167%        204%        235%        263%
 
(C) FAIR VALUE OF DERIVATIVE WARRANTS
 
The table below provides a summary of the fair value of the  derivative  warrant
liability  and the  changes  in the fair  value of the  derivative  warrants  to
purchase 1,152,000 shares of the Company's common stock, including net transfers
in and/or  out,  of  derivative  warrants  measured at fair value on a recurring
basis using significant unobservable inputs (Level 3).
 
                                                    Fair Value Measurement
                                                     Using Level 3 Inputs
                                                 ----------------------------
                                                 Derivative
                                               warrants Assets
                                                 (Liability)            Total
                                                 -----------            -----
Balance, August 6, 2012                           $(411,805)          $(411,805)
Total gains or losses
 (realized/unrealized) included in:
   Net income (loss)                                231,521             231,521
   Other comprehensive income (loss)                     --                  --
   Purchases, issuances and settlements                  --                  --
   Transfers in and/or out of Level 3                    --                  --
                                                 ---------           ---------
Balance, August 6, 2012                            (180,284)           (180,284)
Total gains or losses
 (realized/unrealized) included in:
   Net income (loss)                                 73,723              73,723
   Other comprehensive income (loss)                     --                  --
   Purchases, issuances and settlements                  --                  --
  Transfers in and/or out of Level 3                     --                  --
                                                  ---------           ---------
 
Balance, December 31, 2012                        $(106,561)          $(106,561)
                                                  =========           =========
(D) WARRANTS OUTSTANDING
 
As of December 31, 2012 no warrants have been exercised and warrants to purchase
1,152,000 shares of Company common stock remain outstanding.
 
The table below summarizes the Company's derivative warrant activity
 
                                                  2012 Warrant Activities                              Apic          (Gain) Loss
                                  ----------------------------------------------------------         ---------        ----------
                                                                                                  Reclassification
                                                                  Total         Fair Value of      Change in of      Fair Value of
                                Derivative     Non-derivative    Warrant           Derivative       Derivative        Derivative
                                  Shares           Shares        Shares             Warrants         Liability        Liability
                                  ------           ------        ------             --------         ---------        ---------
                                                                                                      
Derivative warrant at
 August 6, 2012                  1,152,000           --         1,152,000           (411,805)             --                 --
Mark to market                                                                       231,521                           (231,521)
Derivative warrant at
 September 30, 2012              1,152,000           --         1,152,000           (180,284)                          (231,521)
Mark to market                                                                        73,723                            (73,723)
Derivative warrant at
 December 31, 2012               1,152,000           --         1,152,000           (106,561)                          (305,244)
 
(II) WARRANT ACTIVITIES
 
The table below summarizes the Company's warrant activities through December 31,
2012:
 
SUMMARY OF THE COMPANY'S WARRANT ACTIVITIES
 
The table below summarizes the Company's warrant activities:
 
                                 Number of         Exercise      Weighted Average   Fair Value at     Aggregate
                                  Warrant         Price Range       Exercise           Rate of        Intrinsic
                                  Shares           Per Share          Price           Issuance          Value
                                  ------           ---------          -----           --------          -----
Balance, March 31, 2012                 --          $    --          $    --          $      --          $ --
Granted                          1,152,000           0.6405           0.6405            411,805            --
Canceled                                --               --               --                 --            --
Exercised                               --               --               --                 --            --
Expired                                 --               --               --                 --            --
                                 ---------          -------          -------          ---------          ----
Balance, December 31, 2012       1,152,000           0.6405           0.6405            411,805            --
 
Earned and exercisable,
 December 31, 2012               1,152,000           0.6405           0.6405            411,805            --
                                 ---------          -------          -------          ---------          ----
 
Unvested, December 31, 2012             --          $    --          $    --          $      --          $ --
                                 ---------          -------          -------          ---------          ----
 
The  following  table   summarizes   information   concerning   outstanding  and
exercisable warrants as of December 31, 2012:
 
                         Warrants Outstanding                     Warrants Exercisable
                  ----------------------------------       -----------------------------------
                                 Average                                  Average
                                Remaining     Weighted                   Remaining     Weighted
                               Contractual    Average                   Contractual    Average
Range of            Number         Life       Exercise       Number        Life        Exercise
Exercise Prices   Outstanding   (in years)     Price       Exercisable   (in years)     Price
---------------   -----------   ----------     -----       -----------   ----------     -----
                                                                     
$0.6405            1,152,000       4.60       $ 0.6405      1,152,000      4.60        $0.6405
-------            ---------       ----       --------      ---------      ----        -------
 
$0.6405            1,152,000       4.60       $ 0.6405      1,152,000      4.60        $0.6405
=======            =========       ====       ========      =========      ====        =======
XML 57 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
RESEARCH AND DEVELOPMENT (Tables)
9 Months Ended
Dec. 31, 2012
RESEARCH AND DEVELOPMENT (Tables)  
Future minimum payments
Future minimum payments  required under this agreement at December 31, 2012 were
as follows:
 
FISCAL YEAR ENDING MARCH 31:
2013 (remainder of the fiscal year)                                     $ 15,000
2014                                                                      30,000
2015                                                                      30,000
2016                                                                      30,000
                                                                        --------
 
                                                                        $105,000
                                                                        ========
XML 58 R51.htm IDEA: XBRL DOCUMENT v2.4.0.6
RESEARCH AND DEVELOPMENT PAYMENTS (Details) (USD $)
Dec. 31, 2012
AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated $ 274,000
Percentage of commission not less than 2.00%
First year lease payment 30,000
Six month lease payment 15,000
Aggregate security deposit 45,000
Future Minimum payments for the fiscal year 2013 15,000
Future Minimum payments for the fiscal year 2014 30,000
Future Minimum payments for the fiscal year 2015 30,000
Future Minimum payments for the fiscal year 2016 30,000
Future Minimum payments total $ 105,000
XML 59 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONCENTRATIONS AND CREDIT RISK
9 Months Ended
Dec. 31, 2012
CONCENTRATIONS AND CREDIT RISK  
CONCENTRATIONS AND CREDIT RISK
NOTE 15 - CONCENTRATIONS AND CREDIT RISK
 
CREDIT RISK
 
Financial  instruments  that  potentially  subject  the  Company to  significant
concentration of credit risk consist primarily of cash and cash equivalents.
 
As of  December  31,  2012,  substantially  all of the  Company's  cash and cash
equivalents  were  held by major  financial  institutions,  and the  balance  at
certain  accounts  exceeded the maximum amount  insured by the Federal  Deposits
Insurance Corporation ("FDIC").  However, the Company has not experienced losses
on these  accounts and  management  believes  that the Company is not exposed to
significant risks on such accounts.
 
CUSTOMERS AND CREDIT CONCENTRATIONS
 
One (1)  customer  accounted  for all of the sales for the interim  period ended
December  31, 2012 and  accounts  receivable  balances at December  31,  2012. A
reduction in sales from or loss of such customer  would have a material  adverse
effect on the Company's results of operations and financial condition.
 
VENDORS AND ACCOUNTS PAYABLE CONCENTRATIONS
 
Vendor  purchase  concentrations  and  accounts  payable  concentration  are  as
follows:
 
                                                 Accounts Payable at                  Net Purchases
                                                ---------------------             ----------------------
                                                                                                 For the
                                                                                               Period from
                                                                                 For the      April 11, 2011
                                                                              Interim Period   (inception)
                                                                                  Ended          through
                                              December 31,    March 31,        December 31,    December 31,
                                                 2012           2012               2012            2011
                                                ------         ------             ------          ------
 
Growers Synergy Pte. Ltd. - related party         42.5%          16.4%              49.8%             --%
tevia Ventures Corporation                         3.7%          54.1%              10.3%             --%
                                                ------         ------             ------          ------
                                                  46.2%          70.5%              60.1%             --%
                                                ======         ======             ======          ======
 
XML 60 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
PROPERTY AND EQUIPMENT (Tables)
9 Months Ended
Dec. 31, 2012
PROPERTY AND EQUIPMENT (Tables)  
Property and equipment
Property and equipment,  stated at cost, less accumulated depreciation consisted
of the following:
 
                                   Estimated
                                  Useful Life      December 31,        March 31,
                                    (Years)           2012               2012
                                    -------         --------           --------
Property and equipment                 5            $  7,925           $  3,036
Less accumulated depreciation                           (762)                --
                                                    --------           --------
 
                                                    $  7,163           $  3,036
                                                    ========           ========
XML 61 R49.htm IDEA: XBRL DOCUMENT v2.4.0.6
OUTSTANDING AND EXERCISABLE WARRANTS (Details)
Dec. 31, 2012
Warrants Outstanding Number Outstanding
 
Range of Exercise Prices 0.6405 1,152,000
Range of Exercise Prices 0.6405 1,152,000
Range of Exercise Prices 0.6405. 1,152,000
Warrants Outstanding Average Remaining Contractual Life (in years)
 
Range of Exercise Prices 0.6405 4.60
Range of Exercise Prices 0.6405 4.60
Range of Exercise Prices 0.6405. 4.60
Warrants Outstanding Weighted Average Exercise Price
 
Range of Exercise Prices 0.6405 0.6405
Range of Exercise Prices 0.6405 0.6405
Range of Exercise Prices 0.6405. 0.6405
Warrants Exercisable Number Exercisable
 
Range of Exercise Prices 0.6405 1,152,000
Range of Exercise Prices 0.6405 1,152,000
Range of Exercise Prices 0.6405. 1,152,000
Warrants Exercisable Average Remaining Contractual Life (in years)
 
Range of Exercise Prices 0.6405 4.60
Range of Exercise Prices 0.6405 4.60
Range of Exercise Prices 0.6405. 4.60
Warrants Exercisable Weighted Average Exercise Price
 
Range of Exercise Prices 0.6405 0.6405
Range of Exercise Prices 0.6405 0.6405
Range of Exercise Prices 0.6405. 0.6405
XML 62 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS FUTURE MINIMUM PAYMENTS (Details) (USD $)
Dec. 31, 2012
2013 (remainder of the fiscal year) $ 120,000
2014 140,000
Total future payments $ 260,000
XML 63 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statement of Equity (Deficit) (USD $)
Common Stock, $0.001 Par Value Number of Shares
Common Stock, $0.001 Par Value Amount
USD ($)
Additional paid-in Capital
USD ($)
Accumulated Deficit
USD ($)
Total STEV Stockholders Equity (Deficit)
USD ($)
Non- controlling Interest
USD ($)
Total Equity (Deficit)
USD ($)
Balance at Apr. 10, 2011 6,000,000 6,000 (5,900) 0 100 0 100
Common shares deemed issued in reverse acquisition 79,800,000 79,800 (198,088) 0 (118,288) 0 (118,288)
Common shares cancelled in reverse acquisition (33,000,000) (33,000) 33,000 0 0 0 0
Common shares issued for cash at $0.25 per share on October 04, 2011 400,000 400 99,600 0 100,000 0 100,000
Common shares issued for notes conversion at $0.25 per share on October 4, 2011 1,400,000 1,400 348,600 0 350,000 0 350,000
Common shares issued for conversion of accrued interest at $0.25 per share on October 4, 2011 74,850 75 18,638 0 18,713 0 18,713
Common shares cancelled by significant stockholder on October 4, 2011 (3,000,000) (3,000) 3,000 0 0 0 0
Common shares issued for future director services on October 4, 2011 3,000,000 3,000 747,000 0 750,000 0 750,000
Common shares issued for future director services on October 4, 2011.   $ 0 $ (750,000) $ 0 $ (750,000) $ 0 $ (750,000)
Common shares issued for future director services on October 4, 2011 earned during the period.     187,500 0 187,500 0 187,500
Make good shares released to officer for achieving the first milestone on December 23, 2011 3,000,000 3,000 747,000 0 750,000 0 750,000
Common shares issued for notes conversion at $0.25 per share on January 18, 2012 600,000 600 149,400 0 150,000 0 150,000
Common shares issued for conversion of accrued interest at $0.25 per share on January 18, 2012 17,425 17 4,339 0 4,356 0 4,356
Common shares issued for financing services upon agreement at $1.50 per share on January 26, 2012 35,000 35 52,465 0 52,500 0 52,500
Common shares issued for consulting services at $1.39 per share on March 31, 2012 27,500 28 38,197 0 38,225 0 38,225
Net loss.   0 (2,323,551) (2,323,551) 0 (2,323,551)  
Balance at Mar. 31, 2012 58,354,775 58,355 1,474,751 (2,323,551) (790,445) 0 (790,445)
Restricted common shares issued for farm management services to a related party valued at $0.79 per share discounted at 69% on July 5, 2012 500,000 500 272,050 0 272,550 0 272,550
Restriced common shares issued for technology rights valued at $0.79 per share discounted 69% on July 5, 2012 3,000,000 3,000 1,632,300 0 1,635,300 0 1,635,300
Common shares issued for notes conversion at $0.832143 per share on July 6, 2012 600,858 601 499,399 0 500,000 0 500,000
Common shares issued for conversion of accrued interest at $0.832143 per share on July 6, 2012 33,335 33 27,706 0 27,739 0 27,739
Common shares and warrants issued for cash to two investors at $0.46875 per unit on August 6, 2012 1,066,667 1,067 498,933 0 500,000 0 500,000
Warrants issued to investors in connection with the sale of equity units on August 6, 2012   0 (381,301) (381,301) (381,301)    
Commissions and legal fees in connection with the stock sales on August 6, 2012   0 (52,500) 0 (52,500) 0 (52,500)
Warrants issued to placement agent in connection with the sale of equity units on August 6, 2012   0 (30,504) 0 (30,504) 0 (30,504)
Common shares issued for future director services on October 4, 2011 earned during the period   0 281,250 0 281,250 0 281,250
Net loss,   $ 0 $ 0 $ (1,342,473) $ (1,342,473) $ (97,338) $ (1,439,811)
Balance at Dec. 31, 2012 63,555,635 63,556 4,222,085 (3,666,024) 619,617 (97,338) 522,279
XML 64 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
PREPAID EXPENSES
9 Months Ended
Dec. 31, 2012
PREPAID EXPENSES  
PREPAID EXPENSES
NOTE 4 - PREPAID EXPENSES
 
Prepaid expenses consisted of the following:
 
                                                  December 31,         March 31,
                                                      2012               2012
                                                    --------           --------
Prepaid research and development                    $ 23,336           $128,445
Prepaid rent                                              --             21,250
Retainer                                                  --             15,000
Other                                                  2,680              4,179
                                                    --------           --------
 
                                                    $ 26,016           $168,874
                                                    ========           ========
XML 65 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACQUIRED TECHNOLOGY (Tables)
9 Months Ended
Dec. 31, 2012
ACQUIRED TECHNOLOGY (Tables)  
Company Acquired The Rights to Technology
                                   Estimated
                                  Useful Life      December 31,       March 31,
                                    (Years)           2012              2012
                                    -------        ----------        ----------
Technology right                      15           $1,635,300        $       --
Less accumulated amortization                         (54,510)               --
                                                   ----------        ----------
 
                                                   $1,580,790        $       --
                                                   ==========        ==========
XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 86 317 1 false 22 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.steviacorp.com/20121231/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - Consolidated Balance Sheets Sheet http://www.steviacorp.com/20121231/role/idr_ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 000030 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.steviacorp.com/20121231/role/idr_ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals false false R4.htm 000040 - Statement - Consolidated Statements of Operations Sheet http://www.steviacorp.com/20121231/role/idr_ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 000050 - Statement - Consolidated Statement of Equity (Deficit) {Stock Holders} Sheet http://www.steviacorp.com/20121231/role/idr_ConsolidatedStatementOfEquityDeficitStockHolders Consolidated Statement of Equity (Deficit) false false R6.htm 000060 - Statement - Consolidated Statements of Cash Flows Sheet http://www.steviacorp.com/20121231/role/idr_ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R7.htm 000070 - Disclosure - ORGANIZATION AND OPERATIONS Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureORGANIZATIONANDOPERATIONS ORGANIZATION AND OPERATIONS false false R8.htm 000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 000090 - Disclosure - GOING CONCERN Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureGOINGCONCERN GOING CONCERN false false R10.htm 000100 - Disclosure - PREPAID EXPENSES Sheet http://www.steviacorp.com/20121231/role/idr_DisclosurePREPAIDEXPENSES PREPAID EXPENSES false false R11.htm 000110 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.steviacorp.com/20121231/role/idr_DisclosurePROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT false false R12.htm 000120 - Disclosure - ACQUIRED TECHNOLOGY Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureACQUIREDTECHNOLOGY ACQUIRED TECHNOLOGY false false R13.htm 000130 - Disclosure - WEBSITE DEVELOPMENT COSTS Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureWEBSITEDEVELOPMENTCOSTS WEBSITE DEVELOPMENT COSTS false false R14.htm 000140 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS false false R15.htm 000150 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://www.steviacorp.com/20121231/role/idr_DisclosureCONVERTIBLENOTESPAYABLE CONVERTIBLE NOTES PAYABLE false false R16.htm 000160 - Disclosure - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureDERIVATIVEINSTRUMENTSANDTHEFAIRVALUEOFFINANCIALINSTRUMENTS DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS false false R17.htm 000170 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureSTOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY false false R18.htm 000180 - Disclosure - NON-CONTROLLING INTEREST Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureNONCONTROLLINGINTEREST NON-CONTROLLING INTEREST false false R19.htm 000190 - Disclosure - RESEARCH AND DEVELOPMENT Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureRESEARCHANDDEVELOPMENT RESEARCH AND DEVELOPMENT false false R20.htm 000200 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES false false R21.htm 000210 - Disclosure - CONCENTRATIONS AND CREDIT RISK Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureCONCENTRATIONSANDCREDITRISK CONCENTRATIONS AND CREDIT RISK false false R22.htm 000220 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureSUBSEQUENTEVENTS SUBSEQUENT EVENTS false false R23.htm 000230 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R24.htm 000240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R25.htm 000250 - Disclosure - PREPAID EXPENSES. (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosurePREPAIDEXPENSESTables PREPAID EXPENSES. (Tables) false false R26.htm 000260 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosurePROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) false false R27.htm 000270 - Disclosure - ACQUIRED TECHNOLOGY (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureACQUIREDTECHNOLOGYTables ACQUIRED TECHNOLOGY (Tables) false false R28.htm 000280 - Disclosure - WEBSITE DEVELOPMENT COSTS (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureWEBSITEDEVELOPMENTCOSTSTables WEBSITE DEVELOPMENT COSTS (Tables) false false R29.htm 000290 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureRELATEDPARTYTRANSACTIONSTables RELATED PARTY TRANSACTIONS (Tables) false false R30.htm 000300 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) Notes http://www.steviacorp.com/20121231/role/idr_DisclosureCONVERTIBLENOTESPAYABLETables CONVERTIBLE NOTES PAYABLE (Tables) false false R31.htm 000310 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureDERIVATIVEINSTRUMENTSTables DERIVATIVE INSTRUMENTS (Tables) false false R32.htm 000320 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureSTOCKHOLDERSEQUITYTables STOCKHOLDERS' EQUITY (Tables) false false R33.htm 000330 - Disclosure - NON-CONTROLLING INTEREST (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureNONCONTROLLINGINTERESTTables NON-CONTROLLING INTEREST (Tables) false false R34.htm 000340 - Disclosure - RESEARCH AND DEVELOPMENT (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureRESEARCHANDDEVELOPMENTTables RESEARCH AND DEVELOPMENT (Tables) false false R35.htm 000350 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Tables) Sheet http://www.steviacorp.com/20121231/role/idr_DisclosureCONCENTRATIONSANDCREDITRISKTables CONCENTRATIONS AND CREDIT RISK (Tables) false false R36.htm 000360 - Statement - ORGANIZATION AND OPERATIONS (Details) Sheet http://www.steviacorp.com/20121231/role/idr_ORGANIZATIONANDOPERATIONSDetails ORGANIZATION AND OPERATIONS (Details) false false R37.htm 000370 - Statement - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) Sheet http://www.steviacorp.com/20121231/role/idr_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETINCOMELOSSPERCOMMONSHAREDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) false false R38.htm 000380 - Statement - GOING CONCERN (Details) Sheet http://www.steviacorp.com/20121231/role/idr_GOINGCONCERNDetails GOING CONCERN (Details) false false R39.htm 000390 - Statement - ENTITY'S ASSETS (Details) Sheet http://www.steviacorp.com/20121231/role/idr_ENTITYSASSETSDetails ENTITY'S ASSETS (Details) false false R40.htm 000400 - Statement - AMORTIZATION AND DEPRECIATION EXPENSE (Details) Sheet http://www.steviacorp.com/20121231/role/idr_AMORTIZATIONANDDEPRECIATIONEXPENSEDetails AMORTIZATION AND DEPRECIATION EXPENSE (Details) false false R41.htm 000420 - Statement - RELATED PARTY TRANSACTIONS FUTURE MINIMUM PAYMENTS (Details) Sheet http://www.steviacorp.com/20121231/role/idr_RELATEDPARTYTRANSACTIONSFUTUREMINIMUMPAYMENTSDetails RELATED PARTY TRANSACTIONS FUTURE MINIMUM PAYMENTS (Details) false false R42.htm 000450 - Statement - CONVERTIBLE NOTES PAYABLE (Details) Notes http://www.steviacorp.com/20121231/role/idr_CONVERTIBLENOTESPAYABLEDetails CONVERTIBLE NOTES PAYABLE (Details) false false R43.htm 000460 - Statement - CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES (Details) Notes http://www.steviacorp.com/20121231/role/idr_CONVERTIBLENOTESPAYABLEONVARIOUSDATESDetails CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES (Details) false false R44.htm 000470 - Statement - SHARES AUTHORIZED AND TRANSACTION (Details) Sheet http://www.steviacorp.com/20121231/role/idr_SHARESAUTHORIZEDANDTRANSACTIONDetails SHARES AUTHORIZED AND TRANSACTION (Details) false false R45.htm 000480 - Statement - COMMON SHARES ISSUED FOR SERVICES (Details) Sheet http://www.steviacorp.com/20121231/role/idr_COMMONSHARESISSUEDFORSERVICESDetails COMMON SHARES ISSUED FOR SERVICES (Details) false false R46.htm 000530 - Statement - ENTRY INTO SECURITIES PURCHASE AGREEMENT (Details) Sheet http://www.steviacorp.com/20121231/role/idr_ENTRYINTOSECURITIESPURCHASEAGREEMENTDetails ENTRY INTO SECURITIES PURCHASE AGREEMENT (Details) false false R47.htm 000540 - Statement - GARDEN STATE SECURTIES INC (Details) Sheet http://www.steviacorp.com/20121231/role/idr_GARDENSTATESECURTIESINCDetails GARDEN STATE SECURTIES INC (Details) false false R48.htm 000600 - Statement - SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details){Stockholder's Equity} Sheet http://www.steviacorp.com/20121231/role/idr_SUMMARYOFTHECOMPANYSWARRANTSACTIVITIESDetailsStockholderSEquity SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details) false false R49.htm 000610 - Statement - OUTSTANDING AND EXERCISABLE WARRANTS (Details) {Stockholder's Equity} Sheet http://www.steviacorp.com/20121231/role/idr_OUTSTANDINGANDEXERCISABLEWARRANTSDetailsStockholderSEquity OUTSTANDING AND EXERCISABLE WARRANTS (Details) false false R50.htm 000620 - Statement - NON-CONTROLLING INTEREST (Details) {Stockholder's Equity} Sheet http://www.steviacorp.com/20121231/role/idr_NONCONTROLLINGINTERESTDetailsStockholderSEquity NON-CONTROLLING INTEREST (Details) false false R51.htm 000630 - Statement - RESEARCH AND DEVELOPMENT PAYMENTS (Details) Sheet http://www.steviacorp.com/20121231/role/idr_RESEARCHANDDEVELOPMENTPAYMENTSDetails RESEARCH AND DEVELOPMENT PAYMENTS (Details) false false R52.htm 000640 - Statement - COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) Sheet http://www.steviacorp.com/20121231/role/idr_COMMITMENTSANDCONTINGENCIESCOMPENSATIONDetails COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) false false R53.htm 000650 - Statement - CONCENTRATIONS AND CREDIT RISK DURATION (Details) Sheet http://www.steviacorp.com/20121231/role/idr_CONCENTRATIONSANDCREDITRISKDURATIONDetails CONCENTRATIONS AND CREDIT RISK DURATION (Details) false false R54.htm 000660 - Statement - CONCENTRATIONS AND CREDIT RISK INSTANT (Details) Sheet http://www.steviacorp.com/20121231/role/idr_CONCENTRATIONSANDCREDITRISKINSTANTDetails CONCENTRATIONS AND CREDIT RISK INSTANT (Details) false false All Reports Book All Reports Error: The equity rendering routine did not create any data for 000610 - Statement - OUTSTANDING AND EXERCISABLE WARRANTS (Details) {Stockholder's Equity}. The equity statement will use the basic rendering. Process Flow-Through: 000020 - Statement - Consolidated Balance Sheets Process Flow-Through: 000030 - Statement - Consolidated Balance Sheets Parentheticals Process Flow-Through: 000040 - Statement - Consolidated Statements of Operations Process Flow-Through: 000060 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 000360 - Statement - ORGANIZATION AND OPERATIONS (Details) Process Flow-Through: 000370 - Statement - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) Process Flow-Through: 000380 - Statement - GOING CONCERN (Details) Process Flow-Through: 000390 - Statement - ENTITY'S ASSETS (Details) Process Flow-Through: 000400 - Statement - AMORTIZATION AND DEPRECIATION EXPENSE (Details) Process Flow-Through: 000420 - Statement - RELATED PARTY TRANSACTIONS FUTURE MINIMUM PAYMENTS (Details) Process Flow-Through: 000450 - Statement - CONVERTIBLE NOTES PAYABLE (Details) Process Flow-Through: 000460 - Statement - CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES (Details) Process Flow-Through: 000470 - Statement - SHARES AUTHORIZED AND TRANSACTION (Details) Process Flow-Through: 000480 - Statement - COMMON SHARES ISSUED FOR SERVICES (Details) Process Flow-Through: 000530 - Statement - ENTRY INTO SECURITIES PURCHASE AGREEMENT (Details) Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 000540 - Statement - GARDEN STATE SECURTIES INC (Details) Process Flow-Through: Removing column 'Aug. 06, 2012' Process Flow-Through: 000610 - Statement - OUTSTANDING AND EXERCISABLE WARRANTS (Details) {Stockholder's Equity} Process Flow-Through: 000630 - Statement - RESEARCH AND DEVELOPMENT PAYMENTS (Details) Process Flow-Through: 000640 - Statement - COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) Process Flow-Through: 000650 - Statement - CONCENTRATIONS AND CREDIT RISK DURATION (Details) Process Flow-Through: 000660 - Statement - CONCENTRATIONS AND CREDIT RISK INSTANT (Details) stev-20121231.xml stev-20121231.xsd stev-20121231_cal.xml stev-20121231_def.xml stev-20121231_lab.xml stev-20121231_pre.xml true true XML 67 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
GOING CONCERN (Details) (USD $)
Dec. 31, 2012
Mar. 31, 2012
Prepaid research and development $ 23,336 $ 128,445
Prepaid rent 0 21,250
Retainer 0 15,000
Other. 2,680 4,179
Total prepaid expenses $ 26,016 $ 168,874
XML 68 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Dec. 31, 2012
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES
NOTE 14 - COMMITMENTS AND CONTINGENCIES
 
SUPPLY  AGREEMENT - BETWEEN STEVIA VENTURES  INTERNATIONAL  LTD. AND ASIA STEVIA
INVESTMENT DEVELOPMENT COMPANY LTD.
 
On April 12, 2011,  Stevia  Ventures  International  Ltd, the  subsidiary of the
Company  entered  into a Supply  Agreement  (the "Supply  Agreement")  with Asia
Stevia Investment  Development Company Ltd ("ASID"), a foreign-invested  limited
liability company incorporated in Vietnam.
 
(I) SCOPE OF SERVICES
 
Under the terms of the Agreement,  the Company  engaged ASID to plant the Stevia
Seedlings  and supply the Products only to the Company to the exclusion of other
customers  and the Company is desirous  to purchase  the same,  on the terms and
conditions  as set out in  this  Agreement  produce  Products  and  the  Company
purchase the Products from ASID.
 
(II) TERM
 
This  Agreement  shall come into  force on the  Effective  Date and,  subject to
earlier  termination  pursuant to certain  clauses  specified in the  Agreement,
shall  continue in force for a period of three (3) years ("Term") and thereafter
automatically renew on its anniversary each year for an additional period of one
(1) year ("Extended Term").
 
(III) PURCHASE PRICE
 
ASID and the Company shall review and agree on or before  September 30th of each
Year on the  quantity of the  Products  to be  supplied  by the  Supplier to the
Company in the  forthcoming  year and ASID shall  provide the Company with prior
written  notice at any time  during the year  following  the  revision if it has
reason to believe that it would be unable to fulfill its forecast  volumes under
this clause.
 
SUPPLY  AGREEMENT  - BETWEEN  STEVIA  VENTURES  INTERNATIONAL  LTD.  AND  STEVIA
VENTURES CORPORATION
 
On April 12, 2011,  Stevia  Ventures  International  Ltd, the  subsidiary of the
Company also  entered into a Supply  Agreement  (the  "Supply  Agreement")  with
Stevia  Ventures  Corporation  ("SVC"),  a  foreign-invested  limited  liability
company incorporated in Vietnam.
 
(I) SCOPE OF SERVICES
 
Under the terms of the  Agreement,  the Company  engaged SVC to plant the Stevia
Seedlings  and supply the Products only to the Company to the exclusion of other
customers  and the Company is desirous  to purchase  the same,  on the terms and
conditions  as set out in  this  Agreement  produce  Products  and  the  Company
purchase the Products from SVC.
 
(II) TERM
 
This  Agreement  shall come into  force on the  Effective  Date and,  subject to
earlier  termination  pursuant to certain  clauses  specified in the  Agreement,
shall  continue in force for a period of three (3) years ("Term") and thereafter
automatically renew on its anniversary each year for an additional period of one
(1) year ("Extended Term").
 
(III) PURCHASE PRICE
 
SVC and the Company shall review and agree on or before  September  30th of each
Year on the  quantity of the  Products  to be  supplied  by the  Supplier to the
Company in the  forthcoming  year and SVC shall  provide the Company  with prior
written  notice at any time  during the year  following  the  revision if it has
reason to believe that it would be unable to fulfill its forecast  volumes under
this clause.
 
CONSULTING AGREEMENT - DORIAN BANKS
 
ENTRY INTO CONSULTING AGREEMENT
 
On July 1, 2011 the Company entered into a consulting agreement (the "Consulting
Agreement") with Dorian Banks ("Banks").
 
(I) SCOPE OF SERVICES
 
Under the terms of the Consulting Agreement,  the Company engaged the Consultant
to provide advice in general business development, strategy, assistance with new
business  and  land  acquisition,  introductions,  and  assistance  with  Public
Relations ("PR") and Investor Relations ("IR").
 
(II) TERM
 
The term of this Agreement  shall be six (6) months,  commencing on July 1, 2011
and continue until December 31, 2011. This Agreement may be terminated by either
the  Company or the  Consultant  at any time prior to the end of the  Consulting
Period by giving thirty (30) days written notice of termination. Such notice may
be given at any time for any reason, with or without cause. The Company will pay
Consultant  for  all  Service  performed  by  Consultant  through  the  date  of
termination.
 
(III) COMPENSATION
 
The Company shall pay the Consultant a fee of $3,000 per month.
 
EXTENSION OF THE CONSULTING AGREEMENT
 
On December 30, 2011, the Consulting  Agreement was extended with the same terms
and conditions to December 31, 2012.
 
SUMMARY OF THE CONSULTING FEES
 
For the interim period ended December 31, 2012 and for the period from April 11,
2011  (inception)  through  December 31, 2011, the Company  recorded $27,000 and
$18,000 in consulting fees under the Consulting Agreement, respectively.
 
FINANCING CONSULTING AGREEMENT - DAVID CLIFTON
 
ENTRY INTO FINANCIAL CONSULTING AGREEMENT
 
On July 1, 2011 the Company entered into a consulting agreement (the "Consulting
Agreement") with David Clifton ( "Clifton").
 
(I) SCOPE OF SERVICES
 
Under the terms of the  Consulting  Agreement,  the Company  engaged  Clifton to
introduce interested  investors to the Company,  advise the Company on available
financing  options and provide periodic updates on the stevia sector and provide
insights and strategies for the Company to undertake.
 
(II) TERM
 
The term of this Agreement  shall be six (6) months,  commencing on July 1, 2011
and  continuing  until  December 31, 2011.  This  Agreement may be terminated by
either the  Company  or  Clifton at any time prior to the end of the  consulting
period by giving thirty (30) days written notice of termination. Such notice may
be given at any time for any reason, with or without cause. The Company will pay
Clifton for all service performed by him through the date of termination.
 
On December 31, 2011, the financial consulting agreement expired.
 
(III) COMPENSATION
 
The Company shall pay Clifton a fee of $3,000 per month.
 
SUMMARY OF THE CONSULTING FEES
 
The financial  consulting agreement expired on December 31, 2011. For the period
from April 11, 2011 (inception)  through December 31, 2011, the Company recorded
$18,000 in financing cost under this Financing Consulting Agreement.
 
ENTRY INTO ENGAGEMENT AGREEMENT - GARDEN STATE SECURITIES INC.
 
On June  18,  2012,  the  Company  entered  into an  engagement  agreement  (the
"Agreement")  with Garden  State  Securities  Inc.  ("GSS")  with respect to the
engagement of GSS to act as a selling/placement agent for the Company.
 
(I) SCOPE OF SERVICES
 
Under the terms of the Agreement, the Company engaged GSS to review the business
and  operations  of the  Company  and its  historical  and  projected  financial
condition,  advise the Company of "best efforts" Private  Placement  offering of
debt or equity  securities to fulfill the Company's  business plan, and contacts
for the Company possible financing sources.
 
(II) TERM
 
GSS shall act as the Company's  exclusive  placement agent for the period of the
later of; (i) 60 days from the  execution  of the term sheet;  or (ii) the final
termination date of the securities financing (the "Exclusive Period"). GSS shall
act as the Company's  non-exclusive  placement agent after the Exclusive  Period
until terminated.
 
(III) COMPENSATION
 
The  Company  agrees to pay to GSS at each full or  incremental  closing  of any
equity financing,  convertible debt financing, debt conversion or any instrument
convertible into the Company's common stock (the "Securities  Financing") during
the  Exclusive  Period;  (i) a cash  transaction  fee in the amount of 8% of the
amount received by the Company under the Securities Financing; and (ii) warrants
(the "Warrants") with "piggy back" registration rights, equal to 8% of the stock
issued in the Securities  Financing at an exercise price equal to the investor's
warrant  exercise  price  of  the  Securities  Financing  or  the  price  of the
Securities  Financing if no warrants are issued to  investors.  The Company will
also pay,  at  closing,  the  expense of GSS's  legal  counsel  pursuant  to the
Securities  Financing  and/or  Shelf equal to $25,000 for  Securities  Financing
and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to
the Company,  and $18,000 for a Securities  Financing  and/or Shelf resulting in
less than $500,000 of gross  proceeds to the Company.  In addition,  the Company
shall cause,  at its cost and  expense,  the "Blue sky filing" and Form D in due
and proper form and substance and in a timely manner.